Query 021127
Match_columns 317
No_of_seqs 280 out of 2329
Neff 9.9
Searched_HMMs 46136
Date Fri Mar 29 07:48:52 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/021127.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/021127hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 KOG0615 Serine/threonine prote 100.0 7E-49 1.5E-53 335.0 17.9 229 23-253 171-440 (475)
2 KOG0192 Tyrosine kinase specif 100.0 2.9E-47 6.3E-52 336.0 24.8 243 15-260 32-309 (362)
3 KOG0575 Polo-like serine/threo 100.0 2.9E-47 6.3E-52 339.9 22.0 221 24-250 18-269 (592)
4 KOG0581 Mitogen-activated prot 100.0 4.6E-47 1E-51 321.0 19.9 225 19-252 74-337 (364)
5 KOG0598 Ribosomal protein S6 k 100.0 7.2E-46 1.6E-50 313.7 18.8 225 20-250 21-281 (357)
6 KOG0197 Tyrosine kinases [Sign 100.0 7.8E-46 1.7E-50 327.0 19.4 240 10-257 191-464 (468)
7 KOG0595 Serine/threonine-prote 100.0 3.2E-45 7E-50 312.7 17.5 221 24-250 10-268 (429)
8 KOG0661 MAPK related serine/th 100.0 1.2E-44 2.6E-49 314.0 11.5 225 20-251 6-292 (538)
9 KOG0583 Serine/threonine prote 100.0 1.6E-42 3.5E-47 308.5 22.7 230 21-252 14-277 (370)
10 KOG0198 MEKK and related serin 100.0 1.1E-42 2.5E-47 298.4 20.9 226 23-254 16-280 (313)
11 KOG0593 Predicted protein kina 100.0 6.9E-44 1.5E-48 293.6 11.3 221 24-250 2-284 (396)
12 KOG0591 NIMA (never in mitosis 100.0 2.7E-44 5.7E-49 293.3 5.6 226 23-253 18-284 (375)
13 KOG0193 Serine/threonine prote 100.0 1.7E-42 3.8E-47 308.5 15.9 236 16-257 384-656 (678)
14 KOG0592 3-phosphoinositide-dep 100.0 2.4E-42 5.2E-47 304.1 14.5 225 20-250 69-338 (604)
15 KOG0194 Protein tyrosine kinas 100.0 1E-40 2.2E-45 298.7 24.2 239 17-260 150-426 (474)
16 KOG0611 Predicted serine/threo 100.0 2.2E-42 4.9E-47 294.8 12.7 224 24-252 53-305 (668)
17 KOG0585 Ca2+/calmodulin-depend 100.0 3.5E-42 7.7E-47 298.6 13.8 232 21-256 94-378 (576)
18 KOG0588 Serine/threonine prote 100.0 4.8E-42 1E-46 308.3 15.1 224 24-252 12-265 (786)
19 KOG0659 Cdk activating kinase 100.0 2.5E-41 5.3E-46 273.9 16.5 227 24-258 2-287 (318)
20 cd05102 PTKc_VEGFR3 Catalytic 100.0 5.5E-41 1.2E-45 299.3 20.1 233 18-256 1-336 (338)
21 KOG0582 Ste20-like serine/thre 100.0 5.4E-41 1.2E-45 289.4 18.8 234 12-250 14-293 (516)
22 KOG0605 NDR and related serine 100.0 6E-41 1.3E-45 295.2 19.2 225 20-251 137-446 (550)
23 KOG0600 Cdc2-related protein k 100.0 1.2E-41 2.6E-46 297.4 14.5 222 23-250 116-400 (560)
24 KOG0578 p21-activated serine/t 100.0 1.6E-41 3.6E-46 300.8 13.3 217 24-250 273-523 (550)
25 KOG1187 Serine/threonine prote 100.0 3.8E-40 8.2E-45 292.7 19.9 225 24-255 75-353 (361)
26 KOG0616 cAMP-dependent protein 100.0 7E-41 1.5E-45 275.0 13.8 220 23-250 43-297 (355)
27 KOG0663 Protein kinase PITSLRE 100.0 9.6E-41 2.1E-45 278.3 13.7 226 24-257 76-366 (419)
28 PTZ00263 protein kinase A cata 100.0 6.5E-40 1.4E-44 291.2 19.8 222 22-251 16-272 (329)
29 KOG4721 Serine/threonine prote 100.0 5E-41 1.1E-45 297.0 11.7 226 14-254 114-368 (904)
30 cd05104 PTKc_Kit Catalytic dom 100.0 1.1E-39 2.5E-44 294.4 20.7 246 3-254 14-374 (375)
31 KOG0589 Serine/threonine prote 100.0 8.3E-40 1.8E-44 287.8 18.5 223 24-250 4-258 (426)
32 cd05626 STKc_LATS2 Catalytic d 100.0 6.5E-39 1.4E-43 290.3 24.2 222 24-251 1-306 (381)
33 cd05631 STKc_GRK4 Catalytic do 100.0 4E-39 8.7E-44 280.5 21.7 223 25-251 1-262 (285)
34 KOG0597 Serine-threonine prote 100.0 1.4E-40 2.9E-45 294.1 12.5 219 24-250 2-251 (808)
35 PHA02988 hypothetical protein; 100.0 4.6E-39 9.9E-44 279.8 21.8 235 14-255 8-280 (283)
36 KOG0580 Serine/threonine prote 100.0 7.9E-41 1.7E-45 267.1 9.7 225 24-253 22-276 (281)
37 cd05571 STKc_PKB Catalytic dom 100.0 2.7E-39 5.9E-44 286.5 20.5 215 30-250 1-251 (323)
38 cd05106 PTKc_CSF-1R Catalytic 100.0 3.8E-39 8.2E-44 290.8 20.1 243 7-255 21-373 (374)
39 KOG1026 Nerve growth factor re 100.0 1.4E-39 3E-44 301.0 17.3 236 18-258 480-766 (774)
40 cd05096 PTKc_DDR1 Catalytic do 100.0 1.2E-38 2.7E-43 280.0 21.9 226 21-252 2-303 (304)
41 cd05105 PTKc_PDGFR_alpha Catal 100.0 1.2E-38 2.7E-43 289.0 22.2 239 12-256 25-399 (400)
42 cd05614 STKc_MSK2_N N-terminal 100.0 9.8E-39 2.1E-43 284.1 20.8 223 25-251 1-268 (332)
43 KOG0201 Serine/threonine prote 100.0 1.3E-40 2.8E-45 286.6 8.2 222 21-250 10-263 (467)
44 cd05601 STKc_CRIK Catalytic do 100.0 3.5E-38 7.5E-43 280.3 23.2 223 24-251 1-264 (330)
45 KOG4257 Focal adhesion tyrosin 100.0 4.3E-39 9.3E-44 287.3 17.2 234 17-256 382-651 (974)
46 cd05573 STKc_ROCK_NDR_like Cat 100.0 1E-38 2.2E-43 285.9 19.9 221 24-251 1-286 (350)
47 cd05612 STKc_PRKX_like Catalyt 100.0 2.1E-39 4.5E-44 283.2 15.0 221 24-252 1-256 (291)
48 cd05575 STKc_SGK Catalytic dom 100.0 3E-38 6.6E-43 279.8 22.5 215 30-250 1-251 (323)
49 cd05595 STKc_PKB_beta Catalyti 100.0 2.3E-38 4.9E-43 280.6 21.5 215 30-250 1-251 (323)
50 KOG0196 Tyrosine kinase, EPH ( 100.0 5.2E-39 1.1E-43 293.1 17.6 234 19-258 624-895 (996)
51 cd05593 STKc_PKB_gamma Catalyt 100.0 4.5E-38 9.8E-43 279.2 23.4 216 30-251 1-252 (328)
52 KOG0660 Mitogen-activated prot 100.0 1.7E-39 3.6E-44 274.1 13.1 221 23-250 21-310 (359)
53 cd05603 STKc_SGK2 Catalytic do 100.0 3E-38 6.5E-43 279.6 21.8 210 30-245 1-242 (321)
54 KOG0658 Glycogen synthase kina 100.0 1.9E-39 4.2E-44 274.2 13.4 216 25-250 25-306 (364)
55 KOG1989 ARK protein kinase fam 100.0 3.6E-38 7.8E-43 292.7 23.0 238 17-260 30-317 (738)
56 cd05598 STKc_LATS Catalytic do 100.0 3.7E-38 8.1E-43 285.0 22.5 222 24-252 1-303 (376)
57 cd05600 STKc_Sid2p_Dbf2p Catal 100.0 1.8E-38 3.8E-43 282.5 19.9 220 24-251 1-258 (333)
58 cd05064 PTKc_EphR_A10 Catalyti 100.0 2.9E-38 6.2E-43 272.4 20.2 228 21-254 2-265 (266)
59 PTZ00426 cAMP-dependent protei 100.0 1.5E-38 3.2E-43 283.4 18.8 228 16-251 22-285 (340)
60 KOG1095 Protein tyrosine kinas 100.0 3.6E-38 7.9E-43 301.2 22.3 235 20-260 688-967 (1025)
61 cd05599 STKc_NDR_like Catalyti 100.0 3.8E-38 8.3E-43 283.7 21.0 221 24-251 1-297 (364)
62 cd05584 STKc_p70S6K Catalytic 100.0 3.1E-38 6.6E-43 279.8 20.1 218 29-251 1-257 (323)
63 KOG0032 Ca2+/calmodulin-depend 100.0 2.3E-38 5E-43 281.8 19.0 226 22-252 33-295 (382)
64 cd05596 STKc_ROCK Catalytic do 100.0 8E-38 1.7E-42 281.9 22.6 228 18-251 37-305 (370)
65 cd05072 PTKc_Lyn Catalytic dom 100.0 6.8E-38 1.5E-42 269.2 21.0 228 19-254 1-261 (261)
66 cd05071 PTKc_Src Catalytic dom 100.0 6E-38 1.3E-42 269.8 20.4 229 19-255 1-261 (262)
67 KOG0610 Putative serine/threon 100.0 1.4E-38 3E-43 272.3 15.5 230 17-250 70-392 (459)
68 cd05582 STKc_RSK_N N-terminal 100.0 4.8E-38 1E-42 278.0 19.5 215 29-250 1-254 (318)
69 cd07871 STKc_PCTAIRE3 Catalyti 100.0 3.2E-38 6.9E-43 275.3 17.8 221 23-250 4-285 (288)
70 cd05625 STKc_LATS1 Catalytic d 100.0 1.4E-37 3E-42 281.9 22.6 220 24-250 1-305 (382)
71 KOG0033 Ca2+/calmodulin-depend 100.0 1.3E-40 2.7E-45 267.0 2.4 226 22-252 9-269 (355)
72 cd05629 STKc_NDR_like_fungal C 100.0 2.1E-37 4.6E-42 280.1 23.8 221 24-251 1-306 (377)
73 cd05594 STKc_PKB_alpha Catalyt 100.0 1.5E-37 3.2E-42 275.7 22.3 216 30-251 1-253 (325)
74 cd05628 STKc_NDR1 Catalytic do 100.0 2.1E-37 4.6E-42 278.7 23.5 221 24-250 1-293 (363)
75 KOG0577 Serine/threonine prote 100.0 3.4E-39 7.4E-44 286.5 11.5 218 25-250 27-278 (948)
76 cd06649 PKc_MEK2 Catalytic dom 100.0 1.2E-37 2.6E-42 277.0 21.4 223 21-252 2-303 (331)
77 cd05602 STKc_SGK1 Catalytic do 100.0 1.4E-37 3E-42 275.8 21.6 211 30-246 1-243 (325)
78 cd05052 PTKc_Abl Catalytic dom 100.0 1.1E-37 2.4E-42 268.2 20.3 228 19-254 1-262 (263)
79 cd05585 STKc_YPK1_like Catalyt 100.0 1.6E-37 3.5E-42 273.9 21.6 213 32-250 1-247 (312)
80 cd05589 STKc_PKN Catalytic dom 100.0 1.4E-37 3E-42 275.7 21.3 219 26-251 1-258 (324)
81 cd05107 PTKc_PDGFR_beta Cataly 100.0 1.7E-37 3.6E-42 281.5 22.0 241 9-255 22-400 (401)
82 cd05592 STKc_nPKC_theta_delta 100.0 6.7E-38 1.4E-42 276.8 18.9 215 30-250 1-248 (316)
83 cd05605 STKc_GRK4_like Catalyt 100.0 9.3E-38 2E-42 272.0 19.3 222 25-250 1-261 (285)
84 cd05570 STKc_PKC Catalytic dom 100.0 5.6E-38 1.2E-42 277.5 18.1 215 30-250 1-252 (318)
85 cd05054 PTKc_VEGFR Catalytic d 100.0 8.9E-38 1.9E-42 278.2 19.5 233 18-256 1-335 (337)
86 KOG0694 Serine/threonine prote 100.0 2.5E-38 5.4E-43 286.0 16.0 224 20-250 364-624 (694)
87 cd05070 PTKc_Fyn_Yrk Catalytic 100.0 1.6E-37 3.4E-42 266.8 20.3 227 19-253 1-259 (260)
88 cd05108 PTKc_EGFR Catalytic do 100.0 1.7E-37 3.7E-42 274.2 20.9 230 21-257 4-271 (316)
89 KOG0594 Protein kinase PCTAIRE 100.0 1.9E-38 4E-43 268.3 13.9 223 23-250 10-302 (323)
90 cd05621 STKc_ROCK2 Catalytic d 100.0 2.1E-37 4.5E-42 279.0 21.6 229 18-252 37-306 (370)
91 cd05053 PTKc_FGFR Catalytic do 100.0 5.3E-37 1.2E-41 268.1 23.5 235 15-255 3-292 (293)
92 cd07869 STKc_PFTAIRE1 Catalyti 100.0 8.3E-38 1.8E-42 274.6 18.5 221 23-250 4-288 (303)
93 KOG0599 Phosphorylase kinase g 100.0 6.4E-39 1.4E-43 261.0 10.3 227 24-253 17-286 (411)
94 cd05604 STKc_SGK3 Catalytic do 100.0 3E-37 6.5E-42 273.7 22.1 215 30-250 1-251 (325)
95 cd05067 PTKc_Lck_Blk Catalytic 100.0 2.1E-37 4.6E-42 266.0 20.2 227 19-253 1-259 (260)
96 cd05098 PTKc_FGFR1 Catalytic d 100.0 5E-37 1.1E-41 270.2 22.8 243 10-258 4-303 (307)
97 cd05039 PTKc_Csk_like Catalyti 100.0 3.3E-37 7.2E-42 264.1 20.6 225 19-253 1-255 (256)
98 PLN00034 mitogen-activated pro 100.0 1.1E-37 2.5E-42 279.5 18.3 220 21-251 71-329 (353)
99 PF07714 Pkinase_Tyr: Protein 100.0 8.5E-38 1.8E-42 268.5 16.7 219 27-251 2-259 (259)
100 cd07862 STKc_CDK6 Catalytic do 100.0 1.9E-37 4.2E-42 270.5 19.2 221 24-250 1-287 (290)
101 cd05033 PTKc_EphR Catalytic do 100.0 5.8E-37 1.3E-41 264.2 22.0 227 21-254 1-265 (266)
102 cd07848 STKc_CDKL5 Catalytic d 100.0 1.5E-37 3.3E-42 270.7 18.0 220 24-250 1-284 (287)
103 cd05082 PTKc_Csk Catalytic dom 100.0 4E-37 8.6E-42 263.7 20.3 224 19-253 1-255 (256)
104 KOG2345 Serine/threonine prote 100.0 1E-37 2.2E-42 250.5 15.3 234 16-255 13-301 (302)
105 cd05048 PTKc_Ror Catalytic Dom 100.0 2.4E-37 5.2E-42 268.9 19.1 228 21-254 2-283 (283)
106 cd05101 PTKc_FGFR2 Catalytic d 100.0 5.8E-37 1.3E-41 269.3 21.7 239 13-257 4-299 (304)
107 cd05062 PTKc_IGF-1R Catalytic 100.0 4.2E-37 9.2E-42 266.6 20.4 228 19-252 1-276 (277)
108 cd05069 PTKc_Yes Catalytic dom 100.0 4.4E-37 9.6E-42 264.1 20.3 228 19-253 1-259 (260)
109 cd05587 STKc_cPKC Catalytic do 100.0 2.9E-37 6.2E-42 273.7 19.5 220 25-250 1-257 (324)
110 cd06625 STKc_MEKK3_like Cataly 100.0 6.1E-37 1.3E-41 263.4 20.9 225 23-251 1-261 (263)
111 cd05588 STKc_aPKC Catalytic do 100.0 3.6E-37 7.8E-42 273.6 19.9 215 30-250 1-262 (329)
112 cd05620 STKc_nPKC_delta Cataly 100.0 1.6E-37 3.5E-42 274.3 17.5 215 30-250 1-248 (316)
113 cd07859 STKc_TDY_MAPK_plant Ca 100.0 2.5E-37 5.4E-42 275.5 18.8 219 25-250 1-290 (338)
114 cd05114 PTKc_Tec_Rlk Catalytic 100.0 6.8E-37 1.5E-41 262.3 20.8 222 21-251 1-255 (256)
115 cd05099 PTKc_FGFR4 Catalytic d 100.0 1.2E-36 2.6E-41 268.6 22.9 238 15-258 3-297 (314)
116 cd05032 PTKc_InsR_like Catalyt 100.0 7.7E-37 1.7E-41 264.8 21.0 228 19-252 1-276 (277)
117 cd05622 STKc_ROCK1 Catalytic d 100.0 6.7E-37 1.5E-41 275.9 21.2 229 18-252 37-306 (371)
118 cd05618 STKc_aPKC_iota Catalyt 100.0 1.4E-36 3E-41 269.8 22.9 215 30-250 1-262 (329)
119 KOG4279 Serine/threonine prote 100.0 1.7E-37 3.6E-42 280.2 17.0 214 31-250 582-832 (1226)
120 cd06650 PKc_MEK1 Catalytic dom 100.0 6.1E-37 1.3E-41 272.5 20.5 171 21-199 2-176 (333)
121 cd05100 PTKc_FGFR3 Catalytic d 100.0 2.4E-36 5.2E-41 268.9 24.2 238 16-259 4-298 (334)
122 PHA03212 serine/threonine kina 100.0 4.3E-37 9.3E-42 278.6 19.6 215 21-251 89-377 (391)
123 PTZ00036 glycogen synthase kin 100.0 3.3E-37 7.2E-42 283.5 19.1 222 21-252 63-353 (440)
124 cd05068 PTKc_Frk_like Catalyti 100.0 1E-36 2.2E-41 261.9 20.8 227 19-253 1-260 (261)
125 cd05103 PTKc_VEGFR2 Catalytic 100.0 5.1E-37 1.1E-41 274.1 19.6 234 18-257 1-342 (343)
126 cd05591 STKc_nPKC_epsilon Cata 100.0 1.7E-36 3.6E-41 268.5 22.5 216 30-251 1-255 (321)
127 cd05616 STKc_cPKC_beta Catalyt 100.0 1.8E-36 3.9E-41 268.5 22.7 220 25-250 1-257 (323)
128 PTZ00267 NIMA-related protein 100.0 7.4E-37 1.6E-41 284.1 21.1 221 23-250 66-323 (478)
129 cd05148 PTKc_Srm_Brk Catalytic 100.0 2.9E-37 6.3E-42 265.2 16.9 228 19-253 1-260 (261)
130 cd05586 STKc_Sck1_like Catalyt 100.0 1.9E-36 4.2E-41 269.1 22.7 215 32-251 1-254 (330)
131 cd05055 PTKc_PDGFR Catalytic d 100.0 1.4E-36 3.1E-41 266.6 21.2 240 9-254 20-301 (302)
132 KOG4717 Serine/threonine prote 100.0 1.2E-37 2.6E-42 272.9 14.0 225 24-252 18-272 (864)
133 cd05590 STKc_nPKC_eta Catalyti 100.0 3.7E-37 8E-42 272.5 17.1 215 30-250 1-253 (320)
134 PTZ00283 serine/threonine prot 100.0 9.8E-37 2.1E-41 283.7 20.8 226 20-250 28-297 (496)
135 cd05090 PTKc_Ror1 Catalytic do 100.0 1.9E-36 4.1E-41 263.4 21.3 227 22-254 3-283 (283)
136 cd05617 STKc_aPKC_zeta Catalyt 100.0 3.5E-36 7.6E-41 267.1 23.3 215 30-250 1-260 (327)
137 cd05061 PTKc_InsR Catalytic do 100.0 1.8E-36 3.9E-41 264.2 21.0 231 19-255 1-279 (288)
138 cd05607 STKc_GRK7 Catalytic do 100.0 7.1E-37 1.5E-41 265.3 18.4 214 32-249 1-249 (277)
139 cd08219 STKc_Nek3 Catalytic do 100.0 4.6E-36 1E-40 256.9 23.0 220 25-250 1-252 (255)
140 cd05116 PTKc_Syk Catalytic dom 100.0 1.9E-36 4.2E-41 259.6 20.5 217 31-254 2-255 (257)
141 cd05109 PTKc_HER2 Catalytic do 100.0 2.4E-36 5.1E-41 262.2 21.2 230 21-257 4-271 (279)
142 cd05083 PTKc_Chk Catalytic dom 100.0 1.1E-36 2.5E-41 260.6 18.8 223 19-252 1-252 (254)
143 cd05073 PTKc_Hck Catalytic dom 100.0 4E-36 8.6E-41 258.2 22.2 227 19-253 1-259 (260)
144 cd05113 PTKc_Btk_Bmx Catalytic 100.0 1.5E-36 3.3E-41 260.2 19.5 222 21-251 1-255 (256)
145 cd05088 PTKc_Tie2 Catalytic do 100.0 3.9E-36 8.5E-41 264.0 22.4 232 21-258 4-284 (303)
146 cd05111 PTK_HER3 Pseudokinase 100.0 2.6E-36 5.6E-41 262.1 20.8 229 21-256 4-270 (279)
147 cd08228 STKc_Nek6 Catalytic do 100.0 2.6E-36 5.7E-41 260.1 20.6 227 24-254 2-265 (267)
148 cd05630 STKc_GRK6 Catalytic do 100.0 1.6E-36 3.4E-41 264.2 19.1 224 25-252 1-263 (285)
149 cd06646 STKc_MAP4K5 Catalytic 100.0 1.6E-36 3.4E-41 261.5 19.0 222 22-251 7-266 (267)
150 cd05034 PTKc_Src_like Catalyti 100.0 3.3E-36 7.1E-41 258.6 20.8 227 19-253 1-260 (261)
151 cd05051 PTKc_DDR Catalytic dom 100.0 4.1E-36 9E-41 262.8 21.8 225 22-252 3-295 (296)
152 cd05608 STKc_GRK1 Catalytic do 100.0 2.6E-36 5.7E-41 262.1 20.3 215 32-250 1-257 (280)
153 cd05093 PTKc_TrkB Catalytic do 100.0 3.5E-36 7.5E-41 262.4 21.1 230 21-257 2-282 (288)
154 cd05597 STKc_DMPK_like Catalyt 100.0 7.2E-36 1.6E-40 265.5 23.5 224 24-251 1-267 (331)
155 KOG1094 Discoidin domain recep 100.0 4.8E-37 1E-41 272.5 15.6 240 9-254 523-804 (807)
156 cd05056 PTKc_FAK Catalytic dom 100.0 4.7E-36 1E-40 259.1 21.6 230 20-256 2-267 (270)
157 cd05091 PTKc_Ror2 Catalytic do 100.0 1.2E-36 2.6E-41 264.5 18.0 228 21-254 2-283 (283)
158 KOG0586 Serine/threonine prote 100.0 1E-36 2.2E-41 272.7 17.4 224 24-253 56-309 (596)
159 cd05619 STKc_nPKC_theta Cataly 100.0 3.4E-36 7.5E-41 265.8 20.7 215 30-250 1-248 (316)
160 cd05079 PTKc_Jak1_rpt2 Catalyt 100.0 6.1E-36 1.3E-40 260.3 22.0 226 22-254 2-283 (284)
161 cd07876 STKc_JNK2 Catalytic do 100.0 3.4E-36 7.3E-41 270.6 21.0 221 22-252 19-317 (359)
162 cd05059 PTKc_Tec_like Catalyti 100.0 2.8E-36 6.1E-41 258.5 19.5 222 21-251 1-255 (256)
163 cd07872 STKc_PCTAIRE2 Catalyti 100.0 1.6E-36 3.4E-41 267.2 18.4 222 23-251 5-287 (309)
164 cd05115 PTKc_Zap-70 Catalytic 100.0 6E-36 1.3E-40 256.7 21.2 217 31-254 2-255 (257)
165 cd05627 STKc_NDR2 Catalytic do 100.0 3E-36 6.4E-41 271.0 20.1 220 24-250 1-293 (360)
166 cd08529 STKc_FA2-like Catalyti 100.0 6.3E-36 1.4E-40 255.9 21.2 221 25-250 1-253 (256)
167 PF00069 Pkinase: Protein kina 100.0 6.5E-37 1.4E-41 262.6 14.9 219 26-250 1-257 (260)
168 cd05084 PTKc_Fes Catalytic dom 100.0 5.6E-36 1.2E-40 255.9 20.7 216 30-252 1-251 (252)
169 KOG0579 Ste20-like serine/thre 100.0 3E-38 6.6E-43 282.5 6.7 221 24-251 32-290 (1187)
170 cd05081 PTKc_Jak2_Jak3_rpt2 Ca 100.0 6.9E-36 1.5E-40 259.9 21.4 225 22-254 2-283 (284)
171 KOG4278 Protein tyrosine kinas 100.0 3.2E-37 6.9E-42 275.4 13.1 232 17-257 260-526 (1157)
172 cd05066 PTKc_EphR_A Catalytic 100.0 7.1E-36 1.5E-40 257.6 21.1 227 21-254 1-266 (267)
173 cd05623 STKc_MRCK_alpha Cataly 100.0 1.6E-35 3.5E-40 263.4 23.9 223 24-250 1-266 (332)
174 cd05089 PTKc_Tie1 Catalytic do 100.0 9.9E-36 2.2E-40 260.7 22.1 231 24-260 2-281 (297)
175 cd05632 STKc_GRK5 Catalytic do 100.0 5.1E-36 1.1E-40 261.0 20.1 222 25-250 1-261 (285)
176 cd08220 STKc_Nek8 Catalytic do 100.0 5.9E-36 1.3E-40 256.2 20.2 222 25-250 1-253 (256)
177 cd05080 PTKc_Tyk2_rpt2 Catalyt 100.0 1.2E-35 2.7E-40 258.2 22.5 222 24-254 3-281 (283)
178 cd05624 STKc_MRCK_beta Catalyt 100.0 2.3E-35 4.9E-40 262.3 24.2 224 24-251 1-267 (331)
179 cd05049 PTKc_Trk Catalytic dom 100.0 4.2E-36 9.2E-41 260.6 19.1 226 21-252 2-279 (280)
180 PTZ00266 NIMA-related protein 100.0 9.3E-36 2E-40 287.4 23.3 227 21-250 10-295 (1021)
181 cd07863 STKc_CDK4 Catalytic do 100.0 3.2E-36 6.9E-41 262.5 18.1 220 25-250 1-285 (288)
182 cd05065 PTKc_EphR_B Catalytic 100.0 1.3E-35 2.7E-40 256.2 21.7 227 21-254 1-268 (269)
183 cd05097 PTKc_DDR_like Catalyti 100.0 6.2E-36 1.3E-40 261.7 19.9 226 21-252 2-294 (295)
184 cd08221 STKc_Nek9 Catalytic do 100.0 1.4E-35 2.9E-40 254.1 21.6 222 25-251 1-254 (256)
185 cd05094 PTKc_TrkC Catalytic do 100.0 1.3E-35 2.8E-40 259.2 21.1 230 21-257 2-285 (291)
186 KOG0667 Dual-specificity tyros 100.0 1.4E-35 3E-40 267.7 21.3 172 25-205 187-368 (586)
187 cd07853 STKc_NLK Catalytic dom 100.0 2E-36 4.4E-41 273.2 16.1 221 25-252 1-290 (372)
188 cd05045 PTKc_RET Catalytic dom 100.0 1.5E-35 3.3E-40 258.6 21.1 226 25-256 1-288 (290)
189 cd06644 STKc_STK10_LOK Catalyt 100.0 1.3E-35 2.9E-40 259.2 20.6 226 18-250 6-269 (292)
190 PHA03209 serine/threonine kina 100.0 3.1E-36 6.8E-41 270.4 16.8 166 21-200 63-231 (357)
191 cd05043 PTK_Ryk Pseudokinase d 100.0 2.3E-35 5.1E-40 256.0 21.8 232 20-257 2-279 (280)
192 KOG0574 STE20-like serine/thre 100.0 3.2E-38 6.9E-43 260.3 3.5 217 24-250 33-283 (502)
193 cd05060 PTKc_Syk_like Catalyti 100.0 2.2E-35 4.7E-40 253.1 21.2 217 30-254 1-255 (257)
194 cd08223 STKc_Nek4 Catalytic do 100.0 2.1E-35 4.5E-40 253.0 21.0 221 25-250 1-254 (257)
195 cd06645 STKc_MAP4K3 Catalytic 100.0 6.6E-36 1.4E-40 257.6 17.9 221 22-250 7-265 (267)
196 cd05615 STKc_cPKC_alpha Cataly 100.0 6.1E-36 1.3E-40 265.0 18.1 220 25-250 1-257 (323)
197 cd08229 STKc_Nek7 Catalytic do 100.0 1.1E-35 2.4E-40 256.2 19.1 227 24-254 2-265 (267)
198 PRK13184 pknD serine/threonine 100.0 1.3E-35 2.8E-40 285.2 21.4 230 24-257 2-293 (932)
199 cd07878 STKc_p38beta_MAPK11 Ca 100.0 6.4E-36 1.4E-40 267.1 18.1 219 23-251 14-299 (343)
200 cd06632 STKc_MEKK1_plant Catal 100.0 1.5E-35 3.3E-40 253.8 19.7 223 25-250 1-255 (258)
201 cd05050 PTKc_Musk Catalytic do 100.0 1.3E-35 2.8E-40 258.8 19.3 226 21-252 2-287 (288)
202 cd05057 PTKc_EGFR_like Catalyt 100.0 3.9E-35 8.5E-40 254.6 22.2 230 20-256 3-270 (279)
203 cd07861 STKc_CDK1_euk Catalyti 100.0 1E-35 2.3E-40 258.8 18.3 221 25-250 1-282 (285)
204 cd07874 STKc_JNK3 Catalytic do 100.0 5.1E-36 1.1E-40 269.0 16.6 220 22-251 15-312 (355)
205 cd05092 PTKc_TrkA Catalytic do 100.0 1.9E-35 4.1E-40 256.7 19.6 225 21-252 2-279 (280)
206 cd05580 STKc_PKA Catalytic dom 100.0 1.7E-35 3.6E-40 258.4 19.3 219 24-250 1-254 (290)
207 cd05035 PTKc_Axl_like Catalyti 100.0 4.3E-35 9.4E-40 253.1 21.7 224 26-254 1-272 (273)
208 cd05077 PTK_Jak1_rpt1 Pseudoki 100.0 2.2E-35 4.7E-40 253.9 19.7 212 30-251 1-261 (262)
209 cd07875 STKc_JNK1 Catalytic do 100.0 1.3E-35 2.9E-40 267.2 19.0 220 22-251 22-319 (364)
210 cd08224 STKc_Nek6_Nek7 Catalyt 100.0 4.7E-35 1E-39 252.1 21.6 227 24-254 2-265 (267)
211 cd06637 STKc_TNIK Catalytic do 100.0 1.8E-35 4E-40 255.5 19.1 221 23-250 5-269 (272)
212 cd00192 PTKc Catalytic domain 100.0 2.7E-35 5.8E-40 252.5 20.0 216 30-251 1-261 (262)
213 cd06643 STKc_SLK Catalytic dom 100.0 3.9E-35 8.4E-40 255.0 21.1 221 24-251 5-263 (282)
214 cd05075 PTKc_Axl Catalytic dom 100.0 2.9E-35 6.3E-40 254.2 20.0 224 26-254 1-271 (272)
215 cd05036 PTKc_ALK_LTK Catalytic 100.0 2.9E-35 6.2E-40 255.2 20.0 227 21-252 3-276 (277)
216 KOG0604 MAP kinase-activated p 100.0 5.6E-37 1.2E-41 252.5 8.6 239 24-272 61-344 (400)
217 cd05095 PTKc_DDR2 Catalytic do 100.0 4.7E-35 1E-39 256.3 21.1 226 21-252 2-295 (296)
218 cd07847 STKc_CDKL1_4 Catalytic 100.0 2.5E-35 5.5E-40 256.4 19.3 221 24-250 1-283 (286)
219 cd06631 STKc_YSK4 Catalytic do 100.0 4.7E-35 1E-39 252.1 20.7 222 25-250 1-262 (265)
220 cd05063 PTKc_EphR_A2 Catalytic 100.0 4.9E-35 1.1E-39 252.4 20.9 227 21-254 2-267 (268)
221 cd05076 PTK_Tyk2_rpt1 Pseudoki 100.0 2.3E-35 5E-40 255.5 18.6 212 31-251 2-273 (274)
222 cd05046 PTK_CCK4 Pseudokinase 100.0 3.8E-35 8.3E-40 254.0 20.0 226 21-252 2-274 (275)
223 KOG0199 ACK and related non-re 100.0 3.4E-36 7.3E-41 271.8 13.8 231 14-249 100-367 (1039)
224 cd06611 STKc_SLK_like Catalyti 100.0 2E-35 4.3E-40 256.5 17.9 221 23-250 4-262 (280)
225 cd08218 STKc_Nek1 Catalytic do 100.0 5.4E-35 1.2E-39 250.3 20.3 221 25-250 1-253 (256)
226 cd06619 PKc_MKK5 Catalytic dom 100.0 3.9E-35 8.5E-40 254.6 19.7 216 24-252 1-255 (279)
227 cd06651 STKc_MEKK3 Catalytic d 100.0 5.9E-35 1.3E-39 251.7 20.6 223 23-250 1-261 (266)
228 KOG0690 Serine/threonine prote 100.0 2.2E-36 4.7E-41 251.7 11.1 243 2-250 140-424 (516)
229 cd06615 PKc_MEK Catalytic doma 100.0 5.5E-35 1.2E-39 257.3 20.8 220 24-252 1-289 (308)
230 cd06628 STKc_MAPKKK_Byr2_like 100.0 6.1E-35 1.3E-39 251.5 20.6 222 25-250 1-264 (267)
231 cd07873 STKc_PCTAIRE1 Catalyti 100.0 1.8E-35 4E-40 259.5 17.4 222 23-251 5-287 (301)
232 cd06652 STKc_MEKK2 Catalytic d 100.0 5.5E-35 1.2E-39 251.7 20.0 223 23-250 1-261 (265)
233 cd06654 STKc_PAK1 Catalytic do 100.0 6.4E-35 1.4E-39 255.5 20.7 218 23-250 19-270 (296)
234 cd05078 PTK_Jak2_Jak3_rpt1 Pse 100.0 1.1E-35 2.3E-40 255.2 15.4 213 30-251 1-257 (258)
235 cd06655 STKc_PAK2 Catalytic do 100.0 1.1E-34 2.5E-39 253.9 22.2 218 24-251 19-270 (296)
236 cd07841 STKc_CDK7 Catalytic do 100.0 2.6E-35 5.7E-40 258.0 18.0 223 25-250 1-282 (298)
237 cd05112 PTKc_Itk Catalytic dom 100.0 8.6E-35 1.9E-39 249.1 20.7 222 21-251 1-255 (256)
238 cd06638 STKc_myosinIIIA Cataly 100.0 8E-35 1.7E-39 253.4 20.6 224 21-251 15-284 (286)
239 cd05047 PTKc_Tie Catalytic dom 100.0 1.3E-34 2.8E-39 250.2 21.4 220 30-255 1-269 (270)
240 cd06636 STKc_MAP4K4_6 Catalyti 100.0 6.2E-35 1.3E-39 253.6 19.3 222 22-250 14-279 (282)
241 cd06613 STKc_MAP4K3_like Catal 100.0 7.8E-35 1.7E-39 250.0 19.6 220 23-250 2-260 (262)
242 cd05038 PTKc_Jak_rpt2 Catalyti 100.0 1.4E-34 3.1E-39 251.4 21.3 225 23-254 3-283 (284)
243 cd07868 STKc_CDK8 Catalytic do 100.0 4E-35 8.7E-40 259.2 18.0 164 29-200 6-190 (317)
244 cd08227 PK_STRAD_alpha Pseudok 100.0 6.3E-35 1.4E-39 259.1 19.3 168 28-199 2-182 (327)
245 cd05085 PTKc_Fer Catalytic dom 100.0 1.6E-34 3.4E-39 246.6 20.9 216 30-252 1-249 (250)
246 cd07839 STKc_CDK5 Catalytic do 100.0 1.4E-35 3E-40 257.9 14.6 220 25-250 1-281 (284)
247 cd06610 STKc_OSR1_SPAK Catalyt 100.0 1.6E-34 3.4E-39 248.8 20.9 222 24-250 1-264 (267)
248 cd05087 PTKc_Aatyk1_Aatyk3 Cat 100.0 1.9E-34 4.2E-39 248.9 21.2 217 30-252 1-268 (269)
249 cd07832 STKc_CCRK Catalytic do 100.0 5.3E-35 1.1E-39 254.4 17.8 220 25-250 1-282 (286)
250 cd06656 STKc_PAK3 Catalytic do 100.0 8.9E-35 1.9E-39 254.7 19.4 217 24-250 19-269 (297)
251 cd08217 STKc_Nek2 Catalytic do 100.0 1E-34 2.2E-39 249.5 19.3 221 25-250 1-262 (265)
252 cd06612 STKc_MST1_2 Catalytic 100.0 7.6E-35 1.7E-39 249.2 18.3 218 23-250 2-253 (256)
253 cd05058 PTKc_Met_Ron Catalytic 100.0 2.2E-34 4.8E-39 247.4 21.1 220 30-256 1-261 (262)
254 cd05578 STKc_Yank1 Catalytic d 100.0 3.6E-35 7.7E-40 251.8 16.0 220 25-250 1-255 (258)
255 cd05574 STKc_phototropin_like 100.0 1E-34 2.2E-39 256.4 19.3 223 24-250 1-289 (316)
256 PHA03211 serine/threonine kina 100.0 4.6E-35 1E-39 268.9 17.6 163 23-199 168-336 (461)
257 PTZ00284 protein kinase; Provi 100.0 1.3E-34 2.9E-39 268.7 20.9 169 21-200 126-320 (467)
258 smart00219 TyrKc Tyrosine kina 100.0 1.2E-34 2.6E-39 248.1 19.0 220 26-251 1-258 (258)
259 cd06609 STKc_MST3_like Catalyt 100.0 1.4E-34 3E-39 250.4 19.5 218 24-250 1-251 (274)
260 cd06624 STKc_ASK Catalytic dom 100.0 1.9E-34 4.1E-39 248.8 20.1 224 21-250 5-265 (268)
261 cd05040 PTKc_Ack_like Catalyti 100.0 2E-34 4.3E-39 247.0 20.1 217 30-252 1-256 (257)
262 cd06630 STKc_MEKK1 Catalytic d 100.0 1.4E-34 3.1E-39 249.3 19.1 223 25-250 1-264 (268)
263 cd05110 PTKc_HER4 Catalytic do 100.0 8.5E-35 1.8E-39 255.5 17.9 230 21-257 4-271 (303)
264 cd06622 PKc_MAPKK_PBS2_like Ca 100.0 9.5E-35 2.1E-39 253.0 18.0 223 24-252 1-264 (286)
265 PHA03207 serine/threonine kina 100.0 1E-34 2.2E-39 263.7 18.9 216 21-251 89-376 (392)
266 cd05042 PTKc_Aatyk Catalytic d 100.0 1.8E-34 3.9E-39 249.0 19.5 216 30-251 1-267 (269)
267 cd07846 STKc_CDKL2_3 Catalytic 100.0 4.8E-35 1E-39 254.7 15.8 221 24-250 1-283 (286)
268 cd06608 STKc_myosinIII_like Ca 100.0 2.3E-34 4.9E-39 248.7 19.9 221 23-250 5-272 (275)
269 cd05037 PTK_Jak_rpt1 Pseudokin 100.0 1.4E-34 3E-39 248.1 18.2 211 30-251 1-258 (259)
270 cd06629 STKc_MAPKKK_Bck1_like 100.0 2.2E-34 4.9E-39 248.8 19.7 223 25-250 2-269 (272)
271 KOG0584 Serine/threonine prote 100.0 6.9E-36 1.5E-40 267.8 10.0 217 24-250 39-296 (632)
272 cd05577 STKc_GRK Catalytic dom 100.0 2.1E-34 4.4E-39 249.8 19.0 215 32-250 1-254 (277)
273 KOG4236 Serine/threonine prote 100.0 4.8E-35 1E-39 257.2 14.9 219 29-252 569-821 (888)
274 cd06617 PKc_MKK3_6 Catalytic d 100.0 4.1E-34 9E-39 248.5 20.2 221 24-250 1-261 (283)
275 cd07860 STKc_CDK2_3 Catalytic 100.0 1.2E-34 2.6E-39 252.0 16.8 221 25-250 1-281 (284)
276 cd05609 STKc_MAST Catalytic do 100.0 4.4E-34 9.5E-39 251.2 20.5 222 24-251 1-271 (305)
277 cd06626 STKc_MEKK4 Catalytic d 100.0 5E-34 1.1E-38 245.3 20.4 220 25-250 1-261 (264)
278 PLN00009 cyclin-dependent kina 100.0 3.8E-34 8.2E-39 250.2 19.9 223 24-250 2-284 (294)
279 cd08225 STKc_Nek5 Catalytic do 100.0 1.8E-34 3.9E-39 247.1 17.4 222 25-250 1-254 (257)
280 cd06640 STKc_MST4 Catalytic do 100.0 4.5E-34 9.7E-39 247.7 19.8 220 24-252 4-255 (277)
281 cd05041 PTKc_Fes_like Catalyti 100.0 6E-34 1.3E-38 243.2 20.3 216 30-252 1-250 (251)
282 cd06653 STKc_MEKK3_like_1 Cata 100.0 8.2E-34 1.8E-38 244.3 20.9 223 23-250 1-261 (264)
283 cd07833 STKc_CDKL Catalytic do 100.0 2E-34 4.4E-39 250.9 17.2 221 24-250 1-285 (288)
284 KOG4250 TANK binding protein k 100.0 3.1E-35 6.8E-40 266.7 12.4 228 25-256 14-312 (732)
285 cd06917 STKc_NAK1_like Catalyt 100.0 6.3E-34 1.4E-38 246.6 20.0 218 25-250 2-255 (277)
286 cd07867 STKc_CDC2L6 Catalytic 100.0 3.5E-34 7.6E-39 253.1 18.4 163 29-199 6-189 (317)
287 KOG0596 Dual specificity; seri 100.0 1.1E-34 2.5E-39 256.1 15.1 228 16-250 353-627 (677)
288 cd06642 STKc_STK25-YSK1 Cataly 100.0 2.5E-34 5.5E-39 249.2 17.1 220 24-252 4-255 (277)
289 cd05044 PTKc_c-ros Catalytic d 100.0 3.7E-34 8.1E-39 246.9 18.0 217 30-252 1-268 (269)
290 cd06639 STKc_myosinIIIB Cataly 100.0 1.1E-33 2.4E-38 247.0 21.1 221 23-250 21-287 (291)
291 cd06620 PKc_MAPKK_Byr1_like Ca 100.0 2.5E-34 5.5E-39 250.1 16.9 222 22-252 3-268 (284)
292 cd05086 PTKc_Aatyk2 Catalytic 100.0 1.3E-33 2.8E-38 243.7 21.1 217 30-252 1-267 (268)
293 cd07844 STKc_PCTAIRE_like Cata 100.0 6.1E-34 1.3E-38 248.5 19.1 220 24-250 5-288 (291)
294 cd08215 STKc_Nek Catalytic dom 100.0 9.2E-34 2E-38 242.4 19.9 221 25-250 1-255 (258)
295 cd05633 STKc_GRK3 Catalytic do 100.0 5.6E-34 1.2E-38 247.4 18.7 215 31-251 1-256 (279)
296 cd06607 STKc_TAO Catalytic dom 100.0 1E-33 2.2E-38 249.1 20.6 223 22-252 13-269 (307)
297 cd07843 STKc_CDC2L1 Catalytic 100.0 4.1E-34 8.8E-39 249.9 17.8 221 24-250 5-290 (293)
298 cd06647 STKc_PAK_I Catalytic d 100.0 7.7E-34 1.7E-38 248.3 19.6 219 23-251 18-270 (293)
299 cd06616 PKc_MKK4 Catalytic dom 100.0 2.8E-34 6.1E-39 250.2 16.3 223 23-251 3-268 (288)
300 cd06605 PKc_MAPKK Catalytic do 100.0 3.3E-34 7.1E-39 246.6 16.3 219 24-250 1-257 (265)
301 cd05572 STKc_cGK_PKG Catalytic 100.0 1.3E-33 2.9E-38 242.6 20.0 214 32-251 1-253 (262)
302 cd07837 STKc_CdkB_plant Cataly 100.0 5.9E-34 1.3E-38 249.0 18.0 223 24-250 1-291 (295)
303 cd06627 STKc_Cdc7_like Catalyt 100.0 1.8E-33 3.8E-38 240.3 20.4 219 25-250 1-251 (254)
304 KOG0612 Rho-associated, coiled 100.0 2.5E-35 5.5E-40 278.3 9.8 226 19-250 70-338 (1317)
305 cd06658 STKc_PAK5 Catalytic do 100.0 2.5E-34 5.3E-39 251.3 15.1 217 24-250 22-272 (292)
306 cd06623 PKc_MAPKK_plant_like C 100.0 2.2E-33 4.8E-38 241.2 20.4 219 24-250 1-256 (264)
307 cd08528 STKc_Nek10 Catalytic d 100.0 1.2E-33 2.5E-38 243.9 18.6 226 25-252 1-268 (269)
308 cd07858 STKc_TEY_MAPK_plant Ca 100.0 9.6E-34 2.1E-38 252.5 18.6 220 24-250 5-291 (337)
309 cd07845 STKc_CDK10 Catalytic d 100.0 1.2E-33 2.7E-38 248.8 19.0 224 22-251 5-291 (309)
310 KOG2052 Activin A type IB rece 100.0 2.1E-34 4.6E-39 248.5 13.5 221 24-256 211-505 (513)
311 cd07870 STKc_PFTAIRE2 Catalyti 100.0 2.1E-33 4.5E-38 245.2 20.0 220 24-250 5-288 (291)
312 cd06641 STKc_MST3 Catalytic do 100.0 2.2E-33 4.9E-38 243.3 19.9 217 25-250 5-253 (277)
313 cd07849 STKc_ERK1_2_like Catal 100.0 7.9E-34 1.7E-38 252.9 17.2 218 24-250 5-292 (336)
314 KOG0986 G protein-coupled rece 100.0 3E-35 6.6E-40 254.2 7.7 234 13-250 174-446 (591)
315 cd07855 STKc_ERK5 Catalytic do 100.0 8.6E-34 1.9E-38 252.5 17.1 222 24-252 5-296 (334)
316 cd06606 STKc_MAPKKK Catalytic 100.0 4.6E-33 9.9E-38 238.1 20.9 219 25-250 1-257 (260)
317 cd06635 STKc_TAO1 Catalytic do 100.0 4.9E-33 1.1E-37 245.9 21.7 224 24-255 25-282 (317)
318 KOG4645 MAPKKK (MAP kinase kin 100.0 3.4E-35 7.3E-40 280.7 8.3 220 25-250 1236-1494(1509)
319 cd06618 PKc_MKK7 Catalytic dom 100.0 1.8E-33 3.9E-38 246.3 18.7 230 16-252 7-275 (296)
320 KOG1035 eIF-2alpha kinase GCN2 100.0 1.5E-34 3.3E-39 274.9 12.7 221 24-250 479-871 (1351)
321 KOG3653 Transforming growth fa 100.0 3.7E-34 8E-39 248.8 13.8 225 20-256 206-505 (534)
322 cd05074 PTKc_Tyro3 Catalytic d 100.0 4.2E-33 9E-38 240.9 20.5 224 26-254 1-272 (273)
323 cd07836 STKc_Pho85 Catalytic d 100.0 1.9E-33 4.2E-38 244.4 18.5 220 25-250 1-281 (284)
324 cd07850 STKc_JNK Catalytic dom 100.0 2.7E-33 5.8E-38 251.2 19.8 220 22-251 14-312 (353)
325 cd07835 STKc_CDK1_like Catalyt 100.0 1.2E-33 2.6E-38 245.6 17.0 220 26-250 1-280 (283)
326 KOG0200 Fibroblast/platelet-de 100.0 3.3E-33 7.1E-38 265.0 21.1 238 13-256 285-581 (609)
327 cd05122 PKc_STE Catalytic doma 100.0 4.1E-33 9E-38 237.4 19.7 218 25-250 1-251 (253)
328 cd07830 STKc_MAK_like Catalyti 100.0 2.2E-33 4.7E-38 243.9 18.2 219 26-250 1-280 (283)
329 cd07865 STKc_CDK9 Catalytic do 100.0 3E-33 6.4E-38 246.2 19.1 226 19-250 7-307 (310)
330 cd06659 STKc_PAK6 Catalytic do 100.0 9.4E-34 2E-38 248.2 15.6 218 24-251 21-272 (297)
331 cd07831 STKc_MOK Catalytic dom 100.0 3.2E-33 6.9E-38 242.7 18.7 217 26-250 1-279 (282)
332 cd05606 STKc_beta_ARK Catalyti 100.0 5.4E-33 1.2E-37 241.1 19.9 214 31-250 1-255 (278)
333 cd05613 STKc_MSK1_N N-terminal 100.0 3E-33 6.6E-38 244.0 18.1 222 25-250 1-268 (290)
334 cd07864 STKc_CDK12 Catalytic d 100.0 1.9E-33 4.2E-38 246.6 16.7 223 22-250 5-299 (302)
335 cd06621 PKc_MAPKK_Pek1_like Ca 100.0 9.9E-33 2.1E-37 240.5 21.0 221 24-251 1-267 (287)
336 cd06648 STKc_PAK_II Catalytic 100.0 5.5E-33 1.2E-37 241.9 19.3 216 25-250 20-269 (285)
337 cd07842 STKc_CDK8_like Catalyt 100.0 2.4E-33 5.3E-38 247.4 16.9 171 25-199 1-189 (316)
338 cd06614 STKc_PAK Catalytic dom 100.0 7.8E-33 1.7E-37 241.0 19.9 220 22-250 17-270 (286)
339 cd05581 STKc_PDK1 Catalytic do 100.0 1.7E-33 3.7E-38 243.9 15.3 221 24-250 1-277 (280)
340 cd07854 STKc_MAPK4_6 Catalytic 100.0 4E-33 8.7E-38 249.0 17.9 219 23-250 4-300 (342)
341 KOG0587 Traf2- and Nck-interac 100.0 5E-33 1.1E-37 257.2 18.7 222 22-250 17-282 (953)
342 cd08530 STKc_CNK2-like Catalyt 100.0 5E-33 1.1E-37 237.9 17.5 220 25-250 1-253 (256)
343 cd08226 PK_STRAD_beta Pseudoki 100.0 7.8E-33 1.7E-37 245.7 19.2 167 29-199 3-182 (328)
344 KOG0983 Mitogen-activated prot 100.0 8.4E-34 1.8E-38 231.2 11.7 227 17-250 85-349 (391)
345 cd08216 PK_STRAD Pseudokinase 100.0 3.3E-33 7.2E-38 246.5 16.5 223 26-252 4-297 (314)
346 cd07852 STKc_MAPK15 Catalytic 100.0 8.8E-33 1.9E-37 246.3 19.3 219 24-250 7-295 (337)
347 cd07857 STKc_MPK1 Catalytic do 100.0 1E-32 2.2E-37 245.4 19.7 219 25-250 1-292 (332)
348 KOG0662 Cyclin-dependent kinas 100.0 4.1E-34 9E-39 219.8 9.0 220 25-250 3-283 (292)
349 PHA03210 serine/threonine kina 100.0 1.1E-33 2.5E-38 263.8 13.8 226 24-252 148-456 (501)
350 cd07834 STKc_MAPK Catalytic do 100.0 3.1E-33 6.7E-38 248.5 15.8 219 25-250 1-289 (330)
351 cd08222 STKc_Nek11 Catalytic d 100.0 2.2E-33 4.8E-38 240.9 14.4 223 25-250 1-257 (260)
352 cd07856 STKc_Sty1_Hog1 Catalyt 100.0 1.6E-32 3.4E-37 243.7 19.9 219 23-251 9-289 (328)
353 cd07840 STKc_CDK9_like Catalyt 100.0 1E-32 2.2E-37 239.9 18.1 219 26-250 1-284 (287)
354 cd06633 STKc_TAO3 Catalytic do 100.0 2.3E-32 5E-37 241.1 20.4 217 26-250 23-273 (313)
355 cd05583 STKc_MSK_N N-terminal 100.0 9.2E-33 2E-37 240.8 17.6 223 25-251 1-264 (288)
356 PHA02882 putative serine/threo 100.0 1.7E-32 3.8E-37 239.8 18.9 227 20-251 8-293 (294)
357 cd05611 STKc_Rim15_like Cataly 100.0 1.9E-32 4.1E-37 235.2 18.7 212 30-250 2-251 (260)
358 cd07877 STKc_p38alpha_MAPK14 C 100.0 2.1E-32 4.6E-37 244.6 19.7 219 23-251 16-301 (345)
359 cd06634 STKc_TAO2 Catalytic do 100.0 2.2E-32 4.7E-37 240.8 19.4 221 24-252 15-269 (308)
360 cd07880 STKc_p38gamma_MAPK12 C 100.0 2E-32 4.2E-37 244.6 19.3 218 23-250 14-298 (343)
361 cd05579 STKc_MAST_like Catalyt 100.0 6.8E-33 1.5E-37 238.1 15.6 213 32-250 1-257 (265)
362 PTZ00024 cyclin-dependent prot 100.0 1.1E-32 2.3E-37 245.5 17.2 224 24-251 8-314 (335)
363 cd06657 STKc_PAK4 Catalytic do 100.0 2.5E-32 5.4E-37 238.6 18.5 219 29-259 25-277 (292)
364 cd07851 STKc_p38 Catalytic dom 100.0 1.3E-32 2.8E-37 245.8 16.2 222 18-250 10-298 (343)
365 cd07866 STKc_BUR1 Catalytic do 100.0 1.9E-32 4.1E-37 241.1 16.9 222 23-250 7-308 (311)
366 cd07838 STKc_CDK4_6_like Catal 100.0 5E-32 1.1E-36 235.7 19.2 219 26-250 1-284 (287)
367 cd05118 STKc_CMGC Catalytic do 100.0 2.2E-32 4.8E-37 237.4 15.9 219 26-250 1-280 (283)
368 cd05123 STKc_AGC Catalytic dom 100.0 5.6E-32 1.2E-36 230.7 17.0 213 32-250 1-247 (250)
369 PHA03390 pk1 serine/threonine- 100.0 7.8E-32 1.7E-36 232.5 18.0 211 24-250 14-262 (267)
370 cd07879 STKc_p38delta_MAPK13 C 100.0 4.3E-32 9.3E-37 242.3 16.8 222 17-250 9-297 (342)
371 KOG1025 Epidermal growth facto 100.0 8.2E-33 1.8E-37 253.9 12.3 227 25-257 697-960 (1177)
372 KOG1151 Tousled-like protein k 100.0 1.7E-32 3.6E-37 237.0 13.1 225 24-250 463-741 (775)
373 cd07829 STKc_CDK_like Catalyti 100.0 3.6E-32 7.8E-37 236.0 13.9 219 26-250 1-279 (282)
374 KOG0608 Warts/lats-like serine 100.0 1.3E-31 2.9E-36 240.0 17.3 224 20-250 625-928 (1034)
375 KOG0614 cGMP-dependent protein 100.0 1.8E-33 3.9E-38 246.2 3.5 226 21-252 417-679 (732)
376 KOG1006 Mitogen-activated prot 100.0 4.4E-33 9.5E-38 226.1 5.1 227 18-250 58-327 (361)
377 KOG0669 Cyclin T-dependent kin 100.0 6.9E-34 1.5E-38 229.2 -0.6 231 16-252 9-317 (376)
378 KOG0666 Cyclin C-dependent kin 100.0 1E-32 2.2E-37 228.5 5.8 177 24-204 24-218 (438)
379 KOG0607 MAP kinase-interacting 100.0 2.9E-32 6.3E-37 226.6 7.8 217 29-252 83-363 (463)
380 cd05576 STKc_RPK118_like Catal 100.0 5E-31 1.1E-35 223.5 14.8 194 35-244 4-223 (237)
381 PLN03225 Serine/threonine-prot 100.0 4E-31 8.7E-36 248.5 14.8 171 19-198 127-330 (566)
382 PLN00113 leucine-rich repeat r 100.0 1.8E-30 4E-35 261.0 18.6 213 25-257 691-954 (968)
383 KOG1027 Serine/threonine prote 100.0 3.7E-31 8.1E-36 243.7 12.3 213 28-250 513-767 (903)
384 KOG0603 Ribosomal protein S6 k 100.0 2.7E-31 5.8E-36 239.1 10.2 215 23-253 321-566 (612)
385 KOG0668 Casein kinase II, alph 100.0 2E-31 4.4E-36 212.2 7.8 216 22-250 36-322 (338)
386 PLN03224 probable serine/threo 100.0 6.5E-30 1.4E-34 235.1 19.0 230 21-251 142-501 (507)
387 KOG0696 Serine/threonine prote 100.0 1.2E-31 2.6E-36 229.9 6.0 218 20-243 345-594 (683)
388 KOG0664 Nemo-like MAPK-related 100.0 3.7E-32 8.1E-37 221.7 1.4 220 26-252 55-345 (449)
389 KOG0671 LAMMER dual specificit 100.0 3.3E-30 7.1E-35 219.0 12.2 172 23-203 88-287 (415)
390 KOG0576 Mitogen-activated prot 100.0 1.9E-31 4E-36 240.2 4.8 221 22-250 13-271 (829)
391 KOG0695 Serine/threonine prote 100.0 1.1E-30 2.5E-35 218.7 7.1 220 17-242 243-502 (593)
392 smart00220 S_TKc Serine/Threon 100.0 6.8E-29 1.5E-33 209.9 16.0 207 36-250 1-241 (244)
393 cd05610 STKc_MASTL Catalytic d 100.0 1E-28 2.3E-33 237.4 19.0 169 24-197 4-176 (669)
394 cd00180 PKc Catalytic domain o 100.0 1.5E-28 3.2E-33 203.1 17.2 209 32-250 1-214 (215)
395 KOG0984 Mitogen-activated prot 100.0 5.5E-29 1.2E-33 195.4 10.5 181 16-202 38-225 (282)
396 KOG0665 Jun-N-terminal kinase 100.0 2.9E-29 6.3E-34 208.7 8.9 222 18-250 11-310 (369)
397 PRK09188 serine/threonine prot 100.0 2.8E-28 6E-33 215.5 15.4 167 20-199 14-194 (365)
398 KOG1152 Signal transduction se 100.0 3E-29 6.4E-34 222.9 9.2 196 15-214 549-757 (772)
399 KOG0670 U4/U6-associated splic 100.0 9.8E-29 2.1E-33 217.2 10.7 191 7-205 415-615 (752)
400 KOG1167 Serine/threonine prote 100.0 2.5E-28 5.5E-33 210.0 10.6 141 22-174 34-181 (418)
401 KOG1290 Serine/threonine prote 99.9 1.9E-27 4.1E-32 207.7 14.1 145 7-158 60-221 (590)
402 KOG1165 Casein kinase (serine/ 99.9 8.3E-25 1.8E-29 183.3 19.9 237 18-263 22-308 (449)
403 KOG1345 Serine/threonine kinas 99.9 6.8E-26 1.5E-30 184.9 12.2 216 24-250 24-284 (378)
404 KOG1024 Receptor-like protein 99.9 2.4E-26 5.3E-31 196.1 9.9 234 19-257 279-558 (563)
405 KOG1163 Casein kinase (serine/ 99.9 9.9E-25 2.1E-29 175.4 17.6 237 20-265 11-295 (341)
406 cd05147 RIO1_euk RIO kinase fa 99.9 2.2E-25 4.8E-30 181.6 11.7 143 29-176 2-167 (190)
407 cd05145 RIO1_like RIO kinase f 99.9 4.4E-24 9.5E-29 174.5 15.5 145 28-177 1-168 (190)
408 smart00221 STYKc Protein kinas 99.9 8.7E-24 1.9E-28 176.9 15.2 167 26-198 1-172 (225)
409 KOG1164 Casein kinase (serine/ 99.9 6.9E-23 1.5E-27 181.1 19.2 228 25-258 19-301 (322)
410 PRK10345 hypothetical protein; 99.9 2.2E-22 4.8E-27 165.5 14.1 134 29-173 7-156 (210)
411 PLN00181 protein SPA1-RELATED; 99.9 8.4E-24 1.8E-28 208.0 6.6 170 80-252 28-267 (793)
412 PRK10359 lipopolysaccharide co 99.9 3.8E-22 8.2E-27 164.8 14.5 142 21-176 28-184 (232)
413 KOG0590 Checkpoint kinase and 99.9 2.5E-23 5.5E-28 195.6 6.9 220 27-250 321-585 (601)
414 smart00090 RIO RIO-like kinase 99.9 3.6E-22 7.9E-27 168.1 12.0 146 25-177 29-199 (237)
415 PRK12274 serine/threonine prot 99.9 1.1E-21 2.3E-26 158.8 13.7 136 28-177 6-143 (218)
416 PRK14879 serine/threonine prot 99.9 4E-21 8.7E-26 159.8 15.5 138 30-175 2-143 (211)
417 TIGR03724 arch_bud32 Kae1-asso 99.9 9.7E-21 2.1E-25 156.1 13.8 134 31-176 1-139 (199)
418 PRK09605 bifunctional UGMP fam 99.9 9.9E-21 2.1E-25 178.3 15.6 148 17-176 323-477 (535)
419 KOG0195 Integrin-linked kinase 99.8 7.8E-22 1.7E-26 161.5 4.3 227 21-255 187-447 (448)
420 cd05144 RIO2_C RIO kinase fami 99.8 2.8E-20 6.1E-25 153.2 13.2 141 25-177 16-176 (198)
421 COG0515 SPS1 Serine/threonine 99.8 2.7E-19 5.9E-24 157.4 16.8 222 26-250 2-275 (384)
422 PRK01723 3-deoxy-D-manno-octul 99.8 1.2E-19 2.7E-24 153.0 12.7 155 13-175 19-191 (239)
423 smart00750 KIND kinase non-cat 99.8 5.5E-20 1.2E-24 148.4 9.5 134 108-256 1-171 (176)
424 KOG1166 Mitotic checkpoint ser 99.8 4.7E-19 1E-23 170.7 14.7 234 13-257 687-956 (974)
425 KOG4158 BRPK/PTEN-induced prot 99.8 1.4E-19 3.1E-24 155.4 9.9 167 82-252 274-512 (598)
426 cd05119 RIO RIO kinase family, 99.8 1.5E-18 3.2E-23 141.6 12.5 141 28-177 1-165 (187)
427 KOG1240 Protein kinase contain 99.8 7.6E-20 1.6E-24 174.0 4.7 220 25-250 24-291 (1431)
428 KOG0603 Ribosomal protein S6 k 99.8 2.2E-19 4.7E-24 162.6 3.4 202 31-244 1-232 (612)
429 cd05120 APH_ChoK_like Aminogly 99.8 9.1E-18 2E-22 131.5 11.7 132 28-176 2-139 (155)
430 PF14531 Kinase-like: Kinase-l 99.7 1.4E-17 3E-22 141.8 10.0 211 25-241 13-288 (288)
431 TIGR01982 UbiB 2-polyprenylphe 99.6 1.8E-15 3.8E-20 138.5 12.9 143 30-177 123-308 (437)
432 KOG1023 Natriuretic peptide re 99.6 4.9E-16 1.1E-20 140.6 8.2 177 79-257 2-227 (484)
433 cd05151 ChoK Choline Kinase (C 99.6 3E-15 6.4E-20 120.0 10.1 129 29-176 3-137 (170)
434 cd05146 RIO3_euk RIO kinase fa 99.6 3.6E-14 7.9E-19 114.9 12.8 141 29-177 2-175 (197)
435 KOG0606 Microtubule-associated 99.6 2.4E-15 5.3E-20 143.4 5.9 175 23-242 82-304 (1205)
436 KOG3087 Serine/threonine prote 99.6 1.3E-13 2.9E-18 107.6 13.5 148 28-176 11-166 (229)
437 KOG0590 Checkpoint kinase and 99.5 1E-15 2.2E-20 144.5 1.4 225 22-250 18-286 (601)
438 PRK04750 ubiB putative ubiquin 99.5 3.4E-14 7.4E-19 131.7 10.6 144 25-177 121-315 (537)
439 COG3642 Mn2+-dependent serine/ 99.5 2.7E-13 5.8E-18 106.4 13.2 136 30-177 2-142 (204)
440 KOG1033 eIF-2alpha kinase PEK/ 99.5 8.7E-15 1.9E-19 130.6 1.7 145 97-247 330-509 (516)
441 PRK15123 lipopolysaccharide co 99.4 4.6E-11 1E-15 102.1 16.8 138 38-175 36-194 (268)
442 KOG0601 Cyclin-dependent kinas 99.4 8.2E-13 1.8E-17 120.0 5.9 224 22-250 112-379 (524)
443 cd05154 ACAD10_11_like Acyl-Co 99.4 5.1E-12 1.1E-16 105.6 10.4 140 30-176 4-207 (223)
444 PF01163 RIO1: RIO1 family; I 99.3 3.1E-11 6.7E-16 97.4 12.2 130 39-177 1-157 (188)
445 KOG0601 Cyclin-dependent kinas 99.3 5.5E-12 1.2E-16 114.7 7.5 223 23-252 264-516 (524)
446 KOG1266 Protein kinase [Signal 99.2 1E-11 2.3E-16 105.1 3.8 174 75-250 118-331 (458)
447 PF06293 Kdo: Lipopolysacchari 99.2 4.8E-10 1.1E-14 92.6 12.4 106 69-176 56-171 (206)
448 PRK09902 hypothetical protein; 99.1 1.6E-09 3.5E-14 88.1 13.5 141 33-174 27-178 (216)
449 COG0478 RIO-like serine/threon 99.1 9.6E-10 2.1E-14 91.6 10.8 138 27-175 94-251 (304)
450 PF06176 WaaY: Lipopolysacchar 99.1 5.2E-09 1.1E-13 85.5 13.8 141 21-175 28-183 (229)
451 KOG3741 Poly(A) ribonuclease s 99.1 4.5E-09 9.8E-14 94.5 13.9 207 37-250 289-521 (655)
452 KOG1243 Protein kinase [Genera 99.0 1.8E-09 3.9E-14 99.8 10.3 117 46-175 36-154 (690)
453 TIGR02172 Fb_sc_TIGR02172 Fibr 98.9 4.8E-08 1E-12 81.8 12.7 136 30-176 7-183 (226)
454 COG0661 AarF Predicted unusual 98.8 3.7E-08 7.9E-13 91.3 12.5 143 30-177 131-316 (517)
455 PF01636 APH: Phosphotransfera 98.7 4.3E-07 9.3E-12 76.3 14.2 141 29-176 2-198 (239)
456 COG1718 RIO1 Serine/threonine 98.7 2.9E-07 6.3E-12 76.2 12.5 141 30-177 54-217 (268)
457 COG4248 Uncharacterized protei 98.7 8.4E-07 1.8E-11 78.4 15.4 227 22-258 9-304 (637)
458 COG2112 Predicted Ser/Thr prot 98.7 1.6E-07 3.4E-12 73.6 9.2 134 24-177 22-157 (201)
459 KOG0606 Microtubule-associated 98.7 5.9E-09 1.3E-13 100.6 1.1 221 19-245 799-1084(1205)
460 KOG1235 Predicted unusual prot 98.6 3.5E-07 7.7E-12 84.6 11.8 141 30-177 167-356 (538)
461 cd05150 APH Aminoglycoside 3'- 98.6 6.4E-07 1.4E-11 76.1 12.2 74 32-113 6-82 (244)
462 PF13095 FTA2: Kinetochore Sim 98.6 1.7E-06 3.6E-11 70.1 12.2 129 24-173 37-206 (207)
463 PLN02876 acyl-CoA dehydrogenas 98.5 1.5E-06 3.3E-11 86.3 14.0 77 29-109 43-130 (822)
464 cd05155 APH_ChoK_like_1 Unchar 98.4 2.3E-06 4.9E-11 72.3 10.3 72 30-111 3-82 (235)
465 PF12260 PIP49_C: Protein-kina 98.4 1.2E-06 2.6E-11 71.0 7.6 99 72-176 7-112 (188)
466 PRK10593 hypothetical protein; 98.3 1.1E-05 2.3E-10 70.6 13.1 79 25-110 15-100 (297)
467 KOG2137 Protein kinase [Signal 98.3 9.9E-07 2.1E-11 82.3 5.7 118 131-249 105-264 (700)
468 PF10707 YrbL-PhoP_reg: PhoP r 98.3 3E-05 6.4E-10 63.3 13.3 133 29-169 6-165 (199)
469 cd05610 STKc_MASTL Catalytic d 98.3 6.6E-07 1.4E-11 87.0 3.9 104 147-252 499-636 (669)
470 TIGR02721 ycfN_thiK thiamine k 98.3 9E-06 2E-10 69.6 10.4 136 32-177 4-177 (256)
471 TIGR00938 thrB_alt homoserine 98.2 2E-05 4.4E-10 69.3 11.8 143 25-175 23-217 (307)
472 cd05157 ETNK_euk Ethanolamine 98.2 2.2E-05 4.7E-10 66.2 11.1 72 30-110 4-79 (235)
473 KOG0576 Mitogen-activated prot 98.2 3.6E-07 7.9E-12 84.5 0.1 161 26-203 244-408 (829)
474 cd05153 HomoserineK_II Homoser 98.1 1.5E-05 3.2E-10 69.8 9.6 138 29-175 19-205 (296)
475 PRK09550 mtnK methylthioribose 98.1 5.4E-05 1.2E-09 68.4 12.0 80 29-109 31-117 (401)
476 PRK05231 homoserine kinase; Pr 98.0 0.00016 3.4E-09 64.0 14.0 138 29-175 27-217 (319)
477 cd05156 ChoK_euk Choline Kinas 97.9 9.4E-05 2E-09 64.9 10.0 73 30-111 4-85 (302)
478 PLN02236 choline kinase 97.8 0.00018 4E-09 64.2 10.7 151 16-176 27-232 (344)
479 KOG2268 Serine/threonine prote 97.8 2.2E-05 4.8E-10 67.7 4.2 137 26-174 94-250 (465)
480 COG3173 Predicted aminoglycosi 97.7 0.0004 8.6E-09 60.7 10.3 139 28-178 29-231 (321)
481 PLN02421 phosphotransferase, a 97.7 0.00047 1E-08 61.3 10.8 150 17-176 7-214 (330)
482 PLN02756 S-methyl-5-thioribose 97.6 0.0011 2.3E-08 60.0 12.4 85 28-114 36-128 (418)
483 KOG1035 eIF-2alpha kinase GCN2 97.6 0.00035 7.6E-09 69.5 9.9 180 70-252 228-436 (1351)
484 KOG2270 Serine/threonine prote 97.5 0.00037 8.1E-09 61.3 7.6 143 28-176 148-314 (520)
485 cd05152 MPH2' Macrolide 2'-Pho 97.4 0.00096 2.1E-08 57.7 9.1 33 145-177 186-218 (276)
486 TIGR01767 MTRK 5-methylthiorib 97.4 0.001 2.2E-08 59.1 8.9 74 31-108 2-85 (370)
487 PF03881 Fructosamin_kin: Fruc 97.3 0.0032 6.9E-08 54.6 11.3 75 26-108 19-97 (288)
488 TIGR02906 spore_CotS spore coa 97.3 0.0084 1.8E-07 52.7 13.9 30 144-175 187-216 (313)
489 PRK12396 5-methylribose kinase 97.2 0.001 2.2E-08 59.9 7.2 75 29-107 34-117 (409)
490 PF02958 EcKinase: Ecdysteroid 96.9 0.0078 1.7E-07 52.5 9.9 73 33-105 2-98 (294)
491 COG2334 Putative homoserine ki 96.9 0.0089 1.9E-07 52.9 9.9 136 32-175 34-228 (331)
492 PF01633 Choline_kinase: Choli 96.9 0.0024 5.3E-08 52.8 5.9 30 145-175 144-174 (211)
493 PTZ00384 choline kinase; Provi 96.8 0.011 2.4E-07 53.5 10.1 85 17-111 43-137 (383)
494 TIGR02904 spore_ysxE spore coa 96.8 0.023 4.9E-07 50.1 11.5 30 145-175 197-226 (309)
495 PRK06148 hypothetical protein; 96.7 0.016 3.5E-07 59.2 11.7 32 144-175 203-236 (1013)
496 COG3001 Uncharacterized protei 96.7 0.019 4.2E-07 47.5 9.5 79 25-111 17-99 (286)
497 PF07387 Seadorna_VP7: Seadorn 96.7 0.011 2.4E-07 48.7 7.9 157 35-247 73-233 (308)
498 PRK11768 serine/threonine prot 96.2 0.15 3.2E-06 45.3 13.4 29 144-175 196-224 (325)
499 PTZ00296 choline kinase; Provi 96.2 0.044 9.6E-07 50.6 10.2 83 18-110 99-193 (442)
500 PRK06149 hypothetical protein; 96.0 0.05 1.1E-06 55.6 10.5 32 144-175 208-243 (972)
No 1
>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=7e-49 Score=335.00 Aligned_cols=229 Identities=26% Similarity=0.355 Sum_probs=192.5
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHH--HHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEI--AKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
.+.|.+.+.||+|+||.|-+|..+ ++.||||++.+....... ......+.+|+++|++|+|||||++++++... .
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 467889999999999999999775 899999999886654422 11233467999999999999999999999876 6
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC--CCceEEcccCcccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLARE 175 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~a~~ 175 (317)
.||||||++||+|.+++-.++- +.+..-..+++|++.|+.|||++||+||||||+|||+..+ .-.+||+|||+|+.
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred eEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 7999999999999999987665 8888889999999999999999999999999999999865 23689999999999
Q ss_pred cccccccccccCccceeccccccccc--ccccccccccCC--------------------------------CCCCCCCC
Q 021127 176 ESLTEMMTAETGTYRWMAPELYSTVT--LRQGEKKHYNHK--------------------------------NVRPSAEN 221 (317)
Q Consensus 176 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~~~--------------------------------~~~~~~~~ 221 (317)
......+.+.|||+.|.|||++.+.. ......+.|+.+ ...+....
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~ 408 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDR 408 (475)
T ss_pred cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhh
Confidence 88888899999999999999987643 233345566554 11123456
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
++++..+||.+||..||++|||++++++|-|-
T Consensus 409 Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~ 440 (475)
T KOG0615|consen 409 ISEEALDLINWMLVVDPENRPSADEALNHPWF 440 (475)
T ss_pred hhHHHHHHHHHhhEeCcccCcCHHHHhcChhh
Confidence 78899999999999999999999999999653
No 2
>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]
Probab=100.00 E-value=2.9e-47 Score=336.04 Aligned_cols=243 Identities=41% Similarity=0.708 Sum_probs=204.8
Q ss_pred cCCceeecCCceeecceeccccceEEEEeEECCeE-EEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 15 LDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 15 ~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~-vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
....|.|+..++.+.+.||+|+||+||+|.+.|+. ||||++......... ++.|.+|+.+|.+++|||||+++|+|
T Consensus 32 ~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~---~~~f~~E~~il~~l~HpNIV~f~G~~ 108 (362)
T KOG0192|consen 32 ELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES---RKAFRREASLLSRLRHPNIVQFYGAC 108 (362)
T ss_pred cccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH---HHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 34679999999999999999999999999999888 999999876655432 67899999999999999999999999
Q ss_pred ecC--ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCcEEeeCCCCceEEccc
Q 021127 94 KEP--VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG-IIHRDLKPENLLLTEDLKTIKLADF 170 (317)
Q Consensus 94 ~~~--~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~-ivH~Dlkp~Nill~~~~~~~kl~Df 170 (317)
.++ ...+||||+++|+|.+++.......+++..++.|+.||++||.|||+++ ||||||||+|||++.+.-++||+||
T Consensus 109 ~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DF 188 (362)
T KOG0192|consen 109 TSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADF 188 (362)
T ss_pred cCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCC
Confidence 877 4899999999999999998854455999999999999999999999999 9999999999999998228999999
Q ss_pred Ccccccccc-cccccccCccceecccccccc-cccccccccccCC----------------------------CCC-CCC
Q 021127 171 GLAREESLT-EMMTAETGTYRWMAPELYSTV-TLRQGEKKHYNHK----------------------------NVR-PSA 219 (317)
Q Consensus 171 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~~----------------------------~~~-~~~ 219 (317)
|+++..... ...+...||+.|||||++.+. ...+...+.|+.+ ..+ ..+
T Consensus 189 Glsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p 268 (362)
T KOG0192|consen 189 GLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP 268 (362)
T ss_pred ccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC
Confidence 999866543 333446899999999999953 2222223333322 222 335
Q ss_pred CCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCC
Q 021127 220 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 260 (317)
Q Consensus 220 ~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~ 260 (317)
..++..+..||..||..||..||++.+++..|+.+......
T Consensus 269 ~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 269 KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 66899999999999999999999999999999988775544
No 3
>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=2.9e-47 Score=339.86 Aligned_cols=221 Identities=29% Similarity=0.445 Sum_probs=192.5
Q ss_pred CceeecceeccccceEEEEeEE--CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
.+|..++.||+|||.+||++++ +|+.||+|++++..... ...++++.+||+++++|+|||||+++++|++. .+||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k--~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKK--PKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcC--cchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence 5799999999999999999988 39999999999865544 35567899999999999999999999999987 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc-c
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-T 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~-~ 179 (317)
|.|+|..++|..+++.++. ++|.++..+++||+.||.|||+++|+|||||.+|+|++.++ .+||+|||+|..... .
T Consensus 96 vLELC~~~sL~el~Krrk~--ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKP--LTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM-NVKIGDFGLATQLEYDG 172 (592)
T ss_pred EEEecCCccHHHHHHhcCC--CCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcC-cEEecccceeeeecCcc
Confidence 9999999999999986555 99999999999999999999999999999999999999995 899999999987654 3
Q ss_pred cccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
+...+.||||.|+|||++.. .-..-..++|+.+ ..-..|..++.+.++||.+
T Consensus 173 Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~ 251 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRK 251 (592)
T ss_pred cccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHH
Confidence 67788999999999999873 2233344555544 2233466889999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 021127 233 CWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 233 cl~~~p~~Rps~~~~~~~ 250 (317)
+|+.||.+|||+++|+.+
T Consensus 252 lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 252 LLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HhcCCcccCCCHHHHhcC
Confidence 999999999999999988
No 4
>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]
Probab=100.00 E-value=4.6e-47 Score=321.03 Aligned_cols=225 Identities=26% Similarity=0.394 Sum_probs=190.7
Q ss_pred eeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 96 (317)
..|...+++.++.||+|..|+||+++++ ++.+|+|++...... ...+++.+|+++++..+|||||++||.|..+
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~----~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDP----ALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCH----HHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 3455568889999999999999999986 899999999554442 3466799999999999999999999998754
Q ss_pred --ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 97 --VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 97 --~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
...|+||||++|+|.+++...+. +++...-.|+.+|++||.|||+ .+||||||||+|||++.. |.+||||||.+
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~g~--i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNsk-GeVKicDFGVS 226 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRVGR--IPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSK-GEVKICDFGVS 226 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccC-CCEEecccccc
Confidence 39999999999999999987644 9999999999999999999996 899999999999999998 89999999999
Q ss_pred cccccccccccccCccceecccccccccccccccccccCC--------------------------------CCCC-CCC
Q 021127 174 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------------------------NVRP-SAE 220 (317)
Q Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------------------------~~~~-~~~ 220 (317)
...... ...+.+||..|||||-+.+..+.-. .++|+.+ ...| .|.
T Consensus 227 ~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~-sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~ 304 (364)
T KOG0581|consen 227 GILVNS-IANTFVGTSAYMSPERISGESYSVK-SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE 304 (364)
T ss_pred HHhhhh-hcccccccccccChhhhcCCcCCcc-cceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc
Confidence 976655 6678899999999999888655443 4444443 1111 244
Q ss_pred C-ChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 221 N-VPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 221 ~-~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+ +++++++||..||++||.+||++.|+++|-+
T Consensus 305 ~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 305 GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF 337 (364)
T ss_pred ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence 4 8899999999999999999999999999844
No 5
>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]
Probab=100.00 E-value=7.2e-46 Score=313.68 Aligned_cols=225 Identities=30% Similarity=0.404 Sum_probs=191.6
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
.+.+++|++.++||+|+||+||.++.. ++.+|+|++++...-.. +..+...+|..+|.+++||+||+++..|+++
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~--~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~ 98 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK--KEVRHTKAERNILSKIKHPFIVKLIYSFQTEE 98 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh--hhHHHHHHHHHHHHhCCCCcEeeeEEecccCC
Confidence 577899999999999999999998764 89999999998765442 3456788999999999999999999999876
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc-
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE- 175 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~- 175 (317)
.+|+|+||+.||.|..+|++.+. +++..+..++..|+.||.|||++|||||||||+|||++.+ |.++|+|||+++.
T Consensus 99 kLylVld~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~-GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQ-GHIKLTDFGLCKED 175 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCC-CcEEEeccccchhc
Confidence 89999999999999999997655 9999999999999999999999999999999999999999 8999999999994
Q ss_pred cccccccccccCccceecccccccccccccccccccCC---------------------------CCCCC-CCCChHHHH
Q 021127 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPS-AENVPEELS 227 (317)
Q Consensus 176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~-~~~~~~~l~ 227 (317)
......+.+.|||+.|||||++.+..+. ...+||+.+ ...+. +..++.+.+
T Consensus 176 ~~~~~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ar 254 (357)
T KOG0598|consen 176 LKDGDATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEAR 254 (357)
T ss_pred ccCCCccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHH
Confidence 4444566778999999999999886443 344555544 11123 344899999
Q ss_pred HHHHHhhhcCCCCCC----CHHHHHHH
Q 021127 228 IILTSCWKEDPNARP----NFTQIIQM 250 (317)
Q Consensus 228 ~li~~cl~~~p~~Rp----s~~~~~~~ 250 (317)
+++.++|..||++|. ++.+|.+|
T Consensus 255 dll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 255 DLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred HHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 999999999999995 56666655
No 6
>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=7.8e-46 Score=327.04 Aligned_cols=240 Identities=30% Similarity=0.562 Sum_probs=203.5
Q ss_pred ccceec-CCceeecCCceeecceeccccceEEEEeEECCe-EEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCee
Q 021127 10 ADELKL-DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQ-TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV 87 (317)
Q Consensus 10 ~~~~~~-~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~~~-~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 87 (317)
|+.... ...|+|+++.+.+++.||+|.||.||.|.+++. .||+|.+....... ..|.+|+.+|++|+|+|||
T Consensus 191 p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~------~~f~~Ea~iMk~L~H~~lV 264 (468)
T KOG0197|consen 191 PQTPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP------EAFLREAQIMKKLRHEKLV 264 (468)
T ss_pred CCCCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh------hHHHHHHHHHHhCcccCeE
Confidence 444444 678999999999999999999999999999976 89999998765432 3588999999999999999
Q ss_pred eEEeeeecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceE
Q 021127 88 KFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166 (317)
Q Consensus 88 ~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~k 166 (317)
+++|+|.++ .++||||||+.|+|.++|+......+...+.+.|+.|||+||+||+++++|||||.++||||+++ ..+|
T Consensus 265 ~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~-~~vK 343 (468)
T KOG0197|consen 265 KLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDED-LVVK 343 (468)
T ss_pred EEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccC-ceEE
Confidence 999999875 69999999999999999998555669999999999999999999999999999999999999999 6999
Q ss_pred EcccCccccccccccccc--ccCccceecccccccccccccccccccCC-----------------------------CC
Q 021127 167 LADFGLAREESLTEMMTA--ETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NV 215 (317)
Q Consensus 167 l~Dfg~a~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~ 215 (317)
|+|||+|+.......... ..-...|.|||++....+.... ++|+.+ ..
T Consensus 344 IsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kS-DVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyR 422 (468)
T KOG0197|consen 344 ISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKS-DVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYR 422 (468)
T ss_pred EcccccccccCCCceeecCCCCCCceecCHHHHhhCCccccc-ceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCc
Confidence 999999995443332222 2235789999998775544433 333333 45
Q ss_pred CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 216 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 216 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
.+.|..+|+++.++|..||+.+|++|||++.+...++++...
T Consensus 423 lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 423 LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 677999999999999999999999999999999998887654
No 7
>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=3.2e-45 Score=312.65 Aligned_cols=221 Identities=29% Similarity=0.445 Sum_probs=185.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
.+|.+.++||.|+||+||+|+++ +..||||.+.+..... +..+.+..|+.+|+.++|||||++++++..+ .+|+
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~---k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNK---KLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCH---HHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 68999999999999999999986 8899999998765322 3455678999999999999999999999765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC-C----CceEEcccCcccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-L----KTIKLADFGLARE 175 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~-~----~~~kl~Dfg~a~~ 175 (317)
|||||.||+|.+|++..+. +++..+..++.||+.||++||+++||||||||+||||+.. . -.+||+|||+|+.
T Consensus 87 VMEyC~gGDLs~yi~~~~~--l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGR--LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999999998765 9999999999999999999999999999999999999864 1 2589999999999
Q ss_pred cccccccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHH
Q 021127 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEE 225 (317)
Q Consensus 176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~ 225 (317)
........+.||++.|||||++....++...+ .|+.+ .....+..++..
T Consensus 165 L~~~~~a~tlcGSplYMAPEV~~~~~YdAKAD-LWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~ 243 (429)
T KOG0595|consen 165 LQPGSMAETLCGSPLYMAPEVIMSQQYDAKAD-LWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNP 243 (429)
T ss_pred CCchhHHHHhhCCccccCHHHHHhccccchhh-HHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCc
Confidence 88888888899999999999997655554433 33322 111123345566
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+.+|+...++.+|.+|.+..+.+.+
T Consensus 244 ~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 244 LRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred hhhhhhHHHhcCccccCchHHhhhh
Confidence 7789999999999999988877655
No 8
>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.2e-44 Score=314.05 Aligned_cols=225 Identities=28% Similarity=0.388 Sum_probs=189.2
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecC
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 96 (317)
.+.-++|.+.++||.|.||.||+|+.. +..||||.+++....-+ +..=++|+..|++|+ |||||+|.+++.++
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e----e~~nLREvksL~kln~hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE----ECMNLREVKSLRKLNPHPNIIKLKEVIRDN 81 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH----HHHHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence 344578999999999999999999875 88999999987654321 233478999999998 99999999998654
Q ss_pred --ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 97 --VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 97 --~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
.+++||||| ..+|+++++.+ .+.+++.++..|+.||+.||+|+|.+|+.|||+||+|||+..+ ..+||+|||+|+
T Consensus 82 ~~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~-~~iKiaDFGLAR 158 (538)
T KOG0661|consen 82 DRILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGN-DVIKIADFGLAR 158 (538)
T ss_pred CceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEeccc-ceeEeccccccc
Confidence 799999999 67999999886 6679999999999999999999999999999999999999966 489999999999
Q ss_pred ccccccccccccCccceecccccccccccccccccccCC-----------------------------------------
Q 021127 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------------------- 213 (317)
Q Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------------------- 213 (317)
........+..+.|.+|+|||++..-.+.....+.|..+
T Consensus 159 ev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 159 EVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred ccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 887777778889999999999987755555555544433
Q ss_pred -----------CCC-----CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 214 -----------NVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 214 -----------~~~-----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
... ....+.+.+..++|.+|+.+||.+|||+.+++++.
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 000 01234678999999999999999999999999983
No 9
>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-42 Score=308.46 Aligned_cols=230 Identities=27% Similarity=0.417 Sum_probs=195.0
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecC-
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP- 96 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~- 96 (317)
...+.|.+++.||+|+||+|+.|.+. ++.||+|++.+.............+.+|+.++++++ ||||++++.++...
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 45579999999999999999999875 899999987765222110122334668999999998 99999999999765
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
.+++|||||.||+|.+++.+.+. +.+..+..+++|+++|++|||++||+||||||+|||++.+.+.+||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~--l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGR--LKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 79999999999999999998443 9999999999999999999999999999999999999987458999999999977
Q ss_pred -ccccccccccCccceeccccccccc-ccccccccccCC---------------------------CCCCCCCCC-hHHH
Q 021127 177 -SLTEMMTAETGTYRWMAPELYSTVT-LRQGEKKHYNHK---------------------------NVRPSAENV-PEEL 226 (317)
Q Consensus 177 -~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~~---------------------------~~~~~~~~~-~~~l 226 (317)
.......+.+||+.|+|||++.+.. +.....+.|+.+ .....+..+ +.++
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~ 251 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEA 251 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHH
Confidence 4556778889999999999999977 777777888766 112235566 9999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+.|+.+||..||.+|+++.+++.+-|
T Consensus 252 ~~Li~~mL~~~P~~R~t~~~i~~h~w 277 (370)
T KOG0583|consen 252 RSLIEKMLVPDPSTRITLLEILEHPW 277 (370)
T ss_pred HHHHHHHcCCCcccCCCHHHHhhChh
Confidence 99999999999999999999996644
No 10
>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-42 Score=298.37 Aligned_cols=226 Identities=27% Similarity=0.469 Sum_probs=186.4
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee--ecC-c
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC--KEP-V 97 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~--~~~-~ 97 (317)
..++..++.||+|+||.||++.+. +...|||.+....... .+.+.+|+.+|.+++|||||+++|.. .+. .
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-----~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~ 90 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-----SESLEREIRILSRLNHPNIVQYYGSSSSRENDE 90 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-----HHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence 567889999999999999999886 6999999988764322 44578999999999999999999973 343 6
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
+++.|||+++|+|.+++.+.+. .+++..+..++.||++||+|||++|||||||||+|||++...+.+||+|||+++...
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 8999999999999999998775 599999999999999999999999999999999999999832689999999998655
Q ss_pred c----ccccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCCh
Q 021127 178 L----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVP 223 (317)
Q Consensus 178 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~ 223 (317)
. ........||+.|||||++..........++|+.+ .....+..++
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls 249 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLS 249 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccC
Confidence 2 22234568999999999998522221233333332 1234467789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
.+.++|+..|++.||++|||++++++|..-.
T Consensus 250 ~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 250 DEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred HHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 9999999999999999999999999986543
No 11
>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]
Probab=100.00 E-value=6.9e-44 Score=293.59 Aligned_cols=221 Identities=28% Similarity=0.373 Sum_probs=182.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
+.|+.+.++|+|+||.||+++++ |+.||||.+......... .+-.++|+++|++++|+|+|.|+.+|... ..++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~V---kKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhL 78 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVV---KKIALREIRMLKQLKHENLVNLIEVFRRKRKLHL 78 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHH---HHHHHHHHHHHHhcccchHHHHHHHHHhcceeEE
Confidence 46888899999999999999885 999999999766554332 23467999999999999999999999765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-cc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LT 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~ 179 (317)
|+|||+. ++.+-|+.. +..++.+.+..|+.|++.|+.|+|++++|||||||+||||+.+ +.+||||||+|+... ..
T Consensus 79 VFE~~dh-TvL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~-gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 79 VFEYCDH-TVLHELERY-PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQN-GVVKLCDFGFARTLSAPG 155 (396)
T ss_pred Eeeecch-HHHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecC-CcEEeccchhhHhhcCCc
Confidence 9999965 555556553 3349999999999999999999999999999999999999999 799999999999776 66
Q ss_pred cccccccCccceecccccccccccccccccccCC----------------------------------------------
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------------------------- 213 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------------------------- 213 (317)
...+..+.|.+|.|||++.+........++|..+
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 7778888999999999988855555555555443
Q ss_pred --CCCCC----------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 --NVRPS----------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 --~~~~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
...|. -+.++..+.+|+..||+.||++|++.++++.|
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11111 12445678999999999999999999999865
No 12
>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=2.7e-44 Score=293.31 Aligned_cols=226 Identities=26% Similarity=0.434 Sum_probs=184.6
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEee-e-ecC-c
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA-C-KEP-V 97 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~-~-~~~-~ 97 (317)
..+|+++++||.|+||+||++... |..||.|.+...... .+.++....|+.+|++|+|||||+++++ + .++ .
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md---~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMD---AKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhcc---HHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 357999999999999999998774 899999999865543 3667789999999999999999999984 3 344 4
Q ss_pred eEEEEEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh--CC--ccccCCCCCcEEeeCCCCceEEcccC
Q 021127 98 MVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHS--HG--IIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~--~~--ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
++||||+|..|+|.+.++..+ .+.+++..+|+++.|++.||..+|+ .. |+||||||.||||+.+ |.+||+|||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~-gvvKLGDfG 173 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN-GVVKLGDFG 173 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC-Cceeeccch
Confidence 899999999999999997543 4569999999999999999999999 45 9999999999999998 799999999
Q ss_pred cccccccc-cccccccCccceecccccccccccccccccccCC----------------------------CCCCCC-CC
Q 021127 172 LAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSA-EN 221 (317)
Q Consensus 172 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~-~~ 221 (317)
+++..+.. ....+.+|||.||+||.+.+..+....+ +|+.+ ...+.| ..
T Consensus 174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSD-iWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~ 252 (375)
T KOG0591|consen 174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSD-IWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEH 252 (375)
T ss_pred hHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchh-HHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHH
Confidence 99976543 4456678999999999987755444332 23222 223334 57
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
++..+..||..|+..||+.||+.-.+++-+..
T Consensus 253 YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 253 YSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred hhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 78999999999999999999996555554443
No 13
>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-42 Score=308.48 Aligned_cols=236 Identities=33% Similarity=0.626 Sum_probs=196.1
Q ss_pred CCceeecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
...|+|.++++.++..||+|.||+||+|+|.| .||||++.......+ ..+.|.+|+..+++-+|.||+-++|+|..
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~---qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPE---QLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHH---HHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 37899999999999999999999999999986 689999998776653 56679999999999999999999999999
Q ss_pred CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 96 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
+...||+.+|+|.+|+.+|+..+.+ |+..+.+.|++||+.|+.|||.++|||||||..|||+.++ +.|||+|||++..
T Consensus 460 p~~AIiTqwCeGsSLY~hlHv~etk-fdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~-~kVkIgDFGLatv 537 (678)
T KOG0193|consen 460 PPLAIITQWCEGSSLYTHLHVQETK-FDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHED-LKVKIGDFGLATV 537 (678)
T ss_pred CceeeeehhccCchhhhhccchhhh-hhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccC-CcEEEecccceee
Confidence 8889999999999999999876543 9999999999999999999999999999999999999998 7999999999975
Q ss_pred ccccc---ccccccCccceeccccccccccc--ccccccccCC----------------------------CCCC----C
Q 021127 176 ESLTE---MMTAETGTYRWMAPELYSTVTLR--QGEKKHYNHK----------------------------NVRP----S 218 (317)
Q Consensus 176 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~~~----------------------------~~~~----~ 218 (317)
..... ......|...|||||++...... ....++|..+ ...+ .
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~ 617 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKI 617 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhh
Confidence 43321 12334578899999998753211 1112222221 1111 1
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
..+++.++++|+..||..++++||.+.+|+..|+.++..
T Consensus 618 ~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 618 RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 346788999999999999999999999999998888764
No 14
>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]
Probab=100.00 E-value=2.4e-42 Score=304.13 Aligned_cols=225 Identities=30% Similarity=0.397 Sum_probs=189.4
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 96 (317)
...+.+|.+++.||.|+|++|++|+.. ++.||||++.+...-.+ +...-+..|-+.|.+| .||.|++|+..|++.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike--~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~ 146 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKE--KKVKYVTREKEALTQLSGHPGIVKLYFTFQDE 146 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhh--cccchhhHHHHHHHHhhCCCCeEEEEEEeecc
Confidence 445689999999999999999999875 89999999987665442 3345577899999999 899999999999876
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
.+|+|+||+++|+|.++|.+.+. |++.....++.+|+.||+|||++|||||||||+|||++.| +.+||+|||.|+.
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~d-mhikITDFGsAK~ 223 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKD-GHIKITDFGSAKI 223 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCC-CcEEEeecccccc
Confidence 89999999999999999998765 9999999999999999999999999999999999999999 6999999999985
Q ss_pred cccccc--------------cccccCccceecccccccccccccccccccCC---------------------------C
Q 021127 176 ESLTEM--------------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------N 214 (317)
Q Consensus 176 ~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~ 214 (317)
.+.... ...++||-.|++||++.......+.+- |..+ .
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDi-WAlGCilyQmlaG~PPFra~NeyliFqkI~~l 302 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDL-WALGCILYQMLAGQPPFRAANEYLIFQKIQAL 302 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccch-HHHHHHHHHHhcCCCCCccccHHHHHHHHHHh
Confidence 432111 145789999999999887544443332 2222 1
Q ss_pred CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 215 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 215 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
....++++++.+++||.++|..||.+|+|+.+|.+|
T Consensus 303 ~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 303 DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 234478899999999999999999999999999887
No 15
>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1e-40 Score=298.74 Aligned_cols=239 Identities=30% Similarity=0.538 Sum_probs=196.8
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC---C---eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEE
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---N---QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~---~---~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 90 (317)
+.|++..+++.+.++||+|+||.||+|+.. + ..||||........ ...+...|++|+++++.++|||||++|
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~--~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSEL--TKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccc--cHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 479999999999999999999999999875 1 23899988752211 135577899999999999999999999
Q ss_pred eeeecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcc
Q 021127 91 GACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (317)
Q Consensus 91 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~D 169 (317)
|++... .+++|||+|.||+|.++|++.+. .++..+.+.++.+++.||+|||++++|||||.++|+|++.+ +.+||+|
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~-~~vKISD 305 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKK-GVVKISD 305 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCC-CeEEeCc
Confidence 998655 79999999999999999998765 49999999999999999999999999999999999999997 5789999
Q ss_pred cCcccccccccccc-cccCccceecccccccccccccccccccCC------------------------------CCCCC
Q 021127 170 FGLAREESLTEMMT-AETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPS 218 (317)
Q Consensus 170 fg~a~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~ 218 (317)
||+++......... ...-...|+|||.+... ..+...++|..+ ...+.
T Consensus 306 FGLs~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~ 384 (474)
T KOG0194|consen 306 FGLSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI 384 (474)
T ss_pred cccccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC
Confidence 99998654222222 22356799999998876 333344444433 23444
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCC
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 260 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~ 260 (317)
+...|.++..++.+||..+|++||++.++.+.++.+.....+
T Consensus 385 ~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 385 PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 667789999999999999999999999999999998876554
No 16
>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=2.2e-42 Score=294.82 Aligned_cols=224 Identities=24% Similarity=0.365 Sum_probs=198.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
.+|++.+.||+|.||+|-+|... |+.||||.+++....++ ...-.+.+||+++..|+||||+.+|.+|+.. ...|
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkde--qDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDE--QDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccH--HHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 68999999999999999999774 99999999998776553 3455688999999999999999999999876 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||..+|.|++++...+. +++..+..++.||.+|+.|+|.++++|||||.+|||+|.| +.+||+|||++.......
T Consensus 131 vMEYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N-~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQN-NNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEEecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCC-CCeeeeccchhhhhcccc
Confidence 9999999999999998766 9999999999999999999999999999999999999999 789999999999888888
Q ss_pred ccccccCccceecccccccccccccccccccCCC--------CC------------------CCCCCChHHHHHHHHHhh
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKN--------VR------------------PSAENVPEELSIILTSCW 234 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~--------~~------------------~~~~~~~~~l~~li~~cl 234 (317)
...++||++-|.+||++.+..+.....+.|+.+. .+ -..+.-|....-||+.||
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~gLIRwmL 287 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSDASGLIRWML 287 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCchHHHHHHHHH
Confidence 8899999999999999999888877777776551 01 112345677889999999
Q ss_pred hcCCCCCCCHHHHHHHHH
Q 021127 235 KEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 235 ~~~p~~Rps~~~~~~~l~ 252 (317)
..||++|.|+.+|..|.|
T Consensus 288 mVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 288 MVNPERRATIEDIASHWW 305 (668)
T ss_pred hcCcccchhHHHHhhhhe
Confidence 999999999999999977
No 17
>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=3.5e-42 Score=298.60 Aligned_cols=232 Identities=28% Similarity=0.373 Sum_probs=186.3
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHH---------HHHHHHHHHHHHHHHHhcCCCCeeeE
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEE---------IAKKESRFAREVAMLSRVQHRNLVKF 89 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~---------~~~~~~~~~~E~~~l~~l~h~niv~l 89 (317)
..-++|++.+.||+|.||.|-+|++. ++.||||++.+...... .....+++.+||.+|+++.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 44578999999999999999999986 89999999986543211 00113478899999999999999999
Q ss_pred EeeeecC---ceEEEEEccCCCCHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCce
Q 021127 90 IGACKEP---VMVIVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165 (317)
Q Consensus 90 ~~~~~~~---~~~lv~e~~~~g~L~~~l~~~~~~~-l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~ 165 (317)
+.+..+. .+|||+|||..|.+...=. ... +++.+++.|+.+++.||+|||.+|||||||||+|+||+.+ |++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~-g~V 249 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD-GTV 249 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC-CcE
Confidence 9999764 7999999999888654222 223 8999999999999999999999999999999999999999 899
Q ss_pred EEcccCccccc------ccccccccccCccceeccccccc---ccccccccccccCC-----------------------
Q 021127 166 KLADFGLAREE------SLTEMMTAETGTYRWMAPELYST---VTLRQGEKKHYNHK----------------------- 213 (317)
Q Consensus 166 kl~Dfg~a~~~------~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~~~~~~----------------------- 213 (317)
||+|||.+... +........+|||.|+|||.+.+ ..+.....++|..+
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~ 329 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD 329 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence 99999999754 22223344689999999999887 33444555666655
Q ss_pred ------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 214 ------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 214 ------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
...|..+.+.+.+++||.++|.+||++|.++.+|..|.|-...
T Consensus 330 KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 330 KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 1122334567899999999999999999999999999775443
No 18
>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=4.8e-42 Score=308.34 Aligned_cols=224 Identities=27% Similarity=0.410 Sum_probs=201.3
Q ss_pred CceeecceeccccceEEEEeEE--CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
+-|++++-||.|+.|.|-+|++ +|+.+|||++.+..... ......+.+||-+|+.+.||||+++|+++.+. ++|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s--~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELS--SSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccc--cccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 4578999999999999999988 49999999998763211 13345688999999999999999999999876 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
|.||++||.|.+++...++ +++.++..++.||+.|+.|+|..+|+||||||+|+|++.. +.+||+|||+|.......
T Consensus 90 vlEyv~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~-~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVK-NNIKIADFGMASLEVPGK 166 (786)
T ss_pred EEEecCCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcc-cCEeeeccceeecccCCc
Confidence 9999999999999997666 9999999999999999999999999999999999999988 469999999999888888
Q ss_pred ccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHh
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSC 233 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~c 233 (317)
...+.||++.|.|||++.+..+.....++|+.+ .....|..++.+.++|+.+|
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~m 246 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRM 246 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHH
Confidence 888999999999999999999999999999876 23345788999999999999
Q ss_pred hhcCCCCCCCHHHHHHHHH
Q 021127 234 WKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 234 l~~~p~~Rps~~~~~~~l~ 252 (317)
|..||+.|.|+++|++|.+
T Consensus 247 l~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 247 LDVDPSTRITTEEILKHPF 265 (786)
T ss_pred hccCccccccHHHHhhCch
Confidence 9999999999999999955
No 19
>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]
Probab=100.00 E-value=2.5e-41 Score=273.85 Aligned_cols=227 Identities=24% Similarity=0.348 Sum_probs=183.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l 100 (317)
.+|...++||+|.||.||+|+++ |+.||||.++.....+.. ....++||..|+.++|+||+.++++|.. +.+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi---~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~l 78 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI---NRTALREIKLLQELKHPNIIELIDVFPHKSNLSL 78 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCc---cHHHHHHHHHHHHccCcchhhhhhhccCCCceEE
Confidence 57888999999999999999986 899999999887654322 2246899999999999999999999965 48999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
|+||+ ..+|...+++.. ..++..++..|+.+++.||+|||++.|+||||||.|+||+.+ |.+||+|||+|+......
T Consensus 79 VfEfm-~tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~-g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 79 VFEFM-PTDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSD-GQLKIADFGLARFFGSPN 155 (318)
T ss_pred EEEec-cccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCC-CcEEeecccchhccCCCC
Confidence 99999 579999998744 459999999999999999999999999999999999999999 899999999999765443
Q ss_pred -ccccccCccceecccccccccccccccccccCC----------------------------------------------
Q 021127 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------------------------- 213 (317)
Q Consensus 181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------------------------- 213 (317)
.....+-|..|.|||++-+........+.|+.+
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 334447899999999876644333333333322
Q ss_pred ---CCCC------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 214 ---NVRP------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 214 ---~~~~------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
...| .-...+.++.+|+.+||..||.+|+++.|++++ .++...
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~--~yf~~~ 287 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH--PYFKSL 287 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc--hhhhcC
Confidence 0000 122346778999999999999999999999988 445443
No 20
>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V
Probab=100.00 E-value=5.5e-41 Score=299.25 Aligned_cols=233 Identities=30% Similarity=0.557 Sum_probs=184.0
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeE
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKF 89 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l 89 (317)
+|.|+.++|++.++||+|+||.||+|.+. ++.||||++...... .....+.+|+.++..+ +||||+++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~~h~niv~~ 76 (338)
T cd05102 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA----SEHKALMSELKILIHIGNHLNVVNL 76 (338)
T ss_pred CcccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccch----HHHHHHHHHHHHHHHhccCcceeeE
Confidence 48899999999999999999999999742 467999998754432 2245688999999999 89999999
Q ss_pred EeeeecC--ceEEEEEccCCCCHHHHHHhcC-------------------------------------------------
Q 021127 90 IGACKEP--VMVIVTELLSGGTLRKYLLNMR------------------------------------------------- 118 (317)
Q Consensus 90 ~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------- 118 (317)
++++... .+++||||+++|+|.+++....
T Consensus 77 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (338)
T cd05102 77 LGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGS 156 (338)
T ss_pred EeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcc
Confidence 9988643 6899999999999999997532
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc---cccc
Q 021127 119 -----------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTA 184 (317)
Q Consensus 119 -----------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~ 184 (317)
...+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++...... ....
T Consensus 157 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~-~~~kl~DfG~a~~~~~~~~~~~~~~ 235 (338)
T cd05102 157 TNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGS 235 (338)
T ss_pred cccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCC-CcEEEeecccccccccCcchhcccC
Confidence 1247888999999999999999999999999999999999988 689999999997542211 1122
Q ss_pred ccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHHHHHhh
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSIILTSCW 234 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~cl 234 (317)
..++..|+|||++.+..... ..++|+.+ .....+..++..+.+|+.+||
T Consensus 236 ~~~~~~y~aPE~~~~~~~~~-~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 314 (338)
T cd05102 236 ARLPLKWMAPESIFDKVYTT-QSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACW 314 (338)
T ss_pred CCCCccccCcHHhhcCCCCc-ccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence 34567899999876533221 12222111 111224567889999999999
Q ss_pred hcCCCCCCCHHHHHHHHHHhhh
Q 021127 235 KEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 235 ~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
+.||.+|||+.++++.|+.++.
T Consensus 315 ~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 315 QGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred cCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999998765
No 21
>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=5.4e-41 Score=289.40 Aligned_cols=234 Identities=25% Similarity=0.441 Sum_probs=194.8
Q ss_pred ceecCCceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Q 021127 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89 (317)
Q Consensus 12 ~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 89 (317)
.......|-+.++.|++...||.|..++||+|+.. +..||||++........ ...+.+|+..+..++||||+++
T Consensus 14 ~~~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~----ld~l~kE~~~msl~~HPNIv~~ 89 (516)
T KOG0582|consen 14 ASSSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND----LDALRKEVQTMSLIDHPNIVTY 89 (516)
T ss_pred cccccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh----HHHHHHHHHHhhhcCCCCcceE
Confidence 33445578899999999999999999999999885 89999999988776553 3458899999999999999999
Q ss_pred Eeeee-cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEc
Q 021127 90 IGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (317)
Q Consensus 90 ~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~ 168 (317)
+.+|. +..+|+||.||.+|++.+.+....+..+++..+..|+++++.||.|||++|.||||||+.||||+.+ |.|||+
T Consensus 90 ~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~d-G~VkLa 168 (516)
T KOG0582|consen 90 HCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSD-GTVKLA 168 (516)
T ss_pred EEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCC-CcEEEc
Confidence 99886 5589999999999999999998877779999999999999999999999999999999999999999 899999
Q ss_pred ccCccccc-cccccc----ccccCccceecccc-cccccccccccccccCC---------------------------CC
Q 021127 169 DFGLAREE-SLTEMM----TAETGTYRWMAPEL-YSTVTLRQGEKKHYNHK---------------------------NV 215 (317)
Q Consensus 169 Dfg~a~~~-~~~~~~----~~~~gt~~y~aPE~-~~~~~~~~~~~~~~~~~---------------------------~~ 215 (317)
|||.+-.. ...... .+.+||++|||||+ .....-...+.++|+.+ +.
T Consensus 169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~ 248 (516)
T KOG0582|consen 169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQND 248 (516)
T ss_pred CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence 99986532 211111 55689999999999 44444455556666554 11
Q ss_pred CCC----------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 RPS----------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 ~~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.|. ...++..++.++..||+.||.+|||+.+++++
T Consensus 249 pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 249 PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 110 12356789999999999999999999999886
No 22
>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]
Probab=100.00 E-value=6e-41 Score=295.22 Aligned_cols=225 Identities=25% Similarity=0.349 Sum_probs=186.2
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
.+.-++|++++.||+|+||.||+|+.+ |..+|+|++++..... ..+.+.++.|-++|...++++||+|+..|++.
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~--~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLK--KNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE 214 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHh--hhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence 456689999999999999999999764 9999999999876544 34566788999999999999999999999987
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
.+||||||++||++..+|..... |++..+..++.+++.|+..||+.|+|||||||+|+|||.. |.+||+|||++...
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~~~--L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~-GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRKDT--LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAK-GHIKLSDFGLSTGL 291 (550)
T ss_pred eeEEEEEecCCccHHHHHHhcCc--CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCC-CCEeeccccccchh
Confidence 89999999999999999987655 9999999999999999999999999999999999999999 89999999998521
Q ss_pred cc----------------------cccc--------------------------ccccCccceecccccccccccccccc
Q 021127 177 SL----------------------TEMM--------------------------TAETGTYRWMAPELYSTVTLRQGEKK 208 (317)
Q Consensus 177 ~~----------------------~~~~--------------------------~~~~gt~~y~aPE~~~~~~~~~~~~~ 208 (317)
.. .... ...+|||.|||||++.+..+.. ..+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~-~cD 370 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK-ECD 370 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc-ccc
Confidence 00 0000 1225999999999999876433 334
Q ss_pred cccCC-------------------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCC---CHHHHHHHH
Q 021127 209 HYNHK-------------------------------NVRPSAENVPEELSIILTSCWKEDPNARP---NFTQIIQML 251 (317)
Q Consensus 209 ~~~~~-------------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp---s~~~~~~~l 251 (317)
||+.+ ...|....++.+.++||.+||. ||+.|. +++||-+|.
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HP 446 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHP 446 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCC
Confidence 44443 2334455678999999999999 999996 477887763
No 23
>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.2e-41 Score=297.45 Aligned_cols=222 Identities=24% Similarity=0.323 Sum_probs=182.2
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---Cc
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PV 97 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~ 97 (317)
-+.|+.+++||+|.||.||+|++. |+.||+|.++.......... -..+||.+|++|+||||++|.+...+ +.
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~---t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPI---TAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchH---HHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 357888999999999999999985 88999999987764443222 36789999999999999999998754 48
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
+|+|+|||+ -+|.-++.... -.|++.++..|+.|++.||+|||++||+|||||.+|||||.+ |.+||+|||+|++..
T Consensus 193 iYlVFeYMd-hDL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~-G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 193 IYLVFEYMD-HDLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNN-GVLKIADFGLARFYT 269 (560)
T ss_pred EEEEEeccc-chhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCC-CCEEeccccceeecc
Confidence 999999995 58988887643 239999999999999999999999999999999999999998 899999999999654
Q ss_pred ccc--ccccccCccceecccccccccccccccccccCC---------------------------------------CCC
Q 021127 178 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------------------NVR 216 (317)
Q Consensus 178 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------------------~~~ 216 (317)
... ..+..+-|++|.|||++.+..-.....+.|+.+ ...
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 332 456678899999999988755555444444433 000
Q ss_pred C-----------------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 P-----------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 ~-----------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
| ....++....+|+..+|..||.+|.|+.++++.
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0 123467888999999999999999999999876
No 24
>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-41 Score=300.77 Aligned_cols=217 Identities=27% Similarity=0.436 Sum_probs=185.5
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee-cCceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~l 100 (317)
..|....+||+|+.|.||.|+.. ++.||||.+....... .+.+++|+.+|+..+|+|||++++.+. ...+|+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~-----keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK-----KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc-----hhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 56788899999999999999875 7889999998877644 446889999999999999999999775 458999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
||||++||+|.+.+.... +++.++..|+.+++.||+|||.+||+|||||.+|||++.+ |.+||+|||++......
T Consensus 348 VMEym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~-g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMD-GSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred EEeecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccC-CcEEEeeeeeeecccccc
Confidence 999999999999998754 9999999999999999999999999999999999999999 78999999999865443
Q ss_pred cccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSII 229 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~l 229 (317)
....+.+||++|||||++....+.... ++|+.+ .....++.++..+++|
T Consensus 424 ~KR~TmVGTPYWMAPEVvtrk~YG~KV-DIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdF 502 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTRKPYGPKV-DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDF 502 (550)
T ss_pred CccccccCCCCccchhhhhhcccCccc-cchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHH
Confidence 355677999999999998764444332 233332 2233467889999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 021127 230 LTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~ 250 (317)
+.+||+.|+++|+++.++|+|
T Consensus 503 L~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 503 LDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHhhcchhcCCCHHHHhcC
Confidence 999999999999999999998
No 25
>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.8e-40 Score=292.65 Aligned_cols=225 Identities=34% Similarity=0.548 Sum_probs=174.7
Q ss_pred CceeecceeccccceEEEEeEECC-eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC--ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP--VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~l 100 (317)
++|.-.++||+|+||.||+|...+ ..||||.+....... ..+|.+|+.++.+++|||+|+|+|+|.+. ..+|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-----~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-----EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-----hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 456666899999999999999985 899999887665431 23499999999999999999999999865 3899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG---IIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
|+||+++|+|.++|.......++|..+++|+.++|.||+|||+.. ||||||||+|||+|++ ..+||+|||+|+...
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~-~~aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED-FNAKLSDFGLAKLGP 228 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC-CCEEccCccCcccCC
Confidence 999999999999998755326999999999999999999999864 9999999999999998 589999999997665
Q ss_pred c-ccccccc-cCccceecccccccccccccccccccCC---------------------------------------CCC
Q 021127 178 L-TEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------------------NVR 216 (317)
Q Consensus 178 ~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------------------~~~ 216 (317)
. ....... .||.+|+|||++....... ..++|+.+ ...
T Consensus 229 ~~~~~~~~~~~gt~gY~~PEy~~~g~lt~-KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD 307 (361)
T KOG1187|consen 229 EGDTSVSTTVMGTFGYLAPEYASTGKLTE-KSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD 307 (361)
T ss_pred ccccceeeecCCCCccCChhhhccCCcCc-ccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC
Confidence 4 3333333 8999999999875421111 11111111 001
Q ss_pred CC-C-CCCh--H---HHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 217 PS-A-ENVP--E---ELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 217 ~~-~-~~~~--~---~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
+. . ...+ . .+..+..+|++.+|.+||+|.++++.|....
T Consensus 308 ~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 308 PRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 11 1 2222 2 2566778999999999999999998885443
No 26
>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]
Probab=100.00 E-value=7e-41 Score=275.03 Aligned_cols=220 Identities=27% Similarity=0.335 Sum_probs=186.6
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
-++|++.+.||.|+||+|.+++.+ +..+|+|++.+...-. .++.+...+|.++|+.+.||+++++++.+.+. .+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVk--lKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVK--LKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHH--HHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 356889999999999999999886 8999999998766543 46677889999999999999999999999876 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+||||.+||.|..++++.+. +++..+..++.||+.||+|||+++|++|||||+|||+|.+ |.+||+|||+|+.....
T Consensus 121 mvmeyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~-G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQN-GHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEEeccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccC-CcEEEEeccceEEecCc
Confidence 99999999999999998665 9999999999999999999999999999999999999999 89999999999976543
Q ss_pred cccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
+.+.||||.|+|||++........ .+||..+ .....|..++.++++|+..
T Consensus 198 --T~TlCGTPeYLAPEii~sk~ynka-vDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 198 --TWTLCGTPEYLAPEIIQSKGYNKA-VDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred --EEEecCCccccChHHhhcCCCCcc-hhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 567899999999999887554433 3344333 1223467788999999999
Q ss_pred hhhcCCCCC-----CCHHHHHHH
Q 021127 233 CWKEDPNAR-----PNFTQIIQM 250 (317)
Q Consensus 233 cl~~~p~~R-----ps~~~~~~~ 250 (317)
+|+.|-.+| ....+|..|
T Consensus 275 LL~vD~t~R~gnlknG~~dIk~H 297 (355)
T KOG0616|consen 275 LLQVDLTKRFGNLKNGVEDIKNH 297 (355)
T ss_pred HHhhhhHhhhcCcCCCccccccC
Confidence 999999999 344555554
No 27
>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]
Probab=100.00 E-value=9.6e-41 Score=278.35 Aligned_cols=226 Identities=27% Similarity=0.338 Sum_probs=184.4
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---Cce
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PVM 98 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~ 98 (317)
++|+.+++|++|.||.||+|+++ ++.||+|.++-....+... ---++||.+|.+++|||||.+-.+... +.+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFP---ItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFP---ITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCc---chhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 57889999999999999999986 8999999998654332211 135789999999999999999988754 369
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
|+|||||+ -+|..++...+ +++...++..++.|+++||+|||.+.|+|||||++|+|++.. |.+||+|||+|+....
T Consensus 153 y~VMe~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~-G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 153 YIVMEYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHK-GILKIADFGLAREYGS 229 (419)
T ss_pred eeeHHHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccC-CcEEecccchhhhhcC
Confidence 99999994 69999998865 459999999999999999999999999999999999999998 8999999999997654
Q ss_pred c-cccccccCccceecccccccccccccccccccCC--------------------------------------------
Q 021127 179 T-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------------------- 213 (317)
Q Consensus 179 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------------------- 213 (317)
. ...+..+-|+.|.|||++.+....+...+.|+.+
T Consensus 230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 4 3456667899999999988765555555555433
Q ss_pred -------------CCCC--CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 214 -------------NVRP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 214 -------------~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+.+. ....+++.-.+|+..+|..||.+|.|+.+.++| .++..
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e 366 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRE 366 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--ccccc
Confidence 0000 011256888999999999999999999999998 55554
No 28
>PTZ00263 protein kinase A catalytic subunit; Provisional
Probab=100.00 E-value=6.5e-40 Score=291.17 Aligned_cols=222 Identities=24% Similarity=0.309 Sum_probs=182.0
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
..++|++.+.||+|+||.||+|++. ++.||||++....... ......+.+|+.++++++||||+++++++.++ ..
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK--MKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhh--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 3478999999999999999999885 7899999997543211 23345688999999999999999999998765 89
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+++++|.+++..... +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGR--FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK-GHVKVTDFGFAKKVPD 170 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCC-CCEEEeeccCceEcCC
Confidence 999999999999999987544 8999999999999999999999999999999999999988 7999999999986533
Q ss_pred ccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHH
Q 021127 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~ 231 (317)
. .....||+.|+|||++.+.... ...++|+.+ .....+..++..+++|+.
T Consensus 171 ~--~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 247 (329)
T PTZ00263 171 R--TFTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVK 247 (329)
T ss_pred C--cceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHH
Confidence 2 2345799999999998765432 334444433 111224457889999999
Q ss_pred HhhhcCCCCCCC-----HHHHHHHH
Q 021127 232 SCWKEDPNARPN-----FTQIIQML 251 (317)
Q Consensus 232 ~cl~~~p~~Rps-----~~~~~~~l 251 (317)
+||+.||.+||+ +++++.|.
T Consensus 248 ~~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 248 GLLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 999999999986 78888773
No 29
>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]
Probab=100.00 E-value=5e-41 Score=296.96 Aligned_cols=226 Identities=30% Similarity=0.532 Sum_probs=194.7
Q ss_pred ecCCceeecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 14 KLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 14 ~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
+-++.|+|+.+.+.-++-||+|+.|.||+|+..++.||||.++.-. ..+|+-|++|+|+||+.+.|+|
T Consensus 114 qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~elk------------ETdIKHLRkLkH~NII~FkGVC 181 (904)
T KOG4721|consen 114 QQEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRELK------------ETDIKHLRKLKHPNIITFKGVC 181 (904)
T ss_pred hhhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhhh------------hhhHHHHHhccCcceeeEeeee
Confidence 4467899999999999999999999999999999999999875321 2367889999999999999999
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
.+. .++||||||..|-|+..|+.... ++......|..+||.|+.|||.+.|||||||.-||||..+ ..+||+|||.
T Consensus 182 tqsPcyCIiMEfCa~GqL~~VLka~~~--itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~-d~VKIsDFGT 258 (904)
T KOG4721|consen 182 TQSPCYCIIMEFCAQGQLYEVLKAGRP--ITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYD-DVVKISDFGT 258 (904)
T ss_pred cCCceeEEeeeccccccHHHHHhccCc--cCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeecc-ceEEeccccc
Confidence 875 89999999999999999997555 8999999999999999999999999999999999999988 5899999999
Q ss_pred ccccccccccccccCccceecccccccccccccccc-------------------------cccCC---CCCCCCCCChH
Q 021127 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK-------------------------HYNHK---NVRPSAENVPE 224 (317)
Q Consensus 173 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-------------------------~~~~~---~~~~~~~~~~~ 224 (317)
++........-.++||..|||||++.........+. +|..+ ...+.|..+|+
T Consensus 259 S~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~ 338 (904)
T KOG4721|consen 259 SKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPD 338 (904)
T ss_pred hHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCch
Confidence 997666566667899999999999987554433221 12222 23566889999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
-++-||++||+..|..||++.+++.||+-.
T Consensus 339 GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 339 GFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred HHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 999999999999999999999999998754
No 30
>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit. Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce
Probab=100.00 E-value=1.1e-39 Score=294.43 Aligned_cols=246 Identities=31% Similarity=0.486 Sum_probs=194.1
Q ss_pred CCCccccccceecCCceeecCCceeecceeccccceEEEEeEE-------CCeEEEEEEeecCCChHHHHHHHHHHHHHH
Q 021127 3 SRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKY-------KNQTVAIKIVHKGETPEEIAKKESRFAREV 75 (317)
Q Consensus 3 ~~s~~~~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~ 75 (317)
++=.++.|..+..+..|.++.++|++.+.||+|+||.||+|++ ++..||||++...... .....+.+|+
T Consensus 14 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~----~~~~~~~~Ei 89 (375)
T cd05104 14 NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL----TEREALMSEL 89 (375)
T ss_pred ceEEEecCCCCCCccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc----HHHHHHHHHH
Confidence 3445778889999999999999999999999999999999864 2568999998754432 2245688999
Q ss_pred HHHHhc-CCCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC----------------------------------
Q 021127 76 AMLSRV-QHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP---------------------------------- 119 (317)
Q Consensus 76 ~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~---------------------------------- 119 (317)
.++..+ +||||+++++++.++ ..++|||||++|+|.+++.....
T Consensus 90 ~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (375)
T cd05104 90 KVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYM 169 (375)
T ss_pred HHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhh
Confidence 999999 899999999999765 88999999999999999975321
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC
Q 021127 120 ---------------------------------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 160 (317)
Q Consensus 120 ---------------------------------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~ 160 (317)
..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~ 249 (375)
T cd05104 170 DMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTH 249 (375)
T ss_pred hcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEEC
Confidence 13788899999999999999999999999999999999998
Q ss_pred CCCceEEcccCcccccccccc---cccccCccceecccccccccccccccccccCC------------------------
Q 021127 161 DLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------ 213 (317)
Q Consensus 161 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------ 213 (317)
+ +.+||+|||+++....... .....++..|+|||++.+..... ..++|+.+
T Consensus 250 ~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~ 327 (375)
T cd05104 250 G-RITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTF-ESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY 327 (375)
T ss_pred C-CcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCC-CCCHHHHHHHHHHHHhcCCCCCCCCCchHHHH
Confidence 7 6899999999975432211 11223466899999876533221 12222111
Q ss_pred ------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 214 ------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 214 ------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
.....+...+.++++|+.+||+.||++||++.++++.|++.
T Consensus 328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 328 KMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 01122345678999999999999999999999999998864
No 31
>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=8.3e-40 Score=287.81 Aligned_cols=223 Identities=24% Similarity=0.381 Sum_probs=194.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c-eE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V-MV 99 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~-~~ 99 (317)
++|..++++|+|+||.+++.+++ +..+|+|.+......+ ..++...+|+.++.+++|||||.+.+.|.++ . .+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~---~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE---PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc---hhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 68999999999999999988776 7889999998766544 2334678899999999999999999998654 5 89
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
|||+||+||+|.+.+...+...++++.++.|+.|++.|+.|||+++|+|||||+.|||++.+ +.+||+|||+|+.....
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~-~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKD-KKVKLGDFGLAKILNPE 159 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcccc-CceeecchhhhhhcCCc
Confidence 99999999999999998777779999999999999999999999999999999999999999 68899999999987766
Q ss_pred c-ccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHH
Q 021127 180 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 180 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~ 231 (317)
. ...+..||+.||.||++.+..+....+.|.... ...|.+..++.+++.+|.
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~ 239 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVK 239 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHH
Confidence 5 667789999999999999988776554432221 235667888999999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 021127 232 SCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 232 ~cl~~~p~~Rps~~~~~~~ 250 (317)
.||..+|+.||++.+++.+
T Consensus 240 ~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 240 SMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHhhcCCccCCCHHHHhhC
Confidence 9999999999999999986
No 32
>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po
Probab=100.00 E-value=6.5e-39 Score=290.30 Aligned_cols=222 Identities=23% Similarity=0.316 Sum_probs=175.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
..|++++.||+|+||+||+|++. ++.||||++....... ......+.+|+.+++.++|+||+++++++.+. .+++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 78 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLN--RNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF 78 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEE
Confidence 36889999999999999999885 7899999997644322 23345788999999999999999999999765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
||||+++|+|.+++..... +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 79 v~E~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~-~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 79 VMDYIPGGDMMSLLIRMEV--FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred EEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCC-CCEEEeeCcCCccccccc
Confidence 9999999999999986544 8999999999999999999999999999999999999988 79999999997532100
Q ss_pred -----------------------------------------------cccccccCccceecccccccccccccccccccC
Q 021127 180 -----------------------------------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH 212 (317)
Q Consensus 180 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 212 (317)
......+||+.|+|||++.+.... ...++|+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSl 234 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSV 234 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-Cccceeeh
Confidence 001234699999999998764432 33444443
Q ss_pred C-------------------------------CCCCCCCCChHHHHHHHHH--hhhcCCCCCCCHHHHHHHH
Q 021127 213 K-------------------------------NVRPSAENVPEELSIILTS--CWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 213 ~-------------------------------~~~~~~~~~~~~l~~li~~--cl~~~p~~Rps~~~~~~~l 251 (317)
+ ...+....++.++.+||.+ |+..+|..||++.++++|-
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp 306 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHP 306 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCc
Confidence 3 0111223578899999998 5556666799999999884
No 33
>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i
Probab=100.00 E-value=4e-39 Score=280.55 Aligned_cols=223 Identities=24% Similarity=0.332 Sum_probs=180.1
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
.|++.+.||+|+||.||++.+. ++.||+|.+....... ......+.+|+.++.+++|+||+++++++.+. ..++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh--hhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence 4788899999999999999874 8999999987654322 12344678999999999999999999988654 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
|||+++|+|..++.......+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++........
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR-GHIRISDLGLAVQIPEGET 157 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC-CCEEEeeCCCcEEcCCCCe
Confidence 999999999988876554458999999999999999999999999999999999999988 6899999999986543333
Q ss_pred cccccCccceecccccccccccccccccccCC-------------------------------CCCCCCCCChHHHHHHH
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVPEELSIIL 230 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l~~li 230 (317)
.....||..|+|||++.+..+.. ..++|+.+ .....+..++.++.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~-~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTF-SPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCc-ccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 34557899999999987644332 23333322 01112346788999999
Q ss_pred HHhhhcCCCCCCC-----HHHHHHHH
Q 021127 231 TSCWKEDPNARPN-----FTQIIQML 251 (317)
Q Consensus 231 ~~cl~~~p~~Rps-----~~~~~~~l 251 (317)
.+||+.||.+||+ +++++++-
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~ 262 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHP 262 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence 9999999999997 88888873
No 34
>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]
Probab=100.00 E-value=1.4e-40 Score=294.09 Aligned_cols=219 Identities=31% Similarity=0.456 Sum_probs=187.8
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|.+.+.||+|+||.||+|+.+ .+.||+|.+.+....+ +....+.+|++++++++|||||.++++|+.. ++|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~---k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~v 78 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE---KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWV 78 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch---HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEE
Confidence 57889999999999999999876 7899999998876554 4455688999999999999999999999876 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
|.|||.| +|..+|...+. ++++.+..++.+++.||.|||+++|+|||+||.|||+..+ +.+|+||||+|+.....
T Consensus 79 Vte~a~g-~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~-~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 79 VTEYAVG-DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKG-GTLKLCDFGLARAMSTNT 154 (808)
T ss_pred Eehhhhh-hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCC-CceeechhhhhhhcccCc
Confidence 9999966 99999987665 9999999999999999999999999999999999999998 79999999999976544
Q ss_pred cccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
...+...|||.|||||++.+..+....+- |+.+ .....+.+.+..+.+|+..
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDl-WslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~g 233 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDL-WSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQG 233 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhH-HHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHH
Confidence 34456679999999999987655443332 2222 2233466889999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 021127 233 CWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 233 cl~~~p~~Rps~~~~~~~ 250 (317)
.|..||.+|.++.+++.|
T Consensus 234 LL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 234 LLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HhhcChhhcccHHHHhcC
Confidence 999999999999999987
No 35
>PHA02988 hypothetical protein; Provisional
Probab=100.00 E-value=4.6e-39 Score=279.83 Aligned_cols=235 Identities=20% Similarity=0.264 Sum_probs=190.0
Q ss_pred ecCCceeecCCceeec--ceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 021127 14 KLDAKWLIDPKHLFVG--PRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (317)
Q Consensus 14 ~~~~~~~i~~~~y~~~--~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 91 (317)
.+++.+.|+++++... ..||+|++|.||+|.++++.||||.+....... ......+.+|+.++.+++||||++++|
T Consensus 8 ~~~~~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 8 YINDIKCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGH--KVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred hcCcceecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEecccccccc--HHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 3566778888888887 779999999999999999999999997654322 233456889999999999999999999
Q ss_pred eeec-----CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEeeCCCCce
Q 021127 92 ACKE-----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTI 165 (317)
Q Consensus 92 ~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~Dlkp~Nill~~~~~~~ 165 (317)
++.+ ...++||||+++|+|.+++..... +++...+.++.|++.||.|||+. +++||||||+||+++.+ +.+
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~-~~~ 162 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD--LSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN-YKL 162 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhhCCC--CChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCC-CcE
Confidence 9865 268899999999999999987543 89999999999999999999985 99999999999999998 799
Q ss_pred EEcccCcccccccccccccccCccceecccccccc-cccccccccccCC-----------------------------CC
Q 021127 166 KLADFGLAREESLTEMMTAETGTYRWMAPELYSTV-TLRQGEKKHYNHK-----------------------------NV 215 (317)
Q Consensus 166 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~~-----------------------------~~ 215 (317)
||+|||+++...... ....|+..|+|||++.+. .......++|+.+ ..
T Consensus 163 kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~ 240 (283)
T PHA02988 163 KIICHGLEKILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNS 240 (283)
T ss_pred EEcccchHhhhcccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC
Confidence 999999997543322 234688999999998652 1122233333322 11
Q ss_pred CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 216 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 216 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
.+.+..++.++.+|+.+||+.||.+|||+.++++.|..+.
T Consensus 241 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 241 LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 2224467899999999999999999999999999988764
No 36
>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=7.9e-41 Score=267.13 Aligned_cols=225 Identities=23% Similarity=0.342 Sum_probs=191.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|.+++.||+|-||.||.|+.+ +-.||+|++.+..... .....++.+|+++-..|+||||+++|++|.+. ..|+
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~--~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILK--TQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHH--hcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 67999999999999999999886 6779999998766433 34456788999999999999999999999876 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
++||...|+|++.|.......+++.....++.|++.||.|+|.++||||||||+|+|++.. +.+||+|||-+...+ ..
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~-~~lkiAdfGwsV~~p-~~ 177 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAP-SN 177 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCC-CCeeccCCCceeecC-CC
Confidence 9999999999999997666679999999999999999999999999999999999999998 799999999998665 34
Q ss_pred ccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHh
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSC 233 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~c 233 (317)
...+.|||..|.+||+..+...+...+.| ..+ .....|..++...+++|.+|
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w-~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~l 256 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLW-SLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISRL 256 (281)
T ss_pred CceeeecccccCCHhhcCCCCccchhhHH-HHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHHH
Confidence 45678999999999998775443332221 111 12234678999999999999
Q ss_pred hhcCCCCCCCHHHHHHHHHH
Q 021127 234 WKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 234 l~~~p~~Rps~~~~~~~l~~ 253 (317)
+..+|.+|....|+++|.|-
T Consensus 257 l~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 257 LVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred hccCccccccHHHHhhhHHH
Confidence 99999999999999999663
No 37
>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be
Probab=100.00 E-value=2.7e-39 Score=286.50 Aligned_cols=215 Identities=26% Similarity=0.314 Sum_probs=175.0
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccC
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLS 106 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~ 106 (317)
+.||+|+||.||++++. ++.||||++....... .....++.+|+.++++++||||+++++++.++ ..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIA--KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence 46999999999999875 8899999997543221 23345678899999999999999999998765 8999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-cccccccc
Q 021127 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTAE 185 (317)
Q Consensus 107 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~~ 185 (317)
+++|.+++...+. +++..+..++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++... ........
T Consensus 79 ~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~~~~ 155 (323)
T cd05571 79 GGELFFHLSRERV--FSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-CCEEEeeCCCCcccccCCCcccce
Confidence 9999999986544 8999999999999999999999999999999999999988 789999999987532 22233445
Q ss_pred cCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcCC
Q 021127 186 TGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKEDP 238 (317)
Q Consensus 186 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~p 238 (317)
+||+.|+|||++.+.... ...++|+.+ .....+..++.++.+||.+||+.||
T Consensus 156 ~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP 234 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 234 (323)
T ss_pred ecCccccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 799999999998764433 234444433 1112245678999999999999999
Q ss_pred CCCC-----CHHHHHHH
Q 021127 239 NARP-----NFTQIIQM 250 (317)
Q Consensus 239 ~~Rp-----s~~~~~~~ 250 (317)
++|| ++.++++|
T Consensus 235 ~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 235 KQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHcCCCCCCCHHHHHcC
Confidence 9999 79999887
No 38
>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti
Probab=100.00 E-value=3.8e-39 Score=290.84 Aligned_cols=243 Identities=29% Similarity=0.495 Sum_probs=191.1
Q ss_pred cccccceecCCceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHH
Q 021127 7 FYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLS 79 (317)
Q Consensus 7 ~~~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~ 79 (317)
|..+..+.....|.++.++|++.+.||+|+||.||+|.+. +..||||++....... ....+.+|+.+++
T Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~il~ 96 (374)
T cd05106 21 FIDPTQLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD----EREALMSELKILS 96 (374)
T ss_pred eeCCccccccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHH----HHHHHHHHHHHHH
Confidence 5556667778899999999999999999999999998752 3579999997654432 2456889999999
Q ss_pred hc-CCCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcC---------------------------------------
Q 021127 80 RV-QHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMR--------------------------------------- 118 (317)
Q Consensus 80 ~l-~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~--------------------------------------- 118 (317)
.+ +|+||+++++++.+. ..++||||+++|+|.+++....
T Consensus 97 ~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (374)
T cd05106 97 HLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQ 176 (374)
T ss_pred hhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccc
Confidence 99 899999999998765 8999999999999999986432
Q ss_pred -----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcc
Q 021127 119 -----------------------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (317)
Q Consensus 119 -----------------------------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~D 169 (317)
...+++..++.|+.||+.||+|||++||+||||||+||+++.+ +.+||+|
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~-~~~kL~D 255 (374)
T cd05106 177 GSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDG-RVAKICD 255 (374)
T ss_pred ccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCC-CeEEEee
Confidence 1237888999999999999999999999999999999999987 6899999
Q ss_pred cCcccccccccc---cccccCccceecccccccccccccccccccCC------------------------------CCC
Q 021127 170 FGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVR 216 (317)
Q Consensus 170 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~ 216 (317)
||+++....... .....++..|+|||++....+.. ..++|+.+ ...
T Consensus 256 fGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~ 334 (374)
T cd05106 256 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTV-QSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM 334 (374)
T ss_pred ceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCc-cccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc
Confidence 999975432211 11223566899999875433221 12222211 011
Q ss_pred CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 217 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 217 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
..+..++.++.+++.+||+.||.+||++.++++.|++++
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 123456889999999999999999999999999998764
No 39
>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]
Probab=100.00 E-value=1.4e-39 Score=301.03 Aligned_cols=236 Identities=30% Similarity=0.512 Sum_probs=198.1
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEE
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 90 (317)
...|.+.++++.+.||+|+||+||+|+.. ...||||.++..... ..+++|.+|++++..++|||||+|+
T Consensus 480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~----~~~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN----QARQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH----HHHHHHHHHHHHHHhccCCCeEEEE
Confidence 56799999999999999999999999874 467999999876653 3577899999999999999999999
Q ss_pred eeeecC-ceEEEEEccCCCCHHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 021127 91 GACKEP-VMVIVTELLSGGTLRKYLLNMRP------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 157 (317)
Q Consensus 91 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nil 157 (317)
|+|.++ ..++|+|||..|+|.+||+...+ ..++..+.+.|+.|||.||.||-++.+|||||..+|+|
T Consensus 556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCL 635 (774)
T KOG1026|consen 556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCL 635 (774)
T ss_pred EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhce
Confidence 999766 89999999999999999986542 22889999999999999999999999999999999999
Q ss_pred eeCCCCceEEcccCcccccccccccccc---cCccceecccccccccccccccc-----------------cccC-----
Q 021127 158 LTEDLKTIKLADFGLAREESLTEMMTAE---TGTYRWMAPELYSTVTLRQGEKK-----------------HYNH----- 212 (317)
Q Consensus 158 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~---~gt~~y~aPE~~~~~~~~~~~~~-----------------~~~~----- 212 (317)
|.++ -.|||+|||+++.....+..... .-..+||+||.+....+....+. ++..
T Consensus 636 Vge~-l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV 714 (774)
T KOG1026|consen 636 VGEN-LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV 714 (774)
T ss_pred eccc-eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH
Confidence 9999 48999999999976555444332 34679999998776544433222 2211
Q ss_pred ------CCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 213 ------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 213 ------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
+...+.|+++|.+++.||..||+.+|.+||++.||-..|.++....
T Consensus 715 Ie~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 715 IECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 1446678999999999999999999999999999999999887543
No 40
>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k
Probab=100.00 E-value=1.2e-38 Score=279.96 Aligned_cols=226 Identities=27% Similarity=0.463 Sum_probs=176.8
Q ss_pred ecCCceeecceeccccceEEEEeEEC------------------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK------------------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ 82 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~------------------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 82 (317)
+..++|++.++||+|+||.||++.+. +..||+|++...... ....+|.+|+.++.+++
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~ 77 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK----NARNDFLKEVKILSRLK 77 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH----HHHHHHHHHHHHHhhcC
Confidence 45678999999999999999999752 346999998765432 23557899999999999
Q ss_pred CCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhC
Q 021127 83 HRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP-----------------RCLDVCVAIGFALDIARAMECLHSH 144 (317)
Q Consensus 83 h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-----------------~~l~~~~~~~i~~~i~~~L~~lH~~ 144 (317)
||||+++++++.+. ..++||||+++++|.+++..... ..+++..++.++.||+.||+|||+.
T Consensus 78 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 78 DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred CCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 99999999998754 78999999999999999865321 2367888999999999999999999
Q ss_pred CccccCCCCCcEEeeCCCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccCC--------
Q 021127 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------- 213 (317)
Q Consensus 145 ~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------- 213 (317)
||+||||||+|||++.+ +.+||+|||+++...... ......++..|+|||++....... ..++|+.+
T Consensus 158 ~ivH~dlkp~Nill~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~~l~el~~ 235 (304)
T cd05096 158 NFVHRDLATRNCLVGEN-LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTT-ASDVWAFGVTLWEILM 235 (304)
T ss_pred CccccCcchhheEEcCC-ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCc-hhhhHHHHHHHHHHHH
Confidence 99999999999999988 789999999997543221 122334578899999875433221 12222211
Q ss_pred -----------------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 -----------------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 -----------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.....+..++..+.+|+.+||+.||.+|||+.++.+.|+
T Consensus 236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 236 LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred ccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 001123456889999999999999999999999988765
No 41
>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-
Probab=100.00 E-value=1.2e-38 Score=289.00 Aligned_cols=239 Identities=28% Similarity=0.498 Sum_probs=189.0
Q ss_pred ceecCCceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-C
Q 021127 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-H 83 (317)
Q Consensus 12 ~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h 83 (317)
.+..+++|.++.++|+++++||+|+||.||+|.+. +..||||++...... ...+.+.+|+.+++++. |
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~----~~~~~~~~Ei~~l~~l~~H 100 (400)
T cd05105 25 QLPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS----SEKQALMSELKIMTHLGPH 100 (400)
T ss_pred cCCCCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh----HHHHHHHHHHHHHHhcCCC
Confidence 35566899999999999999999999999999863 246999999765432 23456899999999995 9
Q ss_pred CCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcC--------------------------------------------
Q 021127 84 RNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMR-------------------------------------------- 118 (317)
Q Consensus 84 ~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------- 118 (317)
|||+++++++.+. ..++|||||++|+|.+++....
T Consensus 101 pnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (400)
T cd05105 101 LNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDM 180 (400)
T ss_pred CCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccc
Confidence 9999999999765 8999999999999999986532
Q ss_pred --------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 021127 119 --------------------------------------------------PRCLDVCVAIGFALDIARAMECLHSHGIIH 148 (317)
Q Consensus 119 --------------------------------------------------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH 148 (317)
...+++..++.++.|++.||+|||+++|+|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH 260 (400)
T cd05105 181 KQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVH 260 (400)
T ss_pred ccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 123788889999999999999999999999
Q ss_pred cCCCCCcEEeeCCCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccCC------------
Q 021127 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------ 213 (317)
Q Consensus 149 ~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------ 213 (317)
|||||+||+++.+ +.+||+|||+++...... ......++..|+|||++.+..... ..++|+.+
T Consensus 261 ~dikp~Nill~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwSlGvil~ellt~g~~ 338 (400)
T cd05105 261 RDLAARNVLLAQG-KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT-LSDVWSYGILLWEIFSLGGT 338 (400)
T ss_pred CCCChHhEEEeCC-CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCc-hhhHHHHHHHHHHHHHCCCC
Confidence 9999999999988 689999999997543221 112234678899999876532221 12222211
Q ss_pred ------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 214 ------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 214 ------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
...+.+..++.++.+++.+||+.||++||++.++.+.|..++.
T Consensus 339 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 339 PYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred CCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1122345678899999999999999999999999999987653
No 42
>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=9.8e-39 Score=284.07 Aligned_cols=223 Identities=25% Similarity=0.287 Sum_probs=178.1
Q ss_pred ceeecceeccccceEEEEeEE-----CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-c
Q 021127 25 HLFVGPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-V 97 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 97 (317)
+|++.++||+|+||.||+++. +++.||+|++.+..... .......+..|+.++..+ +|+||+++++++.+. .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ-KAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhh-hhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence 588999999999999999876 37889999987533211 123345678899999999 599999999988755 7
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++||||+++|+|.+++..... +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~-~~~kl~DfG~~~~~~ 156 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE-GHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCC-CCEEEeeCcCCcccc
Confidence 8999999999999999976544 8999999999999999999999999999999999999988 799999999997532
Q ss_pred cc--cccccccCccceecccccccccccccccccccCCC-------------------------------CCCCCCCChH
Q 021127 178 LT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKN-------------------------------VRPSAENVPE 224 (317)
Q Consensus 178 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~ 224 (317)
.. .......||+.|+|||++.+........++|+.+. ..+.+..++.
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGP 236 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCH
Confidence 22 12234579999999999876443334455555440 0112345778
Q ss_pred HHHHHHHHhhhcCCCCCC-----CHHHHHHHH
Q 021127 225 ELSIILTSCWKEDPNARP-----NFTQIIQML 251 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rp-----s~~~~~~~l 251 (317)
.+.+++.+||+.||++|| ++++++++.
T Consensus 237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 899999999999999999 788888873
No 43
>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.3e-40 Score=286.59 Aligned_cols=222 Identities=25% Similarity=0.402 Sum_probs=186.9
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
.....|...+.||+|+||.||+|.+. ++.||+|++......++ ..++.+|+.++.+++++||.++|+.+..+ .
T Consensus 10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de----Iediqqei~~Ls~~~~~~it~yygsyl~g~~ 85 (467)
T KOG0201|consen 10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE----IEDIQQEISVLSQCDSPNITEYYGSYLKGTK 85 (467)
T ss_pred CcccccccchhccccccceeeeeeeccccceEEEEEechhhcchh----hHHHHHHHHHHHhcCcchHHhhhhheeeccc
Confidence 34467788899999999999999886 88999999998776543 45688999999999999999999988655 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
+|++||||.||++.+.++.... +++..+..++.+++.||.|||+++.+|||||+.||++..+ |.+||+|||++-...
T Consensus 86 LwiiMey~~gGsv~~lL~~~~~--~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~-g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLLKSGNI--LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES-GDVKLADFGVAGQLT 162 (467)
T ss_pred HHHHHHHhcCcchhhhhccCCC--CccceeeeehHHHHHHhhhhhhcceecccccccceeEecc-CcEEEEecceeeeee
Confidence 9999999999999999986443 5888899999999999999999999999999999999998 899999999998665
Q ss_pred cc-cccccccCccceecccccccccccccccccccCC---------------------------CCCCC-CCCChHHHHH
Q 021127 178 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPS-AENVPEELSI 228 (317)
Q Consensus 178 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~-~~~~~~~l~~ 228 (317)
.. ....+++||+.|||||++.. .....+.++|+.+ ...|. ...++..+++
T Consensus 163 ~~~~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kE 241 (467)
T KOG0201|consen 163 NTVKRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKE 241 (467)
T ss_pred chhhccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHH
Confidence 44 33377899999999999984 3444555566554 11111 3367889999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 021127 229 ILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 229 li~~cl~~~p~~Rps~~~~~~~ 250 (317)
||..||+.||+.||++.++++|
T Consensus 242 FV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 242 FVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred HHHHHhhcCcccCcCHHHHhhh
Confidence 9999999999999999999886
No 44
>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase. Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor
Probab=100.00 E-value=3.5e-38 Score=280.31 Aligned_cols=223 Identities=24% Similarity=0.306 Sum_probs=178.7
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|.+.+.||+|+||.||++++. ++.||||++....... ......+.+|+.+++.++|+||+++++++.+. ..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLA--QETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence 47899999999999999999875 8899999998643211 23455688899999999999999999988765 7999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRT-GHIKLADFGSAARLTANK 156 (330)
T ss_pred EECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCC-CCEEeccCCCCeECCCCC
Confidence 999999999999998752 249999999999999999999999999999999999999988 799999999997543322
Q ss_pred c--cccccCccceeccccccccc-----ccccccccccCCC-------------------------------CCCCCCCC
Q 021127 181 M--MTAETGTYRWMAPELYSTVT-----LRQGEKKHYNHKN-------------------------------VRPSAENV 222 (317)
Q Consensus 181 ~--~~~~~gt~~y~aPE~~~~~~-----~~~~~~~~~~~~~-------------------------------~~~~~~~~ 222 (317)
. .....||+.|+|||++.... ......++|+.+. ..+....+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence 1 22346899999999986421 1122334444330 01122357
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
+.++.+|+..||. +|.+||+++++++|-
T Consensus 237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~ 264 (330)
T cd05601 237 SSDFLDLIQSLLC-GQKERLGYEGLCCHP 264 (330)
T ss_pred CHHHHHHHHHHcc-ChhhCCCHHHHhCCC
Confidence 8899999999998 999999999999873
No 45
>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]
Probab=100.00 E-value=4.3e-39 Score=287.32 Aligned_cols=234 Identities=30% Similarity=0.546 Sum_probs=197.0
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC----C--eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEE
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK----N--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~----~--~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 90 (317)
.++.++++.+.+.++||.|.||.||+|.++ | -.||||.-+.....+. .+.|+.|..+++.++||||++|+
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~----tekflqEa~iMrnfdHphIikLI 457 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD----TEKFLQEASIMRNFDHPHIIKLI 457 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh----HHHHHHHHHHHHhCCCcchhhee
Confidence 378899999999999999999999999885 2 3588998777665543 56799999999999999999999
Q ss_pred eeeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEccc
Q 021127 91 GACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (317)
Q Consensus 91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Df 170 (317)
|+|.+...|||||+++-|.|..||+.++.. ++......++.||+.||+|||++++|||||..+|||+.+. ..+||+||
T Consensus 458 Gv~~e~P~WivmEL~~~GELr~yLq~nk~s-L~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp-~CVKLaDF 535 (974)
T KOG4257|consen 458 GVCVEQPMWIVMELAPLGELREYLQQNKDS-LPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSP-QCVKLADF 535 (974)
T ss_pred eeeeccceeEEEecccchhHHHHHHhcccc-chHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCc-ceeeeccc
Confidence 999999999999999999999999986644 9999999999999999999999999999999999999988 68999999
Q ss_pred Cccccccccccccccc--Cccceecccccccccccc-----------------ccccc-----------ccCCCCCCCCC
Q 021127 171 GLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQ-----------------GEKKH-----------YNHKNVRPSAE 220 (317)
Q Consensus 171 g~a~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~-----------------~~~~~-----------~~~~~~~~~~~ 220 (317)
|+++............ -...|||||-+.-..+.. +..++ ...+...|.|+
T Consensus 536 GLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~ 615 (974)
T KOG4257|consen 536 GLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPP 615 (974)
T ss_pred chhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCC
Confidence 9999776655444434 357899999654322211 11111 22335677899
Q ss_pred CChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 221 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 221 ~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
++|+.+..|+.+||..+|.+||.+.++...|.+++.
T Consensus 616 nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 616 NCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 999999999999999999999999999999888776
No 46
>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the
Probab=100.00 E-value=1e-38 Score=285.88 Aligned_cols=221 Identities=25% Similarity=0.370 Sum_probs=179.3
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|.+.+.||+|+||.||+|++. ++.||||++....... ......+.+|++++..++|+||+++++++.++ ..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK--RNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh--ccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence 47999999999999999999986 8999999997543211 12345688999999999999999999998765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 79 VMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDAD-GHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEeecCCCCccCcccC
Confidence 999999999999998763 39999999999999999999999999999999999999998 799999999997543322
Q ss_pred ------------------------------ccccccCccceecccccccccccccccccccCC-----------------
Q 021127 181 ------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------- 213 (317)
Q Consensus 181 ------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------- 213 (317)
......||+.|+|||++.+.... ...++|+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC-CceeeEecchhhhhhccCCCCCCCCC
Confidence 22344689999999998765332 223333332
Q ss_pred --------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCC-HHHHHHHH
Q 021127 214 --------------NVRPSAENVPEELSIILTSCWKEDPNARPN-FTQIIQML 251 (317)
Q Consensus 214 --------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-~~~~~~~l 251 (317)
...+....++.++.+||.+||. ||.+||+ +.+++++.
T Consensus 235 ~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 235 LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred HHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 1112223468999999999997 9999999 99999874
No 47
>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt
Probab=100.00 E-value=2.1e-39 Score=283.20 Aligned_cols=221 Identities=23% Similarity=0.302 Sum_probs=180.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||+|.+. ++.||||++....... .+....+.+|+.++++++||||+++++++.+. ..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIR--LKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh--hHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence 47899999999999999999886 8899999987543221 23355688999999999999999999988765 7899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++++|.+++...+. +++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++.....
T Consensus 79 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 79 LMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE-GHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred EEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEEEecCcchhccCC-
Confidence 9999999999999987554 8999999999999999999999999999999999999988 79999999999855322
Q ss_pred ccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHh
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSC 233 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~c 233 (317)
.....|++.|+|||++.+.... ...++|+.+ .....+..++..+++|+.+|
T Consensus 155 -~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 232 (291)
T cd05612 155 -TWTLCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKL 232 (291)
T ss_pred -cccccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHH
Confidence 2345789999999988764432 223333322 11123456788999999999
Q ss_pred hhcCCCCCCC-----HHHHHHHHH
Q 021127 234 WKEDPNARPN-----FTQIIQMLL 252 (317)
Q Consensus 234 l~~~p~~Rps-----~~~~~~~l~ 252 (317)
|+.||.+||+ ++++++|.+
T Consensus 233 l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 233 LVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred cCCCHHHccCCccCCHHHHhcCcc
Confidence 9999999995 899988743
No 48
>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr
Probab=100.00 E-value=3e-38 Score=279.85 Aligned_cols=215 Identities=27% Similarity=0.339 Sum_probs=168.5
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHH-HHHhcCCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA-MLSRVQHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||+||+|.+. ++.||||++....... ......+..|.. +++.++||||+++++++.+. ..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK--KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh--hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence 46899999999999985 8899999997543221 122234555555 45778999999999988765 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-ccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~ 184 (317)
++|+|..++..... +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++... .......
T Consensus 79 ~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~ 155 (323)
T cd05575 79 NGGELFFHLQRERS--FPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGIEHSKTTST 155 (323)
T ss_pred CCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC-CcEEEeccCCCcccccCCCcccc
Confidence 99999999976543 8999999999999999999999999999999999999988 799999999987432 2223344
Q ss_pred ccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcC
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKED 237 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~ 237 (317)
.+||+.|+|||++.+.... ...++|+.+ .....+..++..+.++|.+||+.|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKD 234 (323)
T ss_pred ccCChhhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 5799999999998765433 334455443 011223467889999999999999
Q ss_pred CCCCCCHH----HHHHH
Q 021127 238 PNARPNFT----QIIQM 250 (317)
Q Consensus 238 p~~Rps~~----~~~~~ 250 (317)
|.+||++. +++++
T Consensus 235 p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 235 RTKRLGAKDDFLEIKNH 251 (323)
T ss_pred HHhCCCCCCCHHHHHcC
Confidence 99999884 66654
No 49
>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in
Probab=100.00 E-value=2.3e-38 Score=280.60 Aligned_cols=215 Identities=26% Similarity=0.327 Sum_probs=173.4
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccC
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLS 106 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~ 106 (317)
+.||+|+||.||++++. +..||+|++....... ......+.+|+.+++.++||||+++++++... ..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA--KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence 46899999999999875 7899999997643211 23345678899999999999999999988765 8999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc-ccccccc
Q 021127 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAE 185 (317)
Q Consensus 107 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~-~~~~~~~ 185 (317)
+|+|..++..... +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.... .......
T Consensus 79 ~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~ 155 (323)
T cd05595 79 GGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCC-CCEEecccHHhccccCCCCccccc
Confidence 9999998876543 8999999999999999999999999999999999999988 7899999999875322 2222345
Q ss_pred cCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcCC
Q 021127 186 TGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKEDP 238 (317)
Q Consensus 186 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~p 238 (317)
.||+.|+|||++.+.... ...+.|+.+ .....+..++.++.++|.+||+.||
T Consensus 156 ~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP 234 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 234 (323)
T ss_pred cCCcCcCCcccccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 789999999998764432 223334332 1112345778999999999999999
Q ss_pred CCCC-----CHHHHHHH
Q 021127 239 NARP-----NFTQIIQM 250 (317)
Q Consensus 239 ~~Rp-----s~~~~~~~ 250 (317)
.+|| ++.+++++
T Consensus 235 ~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 235 KQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHhCCCCCCCHHHHHcC
Confidence 9998 89999886
No 50
>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]
Probab=100.00 E-value=5.2e-39 Score=293.09 Aligned_cols=234 Identities=29% Similarity=0.507 Sum_probs=198.6
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
.+|++..+.|.++||.|.||.|++|+.+ ...||||.++.... .+++.+|+.|+.|+.++.||||++|.|+.
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt----ekqrrdFL~EAsIMGQFdHPNIIrLEGVV 699 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT----EKQRRDFLSEASIMGQFDHPNIIRLEGVV 699 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc----HHHHhhhhhhhhhcccCCCCcEEEEEEEE
Confidence 4688999999999999999999999885 46799999998766 35688899999999999999999999999
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
... ...||.|||++|+|+.||+++..+ ++..+...++++|+.|++||-+.|+|||||.+.|||++.+ -.+|++|||+
T Consensus 700 Tks~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsn-LvCKVsDFGL 777 (996)
T KOG0196|consen 700 TKSKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSN-LVCKVSDFGL 777 (996)
T ss_pred ecCceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccc-eEEEeccccc
Confidence 776 678899999999999999987655 9999999999999999999999999999999999999999 5999999999
Q ss_pred cccccccc--ccccccC--ccceeccccccccccccc-----------------ccccccCC-----------CCCCCCC
Q 021127 173 AREESLTE--MMTAETG--TYRWMAPELYSTVTLRQG-----------------EKKHYNHK-----------NVRPSAE 220 (317)
Q Consensus 173 a~~~~~~~--~~~~~~g--t~~y~aPE~~~~~~~~~~-----------------~~~~~~~~-----------~~~~~~~ 220 (317)
++...... ..++..| ..+|.|||.+.-..+.+. .+++|+.. ...|.|.
T Consensus 778 SRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm 857 (996)
T KOG0196|consen 778 SRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM 857 (996)
T ss_pred eeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC
Confidence 99653322 2222233 478999998765443332 23333322 4567788
Q ss_pred CChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 221 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 221 ~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
++|..|.+||..||++|-..||++.+|+..|+++++..
T Consensus 858 DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 858 DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 99999999999999999999999999999999998753
No 51
>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate
Probab=100.00 E-value=4.5e-38 Score=279.20 Aligned_cols=216 Identities=25% Similarity=0.315 Sum_probs=174.7
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccC
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLS 106 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~ 106 (317)
+.||+|+||.||++++. ++.||||++....... ......+.+|+.+++.++||||+++++++.+. ..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIA--KDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence 46899999999999875 7899999997643221 23345688999999999999999999998765 8999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-cccccccc
Q 021127 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTAE 185 (317)
Q Consensus 107 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~~ 185 (317)
+|+|..++..... +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++... ........
T Consensus 79 ~g~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~~ 155 (328)
T cd05593 79 GGELFFHLSRERV--FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKTF 155 (328)
T ss_pred CCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCC-CcEEEecCcCCccCCCcccccccc
Confidence 9999998876543 8999999999999999999999999999999999999988 789999999987532 22223345
Q ss_pred cCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcCC
Q 021127 186 TGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKEDP 238 (317)
Q Consensus 186 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~p 238 (317)
+||+.|+|||++.+.... ...++|+.+ .....+..++.++.+|+.+||+.||
T Consensus 156 ~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP 234 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDP 234 (328)
T ss_pred cCCcCccChhhhcCCCCC-ccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCH
Confidence 799999999998764432 233444433 1112345678899999999999999
Q ss_pred CCCC-----CHHHHHHHH
Q 021127 239 NARP-----NFTQIIQML 251 (317)
Q Consensus 239 ~~Rp-----s~~~~~~~l 251 (317)
.+|| ++.+++++.
T Consensus 235 ~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 235 NKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred HHcCCCCCCCHHHHhcCC
Confidence 9997 899998873
No 52
>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-39 Score=274.14 Aligned_cols=221 Identities=28% Similarity=0.353 Sum_probs=182.9
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-----
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE----- 95 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 95 (317)
+..|...+.||.|+||.|+.+.++ ++.||||.+...-.. ....++..+|+.+|+.++|+||+.+++++.-
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~---~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFEN---QIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhc---hHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 345666899999999999999886 899999998743322 2335578999999999999999999998743
Q ss_pred -CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
..+|+|+|+| +.+|.+.++.... ++.+.+..++.|++.||+|+|+.+|+||||||+|++++.+ ..+||+|||+|+
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~-c~lKI~DFGLAR 173 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNAD-CDLKICDFGLAR 173 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccC-CCEEecccccee
Confidence 2689999999 7899999987554 9999999999999999999999999999999999999999 689999999999
Q ss_pred cccc---ccccccccCccceecccccccccccccccccccCC--------------------------------------
Q 021127 175 EESL---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------------- 213 (317)
Q Consensus 175 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------------- 213 (317)
..+. ....+..+.|.+|.|||++....-.....+.|+.+
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 7653 44556678899999999987655555555555544
Q ss_pred ---------------CC--CC---CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 ---------------NV--RP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 ---------------~~--~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.. .+ .-++.++...+|+.+||..||.+|+|++|+++|
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 00 123667889999999999999999999999998
No 53
>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.
Probab=100.00 E-value=3e-38 Score=279.64 Aligned_cols=210 Identities=26% Similarity=0.315 Sum_probs=165.2
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHH-HHHhcCCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA-MLSRVQHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||.||+|++. ++.||+|++.+..... ......+..|.. +++.++||||+++++++.+. ..++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK--KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH--hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence 46999999999999885 7899999987643221 122334555554 57788999999999988765 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc-cccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE-SLTEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~-~~~~~~~~ 184 (317)
++++|..++..... +++..+..++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++.. ........
T Consensus 79 ~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05603 79 NGGELFFHLQRERC--FLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTST 155 (321)
T ss_pred CCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEccCCCCccCCCCCCcccc
Confidence 99999998876443 8999999999999999999999999999999999999988 79999999998753 22223344
Q ss_pred ccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcC
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKED 237 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~ 237 (317)
..||+.|+|||++.+..+. ...++|+.+ .....+...+..+.+++.+||+.|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKD 234 (321)
T ss_pred ccCCcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCC
Confidence 5789999999998764433 334555444 111224466788999999999999
Q ss_pred CCCCCCHH
Q 021127 238 PNARPNFT 245 (317)
Q Consensus 238 p~~Rps~~ 245 (317)
|.+||++.
T Consensus 235 p~~R~~~~ 242 (321)
T cd05603 235 QRRRLGAK 242 (321)
T ss_pred HhhcCCCC
Confidence 99999764
No 54
>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]
Probab=100.00 E-value=1.9e-39 Score=274.20 Aligned_cols=216 Identities=24% Similarity=0.337 Sum_probs=180.1
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---C---
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---P--- 96 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~--- 96 (317)
.|.-.+++|+|+||.||+|... ++.||||..-...... -+|+.+|+.+.|||||+|.-+|.. .
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---------NRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---------cHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 5777899999999999999875 7899999876544321 258999999999999999988742 2
Q ss_pred ceEEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
...+||||++ .+|.++++.. .+..++...+.-+.+||++||+|||+.||+||||||.|+|+|.+.|.+||||||.|+
T Consensus 96 ~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 96 YLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 4568999995 6999999853 223488888999999999999999999999999999999999998999999999999
Q ss_pred ccccccccccccCccceecccccccccccccccccccCC-----------------------------------------
Q 021127 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------------------- 213 (317)
Q Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------------------- 213 (317)
.....+...+...|..|+|||++.+........+.|+.+
T Consensus 175 ~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 175 VLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred eeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 887777667778899999999988877766666666655
Q ss_pred ---------C------CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 ---------N------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 ---------~------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
. ........+++..+|+.++|+.+|.+|.++.+++.|
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0 001234568899999999999999999999999987
No 55
>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]
Probab=100.00 E-value=3.6e-38 Score=292.69 Aligned_cols=238 Identities=23% Similarity=0.378 Sum_probs=191.7
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeee
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGAC 93 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 93 (317)
..+.|...++++.+.|.+|||+.||+|.+. +..||+|++...+ ....+.+.+||++|+.|. |+|||.+++..
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~d-----e~~L~~v~~EI~~MK~L~gh~nIV~yidss 104 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVND-----EEALNAVKREIDIMKLLSGHKNIVSYIDSS 104 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCC-----HHHHHHHHHHHHHHHHhcCCCceeeEeccc
Confidence 478899999999999999999999999987 4899999987663 244567899999999995 99999999932
Q ss_pred -e-----c--CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEeeCCCC
Q 021127 94 -K-----E--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLK 163 (317)
Q Consensus 94 -~-----~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--ivH~Dlkp~Nill~~~~~ 163 (317)
. . -+++|+||||.||.|-+++..+....|++.++++|+.|+++|+++||... |||||||-+||||..+ +
T Consensus 105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~-g 183 (738)
T KOG1989|consen 105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSAD-G 183 (738)
T ss_pred cccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCC-C
Confidence 1 1 26899999999999999999877777999999999999999999999997 9999999999999998 7
Q ss_pred ceEEcccCccccccccc-cc---------ccccCccceeccccccc---cccccc------------------------c
Q 021127 164 TIKLADFGLAREESLTE-MM---------TAETGTYRWMAPELYST---VTLRQG------------------------E 206 (317)
Q Consensus 164 ~~kl~Dfg~a~~~~~~~-~~---------~~~~gt~~y~aPE~~~~---~~~~~~------------------------~ 206 (317)
..||||||.|+..-... .. -...-|+.|+|||++.- ..+... .
T Consensus 184 ~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~ 263 (738)
T KOG1989|consen 184 NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK 263 (738)
T ss_pred CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence 99999999997322111 10 11236899999997542 222222 2
Q ss_pred cccccCCCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCC
Q 021127 207 KKHYNHKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 260 (317)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~ 260 (317)
..+.......|..+.++..+.+||+.||+.||.+||++.+++..+..+.....+
T Consensus 264 laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 264 LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 222222234455578999999999999999999999999999998887765444
No 56
>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.
Probab=100.00 E-value=3.7e-38 Score=284.99 Aligned_cols=222 Identities=23% Similarity=0.312 Sum_probs=175.2
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||++++. ++.||||++....... ......+.+|++++++++|+||+++++.+.++ .+++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLM--RNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHh--hhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEE
Confidence 47999999999999999999875 7899999986532211 12345678899999999999999999998765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
||||+++|+|.+++...+. +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 79 v~E~~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~-~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 79 VMDYIPGGDMMSLLIRLGI--FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCC-CCEEEEeCCCCccccccc
Confidence 9999999999999986543 8999999999999999999999999999999999999988 79999999997421100
Q ss_pred -------------------------------------------cccccccCccceecccccccccccccccccccCC---
Q 021127 180 -------------------------------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--- 213 (317)
Q Consensus 180 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--- 213 (317)
......+||+.|+|||++.+.... ...++|+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil 234 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVIL 234 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeecccee
Confidence 001124699999999998664432 233444333
Q ss_pred ----------------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCC---CHHHHHHHHH
Q 021127 214 ----------------------------NVRPSAENVPEELSIILTSCWKEDPNARP---NFTQIIQMLL 252 (317)
Q Consensus 214 ----------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp---s~~~~~~~l~ 252 (317)
...+....++.++.++|.+|+ .+|.+|+ ++.++++|-+
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~ 303 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPF 303 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCC
Confidence 011122357889999999976 5999999 8999998833
No 57
>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.
Probab=100.00 E-value=1.8e-38 Score=282.55 Aligned_cols=220 Identities=25% Similarity=0.345 Sum_probs=179.8
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.++||+|+||.||+|++. ++.||||++....... ......+.+|++++..++||||+++++++.++ ..++
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFK--LNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhh--hhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence 47999999999999999999885 7899999997643221 23345688999999999999999999998765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++++|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++.....
T Consensus 79 v~e~~~g~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLGV--LSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS-GHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CCEEEEeCcCCccccc--
Confidence 9999999999999976544 8999999999999999999999999999999999999988 7999999999975433
Q ss_pred ccccccCccceecccccccccccccccccccCCC-------------------------------CCCCC----CCChHH
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKN-------------------------------VRPSA----ENVPEE 225 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~----~~~~~~ 225 (317)
......||+.|+|||++.+.... ...++|+.+. ..+.. ..++.+
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~ 232 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDE 232 (333)
T ss_pred ccCCcccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHH
Confidence 23445799999999998765332 2333443330 00111 145889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
+.+|+.+||..+|.+||++.+++++.
T Consensus 233 ~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 233 AWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred HHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 99999999999999999999999884
No 58
>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor
Probab=100.00 E-value=2.9e-38 Score=272.44 Aligned_cols=228 Identities=25% Similarity=0.454 Sum_probs=181.4
Q ss_pred ecCCceeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
|+.++|++.+.||+|+||.||+|.+. +..||+|.++..... .....+.+|+.++++++||||+++++++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 77 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD----KQRRGFLAEALTLGQFDHSNIVRLEGVITR 77 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH----HHHHHHHHHHHHHhcCCCCCcCeEEEEEec
Confidence 67789999999999999999999763 568999998865442 234568899999999999999999999875
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+ ..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++++|||.+.
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~-~~~~l~dfg~~~ 155 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSD-LVCKISGFRRLQ 155 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCC-CcEEECCCcccc
Confidence 4 8999999999999999997643 348999999999999999999999999999999999999988 689999999876
Q ss_pred cccccccc--ccccCccceecccccccccccc-----------------cccccccC-----------CCCCCCCCCChH
Q 021127 175 EESLTEMM--TAETGTYRWMAPELYSTVTLRQ-----------------GEKKHYNH-----------KNVRPSAENVPE 224 (317)
Q Consensus 175 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~~-----------~~~~~~~~~~~~ 224 (317)
........ ....++..|+|||++.+..... +..+++.. ....+.+..++.
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPN 235 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCH
Confidence 53322111 1234567899999875432211 11111110 112234567889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
.+.+++.+||+.+|.+||+++++++.|.++
T Consensus 236 ~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 236 LLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 999999999999999999999999988764
No 59
>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional
Probab=100.00 E-value=1.5e-38 Score=283.40 Aligned_cols=228 Identities=24% Similarity=0.309 Sum_probs=185.5
Q ss_pred CCceeecCCceeecceeccccceEEEEeEEC---CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEee
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 92 (317)
.....+..++|++.+.||+|+||.||+|.+. +..||+|++....... ......+.+|+.+++.++||||++++++
T Consensus 22 ~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~Iv~~~~~ 99 (340)
T PTZ00426 22 KRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK--QKQVDHVFSERKILNYINHPFCVNLYGS 99 (340)
T ss_pred ccCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhh--hhhHHHHHHHHHHHHhCCCCCCcceEEE
Confidence 3456678889999999999999999999864 3689999987543211 2334568899999999999999999999
Q ss_pred eecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 93 CKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 93 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
+.+. ..++||||+++|+|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||
T Consensus 100 ~~~~~~~~lv~Ey~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~-~~ikL~DFG 176 (340)
T PTZ00426 100 FKDESYLYLVLEFVIGGEFFTFLRRNKR--FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKD-GFIKMTDFG 176 (340)
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC-CCEEEecCC
Confidence 9765 79999999999999999986554 8999999999999999999999999999999999999988 799999999
Q ss_pred cccccccccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChH
Q 021127 172 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPE 224 (317)
Q Consensus 172 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~ 224 (317)
++...... .....||+.|+|||++.+.... ...++|+.+ .....+..++.
T Consensus 177 ~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~ 253 (340)
T PTZ00426 177 FAKVVDTR--TYTLCGTPEYIAPEILLNVGHG-KAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDN 253 (340)
T ss_pred CCeecCCC--cceecCChhhcCHHHHhCCCCC-ccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCH
Confidence 99865322 2345799999999998764332 334444433 11122456788
Q ss_pred HHHHHHHHhhhcCCCCCC-----CHHHHHHHH
Q 021127 225 ELSIILTSCWKEDPNARP-----NFTQIIQML 251 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rp-----s~~~~~~~l 251 (317)
.+.++|.+||+.||++|+ +++++++|.
T Consensus 254 ~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 254 NCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred HHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence 999999999999999995 899998873
No 60
>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.6e-38 Score=301.23 Aligned_cols=235 Identities=31% Similarity=0.540 Sum_probs=195.4
Q ss_pred eecCCceeecceeccccceEEEEeEEC---C----eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEee
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK---N----QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~---~----~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 92 (317)
.+.+++.++.+.||+|.||.||.|... + ..||||.+.+..+.. ...+|++|..+++.++|||||+++|+
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~----~~~~Fl~Ea~~m~~f~HpNiv~liGv 763 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQ----EVSDFLKEALLMSKFDHPNIVSLIGV 763 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHH----HHHHHHHHHHHHhcCCCcceeeEEEe
Confidence 466899999999999999999999874 3 348999998776643 36679999999999999999999999
Q ss_pred eecC-ceEEEEEccCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceE
Q 021127 93 CKEP-VMVIVTELLSGGTLRKYLLNMR-----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166 (317)
Q Consensus 93 ~~~~-~~~lv~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~k 166 (317)
|.+. ..+|++|||+||+|..||++.+ ...++..+.+.++.|||.|+.||+++++|||||.++|+|++.. ..+|
T Consensus 764 ~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~-r~VK 842 (1025)
T KOG1095|consen 764 CLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER-RVVK 842 (1025)
T ss_pred ecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc-CcEE
Confidence 9765 7899999999999999999863 3359999999999999999999999999999999999999998 6999
Q ss_pred EcccCccccccccccc-ccc--cCccceecccccccccccccccccccCC-----------------------------C
Q 021127 167 LADFGLAREESLTEMM-TAE--TGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------N 214 (317)
Q Consensus 167 l~Dfg~a~~~~~~~~~-~~~--~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~ 214 (317)
|+|||+|+........ ... .-...|||||.+.+..+.. ..++|+.+ .
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFts-kSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg 921 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTS-KSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG 921 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHHhhccccc-ccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC
Confidence 9999999954333222 111 2357899999998744443 33344433 4
Q ss_pred CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCC
Q 021127 215 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 260 (317)
Q Consensus 215 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~ 260 (317)
..+.|..+|+.++++|.+||+.+|++||++..|++.+.+......+
T Consensus 922 RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 922 RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 5566889999999999999999999999999999988887765544
No 61
>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica
Probab=100.00 E-value=3.8e-38 Score=283.72 Aligned_cols=221 Identities=23% Similarity=0.317 Sum_probs=176.5
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||++++. ++.||||++....... ......+.+|+.++..++|+||+++++++.++ ..++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLE--KEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence 47899999999999999999885 7899999997643221 23345678899999999999999999999765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++|+|.+++..... +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus 79 v~E~~~~g~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKDT--FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EECCCCCcHHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEeecccceeccccc
Confidence 9999999999999986543 9999999999999999999999999999999999999988 799999999986432110
Q ss_pred ---------------------------------------ccccccCccceecccccccccccccccccccCC--------
Q 021127 181 ---------------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------- 213 (317)
Q Consensus 181 ---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------- 213 (317)
.....+||+.|+|||++....+. ...++|+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~ 234 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLV 234 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhc
Confidence 01123689999999988664432 233444433
Q ss_pred -----------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCC---HHHHHHHH
Q 021127 214 -----------------------NVRPSAENVPEELSIILTSCWKEDPNARPN---FTQIIQML 251 (317)
Q Consensus 214 -----------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps---~~~~~~~l 251 (317)
...+....+++++.+||.+|+. +|.+|++ +.+++++-
T Consensus 235 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 235 GYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 0011123468899999999996 9999997 99998874
No 62
>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in
Probab=100.00 E-value=3.1e-38 Score=279.79 Aligned_cols=218 Identities=27% Similarity=0.349 Sum_probs=174.1
Q ss_pred cceeccccceEEEEeEE-----CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEE
Q 021127 29 GPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVT 102 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 102 (317)
.++||+|+||.||+++. .++.||||++........ ......+.+|+.+++.++||||+++++++..+ ..++||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRN-QKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhh-hhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEE
Confidence 36799999999999875 378899999975432111 22345678899999999999999999988754 899999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc-ccc
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEM 181 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~-~~~ 181 (317)
||+++++|.+++...+. +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... ...
T Consensus 80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 80 EYLSGGELFMHLEREGI--FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred eCCCCchHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEeeCcCCeecccCCCc
Confidence 99999999999976544 8899999999999999999999999999999999999988 7999999999874322 222
Q ss_pred cccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhh
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCW 234 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl 234 (317)
.....||+.|+|||++.+.... ...++|+.+ .....+..++..+.++|.+||
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 235 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLL 235 (323)
T ss_pred ccccCCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHc
Confidence 3345799999999998764432 334444433 111234567889999999999
Q ss_pred hcCCCCCC-----CHHHHHHHH
Q 021127 235 KEDPNARP-----NFTQIIQML 251 (317)
Q Consensus 235 ~~~p~~Rp-----s~~~~~~~l 251 (317)
+.+|++|| ++.+++++-
T Consensus 236 ~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 236 KRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred ccCHhHcCCCCCCCHHHHhcCC
Confidence 99999999 899988873
No 63
>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=2.3e-38 Score=281.82 Aligned_cols=226 Identities=29% Similarity=0.406 Sum_probs=189.9
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecC-c
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP-V 97 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~ 97 (317)
....|++.+.||.|.||.||++..+ |+.+|+|++.+...... .....+.+|+.+|+++. |||||.+++++.+. .
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~--~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGK--EDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcccc--ccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 3468999999999999999999885 89999999987765432 23457889999999998 99999999999876 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCC---CceEEcccCccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL---KTIKLADFGLAR 174 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~---~~~kl~Dfg~a~ 174 (317)
+++|||+|.||.|.+.+... .+++..+..++.|++.+++|||+.||+||||||+|+|+.... +.+|++|||++.
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999999999876 299999999999999999999999999999999999997542 379999999999
Q ss_pred ccccccccccccCccceeccccccccccccccc----------------ccccCC--------------CCCCCCCCChH
Q 021127 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEK----------------KHYNHK--------------NVRPSAENVPE 224 (317)
Q Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~----------------~~~~~~--------------~~~~~~~~~~~ 224 (317)
...........+||+.|+|||++....+....+ +++... ...+..+.++.
T Consensus 188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~ 267 (382)
T KOG0032|consen 188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE 267 (382)
T ss_pred EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence 877766778889999999999988543333222 111111 12334567899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.++++|+.|+..||.+|+|+.++++|.|
T Consensus 268 ~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 268 SAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred HHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 9999999999999999999999999844
No 64
>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in
Probab=100.00 E-value=8e-38 Score=281.90 Aligned_cols=228 Identities=23% Similarity=0.321 Sum_probs=182.1
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
.+.+..++|++.+.||+|+||.||++++. ++.||+|++.+..... ......+.+|+.+++.++||||+++++++.+
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~ 114 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIK--RSDSAFFWEERDIMAHANSEWIVQLHYAFQD 114 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hhhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 45567789999999999999999999885 7899999997532211 1223457789999999999999999998876
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+ ..++||||+++|+|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~-~~~kL~DfG~~~ 190 (370)
T cd05596 115 DKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCM 190 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCC-CCEEEEecccee
Confidence 5 799999999999999998753 28899999999999999999999999999999999999988 799999999997
Q ss_pred cccccc--ccccccCccceeccccccccc---ccccccccccCC-----------------------------C--CCCC
Q 021127 175 EESLTE--MMTAETGTYRWMAPELYSTVT---LRQGEKKHYNHK-----------------------------N--VRPS 218 (317)
Q Consensus 175 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~~~-----------------------------~--~~~~ 218 (317)
...... .....+||+.|+|||++.+.. ......++|+.+ . ..+.
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (370)
T cd05596 191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD 270 (370)
T ss_pred eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCC
Confidence 543322 223457999999999876532 122334444433 0 0111
Q ss_pred CCCChHHHHHHHHHhhhcCCCC--CCCHHHHHHHH
Q 021127 219 AENVPEELSIILTSCWKEDPNA--RPNFTQIIQML 251 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~--Rps~~~~~~~l 251 (317)
...++.++.+||.+||+.+|.+ |++++++++|.
T Consensus 271 ~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 271 DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 2357899999999999999988 99999999884
No 65
>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn. Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa
Probab=100.00 E-value=6.8e-38 Score=269.16 Aligned_cols=228 Identities=28% Similarity=0.498 Sum_probs=183.9
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
|.|+.++|++.++||+|+||.||+|... +..||+|.+..... ..+.+.+|+.++++++|+||+++++.+.+.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM------SVQAFLEEANLMKTLQHDKLVRLYAVVTKEE 74 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch------hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 7889999999999999999999999876 67799998765332 234688999999999999999999988654
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..+++|||+++++|.+++.......+++..++.++.|++.||+|||+++++||||||+||+++.+ +.++|+|||++...
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~ 153 (261)
T cd05072 75 PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSES-LMCKIADFGLARVI 153 (261)
T ss_pred CcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCC-CcEEECCCccceec
Confidence 78999999999999999976555568999999999999999999999999999999999999988 78999999999754
Q ss_pred ccccc--cccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHH
Q 021127 177 SLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEE 225 (317)
Q Consensus 177 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~ 225 (317)
..... .....++..|+|||++....... ..++|+.+ ...+....++.+
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (261)
T cd05072 154 EDNEYTAREGAKFPIKWTAPEAINFGSFTI-KSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDE 232 (261)
T ss_pred CCCceeccCCCccceecCCHHHhccCCCCh-hhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 33221 12234567899999875433221 12222211 112234467889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
+.+++.+||..+|++||+++++++.|+++
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 233 LYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999999998753
No 66
>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src. Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo
Probab=100.00 E-value=6e-38 Score=269.84 Aligned_cols=229 Identities=28% Similarity=0.507 Sum_probs=184.2
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCc
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPV 97 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 97 (317)
|.|+.++|++.++||+|+||.||+|.+. +..||+|.+...... ..++.+|+.++++++|+||+++++.+.+..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~------~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~ 74 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS------PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP 74 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC------HHHHHHHHHHHHhCCCCCcceEEEEECCCC
Confidence 6788899999999999999999999886 457999998754332 235889999999999999999999987778
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++||||+++++|.+++.......+++..++.++.|++.||+|||+++++|+||||+||+++.+ +.++|+|||.+....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~-~~~~L~dfg~~~~~~ 153 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIE 153 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCC-CcEEeccCCceeecc
Confidence 8999999999999999986544458999999999999999999999999999999999999988 689999999997543
Q ss_pred ccccc--ccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHH
Q 021127 178 LTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEEL 226 (317)
Q Consensus 178 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l 226 (317)
..... ....++..|+|||+..+..... ..+.|+.+ ...+.+..++..+
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (262)
T cd05071 154 DNEYTARQGAKFPIKWTAPEAALYGRFTI-KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 232 (262)
T ss_pred ccccccccCCcccceecCHhHhccCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHH
Confidence 32211 1234567899999865432211 11111100 1122345678999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
.+++.+||+.+|++||++.++++.|++++
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 233 HDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 99999999999999999999999998765
No 67
>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=1.4e-38 Score=272.29 Aligned_cols=230 Identities=25% Similarity=0.310 Sum_probs=189.8
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
..-.+...+++++++||.|.-|+||+++.. +..+|+|++.+..... .+...+...|.+||+.++||.++.||..++
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~--rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe 147 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS--RKKLKRAQTEREILSLLDHPFLPTLYASFE 147 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh--hhHHHHHHHHHHHHHhcCCCccchhhheee
Confidence 345677788999999999999999999987 4899999998876544 456677888999999999999999999998
Q ss_pred cC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 95 EP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 95 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
.+ ..++|||||+||+|....+.+..+.+++..+..++..|+-||+|||-.|||+|||||+||||.++ |.+.|+||.++
T Consensus 148 t~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvred-GHIMLsDFDLS 226 (459)
T KOG0610|consen 148 TDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVRED-GHIMLSDFDLS 226 (459)
T ss_pred ccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecC-CcEEeeecccc
Confidence 65 88999999999999999999888899999999999999999999999999999999999999999 89999999987
Q ss_pred cccc----------------------------------c-c----------------------cccccccCccceecccc
Q 021127 174 REES----------------------------------L-T----------------------EMMTAETGTYRWMAPEL 196 (317)
Q Consensus 174 ~~~~----------------------------------~-~----------------------~~~~~~~gt~~y~aPE~ 196 (317)
.... . . ......+||..|+|||+
T Consensus 227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv 306 (459)
T KOG0610|consen 227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV 306 (459)
T ss_pred ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence 3100 0 0 01123469999999999
Q ss_pred cccccccccccccccCC-----------------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCC----
Q 021127 197 YSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSIILTSCWKEDPNARPN---- 243 (317)
Q Consensus 197 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps---- 243 (317)
+.+..-.. ..+||..+ ...+....++..+++||+++|.+||.+|..
T Consensus 307 I~G~GHgs-AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rG 385 (459)
T KOG0610|consen 307 IRGEGHGS-AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRG 385 (459)
T ss_pred eecCCCCc-hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccc
Confidence 98744332 34444433 112223366789999999999999999987
Q ss_pred HHHHHHH
Q 021127 244 FTQIIQM 250 (317)
Q Consensus 244 ~~~~~~~ 250 (317)
+.||-+|
T Consensus 386 A~eIK~H 392 (459)
T KOG0610|consen 386 AAEIKRH 392 (459)
T ss_pred hHHhhcC
Confidence 8888877
No 68
>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate
Probab=100.00 E-value=4.8e-38 Score=278.01 Aligned_cols=215 Identities=27% Similarity=0.363 Sum_probs=171.3
Q ss_pred cceeccccceEEEEeEE-----CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEE
Q 021127 29 GPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVT 102 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 102 (317)
++.||+|+||.||+++. +++.||+|++...... .....++.+|++++++++||||+++++++.++ ..++||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 77 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK---VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLIL 77 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEE
Confidence 36799999999999875 3789999999764322 12334577899999999999999999998765 899999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-cc
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EM 181 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~~ 181 (317)
||+++++|.+++..... +++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++...... ..
T Consensus 78 e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 78 DFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred cCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCC-CcEEEeeccCCcccCCCCCc
Confidence 99999999999976443 8999999999999999999999999999999999999988 78999999999754333 22
Q ss_pred cccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhh
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCW 234 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl 234 (317)
.....|++.|+|||++.+.... ...+.|+.+ .....+..++..+.+|+.+||
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l 233 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALF 233 (318)
T ss_pred eecccCChhhcCHHHHcCCCCC-CccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 3345789999999998764332 234444433 111224567889999999999
Q ss_pred hcCCCCCCCH-----HHHHHH
Q 021127 235 KEDPNARPNF-----TQIIQM 250 (317)
Q Consensus 235 ~~~p~~Rps~-----~~~~~~ 250 (317)
+.||.+||++ .+++.+
T Consensus 234 ~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 234 KRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred hcCHhHcCCCCCCCHHHHhCC
Confidence 9999999994 455544
No 69
>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament
Probab=100.00 E-value=3.2e-38 Score=275.31 Aligned_cols=221 Identities=26% Similarity=0.379 Sum_probs=172.9
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
-++|++.++||.|+||.||+|.+. ++.||+|++....... ....+.+|+.++++++||||+++++++... ..+
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG----APCTAIREVSLLKNLKHANIVTLHDIIHTERCLT 79 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC----cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 467999999999999999999875 7899999987543221 123567899999999999999999998755 789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+||||++ ++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 80 lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 80 LVFEYLD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEK-GELKLADFGLARAKSVP 156 (288)
T ss_pred EEEeCCC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEECcCcceeeccCC
Confidence 9999996 59999887643 337899999999999999999999999999999999999988 78999999999754322
Q ss_pred -cccccccCccceecccccccccccccccccccCC---------------------------------------------
Q 021127 180 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------------------------------------- 213 (317)
Q Consensus 180 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------------------------------------- 213 (317)
.......+++.|+|||++.+........++|+.+
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 2223456899999999875422111112222111
Q ss_pred ---CCCC---------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 ---NVRP---------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 ---~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
...+ ....++.++.+|+.+||+.||.+|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 012457789999999999999999999999876
No 70
>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an
Probab=100.00 E-value=1.4e-37 Score=281.86 Aligned_cols=220 Identities=22% Similarity=0.317 Sum_probs=174.8
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
+.|++.++||+|+||.||+|++. ++.||||++....... ......+.+|++++++++|+||+++++.+.++ ..++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~--~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~l 78 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLL--RNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 78 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhh--HHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEE
Confidence 36889999999999999999885 7899999987543221 23455788999999999999999999999765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
|||||++|+|.+++...+. +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 79 v~E~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~-g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 79 VMDYIPGGDMMSLLIRMGI--FPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEEeECCCCccccccc
Confidence 9999999999999976543 8999999999999999999999999999999999999988 79999999997521100
Q ss_pred -----------------------------------------------cccccccCccceecccccccccccccccccccC
Q 021127 180 -----------------------------------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH 212 (317)
Q Consensus 180 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 212 (317)
......+||+.|+|||++.+..+. ...++|+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSl 234 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSV 234 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEec
Confidence 001224689999999998765433 23444443
Q ss_pred C-------------------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 021127 213 K-------------------------------NVRPSAENVPEELSIILTSCWKEDPNARPN---FTQIIQM 250 (317)
Q Consensus 213 ~-------------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps---~~~~~~~ 250 (317)
+ ...+....+++++.++|.+|+ .+|.+|++ ++++++|
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 3 011223457889999998876 49999987 8888876
No 71
>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=1.3e-40 Score=267.00 Aligned_cols=226 Identities=26% Similarity=0.354 Sum_probs=185.1
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-Cce
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 98 (317)
..++|++.+.||+|.|+.|+++.+. |+.+|+|++....... ..-+++.+|+++-+.|+||||++|.+...+ +..
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~---~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ 85 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA---RDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 85 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc---ccHHHHHHHHHHHHhcCCCcEeehhhhhccccee
Confidence 3478999999999999999998764 8999999887544332 234568899999999999999999998865 589
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC--CCceEEcccCccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLAREE 176 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~a~~~ 176 (317)
|+|+|++.|++|..-|-.+.- +++..+-.++.||+++|.|+|.+||||||+||.|+++.+. ..-+||+|||+|...
T Consensus 86 ylvFe~m~G~dl~~eIV~R~~--ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EEEEecccchHHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999999999887765533 8899999999999999999999999999999999999642 246899999999988
Q ss_pred ccccccccccCccceeccccccccccccc----------------ccccccCC--------------CCCCCCCCChHHH
Q 021127 177 SLTEMMTAETGTYRWMAPELYSTVTLRQG----------------EKKHYNHK--------------NVRPSAENVPEEL 226 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~----------------~~~~~~~~--------------~~~~~~~~~~~~l 226 (317)
+.........|||.|||||++....+... ..++|... ...+..++++++.
T Consensus 164 ~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A 243 (355)
T KOG0033|consen 164 NDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA 243 (355)
T ss_pred CCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence 76666777889999999999876444322 22222211 1223467899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
++|+++||..||.+|.|+.|+++|-|
T Consensus 244 k~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 244 KSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred HHHHHHHhccChhhhccHHHHhCCch
Confidence 99999999999999999999998865
No 72
>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of
Probab=100.00 E-value=2.1e-37 Score=280.11 Aligned_cols=221 Identities=23% Similarity=0.321 Sum_probs=174.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|.+.++||+|+||.||++.+. ++.||||++.+..... ......+.+|++++++++||||+++++++.++ ..++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFK--KDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHH--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence 47899999999999999999875 8899999987543211 23345688999999999999999999999865 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++|+|.+++...+. +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 79 v~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~-~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYDT--FSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred EEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC-CCEEEeeccccccccccc
Confidence 9999999999999986543 8999999999999999999999999999999999999988 799999999985211000
Q ss_pred ------------------------------------------------ccccccCccceecccccccccccccccccccC
Q 021127 181 ------------------------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH 212 (317)
Q Consensus 181 ------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 212 (317)
.....+||+.|+|||++.+..+. ...++|+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSl 234 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QECDWWSL 234 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC-CceeeEec
Confidence 00124689999999998654432 23344433
Q ss_pred C-------------------------------CCCCCCCCChHHHHHHHHHhhhcCCCCC---CCHHHHHHHH
Q 021127 213 K-------------------------------NVRPSAENVPEELSIILTSCWKEDPNAR---PNFTQIIQML 251 (317)
Q Consensus 213 ~-------------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~R---ps~~~~~~~l 251 (317)
+ ...+....++.++.+||.+||. +|.+| +++.+++++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp 306 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHP 306 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCC
Confidence 3 0011122467899999999997 77765 5999999884
No 73
>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien
Probab=100.00 E-value=1.5e-37 Score=275.70 Aligned_cols=216 Identities=26% Similarity=0.319 Sum_probs=173.9
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccC
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLS 106 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~ 106 (317)
+.||+|+||.||++.+. ++.||+|++....... .....++.+|++++..++||||+++++++... ..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA--KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 46899999999999874 8899999997643221 22345678899999999999999999988765 8999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCCceEEcccCcccccc-ccccccc
Q 021127 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (317)
Q Consensus 107 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~ 184 (317)
+|+|..++..... +++..+..++.||+.||+|||+ +||+||||||+|||++.+ +.+||+|||+++... .......
T Consensus 79 ~~~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~ 155 (325)
T cd05594 79 GGELFFHLSRERV--FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKT 155 (325)
T ss_pred CCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC-CCEEEecCCCCeecCCCCccccc
Confidence 9999998876543 8999999999999999999997 799999999999999988 799999999987432 2222334
Q ss_pred ccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcC
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKED 237 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~ 237 (317)
..||+.|+|||++.+.... ...++|+.+ .....+..++.++.+|+.+||+.|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~d 234 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKD 234 (325)
T ss_pred ccCCcccCCHHHHccCCCC-CccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 5799999999998765433 334444443 011124567889999999999999
Q ss_pred CCCCC-----CHHHHHHHH
Q 021127 238 PNARP-----NFTQIIQML 251 (317)
Q Consensus 238 p~~Rp-----s~~~~~~~l 251 (317)
|.+|+ ++.++++|.
T Consensus 235 P~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 235 PKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred HHHhCCCCCCCHHHHhcCC
Confidence 99996 899999873
No 74
>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus
Probab=100.00 E-value=2.1e-37 Score=278.70 Aligned_cols=221 Identities=23% Similarity=0.334 Sum_probs=173.0
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||+||++.+. ++.||||++.+..... ......+.+|+.++.+++|+||+++++.+.+. ..++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLE--KEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH--hhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence 47899999999999999999875 7899999997543221 23345678899999999999999999999765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||++||+|.+++...+. +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 79 v~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~-~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKDT--LTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEcCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC-CCEEEeeccCcccccccc
Confidence 9999999999999986543 9999999999999999999999999999999999999988 799999999987432110
Q ss_pred ------------------------------------ccccccCccceecccccccccccccccccccCC-----------
Q 021127 181 ------------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------- 213 (317)
Q Consensus 181 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------- 213 (317)
.....+||+.|+|||++.+.... ...++|+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCC
Confidence 01234799999999998664332 233344332
Q ss_pred --------------------CCCCCCCCChHHHHHHHHHhhh--cCCCCCCCHHHHHHH
Q 021127 214 --------------------NVRPSAENVPEELSIILTSCWK--EDPNARPNFTQIIQM 250 (317)
Q Consensus 214 --------------------~~~~~~~~~~~~l~~li~~cl~--~~p~~Rps~~~~~~~ 250 (317)
...+....++.++.+++.+++. .++..||+++++++|
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 235 PFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 0011123467889999988554 233456899999987
No 75
>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.4e-39 Score=286.48 Aligned_cols=218 Identities=26% Similarity=0.375 Sum_probs=183.7
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
-|.=++.||.|+||.||-|++. .+.||||.+....... ...-++++.|++.|++++|||+|.+-|++... ..|+|
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs--~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS--NEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeecccccccc--HHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 4556788999999999999885 7889999987655433 35567899999999999999999999999654 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
|||| -|+-.+.+.-.+ +++.+..+..|+.+.+.||+|||+.+.||||||+.|||++.. |.|||+|||.|.....
T Consensus 105 MEYC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~-g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 105 MEYC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEP-GLVKLADFGSASIMAP--- 178 (948)
T ss_pred HHHH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCC-CeeeeccccchhhcCc---
Confidence 9999 678888887644 349999999999999999999999999999999999999998 8999999999986553
Q ss_pred cccccCccceecccccccc--cccccccccccCC---------------------------CCCC--CCCCChHHHHHHH
Q 021127 182 MTAETGTYRWMAPELYSTV--TLRQGEKKHYNHK---------------------------NVRP--SAENVPEELSIIL 230 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~~---------------------------~~~~--~~~~~~~~l~~li 230 (317)
.++++|||+|||||++..+ ....+..++|+.+ +..| ....++..+++|+
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv 258 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 258 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence 3578999999999998754 3456777788776 1111 1345688999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 021127 231 TSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 231 ~~cl~~~p~~Rps~~~~~~~ 250 (317)
..||+.-|.+|||.++++.|
T Consensus 259 d~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 259 DSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHHHhhCcccCCcHHHHhhc
Confidence 99999999999999998776
No 76
>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2. Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=1.2e-37 Score=276.96 Aligned_cols=223 Identities=21% Similarity=0.363 Sum_probs=178.9
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
+..++|++.+.||+|+||.||++++. +..||+|++...... ....++.+|++++++++||||+++++++.++ .
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 77 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKP----AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 77 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCH----HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 45689999999999999999999986 788999998765432 2345689999999999999999999998654 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
.++||||+++++|.+++..... +++..+..++.|++.||.|||++ +|+||||||+||+++.+ +.+||+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~ 154 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSR-GEIKLCDFGVSGQL 154 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCC-CcEEEccCcccccc
Confidence 9999999999999999986544 89999999999999999999986 69999999999999988 78999999998754
Q ss_pred ccccccccccCccceecccccccccccccccccccCC-------------------------------------------
Q 021127 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------------------- 213 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------------------- 213 (317)
... ......|++.|+|||++.+..... ..++|+.+
T Consensus 155 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~-~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 155 IDS-MANSFVGTRSYMSPERLQGTHYSV-QSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred ccc-ccccCCCCcCcCCHhHhcCCCCCc-hHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcc
Confidence 322 233457899999999876532211 11111111
Q ss_pred ------------------------------CCCC--CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 ------------------------------NVRP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 ------------------------------~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
...+ ....++.++++||.+||+.||++|||+.+++++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 0000 01236788999999999999999999999999854
No 77
>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt
Probab=100.00 E-value=1.4e-37 Score=275.83 Aligned_cols=211 Identities=27% Similarity=0.343 Sum_probs=165.3
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHH-HHHhcCCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA-MLSRVQHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||.||++++. ++.||+|++....... ......+..|.. +++.++|+||+++++++.+. ..++||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILK--KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHh--hhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence 46999999999999885 6789999997543211 122233444444 56778999999999998755 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-ccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~ 184 (317)
++++|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++... .......
T Consensus 79 ~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~-~~~kl~DfG~a~~~~~~~~~~~~ 155 (325)
T cd05602 79 NGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTST 155 (325)
T ss_pred CCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEEccCCCCcccccCCCCccc
Confidence 99999999986543 8899999999999999999999999999999999999988 789999999987432 2223345
Q ss_pred ccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcC
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKED 237 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~ 237 (317)
.+||+.|+|||++.+..+.. ..++|+.+ ........++..+.+++.+||+.|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDR-TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKD 234 (325)
T ss_pred ccCCccccCHHHHcCCCCCC-ccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccC
Confidence 57999999999987654432 34445443 111224467899999999999999
Q ss_pred CCCCCCHHH
Q 021127 238 PNARPNFTQ 246 (317)
Q Consensus 238 p~~Rps~~~ 246 (317)
|.+||++.+
T Consensus 235 p~~R~~~~~ 243 (325)
T cd05602 235 RTKRLGAKD 243 (325)
T ss_pred HHHCCCCCC
Confidence 999998774
No 78
>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase. Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays
Probab=100.00 E-value=1.1e-37 Score=268.24 Aligned_cols=228 Identities=28% Similarity=0.528 Sum_probs=183.8
Q ss_pred eeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 96 (317)
|.++..+|.+.++||+|+||.||+|.+. +..||+|.+..... ....+.+|++++++++|+||+++++++.+.
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 74 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch------HHHHHHHHHHHHHhCCCCChhheEEEEcCC
Confidence 6788899999999999999999999875 78899999875432 234588999999999999999999998654
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
..++||||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++..
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~df~~~~~ 153 (263)
T cd05052 75 PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRL 153 (263)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC-CcEEeCCCccccc
Confidence 88999999999999999987655568999999999999999999999999999999999999988 7899999999976
Q ss_pred cccccccc--cccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChH
Q 021127 176 ESLTEMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPE 224 (317)
Q Consensus 176 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~ 224 (317)
........ ...++..|+|||.+.+..... ..++|+.+ .....+..++.
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (263)
T cd05052 154 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPP 232 (263)
T ss_pred cccceeeccCCCCCccccCCHHHhccCCCCc-hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCH
Confidence 54332211 123456799999875432211 11111111 11233567789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
++.+++.+||+.||++||++.++++.|+.+
T Consensus 233 ~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 233 KVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 999999999999999999999999998765
No 79
>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl
Probab=100.00 E-value=1.6e-37 Score=273.88 Aligned_cols=213 Identities=24% Similarity=0.331 Sum_probs=171.7
Q ss_pred eccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCCC
Q 021127 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGG 108 (317)
Q Consensus 32 lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g 108 (317)
||+|+||.||++++. ++.||+|++....... ......+.+|+.++++++||||+++++++.+. ..++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVS--RSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence 699999999999885 7889999987542211 23345678899999999999999999988765 899999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-cccccccccC
Q 021127 109 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTAETG 187 (317)
Q Consensus 109 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~g 187 (317)
+|.+++...+. +++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++... ........+|
T Consensus 79 ~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~g 155 (312)
T cd05585 79 ELFHHLQREGR--FDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ-GHIALCDFGLCKLNMKDDDKTNTFCG 155 (312)
T ss_pred cHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCC-CcEEEEECcccccCccCCCccccccC
Confidence 99999986543 8999999999999999999999999999999999999988 789999999997532 2223344579
Q ss_pred ccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcCCCC
Q 021127 188 TYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKEDPNA 240 (317)
Q Consensus 188 t~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~ 240 (317)
|+.|+|||++.+.... ...+.|+.+ .....+..++.++.+++.+||+.||.+
T Consensus 156 t~~y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 234 (312)
T cd05585 156 TPEYLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTR 234 (312)
T ss_pred CcccCCHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHH
Confidence 9999999998765433 234444433 111234567889999999999999999
Q ss_pred CCC---HHHHHHH
Q 021127 241 RPN---FTQIIQM 250 (317)
Q Consensus 241 Rps---~~~~~~~ 250 (317)
||+ +.+++.|
T Consensus 235 R~~~~~~~e~l~h 247 (312)
T cd05585 235 RLGYNGAQEIKNH 247 (312)
T ss_pred cCCCCCHHHHHcC
Confidence 975 6777766
No 80
>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N. Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved
Probab=100.00 E-value=1.4e-37 Score=275.70 Aligned_cols=219 Identities=22% Similarity=0.331 Sum_probs=172.6
Q ss_pred eeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHH---HhcCCCCeeeEEeeeecC-ceE
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML---SRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~-~~~ 99 (317)
|++.+.||+|+||.||+|.+. ++.||||++....... ......+.+|++++ +.++||||+++++++.++ ..+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA--RDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence 678999999999999999885 7899999997543211 12234566666655 566899999999998765 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-c
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-L 178 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~ 178 (317)
+||||+++++|..++.. ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++... .
T Consensus 79 lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~-~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC-CcEEeCcccCCccCCCC
Confidence 99999999999988864 239999999999999999999999999999999999999998 799999999987432 2
Q ss_pred ccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHH
Q 021127 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~ 231 (317)
.......+|++.|+|||++.+.... ...++|+.+ .....+..++..+.++|.
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 233 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYT-RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMR 233 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCC-cccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 2233456799999999998764432 233444432 111234567899999999
Q ss_pred HhhhcCCCCCC-----CHHHHHHHH
Q 021127 232 SCWKEDPNARP-----NFTQIIQML 251 (317)
Q Consensus 232 ~cl~~~p~~Rp-----s~~~~~~~l 251 (317)
+||+.||.+|| ++.+++++.
T Consensus 234 ~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 234 RLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred HHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 99999999999 577887763
No 81
>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D
Probab=100.00 E-value=1.7e-37 Score=281.51 Aligned_cols=241 Identities=27% Similarity=0.494 Sum_probs=188.8
Q ss_pred cccceecCCceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc
Q 021127 9 LADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV 81 (317)
Q Consensus 9 ~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l 81 (317)
.+.....+..|.++.++|.+.++||+|+||.||+|++. +..||||++....... ....+.+|+.++.++
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~----~~~~~~~E~~~l~~l 97 (401)
T cd05107 22 DPMQLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS----EKQALMSELKIMSHL 97 (401)
T ss_pred CCCCCCCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChh----HHHHHHHHHHHHHhc
Confidence 34445666789999999999999999999999999864 3679999997654322 234688999999999
Q ss_pred C-CCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC----------------------------------------
Q 021127 82 Q-HRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP---------------------------------------- 119 (317)
Q Consensus 82 ~-h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------- 119 (317)
. ||||+++++++... ..++||||+.+|+|.+++...+.
T Consensus 98 ~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (401)
T cd05107 98 GPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGG 177 (401)
T ss_pred CCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCcc
Confidence 7 99999999999764 88999999999999999975321
Q ss_pred --------------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 021127 120 --------------------------------------------------------RCLDVCVAIGFALDIARAMECLHS 143 (317)
Q Consensus 120 --------------------------------------------------------~~l~~~~~~~i~~~i~~~L~~lH~ 143 (317)
..+++..++.++.|++.||+|||+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~ 257 (401)
T cd05107 178 YMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS 257 (401)
T ss_pred ccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 136777889999999999999999
Q ss_pred CCccccCCCCCcEEeeCCCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccCC-------
Q 021127 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------- 213 (317)
Q Consensus 144 ~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------- 213 (317)
++++||||||+||+++.+ +.+||+|||+++...... ......++..|+|||++....... ..++|+.+
T Consensus 258 ~~ivHrdlkp~NiLl~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslGvil~e~l 335 (401)
T cd05107 258 KNCVHRDLAARNVLICEG-KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT-LSDVWSFGILLWEIF 335 (401)
T ss_pred CCcCcccCCcceEEEeCC-CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCc-HhHHHHHHHHHHHHH
Confidence 999999999999999987 689999999997532211 112235678899999876432211 11111100
Q ss_pred -----------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 214 -----------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 214 -----------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
...+.+..++.++.+|+.+||+.+|.+||+++++++.|++++
T Consensus 336 ~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 336 TLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111234467889999999999999999999999999998765
No 82
>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp
Probab=100.00 E-value=6.7e-38 Score=276.75 Aligned_cols=215 Identities=27% Similarity=0.349 Sum_probs=168.4
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||.||+|++. ++.||||++....... ......+..|..++..+ +||||+++++++..+ ..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE--DDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 46999999999999885 7889999998643211 12233455667777654 899999999998755 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc-cccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~-~~~~~~ 184 (317)
++|+|..++..... +++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++.... ......
T Consensus 79 ~gg~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~-~~~kL~Dfg~a~~~~~~~~~~~~ 155 (316)
T cd05592 79 NGGDLMFHIQSSGR--FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD-GHIKIADFGMCKENMNGEGKAST 155 (316)
T ss_pred CCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC-CCEEEccCcCCeECCCCCCcccc
Confidence 99999999976544 8999999999999999999999999999999999999988 7899999999975322 223344
Q ss_pred ccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcC
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKED 237 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~ 237 (317)
.+||+.|+|||++.+.... ...++|+.+ .....+..++.++.+++.+||+.|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~ 234 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERD 234 (316)
T ss_pred ccCCccccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCC
Confidence 5799999999998765433 334444433 111224567889999999999999
Q ss_pred CCCCCCHH-HHHHH
Q 021127 238 PNARPNFT-QIIQM 250 (317)
Q Consensus 238 p~~Rps~~-~~~~~ 250 (317)
|.+||++. +++++
T Consensus 235 P~~R~~~~~~l~~h 248 (316)
T cd05592 235 PTKRLGVDGDIRQH 248 (316)
T ss_pred HHHcCCChHHHHcC
Confidence 99999875 56554
No 83
>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,
Probab=100.00 E-value=9.3e-38 Score=271.95 Aligned_cols=222 Identities=26% Similarity=0.341 Sum_probs=179.3
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
.|++.++||+|+||.||++.+. ++.||||++....... ......+.+|+.++++++|+||+++++++.++ ..++|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhh--hhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence 4888999999999999999875 7899999987644322 12345678899999999999999999998654 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
|||+++|+|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY-GHIRISDLGLAVEIPEGET 157 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC-CCEEEeeCCCceecCCCCc
Confidence 999999999998876554559999999999999999999999999999999999999988 7899999999976543333
Q ss_pred cccccCccceecccccccccccccccccccCC-------------------------------CCCCCCCCChHHHHHHH
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVPEELSIIL 230 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l~~li 230 (317)
.....|++.|+|||++.+..... ..++|+.+ .....+..++..+.+|+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~-~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTF-SPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCc-cccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 34457899999999986543322 23333322 00112345788999999
Q ss_pred HHhhhcCCCCCC-----CHHHHHHH
Q 021127 231 TSCWKEDPNARP-----NFTQIIQM 250 (317)
Q Consensus 231 ~~cl~~~p~~Rp-----s~~~~~~~ 250 (317)
.+||+.||.+|| ++++++++
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcC
Confidence 999999999999 88898876
No 84
>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C. Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re
Probab=100.00 E-value=5.6e-38 Score=277.52 Aligned_cols=215 Identities=25% Similarity=0.320 Sum_probs=171.9
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||+||++++. ++.||||++.+..... ......+..|+.++..+ +||||+++++++.+. ..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ--DDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh--hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 46999999999999885 7899999998643221 12344567888888887 799999999998755 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-ccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~ 184 (317)
++++|..++..... +++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++... .......
T Consensus 79 ~~~~L~~~~~~~~~--l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~ 155 (318)
T cd05570 79 NGGDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTST 155 (318)
T ss_pred CCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC-CcEEecccCCCeecCcCCCcccc
Confidence 99999999876544 9999999999999999999999999999999999999998 799999999987422 1222234
Q ss_pred ccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcC
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKED 237 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~ 237 (317)
.+|++.|+|||++.+..... ..+.|+.+ .....+..++.++.+||.+||+.|
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~-~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~d 234 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGP-AVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKN 234 (318)
T ss_pred eecCccccCHHHhcCCCCCc-chhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCC
Confidence 56899999999987654432 23333322 111224567899999999999999
Q ss_pred CCCCCCH-----HHHHHH
Q 021127 238 PNARPNF-----TQIIQM 250 (317)
Q Consensus 238 p~~Rps~-----~~~~~~ 250 (317)
|.+||++ .+++++
T Consensus 235 P~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 235 PEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHcCCCCCCCHHHHhcC
Confidence 9999999 888876
No 85
>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto
Probab=100.00 E-value=8.9e-38 Score=278.21 Aligned_cols=233 Identities=30% Similarity=0.536 Sum_probs=182.4
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeE
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKF 89 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l 89 (317)
.|.++.++|++.+.||+|+||.||+|... ++.||+|++....... ....+..|+.++.++ +|+||+++
T Consensus 1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~----~~~~~~~E~~~~~~l~~h~niv~~ 76 (337)
T cd05054 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATAS----EYKALMTELKILIHIGHHLNVVNL 76 (337)
T ss_pred CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHH----HHHHHHHHHHHHHhhccCcchhhe
Confidence 48999999999999999999999998643 4689999987544322 234578899999999 89999999
Q ss_pred Eeeeec--CceEEEEEccCCCCHHHHHHhcCC------------------------------------------------
Q 021127 90 IGACKE--PVMVIVTELLSGGTLRKYLLNMRP------------------------------------------------ 119 (317)
Q Consensus 90 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------ 119 (317)
++++.. ...+++|||+++++|.+++.....
T Consensus 77 ~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (337)
T cd05054 77 LGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDV 156 (337)
T ss_pred eeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhc
Confidence 998854 478899999999999999864321
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc---ccccc
Q 021127 120 -----------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAE 185 (317)
Q Consensus 120 -----------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~ 185 (317)
..+++..+..++.||+.||+|||++||+||||||+||+++.+ +.++|+|||++....... .....
T Consensus 157 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~-~~vkL~DfG~a~~~~~~~~~~~~~~~ 235 (337)
T cd05054 157 EEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDA 235 (337)
T ss_pred ccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCC-CcEEEeccccchhcccCcchhhccCC
Confidence 247899999999999999999999999999999999999987 689999999998543221 11223
Q ss_pred cCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHHHHHhhh
Q 021127 186 TGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSIILTSCWK 235 (317)
Q Consensus 186 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~cl~ 235 (317)
.++..|+|||++.+...... .++|+.+ .....+...+.++.+++.+||+
T Consensus 236 ~~~~~y~aPE~~~~~~~~~~-~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 314 (337)
T cd05054 236 RLPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWH 314 (337)
T ss_pred CCCccccCcHHhcCCCCCcc-ccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHcc
Confidence 45678999998755322211 1111110 1111234567889999999999
Q ss_pred cCCCCCCCHHHHHHHHHHhhh
Q 021127 236 EDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 236 ~~p~~Rps~~~~~~~l~~~~~ 256 (317)
.+|++||++.+++++|.+++.
T Consensus 315 ~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 315 NNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999998765
No 86
>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.5e-38 Score=285.96 Aligned_cols=224 Identities=23% Similarity=0.359 Sum_probs=184.8
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 96 (317)
.+.-++|.++++||+|+||+|+++..+ ++.+|||++++...-.. ...+..+.|.+++... +||.+++++.+|+.+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~--d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~ 441 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQR--DEVESLMCEKRIFELANRHPFLVNLFSCFQTK 441 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecc--ccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence 456689999999999999999999886 78999999998765432 3345577788888776 699999999999876
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
++|+||||+.||++..+.+ ...+++..+..|+..|+.||.|||++||||||||.+|||+|.+ |.+||+|||+++.
T Consensus 442 ~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~e-Gh~kiADFGlcKe 517 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTE-GHVKIADFGLCKE 517 (694)
T ss_pred CeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEccc-CcEEecccccccc
Confidence 8999999999999444333 2339999999999999999999999999999999999999999 8999999999995
Q ss_pred c-ccccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHH
Q 021127 176 E-SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 176 ~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~ 227 (317)
. .....+++.||||.|||||++.+..+... .+||..+ .....|..++.+..
T Consensus 518 ~m~~g~~TsTfCGTpey~aPEil~e~~Yt~a-VDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~ 596 (694)
T KOG0694|consen 518 GMGQGDRTSTFCGTPEFLAPEVLTEQSYTRA-VDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAI 596 (694)
T ss_pred cCCCCCccccccCChhhcChhhhccCcccch-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHH
Confidence 4 35567788999999999999988666554 3445443 11233667899999
Q ss_pred HHHHHhhhcCCCCCCCH-----HHHHHH
Q 021127 228 IILTSCWKEDPNARPNF-----TQIIQM 250 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~-----~~~~~~ 250 (317)
++|+++|..||++|..+ ++|.+|
T Consensus 597 ~il~~ll~k~p~kRLG~~e~d~~~i~~h 624 (694)
T KOG0694|consen 597 AIMRRLLRKNPEKRLGSGERDAEDIKKH 624 (694)
T ss_pred HHHHHHhccCcccccCCCCCCchhhhhC
Confidence 99999999999999765 555554
No 87
>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk. Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r
Probab=100.00 E-value=1.6e-37 Score=266.78 Aligned_cols=227 Identities=28% Similarity=0.502 Sum_probs=182.9
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCc
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPV 97 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 97 (317)
|.+..++|++.++||+|+||.||+|... +..||+|.+...... ...+.+|+.++++++|+|++++++++.+..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~------~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~ 74 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS------PESFLEEAQIMKKLRHDKLVQLYAVVSEEP 74 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC------HHHHHHHHHHHHhcCCCceEEEEeEECCCC
Confidence 7788899999999999999999999876 677999998764432 235889999999999999999999988778
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.+++|||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~-~~~~l~dfg~~~~~~ 153 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDG-LVCKIADFGLARLIE 153 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCC-ceEEeCCceeeeecc
Confidence 8999999999999999987555558999999999999999999999999999999999999988 689999999997543
Q ss_pred ccccc--ccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHH
Q 021127 178 LTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEEL 226 (317)
Q Consensus 178 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l 226 (317)
..... ....++..|+|||++.+..... ..+.|+.+ ...+.+...+..+
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd05070 154 DNEYTARQGAKFPIKWTAPEAALYGRFTI-KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISL 232 (260)
T ss_pred CcccccccCCCCCccccChHHHhcCCCcc-hhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence 32211 1223456899999865422111 11111110 1222355678899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
.+|+.+||..+|.+|||++++.+.|++
T Consensus 233 ~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 233 HELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 999999999999999999999988865
No 88
>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor
Probab=100.00 E-value=1.7e-37 Score=274.24 Aligned_cols=230 Identities=22% Similarity=0.436 Sum_probs=182.5
Q ss_pred ecCCceeecceeccccceEEEEeEEC--Ce----EEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQ----TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~----~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
+...+|++.+.||+|+||.||+|.+. +. .||+|++...... ....++.+|+.+++.++||||++++|++.
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~g~~~ 79 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP----KANKEILDEAYVMASVDNPHVCRLLGICL 79 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCH----HHHHHHHHHHHHHHhCCCCCCCeEEEEEc
Confidence 55678999999999999999999863 33 4899998754332 23456889999999999999999999998
Q ss_pred cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 95 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
....++|+||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++
T Consensus 80 ~~~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~-~~~kl~DfG~a~ 157 (316)
T cd05108 80 TSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTP-QHVKITDFGLAK 157 (316)
T ss_pred CCCceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCC-CcEEEccccccc
Confidence 888899999999999999998644 238899999999999999999999999999999999999988 689999999998
Q ss_pred cccccccc---ccccCccceecccccccccccccccccccC-----------------------------CCCCCCCCCC
Q 021127 175 EESLTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNH-----------------------------KNVRPSAENV 222 (317)
Q Consensus 175 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~ 222 (317)
........ ....++..|+|||++....... ..++|+. ....+.+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~-~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTH-QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 236 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCc-hhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCC
Confidence 65432221 1223467899999875533221 1111111 1122334567
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+.++.+++.+||+.+|.+||++.+++..+..+...
T Consensus 237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 237 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 78999999999999999999999999998887654
No 89
>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]
Probab=100.00 E-value=1.9e-38 Score=268.31 Aligned_cols=223 Identities=29% Similarity=0.390 Sum_probs=180.7
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCC-eeeEEeeeecC---
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN-LVKFIGACKEP--- 96 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~--- 96 (317)
...|...++||+|.||+||+|+.. |+.||+|.++.....+. .-....+|+.+++.++|+| |++|++++...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG---~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~ 86 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG---VPSTAIREISLLKRLSHANHIVRLHDVIHTSNNH 86 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC---CCchhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence 456788889999999999999885 89999999987654221 1123578999999999999 99999998542
Q ss_pred ----ceEEEEEccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEccc
Q 021127 97 ----VMVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (317)
Q Consensus 97 ----~~~lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Df 170 (317)
..++|+||+ ..+|..++..... ..++...+..++.||+.||+|||+++|+||||||.||+|+++ |.+||+||
T Consensus 87 ~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~-G~lKlaDF 164 (323)
T KOG0594|consen 87 RGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSS-GVLKLADF 164 (323)
T ss_pred cccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCC-CcEeeecc
Confidence 588999999 6799999988663 358888999999999999999999999999999999999998 89999999
Q ss_pred Ccccccc-cccccccccCccceecccccccccccccccccccCC------------------------------------
Q 021127 171 GLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------------ 213 (317)
Q Consensus 171 g~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------------ 213 (317)
|+|+... .....+..++|..|.|||++.+........+.|+.+
T Consensus 165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 9999655 334466778999999999988865555555555433
Q ss_pred --------------CCCCCC-------CCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 --------------NVRPSA-------ENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 --------------~~~~~~-------~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.....+ +....+..+++..||+.+|.+|.|++.+++|
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000001 1223478999999999999999999999987
No 90
>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found
Probab=100.00 E-value=2.1e-37 Score=279.03 Aligned_cols=229 Identities=23% Similarity=0.321 Sum_probs=180.6
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
...+..++|++.+.||+|+||.||++++. ++.||+|++.+..... ......+.+|+.+++.++||||+++++++.+
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIK--RSDSAFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 45567789999999999999999999885 7899999987532211 1234457889999999999999999999876
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+ ..++||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~-~~~kL~DFG~a~ 190 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKH-GHLKLADFGTCM 190 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC-CCEEEEecccce
Confidence 5 799999999999999999753 28899999999999999999999999999999999999988 799999999998
Q ss_pred cccccc--ccccccCccceeccccccccc---ccccccccccCC-----------------------------C--CCCC
Q 021127 175 EESLTE--MMTAETGTYRWMAPELYSTVT---LRQGEKKHYNHK-----------------------------N--VRPS 218 (317)
Q Consensus 175 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~~~-----------------------------~--~~~~ 218 (317)
...... .....+||+.|+|||++.+.. ......++|+.+ . ..+.
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 270 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPE 270 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCC
Confidence 643222 123457999999999986532 122334445433 0 0111
Q ss_pred CCCChHHHHHHHHHhhhcCCCC--CCCHHHHHHHHH
Q 021127 219 AENVPEELSIILTSCWKEDPNA--RPNFTQIIQMLL 252 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~--Rps~~~~~~~l~ 252 (317)
...++..+++++..||..++.+ |+++.++++|-+
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 271 DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 2346888999999999855543 889999999843
No 91
>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,
Probab=100.00 E-value=5.3e-37 Score=268.07 Aligned_cols=235 Identities=32% Similarity=0.572 Sum_probs=187.2
Q ss_pred cCCceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCe
Q 021127 15 LDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNL 86 (317)
Q Consensus 15 ~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 86 (317)
++..|.++.++|++.+.||+|+||.||++.+. ...+|+|.+...... +....+.+|+.++.++ +|+||
T Consensus 3 ~~~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~~E~~~l~~l~~h~~i 78 (293)
T cd05053 3 LDPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE----KDLSDLVSEMEMMKMIGKHKNI 78 (293)
T ss_pred CCcccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH----HHHHHHHHHHHHHHhhcCCCCe
Confidence 46789999999999999999999999999864 367999998765432 2345688999999999 89999
Q ss_pred eeEEeeeecC-ceEEEEEccCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 021127 87 VKFIGACKEP-VMVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDL 151 (317)
Q Consensus 87 v~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dl 151 (317)
+++++++.++ ..+++|||+++++|.+++.... ...+++..++.++.|++.||+|||+++|+||||
T Consensus 79 ~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dl 158 (293)
T cd05053 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDL 158 (293)
T ss_pred eeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccccc
Confidence 9999998755 8999999999999999997532 235899999999999999999999999999999
Q ss_pred CCCcEEeeCCCCceEEcccCcccccccccc---cccccCccceecccccccccccccccccccCC---------------
Q 021127 152 KPENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------- 213 (317)
Q Consensus 152 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------- 213 (317)
||+||+++.+ +.+||+|||+++....... .....++..|+|||++.+..... ..++|+.+
T Consensus 159 kp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~~g~~p~~ 236 (293)
T cd05053 159 AARNVLVTED-HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLLWEIFTLGGSPYP 236 (293)
T ss_pred ceeeEEEcCC-CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCc-ccceeehhhHHHHHhcCCCCCCC
Confidence 9999999988 7999999999985433211 12223567899999876533322 22333322
Q ss_pred --------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 214 --------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 214 --------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
.....+...+..+.+|+.+||..||.+|||+.++++.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 237 GIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 011224456789999999999999999999999999998764
No 92
>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an
Probab=100.00 E-value=8.3e-38 Score=274.61 Aligned_cols=221 Identities=25% Similarity=0.343 Sum_probs=172.0
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
.++|++.++||+|+||.||+|++. ++.||||++....... ....+.+|+.+++.++||||+++++++.+. ..+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG----TPFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc----cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEE
Confidence 468999999999999999999985 7899999987544321 123467899999999999999999998765 789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+||||+ +++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++.....
T Consensus 80 lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 80 LVFEYV-HTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDT-GELKLADFGLARAKSVP 156 (303)
T ss_pred EEEECC-CcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECCCCcceeccCC
Confidence 999999 578888887643 348999999999999999999999999999999999999988 78999999998743322
Q ss_pred -cccccccCccceecccccccccccccccccccCC--------CCC----------------------------------
Q 021127 180 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR---------------------------------- 216 (317)
Q Consensus 180 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~---------------------------------- 216 (317)
.......+++.|+|||++.+........++|+.+ ...
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 2223456899999999875432222222222211 000
Q ss_pred ---C------C---------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 ---P------S---------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 ---~------~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+ . ...++..+.+|+.+||+.||.+|||+.++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0 0 01234678899999999999999999999987
No 93
>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]
Probab=100.00 E-value=6.4e-39 Score=260.97 Aligned_cols=227 Identities=22% Similarity=0.318 Sum_probs=187.7
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCC---hHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGET---PEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP- 96 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~---~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 96 (317)
..|.-.+.||.|..+.|-++.++ +..+|+|++..... .+...+.++.-.+|+.+|+++ .||+|+++.++++.+
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 56777889999999999987664 78899998875432 222344555677899999998 799999999999876
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
.+++|+|.|+.|.|.++|...-. ++++....|+.|+++|+.|||.++||||||||+|||++++ .++||+|||+++..
T Consensus 97 F~FlVFdl~prGELFDyLts~Vt--lSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn-~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVT--LSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDN-MNIKISDFGFACQL 173 (411)
T ss_pred hhhhhhhhcccchHHHHhhhhee--ecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccc-cceEEeccceeecc
Confidence 78999999999999999987554 9999999999999999999999999999999999999999 48999999999999
Q ss_pred ccccccccccCccceeccccccccc-----ccccccccccCC-------------------------------CCCCCCC
Q 021127 177 SLTEMMTAETGTYRWMAPELYSTVT-----LRQGEKKHYNHK-------------------------------NVRPSAE 220 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~~~~~~-------------------------------~~~~~~~ 220 (317)
..+......||||+|+|||.+...- ......+.|..+ -..+...
T Consensus 174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWa 253 (411)
T KOG0599|consen 174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWA 253 (411)
T ss_pred CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchh
Confidence 8888888899999999999865321 112222333222 1234456
Q ss_pred CChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 221 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 221 ~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
+++...++||.+||+.||.+|.|++|+++|-+-
T Consensus 254 dis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 254 DISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred hccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 789999999999999999999999999998543
No 94
>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,
Probab=100.00 E-value=3e-37 Score=273.69 Aligned_cols=215 Identities=27% Similarity=0.328 Sum_probs=167.8
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHH-HHHhcCCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA-MLSRVQHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||.||+|++. ++.||||++....... ......+..|.. +++.++||||+++++++..+ ..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN--RKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence 46899999999999875 8899999997643221 122334555655 46778999999999988754 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-ccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~ 184 (317)
++|+|..++..... +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++... .......
T Consensus 79 ~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~ 155 (325)
T cd05604 79 NGGELFFHLQRERS--FPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ-GHVVLTDFGLCKEGIAQSDTTTT 155 (325)
T ss_pred CCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEEeecCCcccCCCCCCCccc
Confidence 99999998876544 8999999999999999999999999999999999999988 799999999987432 2223345
Q ss_pred ccCccceecccccccccccccccccccCCC---------------------------CCCCCCCChHHHHHHHHHhhhcC
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKN---------------------------VRPSAENVPEELSIILTSCWKED 237 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~cl~~~ 237 (317)
.+||+.|+|||++.+..+. ...++|+.+. ........+..+.+++.+||+.+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~ 234 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKD 234 (325)
T ss_pred ccCChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccC
Confidence 5799999999998765443 2344454430 11123457788999999999999
Q ss_pred CCCCCCHH----HHHHH
Q 021127 238 PNARPNFT----QIIQM 250 (317)
Q Consensus 238 p~~Rps~~----~~~~~ 250 (317)
|.+||++. +++++
T Consensus 235 p~~R~~~~~~~~~i~~h 251 (325)
T cd05604 235 RQRRLGAKEDFLEIQEH 251 (325)
T ss_pred HHhcCCCCCCHHHHhcC
Confidence 99999875 55544
No 95
>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk. Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr
Probab=100.00 E-value=2.1e-37 Score=265.99 Aligned_cols=227 Identities=30% Similarity=0.513 Sum_probs=184.6
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCc
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPV 97 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 97 (317)
|.|..++|++.++||+|+||.||+|... ++.||+|.+...... ..++.+|+.++++++|+||+++++++.+..
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS------PEAFLAEANLMKQLQHPRLVRLYAVVTQEP 74 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc------HHHHHHHHHHHHhcCCcCeeeEEEEEccCC
Confidence 7789999999999999999999999875 688999998765432 235889999999999999999999987778
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.+++|||+.+++|.+++.......+++..++.++.|++.||+|||+.|++||||||+||+++.+ +.++|+|||++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~ 153 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSET-LCCKIADFGLARLIE 153 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCC-CCEEEccCcceeecC
Confidence 9999999999999999976555568999999999999999999999999999999999999988 689999999997544
Q ss_pred cccc--cccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHH
Q 021127 178 LTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEEL 226 (317)
Q Consensus 178 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l 226 (317)
.... .....++..|+|||++....... ..+.|+.+ ...+.+...+.++
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~-~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINYGTFTI-KSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEEL 232 (260)
T ss_pred CCCcccccCCcccccccCHHHhccCCcCc-ccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHH
Confidence 2221 12234567899999875433221 11111111 1122345677899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
.+++.+||+.+|++||++++++..|++
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 233 YELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 999999999999999999999998875
No 96
>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=5e-37 Score=270.15 Aligned_cols=243 Identities=31% Similarity=0.548 Sum_probs=190.2
Q ss_pred ccceecCCceeecCCceeecceeccccceEEEEeEEC---------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHh
Q 021127 10 ADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSR 80 (317)
Q Consensus 10 ~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~ 80 (317)
+.+...+..|.+..++|.+.+.||+|+||.||++++. ...+|+|.+...... .....+.+|+.++..
T Consensus 4 ~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~e~~~l~~ 79 (307)
T cd05098 4 EYELPEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE----KDLSDLISEMEMMKM 79 (307)
T ss_pred cccCCCCCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCCh----HHHHHHHHHHHHHHH
Confidence 3445557789999999999999999999999999763 246999998764332 224468889999999
Q ss_pred c-CCCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhC
Q 021127 81 V-QHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSH 144 (317)
Q Consensus 81 l-~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~lH~~ 144 (317)
+ +|+||+++++++.+. ..++||||+++++|.+++..... ..+++..++.++.|++.||+|||++
T Consensus 80 l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~ 159 (307)
T cd05098 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK 159 (307)
T ss_pred hcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 9 799999999998754 89999999999999999976432 2488999999999999999999999
Q ss_pred CccccCCCCCcEEeeCCCCceEEcccCcccccccccc---cccccCccceecccccccccccccccccccCC--------
Q 021127 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------- 213 (317)
Q Consensus 145 ~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------- 213 (317)
|++||||||+||+++.+ +.+||+|||+++....... .....+++.|+|||++.+..... ..++|+.+
T Consensus 160 gi~H~dlkp~Nill~~~-~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~~l~el~~ 237 (307)
T cd05098 160 KCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH-QSDVWSFGVLLWEIFT 237 (307)
T ss_pred CcccccccHHheEEcCC-CcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCc-HHHHHHHHHHHHHHHc
Confidence 99999999999999988 7899999999875432211 11223457899999875432211 11111111
Q ss_pred ---------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 214 ---------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 214 ---------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
.....+..++.++.+|+.+||..+|.+||++.++++.|.+++...
T Consensus 238 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 238 LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred CCCCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 112234567889999999999999999999999999999987653
No 97
>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk
Probab=100.00 E-value=3.3e-37 Score=264.14 Aligned_cols=225 Identities=32% Similarity=0.591 Sum_probs=184.2
Q ss_pred eeecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-Cc
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PV 97 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 97 (317)
|.++.++|++.+.||.|+||.||+|...++.||||.+..... ...++.+|+.++++++|+||+++++++.+ ..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 74 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST------AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNP 74 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh------HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCC
Confidence 567889999999999999999999999999999999875543 24568899999999999999999999874 48
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++||||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||.++...
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~-~~~~l~d~g~~~~~~ 153 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED-LVAKVSDFGLAKEAS 153 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCC-CCEEEcccccccccc
Confidence 9999999999999999987664469999999999999999999999999999999999999988 689999999998653
Q ss_pred cccccccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHHH
Q 021127 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSI 228 (317)
Q Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~ 228 (317)
... ....++..|+|||.+.+..... ..+.|+.+ .....+..++..+.+
T Consensus 154 ~~~--~~~~~~~~~~ape~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd05039 154 QGQ--DSGKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYK 230 (256)
T ss_pred ccc--ccCCCcccccCchhhcCCcCCc-HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHH
Confidence 221 1334567899999875432211 11111110 011224467899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 229 ILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 229 li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
++.+||..+|.+||++.++++.|..
T Consensus 231 li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 231 VMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHHhccChhhCcCHHHHHHHHhc
Confidence 9999999999999999999998864
No 98
>PLN00034 mitogen-activated protein kinase kinase; Provisional
Probab=100.00 E-value=1.1e-37 Score=279.46 Aligned_cols=220 Identities=25% Similarity=0.382 Sum_probs=174.7
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
...++|++.++||+|+||.||+|++. ++.||||++...... .....+.+|+++++.++|+||+++++++.+. .
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 146 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED----TVRRQICREIEILRDVNHPNVVKCHDMFDHNGE 146 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcH----HHHHHHHHHHHHHHhCCCCCcceeeeEeccCCe
Confidence 34567889999999999999999885 789999998755432 2345688999999999999999999998755 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++||||+++++|.... ..++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 147 ~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kL~DfG~~~~~~ 219 (353)
T PLN00034 147 IQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSA-KNVKIADFGVSRILA 219 (353)
T ss_pred EEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-CCEEEcccccceecc
Confidence 99999999999986532 25678888999999999999999999999999999999988 799999999997543
Q ss_pred cc-cccccccCccceeccccccccc----ccccccccccCC-------------------------------CCCCCCCC
Q 021127 178 LT-EMMTAETGTYRWMAPELYSTVT----LRQGEKKHYNHK-------------------------------NVRPSAEN 221 (317)
Q Consensus 178 ~~-~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~~~~~~-------------------------------~~~~~~~~ 221 (317)
.. .......||..|+|||++.... ......++|+.+ .....+..
T Consensus 220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (353)
T PLN00034 220 QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPAT 299 (353)
T ss_pred cccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCc
Confidence 22 2223457899999999874321 111123333322 01112446
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
++.++.+||.+||+.||++||++.++++|-
T Consensus 300 ~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 300 ASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 788999999999999999999999999983
No 99
>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity. Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....
Probab=100.00 E-value=8.5e-38 Score=268.48 Aligned_cols=219 Identities=34% Similarity=0.620 Sum_probs=169.2
Q ss_pred eecceeccccceEEEEeEEC------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceE
Q 021127 27 FVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (317)
Q Consensus 27 ~~~~~lG~G~~g~V~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 99 (317)
.+.+.||.|.||.||+|.+. +..|+||.+...... .....+.+|++.+++++||||++++|++.+ +..+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSE----EEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSH----HHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccccc----ccceeeeeccccccccccccccccccccccccccc
Confidence 57789999999999999887 688999999654332 235679999999999999999999999985 4799
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+|+||+++|+|.++|.......+++..++.|+.||+.||.|||+++++|+||+++||+++.+ +.+||+|||++......
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~-~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSN-GQVKLSDFGLSRPISEK 156 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETT-TEEEEESTTTGEETTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccc
Confidence 99999999999999998745559999999999999999999999999999999999999998 69999999999865221
Q ss_pred ---cccccccCccceeccccccccccccccccccc-----------------------------CCCCCCCCCCChHHHH
Q 021127 180 ---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-----------------------------HKNVRPSAENVPEELS 227 (317)
Q Consensus 180 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~l~ 227 (317)
.......+...|+|||.+...... ...+.|+ .....+.+..++..+.
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~-~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYT-KKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIY 235 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEES-HHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHH
T ss_pred ccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccceeccchhHHHH
Confidence 122333467889999986553211 1111111 1122334567899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
++|.+||..||++||++.++++.|
T Consensus 236 ~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 236 SLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHhcC
Confidence 999999999999999999999865
No 100
>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla
Probab=100.00 E-value=1.9e-37 Score=270.49 Aligned_cols=221 Identities=28% Similarity=0.390 Sum_probs=171.0
Q ss_pred CceeecceeccccceEEEEeEEC---CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc---CCCCeeeEEeeee---
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV---QHRNLVKFIGACK--- 94 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~--- 94 (317)
++|++.+.||+|+||.||+|++. ++.||||.+........ ....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~ 77 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG---MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 77 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC---chHHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence 47999999999999999999873 67899999876543221 122355677766665 6999999999874
Q ss_pred ---cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 95 ---EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 95 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
+...++||||+. ++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 78 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~-~~~kl~Dfg 155 (290)
T cd07862 78 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFG 155 (290)
T ss_pred CCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCC-CCEEEcccc
Confidence 236899999995 699999987655568999999999999999999999999999999999999988 799999999
Q ss_pred cccccccccccccccCccceecccccccccccccccccccCC--------CC--------------------------C-
Q 021127 172 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV--------------------------R- 216 (317)
Q Consensus 172 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~--------------------------~- 216 (317)
+++............|++.|+|||++.+..... ..+.|+.+ .. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYAT-PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred ceEeccCCcccccccccccccChHHHhCCCCCC-ccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 998654444444567899999999875533221 22222211 00 0
Q ss_pred -------------------CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 -------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 -------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.....++..+.+|+.+||+.||++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0012467788999999999999999999999875
No 101
>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment
Probab=100.00 E-value=5.8e-37 Score=264.16 Aligned_cols=227 Identities=28% Similarity=0.504 Sum_probs=180.9
Q ss_pred ecCCceeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
|++++|++.+.||+|+||.||+|.+. ...||||.+...... .....|.+|+.++++++|+||+++++++.+
T Consensus 1 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (266)
T cd05033 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD----KQRLDFLTEASIMGQFDHPNIIRLEGVVTK 76 (266)
T ss_pred CChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCCh----HHHHHHHHHHHHHHhCCCCCcceEeEEEec
Confidence 46788999999999999999999874 357999998765432 234568899999999999999999998865
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+ ..++||||+++++|.+++..... .+++..++.++.|++.||+|||+++|+|+||||+||+++.+ +.++|+|||++.
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~-~~~~l~dfg~~~ 154 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSR 154 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CCEEECccchhh
Confidence 4 78999999999999999976443 48999999999999999999999999999999999999988 689999999998
Q ss_pred cccc-ccc--cccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCC
Q 021127 175 EESL-TEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENV 222 (317)
Q Consensus 175 ~~~~-~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~ 222 (317)
.... ... .....++..|+|||.+.+..... ..+.|+.+ ...+.+..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~-~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (266)
T cd05033 155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTS-ASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDC 233 (266)
T ss_pred cccccccceeccCCCCCccccChhhhccCCCcc-ccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 6531 111 11223467899999876532211 11111110 112334567
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
+..+.+++.+||+.+|++||++.+++++|.++
T Consensus 234 ~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 234 PSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 89999999999999999999999999998865
No 102
>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes
Probab=100.00 E-value=1.5e-37 Score=270.75 Aligned_cols=220 Identities=25% Similarity=0.307 Sum_probs=172.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||+++++ ++.||||++....... .....+.+|+.+++.++|+||+++++++.+. ..++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE---EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYL 77 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc---cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEE
Confidence 47999999999999999999986 7889999997654322 2344678899999999999999999988654 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||++++.+..+.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 78 VFEYVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHN-DVLKLCDFGFARNLSEGS 154 (287)
T ss_pred EEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEEeeccCcccccccc
Confidence 99999887666544332 348999999999999999999999999999999999999988 789999999998643221
Q ss_pred --ccccccCccceecccccccccccccccccccCC--------CC-----------------------------------
Q 021127 181 --MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV----------------------------------- 215 (317)
Q Consensus 181 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~----------------------------------- 215 (317)
......|++.|+|||++.+.... ...+.|+.+ ..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred cccccccccccccCCcHHHcCCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 22334689999999987654332 222333211 00
Q ss_pred -----CCC-----------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 -----RPS-----------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 -----~~~-----------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+. ...++.++.+|+.+||+.||++|||++++++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000 11357789999999999999999999999876
No 103
>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re
Probab=100.00 E-value=4e-37 Score=263.70 Aligned_cols=224 Identities=29% Similarity=0.540 Sum_probs=181.8
Q ss_pred eeecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee-c-C
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-E-P 96 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~-~ 96 (317)
|.++..+|++.+.||+|+||.||++...+..||+|.+..... ...+.+|+.++++++|+|++++++++. + +
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT-------AQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 73 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCch-------HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCC
Confidence 678889999999999999999999999999999999864432 335889999999999999999999763 3 4
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++||||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++..
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~ 152 (256)
T cd05082 74 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSED-NVAKVSDFGLTKEA 152 (256)
T ss_pred ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCC-CcEEecCCccceec
Confidence 78999999999999999987665568999999999999999999999999999999999999988 79999999998754
Q ss_pred ccccccccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHH
Q 021127 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~ 227 (317)
.... ....++..|+|||++.+..... ..+.|+.+ .....+..++..+.
T Consensus 153 ~~~~--~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (256)
T cd05082 153 SSTQ--DTGKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVY 229 (256)
T ss_pred cccC--CCCccceeecCHHHHccCCCCc-hhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 3221 2334567899999876533221 12222211 01112346788999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
+++.+||+.+|++|||+.++++.|+.
T Consensus 230 ~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 230 DVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 99999999999999999999998864
No 104
>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]
Probab=100.00 E-value=1e-37 Score=250.54 Aligned_cols=234 Identities=21% Similarity=0.300 Sum_probs=189.5
Q ss_pred CCceeecCCceeecceeccccceEEEEeEE--CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
+....|+.++|.+.++||.|||+.||+++. ++..+|+|.+..... +.++..++|++..++++||||++++++.
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~-----~~~e~~~rEid~~rkf~s~~vl~l~dh~ 87 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ-----EDIEEALREIDNHRKFNSPNVLRLVDHQ 87 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch-----HHHHHHHHHHHHHHhhCCcchHHHHHHH
Confidence 567789999999999999999999999875 588999999987663 3356689999999999999999999876
Q ss_pred e----c--CceEEEEEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEeeCCCC
Q 021127 94 K----E--PVMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLK 163 (317)
Q Consensus 94 ~----~--~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~~--ivH~Dlkp~Nill~~~~~ 163 (317)
. + ...|++++|...|+|.+.+...+ +..+++.+++.|+.+|++||++||+.. ++||||||.||++..+ +
T Consensus 88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~-~ 166 (302)
T KOG2345|consen 88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS-G 166 (302)
T ss_pred HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC-C
Confidence 2 1 26999999999999999997643 345999999999999999999999998 9999999999999987 6
Q ss_pred ceEEcccCcccccccccc----------cccccCccceeccccccccc--ccccccccccCC------------------
Q 021127 164 TIKLADFGLAREESLTEM----------MTAETGTYRWMAPELYSTVT--LRQGEKKHYNHK------------------ 213 (317)
Q Consensus 164 ~~kl~Dfg~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~~~------------------ 213 (317)
.++|.|||.++.....-. ......|..|.|||++.-.. .-....++|+.+
T Consensus 167 ~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~ 246 (302)
T KOG2345|consen 167 LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ 246 (302)
T ss_pred ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh
Confidence 999999999874332111 12234689999999875321 122233344333
Q ss_pred -------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 214 -------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 214 -------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
...|....+++.+.++|+.||+.||.+||++.+++..++++.
T Consensus 247 ~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 223444568999999999999999999999999999988764
No 105
>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer
Probab=100.00 E-value=2.4e-37 Score=268.87 Aligned_cols=228 Identities=32% Similarity=0.570 Sum_probs=180.7
Q ss_pred ecCCceeecceeccccceEEEEeEECC-------eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
++.++|++.+.||+|+||.||+|...+ ..||+|.+...... .....+.+|+.++.+++||||+++++++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~~~ei~~l~~l~h~~i~~~~~~~ 77 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP----KVQQEFRQEAELMSDLQHPNIVCLLGVC 77 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH----HHHHHHHHHHHHHHhcCCcccceEEEEE
Confidence 445689999999999999999998642 56999998755432 2345688999999999999999999998
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 158 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill 158 (317)
.+. ..+++|||+++++|.+++..... ..+++..++.++.|++.||+|||++|++|+||||+||++
T Consensus 78 ~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~ 157 (283)
T cd05048 78 TKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV 157 (283)
T ss_pred cCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE
Confidence 754 78999999999999999976421 348899999999999999999999999999999999999
Q ss_pred eCCCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccCC----------------------
Q 021127 159 TEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------- 213 (317)
Q Consensus 159 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------- 213 (317)
+.+ +.++|+|||++....... ......+++.|+|||.+.+..... ..++|+.+
T Consensus 158 ~~~-~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 158 GEG-LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTT-ESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred cCC-CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCch-hhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 988 689999999987542221 123345678899999875433221 11222111
Q ss_pred -------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 214 -------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 214 -------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
.....+..+|.++.+|+.+||+.||.+||++.+++++|+++
T Consensus 236 ~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 236 IEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 12233567889999999999999999999999999998753
No 106
>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=5.8e-37 Score=269.35 Aligned_cols=239 Identities=31% Similarity=0.549 Sum_probs=188.1
Q ss_pred eecCCceeecCCceeecceeccccceEEEEeEEC---------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-C
Q 021127 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-Q 82 (317)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 82 (317)
+.....|.+...+|.+.+.||+|+||.||++++. +..||+|.+...... ....++.+|+.++..+ +
T Consensus 4 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~~~E~~~l~~l~~ 79 (304)
T cd05101 4 LPEDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE----KDLSDLVSEMEMMKMIGK 79 (304)
T ss_pred cccCCcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccch----HHHHHHHHHHHHHHhhcc
Confidence 4445679999999999999999999999999741 357999988754322 2345688999999999 8
Q ss_pred CCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 021127 83 HRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGII 147 (317)
Q Consensus 83 h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~lH~~~iv 147 (317)
||||+++++++... ..++||||+++++|.+++..... ..+++.+++.++.||+.||+|||++|++
T Consensus 80 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~giv 159 (304)
T cd05101 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCI 159 (304)
T ss_pred CCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCee
Confidence 99999999998755 78999999999999999976432 2478889999999999999999999999
Q ss_pred ccCCCCCcEEeeCCCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccCC-----------
Q 021127 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------- 213 (317)
Q Consensus 148 H~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------- 213 (317)
||||||+||+++.+ +.+||+|||+++...... ......++..|+|||++.+..... ..++|+.+
T Consensus 160 H~dlkp~Nili~~~-~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~g~ 237 (304)
T cd05101 160 HRDLAARNVLVTEN-NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLMWEIFTLGG 237 (304)
T ss_pred ecccccceEEEcCC-CcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCc-hhhHHHHHHHHHHHHcCCC
Confidence 99999999999988 789999999998553321 122234567899999875532211 12222211
Q ss_pred ------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 214 ------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 214 ------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
.....+..++.++.+|+.+||+.+|.+||++.++++.|.+++..
T Consensus 238 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 238 SPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred CCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 11122456788999999999999999999999999999988754
No 107
>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh
Probab=100.00 E-value=4.2e-37 Score=266.61 Aligned_cols=228 Identities=27% Similarity=0.520 Sum_probs=179.2
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 91 (317)
|.+..++|++.+.||+|+||.||+|.+. +..||||.+...... .....+.+|+.+++.++|+||+++++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~----~~~~~~~~e~~~l~~l~~~~iv~~~~ 76 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM----RERIEFLNEASVMKEFNCHHVVRLLG 76 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH----HHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 6788899999999999999999998764 367999998654332 23446889999999999999999999
Q ss_pred eeecC-ceEEEEEccCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCC
Q 021127 92 ACKEP-VMVIVTELLSGGTLRKYLLNMRP--------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 162 (317)
Q Consensus 92 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~ 162 (317)
++.++ ..++||||+++++|.+++..... ..+++..++.++.|++.||+|||++|++|+||||+||+++.+
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~- 155 (277)
T cd05062 77 VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED- 155 (277)
T ss_pred EEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCC-
Confidence 98765 88999999999999999976332 236788899999999999999999999999999999999988
Q ss_pred CceEEcccCcccccccccc---cccccCccceecccccccccccccccccccCC--------------------------
Q 021127 163 KTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------- 213 (317)
Q Consensus 163 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------- 213 (317)
+.++|+|||++........ .....++..|+|||++.+..... ..++|+.+
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCc-hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 6899999999874432211 11234577899999876532211 11222111
Q ss_pred ---CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 ---NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 ---~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.....+..++..+.+++.+||+.||++|||+.++++.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 235 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 112234567889999999999999999999999998875
No 108
>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes. Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an
Probab=100.00 E-value=4.4e-37 Score=264.06 Aligned_cols=228 Identities=29% Similarity=0.495 Sum_probs=181.4
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCc
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPV 97 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 97 (317)
|++..++|.+.+.||+|++|.||++.+. +..+|+|.+...... ...+.+|+.++++++|+|++++++++.+..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM------PEAFLQEAQIMKKLRHDKLVPLYAVVSEEP 74 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc------HHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 6788889999999999999999999886 457999987654321 245888999999999999999999988778
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++||||+.+++|.+++.......+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~-~~~~l~dfg~~~~~~ 153 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN-LVCKIADFGLARLIE 153 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC-CeEEECCCccceEcc
Confidence 8999999999999999987555558999999999999999999999999999999999999988 689999999997543
Q ss_pred ccccc--ccccCccceecccccccccccc-----------------cccccccC-----------CCCCCCCCCChHHHH
Q 021127 178 LTEMM--TAETGTYRWMAPELYSTVTLRQ-----------------GEKKHYNH-----------KNVRPSAENVPEELS 227 (317)
Q Consensus 178 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~~-----------~~~~~~~~~~~~~l~ 227 (317)
..... ....++..|+|||...+..... +..++... ....+.+...+..+.
T Consensus 154 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05069 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLH 233 (260)
T ss_pred CCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHH
Confidence 22211 1224567899999765321110 11111000 011223456789999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
+++.+||+.||.+||+++++++.|++
T Consensus 234 ~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 234 ELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHccCCcccCcCHHHHHHHHhc
Confidence 99999999999999999999998864
No 109
>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C. Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory
Probab=100.00 E-value=2.9e-37 Score=273.71 Aligned_cols=220 Identities=23% Similarity=0.282 Sum_probs=174.1
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC-CCeeeEEeeeecC-ceEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH-RNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~-~~~l 100 (317)
+|++.+.||+|+||.||+|.+. ++.||||++.+..... ......+..|++++..+.| ++|+++++++.+. ..++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ--DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence 5889999999999999999886 6789999997643211 1234567889999999966 4688888888654 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-cc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LT 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~ 179 (317)
||||+++|+|.+++..... +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.... ..
T Consensus 79 v~E~~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCC-CCEEEeecCcceecCCCC
Confidence 9999999999999976544 8999999999999999999999999999999999999988 789999999987432 22
Q ss_pred cccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
......+||+.|+|||++.+.... ...++|+.+ .....+..++.++.+++.+
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 234 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG 234 (324)
T ss_pred CceeeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 223345799999999998765433 223444332 1112245678899999999
Q ss_pred hhhcCCCCCCCH-----HHHHHH
Q 021127 233 CWKEDPNARPNF-----TQIIQM 250 (317)
Q Consensus 233 cl~~~p~~Rps~-----~~~~~~ 250 (317)
||..||.+|++. ++++++
T Consensus 235 ~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 235 LLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HhhcCHHHcCCCCCCCHHHHhcC
Confidence 999999999986 566665
No 110
>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t
Probab=100.00 E-value=6.1e-37 Score=263.39 Aligned_cols=225 Identities=24% Similarity=0.401 Sum_probs=181.2
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
+++|.+.+.||+|++|.||++.+. ++.||+|.+...............+.+|+.++++++||||+++++++.++ ..+
T Consensus 1 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 1 PTNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLS 80 (263)
T ss_pred CCcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEE
Confidence 367999999999999999999764 79999999886554333334456788999999999999999999998765 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+|+||+++++|.+++..... +++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||+++.....
T Consensus 81 ~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~-~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYGA--LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEEECCCCcHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccceecccc
Confidence 99999999999999986544 8999999999999999999999999999999999999988 78999999998754322
Q ss_pred ccc----ccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHH
Q 021127 180 EMM----TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEEL 226 (317)
Q Consensus 180 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l 226 (317)
... ....++..|+|||++.+.... ...+.|+.+ .....+..++..+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYG-RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDA 236 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCC-chhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHH
Confidence 111 234578899999987664321 122222211 1122345678999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
.+++.+||..+|.+|||+.+++++.
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 237 RNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred HHHHHHHhhcCcccCCCHHHHhhCC
Confidence 9999999999999999999998874
No 111
>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl
Probab=100.00 E-value=3.6e-37 Score=273.59 Aligned_cols=215 Identities=26% Similarity=0.348 Sum_probs=171.8
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||.||++++. ++.||||+++...... ......+..|..++..+ +||||+++++++.+. ..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~--~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVND--DEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 46899999999999885 7899999998653322 12344678899999888 799999999998765 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc-cccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE-SLTEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~-~~~~~~~~ 184 (317)
++|+|..++...+. +++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++.. ........
T Consensus 79 ~~g~L~~~~~~~~~--l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~~~~~~~ 155 (329)
T cd05588 79 SGGDLMFHMQRQRK--LPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTTST 155 (329)
T ss_pred CCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEECcCccccccccCCCcccc
Confidence 99999998876543 9999999999999999999999999999999999999988 78999999998742 22223345
Q ss_pred ccCccceecccccccccccccccccccCC------------------------------------CCCCCCCCChHHHHH
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------------NVRPSAENVPEELSI 228 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~l~~ 228 (317)
.+||+.|+|||++.+..... ..++|+.+ .....+..++.++.+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~-~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 234 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGF-SVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASS 234 (329)
T ss_pred ccCCccccCHHHHcCCCCCC-ccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 67999999999987643322 23333322 011224567888999
Q ss_pred HHHHhhhcCCCCCCC------HHHHHHH
Q 021127 229 ILTSCWKEDPNARPN------FTQIIQM 250 (317)
Q Consensus 229 li~~cl~~~p~~Rps------~~~~~~~ 250 (317)
++.+||+.||.+|++ ++++++|
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 235 VLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 999999999999997 6788776
No 112
>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I
Probab=100.00 E-value=1.6e-37 Score=274.33 Aligned_cols=215 Identities=25% Similarity=0.348 Sum_probs=168.6
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||.||+|++. ++.||+|++....... ......+..|..++... +||||+++++++.+. ..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI--DDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--cchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence 46999999999999885 7899999997643211 12233466777777754 899999999998765 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc-cccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~-~~~~~~ 184 (317)
.+|+|..++..... +++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++.... ......
T Consensus 79 ~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05620 79 NGGDLMFHIQDKGR--FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD-GHIKIADFGMCKENVFGDNRAST 155 (316)
T ss_pred CCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEeCccCCCeecccCCCceec
Confidence 99999999876543 8999999999999999999999999999999999999988 7899999999874321 222344
Q ss_pred ccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcC
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKED 237 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~ 237 (317)
.+||+.|+|||++.+..+. ...++|+.+ .....+..++.++++++.+||+.|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 234 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERD 234 (316)
T ss_pred cCCCcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCC
Confidence 5789999999998765433 233444433 011124457889999999999999
Q ss_pred CCCCCCHH-HHHHH
Q 021127 238 PNARPNFT-QIIQM 250 (317)
Q Consensus 238 p~~Rps~~-~~~~~ 250 (317)
|.+||++. ++++|
T Consensus 235 P~~R~~~~~~~~~h 248 (316)
T cd05620 235 PTRRLGVVGNIRGH 248 (316)
T ss_pred HHHcCCChHHHHcC
Confidence 99999984 66655
No 113
>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos
Probab=100.00 E-value=2.5e-37 Score=275.55 Aligned_cols=219 Identities=24% Similarity=0.305 Sum_probs=171.0
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec------C
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE------P 96 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~ 96 (317)
+|++.++||+|+||.||+|.+. ++.||||.+....... ....++.+|+.++++++||||+++++++.. .
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 77 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV---SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 77 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccc---hhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence 5899999999999999999875 7899999987532221 223468899999999999999999998742 2
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++||||+ +++|.+++..... +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 78 ~~~lv~e~~-~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kL~Dfg~~~~~ 153 (338)
T cd07859 78 DIYVVFELM-ESDLHQVIKANDD--LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVA 153 (338)
T ss_pred eEEEEEecC-CCCHHHHHHhccc--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CcEEEccCcccccc
Confidence 479999999 5799999876544 8999999999999999999999999999999999999988 79999999999753
Q ss_pred cccc----ccccccCccceecccccccc-cccccccccccCC--------CCC---------------------------
Q 021127 177 SLTE----MMTAETGTYRWMAPELYSTV-TLRQGEKKHYNHK--------NVR--------------------------- 216 (317)
Q Consensus 177 ~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~~--------~~~--------------------------- 216 (317)
.... ......||+.|+|||++.+. .......++|+.+ ...
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 2211 12345789999999987542 1112222333221 000
Q ss_pred ------------------C-----CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 ------------------P-----SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 ------------------~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+ ....++..+.+++.+||+.||++|||+.+++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 012456778999999999999999999999987
No 114
>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h
Probab=100.00 E-value=6.8e-37 Score=262.27 Aligned_cols=222 Identities=26% Similarity=0.503 Sum_probs=175.5
Q ss_pred ecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
|++++|++.+.||+|+||.||++.+. +..+|+|.+...... ...+.+|+.++++++||||+++++++.+. ..
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd05114 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS------EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPL 74 (256)
T ss_pred CCHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc------HHHHHHHHHHHHHCCCCCceeEEEEEccCCCE
Confidence 46788999999999999999999886 568999987654322 23588899999999999999999998755 89
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+++|+|.+++..... .+++..++.++.|++.||+|||++|++||||+|+||+++.+ +.+||+|||+++....
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSST-GVVKVSDFGMTRYVLD 152 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCC-CeEEECCCCCccccCC
Confidence 999999999999999875432 38999999999999999999999999999999999999988 6899999999875432
Q ss_pred cccc--ccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHH
Q 021127 179 TEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 179 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~ 227 (317)
.... ....++..|+|||++.+..... ..+.|+.+ .....+...+..+.
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 231 (256)
T cd05114 153 DEYTSSSGAKFPVKWSPPEVFNFSKYSS-KSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVY 231 (256)
T ss_pred CceeccCCCCCchhhCChhhcccCccch-hhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 2211 1223566899999876432111 11111110 11122445678899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
+++.+||+.+|.+||++.++++.|
T Consensus 232 ~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 232 EVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHHccCCcccCcCHHHHHHhh
Confidence 999999999999999999998875
No 115
>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=1.2e-36 Score=268.56 Aligned_cols=238 Identities=30% Similarity=0.564 Sum_probs=187.8
Q ss_pred cCCceeecCCceeecceeccccceEEEEeEEC---------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCC
Q 021127 15 LDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHR 84 (317)
Q Consensus 15 ~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 84 (317)
.+..|.++.++|.+.++||+|+||.||+++.. ...+|+|.+...... .....+.+|+.+++++ +||
T Consensus 3 ~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~E~~~l~~l~~h~ 78 (314)
T cd05099 3 LDPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD----KDLADLISEMELMKLIGKHK 78 (314)
T ss_pred CcccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh----HHHHHHHHHHHHHHhccCCC
Confidence 57789999999999999999999999998752 457999998755432 2245688999999999 699
Q ss_pred CeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 021127 85 NLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHR 149 (317)
Q Consensus 85 niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~ 149 (317)
||+++++++.+. ..++||||+++|+|.+++..... ..+++..+..++.|++.||.|||++|++||
T Consensus 79 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~ 158 (314)
T cd05099 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHR 158 (314)
T ss_pred CeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 999999998754 78999999999999999976431 348899999999999999999999999999
Q ss_pred CCCCCcEEeeCCCCceEEcccCcccccccccc---cccccCccceecccccccccccccccccccCC-------------
Q 021127 150 DLKPENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------- 213 (317)
Q Consensus 150 Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------- 213 (317)
||||+||+++.+ +.+||+|||+++....... .....++..|+|||++.+..... ..++|+.+
T Consensus 159 dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~~l~el~~~g~~p 236 (314)
T cd05099 159 DLAARNVLVTED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTH-QSDVWSFGILMWEIFTLGGSP 236 (314)
T ss_pred cccceeEEEcCC-CcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCc-cchhhHHHHHHHHHHhCCCCC
Confidence 999999999988 6899999999975432211 12223456899999875532221 22222211
Q ss_pred ----------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 214 ----------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 214 ----------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
.....+..++.++.+++.+||+.+|++||++.++++.|+++....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 237 YPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 111224566789999999999999999999999999999887643
No 116
>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological
Probab=100.00 E-value=7.7e-37 Score=264.81 Aligned_cols=228 Identities=28% Similarity=0.506 Sum_probs=181.6
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 91 (317)
|.|+.++|++.+.||+|+||.||+|.+. +..||+|.+...... .....+.+|+.+++.++|+||+++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~ 76 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM----RERIEFLNEASVMKEFNCHHVVRLLG 76 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH----HHHHHHHHHHHHHHhCCCCceeEEEE
Confidence 7789999999999999999999998875 267999998655432 22456889999999999999999999
Q ss_pred eeecC-ceEEEEEccCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCC
Q 021127 92 ACKEP-VMVIVTELLSGGTLRKYLLNMRP--------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 162 (317)
Q Consensus 92 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~ 162 (317)
++.++ ..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+++++||||||+||+++.+
T Consensus 77 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~- 155 (277)
T cd05032 77 VVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED- 155 (277)
T ss_pred EEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC-
Confidence 98755 89999999999999999975332 236888999999999999999999999999999999999998
Q ss_pred CceEEcccCccccccccc---ccccccCccceecccccccccccccccccccCC--------------------------
Q 021127 163 KTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------- 213 (317)
Q Consensus 163 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------- 213 (317)
+.+||+|||+++...... ......++..|+|||.+....... ..+.|+.+
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 234 (277)
T cd05032 156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTT-KSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV 234 (277)
T ss_pred CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCc-ccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH
Confidence 799999999987543221 122334678899999875433221 12222211
Q ss_pred ---CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 ---NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 ---~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.....+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 122235567899999999999999999999999998875
No 117
>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an
Probab=100.00 E-value=6.7e-37 Score=275.91 Aligned_cols=229 Identities=22% Similarity=0.321 Sum_probs=181.1
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
...+..++|++.+.||+|+||.||++++. ++.||+|++.+..... ......+.+|+.+++.++||||+++++++.+
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~--~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK--RSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhh--hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 45677799999999999999999999886 7899999987533211 1234457889999999999999999999876
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+ ..++||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~-~~ikL~DfG~a~ 190 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCM 190 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCC-CCEEEEeCCcee
Confidence 5 799999999999999998753 28899999999999999999999999999999999999988 799999999997
Q ss_pred cccccc--ccccccCccceeccccccccc---ccccccccccCC-------------------------------CCCCC
Q 021127 175 EESLTE--MMTAETGTYRWMAPELYSTVT---LRQGEKKHYNHK-------------------------------NVRPS 218 (317)
Q Consensus 175 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~~~-------------------------------~~~~~ 218 (317)
...... .....+||+.|+|||++.... ......++|+.+ ...+.
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 270 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCC
Confidence 553322 223457999999999986532 122344455443 01122
Q ss_pred CCCChHHHHHHHHHhhhcCCCC--CCCHHHHHHHHH
Q 021127 219 AENVPEELSIILTSCWKEDPNA--RPNFTQIIQMLL 252 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~--Rps~~~~~~~l~ 252 (317)
...++..++++|..||..++.+ |+++.++++|.+
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 271 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 3367899999999999844433 789999998853
No 118
>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o
Probab=100.00 E-value=1.4e-36 Score=269.79 Aligned_cols=215 Identities=26% Similarity=0.348 Sum_probs=170.4
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||.||++++. ++.||+|++.+..... ......+.+|+.++.++ +||||+++++++.+. ..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVND--DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcc--hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence 46999999999999885 7899999998653222 12344577888888776 899999999998754 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-ccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~ 184 (317)
++|+|..++..... +++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++... .......
T Consensus 79 ~~~~L~~~~~~~~~--l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~-~~~kL~DfG~~~~~~~~~~~~~~ 155 (329)
T cd05618 79 NGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTST 155 (329)
T ss_pred CCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC-CCEEEeeCCccccccCCCCcccc
Confidence 99999998876543 9999999999999999999999999999999999999988 799999999987432 2222344
Q ss_pred ccCccceecccccccccccccccccccCC------------------------------------CCCCCCCCChHHHHH
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------------NVRPSAENVPEELSI 228 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~l~~ 228 (317)
..||+.|+|||++.+..... ..++|+.+ .....+..++..+.+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 234 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGF-SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAAS 234 (329)
T ss_pred ccCCccccCHHHHcCCCCCC-ccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 57999999999987643322 23333322 011124567788999
Q ss_pred HHHHhhhcCCCCCCC------HHHHHHH
Q 021127 229 ILTSCWKEDPNARPN------FTQIIQM 250 (317)
Q Consensus 229 li~~cl~~~p~~Rps------~~~~~~~ 250 (317)
++.+||+.||.+||+ +.++++|
T Consensus 235 ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 235 VLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 999999999999998 4677766
No 119
>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-37 Score=280.19 Aligned_cols=214 Identities=25% Similarity=0.438 Sum_probs=179.4
Q ss_pred eeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCC
Q 021127 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSG 107 (317)
Q Consensus 31 ~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~ 107 (317)
+||+|.||+||.|++. ...+|||.++...+.. .+.+.+||.++++|+|.|||+++|.+.++ .+-|.||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~-----~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSRE-----VQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchh-----hccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence 5899999999999886 5678999998766533 55688999999999999999999999765 78899999999
Q ss_pred CCHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc-cccccccc
Q 021127 108 GTLRKYLLNMRPRCL--DVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE-SLTEMMTA 184 (317)
Q Consensus 108 g~L~~~l~~~~~~~l--~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~-~~~~~~~~ 184 (317)
|+|..+|+...+ ++ ++.+.-.+.+||++||.|||++.|||||||-+|+||+...|.+||+|||.++.. .....+.+
T Consensus 657 GSLSsLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 657 GSLSSLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred CcHHHHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 999999987443 35 788888999999999999999999999999999999987789999999999854 44456677
Q ss_pred ccCccceeccccccccccc-ccccccccCC------------------------------CCCCCCCCChHHHHHHHHHh
Q 021127 185 ETGTYRWMAPELYSTVTLR-QGEKKHYNHK------------------------------NVRPSAENVPEELSIILTSC 233 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~-~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~c 233 (317)
+.||+.|||||++....-. ....++|+.+ ...+.|..++.+.+.+|.+|
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filrc 815 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRC 815 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHH
Confidence 8999999999998764322 2233444433 23455778889999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 021127 234 WKEDPNARPNFTQIIQM 250 (317)
Q Consensus 234 l~~~p~~Rps~~~~~~~ 250 (317)
+.+||.+||++.++++-
T Consensus 816 Fepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 816 FEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred cCCCcccCccHHHhccC
Confidence 99999999999999863
No 120
>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1. Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=6.1e-37 Score=272.54 Aligned_cols=171 Identities=25% Similarity=0.392 Sum_probs=146.0
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
+..++|++.++||+|+||.||++.+. +..+|+|.+...... .....+.+|++++++++|+||+++++++.++ .
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 77 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP----AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 77 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH----HHHHHHHHHHHHHHHCCCCcccceeEEEEECCE
Confidence 55689999999999999999999886 788999988765432 2345688999999999999999999998755 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
.++||||+++++|.+++...+. +++..+..++.|++.||.|||++ +++||||||+|||++.+ +.+||+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~ 154 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQL 154 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCC-CCEEEeeCCcchhh
Confidence 9999999999999999986544 89999999999999999999985 79999999999999988 68999999998754
Q ss_pred ccccccccccCccceeccccccc
Q 021127 177 SLTEMMTAETGTYRWMAPELYST 199 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~ 199 (317)
... ......|+..|+|||++.+
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~ 176 (333)
T cd06650 155 IDS-MANSFVGTRSYMSPERLQG 176 (333)
T ss_pred hhh-ccccCCCCccccCHHHhcC
Confidence 322 2234568999999998765
No 121
>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=2.4e-36 Score=268.92 Aligned_cols=238 Identities=32% Similarity=0.559 Sum_probs=186.7
Q ss_pred CCceeecCCceeecceeccccceEEEEeEEC---------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCC
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRN 85 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 85 (317)
+.+|++...+|++.+.||+|+||.||++.+. +..||+|.+...... .....+.+|+.+++++ +|+|
T Consensus 4 ~~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~~h~~ 79 (334)
T cd05100 4 DPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD----KDLSDLVSEMEMMKMIGKHKN 79 (334)
T ss_pred CcccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH----HHHHHHHHHHHHHHhhcCCCC
Confidence 4689999999999999999999999999752 236899988754332 2345688999999999 8999
Q ss_pred eeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 021127 86 LVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRD 150 (317)
Q Consensus 86 iv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~D 150 (317)
|+++++++.+. ..+++|||+++|+|.+++..... ..+++..++.++.|++.||+|||++|++|||
T Consensus 80 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~d 159 (334)
T cd05100 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRD 159 (334)
T ss_pred eeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 99999998755 78999999999999999976421 2378889999999999999999999999999
Q ss_pred CCCCcEEeeCCCCceEEcccCcccccccccc---cccccCccceecccccccccccccccccccCC--------------
Q 021127 151 LKPENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------- 213 (317)
Q Consensus 151 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------- 213 (317)
|||+||+++.+ +.+||+|||+++....... .....++..|+|||++.+...... .++|+.+
T Consensus 160 lkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~ 237 (334)
T cd05100 160 LAARNVLVTED-NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPY 237 (334)
T ss_pred cccceEEEcCC-CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCch-hhhHHHHHHHHHHHhcCCCCC
Confidence 99999999988 6899999999975432211 122234568999998755332211 1222111
Q ss_pred ---------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccC
Q 021127 214 ---------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 259 (317)
Q Consensus 214 ---------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~ 259 (317)
.....+..++.++.+++.+||+.+|.+||++.++++.|+++.....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 238 PGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 1122345667899999999999999999999999999998875443
No 122
>PHA03212 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=4.3e-37 Score=278.57 Aligned_cols=215 Identities=21% Similarity=0.316 Sum_probs=169.8
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
+...+|++.++||+|+||.||++.+. ++.||||.... ..+.+|+.++++++||||+++++++..+ .
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 157 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----------GGTATEAHILRAINHPSIIQLKGTFTYNKF 157 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----------hhhHHHHHHHHhCCCCCCCCEeEEEEECCe
Confidence 45578999999999999999999885 78999996432 2367899999999999999999998754 7
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++|+|++ +++|..++..... +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 158 ~~lv~e~~-~~~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~-~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 158 TCLILPRY-KTDLYCYLAAKRN--IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHP-GDVCLGDFGAACFPV 233 (391)
T ss_pred eEEEEecC-CCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCC-CCEEEEeCCcccccc
Confidence 89999999 5799998876543 8999999999999999999999999999999999999988 789999999997432
Q ss_pred cc--cccccccCccceecccccccccccccccccccCC------------------------------------------
Q 021127 178 LT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------------------ 213 (317)
Q Consensus 178 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------------------ 213 (317)
.. .......||+.|+|||++.+..+.. ..++|+.+
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~ 312 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDPYGP-AVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE 312 (391)
T ss_pred cccccccccccCccCCCChhhhcCCCCCc-HHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence 21 2223457999999999876532211 11111111
Q ss_pred --------------------CC----CCC---CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 214 --------------------NV----RPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 214 --------------------~~----~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
.. .+. ...++.++.+||.+||+.||.+|||+.+++++-
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp 377 (391)
T PHA03212 313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA 377 (391)
T ss_pred cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence 00 000 013466889999999999999999999999873
No 123
>PTZ00036 glycogen synthase kinase; Provisional
Probab=100.00 E-value=3.3e-37 Score=283.48 Aligned_cols=222 Identities=24% Similarity=0.334 Sum_probs=171.4
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE--- 95 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--- 95 (317)
...++|++.++||+|+||.||+|.+. ++.||||.+..... ...+|+.+++.++|+||+++++++..
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---------~~~~Ei~il~~l~h~niv~l~~~~~~~~~ 133 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---------YKNRELLIMKNLNHINIIFLKDYYYTECF 133 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---------hHHHHHHHHHhcCCCCCcceeeeEeeccc
Confidence 34568999999999999999999874 78999998864332 13469999999999999999887632
Q ss_pred -----C-ceEEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEE
Q 021127 96 -----P-VMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (317)
Q Consensus 96 -----~-~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl 167 (317)
. .+++||||++ ++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.+.+.+||
T Consensus 134 ~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 134 KKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred ccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceee
Confidence 1 4678999996 5787777532 23458999999999999999999999999999999999999976457999
Q ss_pred cccCcccccccccccccccCccceecccccccccccccccccccCC--------CC------------------------
Q 021127 168 ADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------------------ 215 (317)
Q Consensus 168 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------------------ 215 (317)
+|||+++............||+.|+|||++.+........++|+.+ ..
T Consensus 213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred eccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 9999998654444444567899999999876532222222222221 00
Q ss_pred ------------------------CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 216 ------------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 216 ------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
...+...+.++.+||.+||+.||.+|||+.++++|-+
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 0012345788999999999999999999999998843
No 124
>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a
Probab=100.00 E-value=1e-36 Score=261.92 Aligned_cols=227 Identities=30% Similarity=0.510 Sum_probs=181.4
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
|+++.++|++.+.||+|++|.||+|.+. ++.||||.+...... .+.+.+|+.++++++|+||+++++++...
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD------PKDFLAEAQIMKKLRHPKLIQLYAVCTLEE 74 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc------HHHHHHHHHHHHHCCCCCccceeEEEecCC
Confidence 6788899999999999999999999875 678999998754321 33588899999999999999999988654
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++||||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++...
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~ 153 (261)
T cd05068 75 PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGEN-NICKVADFGLARVI 153 (261)
T ss_pred CeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCC-CCEEECCcceEEEc
Confidence 78999999999999999987654558999999999999999999999999999999999999988 68999999999865
Q ss_pred cccccc--ccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHH
Q 021127 177 SLTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEE 225 (317)
Q Consensus 177 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~ 225 (317)
...... .....+..|+|||++.+...... .+.|+.+ ...+.+..++..
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (261)
T cd05068 154 KEDIYEAREGAKFPIKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKE 232 (261)
T ss_pred cCCcccccCCCcCceeccCccccccCCCCch-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence 422111 11123457999998654322111 1111100 112234567899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
+.+++.+||+.+|.+||++.++.+.|++
T Consensus 233 ~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 233 LYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 9999999999999999999999998875
No 125
>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp
Probab=100.00 E-value=5.1e-37 Score=274.14 Aligned_cols=234 Identities=29% Similarity=0.538 Sum_probs=181.3
Q ss_pred ceeecCCceeecceeccccceEEEEeEE-------CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeE
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKY-------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKF 89 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l 89 (317)
.|.+..++|++.+.||+|+||.||+|.+ .++.||||+++...... ....+.+|+.++.++ +|+||+++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~~h~niv~~ 76 (343)
T cd05103 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS----EHRALMSELKILIHIGHHLNVVNL 76 (343)
T ss_pred CcccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChH----HHHHHHHHHHHHHhccCCccHhhh
Confidence 4888999999999999999999999974 26789999997654322 234688899999999 78999999
Q ss_pred Eeeeec--CceEEEEEccCCCCHHHHHHhcC-------------------------------------------------
Q 021127 90 IGACKE--PVMVIVTELLSGGTLRKYLLNMR------------------------------------------------- 118 (317)
Q Consensus 90 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------- 118 (317)
++++.. ...++||||+++|+|.+++....
T Consensus 77 ~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (343)
T cd05103 77 LGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEK 156 (343)
T ss_pred cceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCC
Confidence 998754 36889999999999999987532
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc--
Q 021127 119 ----------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-- 180 (317)
Q Consensus 119 ----------------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-- 180 (317)
...+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~ 235 (343)
T cd05103 157 SLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDY 235 (343)
T ss_pred ccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCC-CcEEEEecccccccccCcch
Confidence 1236788889999999999999999999999999999999988 689999999987542211
Q ss_pred -ccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHH
Q 021127 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSII 229 (317)
Q Consensus 181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~l 229 (317)
......++..|+|||++.+..+.. ..++|+.+ .....+...+.++.++
T Consensus 236 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (343)
T cd05103 236 VRKGDARLPLKWMAPETIFDRVYTI-QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 314 (343)
T ss_pred hhcCCCCCCcceECcHHhcCCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 111223567899999875432211 11111100 1112234467789999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 230 LTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+.+||+.||.+||++.+++++|+.++..
T Consensus 315 ~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 315 MLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999988753
No 126
>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to
Probab=100.00 E-value=1.7e-36 Score=268.48 Aligned_cols=216 Identities=25% Similarity=0.321 Sum_probs=172.2
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||.||+|++. ++.||||++....... ......+..|.+++..+ +||||+++++++.++ ..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQ--DDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhh--hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence 46999999999999886 6899999987643211 12344577888888876 899999999999765 799999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-ccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~ 184 (317)
++++|..++..... +++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++.... .......
T Consensus 79 ~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05591 79 NGGDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTTT 155 (321)
T ss_pred CCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEeecccceecccCCccccc
Confidence 99999999876544 8999999999999999999999999999999999999988 799999999987432 2222344
Q ss_pred ccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcC
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKED 237 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~ 237 (317)
..||+.|+|||++.+..... ..++|+.+ .....+..++.++.+++.+||+.|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~d 234 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGP-SVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKN 234 (321)
T ss_pred cccCccccCHHHHcCCCCCC-ccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccC
Confidence 57899999999987644332 34444433 011123456889999999999999
Q ss_pred CCCCC-------CHHHHHHHH
Q 021127 238 PNARP-------NFTQIIQML 251 (317)
Q Consensus 238 p~~Rp-------s~~~~~~~l 251 (317)
|++|| ++.+++++.
T Consensus 235 p~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 235 PNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred HHHcCCCCCCCCCHHHHhcCC
Confidence 99999 888888773
No 127
>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and
Probab=100.00 E-value=1.8e-36 Score=268.50 Aligned_cols=220 Identities=23% Similarity=0.290 Sum_probs=175.2
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~l 100 (317)
+|.+.+.||+|+||.||+|++. ++.||||++.+..... ......+..|..++..+ .|++|+++++++.+. ..++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ--DDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence 5889999999999999999886 6789999998643221 12334567788888777 689999999988765 7999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc-c
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-T 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~-~ 179 (317)
||||+++|+|.+++..... +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... .
T Consensus 79 v~E~~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEcCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCC-CcEEEccCCCceecCCCC
Confidence 9999999999999876544 8999999999999999999999999999999999999998 7999999999975322 2
Q ss_pred cccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
......+||+.|+|||++.+.... ...++|+.+ .....+..++.++.+++.+
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 234 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG 234 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHH
Confidence 223445799999999998765443 334455443 1112245678999999999
Q ss_pred hhhcCCCCCCCH-----HHHHHH
Q 021127 233 CWKEDPNARPNF-----TQIIQM 250 (317)
Q Consensus 233 cl~~~p~~Rps~-----~~~~~~ 250 (317)
||+.||.+|++. .+++++
T Consensus 235 ~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 235 LMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred HcccCHHhcCCCCCCCHHHHhcC
Confidence 999999999984 666654
No 128
>PTZ00267 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=7.4e-37 Score=284.12 Aligned_cols=221 Identities=21% Similarity=0.332 Sum_probs=175.9
Q ss_pred CCceeecceeccccceEEEEeEEC---CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
...|.+.+.||+|+||.||+|... ++.||+|.+..... .....+.+|+.+++.++||||+++++++..+ ..
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~-----~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE-----RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKL 140 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH-----HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEE
Confidence 345999999999999999999764 57789987654332 2334577899999999999999999998754 89
Q ss_pred EEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 99 VIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
++||||+++|+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~-~~~kL~DFgla~~~ 219 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT-GIIKLGDFGFSKQY 219 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCC-CcEEEEeCcCceec
Confidence 9999999999999988643 22348999999999999999999999999999999999999988 79999999999854
Q ss_pred cccc---ccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHH
Q 021127 177 SLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEE 225 (317)
Q Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~ 225 (317)
.... .....+||+.|+|||++.+..+.. ..++|+.+ ...+.+..++.+
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~ 298 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSK-KADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSG 298 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCc-HHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHH
Confidence 3221 233456999999999876643322 12222211 122334567889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+.++|.+||+.||++||++.+++.+
T Consensus 299 ~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 299 MKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHHHHHHHhccChhhCcCHHHHHhC
Confidence 9999999999999999999998764
No 129
>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk. Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom
Probab=100.00 E-value=2.9e-37 Score=265.18 Aligned_cols=228 Identities=31% Similarity=0.548 Sum_probs=183.4
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
|+....+|++.++||.|+||.||+|.+. +..+|+|++..... .....+.+|+.+++.++|+||+++++++.+.
T Consensus 1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 75 (261)
T cd05148 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL-----LKQQDFQKEVQALKRLRHKHLISLFAVCSVGE 75 (261)
T ss_pred CcCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch-----hhHHHHHHHHHHHhcCCCcchhheeeeEecCC
Confidence 3455678999999999999999999886 68899999876543 2234588899999999999999999998765
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++||||+++++|.+++.......+++..++.++.|++.||+|||++|++|+||+|+||+++.+ +.+||+|||++...
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~-~~~kl~d~g~~~~~ 154 (261)
T cd05148 76 PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGED-LVCKVADFGLARLI 154 (261)
T ss_pred CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCC-ceEEEccccchhhc
Confidence 78999999999999999987665668999999999999999999999999999999999999988 68999999999754
Q ss_pred ccccc-cccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHH
Q 021127 177 SLTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEEL 226 (317)
Q Consensus 177 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l 226 (317)
..... .....++..|+|||++....... ..++|..+ ...+.+..++..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~-~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (261)
T cd05148 155 KEDVYLSSDKKIPYKWTAPEAASHGTFST-KSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEI 233 (261)
T ss_pred CCccccccCCCCceEecCHHHHccCCCCc-hhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHH
Confidence 32211 12334567899999875432211 11111110 1223356778999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
.+++.+||+.||.+|||+.++++.|+.
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 234 YKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 999999999999999999999999875
No 130
>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of
Probab=100.00 E-value=1.9e-36 Score=269.07 Aligned_cols=215 Identities=25% Similarity=0.319 Sum_probs=168.5
Q ss_pred eccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc---CCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV---QHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 32 lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
||+|+||+||+|++. ++.||||++....... ......+..|..++... .||||+++++++.+. ..++||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA--KKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh--hhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence 799999999999885 7899999987543221 12233456677777665 699999999998765 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-ccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~ 184 (317)
++|+|..++..... +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.... .......
T Consensus 79 ~~g~L~~~l~~~~~--~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~~ 155 (330)
T cd05586 79 SGGELFWHLQKEGR--FSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT-GHIALCDFGLSKANLTDNKTTNT 155 (330)
T ss_pred CCChHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEecCCcCcCCCCCCCCccC
Confidence 99999999876543 8999999999999999999999999999999999999988 789999999987532 2223345
Q ss_pred ccCccceecccccccccccccccccccCCC----------------------------CCCCCCCChHHHHHHHHHhhhc
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKN----------------------------VRPSAENVPEELSIILTSCWKE 236 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~cl~~ 236 (317)
.+||+.|+|||++.+........+.|+.+. .......++.++.+++.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~ 235 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNR 235 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCC
Confidence 679999999999865433334455555441 0111234688999999999999
Q ss_pred CCCCCC----CHHHHHHHH
Q 021127 237 DPNARP----NFTQIIQML 251 (317)
Q Consensus 237 ~p~~Rp----s~~~~~~~l 251 (317)
||.+|| ++.+++++.
T Consensus 236 ~P~~R~~~~~~~~~ll~h~ 254 (330)
T cd05586 236 NPQHRLGAHRDAVELKEHP 254 (330)
T ss_pred CHHHCCCCCCCHHHHhcCc
Confidence 999998 677887763
No 131
>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept
Probab=100.00 E-value=1.4e-36 Score=266.61 Aligned_cols=240 Identities=30% Similarity=0.506 Sum_probs=187.7
Q ss_pred cccceecCCceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc
Q 021127 9 LADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV 81 (317)
Q Consensus 9 ~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l 81 (317)
.+.....+..|.+..++|.+.+.||+|+||.||++.+. +..||||.+...... .....+.+|+.+++++
T Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l 95 (302)
T cd05055 20 DPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS----SEREALMSELKIMSHL 95 (302)
T ss_pred CcccccccccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh----HHHHHHHHHHHHHHhc
Confidence 33444556678899999999999999999999998751 457999998765432 2245688999999999
Q ss_pred -CCCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 021127 82 -QHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 159 (317)
Q Consensus 82 -~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~ 159 (317)
+|+||+++++++... ..++||||+.+++|.+++.......+++.++..++.|++.||+|||+++++|+||||+||+++
T Consensus 96 ~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~ 175 (302)
T cd05055 96 GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT 175 (302)
T ss_pred cCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc
Confidence 899999999998754 799999999999999999865544589999999999999999999999999999999999999
Q ss_pred CCCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccCC-----------------------
Q 021127 160 EDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------- 213 (317)
Q Consensus 160 ~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------- 213 (317)
.+ +.++|+|||+++...... ......++..|+|||++.+..... ..++|+.+
T Consensus 176 ~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslGvil~el~t~g~~p~~~~~~~~~~ 253 (302)
T cd05055 176 HG-KIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTF-ESDVWSYGILLWEIFSLGSNPYPGMPVDSKF 253 (302)
T ss_pred CC-CeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCc-HhHHHHHHHHHHHHHhCCCCCcCCCCchHHH
Confidence 87 689999999997543221 112234567899999865432211 11111100
Q ss_pred -------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 214 -------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 214 -------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
.....+...+..+.+++.+||+.+|++|||+.++++.|.++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 254 YKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 01122345688999999999999999999999999998764
No 132
>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.2e-37 Score=272.92 Aligned_cols=225 Identities=24% Similarity=0.367 Sum_probs=198.2
Q ss_pred CceeecceeccccceEEEEeEE--CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
+=|.+.+-||+|-|..|-+|++ +|..||||++.+...... ....+.+|++.++.++|||||+||.+.... .+|+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~---st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL---STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh---hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 4578899999999999999877 599999999998776542 234578999999999999999999999765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
|+|+-.+|+|++||.+...+ +.++.+.+++.||+.|+.|+|+..+|||||||+|+.+-+..|-+||+|||++.......
T Consensus 95 iLELGD~GDl~DyImKHe~G-l~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEG-LNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EEEecCCchHHHHHHhhhcc-ccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 99999999999999875543 99999999999999999999999999999999999988777899999999999888888
Q ss_pred ccccccCccceecccccccccccccccccccCCCC---------------------------CCCCCCChHHHHHHHHHh
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKNV---------------------------RPSAENVPEELSIILTSC 233 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~c 233 (317)
...+.||++.|.|||++.+..++....++|+.+.. ...|..++.+.++||..|
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sM 253 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSM 253 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHH
Confidence 88899999999999999999999888888876611 112566789999999999
Q ss_pred hhcCCCCCCCHHHHHHHHH
Q 021127 234 WKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 234 l~~~p~~Rps~~~~~~~l~ 252 (317)
|..||.+|.+.++|...-|
T Consensus 254 LvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 254 LVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred HhcCchhhccHHHHhcccc
Confidence 9999999999999987743
No 133
>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal
Probab=100.00 E-value=3.7e-37 Score=272.48 Aligned_cols=215 Identities=25% Similarity=0.350 Sum_probs=171.0
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||.||+|++. ++.||||++.+..... ......+..|..++..+ +||||+++++++.+. ..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQ--DDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh--ccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence 46899999999999885 7899999987543211 12344577888888876 799999999998765 799999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-ccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~ 184 (317)
++|+|.+++..... +++..+..++.|++.||+|||++|++||||||+|||++.+ +.+||+|||+++... .......
T Consensus 79 ~~g~L~~~i~~~~~--l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~-~~~kL~DfG~~~~~~~~~~~~~~ 155 (320)
T cd05590 79 NGGDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGIFNGKTTST 155 (320)
T ss_pred CCchHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC-CcEEEeeCCCCeecCcCCCcccc
Confidence 99999999876544 9999999999999999999999999999999999999988 799999999987532 2223344
Q ss_pred ccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcC
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKED 237 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~ 237 (317)
..||+.|+|||++.+.... ...++|+.+ .....+..++.++.+++.+||+.|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~d 234 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKN 234 (320)
T ss_pred cccCccccCHHHHcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccC
Confidence 5799999999998764432 233444433 111224457889999999999999
Q ss_pred CCCCCCH------HHHHHH
Q 021127 238 PNARPNF------TQIIQM 250 (317)
Q Consensus 238 p~~Rps~------~~~~~~ 250 (317)
|.+||++ +++++|
T Consensus 235 P~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 235 PTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred HHHCCCCCCCCCHHHHHcC
Confidence 9999998 666665
No 134
>PTZ00283 serine/threonine protein kinase; Provisional
Probab=100.00 E-value=9.8e-37 Score=283.74 Aligned_cols=226 Identities=23% Similarity=0.374 Sum_probs=181.2
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
....++|++.+.||+|+||+||++++. ++.||||++....... ....++.+|+..+..++|+||+++++.+...
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~---~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE---ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH---HHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 345689999999999999999999874 8999999997655432 3345688999999999999999998776321
Q ss_pred --------ceEEEEEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceE
Q 021127 97 --------VMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166 (317)
Q Consensus 97 --------~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~k 166 (317)
..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+|
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~-~~vk 183 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSN-GLVK 183 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCC-CCEE
Confidence 3689999999999999997532 2358999999999999999999999999999999999999988 7899
Q ss_pred EcccCcccccccc---cccccccCccceecccccccccccccccccccCC----------------------------CC
Q 021127 167 LADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NV 215 (317)
Q Consensus 167 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~ 215 (317)
|+|||+++..... ......+||+.|+|||++.+..+.. ..++|+.+ ..
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~-k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~ 262 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSK-KADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY 262 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 9999999754321 2233457999999999987643321 22222211 12
Q ss_pred CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+.+..++.++.+++.+||+.||.+||++.+++++
T Consensus 263 ~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 263 DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 23456788999999999999999999999999876
No 135
>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=1.9e-36 Score=263.36 Aligned_cols=227 Identities=28% Similarity=0.511 Sum_probs=178.5
Q ss_pred cCCceeecceeccccceEEEEeEE------CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
+-.+|++.++||+|+||.||+|.+ .+..||+|.+...... .....+.+|+.++++++|+||+++++++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 78 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP----QQWGEFQQEASLMAELHHPNIVCLLGVVTQ 78 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH----HHHHHHHHHHHHHhhCCCCCeeeEEEEEec
Confidence 447899999999999999999975 2578999998754432 234568899999999999999999999876
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMR---------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 159 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~---------------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~ 159 (317)
. ..++||||+++++|.+++.... ...+++.+++.++.|++.||+|||++|++||||||+||+++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 4 7899999999999999986322 12378899999999999999999999999999999999999
Q ss_pred CCCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccCC-----------------------
Q 021127 160 EDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------- 213 (317)
Q Consensus 160 ~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------- 213 (317)
.+ +.+||+|||+++...... ......++..|+|||++.+..... ..+.|+.+
T Consensus 159 ~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05090 159 EQ-LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSS-DSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236 (283)
T ss_pred CC-CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCc-hhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 88 689999999997542221 122334567899999876433211 11222111
Q ss_pred ------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 214 ------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 214 ------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
...+.+..++..+.+++.+||+.||++||++.+++++|..|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05090 237 EMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence 11233556789999999999999999999999999988754
No 136
>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways
Probab=100.00 E-value=3.5e-36 Score=267.05 Aligned_cols=215 Identities=26% Similarity=0.328 Sum_probs=171.4
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||.||+++.. ++.||+|++....... ......+.+|+.++.++ +|+||+++++++.+. .+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHD--DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence 46999999999999875 7899999998654322 23345678899999888 699999999998755 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-ccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~ 184 (317)
++|+|..++...+. +++..+..++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++... .......
T Consensus 79 ~~~~L~~~~~~~~~--l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~ 155 (327)
T cd05617 79 NGGDLMFHMQRQRK--LPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTST 155 (327)
T ss_pred CCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC-CCEEEeccccceeccCCCCceec
Confidence 99999998876544 9999999999999999999999999999999999999988 789999999987432 2223345
Q ss_pred ccCccceecccccccccccccccccccCC----------------------------------CCCCCCCCChHHHHHHH
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------------NVRPSAENVPEELSIIL 230 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------------~~~~~~~~~~~~l~~li 230 (317)
.+||+.|+|||++.+.... ...++|+.+ .....+..++..+.+++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li 234 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVL 234 (327)
T ss_pred ccCCcccCCHHHHCCCCCC-chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 6799999999998764432 223333322 01123456778899999
Q ss_pred HHhhhcCCCCCCCH------HHHHHH
Q 021127 231 TSCWKEDPNARPNF------TQIIQM 250 (317)
Q Consensus 231 ~~cl~~~p~~Rps~------~~~~~~ 250 (317)
.+||+.||.+|+++ .++++|
T Consensus 235 ~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 235 KGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 99999999999984 577766
No 137
>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta
Probab=100.00 E-value=1.8e-36 Score=264.22 Aligned_cols=231 Identities=26% Similarity=0.523 Sum_probs=180.6
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 91 (317)
|.++.++|++.++||+|+||.||+|..+ +..||+|.+...... .....+.+|+.+++.++|+||+++++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~ 76 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL----RERIEFLNEASVMKGFTCHHVVRLLG 76 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH----HHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 7899999999999999999999998653 357999988654432 22345788999999999999999999
Q ss_pred eeecC-ceEEEEEccCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCC
Q 021127 92 ACKEP-VMVIVTELLSGGTLRKYLLNMRP--------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 162 (317)
Q Consensus 92 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~ 162 (317)
++.++ ..++||||+++|+|.+++..... ..++...+..++.|++.||.|||+++++||||||+||+++.+
T Consensus 77 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~- 155 (288)
T cd05061 77 VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD- 155 (288)
T ss_pred EEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC-
Confidence 88655 78999999999999999975331 235677889999999999999999999999999999999988
Q ss_pred CceEEcccCcccccccccc---cccccCccceecccccccccccccccccccC---------------------------
Q 021127 163 KTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNH--------------------------- 212 (317)
Q Consensus 163 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~--------------------------- 212 (317)
+.++|+|||+++....... .....++..|+|||.+.+..... ..+.|+.
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~-~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTT-SSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCCh-HhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 7899999999875432211 12224567899999876432211 1111110
Q ss_pred --CCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 213 --KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 213 --~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
......+...+..+.+++.+||+.||.+|||+.++++.+.+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 0112234566889999999999999999999999999988764
No 138
>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr
Probab=100.00 E-value=7.1e-37 Score=265.32 Aligned_cols=214 Identities=26% Similarity=0.345 Sum_probs=169.0
Q ss_pred eccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCCC
Q 021127 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGG 108 (317)
Q Consensus 32 lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g 108 (317)
||+|+||.||+++.. ++.||+|.+....... ......+..|++++++++||||+++++++.++ ..++||||++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK--KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc--chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence 699999999999875 8999999986533211 11233456799999999999999999988765 899999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccccccccCc
Q 021127 109 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT 188 (317)
Q Consensus 109 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt 188 (317)
+|..++.......+++..++.++.|++.||+|||+.|++||||||+||+++.+ +.++|+|||++.............|+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ-GNCRLSDLGLAVELKDGKTITQRAGT 157 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCC-CCEEEeeceeeeecCCCceeeccCCC
Confidence 99998876655568999999999999999999999999999999999999988 68999999998765443333445789
Q ss_pred cceecccccccccccccccccccCC--------------------------------CCCCCCCCChHHHHHHHHHhhhc
Q 021127 189 YRWMAPELYSTVTLRQGEKKHYNHK--------------------------------NVRPSAENVPEELSIILTSCWKE 236 (317)
Q Consensus 189 ~~y~aPE~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~~l~~li~~cl~~ 236 (317)
..|+|||++.+.... ...+.|+.+ ........++.++.+|+.+||+.
T Consensus 158 ~~y~aPE~~~~~~~~-~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPYS-YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 999999987664422 222333222 00011235788999999999999
Q ss_pred CCCCCCCHHHHHH
Q 021127 237 DPNARPNFTQIIQ 249 (317)
Q Consensus 237 ~p~~Rps~~~~~~ 249 (317)
||.+||++.++++
T Consensus 237 ~P~~R~~~~~~~~ 249 (277)
T cd05607 237 KPEDRLGSREKND 249 (277)
T ss_pred CHhhCCCCccchh
Confidence 9999999966553
No 139
>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati
Probab=100.00 E-value=4.6e-36 Score=256.88 Aligned_cols=220 Identities=22% Similarity=0.385 Sum_probs=177.9
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.++||.|+||.||++.+. ++.+|+|.++..... ...+.+.+|+.+++.++|+||+++++.+.++ ..++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS----SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV 76 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch----HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence 5889999999999999999875 889999998754432 2345678899999999999999999998755 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-c
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-E 180 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~ 180 (317)
|||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||.+...... .
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC-CcEEEcccCcceeeccccc
Confidence 999999999999876555568999999999999999999999999999999999999988 78999999998754322 2
Q ss_pred ccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHHHH
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
......|++.|+|||++.+..... ..+.|+.+ ...+.+..++..+.+|+.+
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~-~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 234 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNN-KSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQ 234 (255)
T ss_pred ccccccCCccccCHHHHccCCcCc-hhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHH
Confidence 223456888999999876543222 22223222 1222345678889999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 021127 233 CWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 233 cl~~~p~~Rps~~~~~~~ 250 (317)
||+.||++||++.+++..
T Consensus 235 ~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 235 MFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHhCCcccCCCHHHHhhc
Confidence 999999999999998753
No 140
>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase. Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio
Probab=100.00 E-value=1.9e-36 Score=259.63 Aligned_cols=217 Identities=24% Similarity=0.460 Sum_probs=172.5
Q ss_pred eeccccceEEEEeEE----CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCceEEEEEccC
Q 021127 31 RIGEGAHAKVYEGKY----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLS 106 (317)
Q Consensus 31 ~lG~G~~g~V~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~ 106 (317)
+||+|+||.||+|.+ ++..+|+|++....... .....+.+|+.+++.+.|+||+++++++.+...++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDP---ALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcH---HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCC
Confidence 689999999999965 36889999987554322 34567899999999999999999999998778899999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc----c
Q 021127 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM----M 182 (317)
Q Consensus 107 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~----~ 182 (317)
+++|.+++..... +++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++........ .
T Consensus 79 ~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 79 LGPLNKFLQKNKH--VTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC-CeEEECCCccccccCCCCCeeeec
Confidence 9999999976443 8999999999999999999999999999999999999988 6899999999975432211 1
Q ss_pred ccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHHHHHHHh
Q 021127 183 TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSIILTSC 233 (317)
Q Consensus 183 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~c 233 (317)
....++..|+|||.+....... ..++|+.+ ...+.+..++.++.++|.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~ 234 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSS-KSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLC 234 (257)
T ss_pred CCCCCCccccCHhHhccCCcCc-hhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 2223457899999865422111 11111100 11234567889999999999
Q ss_pred hhcCCCCCCCHHHHHHHHHHh
Q 021127 234 WKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 234 l~~~p~~Rps~~~~~~~l~~~ 254 (317)
|+.||++||++++|.+.|++.
T Consensus 235 ~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 235 WTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred hccCchhCcCHHHHHHHHhcc
Confidence 999999999999999998764
No 141
>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2. Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve
Probab=100.00 E-value=2.4e-36 Score=262.22 Aligned_cols=230 Identities=23% Similarity=0.444 Sum_probs=181.9
Q ss_pred ecCCceeecceeccccceEEEEeEEC--Ce----EEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQ----TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~----~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
+...+|++.++||+|+||+||+|++. +. .||+|++...... .....+.+|+.++..+.|+||+++++++.
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP----KANKEILDEAYVMAGVGSPYVCRLLGICL 79 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCH----HHHHHHHHHHHHHHhcCCCCCceEEEEEc
Confidence 55688999999999999999999863 33 5899998765443 23456889999999999999999999998
Q ss_pred cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 95 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
....++++||+++|+|.+++.... ..+++..++.++.|++.||+|||+++++||||||+||+++.+ +.+||+|||+++
T Consensus 80 ~~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~-~~~kL~dfG~~~ 157 (279)
T cd05109 80 TSTVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSP-NHVKITDFGLAR 157 (279)
T ss_pred CCCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC-CcEEECCCCcee
Confidence 888899999999999999997643 348999999999999999999999999999999999999887 689999999998
Q ss_pred cccccccc---ccccCccceecccccccccccccccccccC-----------------------------CCCCCCCCCC
Q 021127 175 EESLTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNH-----------------------------KNVRPSAENV 222 (317)
Q Consensus 175 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~ 222 (317)
........ ....++..|+|||.+.+..... ..++|+. ....+.+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTH-QSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPIC 236 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCc-hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccC
Confidence 55432211 1223467899999875432211 1111111 1122334567
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+.++.+++.+||+.||++||++.++++.+.++...
T Consensus 237 ~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 237 TIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 88999999999999999999999999988777543
No 142
>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase. Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki
Probab=100.00 E-value=1.1e-36 Score=260.56 Aligned_cols=223 Identities=32% Similarity=0.600 Sum_probs=181.4
Q ss_pred eeecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCce
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVM 98 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 98 (317)
|.+..++|++.+.||+|+||.||++..+++.||+|.+..... ...+.+|+.++++++|+|++++++++.....
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~-------~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (254)
T cd05083 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVT-------AQAFLEETAVMTKLHHKNLVRLLGVILHNGL 73 (254)
T ss_pred CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcch-------HHHHHHHHHHHHhCCCCCcCeEEEEEcCCCc
Confidence 567778999999999999999999998899999999865432 2358899999999999999999999987788
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++.....
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~-~~~kl~Dfg~~~~~~~ 152 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSED-GVAKVSDFGLARVGSM 152 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC-CcEEECCCccceeccc
Confidence 999999999999999987655558999999999999999999999999999999999999988 6899999999875432
Q ss_pred ccccccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHHHH
Q 021127 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSII 229 (317)
Q Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~l 229 (317)
. ......+..|+|||.+.+..... ..+.|+.+ .....+..++..+.++
T Consensus 153 ~--~~~~~~~~~y~~pe~~~~~~~~~-~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (254)
T cd05083 153 G--VDNSKLPVKWTAPEALKHKKFSS-KSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVL 229 (254)
T ss_pred c--CCCCCCCceecCHHHhccCCcCc-hhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHH
Confidence 2 12233456899999875432211 11111111 1112245678899999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHH
Q 021127 230 LTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+.+||+.+|++||+++++++.|+
T Consensus 230 i~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 230 MTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred HHHHcCCChhhCcCHHHHHHHHc
Confidence 99999999999999999998875
No 143
>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase. Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa
Probab=100.00 E-value=4e-36 Score=258.16 Aligned_cols=227 Identities=29% Similarity=0.497 Sum_probs=182.7
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCc
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPV 97 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 97 (317)
|+|..++|++.++||+|+||.||++.+. +..+|+|.+..... ....+.+|+.++++++|+||+++++.+.+..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 74 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM------SVEAFLAEANVMKTLQHDKLVKLHAVVTKEP 74 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh------HHHHHHHHHHHHHhcCCCCcceEEEEEcCCC
Confidence 7899999999999999999999999875 56799998765321 2346889999999999999999999988888
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.+++|||+++++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.+||+|||.+....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~ 153 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS-LVCKIADFGLARVIE 153 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC-CcEEECCCcceeecc
Confidence 8999999999999999987555558899999999999999999999999999999999999988 799999999987543
Q ss_pred cccc--cccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHH
Q 021127 178 LTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEEL 226 (317)
Q Consensus 178 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l 226 (317)
.... .....++..|+|||++....... ..+.|+.+ ...+.+...+.++
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFGSFTI-KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL 232 (260)
T ss_pred CCCcccccCCcccccccCHhHhccCCcCc-cccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHH
Confidence 2211 11223567799999875432211 12222211 1112345677899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
.+++.+||+.+|++||++.++.+.|+.
T Consensus 233 ~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 233 YNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 999999999999999999999998865
No 144
>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome. Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds
Probab=100.00 E-value=1.5e-36 Score=260.17 Aligned_cols=222 Identities=29% Similarity=0.500 Sum_probs=175.4
Q ss_pred ecCCceeecceeccccceEEEEeEECC-eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
|++++|.+.+.||+|+||.||+|.+.+ ..+|||.+...... ...+.+|+.++.+++||||+++++++.+. ..
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd05113 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS------EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPI 74 (256)
T ss_pred CChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc------HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCc
Confidence 467889999999999999999998874 46999988754322 23588999999999999999999998755 78
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+.+++|.+++..... .+++..++.++.||+.||+|||++|++|+||||+||+++.+ +.+||+|||.++....
T Consensus 75 ~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~-~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 75 YIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQ-GCVKVSDFGLSRYVLD 152 (256)
T ss_pred EEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC-CCEEECCCccceecCC
Confidence 999999999999999976443 48999999999999999999999999999999999999988 6899999999875432
Q ss_pred cccc--ccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHH
Q 021127 179 TEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 179 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~ 227 (317)
.... ....++..|+|||++.+..... ..+.|+.+ .....+...+..++
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~-~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd05113 153 DEYTSSVGSKFPVRWSPPEVLLYSKFSS-KSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVY 231 (256)
T ss_pred CceeecCCCccChhhCCHHHHhcCcccc-hhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 2211 1223567899999876432211 11111110 11122445678999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
+++.+||+.+|.+||++.++++.+
T Consensus 232 ~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 232 AIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHHHhh
Confidence 999999999999999999998875
No 145
>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2. Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A
Probab=100.00 E-value=3.9e-36 Score=264.00 Aligned_cols=232 Identities=28% Similarity=0.462 Sum_probs=179.9
Q ss_pred ecCCceeecceeccccceEEEEeEEC--Ce--EEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeec
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQ--TVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE 95 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~--~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 95 (317)
+..++|++.+.||+|+||.||+|.+. +. .+|+|.+...... .....+.+|++++.++ +|+||+++++++.+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~ 79 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK----DDHRDFAGELEVLCKLGHHPNIINLLGACEH 79 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCH----HHHHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence 45578999999999999999999874 33 4677776543322 2345688899999999 89999999999875
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 160 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~ 160 (317)
. ..++||||+++++|.+++..... ..+++..++.++.|++.||+|||++|++||||||+||+++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 159 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC
Confidence 4 89999999999999999975431 24789999999999999999999999999999999999998
Q ss_pred CCCceEEcccCcccccccccccccccCccceecccccccccccccccccccCC---------------------------
Q 021127 161 DLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------------------- 213 (317)
Q Consensus 161 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------------------- 213 (317)
+ +.+||+|||++.............++..|+|||++.+.... ...++|+.+
T Consensus 160 ~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 237 (303)
T cd05088 160 N-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237 (303)
T ss_pred C-CcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCc-ccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 8 68999999998643222112222346679999987553322 223333322
Q ss_pred --CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 214 --NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 214 --~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
.....+..++.++.+|+.+||+.+|++||+++++++.+..++...
T Consensus 238 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 011123456789999999999999999999999999998877654
No 146
>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3. Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r
Probab=100.00 E-value=2.6e-36 Score=262.05 Aligned_cols=229 Identities=21% Similarity=0.394 Sum_probs=178.4
Q ss_pred ecCCceeecceeccccceEEEEeEEC--Ce----EEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQ----TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~----~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
+..++|++.+.||+|+||.||+|.+. ++ .+++|.+...... ....++..|+..+.+++||||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~~~~~l~~l~h~~iv~~~~~~~ 79 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR----QTFQEITDHMLAMGSLDHAYIVRLLGICP 79 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccch----HHHHHHHHHHHHHhcCCCCCcceEEEEEC
Confidence 44578899999999999999999873 43 4788877543321 22346778888999999999999999988
Q ss_pred cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 95 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+...++++||+++|+|.+++.... ..+++..++.++.||+.||+|||++|++||||||+||+++.+ +.+||+|||+++
T Consensus 80 ~~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~-~~~kl~Dfg~~~ 157 (279)
T cd05111 80 GASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSD-SIVQIADFGVAD 157 (279)
T ss_pred CCccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEEcCCccce
Confidence 778889999999999999997643 348999999999999999999999999999999999999988 689999999997
Q ss_pred cccccc---ccccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCC
Q 021127 175 EESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENV 222 (317)
Q Consensus 175 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~ 222 (317)
...... ......++..|+|||.+.+..... ..+.|+.+ ...+.+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~-~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTH-QSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQIC 236 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCc-hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCC
Confidence 543221 122334677899999875432211 11111111 112224456
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
+.++.+++.+||..||.+|||+.++++.|..+.+
T Consensus 237 ~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 237 TIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 7789999999999999999999999999888765
No 147
>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase
Probab=100.00 E-value=2.6e-36 Score=260.10 Aligned_cols=227 Identities=26% Similarity=0.430 Sum_probs=179.2
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l 100 (317)
++|++.+.||+|+||.||+|++. ++.||||.+....... .+....+.+|+.+++.++||||+++++++.+ +..++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMD--AKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCC--HHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence 57999999999999999999874 8999999887543322 2345568899999999999999999998865 48899
Q ss_pred EEEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 101 VTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
|+||+++++|.+++.... ...+++..++.++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~-~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCC-CCEEECccccceeccc
Confidence 999999999999886432 2348899999999999999999999999999999999999988 6899999999875433
Q ss_pred cc-ccccccCccceecccccccccccccccccccCC------------------------------CCCCC-CCCChHHH
Q 021127 179 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPS-AENVPEEL 226 (317)
Q Consensus 179 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~-~~~~~~~l 226 (317)
.. ......+++.|+|||.+.+..... ..+.|+.+ ...+. ...++..+
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~-~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNF-KSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCc-hhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 22 122346888999999876533221 12222211 00111 23566889
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
.+++.+||+.+|++||++.++++.++.+
T Consensus 238 ~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 238 RELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 9999999999999999999999998764
No 148
>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as
Probab=100.00 E-value=1.6e-36 Score=264.23 Aligned_cols=224 Identities=24% Similarity=0.326 Sum_probs=178.7
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
.|++.+.||+|+||.||++.+. ++.||||.+....... ......+.+|+.++++++|+||+++++.+.+. ..++|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccc--hHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEE
Confidence 3678889999999999999885 7899999987654322 12334577899999999999999999988654 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
|||+++++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.+ +.++|+|||++........
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC-CCEEEeeccceeecCCCcc
Confidence 999999999999876555569999999999999999999999999999999999999988 6899999999875543333
Q ss_pred cccccCccceecccccccccccccccccccCC-------------------------------CCCCCCCCChHHHHHHH
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVPEELSIIL 230 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l~~li 230 (317)
.....|+..|+|||++.+..... ..+.|+.+ .....+..++.++.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~-~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTF-SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCC-ccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 33457899999999986543322 22333221 00112345778899999
Q ss_pred HHhhhcCCCCCCC-----HHHHHHHHH
Q 021127 231 TSCWKEDPNARPN-----FTQIIQMLL 252 (317)
Q Consensus 231 ~~cl~~~p~~Rps-----~~~~~~~l~ 252 (317)
.+||+.||++||| +.++++|-+
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChh
Confidence 9999999999999 889988743
No 149
>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=1.6e-36 Score=261.54 Aligned_cols=222 Identities=24% Similarity=0.361 Sum_probs=174.8
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
..++|++.+.||+|+||.||+|++. ++.||+|++....... ...+.+|+.++++++|+||+++++++... ..
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~-----~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD-----FSLIQQEIFMVKECKHCNIVAYFGSYLSREKL 81 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch-----HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence 3468999999999999999999874 7899999987543322 23577899999999999999999998654 88
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+++++|.+++..... +++..+..++.|++.||+|||++||+||||+|+||+++.+ +.++|+|||++.....
T Consensus 82 ~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 82 WICMEYCGGGSLQDIYHVTGP--LSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDN-GDVKLADFGVAAKITA 158 (267)
T ss_pred EEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CCEEECcCccceeecc
Confidence 999999999999999876543 8999999999999999999999999999999999999988 6899999999975432
Q ss_pred cc-ccccccCccceeccccccccc--ccccccccccCC----------------------------C-CC---CCCCCCh
Q 021127 179 TE-MMTAETGTYRWMAPELYSTVT--LRQGEKKHYNHK----------------------------N-VR---PSAENVP 223 (317)
Q Consensus 179 ~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~~~----------------------------~-~~---~~~~~~~ 223 (317)
.. ......|+..|+|||.+.... ......+.|+.+ . .. .....++
T Consensus 159 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06646 159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWS 238 (267)
T ss_pred cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccC
Confidence 21 223346889999999874211 011112222111 0 00 1123467
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
..+.+++.+||..+|++||+++++++++
T Consensus 239 ~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 239 STFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 8999999999999999999999998864
No 150
>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t
Probab=100.00 E-value=3.3e-36 Score=258.64 Aligned_cols=227 Identities=30% Similarity=0.526 Sum_probs=183.1
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-C
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-P 96 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~ 96 (317)
|.++.++|++.++||+|+||.||+|.+. ++.||||.+...... ...+.+|+.++++++|+||+++++++.+ .
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS------PEAFLQEAQIMKKLRHDKLVQLYAVCSEEE 74 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC------HHHHHHHHHHHhhCCCCCEeeeeeeeecCC
Confidence 6789999999999999999999999876 578999998754432 2358899999999999999999999876 5
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++||||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.+||+|||++...
T Consensus 75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~-~~~~l~d~g~~~~~ 153 (261)
T cd05034 75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGEN-LVCKIADFGLARLI 153 (261)
T ss_pred ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCC-CCEEECccccceec
Confidence 89999999999999999987655569999999999999999999999999999999999999998 79999999998754
Q ss_pred ccccc--cccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHH
Q 021127 177 SLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEE 225 (317)
Q Consensus 177 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~ 225 (317)
..... .....++..|+|||.+.+..... ..+.|+.+ ...+.+...+.+
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAANYGRFTI-KSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEE 232 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhccCCcCc-hhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 32211 11223456899999876532221 11111100 122335567889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
+.+++.+||+.+|.+||+++++++.|+.
T Consensus 233 ~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 233 LYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 9999999999999999999999988764
No 151
>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke
Probab=100.00 E-value=4.1e-36 Score=262.77 Aligned_cols=225 Identities=26% Similarity=0.471 Sum_probs=177.9
Q ss_pred cCCceeecceeccccceEEEEeEECC------------------eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYKN------------------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH 83 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~------------------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 83 (317)
..++|++.++||+|+||.||++.+.+ ..||+|.+...... .....+.+|++++++++|
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~----~~~~~~~~e~~~l~~l~~ 78 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD----NAREDFLKEVKILSRLSD 78 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH----HHHHHHHHHHHHHHhcCC
Confidence 45789999999999999999987642 46899998866543 335578899999999999
Q ss_pred CCeeeEEeeeec-CceEEEEEccCCCCHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 021127 84 RNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRP---------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 153 (317)
Q Consensus 84 ~niv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~---------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp 153 (317)
+||+++++++.. +..+++||++++++|.+++..... ..+++..++.++.|++.||+|||++|++||||||
T Consensus 79 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp 158 (296)
T cd05051 79 PNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT 158 (296)
T ss_pred CCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccch
Confidence 999999999876 489999999999999999976541 2489999999999999999999999999999999
Q ss_pred CcEEeeCCCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccCC-----------------
Q 021127 154 ENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------- 213 (317)
Q Consensus 154 ~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------- 213 (317)
+||+++.+ +.++|+|||+++...... ......++..|+|||++.+.... ...++|+.+
T Consensus 159 ~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 159 RNCLVGKN-YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred hceeecCC-CceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCC-ccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 99999998 799999999987543221 12233467789999986542211 111222111
Q ss_pred --------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 --------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 --------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
...+.+..++.++.+++.+||+.||.+|||+.++++.|.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 237 LTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred cChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 011223456789999999999999999999999998875
No 152
>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g
Probab=100.00 E-value=2.6e-36 Score=262.15 Aligned_cols=215 Identities=24% Similarity=0.316 Sum_probs=169.3
Q ss_pred eccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCCC
Q 021127 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGG 108 (317)
Q Consensus 32 lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g 108 (317)
||+|+||+||++.+. ++.||+|.+....... ......+..|+++++.++|+||+++.+++... ..++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK--RKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhh--hHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence 699999999999875 7899999987643322 12335678899999999999999999988655 799999999999
Q ss_pred CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-cccccc
Q 021127 109 TLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAE 185 (317)
Q Consensus 109 ~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~ 185 (317)
+|..++... ....+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++...... ......
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCccceecCCCCcccccc
Confidence 999887542 22358999999999999999999999999999999999999987 78999999999754322 222334
Q ss_pred cCccceecccccccccccccccccccCC-------------------------------CCCCCCCCChHHHHHHHHHhh
Q 021127 186 TGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVPEELSIILTSCW 234 (317)
Q Consensus 186 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l~~li~~cl 234 (317)
.||+.|+|||++.+..... ..+.|+.+ .....+..++..+.+++.+||
T Consensus 158 ~g~~~y~aPE~~~~~~~~~-~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDF-SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236 (280)
T ss_pred CCCcCccCHHHhcCCCCCc-cccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence 6899999999987643322 22222211 011123457889999999999
Q ss_pred hcCCCCCC-----CHHHHHHH
Q 021127 235 KEDPNARP-----NFTQIIQM 250 (317)
Q Consensus 235 ~~~p~~Rp-----s~~~~~~~ 250 (317)
+.||++|| +++++++|
T Consensus 237 ~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 237 AKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHhcCCCCCCHHHHhcC
Confidence 99999999 77888877
No 153
>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly
Probab=100.00 E-value=3.5e-36 Score=262.42 Aligned_cols=230 Identities=29% Similarity=0.502 Sum_probs=181.9
Q ss_pred ecCCceeecceeccccceEEEEeEE-------CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKY-------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
|...+|.+.+.||+|+||.||++.. ++..+|+|.+..... .....+.+|+.++++++|+||+++++++
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-----NARKDFHREAELLTNLQHEHIVKFYGVC 76 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH-----HHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 5678899999999999999999974 145689998865432 2345688999999999999999999998
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRP-----------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 161 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~-----------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~ 161 (317)
.+. ..++||||+++++|.+++...+. ..+++..++.++.|++.||+|||++|++||||||+||+++.+
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 77 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 156 (288)
T ss_pred ecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 754 89999999999999999975431 248999999999999999999999999999999999999988
Q ss_pred CCceEEcccCcccccccccc---cccccCccceecccccccccccccccccccCC-------------------------
Q 021127 162 LKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------- 213 (317)
Q Consensus 162 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------- 213 (317)
+.+||+|||+++....... .....++..|+|||++.+..... ..++|+.+
T Consensus 157 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~ 234 (288)
T cd05093 157 -LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT-ESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234 (288)
T ss_pred -CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 7899999999975432211 12234577899999876532221 11111111
Q ss_pred ----CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 214 ----NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 214 ----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
.....+..++.++.+|+.+||+.||.+|||+.++++.|+++...
T Consensus 235 i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11223446788999999999999999999999999999888754
No 154
>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,
Probab=100.00 E-value=7.2e-36 Score=265.48 Aligned_cols=224 Identities=23% Similarity=0.315 Sum_probs=173.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||+++.. ++.||||++.+..... ......+.+|+.++..++|+||+++++++.++ ..++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLK--RAETACFREERDVLVNGDRRWITNLHYAFQDENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhh--hhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEE
Confidence 47999999999999999999885 7899999987532211 12345678899999999999999999998765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus 79 v~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADG 156 (331)
T ss_pred EEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCC-CCEEEEECCceeecCCCC
Confidence 999999999999997633 238999999999999999999999999999999999999988 789999999987543222
Q ss_pred c--cccccCccceecccccccc----cccccccccccCC--------------------------------CCCCCCCCC
Q 021127 181 M--MTAETGTYRWMAPELYSTV----TLRQGEKKHYNHK--------------------------------NVRPSAENV 222 (317)
Q Consensus 181 ~--~~~~~gt~~y~aPE~~~~~----~~~~~~~~~~~~~--------------------------------~~~~~~~~~ 222 (317)
. .....||+.|+|||++... .......++|+.+ ...+....+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence 1 1234689999999998632 1122233444433 001112346
Q ss_pred hHHHHHHHHHhhhcCCC--CCCCHHHHHHHH
Q 021127 223 PEELSIILTSCWKEDPN--ARPNFTQIIQML 251 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~--~Rps~~~~~~~l 251 (317)
+..+++++.+||..++. .|+++.++++|-
T Consensus 237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 88999999998865443 378999999883
No 155
>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]
Probab=100.00 E-value=4.8e-37 Score=272.45 Aligned_cols=240 Identities=26% Similarity=0.406 Sum_probs=197.0
Q ss_pred cccceecCCceeecCCceeecceeccccceEEEEeEECC-eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCee
Q 021127 9 LADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV 87 (317)
Q Consensus 9 ~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 87 (317)
...+-+....-+++++...+.++||+|-||.|.++...+ ..||||.++...... .+..|.+|+++|.+|+||||+
T Consensus 523 ~~~~~k~~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~----~r~~F~kEIkiLsqLkhPNIv 598 (807)
T KOG1094|consen 523 PPGVGKGPALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKN----ARNDFLKEIKILSRLKHPNIV 598 (807)
T ss_pred CcccccCcchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchh----HHHHHHHHHHHHhccCCCCee
Confidence 334455666678999999999999999999999999885 999999998766533 367899999999999999999
Q ss_pred eEEeeee-cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceE
Q 021127 88 KFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166 (317)
Q Consensus 88 ~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~k 166 (317)
+|+|+|. ++.+++|+||+++|+|.+|+.++....+.-.....|+.||++||+||.+.++|||||.+.|+|++.+ .++|
T Consensus 599 eLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e-~~iK 677 (807)
T KOG1094|consen 599 ELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGE-FTIK 677 (807)
T ss_pred EEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCc-ccEE
Confidence 9999996 4589999999999999999998765445666778899999999999999999999999999999999 5899
Q ss_pred EcccCccccccccccc---ccccCccceecccccccccccccccccccCC------------------------------
Q 021127 167 LADFGLAREESLTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------ 213 (317)
Q Consensus 167 l~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------ 213 (317)
|+|||+++........ ...+-...|||||.+....+....+.| ..+
T Consensus 678 iadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvW-afgvTlwE~~~~C~e~Py~~lt~e~vven~~~~ 756 (807)
T KOG1094|consen 678 IADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVW-AFGVTLWEVFMLCREQPYSQLTDEQVVENAGEF 756 (807)
T ss_pred ecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhh-hhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhh
Confidence 9999999965444332 233567899999987654444332221 111
Q ss_pred -------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 214 -------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 214 -------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
...+.|.-+|..+.++|.+||..|-.+||+++++-.+|.+.
T Consensus 757 ~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 757 FRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 23445778899999999999999999999999998887654
No 156
>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase. Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions
Probab=100.00 E-value=4.7e-36 Score=259.06 Aligned_cols=230 Identities=30% Similarity=0.519 Sum_probs=183.5
Q ss_pred eecCCceeecceeccccceEEEEeEECC-----eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYKN-----QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
.+...+|.+.++||+|+||.||+|.+.+ ..||||........ ...+.+.+|+.++++++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 77 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP----SVREKFLQEAYIMRQFDHPHIVKLIGVIT 77 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH----HHHHHHHHHHHHHHhCCCCchhceeEEEc
Confidence 4677889999999999999999998642 46899988655432 23457899999999999999999999998
Q ss_pred cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 95 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+...++||||+++++|.+++..... .+++..++.++.|++.||+|||+.|++|+||||+||+++.+ +.+||+|||+++
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~-~~~~l~d~g~~~ 155 (270)
T cd05056 78 ENPVWIVMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSP-DCVKLGDFGLSR 155 (270)
T ss_pred CCCcEEEEEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecC-CCeEEccCceee
Confidence 8888999999999999999976433 48999999999999999999999999999999999999988 689999999987
Q ss_pred cccccccc--ccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCCh
Q 021127 175 EESLTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVP 223 (317)
Q Consensus 175 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~ 223 (317)
........ ....++..|+|||.+...... ...+.|+.+ ...+.+..++
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05056 156 YLEDESYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCP 234 (270)
T ss_pred ecccccceecCCCCccccccChhhhccCCCC-chhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCC
Confidence 54333211 122345689999986543221 111111100 1223356778
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
..+.+++.+||..+|.+|||+.++++.|.++..
T Consensus 235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 235 PTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999999988754
No 157
>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=1.2e-36 Score=264.53 Aligned_cols=228 Identities=27% Similarity=0.455 Sum_probs=178.7
Q ss_pred ecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
|+..+|.+.+.||+|+||.||+|.+. +..||||++...... .....+.+|+.++..++||||+++++++
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~~~~l~h~~iv~~~~~~ 77 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG----PLREEFKHEAMMRSRLQHPNIVCLLGVV 77 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH----HHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 44567889999999999999999863 477999998755432 2345688999999999999999999998
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 158 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill 158 (317)
.+. ..++++||+.+++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+||++
T Consensus 78 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~ 157 (283)
T cd05091 78 TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV 157 (283)
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe
Confidence 764 7899999999999999985321 1247888999999999999999999999999999999999
Q ss_pred eCCCCceEEcccCcccccccccc---cccccCccceecccccccccccccccccccCC----------------------
Q 021127 159 TEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------- 213 (317)
Q Consensus 159 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------- 213 (317)
+.+ +.+||+|||+++....... .....+++.|+|||++....... ..++|+.+
T Consensus 158 ~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 158 FDK-LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSI-DSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred cCC-CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCc-chhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 988 6899999999875432211 12334578899999875432211 12222111
Q ss_pred -------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 214 -------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 214 -------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
...+.+..++..+.+|+.+||+.+|.+||+++++++.|+.+
T Consensus 236 ~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 283 (283)
T cd05091 236 IEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283 (283)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhCC
Confidence 12233567889999999999999999999999999988653
No 158
>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=1e-36 Score=272.68 Aligned_cols=224 Identities=29% Similarity=0.375 Sum_probs=195.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l 100 (317)
..|.+.+.||+|.|+.|.+|++. +..||||.+.+..... ..++.+.+|++++..++|||||+++.+... ..+|+
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~---~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP---SKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh---HHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 67899999999999999999885 8999999998876544 345568899999999999999999999974 58999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+.+|.+.+++.+.+. ..+..+..++.|+.+|++|||+++|||||||++||||+.++ .+||+|||++.......
T Consensus 133 V~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~m-nikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENM-NIKIADFGFSTFFDYGL 209 (596)
T ss_pred EEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccccc-ceeeeccccceeecccc
Confidence 9999999999999998765 77789999999999999999999999999999999999995 69999999999888888
Q ss_pred ccccccCccceecccccccccccccccccccCCCC---------------------------CCCCCCChHHHHHHHHHh
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKNV---------------------------RPSAENVPEELSIILTSC 233 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~c 233 (317)
...+.+|++.|.|||++.+..+.....+.|..+.. ...+.-++.+..++|+++
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~ 289 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKF 289 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHHh
Confidence 88889999999999999998877777777765511 111334467899999999
Q ss_pred hhcCCCCCCCHHHHHHHHHH
Q 021127 234 WKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 234 l~~~p~~Rps~~~~~~~l~~ 253 (317)
|..+|.+|++.+++..+-|.
T Consensus 290 lvl~Pskr~~~dqim~~~W~ 309 (596)
T KOG0586|consen 290 LVLNPSKRGPCDQIMKDRWR 309 (596)
T ss_pred hccCccccCCHHHhhhhccc
Confidence 99999999999999887664
No 159
>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in
Probab=100.00 E-value=3.4e-36 Score=265.79 Aligned_cols=215 Identities=27% Similarity=0.352 Sum_probs=168.3
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHh-cCCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSR-VQHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||.||+|++. ++.||||++....... ......+..|..++.. ++||||+++++++.+. ..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM--DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--cchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 46999999999999886 6889999998643211 1223346677788876 4999999999998765 889999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc-cccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~-~~~~~~ 184 (317)
++|+|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++..... ......
T Consensus 79 ~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05619 79 NGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD-GHIKIADFGMCKENMLGDAKTCT 155 (316)
T ss_pred CCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-CCEEEccCCcceECCCCCCceee
Confidence 99999999986543 8999999999999999999999999999999999999988 6899999999874321 122334
Q ss_pred ccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcC
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKED 237 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~ 237 (317)
..||+.|+|||++.+..+. ...+.|+.+ .....+..++.++++++.+||+.|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVRE 234 (316)
T ss_pred ecCCccccCHHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccC
Confidence 5789999999998764432 223333322 011123457888999999999999
Q ss_pred CCCCCCHH-HHHHH
Q 021127 238 PNARPNFT-QIIQM 250 (317)
Q Consensus 238 p~~Rps~~-~~~~~ 250 (317)
|.+||++. +++++
T Consensus 235 P~~R~~~~~~l~~h 248 (316)
T cd05619 235 PERRLGVKGDIRQH 248 (316)
T ss_pred HhhcCCChHHHHcC
Confidence 99999996 67665
No 160
>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a
Probab=100.00 E-value=6.1e-36 Score=260.31 Aligned_cols=226 Identities=25% Similarity=0.485 Sum_probs=179.1
Q ss_pred cCCceeecceeccccceEEEEeEE------CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
+...|++.++||+|+||.||++++ .+..||+|.+...... .....+.+|+.++++++|+||+++++++.+
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (284)
T cd05079 2 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG----NHIADLKKEIEILRNLYHENIVKYKGICTE 77 (284)
T ss_pred chhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH----HHHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 345678999999999999999874 3678999998754332 234568899999999999999999998864
Q ss_pred ---CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 96 ---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 96 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
...++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||+
T Consensus 78 ~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~-~~~~l~dfg~ 155 (284)
T cd05079 78 DGGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGDFGL 155 (284)
T ss_pred CCCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCC-CCEEECCCcc
Confidence 36899999999999999997643 248999999999999999999999999999999999999988 6899999999
Q ss_pred cccccccc----ccccccCccceecccccccccccccccccccCC-----------------------------------
Q 021127 173 AREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------------- 213 (317)
Q Consensus 173 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------------- 213 (317)
++...... ......++..|+|||++.+..... ..+.|+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~-~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYI-ASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR 234 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCc-cccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH
Confidence 97543221 112345677899999876533221 22333222
Q ss_pred --------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 214 --------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 214 --------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
...+.+..++..+.+|+.+||+.||.+||++.++++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 235 LVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11122456788999999999999999999999999998765
No 161
>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=3.4e-36 Score=270.57 Aligned_cols=221 Identities=25% Similarity=0.321 Sum_probs=172.7
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC---
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP--- 96 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 96 (317)
..++|++.+.||+|+||.||++.+. ++.||||++....... ....++.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ---THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccch---hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence 3478999999999999999999875 7899999987653322 2344678999999999999999999988532
Q ss_pred ----ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 97 ----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 97 ----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
..++||||+. ++|.+.+.. .+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+
T Consensus 96 ~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~-~~~kl~Dfg~ 169 (359)
T cd07876 96 EEFQDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGL 169 (359)
T ss_pred cccceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEecCCC
Confidence 4799999995 567766642 28899999999999999999999999999999999999988 7999999999
Q ss_pred ccccccccccccccCccceecccccccccccccccccccCC--------CC-----------------------------
Q 021127 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV----------------------------- 215 (317)
Q Consensus 173 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~----------------------------- 215 (317)
++............||+.|+|||++.+..... ..+.|+.+ ..
T Consensus 170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred ccccccCccCCCCcccCCCCCchhccCCCCCc-chhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 97654443444567899999999886643322 12222211 00
Q ss_pred -----------C---------------------CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 216 -----------R---------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 216 -----------~---------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
. ......+..+++||.+||+.||++|||+.|+++|.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 0 001123567899999999999999999999999844
No 162
>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows
Probab=100.00 E-value=2.8e-36 Score=258.48 Aligned_cols=222 Identities=32% Similarity=0.561 Sum_probs=175.8
Q ss_pred ecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
|++.+|++.+.||+|+||.||++.+. +..+|+|.+...... ...+.+|+++++.++|+||+++++++.+. ..
T Consensus 1 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05059 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS------EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPI 74 (256)
T ss_pred CChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC------HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCce
Confidence 46678999999999999999999886 567999998754332 23578899999999999999999998654 78
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+++++|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++....
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED-NVVKVSDFGLARYVLD 152 (256)
T ss_pred EEEEecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCC-CcEEECCcccceeccc
Confidence 999999999999999976443 48999999999999999999999999999999999999988 7899999999875432
Q ss_pred cccc--ccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHH
Q 021127 179 TEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 179 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~ 227 (317)
.... ....++..|+|||.+.+..... ..+.|+.+ .....+..++.++.
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd05059 153 DQYTSSQGTKFPVKWAPPEVFDYSRFSS-KSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVY 231 (256)
T ss_pred ccccccCCCCCCccccCHHHhccCCCCc-hhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHH
Confidence 2111 1122345799999876533221 11111110 11223456789999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
+++.+||+.+|++|||+.++++.|
T Consensus 232 ~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 232 TIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHHHh
Confidence 999999999999999999999875
No 163
>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play
Probab=100.00 E-value=1.6e-36 Score=267.21 Aligned_cols=222 Identities=24% Similarity=0.362 Sum_probs=172.7
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
.++|.+.++||+|+||.||+|++. ++.||+|.+....... ....+.+|+.++++++|+||+++++++..+ ..+
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLT 80 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC----cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence 367999999999999999999875 7889999987654322 123467899999999999999999998654 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+||||++ ++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus 81 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 81 LVFEYLD-KDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSVP 157 (309)
T ss_pred EEEeCCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECccccceecCCC
Confidence 9999996 58888887643 338899999999999999999999999999999999999988 78999999999754322
Q ss_pred -cccccccCccceecccccccccccccccccccCC---------------------------------------------
Q 021127 180 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------------------------------------- 213 (317)
Q Consensus 180 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------------------------------------- 213 (317)
.......+++.|+|||++.+........+.|+.+
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 2223346789999999875422111112222111
Q ss_pred -------CC-----CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 214 -------NV-----RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 214 -------~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
.. ......++.++.+||.+||+.||.+|||+.+++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 00 001124678899999999999999999999999873
No 164
>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa. Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho
Probab=100.00 E-value=6e-36 Score=256.67 Aligned_cols=217 Identities=24% Similarity=0.498 Sum_probs=171.1
Q ss_pred eeccccceEEEEeEEC----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCceEEEEEccC
Q 021127 31 RIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLS 106 (317)
Q Consensus 31 ~lG~G~~g~V~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~ 106 (317)
.||+|+||.||+|.+. +..||+|++...... .....+.+|+.++++++|+||+++++++.....++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~----~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK----SVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccCh----HHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCC
Confidence 3899999999999764 456999998765432 23456889999999999999999999998778999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc----c
Q 021127 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM----M 182 (317)
Q Consensus 107 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~----~ 182 (317)
+++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++........ .
T Consensus 78 ~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 78 GGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQ-HYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred CCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCC-CcEEeccCCccccccCCccceecc
Confidence 999999997533 348999999999999999999999999999999999999988 6899999999874432211 1
Q ss_pred ccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHHHHHHHh
Q 021127 183 TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSIILTSC 233 (317)
Q Consensus 183 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~c 233 (317)
....++..|+|||++....... ..+.|+.+ .....+...+.++.+++.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSS-RSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDC 234 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCc-hhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 1123357899999875433211 11222111 11223456789999999999
Q ss_pred hhcCCCCCCCHHHHHHHHHHh
Q 021127 234 WKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 234 l~~~p~~Rps~~~~~~~l~~~ 254 (317)
|..+|++||++.++.+.|+.+
T Consensus 235 ~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 235 WIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred cCCChhhCcCHHHHHHHHhhh
Confidence 999999999999999998765
No 165
>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul
Probab=100.00 E-value=3e-36 Score=271.00 Aligned_cols=220 Identities=23% Similarity=0.347 Sum_probs=173.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||++... ++.||||++....... ......+.+|+.++..++|+||+++++.+.+. ..++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLE--KEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhh--hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 46889999999999999999885 7899999997533211 23355688899999999999999999998765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||++||+|.+++..... +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 79 v~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~-~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKDT--LSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EEeCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC-CCEEEeeccCCccccccc
Confidence 9999999999999986544 8999999999999999999999999999999999999988 799999999986432110
Q ss_pred ------------------------------------ccccccCccceecccccccccccccccccccCCC----------
Q 021127 181 ------------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKN---------- 214 (317)
Q Consensus 181 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~---------- 214 (317)
.....+||+.|+|||++.+.... ...++|+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCC
Confidence 01134699999999998764433 2344444330
Q ss_pred ---------------------CCCCCCCChHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 021127 215 ---------------------VRPSAENVPEELSIILTSCWKEDPNARPN---FTQIIQM 250 (317)
Q Consensus 215 ---------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps---~~~~~~~ 250 (317)
..+....++.++++||.+|+. ||.+|++ +.++++|
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 235 PFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 001112367889999999774 9999984 7788877
No 166
>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc
Probab=100.00 E-value=6.3e-36 Score=255.95 Aligned_cols=221 Identities=22% Similarity=0.361 Sum_probs=179.5
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|.+.+.||+|++|.||++.+. ++.|++|.+....... .....+.+|++++++++||||+++++++.+. ..++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR---REREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV 77 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCH---HHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence 4788999999999999999885 7899999987654332 3355688999999999999999999998754 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc-
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE- 180 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~- 180 (317)
|||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||+++......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~-~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY-DNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC-CCEEEcccccceeccCccc
Confidence 999999999999987644569999999999999999999999999999999999999988 689999999987543322
Q ss_pred ccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHHHH
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
......|++.|+|||++.+..... ..+.|+.+ ...+.+..++.++.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNE-KSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQ 235 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCC-ccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHH
Confidence 223446889999999877644322 22333221 1112233678899999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 021127 233 CWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 233 cl~~~p~~Rps~~~~~~~ 250 (317)
||+.+|++||++.+++++
T Consensus 236 ~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 236 CLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HccCCcccCcCHHHHhhC
Confidence 999999999999999875
No 167
>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity. Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....
Probab=100.00 E-value=6.5e-37 Score=262.56 Aligned_cols=219 Identities=32% Similarity=0.523 Sum_probs=174.3
Q ss_pred eeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEEEE
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVT 102 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~ 102 (317)
|++.+.||+|+||+||++++. ++.||+|++........ ......+|+.++++++|+||+++++++.+ ...++||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE---EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM 77 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH---HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc---ccchhhhhhhccccccccccccccccccccccccccc
Confidence 789999999999999999997 67899999988765432 22234569999999999999999999975 4889999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc-ccccc
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE-SLTEM 181 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~-~~~~~ 181 (317)
|++.+++|.+++..... +++..++.++.|++.||++||++|++|+||||+||+++.+ +.++|+|||.+... .....
T Consensus 78 ~~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~-~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 78 EYCPGGSLQDYLQKNKP--LSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN-GEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp EEETTEBHHHHHHHHSS--BBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT-SEEEESSGTTTEESTSTTSE
T ss_pred ccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccc
Confidence 99999999999985444 9999999999999999999999999999999999999987 78999999999752 33334
Q ss_pred cccccCccceecccccccccccccccccccCC--------C--------------------------CCCCCCCChHHHH
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N--------------------------VRPSAENVPEELS 227 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~--------------------------~~~~~~~~~~~l~ 227 (317)
.....++..|+|||++..........+.|+.+ . ........+..+.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELR 234 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHH
Confidence 45567899999999987222222222222211 0 0001112247899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+++.+||+.||++||++.+++++
T Consensus 235 ~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 235 DLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHHHSSSSGGGSTTHHHHHTS
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999876
No 168
>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes. Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular
Probab=100.00 E-value=5.6e-36 Score=255.90 Aligned_cols=216 Identities=31% Similarity=0.553 Sum_probs=169.1
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccC
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLS 106 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~ 106 (317)
++||+|+||.||+|.+. ++.||+|.+...... .....+.+|++++++++|+||+++++++... ..++||||++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPP----DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 76 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCH----HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence 46899999999999874 888999987654332 2345688999999999999999999998755 7899999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccccc---
Q 021127 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT--- 183 (317)
Q Consensus 107 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~--- 183 (317)
+++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++..........
T Consensus 77 ~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 77 GGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK-NVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred CCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCC-CcEEECccccCcccccccccccCC
Confidence 999999997643 348999999999999999999999999999999999999988 689999999987543221111
Q ss_pred cccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHHHHHHHhh
Q 021127 184 AETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSIILTSCW 234 (317)
Q Consensus 184 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~cl 234 (317)
....+..|+|||.+.+..... ..+.|+.+ ...+.+..++..+.+|+.+||
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 233 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSS-ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCW 233 (252)
T ss_pred CCCCceeecCchhhcCCCCCh-HHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHc
Confidence 112345799999875432211 11111111 112334567889999999999
Q ss_pred hcCCCCCCCHHHHHHHHH
Q 021127 235 KEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 235 ~~~p~~Rps~~~~~~~l~ 252 (317)
+.+|++|||+.++++.|.
T Consensus 234 ~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 234 EYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCChhhCcCHHHHHHHHh
Confidence 999999999999998864
No 169
>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3e-38 Score=282.46 Aligned_cols=221 Identities=28% Similarity=0.433 Sum_probs=180.2
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee-ecCceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC-KEPVMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~l 100 (317)
+.|.|+..||.|+||.||+|..+ +-..|-|++..... ....+|+-||++|..+.||+||+|++.| .++.+||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkse-----EELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwi 106 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSE-----EELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWI 106 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccch-----hHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEE
Confidence 34566777999999999999876 55568888865543 3366799999999999999999999854 6789999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-cc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LT 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~ 179 (317)
+.|||.||-.+..+-..+ ..+++.++.-+++|++.||.|||+++|||||||+.|||++-+ |.++|+|||.+-... ..
T Consensus 107 liEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tld-GdirLADFGVSAKn~~t~ 184 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLD-GDIRLADFGVSAKNKSTR 184 (1187)
T ss_pred EEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEec-CcEeeecccccccchhHH
Confidence 999999999999887754 349999999999999999999999999999999999999999 799999999975432 22
Q ss_pred cccccccCccceeccccccccccccc----ccccccCC------------------------------CCCCCCCCChHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQG----EKKHYNHK------------------------------NVRPSAENVPEE 225 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~----~~~~~~~~------------------------------~~~~~~~~~~~~ 225 (317)
....++.|||+|||||+....++... ..++|+.+ .....|..++..
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~ 264 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRS 264 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhH
Confidence 34466789999999999765444332 33455544 111225667889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
+.+|+.+||..||..||++.++++|-
T Consensus 265 F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 265 FSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred HHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 99999999999999999999999873
No 170
>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th
Probab=100.00 E-value=6.9e-36 Score=259.90 Aligned_cols=225 Identities=28% Similarity=0.521 Sum_probs=175.4
Q ss_pred cCCceeecceeccccceEEEEeEE------CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
+..+|++.+.||+|+||.||++.. ++..||||.+..... .....+.+|++++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 76 (284)
T cd05081 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA-----EHLRDFEREIEILKSLQHDNIVKYKGVCYS 76 (284)
T ss_pred ccccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH-----HHHHHHHHHHHHHHhCCCCCeeEEEEEEcc
Confidence 456899999999999999999874 367899999875432 234568899999999999999999998642
Q ss_pred ---CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 96 ---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 96 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
...++||||+++++|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~-~~~~l~dfg~ 154 (284)
T cd05081 77 AGRRNLRLVMEYLPYGSLRDYLQKHRE-RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESE-NRVKIGDFGL 154 (284)
T ss_pred CCCCceEEEEEecCCCCHHHHHHhcCc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCC-CeEEECCCcc
Confidence 368999999999999999976432 38999999999999999999999999999999999999988 6899999999
Q ss_pred ccccccccc----cccccCccceecccccccccccccccccccCC-----------------------------------
Q 021127 173 AREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------------- 213 (317)
Q Consensus 173 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------------- 213 (317)
+........ .....++..|+|||++.+..... ..++|+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSV-ASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVY 233 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCCcCh-HHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchH
Confidence 985432211 11123445699999875432111 11111111
Q ss_pred ---------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 214 ---------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 214 ---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
...+.+..++.++.+|+.+||..+|++|||+.++++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11122456788999999999999999999999999998754
No 171
>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.2e-37 Score=275.45 Aligned_cols=232 Identities=31% Similarity=0.562 Sum_probs=195.3
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
+.|++++.++...++||-|.||.||.|.|+ .-.||||.++.... ....|+.|..+++.+.|||+|+|+|+|.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM------eveEFLkEAAvMKeikHpNLVqLLGVCT 333 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVMKEIKHPNLVQLLGVCT 333 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch------hHHHHHHHHHHHHhhcCccHHHHhhhhc
Confidence 589999999999999999999999999998 68899999875543 2457999999999999999999999996
Q ss_pred -cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 95 -EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 95 -~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
+..+|||+|||..|+|.+||+.....-++.-..+.++.||.+|++||..+++|||||.+.|+|+.++ ..+||+|||++
T Consensus 334 ~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEn-hiVKvADFGLs 412 (1157)
T KOG4278|consen 334 HEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HIVKVADFGLS 412 (1157)
T ss_pred cCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccccc-ceEEeeccchh
Confidence 5589999999999999999998766668888899999999999999999999999999999999999 69999999999
Q ss_pred cccccccccccccC---ccceeccccccccccccccccccc-----------------------------CCCCCCCCCC
Q 021127 174 REESLTEMMTAETG---TYRWMAPELYSTVTLRQGEKKHYN-----------------------------HKNVRPSAEN 221 (317)
Q Consensus 174 ~~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~ 221 (317)
+....... +...| .+.|.|||-+.-..+.... +.|. .+..+..+++
T Consensus 413 RlMtgDTY-TAHAGAKFPIKWTAPEsLAyNtFSiKS-DVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeG 490 (1157)
T KOG4278|consen 413 RLMTGDTY-TAHAGAKFPIKWTAPESLAYNTFSIKS-DVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEG 490 (1157)
T ss_pred hhhcCCce-ecccCccCcccccCcccccccccccch-hhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCC
Confidence 97654432 22223 5789999976543332222 1121 1234556889
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+|+.+++||+.||+++|.+||++.++-+.++.++..
T Consensus 491 CPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 491 CPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred CCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 999999999999999999999999999998877653
No 172
>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul
Probab=100.00 E-value=7.1e-36 Score=257.57 Aligned_cols=227 Identities=28% Similarity=0.498 Sum_probs=178.4
Q ss_pred ecCCceeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
|++.+|++.+.||+|+||.||+|.+. +..+|+|.+...... .....+.+|+.++++++||||+++++++.+
T Consensus 1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (267)
T cd05066 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE----KQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (267)
T ss_pred CCHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH----HHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 46788999999999999999999863 347999998754432 234568899999999999999999999865
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+ ..++||||+++++|.+++.... ..+++.+++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~-~~~~l~dfg~~~ 154 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSN-LVCKVSDFGLSR 154 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCC-CeEEeCCCCccc
Confidence 4 8899999999999999997643 348999999999999999999999999999999999999988 689999999997
Q ss_pred ccccccc----cccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCC
Q 021127 175 EESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAEN 221 (317)
Q Consensus 175 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~ 221 (317)
....... .....++..|+|||.+.+..... ..+.|+.+ ...+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~-~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTS-ASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMD 233 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhccCccCc-hhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCC
Confidence 5432211 11122356899999876532211 11111110 11233446
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
++..+.+++.+||+.+|.+||++.++++.|.+.
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 234 CPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 788999999999999999999999999998764
No 173
>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw
Probab=100.00 E-value=1.6e-35 Score=263.40 Aligned_cols=223 Identities=21% Similarity=0.286 Sum_probs=173.8
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.++||+|+||.||+++++ ++.||+|++.+..... ......+.+|+.++..++|+||+++++++.+. ..++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK--RAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHH--hhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence 47899999999999999999886 6889999986532211 12234578899999999999999999998765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++|+|.+++..... .+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++.......
T Consensus 79 v~ey~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~-~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EEeccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC-CCEEEeecchheecccCC
Confidence 9999999999999986432 38999999999999999999999999999999999999988 789999999987532221
Q ss_pred --ccccccCccceecccccccc----cccccccccccCC-----------------------------C---CCCCCCCC
Q 021127 181 --MMTAETGTYRWMAPELYSTV----TLRQGEKKHYNHK-----------------------------N---VRPSAENV 222 (317)
Q Consensus 181 --~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~~~~~-----------------------------~---~~~~~~~~ 222 (317)
......||+.|+|||++... .......++|+.+ . .......+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV 236 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence 12235799999999998632 1122334444433 0 01112357
Q ss_pred hHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 021127 223 PEELSIILTSCWKEDPNA--RPNFTQIIQM 250 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~--Rps~~~~~~~ 250 (317)
+.++++|+.+|+..++.. |+++.++++|
T Consensus 237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 889999999988654444 6899999988
No 174
>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1. Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.
Probab=100.00 E-value=9.9e-36 Score=260.69 Aligned_cols=231 Identities=29% Similarity=0.462 Sum_probs=178.8
Q ss_pred CceeecceeccccceEEEEeEEC--C--eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-c
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--N--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-V 97 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~--~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 97 (317)
++|++.+.||+|+||.||+|... + ..+++|.++..... ...+.+.+|+.++.++ +||||+++++++.+. .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE----NDHRDFAGELEVLCKLGHHPNIINLLGACENRGY 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCH----HHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence 68999999999999999999875 3 34788887643322 2245688999999999 799999999998754 7
Q ss_pred eEEEEEccCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCC
Q 021127 98 MVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 163 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~ 163 (317)
.++||||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~ 156 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN-L 156 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC-C
Confidence 899999999999999997532 1248899999999999999999999999999999999999988 6
Q ss_pred ceEEcccCcccccccccccccccCccceecccccccccccccccccccCC-----------------------------C
Q 021127 164 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------N 214 (317)
Q Consensus 164 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~ 214 (317)
.+||+|||++..............+..|+|||++....... ..++|+.+ .
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTT-KSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 89999999986432221112223356799999876533221 12222211 0
Q ss_pred CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCC
Q 021127 215 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 260 (317)
Q Consensus 215 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~ 260 (317)
....+..++..+.+|+.+||+.+|.+||+++++++.|..+......
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 1122446788999999999999999999999999999988876543
No 175
>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with
Probab=100.00 E-value=5.1e-36 Score=261.03 Aligned_cols=222 Identities=24% Similarity=0.322 Sum_probs=176.8
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
.|+..+.||+|+||+||++.+. ++.||+|.+....... ......+.+|+++++.++|+||+++.+.+..+ ..++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK--RKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhh--hhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEE
Confidence 3678899999999999999885 7899999987643322 12234578899999999999999999887654 88999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
|||+++++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY-GHIRISDLGLAVKIPEGES 157 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC-CCEEEecCCcceecCCCCc
Confidence 999999999998876555569999999999999999999999999999999999999988 6899999999875443333
Q ss_pred cccccCccceecccccccccccccccccccCC-------------------------------CCCCCCCCChHHHHHHH
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVPEELSIIL 230 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l~~li 230 (317)
.....|+..|+|||++.+..... ..+.|+.+ .....+..++.++.+|+
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTL-SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCc-ccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 34457899999999986543322 22333221 01112345788899999
Q ss_pred HHhhhcCCCCCCC-----HHHHHHH
Q 021127 231 TSCWKEDPNARPN-----FTQIIQM 250 (317)
Q Consensus 231 ~~cl~~~p~~Rps-----~~~~~~~ 250 (317)
..||+.||++||+ +.+++.+
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcC
Confidence 9999999999999 7787776
No 176
>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with
Probab=100.00 E-value=5.9e-36 Score=256.15 Aligned_cols=222 Identities=25% Similarity=0.371 Sum_probs=181.0
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv 101 (317)
+|++.+.||+|++|.||++... ++.+|||.+....... .....+.+|++++++++|+||+++++.+.. +..++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK---DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIV 77 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc---HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEE
Confidence 5889999999999999998874 7899999998654332 234568899999999999999999998865 479999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
|||+++++|.+++.......+++..+..++.+++.||+|||++|++|+||+|+||+++.+.+.+||+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999999998765555899999999999999999999999999999999999987645789999999986554433
Q ss_pred cccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHHHHh
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIILTSC 233 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li~~c 233 (317)
.....++..|+|||.+.+.... ...+.|+.+ ...+.+..++.++.+++.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 236 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSM 236 (256)
T ss_pred ccccccCCcccCchhccCCCCC-cccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHH
Confidence 3445688999999988654322 222333221 11223456788999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 021127 234 WKEDPNARPNFTQIIQM 250 (317)
Q Consensus 234 l~~~p~~Rps~~~~~~~ 250 (317)
|+.+|.+|||+.+++++
T Consensus 237 l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 237 LNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ccCChhhCCCHHHHhhC
Confidence 99999999999999876
No 177
>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign
Probab=100.00 E-value=1.2e-35 Score=258.22 Aligned_cols=222 Identities=29% Similarity=0.495 Sum_probs=173.9
Q ss_pred Cce-eecceeccccceEEEEeEE------CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-
Q 021127 24 KHL-FVGPRIGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE- 95 (317)
Q Consensus 24 ~~y-~~~~~lG~G~~g~V~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~- 95 (317)
++| ++.+.||+|+||+||++.. .+..||+|++...... .....+.+|++++++++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ----QNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh----HHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 344 8999999999999988653 3678999998765432 234568899999999999999999998753
Q ss_pred --CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 96 --PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 96 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
...++||||+++++|.+++... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~ 154 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND-RLVKIGDFGLA 154 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCC-CcEEEeecccc
Confidence 2589999999999999999763 29999999999999999999999999999999999999988 68999999999
Q ss_pred cccccccc----cccccCccceecccccccccccccccccccCC------------------------------------
Q 021127 174 REESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------------ 213 (317)
Q Consensus 174 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------------ 213 (317)
+....... .....++..|+|||.+....... ..++|+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~-~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSY-ASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL 233 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCc-ccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhh
Confidence 75433211 12234567799999875432211 11222111
Q ss_pred -------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 214 -------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 214 -------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
...+.+..++.++.+++.+||+.+|++|||++++++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 01112445678999999999999999999999999998875
No 178
>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.
Probab=100.00 E-value=2.3e-35 Score=262.27 Aligned_cols=224 Identities=21% Similarity=0.280 Sum_probs=174.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||++++. ++.||+|++.+..... ......+.+|+.++..++|+||+++++++.+. ..++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLK--RAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHh--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 47999999999999999999885 7889999987532211 22344578899999999999999999998765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||++||+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++.......
T Consensus 79 v~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCC-CCEEEEeccceeeccCCC
Confidence 999999999999998643 238999999999999999999999999999999999999988 789999999997543322
Q ss_pred c--cccccCccceeccccccccc----ccccccccccCC-----------------------------C---CCCCCCCC
Q 021127 181 M--MTAETGTYRWMAPELYSTVT----LRQGEKKHYNHK-----------------------------N---VRPSAENV 222 (317)
Q Consensus 181 ~--~~~~~gt~~y~aPE~~~~~~----~~~~~~~~~~~~-----------------------------~---~~~~~~~~ 222 (317)
. .....||+.|+|||++.+.. ......++|+.+ . .......+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV 236 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence 1 12356999999999886521 112233444433 0 00112346
Q ss_pred hHHHHHHHHHhhhcCCCC--CCCHHHHHHHH
Q 021127 223 PEELSIILTSCWKEDPNA--RPNFTQIIQML 251 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~--Rps~~~~~~~l 251 (317)
+.++++++.+||..++.+ |++++++++|.
T Consensus 237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred CHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 889999999999866544 46899998873
No 179
>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt
Probab=100.00 E-value=4.2e-36 Score=260.57 Aligned_cols=226 Identities=30% Similarity=0.518 Sum_probs=179.5
Q ss_pred ecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
+..++|.+.+.||+|+||.||+|.+. ++.||||.+...... .....+.+|++++++++|+||+++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 77 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN----DARKDFEREAELLTNFQHENIVKFYGVC 77 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH----HHHHHHHHHHHHHHhcCCCCchheeeEE
Confidence 34578999999999999999999763 468999998765442 2345789999999999999999999998
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRP------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 160 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~ 160 (317)
... ..++||||+++++|.+++...+. ..+++..+..++.|++.||+|||++|++||||||+||+++.
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~ 157 (280)
T cd05049 78 TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY 157 (280)
T ss_pred ecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence 765 89999999999999999976431 34789999999999999999999999999999999999998
Q ss_pred CCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccCC------------------------
Q 021127 161 DLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------ 213 (317)
Q Consensus 161 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------ 213 (317)
+ +.+||+|||+++...... ......+++.|+|||++.+..... ..++|+.+
T Consensus 158 ~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05049 158 D-LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTT-ESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235 (280)
T ss_pred C-CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcch-hhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 8 799999999987532221 112334578899999876543322 12222111
Q ss_pred -----CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 -----NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 -----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.....+..++..+.+++.+||+.||.+||++.++++.|.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 236 CITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 112234567899999999999999999999999998875
No 180
>PTZ00266 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=9.3e-36 Score=287.41 Aligned_cols=227 Identities=21% Similarity=0.340 Sum_probs=178.8
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE--- 95 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--- 95 (317)
+..++|++.++||.|+||+||++++. +..||+|++....... .....+..|+.++++++||||+++++++.+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e---~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE---REKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH---HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 44478999999999999999999886 7889999987654433 234568899999999999999999998743
Q ss_pred CceEEEEEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-------CccccCCCCCcEEeeCC-----
Q 021127 96 PVMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSH-------GIIHRDLKPENLLLTED----- 161 (317)
Q Consensus 96 ~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~-------~ivH~Dlkp~Nill~~~----- 161 (317)
..+||||||+++++|.++|.... ...+++..++.|+.||+.||+|||+. +||||||||+||||+.+
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 36899999999999999997632 23499999999999999999999984 49999999999999642
Q ss_pred -----------CCceEEcccCcccccccccccccccCccceeccccccccc-ccccccccccCC----------------
Q 021127 162 -----------LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVT-LRQGEKKHYNHK---------------- 213 (317)
Q Consensus 162 -----------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~~---------------- 213 (317)
...+||+|||++.............||+.|+|||++.+.. ......++|+.+
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 1348999999998655444444567999999999875421 122223333322
Q ss_pred ------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 ------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 ------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.........+.++.+||..||..+|.+||++.+++.+
T Consensus 247 ~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 247 NNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 0111123567899999999999999999999999976
No 181
>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou
Probab=100.00 E-value=3.2e-36 Score=262.49 Aligned_cols=220 Identities=29% Similarity=0.390 Sum_probs=169.4
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc---CCCCeeeEEeeeec----
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV---QHRNLVKFIGACKE---- 95 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 95 (317)
+|++.+.||+|+||.||+|++. ++.||+|.+........ ....+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG---LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC---CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence 5889999999999999999885 78999999876432221 112245566666554 79999999998753
Q ss_pred --CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 96 --PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 96 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
...++||||+. ++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++
T Consensus 78 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~-~~~kl~dfg~~ 155 (288)
T cd07863 78 RETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GQVKLADFGLA 155 (288)
T ss_pred CCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECccCcc
Confidence 25799999996 589999877555558999999999999999999999999999999999999988 78999999999
Q ss_pred cccccccccccccCccceecccccccccccccccccccCC--------CC------------------------------
Q 021127 174 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------------------------ 215 (317)
Q Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------------------------ 215 (317)
+............|+..|+|||++.+.... ...++|+.+ ..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred ccccCcccCCCccccccccCchHhhCCCCC-CcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 865444333445689999999987653322 122222211 00
Q ss_pred ----------------CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 ----------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 ----------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
......++..+.+++.+||+.||++|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00012467788999999999999999999999876
No 182
>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr
Probab=100.00 E-value=1.3e-35 Score=256.24 Aligned_cols=227 Identities=28% Similarity=0.476 Sum_probs=177.9
Q ss_pred ecCCceeecceeccccceEEEEeEEC--C---eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--N---QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~---~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
|+...|++.+.||+|+||.||+|.+. + ..||||++...... .....|..|+.+++.++||||+++++++.+
T Consensus 1 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 76 (269)
T cd05065 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTE----KQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (269)
T ss_pred CChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCH----HHHHHHHHHHHHHHhCCCcCcceEEEEECC
Confidence 34577999999999999999999875 2 36999998765432 234568999999999999999999999876
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+ ..++||||+++++|.+++.... ..+++.+++.++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||++.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~-~~~kl~dfg~~~ 154 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSR 154 (269)
T ss_pred CCceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCC-CcEEECCCcccc
Confidence 5 7899999999999999997643 348999999999999999999999999999999999999988 689999999987
Q ss_pred cccccccc---cccc---CccceecccccccccccccccccccCC-----------------------------CCCCCC
Q 021127 175 EESLTEMM---TAET---GTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSA 219 (317)
Q Consensus 175 ~~~~~~~~---~~~~---gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~ 219 (317)
........ .... .+..|+|||.+....... ..++|+.+ ...+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 233 (269)
T cd05065 155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPP 233 (269)
T ss_pred ccccCccccccccccCCCcceeecCHhHhccCcccc-hhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCc
Confidence 54322111 1111 245799999876533221 12222211 112334
Q ss_pred CCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 220 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 220 ~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
..++..+.+++.+||+.+|.+||++.+++..|+++
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 234 MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 56788999999999999999999999999988764
No 183
>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including
Probab=100.00 E-value=6.2e-36 Score=261.73 Aligned_cols=226 Identities=24% Similarity=0.428 Sum_probs=175.1
Q ss_pred ecCCceeecceeccccceEEEEeEEC----------------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCC
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK----------------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR 84 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~----------------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 84 (317)
+...+|++.++||+|+||.||++.+. ...||+|.+...... .....|.+|++++++++|+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~ei~~l~~l~h~ 77 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK----TARNDFLKEIKIMSRLKNP 77 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCH----HHHHHHHHHHHHHHhCCCC
Confidence 45578999999999999999998753 235899998765432 2345689999999999999
Q ss_pred CeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 021127 85 NLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP----------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 153 (317)
Q Consensus 85 niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~----------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp 153 (317)
||+++++++... ..++||||+++++|.+++..... ..+++..++.++.|++.||+|||++|++||||||
T Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp 157 (295)
T cd05097 78 NIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLAT 157 (295)
T ss_pred CcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccCh
Confidence 999999998654 88999999999999999965321 1368889999999999999999999999999999
Q ss_pred CcEEeeCCCCceEEcccCcccccccccc---cccccCccceecccccccccccccccccccCC-----------------
Q 021127 154 ENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------- 213 (317)
Q Consensus 154 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------- 213 (317)
+||+++.+ +.+||+|||++........ .....++..|+|||++...... ...++|+.+
T Consensus 158 ~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 158 RNCLVGNH-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hhEEEcCC-CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcC-chhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 99999987 6899999999875432211 1223456789999986543221 111222111
Q ss_pred --------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 --------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 --------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.....+...|..+.+|+.+||+.||++||+++++++.|.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 236 LSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred cChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 001123456789999999999999999999999998875
No 184
>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa
Probab=100.00 E-value=1.4e-35 Score=254.06 Aligned_cols=222 Identities=25% Similarity=0.392 Sum_probs=179.4
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.+.||.|+||.||.++.. ++.+++|.+....... ....++.+|+.++++++|+||+++++++.+. ..+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~ 77 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE---KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE 77 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch---hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEE
Confidence 5899999999999998887764 7889999987654332 2345688999999999999999999998765 78999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc-
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE- 180 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~- 180 (317)
|||+++++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~-~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA-GLIKLGDFGISKILGSEYS 156 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC-CCEEECcCcceEEcccccc
Confidence 999999999999987644558999999999999999999999999999999999999988 689999999997543322
Q ss_pred ccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHHHH
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
......+++.|+|||++.+..... ..+.|+.+ ...+.+..++.++.+++.+
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~-~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNF-KSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHS 235 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCC-cchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHH
Confidence 223456899999999876543221 12222211 1222345678899999999
Q ss_pred hhhcCCCCCCCHHHHHHHH
Q 021127 233 CWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 233 cl~~~p~~Rps~~~~~~~l 251 (317)
||+.+|.+||++.++++++
T Consensus 236 ~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 236 LLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HcccCcccCCCHHHHhhCc
Confidence 9999999999999998763
No 185
>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n
Probab=100.00 E-value=1.3e-35 Score=259.20 Aligned_cols=230 Identities=28% Similarity=0.488 Sum_probs=180.9
Q ss_pred ecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
+...+|.+.+.||+|+||.||++.+. +..+++|.+..... .....+.+|+.++++++|+||+++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-----AARKDFQREAELLTNLQHEHIVKFYGVC 76 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-----HHHHHHHHHHHHHhcCCCCCcceEEEEE
Confidence 34578999999999999999999752 45688888764332 2345688999999999999999999998
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 158 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill 158 (317)
.+. ..++||||+++++|.+++..... ..+++..++.++.||+.||+|||++|++||||||+||++
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~ 156 (291)
T cd05094 77 GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV 156 (291)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE
Confidence 765 78999999999999999975431 238899999999999999999999999999999999999
Q ss_pred eCCCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccCC----------------------
Q 021127 159 TEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------- 213 (317)
Q Consensus 159 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------- 213 (317)
+.+ +.++|+|||+++...... ......++..|+|||++.+..... ..+.|+.+
T Consensus 157 ~~~-~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~t~g~~p~~~~~~~~~ 234 (291)
T cd05094 157 GAN-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT-ESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234 (291)
T ss_pred ccC-CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 988 699999999997543321 122345678899999876533221 11222111
Q ss_pred -------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 214 -------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 214 -------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
.....+...|..+.+++.+||+.+|.+||++.++++.|.++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 235 IECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 11122445688999999999999999999999999999988653
No 186
>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]
Probab=100.00 E-value=1.4e-35 Score=267.71 Aligned_cols=172 Identities=30% Similarity=0.372 Sum_probs=147.8
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-C-----CCeeeEEeeee-c
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-H-----RNLVKFIGACK-E 95 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~-~ 95 (317)
+|.+.+.||+|+||.|.+|.+. ++.||||+++.... ...+-..|+.+|..|+ | -|+|+++++|. .
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~------f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR------FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH------HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 8899999999999999999885 89999999987643 3345677999999996 3 58999999996 4
Q ss_pred CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC-CCCceEEcccCccc
Q 021127 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE-DLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~-~~~~~kl~Dfg~a~ 174 (317)
++.+||+|.+ +.+|+++|+.++..+++...+..|+.||+.||.+||+.||||+||||+||||.. +...+||+|||.++
T Consensus 261 ~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence 5999999999 789999999998888999999999999999999999999999999999999973 33579999999999
Q ss_pred ccccccccccccCccceeccccccccccccc
Q 021127 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQG 205 (317)
Q Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 205 (317)
.....-. +.+.+..|.|||++.+..+...
T Consensus 340 ~~~q~vy--tYiQSRfYRAPEVILGlpY~~~ 368 (586)
T KOG0667|consen 340 FESQRVY--TYIQSRFYRAPEVILGLPYDTA 368 (586)
T ss_pred ccCCcce--eeeeccccccchhhccCCCCCc
Confidence 7654432 5677899999999887554443
No 187
>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase. Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription
Probab=100.00 E-value=2e-36 Score=273.23 Aligned_cols=221 Identities=27% Similarity=0.332 Sum_probs=173.5
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC------
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP------ 96 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 96 (317)
+|++.+.||+|+||.||++.+. ++.||||.+....... ....++.+|+++++.++|+||+++++++...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 77 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNL---VSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE 77 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccch---HHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccc
Confidence 4788999999999999999874 8999999986543222 2345688999999999999999999998643
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++||||+. ++|.+.+.... .+++..+..++.||+.||+|||++|++||||||+|||++.+ +.+||+|||+++..
T Consensus 78 ~~~lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~a~~~ 153 (372)
T cd07853 78 EIYVVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN-CVLKICDFGLARVE 153 (372)
T ss_pred eEEEEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCC-CCEEeccccceeec
Confidence 5899999995 68888886544 39999999999999999999999999999999999999988 79999999999754
Q ss_pred ccc--cccccccCccceecccccccccccccccccccCC--------CC-------------------------------
Q 021127 177 SLT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------------------------- 215 (317)
Q Consensus 177 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------------------------- 215 (317)
... .......+++.|+|||++.+........++|+.+ ..
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 322 1223346789999999876533222233333322 00
Q ss_pred -------------C-------CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 216 -------------R-------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 216 -------------~-------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
. ......+.++.+||.+||+.||.+|||+.+++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 0 112345778999999999999999999999998844
No 188
>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein. Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi
Probab=100.00 E-value=1.5e-35 Score=258.62 Aligned_cols=226 Identities=28% Similarity=0.523 Sum_probs=176.5
Q ss_pred ceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
+|++.+.||+|+||.||+|... ...+++|.+....... ...++.+|+.+++.++||||+++++.+...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSS----ELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHH----HHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 4788999999999999999864 2568999887654432 245688999999999999999999988654
Q ss_pred ceEEEEEccCCCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 021127 97 VMVIVTELLSGGTLRKYLLNMR----------------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 154 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~ 154 (317)
..++++||+.+++|.+++.... ...+++..++.++.|++.||+|||+++++||||||+
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ 156 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR 156 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence 7899999999999999986532 124789999999999999999999999999999999
Q ss_pred cEEeeCCCCceEEcccCcccccccccc---cccccCccceecccccccccccccccccccCC------------------
Q 021127 155 NLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------ 213 (317)
Q Consensus 155 Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------ 213 (317)
||+++.+ +.+||+|||+++....... .....++..|+|||.+.+..... ..+.|+.+
T Consensus 157 nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~-~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 157 NVLVAEG-RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTT-QSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred eEEEcCC-CcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcch-HhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999988 6899999999975422211 12234567899999765422111 11111110
Q ss_pred -----------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 214 -----------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 214 -----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
.....+..++.++.+++.+||+.+|.+||++.++++.|++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 235 PERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1122355678899999999999999999999999999998764
No 189
>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase. Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.
Probab=100.00 E-value=1.3e-35 Score=259.24 Aligned_cols=226 Identities=28% Similarity=0.394 Sum_probs=179.4
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
.+..+.+.|++.++||.|+||.||+|++. +..||+|.+..... .....+.+|+.+++.++|+||+++++.+..
T Consensus 6 ~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (292)
T cd06644 6 RDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-----EELEDYMVEIEILATCNHPYIVKLLGAFYW 80 (292)
T ss_pred cccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH-----HHHHHHHHHHHHHHhCCCCcEeeeEEEEEe
Confidence 45566688999999999999999999885 78999999876432 234568889999999999999999998764
Q ss_pred -CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+..++||||+++++|..++.+.. ..+++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~dfg~~~ 158 (292)
T cd06644 81 DGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLD-GDIKLADFGVSA 158 (292)
T ss_pred CCeEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCC-CCEEEccCccce
Confidence 48999999999999998876533 348999999999999999999999999999999999999987 789999999986
Q ss_pred ccccc-cccccccCccceecccccccccc----cccccccccCC------------------------------CCCCCC
Q 021127 175 EESLT-EMMTAETGTYRWMAPELYSTVTL----RQGEKKHYNHK------------------------------NVRPSA 219 (317)
Q Consensus 175 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~~~------------------------------~~~~~~ 219 (317)
..... .......+++.|+|||++.+... .....++|+.+ .....+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T cd06644 159 KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQP 238 (292)
T ss_pred eccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCC
Confidence 43222 12234467889999998853221 11223333322 001123
Q ss_pred CCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 220 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 220 ~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
..++.++.+++.+||+.||++||++.+++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 239 SKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 4567889999999999999999999999886
No 190
>PHA03209 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=3.1e-36 Score=270.43 Aligned_cols=166 Identities=23% Similarity=0.332 Sum_probs=139.8
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
+...+|++.+.||+|+||.||+|++. ++.||+|+..... ...|+.++++++|+||+++++++.+. .
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-----------~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 131 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-----------TLIEAMLLQNVNHPSVIRMKDTLVSGAI 131 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-----------cHHHHHHHHhCCCCCCcChhheEEeCCe
Confidence 34457999999999999999999986 6789999854332 34689999999999999999998765 7
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++|||++ .++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 132 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 132 TCMVLPHY-SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDV-DQVCIGDLGAAQFPV 208 (357)
T ss_pred eEEEEEcc-CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEecCccccccc
Confidence 89999999 578998887643 348999999999999999999999999999999999999988 689999999997544
Q ss_pred cccccccccCccceecccccccc
Q 021127 178 LTEMMTAETGTYRWMAPELYSTV 200 (317)
Q Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~ 200 (317)
.........||..|+|||++.+.
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~ 231 (357)
T PHA03209 209 VAPAFLGLAGTVETNAPEVLARD 231 (357)
T ss_pred cCcccccccccccccCCeecCCC
Confidence 33333455789999999987653
No 191
>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase). Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It
Probab=100.00 E-value=2.3e-35 Score=256.03 Aligned_cols=232 Identities=23% Similarity=0.435 Sum_probs=182.9
Q ss_pred eecCCceeecceeccccceEEEEeEEC------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
.|+.++|++.+.||+|+||.||+|.+. +..|++|.+...... .....+.+|+.++++++|+||+++++++
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~ 77 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE----IQVTLLLQESCLLYGLSHQNILPILHVC 77 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCH----HHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 367889999999999999999999875 478999988754332 3356688999999999999999999987
Q ss_pred ec--CceEEEEEccCCCCHHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCce
Q 021127 94 KE--PVMVIVTELLSGGTLRKYLLNMRP------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165 (317)
Q Consensus 94 ~~--~~~~lv~e~~~~g~L~~~l~~~~~------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~ 165 (317)
.+ ...+++++|+++++|.+++..... ..+++..++.++.|++.||+|||+++++|+||||+||+++.+ +.+
T Consensus 78 ~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~-~~~ 156 (280)
T cd05043 78 IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE-LQV 156 (280)
T ss_pred ecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCC-CcE
Confidence 54 478999999999999999976432 348999999999999999999999999999999999999988 689
Q ss_pred EEcccCcccccccccc---cccccCccceecccccccccccccccccccCC-----------------------------
Q 021127 166 KLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------- 213 (317)
Q Consensus 166 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------- 213 (317)
||+|||+++....... .....++..|+|||++.+..... ..+.|+.+
T Consensus 157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~-~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 235 (280)
T cd05043 157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSS-ASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG 235 (280)
T ss_pred EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCc-hhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC
Confidence 9999999975432211 12234567899999875432211 11222111
Q ss_pred CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 214 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 214 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
.....+..++.++.+++.+||..||++|||+.++++.|.++...
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 236 YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 11122345688999999999999999999999999999887653
No 192
>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]
Probab=100.00 E-value=3.2e-38 Score=260.25 Aligned_cols=217 Identities=24% Similarity=0.356 Sum_probs=180.4
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee-cCceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~l 100 (317)
+-|.++.+||+|+||.||+|.++ |+.+|||.++.... .+.+..|+.+++++..|+||++||.+. ...+||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-------LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI 105 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-------LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI 105 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-------HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence 45678999999999999999775 89999999987654 446899999999999999999999765 458999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
|||||..|+..+.++.+. +.+++..+..++...+.||+|||...-||||||+.|||++.+ |.+||+|||.|-.....
T Consensus 106 VMEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~-G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTD-GIAKLADFGVAGQLTDTM 183 (502)
T ss_pred ehhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEccc-chhhhhhccccchhhhhH
Confidence 999999999999988644 459999999999999999999999999999999999999998 79999999999765433
Q ss_pred cccccccCccceecccccccccccccccccccCC---------------------------CCC---CCCCCChHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVR---PSAENVPEELSII 229 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~---~~~~~~~~~l~~l 229 (317)
...++..||+.|||||++....+....+ +|+.+ +.. ..|...+.++.++
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~AD-IWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DF 262 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKAD-IWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDF 262 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhh-HhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHH
Confidence 2345668999999999987655443322 22221 111 1245567889999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 021127 230 LTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~ 250 (317)
+++||..+|++|-|+.++++|
T Consensus 263 i~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 263 IRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HHHHhcCCHHHHHHHHHHhhh
Confidence 999999999999999999887
No 193
>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi
Probab=100.00 E-value=2.2e-35 Score=253.07 Aligned_cols=217 Identities=29% Similarity=0.509 Sum_probs=173.3
Q ss_pred ceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCceEEEEEc
Q 021127 30 PRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTEL 104 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~ 104 (317)
++||+|+||.||+|.+. +..+|+|.+...... .....+.+|+.+++.+.|+||+++++++.....++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA----AGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch----HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEe
Confidence 47999999999999764 267999998766543 234568899999999999999999999987789999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccccc--
Q 021127 105 LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM-- 182 (317)
Q Consensus 105 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~-- 182 (317)
+++++|.+++.... .+++..++.++.|++.||+|||+++++|+||||+||+++.+ +.+||+|||+++........
T Consensus 77 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~-~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 77 APLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC-CcEEeccccccceeecCCcccc
Confidence 99999999998755 38999999999999999999999999999999999999988 68999999999854322211
Q ss_pred --ccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHHHHHH
Q 021127 183 --TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 183 --~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~ 231 (317)
....++..|+|||.+.+..... ..+.|+.+ ...+.+..++..+++++.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 232 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSS-KSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIML 232 (257)
T ss_pred cccCccccccccCHHHhcCCCCCc-cchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence 1122356799999875433221 11221111 112335567899999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHh
Q 021127 232 SCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 232 ~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
+||..+|.+||++.++++.|.+.
T Consensus 233 ~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 233 SCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHhcCChhhCcCHHHHHHHHHhc
Confidence 99999999999999999998764
No 194
>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.
Probab=100.00 E-value=2.1e-35 Score=252.97 Aligned_cols=221 Identities=24% Similarity=0.402 Sum_probs=177.5
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec--CceEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE--PVMVI 100 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~l 100 (317)
+|++.+.||.|++|.||++.+. ++.||+|.+....... .....+.+|++++++++|+|++++++.+.. ...++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR---RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI 77 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH---HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEE
Confidence 5899999999999999999875 6889999987644322 234457889999999999999999988753 36889
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
||||+++++|.+++.......+++.+++.++.+++.||++||++|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~-~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQC 156 (257)
T ss_pred EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC-CcEEEecccceEEecccC
Confidence 9999999999999987555568999999999999999999999999999999999999988 78999999999754322
Q ss_pred cccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li~ 231 (317)
.......+++.|+|||++.+...... .++|+.+ .....+..++..+.+++.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYK-SDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIA 235 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHH
Confidence 22234468899999998765433221 2222211 111234567789999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 021127 232 SCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 232 ~cl~~~p~~Rps~~~~~~~ 250 (317)
+||+.||++||++.+++++
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 236 TMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHhccCcccCCCHHHHhcC
Confidence 9999999999999999876
No 195
>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=6.6e-36 Score=257.64 Aligned_cols=221 Identities=24% Similarity=0.389 Sum_probs=174.7
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-Cce
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 98 (317)
+.++|.+.++||+|+||.||+|.+. ++.||+|+++..... ....+.+|+.+++.++||||+++++.+.. +..
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE-----DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKL 81 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh-----HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Confidence 3468999999999999999999874 789999998765432 13357789999999999999999998865 489
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+++++|.+++...+. +++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 82 WICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDN-GHVKLADFGVSAQITA 158 (267)
T ss_pred EEEEeccCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECcceeeeEccC
Confidence 999999999999999876554 8999999999999999999999999999999999999988 6899999999875432
Q ss_pred c-cccccccCccceeccccccc--ccccccccccccCC----------------------------CCC-C---CCCCCh
Q 021127 179 T-EMMTAETGTYRWMAPELYST--VTLRQGEKKHYNHK----------------------------NVR-P---SAENVP 223 (317)
Q Consensus 179 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~~~~~----------------------------~~~-~---~~~~~~ 223 (317)
. .......|+..|+|||++.. ........+.|+.+ ... + ....++
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06645 159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWS 238 (267)
T ss_pred cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCC
Confidence 2 12234468999999998642 11111222333211 000 0 012467
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
..+.+++.+||+.+|++||++++++++
T Consensus 239 ~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 239 NSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 789999999999999999999999876
No 196
>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a
Probab=100.00 E-value=6.1e-36 Score=265.04 Aligned_cols=220 Identities=22% Similarity=0.285 Sum_probs=172.6
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecC-ceEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~~~l 100 (317)
+|.+.+.||+|+||.||+|.++ ++.||||++.+..... ......+..|..++..+. |++|+++++++.+. ..++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ--DDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence 4678899999999999999885 7899999987643211 123445778888888885 57788899888754 7999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
||||+++|+|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++.....
T Consensus 79 v~Ey~~~g~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~-~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE-GHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEeccccccccCCCC
Confidence 9999999999999976544 9999999999999999999999999999999999999988 78999999998753222
Q ss_pred cccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
.......||+.|+|||++.+.... ...++|+.+ .....+..++.++.+++.+
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 234 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG 234 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHH
Confidence 222345689999999998764432 334444433 1112245678899999999
Q ss_pred hhhcCCCCCCCH-----HHHHHH
Q 021127 233 CWKEDPNARPNF-----TQIIQM 250 (317)
Q Consensus 233 cl~~~p~~Rps~-----~~~~~~ 250 (317)
||+.+|.+|++. .++.+|
T Consensus 235 ~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 235 LMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred HcccCHhhCCCCCCCCHHHHhcC
Confidence 999999999975 455554
No 197
>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.
Probab=100.00 E-value=1.1e-35 Score=256.18 Aligned_cols=227 Identities=25% Similarity=0.420 Sum_probs=179.5
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|++|.||++.+. ++.+|||.+......+ .....++.+|+.+++.++|+||+++++++.++ ..++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD--AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhh--HHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence 47889999999999999999864 8899999887644322 23456788999999999999999999988654 8899
Q ss_pred EEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 101 VTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
+|||+++++|.+++... ....+++..++.++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEECcchhhhcccc
Confidence 99999999999998742 22348999999999999999999999999999999999999988 7899999999875432
Q ss_pred cc-ccccccCccceecccccccccccccccccccCC------------------------------CCC-CCCCCChHHH
Q 021127 179 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVR-PSAENVPEEL 226 (317)
Q Consensus 179 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~-~~~~~~~~~l 226 (317)
.. ......++..|+|||.+.+..... ..+.|+.+ ... .....++..+
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNF-KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccc-hhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHH
Confidence 22 223346889999999875532221 11222111 001 1123577899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
.+++.+||+.||.+|||+.+|++.+.++
T Consensus 238 ~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 238 RQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred HHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 9999999999999999999999998765
No 198
>PRK13184 pknD serine/threonine-protein kinase; Reviewed
Probab=100.00 E-value=1.3e-35 Score=285.18 Aligned_cols=230 Identities=24% Similarity=0.322 Sum_probs=178.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.++||+|+||.||+|.+. ++.||||++....... .....++.+|++++++++||||+++++++.++ ..++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~--e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSEN--PLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccC--HHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence 68999999999999999999885 7899999987644322 23456799999999999999999999998765 8899
Q ss_pred EEEccCCCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 101 VTELLSGGTLRKYLLNMR---------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
||||++|++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~d-g~vKLiDFG 158 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLF-GEVVILDWG 158 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCC-CCEEEEecC
Confidence 999999999999986421 1235677889999999999999999999999999999999988 789999999
Q ss_pred cccccccc-------------------cccccccCccceecccccccccccccccccccCC-------------------
Q 021127 172 LAREESLT-------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------- 213 (317)
Q Consensus 172 ~a~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------- 213 (317)
+++..... ......+||+.|+|||++.+..... ..++|+.+
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~-kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASE-STDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCc-HhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 99754110 0011246899999999876543321 22222211
Q ss_pred -------C----CCCCCCCChHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHhhhc
Q 021127 214 -------N----VRPSAENVPEELSIILTSCWKEDPNARP-NFTQIIQMLLNYLSA 257 (317)
Q Consensus 214 -------~----~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~~~~~~l~~~~~~ 257 (317)
. .......+|..+.+++.+||+.||++|| +++++++.|..++..
T Consensus 238 ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 238 KISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 0001235778899999999999999996 567777888877654
No 199
>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is
Probab=100.00 E-value=6.4e-36 Score=267.13 Aligned_cols=219 Identities=23% Similarity=0.287 Sum_probs=172.6
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-----
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE----- 95 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 95 (317)
+++|++.+.||+|+||.||+|.+. ++.||||.+....... .....+.+|+.++++++|+||+++++++..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL---IHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh---HHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 578999999999999999999875 7889999987543221 234457789999999999999999988742
Q ss_pred --CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 96 --PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 96 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
...+++++++ +++|.+++... .+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~-~~~kl~Dfg~~ 165 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED-CELRILDFGLA 165 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCC-CCEEEcCCccc
Confidence 2478999988 88998877642 39999999999999999999999999999999999999988 78999999999
Q ss_pred cccccccccccccCccceecccccccccccccccccccCC--------CCCCC---------------------------
Q 021127 174 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVRPS--------------------------- 218 (317)
Q Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~~~--------------------------- 218 (317)
+..... .....||+.|+|||++.+........++|+.+ ...+.
T Consensus 166 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 166 RQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred eecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 865432 23457899999999986533333333444322 00000
Q ss_pred -----------------------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 219 -----------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 219 -----------------------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
....++.+.+|+.+||+.||.+|||+.++++|-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp 299 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 012345678999999999999999999999883
No 200
>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops
Probab=100.00 E-value=1.5e-35 Score=253.81 Aligned_cols=223 Identities=26% Similarity=0.454 Sum_probs=179.2
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|+..+.||+|++|.||+|... ++.|++|.+..........+....+.+|+.+++.++|+||+++++++.+. ..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999885 78999999876553322234456788999999999999999999998765 79999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
+||+++++|.+++..... +++..++.++.|++.||+|||+.|++|+||+|+||+++.+ +.+||+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~-~~~kl~d~~~~~~~~~~~~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGS--FPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFSF 157 (258)
T ss_pred EEecCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEccCccceecccccc
Confidence 999999999999986543 8999999999999999999999999999999999999988 6899999999876544333
Q ss_pred cccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHHHHHHH
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
.....++..|+|||.+..........+.|+.+ .....+..++..+.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 34556889999999875533112222222211 1112245678899999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 021127 233 CWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 233 cl~~~p~~Rps~~~~~~~ 250 (317)
||+.+|.+||++.+++.+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 238 CLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HhhcCcccCcCHHHHhcC
Confidence 999999999999999875
No 201
>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase. Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M
Probab=100.00 E-value=1.3e-35 Score=258.77 Aligned_cols=226 Identities=28% Similarity=0.493 Sum_probs=177.5
Q ss_pred ecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
++.++|++.+.||+|+||.||++.+. +..||+|++...... .....+.+|+.++++++||||+++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~ei~~l~~l~h~~iv~~~~~~ 77 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA----DMQADFQREAALMAEFDHPNIVKLLGVC 77 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH----HHHHHHHHHHHHHHhcCCCchheEEEEE
Confidence 45678999999999999999999863 578999998765432 2345688999999999999999999998
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRP--------------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLK 152 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlk 152 (317)
.++ ..++||||+++++|.+++..... ..+++..++.++.|++.||+|||+++++|||||
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~ 157 (288)
T cd05050 78 AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA 157 (288)
T ss_pred cCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 765 78999999999999999975321 237888999999999999999999999999999
Q ss_pred CCcEEeeCCCCceEEcccCcccccccccc---cccccCccceecccccccccccccccccccCC----------------
Q 021127 153 PENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------- 213 (317)
Q Consensus 153 p~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------- 213 (317)
|+||+++.+ +.++|+|||++........ .....++..|+|||.+.+..... ..++|+.+
T Consensus 158 p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 158 TRNCLVGEN-MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTT-ESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred HhheEecCC-CceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCc-hhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999988 7899999999875432211 12223466799999865432211 11222111
Q ss_pred -------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 -------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 -------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
...+.+..++.++.+|+.+||+.+|.+|||+.|+++.|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 236 MAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 112234567899999999999999999999999998875
No 202
>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea
Probab=100.00 E-value=3.9e-35 Score=254.57 Aligned_cols=230 Identities=24% Similarity=0.464 Sum_probs=182.2
Q ss_pred eecCCceeecceeccccceEEEEeEEC--C----eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--N----QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~----~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
++...+|++.+.||+|+||.||+|.+. + ..+|+|.+...... .....+.+|+.++++++|+||+++++++
T Consensus 3 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 78 (279)
T cd05057 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP----KANKEILDEAYVMASVDHPHVVRLLGIC 78 (279)
T ss_pred ccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCH----HHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 356688999999999999999999864 2 36899988766542 3345688999999999999999999999
Q ss_pred ecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 94 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
.....++||||+++|+|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++
T Consensus 79 ~~~~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~-~~~kL~dfg~~ 156 (279)
T cd05057 79 LSSQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTP-QHVKITDFGLA 156 (279)
T ss_pred ecCceEEEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCC-CeEEECCCccc
Confidence 88889999999999999999987543 38999999999999999999999999999999999999987 68999999999
Q ss_pred ccccccccc---ccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCC
Q 021127 174 REESLTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAEN 221 (317)
Q Consensus 174 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~ 221 (317)
+........ ....++..|+|||.+....... ..+.|+.+ ...+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (279)
T cd05057 157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH-KSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPI 235 (279)
T ss_pred ccccCcccceecCCCcccccccCHHHhhcCCcCc-hhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCC
Confidence 854322211 1122356899999765422111 11111111 11233445
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
.+..+.+++.+||..+|.+||++.++++.|..+.+
T Consensus 236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 236 CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 67889999999999999999999999999998865
No 203
>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2
Probab=100.00 E-value=1e-35 Score=258.77 Aligned_cols=221 Identities=29% Similarity=0.405 Sum_probs=172.3
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.+.||+|++|.||+|++. ++.||||.+....... .....+.+|+.++++++||||+++++++.++ ..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE---GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLI 77 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC---CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEE
Confidence 5889999999999999999885 7899999987543221 1234577899999999999999999998754 89999
Q ss_pred EEccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 102 TELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
|||++ ++|.+++..... ..+++..++.++.|++.||+|||++|++|+||+|+||+++.+ +.+||+|||++......
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIPV 155 (285)
T ss_pred EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCC-CcEEECcccceeecCCCc
Confidence 99996 689988875432 458999999999999999999999999999999999999988 78999999998754322
Q ss_pred cccccccCccceecccccccccccccccccccCC--------C-------------------------------------
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N------------------------------------- 214 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~------------------------------------- 214 (317)
.......+++.|+|||++.+........+.|+.+ .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 1223345788999999875432222222222211 0
Q ss_pred -----------CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 215 -----------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 215 -----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.......++.++.++|.+||+.||.+|||+.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000123467889999999999999999999999876
No 204
>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok
Probab=100.00 E-value=5.1e-36 Score=269.02 Aligned_cols=220 Identities=25% Similarity=0.317 Sum_probs=172.1
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec----
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---- 95 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---- 95 (317)
..++|++.+.||+|+||.||++.+. ++.||||.+....... ....++.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ---THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccCh---HHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 4578999999999999999999875 8899999987654332 234567889999999999999999998743
Q ss_pred ---CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 96 ---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 96 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
...++||||++ ++|.+.+.. .+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+
T Consensus 92 ~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~-~~~kl~Dfg~ 165 (355)
T cd07874 92 EEFQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGL 165 (355)
T ss_pred cccceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCC-CCEEEeeCcc
Confidence 24799999995 577777653 28899999999999999999999999999999999999988 7999999999
Q ss_pred ccccccccccccccCccceecccccccccccccccccccCCC--------------------------------------
Q 021127 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKN-------------------------------------- 214 (317)
Q Consensus 173 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~-------------------------------------- 214 (317)
++............||..|+|||++.+..+.. ..+.|+.+.
T Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred cccCCCccccCCccccCCccCHHHHcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 98655444445567899999999876533221 111111110
Q ss_pred -------------------------------CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 215 -------------------------------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 215 -------------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
........+..+++||.+||+.||++|||+.+++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 0000112356789999999999999999999999883
No 205
>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory
Probab=100.00 E-value=1.9e-35 Score=256.74 Aligned_cols=225 Identities=27% Similarity=0.472 Sum_probs=176.8
Q ss_pred ecCCceeecceeccccceEEEEeEE-------CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKY-------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
|+..+|.+.++||+|+||.||++.. ++..+|+|.+..... .....+.+|+++++.++|+||+++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-----SARQDFQREAELLTVLQHQHIVRFYGVC 76 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH-----HHHHHHHHHHHHHhcCCCCCCceEEEEE
Confidence 4567899999999999999999864 256789998765432 2345689999999999999999999998
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRP-------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 159 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~ 159 (317)
.++ ..+++|||+++++|.+++..... ..+++..++.++.|++.||+|||++|++||||||+||+++
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 77 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG 156 (280)
T ss_pred ecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc
Confidence 765 78999999999999999976432 2488999999999999999999999999999999999999
Q ss_pred CCCCceEEcccCcccccccccc---cccccCccceecccccccccccccccccccCC-----------------------
Q 021127 160 EDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------- 213 (317)
Q Consensus 160 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------- 213 (317)
.+ +.+||+|||++........ .....+++.|+|||.+.+...... .+.|+.+
T Consensus 157 ~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~ 234 (280)
T cd05092 157 QG-LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234 (280)
T ss_pred CC-CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCccCCHHHHH
Confidence 87 6899999999874432211 122235678999998765332211 1111111
Q ss_pred ------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 ------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 ------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.....+..++..+.+|+.+||+.||.+||++.++++.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 ECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 112224567899999999999999999999999998875
No 206
>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi
Probab=100.00 E-value=1.7e-35 Score=258.39 Aligned_cols=219 Identities=25% Similarity=0.318 Sum_probs=178.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|++|.||++.+. ++.||+|++....... .+....+.+|++++++++||||+++++++.++ ..++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVK--LKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE
Confidence 47999999999999999999885 7899999987543222 23456788999999999999999999998765 7999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++++|.+++..... +++..+..++.|++.||+|||++|++|+||+|+||+++.+ +.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 79 VMEYVPGGELFSHLRKSGR--FPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSD-GYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC-CCEEEeeCCCccccCCC-
Confidence 9999999999999987543 8999999999999999999999999999999999999988 78999999999865433
Q ss_pred ccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHh
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSC 233 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~c 233 (317)
.....+++.|+|||.+.+.... ...+.|+.+ .....+..++..+++++.+|
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 232 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYG-KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNL 232 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHH
Confidence 3345688999999987654322 122222221 11223456788999999999
Q ss_pred hhcCCCCCC-----CHHHHHHH
Q 021127 234 WKEDPNARP-----NFTQIIQM 250 (317)
Q Consensus 234 l~~~p~~Rp-----s~~~~~~~ 250 (317)
|..||.+|+ ++++++++
T Consensus 233 l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 233 LQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ccCCHHHccCcccCCHHHHHcC
Confidence 999999998 88888876
No 207
>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu
Probab=100.00 E-value=4.3e-35 Score=253.14 Aligned_cols=224 Identities=30% Similarity=0.507 Sum_probs=175.0
Q ss_pred eeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC----
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP---- 96 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 96 (317)
|++.+.||+|+||.||+|... +..||||.+....... .....+.+|+..++.++|+||+++++++.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 77 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY---SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ 77 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCH---HHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence 568899999999999999864 3679999987644332 2345688999999999999999999987432
Q ss_pred ---ceEEEEEccCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcc
Q 021127 97 ---VMVIVTELLSGGTLRKYLLNMR----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (317)
Q Consensus 97 ---~~~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~D 169 (317)
..++||||+++++|..++.... ...+++..++.++.|++.||+|||+++++||||||+||+++++ +.+||+|
T Consensus 78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~d 156 (273)
T cd05035 78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRED-MTVCVAD 156 (273)
T ss_pred cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCC-CeEEECC
Confidence 3789999999999999986432 2358999999999999999999999999999999999999988 6899999
Q ss_pred cCcccccccccc---cccccCccceecccccccccccccccccccCC-----------------------------CCCC
Q 021127 170 FGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRP 217 (317)
Q Consensus 170 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~ 217 (317)
||+++....... .....++..|+|||.+.+..... ..++|+.+ ....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~-~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTS-KSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK 235 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCc-ccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999985432211 11223467899999875433222 22222211 1122
Q ss_pred CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 218 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 218 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
.+..++.++.+++.+||+.||.+||++.++++.|.++
T Consensus 236 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 236 QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 3456788999999999999999999999999998875
No 208
>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom
Probab=100.00 E-value=2.2e-35 Score=253.94 Aligned_cols=212 Identities=22% Similarity=0.377 Sum_probs=163.6
Q ss_pred ceeccccceEEEEeEEC--------------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 30 PRIGEGAHAKVYEGKYK--------------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--------------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
+.||+|+||.||+|+.. ...|++|++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-----~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR-----DISLAFFETASMMRQVSHKHIVLLYGVCVR 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh-----hHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 46899999999999752 23588998765322 234468889999999999999999999876
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCc-------eEE
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT-------IKL 167 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~-------~kl 167 (317)
+ ..++||||+++++|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +. +++
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~~~~~~~~~l 153 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLARE-GIDGECGPFIKL 153 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecC-CccCCCCceeEe
Confidence 5 7899999999999999887543 338999999999999999999999999999999999999865 33 899
Q ss_pred cccCcccccccccccccccCccceecccccccccccccccccccCC---------C------------------CCCCCC
Q 021127 168 ADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------N------------------VRPSAE 220 (317)
Q Consensus 168 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------~------------------~~~~~~ 220 (317)
+|||++...... ....++..|+|||.+..........++|+.+ . ......
T Consensus 154 ~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 230 (262)
T cd05077 154 SDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVT 230 (262)
T ss_pred CCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCccCCC
Confidence 999998654322 2345788999999876432222223333322 0 001122
Q ss_pred CChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 221 NVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 221 ~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
..+.++.+||.+||+.||.+||++.+|++.+
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 3467899999999999999999999998875
No 209
>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=1.3e-35 Score=267.20 Aligned_cols=220 Identities=26% Similarity=0.328 Sum_probs=172.1
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec----
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---- 95 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---- 95 (317)
..++|++.+.||+|+||.||++.+. ++.||||++....... ....++.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ---THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCc---hhHHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence 3578999999999999999999875 7889999987643322 224467889999999999999999998742
Q ss_pred ---CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 96 ---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 96 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
...++||||++ ++|.+.+.. .+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+
T Consensus 99 ~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~ 172 (364)
T cd07875 99 EEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGL 172 (364)
T ss_pred cccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCC-CcEEEEeCCC
Confidence 25799999995 578777753 28899999999999999999999999999999999999988 7999999999
Q ss_pred ccccccccccccccCccceecccccccccccccccccccCC--------CC-----------------------------
Q 021127 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV----------------------------- 215 (317)
Q Consensus 173 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~----------------------------- 215 (317)
++............||..|+|||++.+..+.. ..+.|+.+ ..
T Consensus 173 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 173 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred ccccCCCCcccCCcccCCcCCHHHHhCCCCCc-hhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 98655444445567899999999876533222 12222211 00
Q ss_pred -----------CC---------------------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 216 -----------RP---------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 216 -----------~~---------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
.+ .....+..+++||.+||+.||.+|||+.++++|-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 00 0111245789999999999999999999999883
No 210
>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a
Probab=100.00 E-value=4.7e-35 Score=252.11 Aligned_cols=227 Identities=26% Similarity=0.439 Sum_probs=180.4
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||+|... ++.||+|.++...... .....++.+|++++++++|+||+++++++.+. ..++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD--AKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc--hhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 57999999999999999999885 8899999987543322 13355788999999999999999999988654 8899
Q ss_pred EEEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 101 VTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
||||+++++|.+++.... ...+++..++.++.+++.||+|||+.|++||||+|+||+++.+ +.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~-~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITAT-GVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCC-CcEEEeccceeeeccC
Confidence 999999999999987532 2348999999999999999999999999999999999999988 6899999999875433
Q ss_pred cc-ccccccCccceecccccccccccccccccccCC------------------------------CCCCCCC-CChHHH
Q 021127 179 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAE-NVPEEL 226 (317)
Q Consensus 179 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~-~~~~~l 226 (317)
.. ......++..|+|||.+.+..... ..+.|+.+ ...+.+. .++..+
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNF-KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL 237 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCc-hhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHH
Confidence 21 223346888999999875533221 11222111 1111222 567799
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
.+++.+||..+|.+||++.++++.+..+
T Consensus 238 ~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 238 RDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred HHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 9999999999999999999999998765
No 211
>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase. Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ
Probab=100.00 E-value=1.8e-35 Score=255.51 Aligned_cols=221 Identities=26% Similarity=0.419 Sum_probs=175.9
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeec----
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE---- 95 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---- 95 (317)
.+.|++.+.||+|+||.||+|.+. ++.||+|++...... ...+..|+.++.++ +|+||+++++.+..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE------EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc------HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 357899999999999999999875 789999998765422 23577899999998 79999999998853
Q ss_pred ---CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 96 ---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 96 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
...++||||+.+++|.+++.......+++..+..++.|++.||+|||+++|+|+||+|+||+++.+ +.++|+|||+
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~-~~~~l~Dfg~ 157 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGV 157 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCC-CCEEEccCCC
Confidence 358999999999999999987555568999999999999999999999999999999999999988 6899999999
Q ss_pred ccccccc-cccccccCccceeccccccccc----ccccccccccCC-----------------------------CCCCC
Q 021127 173 AREESLT-EMMTAETGTYRWMAPELYSTVT----LRQGEKKHYNHK-----------------------------NVRPS 218 (317)
Q Consensus 173 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~~~~~~-----------------------------~~~~~ 218 (317)
+...... .......|+..|+|||++.... ......+.|+.+ .....
T Consensus 158 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06637 158 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 237 (272)
T ss_pred ceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCC
Confidence 8754322 2223456899999999875321 111223333322 01111
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
...++.++.+|+.+||..+|.+|||+.+++++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 33567899999999999999999999999876
No 212
>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan
Probab=100.00 E-value=2.7e-35 Score=252.46 Aligned_cols=216 Identities=34% Similarity=0.634 Sum_probs=175.0
Q ss_pred ceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEE
Q 021127 30 PRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTE 103 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 103 (317)
+.||+|+||.||+|.+. +..|++|.+....... ....+.+|++.+..++|+||+++++++.+. ..++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE----ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE 76 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh----HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence 46899999999999886 6789999988665432 345688999999999999999999998764 8999999
Q ss_pred ccCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 104 LLSGGTLRKYLLNMR-------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 104 ~~~~g~L~~~l~~~~-------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
|+++++|.+++.... ...+++..++.++.|++.||+|||++|++|+||+|+||+++.+ +.+||+|||.+...
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~-~~~~l~dfg~~~~~ 155 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED-LVVKISDFGLSRDV 155 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCC-CcEEEccccccccc
Confidence 999999999998752 2449999999999999999999999999999999999999998 79999999999865
Q ss_pred cccc---ccccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChH
Q 021127 177 SLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPE 224 (317)
Q Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~ 224 (317)
.... ......++..|+|||.+...... ...+.|+.+ .....+..++.
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPD 234 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccCCcc-hhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCCh
Confidence 4331 22334578899999987653211 111222111 12233566789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
++.+++.+||+.+|.+|||+.+++++|
T Consensus 235 ~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 235 ELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 999999999999999999999999886
No 213
>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase. Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.
Probab=100.00 E-value=3.9e-35 Score=254.96 Aligned_cols=221 Identities=27% Similarity=0.385 Sum_probs=174.8
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
+-|++.+.||+|+||.||++.+. +..+++|.+..... .....+.+|+.+++.++|+||+++++.+... ..++
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~ 79 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE-----EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 79 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH-----HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEE
Confidence 34678899999999999999886 67889998865432 2345688899999999999999999988654 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
||||+++++|..++.... ..+++..+..++.|++.||+|||+.|++||||||+||+++.+ +.+||+|||++......
T Consensus 80 v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 80 LIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTI 157 (282)
T ss_pred EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC-CCEEEccccccccccccc
Confidence 999999999998876532 348999999999999999999999999999999999999988 78999999998754322
Q ss_pred cccccccCccceecccccccc----cccccccccccCC------------------------------CCCCCCCCChHH
Q 021127 180 EMMTAETGTYRWMAPELYSTV----TLRQGEKKHYNHK------------------------------NVRPSAENVPEE 225 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~ 225 (317)
.......++..|+|||++... .......++|+.+ .....+..++.+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSE 237 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHH
Confidence 222345688999999987421 1111223333322 011224457889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
+.++|.+||+.||.+||++.+++++.
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 238 FKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCC
Confidence 99999999999999999999998874
No 214
>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl. Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor
Probab=100.00 E-value=2.9e-35 Score=254.24 Aligned_cols=224 Identities=27% Similarity=0.477 Sum_probs=172.1
Q ss_pred eeecceeccccceEEEEeEEC--C--eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec------
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK--N--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE------ 95 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~--~--~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------ 95 (317)
|.+.++||+|+||.||+|.+. + ..||+|.+....... .....+.+|+.+++.++|+||+++++.+.+
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTR---SEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence 357789999999999999875 2 368999887654322 234568899999999999999999997632
Q ss_pred -CceEEEEEccCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEccc
Q 021127 96 -PVMVIVTELLSGGTLRKYLLNM----RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (317)
Q Consensus 96 -~~~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Df 170 (317)
...+++|||+++|+|.+++... ....+++..+..++.|++.||+|||+++|+||||||+||+++.+ +.+||+||
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Df 156 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNEN-MNVCVADF 156 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCC-CCEEECCC
Confidence 2468999999999999988532 22348999999999999999999999999999999999999988 68999999
Q ss_pred Ccccccccccc---cccccCccceecccccccccccccccccccC-----------------------------CCCCCC
Q 021127 171 GLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNH-----------------------------KNVRPS 218 (317)
Q Consensus 171 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-----------------------------~~~~~~ 218 (317)
|+++....... .....+++.|+|||.+....... ..++|+. ....+.
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~-~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTT-KSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ 235 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcCh-HHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99986433221 12224567899999876432211 1111110 011233
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 236 PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 456788999999999999999999999999998764
No 215
>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase. Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well
Probab=100.00 E-value=2.9e-35 Score=255.18 Aligned_cols=227 Identities=29% Similarity=0.514 Sum_probs=175.5
Q ss_pred ecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
+..++|++.+.||+|++|.||+|.+. +..||+|.+...... .....+.+|+.++++++|+||+++++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE----QDESDFLMEALIMSKFNHQNIVRLIGVS 78 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34578999999999999999999884 367899987654432 2244688999999999999999999987
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCC--Cce
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRP-----RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTI 165 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~--~~~ 165 (317)
.+. ..++||||+++++|.+++...+. ..+++..++.++.||+.||+|||+++++||||||+||+++.+. ..+
T Consensus 79 ~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 79 FERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred ccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcce
Confidence 654 78999999999999999976542 2489999999999999999999999999999999999998641 258
Q ss_pred EEcccCcccccccccc---cccccCccceecccccccccccccccccccCC-----------------------------
Q 021127 166 KLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------- 213 (317)
Q Consensus 166 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------- 213 (317)
||+|||+++....... ......+..|+|||++.+..... ..++|+.+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 237 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTS-KTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCc-hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999985432211 11223356899999875432211 11111110
Q ss_pred CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.....+..++..+.+++.+||+.+|++||++.+++++|.
T Consensus 238 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111224567889999999999999999999999999875
No 216
>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]
Probab=100.00 E-value=5.6e-37 Score=252.47 Aligned_cols=239 Identities=24% Similarity=0.351 Sum_probs=190.1
Q ss_pred Cceeec-ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeec----
Q 021127 24 KHLFVG-PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE---- 95 (317)
Q Consensus 24 ~~y~~~-~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---- 95 (317)
++|.+. ++||-|-.|.|-.+.++ ++.+|+|++.... +..+|++++-.. .|+|||.+++++.+
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----------KARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH----------HHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 345543 57999999999988775 8999999986432 356789988766 79999999999853
Q ss_pred -CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC--CCceEEcccCc
Q 021127 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGL 172 (317)
Q Consensus 96 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~ 172 (317)
..+.+|||.++||.|...+++++...+++.++-+|+.||+.|+.|||+.+|.||||||+|+|.... ...+||+|||+
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence 368899999999999999999998899999999999999999999999999999999999999742 24789999999
Q ss_pred ccccccccccccccCccceecccccccccccccccc----------------cccCC------------------CCCCC
Q 021127 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK----------------HYNHK------------------NVRPS 218 (317)
Q Consensus 173 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~----------------~~~~~------------------~~~~~ 218 (317)
|+.........+.+.|++|.|||++....++...+. +|+.. ...+.
T Consensus 211 AK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pE 290 (400)
T KOG0604|consen 211 AKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPE 290 (400)
T ss_pred ccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChh
Confidence 998765566677789999999999876543332221 11111 11222
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCCCCCCCCCccccC
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNS 272 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 272 (317)
...+++..+++|+.+|..+|.+|.|+.+++++-|-......|..++...+....
T Consensus 291 Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t~~~l~~ 344 (400)
T KOG0604|consen 291 WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLSTSRMLKE 344 (400)
T ss_pred HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchhhhhcch
Confidence 456789999999999999999999999999997766666666666555554443
No 217
>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit
Probab=100.00 E-value=4.7e-35 Score=256.27 Aligned_cols=226 Identities=26% Similarity=0.463 Sum_probs=175.1
Q ss_pred ecCCceeecceeccccceEEEEeEEC------------------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK------------------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ 82 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~------------------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 82 (317)
++.++|++.++||+|+||.||++.+. ...||+|++...... .....+.+|+.+++.++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~----~~~~~~~~E~~~l~~l~ 77 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK----NARNDFLKEIKIMSRLK 77 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCH----HHHHHHHHHHHHHHhCC
Confidence 34578999999999999999998542 346899998755332 23457889999999999
Q ss_pred CCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 021127 83 HRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP---------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLK 152 (317)
Q Consensus 83 h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~---------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlk 152 (317)
|+||+++++++... ..++||||+++++|.+++..... ..+++..++.++.|++.||+|||++|++|+|||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlk 157 (296)
T cd05095 78 DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA 157 (296)
T ss_pred CCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence 99999999998754 78999999999999999976432 237788999999999999999999999999999
Q ss_pred CCcEEeeCCCCceEEcccCcccccccccc---cccccCccceecccccccccccccccccccCC----------------
Q 021127 153 PENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------- 213 (317)
Q Consensus 153 p~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------- 213 (317)
|+||+++.+ +.++|+|||+++....... .....++..|+|||+..+..+. ...++|+.+
T Consensus 158 p~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 158 TRNCLVGKN-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFT-TASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred hheEEEcCC-CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCcc-chhhhhHHHHHHHHHHHhCCCCCcc
Confidence 999999987 6899999999875432211 1122346789999975443221 112222211
Q ss_pred ---------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 ---------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 ---------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
...+.+..++..+.+|+.+||+.||.+||++.++++.|.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 236 QLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 112234567789999999999999999999999998875
No 218
>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio
Probab=100.00 E-value=2.5e-35 Score=256.40 Aligned_cols=221 Identities=27% Similarity=0.343 Sum_probs=173.2
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|++|.||+|.+. ++.||+|++....... ...+.+.+|+.++++++|+||+++++++.++ ..++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 77 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP---VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL 77 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc---cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence 47999999999999999999885 7899999987543221 1233578899999999999999999998765 7899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||++++.|..++.... .+++..++.++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 78 VFEYCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPG 154 (286)
T ss_pred EEeccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCC-CcEEECccccceecCCCc
Confidence 999999988888776543 38999999999999999999999999999999999999988 789999999998654332
Q ss_pred -ccccccCccceecccccccccccccccccccCC--------CC------------------------------------
Q 021127 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------------------------------ 215 (317)
Q Consensus 181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------------------------------ 215 (317)
......++..|+|||++.+........++|+.+ ..
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 223345788999999875422212222222211 00
Q ss_pred ----CCC----------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 ----RPS----------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 ----~~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+. ...++..+.+|+.+||+.+|++||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000 12457889999999999999999999999876
No 219
>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4. Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.
Probab=100.00 E-value=4.7e-35 Score=252.09 Aligned_cols=222 Identities=27% Similarity=0.470 Sum_probs=176.9
Q ss_pred ceeecceeccccceEEEEeEEC-CeEEEEEEeecCCCh-HHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETP-EEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.+.||+|+||.||+|... ++.+|+|.+...... ....+....+.+|++++++++|+||+++++++.+. ..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4788999999999999999874 788999998754332 22234456789999999999999999999998765 88999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc---
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL--- 178 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~--- 178 (317)
+||+++++|.+++..... +++..+..++.|++.||+|||+.+++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGP--LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCC-CeEEeccchhhHhhhhccc
Confidence 999999999999976543 8999999999999999999999999999999999999988 7899999999875321
Q ss_pred ----ccccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChH
Q 021127 179 ----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPE 224 (317)
Q Consensus 179 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~ 224 (317)
........|+..|+|||++.+..... ..+.|..+ .....+..++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~-~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGR-KSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcc-hhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCH
Confidence 11122346889999999876533221 11111111 11223556789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
++.+++.+||+.+|.+||++.+++++
T Consensus 237 ~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 237 AAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 99999999999999999999999875
No 220
>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored
Probab=100.00 E-value=4.9e-35 Score=252.36 Aligned_cols=227 Identities=27% Similarity=0.483 Sum_probs=178.0
Q ss_pred ecCCceeecceeccccceEEEEeEEC--C---eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--N---QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~---~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
|.+.+|+..+.||+|+||.||+|... + ..+|+|.+...... .....+..|++++++++|+||+++++++.+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE----KQRQDFLSEASIMGQFSHHNIIRLEGVVTK 77 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH----HHHHHHHHHHHHHhcCCCCCeeEEEEEEcc
Confidence 55678999999999999999999874 2 37999998765432 234568899999999999999999999875
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
. ..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.+||+|||++.
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~-~~~kl~dfg~~~ 155 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSN-LECKVSDFGLSR 155 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCC-CcEEECCCccce
Confidence 4 7899999999999999997643 348999999999999999999999999999999999999988 689999999987
Q ss_pred cccccccc----ccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCC
Q 021127 175 EESLTEMM----TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAEN 221 (317)
Q Consensus 175 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~ 221 (317)
........ .....+..|+|||++....... ..++|+.+ ...+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 234 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTS-ASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMD 234 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcCCcCh-HhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCC
Confidence 54322111 1112345799999875432211 11111110 12233456
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
++..+.+++.+||+.+|.+||++.++++.|.++
T Consensus 235 ~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 235 CPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 788999999999999999999999999998765
No 221
>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt
Probab=100.00 E-value=2.3e-35 Score=255.45 Aligned_cols=212 Identities=22% Similarity=0.395 Sum_probs=161.4
Q ss_pred eeccccceEEEEeEEC--------------------------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCC
Q 021127 31 RIGEGAHAKVYEGKYK--------------------------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR 84 (317)
Q Consensus 31 ~lG~G~~g~V~~~~~~--------------------------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 84 (317)
+||+|+||.||+|... ...||+|++..... .....+.+|+.+++.++||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-----~~~~~~~~~~~~~~~l~h~ 76 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-----DIALAFFETASLMSQVSHI 76 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-----HHHHHHHHHHHHHhcCCCC
Confidence 6999999999998641 23588998864321 2345688899999999999
Q ss_pred CeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCC-
Q 021127 85 NLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL- 162 (317)
Q Consensus 85 niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~- 162 (317)
||+++++++.++ ..++||||+++|+|..++.... ..+++..+..++.|++.||+|||++||+||||||+||+++...
T Consensus 77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCc
Confidence 999999998755 7899999999999999987533 3489999999999999999999999999999999999997541
Q ss_pred -----CceEEcccCcccccccccccccccCccceecccccccccccccccccccCC------------------------
Q 021127 163 -----KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------ 213 (317)
Q Consensus 163 -----~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------ 213 (317)
..+|++|||++...... ....++..|+|||.+.+........+.|+.+
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 24899999988643211 2235778899999876432112222222111
Q ss_pred ---CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 214 ---NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 214 ---~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
.....+...+..+.++|.+||+.+|++||++.++++.|
T Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 233 FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 00112333456899999999999999999999999875
No 222
>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4. Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s
Probab=100.00 E-value=3.8e-35 Score=253.98 Aligned_cols=226 Identities=24% Similarity=0.472 Sum_probs=178.2
Q ss_pred ecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
|..++|++.+.||.|+||.||+|+.. .+.|++|.+...... .....+.+|++++++++|+||+++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 77 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE----NLQSEFRRELDMFRKLSHKNVVRLLGLC 77 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch----HHHHHHHHHHHHHHhcCCcceeeeEEEE
Confidence 45588999999999999999999863 467999988654432 2345688999999999999999999998
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCce
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRP-------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~-------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~ 165 (317)
.+. ..++||||+++++|.+++..... ..+++..+..++.|++.||+|||+++++||||||+||+++.+ +.+
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~-~~~ 156 (275)
T cd05046 78 REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQ-REV 156 (275)
T ss_pred CCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCC-CcE
Confidence 764 78999999999999999986551 148999999999999999999999999999999999999988 689
Q ss_pred EEcccCccccccccc--ccccccCccceecccccccccccccccccccCC------------------------------
Q 021127 166 KLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------ 213 (317)
Q Consensus 166 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------ 213 (317)
+|+|||++....... ......++..|+|||.+.+..... ..++|+.+
T Consensus 157 ~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~ 235 (275)
T cd05046 157 KVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFST-KSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK 235 (275)
T ss_pred EEcccccccccCcccccccCCceeEEeecChhhhccCCCCc-hhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC
Confidence 999999987432221 122335677899999865432211 11111111
Q ss_pred CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
...+.+..++..+.+++.+||+.+|.+||++.++++.|.
T Consensus 236 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 236 LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 012234567899999999999999999999999998875
No 223
>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=3.4e-36 Score=271.83 Aligned_cols=231 Identities=28% Similarity=0.478 Sum_probs=193.9
Q ss_pred ecCCceeecCCceeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 021127 14 KLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88 (317)
Q Consensus 14 ~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 88 (317)
..+....|..+++.+.++||+|+||.|++|.|+ ...||||+++...... ...+|++|+..+.+|+|+|+++
T Consensus 100 ~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~----~mddflrEas~M~~L~H~hliR 175 (1039)
T KOG0199|consen 100 SIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA----IMDDFLREASHMLKLQHPHLIR 175 (1039)
T ss_pred CCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch----hHHHHHHHHHHHHhccCcceeE
Confidence 455678899999999999999999999999997 2569999998765432 3457999999999999999999
Q ss_pred EEeeeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEc
Q 021127 89 FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (317)
Q Consensus 89 l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~ 168 (317)
|||+..+....+|||+++.|+|.+.|++.....|-......|+.||+.||.||.++++|||||...|+++-.. ..+||+
T Consensus 176 LyGvVl~qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasp-rtVKI~ 254 (1039)
T KOG0199|consen 176 LYGVVLDQPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASP-RTVKIC 254 (1039)
T ss_pred EeeeeccchhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheeccc-ceeeee
Confidence 9999998889999999999999999998666668899999999999999999999999999999999999886 689999
Q ss_pred ccCcccccccccccccc----cCccceecccccccccccccccccc----------------------------cCCCCC
Q 021127 169 DFGLAREESLTEMMTAE----TGTYRWMAPELYSTVTLRQGEKKHY----------------------------NHKNVR 216 (317)
Q Consensus 169 Dfg~a~~~~~~~~~~~~----~gt~~y~aPE~~~~~~~~~~~~~~~----------------------------~~~~~~ 216 (317)
|||+.+.....+..... .-...|+|||.+....+....+.|. +.+...
T Consensus 255 DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erL 334 (1039)
T KOG0199|consen 255 DFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERL 334 (1039)
T ss_pred cccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccC
Confidence 99999966544333222 2356899999987755544433221 112445
Q ss_pred CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 021127 217 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 249 (317)
Q Consensus 217 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~ 249 (317)
+.++.+++.+++++..||..+|.+|||+..|.+
T Consensus 335 pRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred CCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 668899999999999999999999999999974
No 224
>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti
Probab=100.00 E-value=2e-35 Score=256.51 Aligned_cols=221 Identities=29% Similarity=0.426 Sum_probs=177.2
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
.++|++.+.||.|++|.||++.+. +..||+|++..... .....+.+|+.++++++|+||+++++.+.++ ..+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE-----EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH-----HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEE
Confidence 367999999999999999999885 78999999875432 2345688999999999999999999998755 889
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~-~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 79 ILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLD-GDVKLADFGVSAKNKST 156 (280)
T ss_pred EEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCC-CCEEEccCccchhhccc
Confidence 9999999999999987643 249999999999999999999999999999999999999988 79999999998644322
Q ss_pred -cccccccCccceecccccccccc----cccccccccCC---------------------------C---CCCCCCCChH
Q 021127 180 -EMMTAETGTYRWMAPELYSTVTL----RQGEKKHYNHK---------------------------N---VRPSAENVPE 224 (317)
Q Consensus 180 -~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~~~---------------------------~---~~~~~~~~~~ 224 (317)
.......+++.|+|||++..... .....+.|+.+ . ....+..++.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSS 236 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCH
Confidence 12233468899999998753211 11122333221 0 1112346788
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
++.+++.+||+.+|.+||++.+++++
T Consensus 237 ~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 237 SFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhcC
Confidence 99999999999999999999999987
No 225
>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti
Probab=100.00 E-value=5.4e-35 Score=250.32 Aligned_cols=221 Identities=27% Similarity=0.416 Sum_probs=178.8
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.++||+|+||.||++... ++.||+|.+....... .....+.+|+.++++++|+||+++++++.+. ..++|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP---KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV 77 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh---HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEE
Confidence 5889999999999999999874 7899999987543322 2234688999999999999999999998765 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
|||+.+++|.+++.......+++..++.++.|++.||+|||++|++|+||+|+||+++.+ +.++|+|||++........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~-~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEEeeccceeecCcchh
Confidence 999999999999987554458999999999999999999999999999999999999988 6899999999975433221
Q ss_pred -cccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHHHH
Q 021127 182 -MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 182 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
.....|++.|+|||++.+..... ..+.|+.+ ...+.+..++.++.+++.+
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~-~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNN-KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQ 235 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCC-ccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHH
Confidence 22345788999999876543322 22333221 1122355678899999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 021127 233 CWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 233 cl~~~p~~Rps~~~~~~~ 250 (317)
||+.+|.+||++.+++++
T Consensus 236 ~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 236 LFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HhhCChhhCcCHHHHhhC
Confidence 999999999999999886
No 226
>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5. Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p
Probab=100.00 E-value=3.9e-35 Score=254.62 Aligned_cols=216 Identities=23% Similarity=0.377 Sum_probs=171.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||+|.+. ++.||+|++...... .....+.+|++++.+++||||+++++.+... ..++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITV----ELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISI 76 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCCh----HHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEE
Confidence 46888999999999999999874 788999998765432 2345688999999999999999999988654 7899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++++|..+. .+++..+..++.|++.||+|||+.||+|+||||+||+++.+ +.++|+|||++......
T Consensus 77 v~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~-~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 77 CTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred EEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCC-CCEEEeeCCcceecccc-
Confidence 99999999997542 27889999999999999999999999999999999999998 79999999999754322
Q ss_pred ccccccCccceecccccccccccccccccccCC------------------------------------CCCCCCCCChH
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------------NVRPSAENVPE 224 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~ 224 (317)
......|+..|+|||++.+..... ..+.|+.+ .........+.
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGI-HSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSE 227 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCC-cchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCH
Confidence 233457899999999876533221 12222111 00001234678
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
++.+++.+||+.+|++||++++++++.+
T Consensus 228 ~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 228 KFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred HHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 8999999999999999999999998743
No 227
>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development
Probab=100.00 E-value=5.9e-35 Score=251.71 Aligned_cols=223 Identities=25% Similarity=0.409 Sum_probs=175.3
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---Cc
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PV 97 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~ 97 (317)
|.+|++.+.||+|+||.||+|.+. +..||+|.+..........+....+.+|+.++++++|+||+++++++.+ ..
T Consensus 1 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 1 PINWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCE
Confidence 467999999999999999999874 7899999987654333333445678899999999999999999998764 36
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++++||+++++|.+++..... +++..++.++.|++.||+|||+++++||||+|+||+++.+ +.+||+|||++....
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~-~~~~l~dfg~~~~~~ 157 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYGA--LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEccCCCccccc
Confidence 8899999999999999986544 8999999999999999999999999999999999999988 689999999987442
Q ss_pred cc----cccccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChH
Q 021127 178 LT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPE 224 (317)
Q Consensus 178 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~ 224 (317)
.. .......++..|+|||.+.+.... ...+.|+.+ .....+..++.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYG-RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE 236 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCC-chhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCH
Confidence 21 111234578899999988654322 222333322 01111344577
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+.+++ +||..+|++||+++++++|
T Consensus 237 ~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 237 HARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 788888 6888999999999999876
No 228
>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.2e-36 Score=251.75 Aligned_cols=243 Identities=25% Similarity=0.303 Sum_probs=194.2
Q ss_pred CCCCccccccceecCC------ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHH
Q 021127 2 ESRSRFYLADELKLDA------KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR 73 (317)
Q Consensus 2 ~~~s~~~~~~~~~~~~------~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~ 73 (317)
.+-|..+..+++...+ .-.+--++|.++++||+|.||+|-+++.+ ++.+|||++++...-.. .....-+.
T Consensus 140 ~s~s~d~~~e~m~i~~t~~~~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiak--dEVAHTlT 217 (516)
T KOG0690|consen 140 GSPSDDFGSEEMSIAETEEAKRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAK--DEVAHTLT 217 (516)
T ss_pred CCCCccccceeeeecccccccccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeeh--HHhhhhhh
Confidence 3444444555555542 22344577889999999999999998875 89999999987654331 22345567
Q ss_pred HHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 021127 74 EVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLK 152 (317)
Q Consensus 74 E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlk 152 (317)
|-++|+..+||.+..|-..|+.. .+++||||..||.|.-+|...+. +++.....+...|+.||.|||+++||+||||
T Consensus 218 E~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~--FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlK 295 (516)
T KOG0690|consen 218 ENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERV--FSEDRTRFYGAEIVSALGYLHSRNIVYRDLK 295 (516)
T ss_pred HHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhc--ccchhhhhhhHHHHHHhhhhhhCCeeeeech
Confidence 88999999999999998888755 89999999999999999986444 9999999999999999999999999999999
Q ss_pred CCcEEeeCCCCceEEcccCcccc-cccccccccccCccceecccccccccccccccccccCC------------------
Q 021127 153 PENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------ 213 (317)
Q Consensus 153 p~Nill~~~~~~~kl~Dfg~a~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------ 213 (317)
.+|.|++.+ |.+||+|||+++. ......+.+.||||.|+|||++....+... .+||..+
T Consensus 296 LENLlLDkD-GHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgra-VDWWG~GVVMYEMmCGRLPFyn~dh 373 (516)
T KOG0690|consen 296 LENLLLDKD-GHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRA-VDWWGVGVVMYEMMCGRLPFYNKDH 373 (516)
T ss_pred hhhheeccC-CceEeeecccchhcccccceeccccCChhhcCchhhccccccce-eehhhhhHHHHHHHhccCcccccch
Confidence 999999999 8999999999984 355566788999999999999987665543 3344433
Q ss_pred ---------CCCCCCCCChHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 021127 214 ---------NVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQM 250 (317)
Q Consensus 214 ---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~~~~~ 250 (317)
.....|..++++.+.|+..+|..||.+|. .+.+|.++
T Consensus 374 ~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 374 EKLFELILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred hHHHHHHHhhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 12334778899999999999999999994 35566554
No 229
>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase. Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down
Probab=100.00 E-value=5.5e-35 Score=257.32 Aligned_cols=220 Identities=22% Similarity=0.376 Sum_probs=175.0
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||++.+. +..+|+|.+...... ....++.+|++++++++||||+++++++.++ ..++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKP----AIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI 76 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCH----HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence 46899999999999999999875 788999988754332 2345688999999999999999999998654 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
||||+++++|.+++..... +++..+..++.|++.||.|||+ .+++|+||||+||+++.+ +.+||+|||++......
T Consensus 77 v~ey~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 77 CMEHMDGGSLDQVLKKAGR--IPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS 153 (308)
T ss_pred EeeccCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecC-CcEEEccCCCccccccc
Confidence 9999999999999986543 8999999999999999999998 599999999999999988 68999999998754322
Q ss_pred cccccccCccceecccccccccccccccccccCC--------CC------------------------------------
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------------------------------ 215 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------------------------------ 215 (317)
......++..|+|||++.+..... ..+.|+.+ ..
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~-~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 -MANSFVGTRSYMSPERLQGTHYTV-QSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred -ccccCCCCcCccChhHhcCCCCCc-cchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 223457889999999876533211 12222111 00
Q ss_pred -------------------CC--CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 216 -------------------RP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 216 -------------------~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.+ ....++.++++|+.+||..+|++||++.+++++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 00 01135678999999999999999999999998854
No 230
>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate
Probab=100.00 E-value=6.1e-35 Score=251.55 Aligned_cols=222 Identities=26% Similarity=0.462 Sum_probs=175.8
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHH----HHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEE----IAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
+|.+.+.||+|++|.||+|.+. ++.||+|.+........ .......+.+|+.++++++||||+++++++.+. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999874 78899998876543221 123345788999999999999999999998754 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++||||+++++|.+++...+. +++..+..++.|++.||+|||++|++||||+|+||+++.+ +.++|+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~-~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGA--FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNK-GGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccC--ccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCC-CCEEecccCCCcccc
Confidence 8999999999999999987544 8999999999999999999999999999999999999988 689999999987543
Q ss_pred ccc-------ccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCC
Q 021127 178 LTE-------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENV 222 (317)
Q Consensus 178 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~ 222 (317)
... ......|+..|+|||.+.+..... ..+.|..+ .....+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTR-KADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNI 236 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCc-hhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCccc
Confidence 211 112235788999999876543221 12222211 112234567
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+..+.++|.+||+.||.+||++.+++++
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 237 SSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 8999999999999999999999999875
No 231
>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl
Probab=100.00 E-value=1.8e-35 Score=259.46 Aligned_cols=222 Identities=25% Similarity=0.377 Sum_probs=172.8
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
-++|++.++||.|+||.||+|++. ++.||+|.+....... ....+.+|+.++++++|+||+++++++.+. ..+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 80 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 80 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC----chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence 367999999999999999999875 7899999987544322 123467899999999999999999998755 789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+||||+. ++|.+++..... .+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||++......
T Consensus 81 lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSIP 157 (301)
T ss_pred EEEeccc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCC-CcEEECcCcchhccCCC
Confidence 9999996 699998876433 48999999999999999999999999999999999999988 68999999999754322
Q ss_pred -cccccccCccceecccccccccccccccccccCC---------------------------------------------
Q 021127 180 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------------------------------------- 213 (317)
Q Consensus 180 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------------------------------------- 213 (317)
.......+++.|+|||++.+........++|+.+
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 1223345788999999865422111111111111
Q ss_pred ----CCC--------CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 214 ----NVR--------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 214 ----~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
... .....++..+.+||.+||+.||.+|||+.+++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~ 287 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 000 00135678899999999999999999999999873
No 232
>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re
Probab=100.00 E-value=5.5e-35 Score=251.71 Aligned_cols=223 Identities=24% Similarity=0.397 Sum_probs=175.2
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---Cc
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PV 97 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~ 97 (317)
+.+|++.+.||+|+||.||++.+. +..||||.+...............+.+|+.+++++.|+||+++++++.+ ..
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 478999999999999999999875 7899999986543222222345678899999999999999999998864 35
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
+++||||+++++|.+++..... +++..++.++.|++.||+|||+++++|+||+|+||+++.+ +.++|+|||++....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGA--LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSV-GNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCC-CCEEECcCccccccc
Confidence 7899999999999999976543 8899999999999999999999999999999999999988 789999999987532
Q ss_pred cc----cccccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChH
Q 021127 178 LT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPE 224 (317)
Q Consensus 178 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~ 224 (317)
.. .......++..|+|||++.+... ....++|+.+ .....+..++.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD 236 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCH
Confidence 21 11233458889999998865332 2223333222 01112345667
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+.+++.+|+. +|.+||++++++++
T Consensus 237 ~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 237 HCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 88999999995 99999999999876
No 233
>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=6.4e-35 Score=255.45 Aligned_cols=218 Identities=25% Similarity=0.419 Sum_probs=175.4
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 99 (317)
..+|++.+.||+|++|.||+|.+. ++.||+|.+....... ...+.+|+.+++.+.|+||+++++.+.. ...+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~-----~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~ 93 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-----KELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch-----HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence 368999999999999999999874 7899999987655432 3457889999999999999999998865 4899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+||||+++++|.+++... .+++.++..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++......
T Consensus 94 lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~-~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPE 169 (296)
T ss_pred EeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCEEECccccchhcccc
Confidence 999999999999998653 38999999999999999999999999999999999999988 68999999998754322
Q ss_pred c-ccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHH
Q 021127 180 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSI 228 (317)
Q Consensus 180 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~ 228 (317)
. ......+++.|+|||.+.+.... ...+.|..+ .....+..++..+.+
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248 (296)
T ss_pred ccccCcccCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHH
Confidence 1 22334688999999987653221 112222111 011124457788999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 021127 229 ILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 229 li~~cl~~~p~~Rps~~~~~~~ 250 (317)
++.+||..+|++||++.+++++
T Consensus 249 li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 249 FLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHHHHCcCCcccCcCHHHHhhC
Confidence 9999999999999999999986
No 234
>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity
Probab=100.00 E-value=1.1e-35 Score=255.24 Aligned_cols=213 Identities=23% Similarity=0.395 Sum_probs=166.3
Q ss_pred ceeccccceEEEEeEEC---------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceE
Q 021127 30 PRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 99 (317)
+.||+|+||.||+|.+. ...||+|.+.... ....+.+.+|+.+++.+.||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-----RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-----HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcE
Confidence 46899999999999764 2348888875432 2334568889999999999999999999876 4889
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCC-------ceEEcccCc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK-------TIKLADFGL 172 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~-------~~kl~Dfg~ 172 (317)
+||||+++|+|.+++...+. .+++..++.++.||+.||+|||++||+||||||+||+++.+.. .++++|||+
T Consensus 76 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred EEEecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 99999999999999986543 4899999999999999999999999999999999999987632 269999999
Q ss_pred ccccccccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHH
Q 021127 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEE 225 (317)
Q Consensus 173 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~ 225 (317)
+...... ....++..|+|||++.+........++|+.+ .....+...+.+
T Consensus 155 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (258)
T cd05078 155 SITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTE 231 (258)
T ss_pred ccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCcHH
Confidence 8654322 2346788999999987533223333333322 011123345578
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
+.+|+.+||+.||++|||++++++.|
T Consensus 232 ~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 232 LANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHHHHHhccChhhCCCHHHHHHhc
Confidence 99999999999999999999999875
No 235
>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=1.1e-34 Score=253.86 Aligned_cols=218 Identities=25% Similarity=0.430 Sum_probs=176.4
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||.|++|.||+|.+. ++.||||.+....... ...+.+|+.+++.++|+||+++++++.+. ..++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK-----KELIINEILVMKELKNPNIVNFLDSFLVGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch-----HHHHHHHHHHHHhcCCCceeeeeeeEecCceEEE
Confidence 57999999999999999999864 8899999987544322 34578899999999999999999998754 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
|+||+++++|..++... .+++.++..++.|++.||+|||++|++|+||+|+||+++.+ +.+||+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~-~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 94 VMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEccCccchhccccc
Confidence 99999999999988753 38999999999999999999999999999999999999988 789999999987543322
Q ss_pred -ccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHH
Q 021127 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSII 229 (317)
Q Consensus 181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~l 229 (317)
......++..|+|||.+.+..... ..+.|+.+ .....+..++..+.++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDF 248 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHH
Confidence 123346889999999876533221 12222211 0112245678899999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHH
Q 021127 230 LTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~l 251 (317)
|.+||..||.+||++.+++++-
T Consensus 249 i~~~l~~dp~~Rpt~~~il~~~ 270 (296)
T cd06655 249 LNRCLEMDVEKRGSAKELLQHP 270 (296)
T ss_pred HHHHhhcChhhCCCHHHHhhCh
Confidence 9999999999999999999883
No 236
>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is
Probab=100.00 E-value=2.6e-35 Score=258.00 Aligned_cols=223 Identities=28% Similarity=0.373 Sum_probs=174.5
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.+.||+|++|.||+|.+. ++.||||.+...............+..|++++++++|+||+++++++.+. ..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4888999999999999999875 78999999987654321123344577899999999999999999998765 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-c
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-E 180 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~ 180 (317)
|||+ +++|.+++.... ..+++..++.++.||++||+|||++|++|+||+|+||+++.+ +.++|+|||+++..... .
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC-CCEEEccceeeeeccCCCc
Confidence 9999 999999997654 349999999999999999999999999999999999999988 79999999999865432 2
Q ss_pred ccccccCccceecccccccccccccccccccCC--------C--------------------------------------
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N-------------------------------------- 214 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~-------------------------------------- 214 (317)
......+++.|+|||.+.+........+.|+.+ .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 223345678899999874422111112222111 0
Q ss_pred ---------CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 215 ---------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 215 ---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
........+..+.++|.+||+.||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000013446789999999999999999999999986
No 237
>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase. Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ
Probab=100.00 E-value=8.6e-35 Score=249.09 Aligned_cols=222 Identities=28% Similarity=0.526 Sum_probs=175.6
Q ss_pred ecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
|++.+|++.+.||+|+||.||++.+. +..+|+|.+...... ...+.+|++++++++|||++++++++... ..
T Consensus 1 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05112 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS------EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPI 74 (256)
T ss_pred CChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC------HHHHHHHHHHHHhCCCCCeeeEEEEEccCCce
Confidence 46789999999999999999999876 788999988755432 23578899999999999999999998654 78
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+++++|.+++.... ..++++.++.++.|++.||+|||+++++|+||||+||+++.+ +.++|+|||++.....
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 75 CLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGEN-QVVKVSDFGMTRFVLD 152 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCC-CeEEECCCcceeeccc
Confidence 99999999999999987643 238999999999999999999999999999999999999987 6899999999875432
Q ss_pred ccc--cccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHH
Q 021127 179 TEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 179 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~ 227 (317)
... .....++..|+|||.+.+..... ..+.|+.+ .....+...+..+.
T Consensus 153 ~~~~~~~~~~~~~~~~aPe~~~~~~~~~-~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd05112 153 DQYTSSTGTKFPVKWSSPEVFSFSKYSS-KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVY 231 (256)
T ss_pred CcccccCCCccchhhcCHhHhccCCcCh-HHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 211 11223457899999876432211 11222111 01112344688999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
+|+.+||+.+|++||++.++++.|
T Consensus 232 ~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 232 ELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHHHcccChhhCCCHHHHHHhh
Confidence 999999999999999999999876
No 238
>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin. Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear
Probab=100.00 E-value=8e-35 Score=253.39 Aligned_cols=224 Identities=24% Similarity=0.365 Sum_probs=173.7
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeee---
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK--- 94 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~--- 94 (317)
...++|++.+.||+|+||.||++.+. ++.+|+|++...... ...+.+|+.+++++ +|+||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~------~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI------DEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch------HHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 35579999999999999999999875 789999987653321 23467899999999 7999999999873
Q ss_pred ---cCceEEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcc
Q 021127 95 ---EPVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (317)
Q Consensus 95 ---~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~D 169 (317)
++..++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+++||||||+||+++.+ +.+||+|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~-~~~kl~d 167 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTE-GGVKLVD 167 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCC-CCEEEcc
Confidence 23689999999999999988642 22348899999999999999999999999999999999999988 6899999
Q ss_pred cCccccccccc-ccccccCccceecccccccccc----cccccccccCC------------------------------C
Q 021127 170 FGLAREESLTE-MMTAETGTYRWMAPELYSTVTL----RQGEKKHYNHK------------------------------N 214 (317)
Q Consensus 170 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~~~------------------------------~ 214 (317)
||++....... ......|++.|+|||++..... .....++|+.+ .
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (286)
T cd06638 168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP 247 (286)
T ss_pred CCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC
Confidence 99987543222 2233468999999998753210 11122222211 0
Q ss_pred CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 215 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 215 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
....+..++..+.+++.+||+.||++|||+.++++++
T Consensus 248 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 248 TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0111334577899999999999999999999999874
No 239
>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l
Probab=100.00 E-value=1.3e-34 Score=250.16 Aligned_cols=220 Identities=30% Similarity=0.491 Sum_probs=169.0
Q ss_pred ceeccccceEEEEeEEC--C--eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEEEEE
Q 021127 30 PRIGEGAHAKVYEGKYK--N--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTE 103 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~--~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e 103 (317)
+.||+|+||.||+|.+. + ..+++|.+...... .....+.+|+.++.++ .||||+++++++... ..++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK----DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCH----HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence 36899999999999875 3 35788887743322 2244688999999999 899999999998754 7899999
Q ss_pred ccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcc
Q 021127 104 LLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (317)
Q Consensus 104 ~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~D 169 (317)
|+++++|.+++..... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~-~~~kl~d 155 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIAD 155 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCC-CeEEECC
Confidence 9999999999976431 247899999999999999999999999999999999999988 6899999
Q ss_pred cCcccccccccccccccCccceecccccccccccccccccccCC-----------------------------CCCCCCC
Q 021127 170 FGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAE 220 (317)
Q Consensus 170 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~ 220 (317)
||++..............+..|+|||++...... ...+.|+.+ .....+.
T Consensus 156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05047 156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234 (270)
T ss_pred CCCccccchhhhccCCCCccccCChHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence 9998643222111222345679999987543221 112222211 0112234
Q ss_pred CChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 221 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 221 ~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
.++.++.+++.+||+.||.+|||+.++++.|..++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 56788999999999999999999999999988765
No 240
>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea
Probab=100.00 E-value=6.2e-35 Score=253.65 Aligned_cols=222 Identities=25% Similarity=0.405 Sum_probs=175.8
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeee----
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK---- 94 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~---- 94 (317)
..+.|++.+.||+|+||.||+|.+. ++.||+|++..... ....+..|+.++.++ +|+||+++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED------EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH------HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 5578999999999999999999885 78999999865432 233577899999998 7999999999874
Q ss_pred ---cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 95 ---EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 95 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
+...+++|||+++|+|.+++.......+++..++.++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~-~~~~l~dfg 166 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTEN-AEVKLVDFG 166 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCc
Confidence 2368999999999999999987665568899999999999999999999999999999999999988 689999999
Q ss_pred cccccccc-cccccccCccceeccccccccc----ccccccccccCC-----------------------------CCCC
Q 021127 172 LAREESLT-EMMTAETGTYRWMAPELYSTVT----LRQGEKKHYNHK-----------------------------NVRP 217 (317)
Q Consensus 172 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~~~~~~-----------------------------~~~~ 217 (317)
++...... .......|++.|+|||++.... ......+.|+.+ ....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 246 (282)
T cd06636 167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246 (282)
T ss_pred chhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC
Confidence 98754322 1223456889999999875311 111123333322 0011
Q ss_pred CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
....++.++.+||.+||+.||.+||++.+++++
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 123578899999999999999999999999875
No 241
>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ
Probab=100.00 E-value=7.8e-35 Score=250.04 Aligned_cols=220 Identities=28% Similarity=0.419 Sum_probs=176.5
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
.++|++.+.||.|+||.||++.+. +..+++|++...... ....+.+|+.++++++||||+++++++.++ ..+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-----DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-----hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEE
Confidence 478999999999999999999875 688999999865432 245688999999999999999999988654 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
++|||+++++|.+++.... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.+ +.+||+|||++......
T Consensus 77 l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTED-GDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCC-CCEEECccccchhhhhh
Confidence 9999999999999987642 238999999999999999999999999999999999999988 78999999998754432
Q ss_pred c-ccccccCccceecccccccc---cccccccccccCC---------------------------C--C---CCCCCCCh
Q 021127 180 E-MMTAETGTYRWMAPELYSTV---TLRQGEKKHYNHK---------------------------N--V---RPSAENVP 223 (317)
Q Consensus 180 ~-~~~~~~gt~~y~aPE~~~~~---~~~~~~~~~~~~~---------------------------~--~---~~~~~~~~ 223 (317)
. ......++..|+|||++... ... ...+.|+.+ . . ......++
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWS 233 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhh
Confidence 2 22344678899999998654 222 223333222 0 0 00122346
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.++.+++.+||..+|.+|||+.+++.+
T Consensus 234 ~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 234 PVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 789999999999999999999999865
No 242
>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut
Probab=100.00 E-value=1.4e-34 Score=251.35 Aligned_cols=225 Identities=28% Similarity=0.543 Sum_probs=178.0
Q ss_pred CCceeecceeccccceEEEEeEEC------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE- 95 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~- 95 (317)
...|++.+.||+|+||.||++.+. +..||||++...... .....+.+|+++++.+.|+||+++++++..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE----QHRSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch----HHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 467889999999999999999864 578999999865543 235578999999999999999999998864
Q ss_pred -C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 96 -P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 96 -~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
. ..++||||+++++|.+++..... .+++..++.++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~ 156 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE-DLVKISDFGLA 156 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-CCEEEcccccc
Confidence 3 68999999999999999986543 38999999999999999999999999999999999999988 79999999999
Q ss_pred cccccccc----cccccCccceecccccccccccccccccccCC------------------------------------
Q 021127 174 REESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------------ 213 (317)
Q Consensus 174 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------------ 213 (317)
........ .....++..|+|||.+.+.... ...+.|+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFS-SASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCC-cccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 86542211 1122345679999976543221 111222211
Q ss_pred -------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 214 -------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 214 -------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
...+.+..++.++.+++.+||+.+|.+||++.++++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11122345678899999999999999999999999998764
No 243
>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p
Probab=100.00 E-value=4e-35 Score=259.16 Aligned_cols=164 Identities=25% Similarity=0.381 Sum_probs=131.7
Q ss_pred cceeccccceEEEEeEEC----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---CceEEE
Q 021127 29 GPRIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PVMVIV 101 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~lv 101 (317)
+++||+|+||.||+|++. ++.||+|.+...... ..+.+|+.++++++||||+++++++.. ...++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-------MSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc-------HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence 468999999999999863 578999998755432 236789999999999999999998843 368999
Q ss_pred EEccCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC---CCCceEEcccC
Q 021127 102 TELLSGGTLRKYLLNMR-------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE---DLKTIKLADFG 171 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~-------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~---~~~~~kl~Dfg 171 (317)
|||+ +++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++. ..+.+||+|||
T Consensus 79 ~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 79 FDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred Eecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 9999 568888876321 224899999999999999999999999999999999999942 22589999999
Q ss_pred ccccccccc----ccccccCccceecccccccc
Q 021127 172 LAREESLTE----MMTAETGTYRWMAPELYSTV 200 (317)
Q Consensus 172 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~ 200 (317)
+++...... ......||+.|+|||++.+.
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 190 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGA 190 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCC
Confidence 997543221 22345689999999987653
No 244
>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha. Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype
Probab=100.00 E-value=6.3e-35 Score=259.05 Aligned_cols=168 Identities=15% Similarity=0.273 Sum_probs=137.2
Q ss_pred ecceeccc--cceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEE
Q 021127 28 VGPRIGEG--AHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVT 102 (317)
Q Consensus 28 ~~~~lG~G--~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 102 (317)
+.++||+| +|++||++... ++.||||.+....... .....+.+|+.+++.++||||+++++++..+ ..++||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN---EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccH---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence 57789999 78999999875 8999999987654433 2234577899999999999999999998654 899999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc---
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT--- 179 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~--- 179 (317)
||+++++|.+++.......+++..++.++.|++.||+|||++||+||||||+||+++.+ +.++++||+.+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~-~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC-CcEEEcccchhhcccccccc
Confidence 99999999999976544458999999999999999999999999999999999999988 68999999865432111
Q ss_pred -----cccccccCccceeccccccc
Q 021127 180 -----EMMTAETGTYRWMAPELYST 199 (317)
Q Consensus 180 -----~~~~~~~gt~~y~aPE~~~~ 199 (317)
.......++..|+|||++.+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~ 182 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQ 182 (327)
T ss_pred ccccccccccccceecccChHHhhc
Confidence 01122346778999998754
No 245
>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer. Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c
Probab=100.00 E-value=1.6e-34 Score=246.59 Aligned_cols=216 Identities=28% Similarity=0.525 Sum_probs=169.5
Q ss_pred ceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCC
Q 021127 30 PRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSG 107 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~ 107 (317)
++||+|+||.||+|... +..+|+|.+...... .....+.+|++++++++||||+++++++... ..++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ----ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCH----HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence 46899999999999875 678999998765432 2234688999999999999999999998765 78999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccccc--ccc
Q 021127 108 GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM--TAE 185 (317)
Q Consensus 108 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~--~~~ 185 (317)
++|.+++.... ..+++..++.++.|++.||.|||++|++||||+|+||+++.+ +.+||+|||++......... ...
T Consensus 77 ~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 77 GDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGEN-NVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCC-CeEEECCCccceeccccccccCCCC
Confidence 99999987643 348999999999999999999999999999999999999988 68999999998754322111 122
Q ss_pred cCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHHHHHHHhhhc
Q 021127 186 TGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSIILTSCWKE 236 (317)
Q Consensus 186 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~cl~~ 236 (317)
.++..|+|||++.+..... ..+.|+.+ .....+..++..+.+++.+||+.
T Consensus 155 ~~~~~y~aPE~~~~~~~~~-~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 233 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSS-ESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDY 233 (250)
T ss_pred CCcccccCHHHhccCCCCc-hhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccc
Confidence 3456799999876532211 11111111 11122456789999999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 021127 237 DPNARPNFTQIIQMLL 252 (317)
Q Consensus 237 ~p~~Rps~~~~~~~l~ 252 (317)
+|++||++.++++.|.
T Consensus 234 ~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 234 KPENRPKFSELQKELA 249 (250)
T ss_pred CcccCCCHHHHHHHhc
Confidence 9999999999998764
No 246
>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also
Probab=100.00 E-value=1.4e-35 Score=257.90 Aligned_cols=220 Identities=25% Similarity=0.391 Sum_probs=172.1
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.+.||+|+||.||+|++. |+.||+|.++...... .....+.+|+.++++++|+||+++++++.+. ..++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~---~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE---GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLV 77 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc---cCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEE
Confidence 5889999999999999999985 8899999987643322 1223577899999999999999999998765 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-c
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-E 180 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~ 180 (317)
+||+. ++|.+++.... ..+++..++.++.||+.||.|||++|++||||||+||+++.+ +.+||+|||++...... .
T Consensus 78 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 78 FEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVR 154 (284)
T ss_pred EecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC-CcEEECccchhhccCCCCC
Confidence 99995 68888876543 338999999999999999999999999999999999999988 78999999999754322 1
Q ss_pred ccccccCccceecccccccccccccccccccCC--------CCC------------------------------------
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR------------------------------------ 216 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~------------------------------------ 216 (317)
......++..|+|||++.+........+.|+.+ ...
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 223345788999999876533222222333221 000
Q ss_pred -------------CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 -------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 -------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.....++.++.+++.+||+.||.+|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0112467889999999999999999999999876
No 247
>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase. Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1
Probab=100.00 E-value=1.6e-34 Score=248.77 Aligned_cols=222 Identities=27% Similarity=0.424 Sum_probs=178.4
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||.|+||+||+|... +..+|+|++....... ....+.+|+..++.++|+||+++++.+... ..++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 76 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT----SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL 76 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch----HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence 47899999999999999999874 7889999987654332 345688999999999999999999988654 8999
Q ss_pred EEEccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
|||++++++|.+++..... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~-~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGED-GSVKIADFGVSASLADG 155 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-CCEEEcccchHHHhccC
Confidence 9999999999999986543 458999999999999999999999999999999999999988 68999999998754322
Q ss_pred c-----ccccccCccceecccccccccccccccccccCC--------CC----------------------CCC---CCC
Q 021127 180 E-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV----------------------RPS---AEN 221 (317)
Q Consensus 180 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~----------------------~~~---~~~ 221 (317)
. ......|+..|+|||++..........+.|+.+ .. ... ...
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKK 235 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccc
Confidence 1 113346889999999876653333333444322 00 000 125
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
++..+.+++.+||+.||++||++.+++++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 236 YSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 67889999999999999999999999876
No 248
>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells
Probab=100.00 E-value=1.9e-34 Score=248.90 Aligned_cols=217 Identities=27% Similarity=0.436 Sum_probs=164.2
Q ss_pred ceeccccceEEEEeEEC----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEc
Q 021127 30 PRIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTEL 104 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 104 (317)
+.||+|+||.||+|.+. +..+|+|.+....... ....+.+|+.++++++||||+++++++.+. ..++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQ----EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF 76 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChH----HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence 46899999999999764 4579999887654322 234688899999999999999999998765 78999999
Q ss_pred cCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 105 LSGGTLRKYLLNMRP---RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 105 ~~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
+++|+|.+++..... ...++..+..++.|++.||+|||+++++|+||||+||+++.+ +.+||+|||+++.......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEECCccccccccCcce
Confidence 999999999975332 236778888999999999999999999999999999999988 6899999999974332211
Q ss_pred ---cccccCccceecccccccccc------cccccccccCC----------C---------------------CCCC---
Q 021127 182 ---MTAETGTYRWMAPELYSTVTL------RQGEKKHYNHK----------N---------------------VRPS--- 218 (317)
Q Consensus 182 ---~~~~~gt~~y~aPE~~~~~~~------~~~~~~~~~~~----------~---------------------~~~~--- 218 (317)
.....++..|+|||++..... .....+.|+.+ . ..+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRL 235 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCcc
Confidence 123356788999998753211 11122222211 0 0000
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
....+..+.+++.+|| .+|++|||+++|+..|.
T Consensus 236 ~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 236 KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1245678899999999 68999999999997753
No 249
>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase. Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea
Probab=100.00 E-value=5.3e-35 Score=254.38 Aligned_cols=220 Identities=28% Similarity=0.360 Sum_probs=175.8
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.+.||+|++|.||+|.+. +..||+|++....... .....+.+|+.++++++|+||+++++++.++ ..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 77 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG---GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLV 77 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc---hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEE
Confidence 5889999999999999999874 7899999998755322 2234688999999999999999999998755 78999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc-
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE- 180 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~- 180 (317)
|||+ +++|.+++.... ..+++..++.++.||+.||+|||+.|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 78 ~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 78 MEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD-GVLKIADFGLARLFSEEEP 154 (286)
T ss_pred eccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC-CcEEEeeeeecccccCCCC
Confidence 9999 999999987644 449999999999999999999999999999999999999987 789999999998654332
Q ss_pred -ccccccCccceecccccccccccccccccccCC--------C-------------------------------------
Q 021127 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N------------------------------------- 214 (317)
Q Consensus 181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~------------------------------------- 214 (317)
......++..|+|||++.+........++|+.+ .
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 123456889999999875432222222222211 0
Q ss_pred ---CC---------CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 215 ---VR---------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 215 ---~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.. ......+..+.+++.+||+.+|.+||+++++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0012456889999999999999999999999887
No 250
>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=8.9e-35 Score=254.67 Aligned_cols=217 Identities=25% Similarity=0.423 Sum_probs=174.8
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||++.+. ++.||+|.+....... ...+.+|+.+++.++|+||+++++++..+ ..++
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK-----KELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch-----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 78999999999999999999874 8899999987654332 34578899999999999999999998755 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++++|.+++.+. .+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~-~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 94 VMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred eecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEECcCccceEccCCc
Confidence 99999999999998653 38999999999999999999999999999999999999988 789999999987543222
Q ss_pred -ccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHH
Q 021127 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSII 229 (317)
Q Consensus 181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~l 229 (317)
......+++.|+|||.+.+..... ..+.|+.+ .....+..++..++++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDF 248 (297)
T ss_pred cCcCcccCCccccCHHHHcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHH
Confidence 123346888999999876532211 11111110 0111234567889999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 021127 230 LTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~ 250 (317)
+.+||+.+|++||++.+++++
T Consensus 249 i~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 249 LNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999987
No 251
>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi
Probab=100.00 E-value=1e-34 Score=249.47 Aligned_cols=221 Identities=24% Similarity=0.412 Sum_probs=177.8
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---CceE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PVMV 99 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~ 99 (317)
+|++.+.||.|+||.||++.+. ++.||+|.+....... ....++.+|+.++++++|+||+++++.+.. ...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE---KEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCH---HHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence 5889999999999999999875 7889999987654432 334568899999999999999999997742 3689
Q ss_pred EEEEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH-----hCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 100 IVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLH-----SHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~lH-----~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
++|||+++++|.+++.... ...+++..++.++.|++.||+||| +.+++|+||+|+||+++.+ +.+||+|||+
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~-~~~kl~d~g~ 156 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGL 156 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecC-CCEEEecccc
Confidence 9999999999999997532 345899999999999999999999 8999999999999999988 7999999999
Q ss_pred ccccccccc-cccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCCh
Q 021127 173 AREESLTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVP 223 (317)
Q Consensus 173 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~ 223 (317)
+........ .....++..|+|||++.+..... ..+.|..+ .....+..++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDE-KSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYS 235 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcCCCCCc-hhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccC
Confidence 986544332 33456899999999876543221 12222211 1123345678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
..+.+++.+||+.+|.+||++.+++++
T Consensus 236 ~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 236 SELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 899999999999999999999999886
No 252
>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a
Probab=100.00 E-value=7.6e-35 Score=249.25 Aligned_cols=218 Identities=27% Similarity=0.414 Sum_probs=176.5
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
.++|++.+.||+|+||.||+|.+. ++.+++|.+..... ...+.+|++++++++|+||+++++++.+. ..+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 74 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-------LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLW 74 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-------HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEE
Confidence 478999999999999999999886 68999999865321 45688999999999999999999998765 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+++||+++++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++......
T Consensus 75 l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~-~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEE-GQAKLADFGVSGQLTDT 152 (256)
T ss_pred EEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCC-CcEEEcccccchhcccC
Confidence 9999999999999997643 348999999999999999999999999999999999999988 68999999999865433
Q ss_pred c-ccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHH
Q 021127 180 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSI 228 (317)
Q Consensus 180 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~ 228 (317)
. ......++..|+|||++.+..... ..+.|+.+ .....+..++.++.+
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~~~~~-~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQEIGYNN-KADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFND 231 (256)
T ss_pred ccccccccCCccccCHHHHhcCCCCc-hhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHH
Confidence 2 223345788999999876543322 22222211 000112346678999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 021127 229 ILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 229 li~~cl~~~p~~Rps~~~~~~~ 250 (317)
++.+||+.||.+|||+.+++++
T Consensus 232 ~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 232 FVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred HHHHHHhcChhhCcCHHHHhcC
Confidence 9999999999999999999875
No 253
>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron. Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca
Probab=100.00 E-value=2.2e-34 Score=247.37 Aligned_cols=220 Identities=29% Similarity=0.484 Sum_probs=169.6
Q ss_pred ceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee--cCceEEEE
Q 021127 30 PRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK--EPVMVIVT 102 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~lv~ 102 (317)
+.||+|+||.||+|.+. ...||||.+...... .....+.+|+.+++.++||||+++++++. ++..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL----EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCH----HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence 46899999999999863 357999987643322 23456889999999999999999999774 34688999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc--
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-- 180 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-- 180 (317)
||+.+++|.+++..... .+++..++.++.|++.||+|||+.+++||||||+||+++.+ +.+||+|||+++......
T Consensus 77 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~-~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 77 PYMKHGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDES-FTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred ecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC-CcEEECCccccccccCCcce
Confidence 99999999999976432 36788889999999999999999999999999999999988 689999999987432211
Q ss_pred ---ccccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHHH
Q 021127 181 ---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSI 228 (317)
Q Consensus 181 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~ 228 (317)
......++..|+|||.+....... ..++|+.+ .....+..++..+.+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTT-KSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYE 233 (262)
T ss_pred eecccccCcCCccccChhHhccCccch-HHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHH
Confidence 111234567899999875433211 12222211 112224456889999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 229 ILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 229 li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
++.+||+.+|++||++.++++.|.+++.
T Consensus 234 li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 234 VMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 9999999999999999999999988753
No 254
>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1. Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.
Probab=100.00 E-value=3.6e-35 Score=251.82 Aligned_cols=220 Identities=26% Similarity=0.331 Sum_probs=178.7
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.++||.|+||.||++.+. +..||+|++....... .+....+.+|+.++++++||||+++++.+.++ ..++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE--KGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcc--hhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence 5899999999999999999886 8899999997643222 13456789999999999999999999988765 79999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
+||+.+++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 79 VDLLLGGDLRYHLSQKV--KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ-GHVHITDFNIATKVTPDTL 155 (258)
T ss_pred EeCCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC-CCEEEeecccccccCCCcc
Confidence 99999999999998753 38999999999999999999999999999999999999988 6899999999986544433
Q ss_pred cccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHHHH
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~ 231 (317)
.....|+..|+|||++.+.... ...+.|..+ .....+..++..+.++|.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYS-VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAIN 234 (258)
T ss_pred ccccCCChhhcCHHHHcccCCC-CcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHH
Confidence 3455688899999987653321 222222222 112235567899999999
Q ss_pred HhhhcCCCCCCCH--HHHHHH
Q 021127 232 SCWKEDPNARPNF--TQIIQM 250 (317)
Q Consensus 232 ~cl~~~p~~Rps~--~~~~~~ 250 (317)
+||+.||.+||++ .+++++
T Consensus 235 ~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 235 KLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred HHccCChhHcCCccHHHHhcC
Confidence 9999999999999 776544
No 255
>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin
Probab=100.00 E-value=1e-34 Score=256.45 Aligned_cols=223 Identities=27% Similarity=0.382 Sum_probs=177.5
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|++|.||++... ++.||||.+....... .....++.+|+++++.++|+||+++++.+.++ ..++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK--RNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch--HHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEE
Confidence 47899999999999999999885 7899999998765432 23455788999999999999999999998765 7999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+.+++|.+++.......+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES-GHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCC-CCEEEeecchhhcccccc
Confidence 9999999999999986544569999999999999999999999999999999999999988 789999999986432211
Q ss_pred ------------------------------ccccccCccceecccccccccccccccccccCC-----------------
Q 021127 181 ------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------- 213 (317)
Q Consensus 181 ------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------- 213 (317)
......|+..|+|||++.+..... ..++|+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~-~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGS-AVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCc-hHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 011235788999999876543221 22222211
Q ss_pred ------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCC----HHHHHHH
Q 021127 214 ------------NVRPSAENVPEELSIILTSCWKEDPNARPN----FTQIIQM 250 (317)
Q Consensus 214 ------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps----~~~~~~~ 250 (317)
...+....++..+.+++.+||+.||++||+ +++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 237 RDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred hHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 011112236889999999999999999999 8888876
No 256
>PHA03211 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=4.6e-35 Score=268.95 Aligned_cols=163 Identities=25% Similarity=0.305 Sum_probs=137.3
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 99 (317)
...|.+.+.||+|+||.||++.+. ++.||||.... ..+.+|++++++++|+||+++++++.. +..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 457999999999999999999986 68899996432 125689999999999999999998865 4789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+|||++ .++|..++.... ..+++..++.|+.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 237 lv~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~-~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 237 LVLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGP-EDICLGDFGAACFARGS 313 (461)
T ss_pred EEEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCC-CCEEEcccCCceecccc
Confidence 999999 579999887543 249999999999999999999999999999999999999988 68999999999754322
Q ss_pred c---ccccccCccceeccccccc
Q 021127 180 E---MMTAETGTYRWMAPELYST 199 (317)
Q Consensus 180 ~---~~~~~~gt~~y~aPE~~~~ 199 (317)
. ......||+.|+|||++.+
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~ 336 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAG 336 (461)
T ss_pred cccccccccCCCcCCcCHHHHcC
Confidence 1 1223569999999998765
No 257
>PTZ00284 protein kinase; Provisional
Probab=100.00 E-value=1.3e-34 Score=268.69 Aligned_cols=169 Identities=22% Similarity=0.336 Sum_probs=133.8
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC------CCCeeeEEee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ------HRNLVKFIGA 92 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~ 92 (317)
+..++|++.++||+|+||+||+|.+. ++.||||+++..... ...+..|+.++..++ |.++++++++
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~------~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY------TRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhh------HHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 44678999999999999999999875 788999998653221 122344556555554 5568999998
Q ss_pred eec--CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCC------
Q 021127 93 CKE--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLK------ 163 (317)
Q Consensus 93 ~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~------ 163 (317)
+.. ...++||+++ +++|.+++...+. +++..+..|+.||+.||+|||+ .|||||||||+|||++.+..
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~~~--l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKHGP--FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccc
Confidence 864 3789999998 8899999876543 9999999999999999999998 59999999999999986521
Q ss_pred ---------ceEEcccCcccccccccccccccCccceecccccccc
Q 021127 164 ---------TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 200 (317)
Q Consensus 164 ---------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 200 (317)
.+||+|||.+..... .....+||+.|+|||++.+.
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~ 320 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGL 320 (467)
T ss_pred ccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcC
Confidence 499999998864322 23456799999999987653
No 258
>smart00219 TyrKc Tyrosine kinase, catalytic domain. Phosphotransferases. Tyrosine-specific kinase subfamily.
Probab=100.00 E-value=1.2e-34 Score=248.10 Aligned_cols=220 Identities=35% Similarity=0.674 Sum_probs=174.4
Q ss_pred eeecceeccccceEEEEeEECC------eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-Cce
Q 021127 26 LFVGPRIGEGAHAKVYEGKYKN------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 98 (317)
+++.+.||.|+||.||++.+.+ ..||+|.+....... ....+..|+.++..++|+||+++++++.+ +..
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ----QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPL 76 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH----HHHHHHHHHHHHHhcCCCchheEEEEEcCCCee
Confidence 3577899999999999998864 789999997655432 34568899999999999999999999876 489
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
+++|||+++++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~-~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN-LVVKISDFGLSRDLYD 155 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccC-CeEEEcccCCceeccc
Confidence 999999999999999986544338999999999999999999999999999999999999988 6899999999975543
Q ss_pred ccccc--cccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHH
Q 021127 179 TEMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 179 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~ 227 (317)
..... ...++..|+|||.+.+.... ...+.|..+ .....+...+.++.
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFT-SKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIY 234 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHH
Confidence 32211 12367899999987432111 111111110 11223455789999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
+++.+||..||.+|||+.++++.|
T Consensus 235 ~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 235 KLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHHCcCChhhCcCHHHHHhhC
Confidence 999999999999999999998753
No 259
>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)
Probab=100.00 E-value=1.4e-34 Score=250.43 Aligned_cols=218 Identities=27% Similarity=0.427 Sum_probs=176.8
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||.|++|.||+|.+. ++.||+|.+....... ....+.+|+.+++.++|+||+++++++.++ ..++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED----EIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI 76 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccch----HHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence 47889999999999999999875 7899999987654322 234578899999999999999999988655 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
|+||+++++|.+++... .+++..++.++.|++.||.|||+++++|+||+|+||+++.+ +.++|+|||+++.....
T Consensus 77 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 77 IMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEE-GDVKLADFGVSGQLTSTM 152 (274)
T ss_pred EEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEcccccceeecccc
Confidence 99999999999999764 48999999999999999999999999999999999999998 78999999999865433
Q ss_pred cccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCC-ChHHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAEN-VPEELSIIL 230 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~-~~~~l~~li 230 (317)
.......++..|+|||.+.+... ....+.|+.+ .....+.. ++.++.+++
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFV 231 (274)
T ss_pred cccccccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHH
Confidence 22334568889999998876442 2222233221 00011122 788899999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 021127 231 TSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 231 ~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+||..+|++|||+++++++
T Consensus 232 ~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 232 SLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHHhhCChhhCcCHHHHhhC
Confidence 99999999999999999886
No 260
>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase. Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina
Probab=100.00 E-value=1.9e-34 Score=248.79 Aligned_cols=224 Identities=23% Similarity=0.352 Sum_probs=172.7
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
++-.+......||+|+||.||+|.+. +..||+|.+...... ..+.+.+|+.++++++|+||+++++++..+ .
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR-----YVQPLHEEIALHSYLKHRNIVQYLGSDSENGF 79 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH-----HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE
Confidence 34444445568999999999999875 678999988765432 244688999999999999999999998754 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCL--DVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l--~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
.++|+||+++++|.+++..... .+ ++..+..++.|++.||+|||++||+||||||+||+++.+.+.++|+|||++..
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEEEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 8999999999999999986432 24 78889999999999999999999999999999999987446899999999875
Q ss_pred cccc-cccccccCccceeccccccccc-ccccccccccCC------------------------------CCCCCCCCCh
Q 021127 176 ESLT-EMMTAETGTYRWMAPELYSTVT-LRQGEKKHYNHK------------------------------NVRPSAENVP 223 (317)
Q Consensus 176 ~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~~------------------------------~~~~~~~~~~ 223 (317)
.... .......++..|+|||++.... ......+.|+.+ .....+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06624 159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLS 238 (268)
T ss_pred cccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccC
Confidence 4322 1222345789999999875422 111122222211 0111244677
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.++.+++.+||+.+|.+|||+.+++++
T Consensus 239 ~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 239 AEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 899999999999999999999999876
No 261
>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase. Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and
Probab=100.00 E-value=2e-34 Score=246.96 Aligned_cols=217 Identities=27% Similarity=0.493 Sum_probs=173.0
Q ss_pred ceeccccceEEEEeEEC---C--eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCceEEEEEc
Q 021127 30 PRIGEGAHAKVYEGKYK---N--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTEL 104 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~---~--~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~ 104 (317)
++||+|++|.||+|.+. + ..||||.+...... ...+++.+|+.++++++|+||+++++.+.+...++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS----DIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH----HHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEe
Confidence 46899999999999874 2 36999998776543 345678999999999999999999999877889999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc----
Q 021127 105 LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---- 180 (317)
Q Consensus 105 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---- 180 (317)
+++++|.+++.......+++..++.++.|++.||+|||++|++|+||+|+||+++.+ +.+||+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC-CEEEecccccccccccccccee
Confidence 999999999987653458999999999999999999999999999999999999998 799999999997543321
Q ss_pred ccccccCccceecccccccccccccccccccC------------------------------CCCCCCCCCChHHHHHHH
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH------------------------------KNVRPSAENVPEELSIIL 230 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~l~~li 230 (317)
......++..|+|||.+.+...... .+.|+. ......+..+|..+.+++
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 234 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVM 234 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHH
Confidence 1122356788999998654322111 111110 111223456788999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHH
Q 021127 231 TSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 231 ~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.+||+.+|++||++.++++.|.
T Consensus 235 ~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 235 LQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHCCCCcccCCCHHHHHHHhc
Confidence 9999999999999999998764
No 262
>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their
Probab=100.00 E-value=1.4e-34 Score=249.30 Aligned_cols=223 Identities=22% Similarity=0.409 Sum_probs=175.9
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChH-HHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPE-EIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
+|+..+.||+|++|.||++... ++.||+|++....... ...+....+.+|+.++++++|+||+++++++.++ ..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999874 8899999987544221 1223456789999999999999999999998765 7899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++++|.+++..... +++..++.++.|++.||+|||++|++|+||+|+||+++.+...+||+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGA--FKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 9999999999999986543 89999999999999999999999999999999999998764469999999987543321
Q ss_pred -----ccccccCccceecccccccccccccccccccCC--------------------------------CCCCCCCCCh
Q 021127 181 -----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------------------------NVRPSAENVP 223 (317)
Q Consensus 181 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~ 223 (317)
......++..|+|||++.+.... ...+.|+.+ .....+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 11234578899999987653321 122222211 0112234567
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.++.+++.+||..+|.+||++.+++++
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 889999999999999999999999876
No 263
>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4. Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin
Probab=100.00 E-value=8.5e-35 Score=255.51 Aligned_cols=230 Identities=25% Similarity=0.482 Sum_probs=179.4
Q ss_pred ecCCceeecceeccccceEEEEeEEC--Ce----EEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQ----TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~----~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
+..++|+..+.||+|+||.||+|.+. +. .||+|.+...... .....+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~~~~l~h~niv~~~~~~~ 79 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP----KANVEFMDEALIMASMDHPHLVRLLGVCL 79 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCH----HHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 45678899999999999999999873 33 5799988754432 22345889999999999999999999998
Q ss_pred cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 95 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
....++++||+++|+|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++
T Consensus 80 ~~~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~-~~~kL~Dfg~~~ 157 (303)
T cd05110 80 SPTIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSP-NHVKITDFGLAR 157 (303)
T ss_pred CCCceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCC-CceEEccccccc
Confidence 777889999999999999987643 238999999999999999999999999999999999999887 689999999998
Q ss_pred ccccccc---cccccCccceecccccccccccccccccccC-----------------------------CCCCCCCCCC
Q 021127 175 EESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNH-----------------------------KNVRPSAENV 222 (317)
Q Consensus 175 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~ 222 (317)
....... .....++..|+|||.+.+...... .+.|+. ....+.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPIC 236 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Confidence 5432211 122335678999998754322111 111111 0112223456
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+..+.+++.+||..+|++||++.++++.+.++...
T Consensus 237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 237 TIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 78899999999999999999999999999887644
No 264
>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=9.5e-35 Score=252.99 Aligned_cols=223 Identities=21% Similarity=0.341 Sum_probs=176.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l 100 (317)
++|++.+.||+|+||.||++.+. +..||+|.+...... .....+.+|+.++++++|+||+++++.+.. +..++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE----SKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYM 76 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCH----HHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEE
Confidence 46899999999999999999986 889999998754332 224568899999999999999999998865 48999
Q ss_pred EEEccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 101 VTELLSGGTLRKYLLNMR-PRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
||||+++++|..++.... ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.+ +.+||+|||++.....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVA 155 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCC-CCEEEeecCCcccccC
Confidence 999999999999887632 2248999999999999999999997 599999999999999987 7899999999875432
Q ss_pred ccccccccCccceecccccccccc-----cccccccccCC-------------------------------CCCCCCCCC
Q 021127 179 TEMMTAETGTYRWMAPELYSTVTL-----RQGEKKHYNHK-------------------------------NVRPSAENV 222 (317)
Q Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~~~~~~~-------------------------------~~~~~~~~~ 222 (317)
. ......++..|+|||++.+... .....+.|+.+ .....+..+
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 156 S-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred C-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 2 2233468889999998754322 11122222211 111224457
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+.++.+||.+||+.+|.+||++.+++++.+
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 889999999999999999999999998743
No 265
>PHA03207 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=1e-34 Score=263.73 Aligned_cols=216 Identities=23% Similarity=0.326 Sum_probs=168.8
Q ss_pred ecCCceeecceeccccceEEEEeEEC----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 96 (317)
+...+|.+.+.||.|+||.||++... +..||+|.+.... ...+|++++++++|+||+++++++...
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----------~~~~E~~il~~l~h~~iv~~~~~~~~~ 158 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----------TPGREIDILKTISHRAIINLIHAYRWK 158 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----------cHHHHHHHHHhcCCCCccceeeeEeeC
Confidence 44567999999999999999998753 5779999876532 245799999999999999999988754
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
..++|||++ +++|.+++.... .+++..++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 159 ~~~~lv~e~~-~~~l~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~-~~~~l~DfG~a~~ 234 (392)
T PHA03207 159 STVCMVMPKY-KCDLFTYVDRSG--PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEP-ENAVLGDFGAACK 234 (392)
T ss_pred CEEEEEehhc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC-CCEEEccCccccc
Confidence 899999999 578999885433 49999999999999999999999999999999999999988 7899999999975
Q ss_pred ccccc---ccccccCccceecccccccccccccccccccCC---------------------------------------
Q 021127 176 ESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------------------------------- 213 (317)
Q Consensus 176 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------------------------------- 213 (317)
..... ......||+.|+|||++.+..+.. ..++|+.+
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCA-KTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 43221 122456899999999876532211 11111111
Q ss_pred -----------------CCCC--------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 214 -----------------NVRP--------SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 214 -----------------~~~~--------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
...+ ....++.++.++|.+||..||++|||+.+++.+-
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0000 0123466788999999999999999999999983
No 266
>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina
Probab=100.00 E-value=1.8e-34 Score=249.03 Aligned_cols=216 Identities=26% Similarity=0.431 Sum_probs=162.5
Q ss_pred ceeccccceEEEEeEEC----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEc
Q 021127 30 PRIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTEL 104 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 104 (317)
++||+|+||.||+|... ...+|+|.+...... .....+.+|+..++.++|+||+++++.+.+. ..++||||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATP----DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF 76 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCCh----HHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence 46899999999999653 457888887654332 2344688999999999999999999998755 79999999
Q ss_pred cCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 105 LSGGTLRKYLLNMRP---RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 105 ~~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
+++|+|.+++..... ...++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++........
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD-LSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC-CcEEEeccccccccccchh
Confidence 999999999976442 235678889999999999999999999999999999999998 7999999999864322211
Q ss_pred ---cccccCccceeccccccccc------ccccccccccCC-------------------------------C---CCCC
Q 021127 182 ---MTAETGTYRWMAPELYSTVT------LRQGEKKHYNHK-------------------------------N---VRPS 218 (317)
Q Consensus 182 ---~~~~~gt~~y~aPE~~~~~~------~~~~~~~~~~~~-------------------------------~---~~~~ 218 (317)
.....++..|+|||++.... ......++|+.+ . ....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQL 235 (269)
T ss_pred eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcc
Confidence 12234567899999864211 111112222111 0 0111
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
+..++..+.+++..|| .||++||+++++++.|
T Consensus 236 ~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 236 DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 3356788899999999 5999999999999875
No 267
>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI
Probab=100.00 E-value=4.8e-35 Score=254.74 Aligned_cols=221 Identities=29% Similarity=0.380 Sum_probs=174.3
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.++||+|+||.||+|.+. ++.||+|.+....... .....+.+|+++++.++|+||+++++++.++ ..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 77 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK---MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL 77 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc---hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence 47899999999999999999985 7899999987544322 2344578899999999999999999998755 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
||||+++++|..+...... +++..++.++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 78 v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~-~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 78 VFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPG 154 (286)
T ss_pred EEecCCccHHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CcEEEEeeeeeeeccCCc
Confidence 9999999988887664333 8999999999999999999999999999999999999988 78999999998754322
Q ss_pred cccccccCccceecccccccccccccccccccCC--------CC------------------------------------
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------------------------------ 215 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------------------------------ 215 (317)
.......++..|+|||++.+........++|+.+ ..
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 2223346788999999875432222222222211 00
Q ss_pred --------------CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 --------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 --------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
......++..+.+|+.+||+.+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00123567889999999999999999999999876
No 268
>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I
Probab=100.00 E-value=2.3e-34 Score=248.69 Aligned_cols=221 Identities=28% Similarity=0.421 Sum_probs=175.5
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC---
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP--- 96 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--- 96 (317)
.++|++.+.||+|++|.||+|.+. ++.+++|++..... ....+.+|+.+++++ .|+||+++++++.+.
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED------EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch------hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 478999999999999999999985 68899999876543 234688999999999 799999999998543
Q ss_pred ----ceEEEEEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEccc
Q 021127 97 ----VMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (317)
Q Consensus 97 ----~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Df 170 (317)
..++||||+++++|.+++.... ...+++..+..++.|++.||+|||++|++|+||+|+||+++.+ +.++|+||
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~-~~~~l~d~ 157 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKN-AEVKLVDF 157 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccC-CeEEECCC
Confidence 4899999999999999987643 4458999999999999999999999999999999999999988 78999999
Q ss_pred Ccccccccc-cccccccCccceecccccccccc----cccccccccCC--------C----------------------C
Q 021127 171 GLAREESLT-EMMTAETGTYRWMAPELYSTVTL----RQGEKKHYNHK--------N----------------------V 215 (317)
Q Consensus 171 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~~~--------~----------------------~ 215 (317)
|++...... .......|+..|+|||++..... .....+.|+.+ . .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT 237 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence 998754322 22234568899999998754221 11123333322 0 0
Q ss_pred CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
...+..++.++.+|+.+||..||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 01122366789999999999999999999999875
No 269
>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki
Probab=100.00 E-value=1.4e-34 Score=248.11 Aligned_cols=211 Identities=22% Similarity=0.407 Sum_probs=164.4
Q ss_pred ceeccccceEEEEeEECC------------eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCc
Q 021127 30 PRIGEGAHAKVYEGKYKN------------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPV 97 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~~------------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 97 (317)
+.||+|+||.||+|.+.+ ..+++|.+...... ...+.+|+.++++++|+||+++++++....
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD------SLAFFETASLMSQLSHKHLVKLYGVCVRDE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh------HHHHHHHHHHHHcCCCcchhheeeEEecCC
Confidence 468999999999998863 24788877644321 456889999999999999999999887677
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCC-------ceEEccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK-------TIKLADF 170 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~-------~~kl~Df 170 (317)
.++||||+++++|.+++..... .+++..++.++.||+.||+|||++||+||||||+||+++.+ + .+||+||
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~-~~~~~~~~~~kl~Df 152 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARY-GLNEGYVPFIKLSDP 152 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecC-ccccCCceeEEeCCC
Confidence 8999999999999999986542 48999999999999999999999999999999999999977 4 6999999
Q ss_pred CcccccccccccccccCccceecccccccc-cccccccccccCC----------C-----------------CCCCCCCC
Q 021127 171 GLAREESLTEMMTAETGTYRWMAPELYSTV-TLRQGEKKHYNHK----------N-----------------VRPSAENV 222 (317)
Q Consensus 171 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~~----------~-----------------~~~~~~~~ 222 (317)
|++..... .....++..|+|||++.+. .......+.|+.+ . ....+...
T Consensus 153 g~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (259)
T cd05037 153 GIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPD 229 (259)
T ss_pred Cccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCCCC
Confidence 99986433 2234567789999997654 1111122222211 0 00011122
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
...+.+++.+||..+|.+||++.++++.|
T Consensus 230 ~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 230 CAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 36899999999999999999999998865
No 270
>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte
Probab=100.00 E-value=2.2e-34 Score=248.78 Aligned_cols=223 Identities=24% Similarity=0.408 Sum_probs=174.3
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChH-----HHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPE-----EIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
+|.+.+.||+|+||.||+|... ++.||||.+....... ......+.+.+|+.++++++|+|++++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5788999999999999999764 7899999886432211 1122345678899999999999999999998765
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++++||||+|+||+++.+ +.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~-~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDAD-GICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCC-CeEEEeeccccccc
Confidence 7899999999999999998764 38999999999999999999999999999999999999988 79999999999754
Q ss_pred cccc---ccccccCccceeccccccccc-ccccccccccCC-----------------------------CCCC----CC
Q 021127 177 SLTE---MMTAETGTYRWMAPELYSTVT-LRQGEKKHYNHK-----------------------------NVRP----SA 219 (317)
Q Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~~-----------------------------~~~~----~~ 219 (317)
.... ......++..|+|||.+.... ......+.|+.+ .... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 3211 122345788999999876533 112222222211 0001 12
Q ss_pred CCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 220 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 220 ~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
..++.++.+++.+||..+|.+||++++++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 3457899999999999999999999999876
No 271
>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=6.9e-36 Score=267.76 Aligned_cols=217 Identities=25% Similarity=0.439 Sum_probs=170.6
Q ss_pred Cce-eecceeccccceEEEEeEEC--CeEEE---EEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 24 KHL-FVGPRIGEGAHAKVYEGKYK--NQTVA---IKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 24 ~~y-~~~~~lG~G~~g~V~~~~~~--~~~va---iK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
++| ++..+||+|+|-+||+|.++ |..|| ||.-..... .+..++|..|+.+|+.|+||||+++|+++.+.
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~----~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~ 114 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQS----PEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD 114 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcC----hHHHHHHHHHHHHHccCCCCceeeeeeheecCC
Confidence 344 46778999999999999886 44444 332222222 24457899999999999999999999988643
Q ss_pred --ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 97 --VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--GIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 97 --~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~--~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
.+.+|+|++..|+|..|+.+.+. ++.+.+..|+.||+.||.|||++ .|||||||.+||||+.+.|.|||+|+|+
T Consensus 115 n~~in~iTEL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGL 192 (632)
T KOG0584|consen 115 NKTINFITELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGL 192 (632)
T ss_pred CceeeeeeecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhH
Confidence 58899999999999999998776 89999999999999999999998 5999999999999999999999999999
Q ss_pred ccccccccccccccCccceecccccccccccccccccccCC----------------------------CCCCC--CCCC
Q 021127 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPS--AENV 222 (317)
Q Consensus 173 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~--~~~~ 222 (317)
|........ ....|||.|||||+|... + ....++|+++ +..|. ..--
T Consensus 193 Atl~r~s~a-ksvIGTPEFMAPEmYEE~-Y-nE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 193 ATLLRKSHA-KSVIGTPEFMAPEMYEEN-Y-NELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK 269 (632)
T ss_pred HHHhhcccc-ceeccCccccChHHHhhh-c-chhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC
Confidence 987654433 336899999999998732 1 1222223322 11111 1112
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+++++||.+||.. ..+|||+.|+|++
T Consensus 270 dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 270 DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 46899999999999 9999999999976
No 272
>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of
Probab=100.00 E-value=2.1e-34 Score=249.83 Aligned_cols=215 Identities=25% Similarity=0.343 Sum_probs=170.8
Q ss_pred eccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCCC
Q 021127 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGG 108 (317)
Q Consensus 32 lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g 108 (317)
||+|+||+||++.+. ++.||+|.+....... ......+.+|++++++++||||+++++++... ..++||||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK--RKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh--hhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence 699999999999775 8899999987643221 22345678899999999999999999988654 899999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccccccccCc
Q 021127 109 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT 188 (317)
Q Consensus 109 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt 188 (317)
+|.+++.......+++..++.++.|++.||.|||++|++||||+|+||+++.+ +.++|+|||++.............++
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH-GNVRISDLGLAVELKGGKKIKGRAGT 157 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEccCcchhhhccCCccccccCC
Confidence 99999987665569999999999999999999999999999999999999988 68999999998755433333345678
Q ss_pred cceecccccccccccccccccccCC-------------------------------CCCCCCCCChHHHHHHHHHhhhcC
Q 021127 189 YRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVPEELSIILTSCWKED 237 (317)
Q Consensus 189 ~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l~~li~~cl~~~ 237 (317)
..|+|||++.+... ....+.|+.+ .....+..++..+.++|.+||+.|
T Consensus 158 ~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 158 PGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 89999998765332 1122222211 011123456889999999999999
Q ss_pred CCCCC-----CHHHHHHH
Q 021127 238 PNARP-----NFTQIIQM 250 (317)
Q Consensus 238 p~~Rp-----s~~~~~~~ 250 (317)
|.+|| ++.+++++
T Consensus 237 p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 237 PEKRLGCRGGSADEVREH 254 (277)
T ss_pred hhHccCCCcccHHHHHhC
Confidence 99999 77778765
No 273
>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]
Probab=100.00 E-value=4.8e-35 Score=257.20 Aligned_cols=219 Identities=25% Similarity=0.363 Sum_probs=184.1
Q ss_pred cceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 29 GPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
.+.||+|.||+||-|++. |+.||||++.+...+. +.+..+.+|+.+|+.+.||.||.+...|+.. ..++|||-+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~---kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl 645 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT---KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL 645 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCC---chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh
Confidence 568999999999998775 9999999998876654 4456789999999999999999999999876 789999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC--CCCceEEcccCcccccccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE--DLKTIKLADFGLAREESLTEMMT 183 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~--~~~~~kl~Dfg~a~~~~~~~~~~ 183 (317)
.|++.+.|......++++.....++.||+.||.|||.++|+|+||||+|||+.. +.-++||||||+|+.........
T Consensus 646 -~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr 724 (888)
T KOG4236|consen 646 -HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR 724 (888)
T ss_pred -cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhh
Confidence 678878777666677999999999999999999999999999999999999974 34589999999999988877888
Q ss_pred cccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHHHHHHHhh
Q 021127 184 AETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSIILTSCW 234 (317)
Q Consensus 184 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~cl 234 (317)
..+||+.|+|||++....+....+.| +.+ ........++.+..+||..+|
T Consensus 725 sVVGTPAYLaPEVLrnkGyNrSLDMW-SVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LL 803 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRNKGYNRSLDMW-SVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLL 803 (888)
T ss_pred hhcCCccccCHHHHhhccccccccce-eeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHH
Confidence 88999999999999876655443332 211 111123567889999999999
Q ss_pred hcCCCCCCCHHHHHHHHH
Q 021127 235 KEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 235 ~~~p~~Rps~~~~~~~l~ 252 (317)
+..-.+|.|++..+.|.|
T Consensus 804 qVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 804 QVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred HHHHHHhcchHhhccchh
Confidence 999999999999887754
No 274
>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6. Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs
Probab=100.00 E-value=4.1e-34 Score=248.45 Aligned_cols=221 Identities=25% Similarity=0.384 Sum_probs=170.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHH-HHhcCCCCeeeEEeeeecC-ceE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAM-LSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
++|++.+.||+|+||.||++.+. ++.||||.+........ ..++..|+.. ++.++|+||+++++++..+ ..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~ 76 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE----QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW 76 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH----HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence 47899999999999999999885 89999999876543221 2345556665 5567999999999998654 899
Q ss_pred EEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 100 IVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
++|||++ ++|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||+++.+ +.+||+|||++...
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~-~~~kl~dfg~~~~~ 154 (283)
T cd06617 77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRN-GQVKLCDFGISGYL 154 (283)
T ss_pred EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC-CCEEEeeccccccc
Confidence 9999995 7898888653 223589999999999999999999998 99999999999999988 79999999999865
Q ss_pred ccccccccccCccceecccccccccc---cccccccccCC----------------------------CCCC--CCCCCh
Q 021127 177 SLTEMMTAETGTYRWMAPELYSTVTL---RQGEKKHYNHK----------------------------NVRP--SAENVP 223 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~~~----------------------------~~~~--~~~~~~ 223 (317)
..........++..|+|||++.+... .....+.|..+ ...+ ....++
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS 234 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccC
Confidence 43333333568889999998764211 11223333222 0001 123468
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.++.+++.+||..+|.+||++.+++++
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 899999999999999999999999986
No 275
>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex
Probab=100.00 E-value=1.2e-34 Score=252.04 Aligned_cols=221 Identities=26% Similarity=0.393 Sum_probs=174.2
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.+.||.|++|.||+|.+. ++.||||.+....... .....+.+|++++++++||||+++++++.++ ..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 77 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc---ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence 4889999999999999999884 7899999887544322 1234688899999999999999999998654 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-c
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-E 180 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~ 180 (317)
|||+. ++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.+||+|||++...... .
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~-~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVR 155 (284)
T ss_pred eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEeeccchhhcccCcc
Confidence 99995 689999876555568999999999999999999999999999999999999988 68999999998754322 1
Q ss_pred ccccccCccceecccccccccccccccccccCC--------CCC------------------------------------
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR------------------------------------ 216 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~------------------------------------ 216 (317)
......++..|+|||++.+........++|+.+ ...
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 223345788999999876533222223333322 000
Q ss_pred ------------CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 ------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 ------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.....++.+++++|.+||+.||.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0012457788999999999999999999999876
No 276
>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a
Probab=100.00 E-value=4.4e-34 Score=251.22 Aligned_cols=222 Identities=25% Similarity=0.343 Sum_probs=171.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||++.+. ++.||+|.+....... ......+.+|+++++.++||||+++++.+..+ ..++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLIL--RNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhh--HHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEE
Confidence 46899999999999999999886 6889999987653221 23345788999999999999999999988755 7899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||++|++|.+++...+. +++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++......
T Consensus 79 v~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~-~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGA--LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSM-GHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCC-CCEEEeeCCCccccCcCc
Confidence 9999999999999977543 8999999999999999999999999999999999999987 799999999986311100
Q ss_pred ----------------ccccccCccceecccccccccccccccccccCC---------------------------C--C
Q 021127 181 ----------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------N--V 215 (317)
Q Consensus 181 ----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~--~ 215 (317)
......++..|+|||.+....... ..+.|+.+ . .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGK-PVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 234 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 011235788899999875532221 12222111 0 0
Q ss_pred CC-CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 216 RP-SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 216 ~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
.+ ....++.++.++|.+||+.||++||++.++.+.+
T Consensus 235 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 235 WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 11 1225788999999999999999999854444433
No 277
>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4
Probab=100.00 E-value=5e-34 Score=245.27 Aligned_cols=220 Identities=30% Similarity=0.452 Sum_probs=175.8
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.+.||+|+||.||++... ++.||+|.++..... ......+.+|+.++++++|+||+++++.+.+. ..++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND---PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIF 77 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc---hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEE
Confidence 5889999999999999999874 789999999866543 24466789999999999999999999988654 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
+||+++++|.+++..... +++..+..++.+++.||+|||+.|++|+||+|+||+++.+ +.+||+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~-~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 78 MEYCSGGTLEELLEHGRI--LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred EecCCCCcHHHHHhhcCC--CChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEcccccccccCCCCC
Confidence 999999999999986443 8899999999999999999999999999999999999997 7899999999875433222
Q ss_pred c-----ccccCccceeccccccccc--ccccccccccCC-------------------------------CCCCCCCCCh
Q 021127 182 M-----TAETGTYRWMAPELYSTVT--LRQGEKKHYNHK-------------------------------NVRPSAENVP 223 (317)
Q Consensus 182 ~-----~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~~~-------------------------------~~~~~~~~~~ 223 (317)
. ....++..|+|||++.+.. ......+.|..+ ...+....++
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLS 234 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccC
Confidence 1 1245788999999876543 111122222211 0111122347
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
..+.+++.+||+.+|.+||++.+++.+
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 235 PEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 889999999999999999999999865
No 278
>PLN00009 cyclin-dependent kinase A; Provisional
Probab=100.00 E-value=3.8e-34 Score=250.23 Aligned_cols=223 Identities=26% Similarity=0.349 Sum_probs=173.4
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||.|++|.||+|.+. ++.||+|.+....... .....+.+|++++++++|+||+++++++.++ ..++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE---GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYL 78 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc---cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEE
Confidence 57999999999999999999875 7889999986543321 2234578899999999999999999998765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
||||++ ++|.+++.......+++..+..++.||+.||+|||++|++|+||+|+||+++.+.+.+||+|||++......
T Consensus 79 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 79 VFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred EEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 999995 688888876555447888999999999999999999999999999999999865467999999999754322
Q ss_pred cccccccCccceecccccccccccccccccccCC--------CCCC----------------------------------
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVRP---------------------------------- 217 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~~---------------------------------- 217 (317)
.......+++.|+|||++.+........++|+.+ ...+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence 1223345788999999875532222222232221 0000
Q ss_pred --------------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 --------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 --------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
....++.++.+++.+||+.+|++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 023567889999999999999999999999986
No 279
>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.
Probab=100.00 E-value=1.8e-34 Score=247.07 Aligned_cols=222 Identities=26% Similarity=0.449 Sum_probs=176.2
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.+.||+|+||.||++.++ +..||+|.+....... .....+.+|+.+++.++|+||+++++.+.+. ..++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv 77 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV---KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIV 77 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc---hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEE
Confidence 5889999999999999999885 7889999987643221 2234678899999999999999999988655 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc-
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE- 180 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~- 180 (317)
+||+++++|.+++.......+++..+..++.|++.||+|||+++++|+||+|+||+++.+...+||+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999999999875555589999999999999999999999999999999999999874457999999987543322
Q ss_pred ccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHHHH
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
......|++.|+|||++.+..... ..+.|+.+ ...+....++.++.+++.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNN-KTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence 222345888999999876532211 12222211 1112234568899999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 021127 233 CWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 233 cl~~~p~~Rps~~~~~~~ 250 (317)
||..+|++|||+.+++++
T Consensus 237 ~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 237 LFKVSPRDRPSITSILKR 254 (257)
T ss_pred HhccChhhCcCHHHHhhC
Confidence 999999999999999876
No 280
>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter
Probab=100.00 E-value=4.5e-34 Score=247.70 Aligned_cols=220 Identities=27% Similarity=0.437 Sum_probs=176.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
..|+..++||.|+||.||+|.+. +..||||++...... .....+.+|+.++++++|+||+++++++.++ ..++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE----DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI 79 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 46788899999999999999874 789999998765432 2345688999999999999999999998765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++++|.+++... .+++..+..++.|++.||+|||+++++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 80 IMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCC-CCEEEcccccceeccCCc
Confidence 99999999999998752 38999999999999999999999999999999999999988 689999999997543322
Q ss_pred c-cccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHHH
Q 021127 181 M-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 181 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li~ 231 (317)
. .....++..|+|||++.+.... ...+.|+.+ .....+..++..+.+++.
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYD-SKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFID 234 (277)
T ss_pred cccccccCcccccCHhHhccCCCc-cHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHH
Confidence 1 2234578899999987653321 112222211 011123356788999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHH
Q 021127 232 SCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 232 ~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+||+.+|.+||++.+++++.+
T Consensus 235 ~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 235 ACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred HHcccCcccCcCHHHHHhChH
Confidence 999999999999999998844
No 281
>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k
Probab=100.00 E-value=6e-34 Score=243.16 Aligned_cols=216 Identities=33% Similarity=0.574 Sum_probs=171.3
Q ss_pred ceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCC
Q 021127 30 PRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSG 107 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~ 107 (317)
++||.|+||.||++.+. ++.||+|.+...... .....+.+|++++++++|+||+++++++.+. ..++||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP----DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH----HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 46899999999999886 899999998765543 2345688999999999999999999998765 79999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccccc---cc
Q 021127 108 GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM---TA 184 (317)
Q Consensus 108 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~ 184 (317)
++|.+++..... .+++..++.++.+++.||+|||+++++||||+|+||+++.+ +.++|+|||++......... ..
T Consensus 77 ~~l~~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 77 GSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGEN-NVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred CcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCC-CcEEEeeccccccccCCcceecccc
Confidence 999999976432 48899999999999999999999999999999999999988 79999999999754322111 11
Q ss_pred ccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHHHHHHHhhh
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSIILTSCWK 235 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~cl~ 235 (317)
..++..|+|||++.+.... ...++|+.+ ...+.+..++.++.+++.+||+
T Consensus 155 ~~~~~~y~~PE~~~~~~~~-~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 233 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYT-SESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWA 233 (251)
T ss_pred CcceeccCChHhhccCCCC-cchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhc
Confidence 2335679999987653221 112222211 1122345678899999999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 021127 236 EDPNARPNFTQIIQMLL 252 (317)
Q Consensus 236 ~~p~~Rps~~~~~~~l~ 252 (317)
.+|.+||++.++++.|.
T Consensus 234 ~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 234 YDPENRPSFSEIYNELQ 250 (251)
T ss_pred cChhhCcCHHHHHHHhh
Confidence 99999999999998875
No 282
>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho
Probab=100.00 E-value=8.2e-34 Score=244.30 Aligned_cols=223 Identities=23% Similarity=0.394 Sum_probs=177.1
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---Cc
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PV 97 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~ 97 (317)
+.+|.+.+.||+|+||.||+|.+. +..||+|.+...............+.+|+.++++++|+||+++++++.+ ..
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 1 PVNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CCceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCE
Confidence 468999999999999999999874 7899999986543322223445678899999999999999999998864 35
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
+++++||+++++|.+++..... +++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||+++...
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~ 157 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGA--LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEECccccccccc
Confidence 8899999999999999986544 8899999999999999999999999999999999999988 689999999997543
Q ss_pred cc----cccccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChH
Q 021127 178 LT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPE 224 (317)
Q Consensus 178 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~ 224 (317)
.. .......++..|+|||++.+.... ...+.|+.+ .....+..+++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 236 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYG-RKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD 236 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCH
Confidence 21 112234588999999988653322 122222211 11223567889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+.+++.+||+ +|..||++.+++.|
T Consensus 237 ~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 237 ACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHHHHHHhc-CcccCccHHHHhcC
Confidence 99999999999 57999999998775
No 283
>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning
Probab=100.00 E-value=2e-34 Score=250.93 Aligned_cols=221 Identities=28% Similarity=0.345 Sum_probs=173.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|++|.||+|.+. ++.||||.+....... .....+.+|++++++++|+||+++++++.++ ..++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 77 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDE---DVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYL 77 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccc---cchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEE
Confidence 47999999999999999999885 7899999987543322 2345688999999999999999999998754 7999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||++++.+..+.... ..+++..++.++.|++.||+|||+++++|+||+|+||+++.+ +.+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~-~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 78 VFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSES-GVLKLCDFGFARALRARP 154 (288)
T ss_pred EEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEEeeecccccCCCc
Confidence 99999887666655443 338999999999999999999999999999999999999988 789999999988654332
Q ss_pred --ccccccCccceecccccccccccccccccccCC--------CC-----------------------------------
Q 021127 181 --MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV----------------------------------- 215 (317)
Q Consensus 181 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~----------------------------------- 215 (317)
......++..|+|||++.+........+.|+.+ ..
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 223456788999999876652222223333211 00
Q ss_pred -----C-----------CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 -----R-----------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 -----~-----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
. ..+..++.++.+||.+||..+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0 0112347889999999999999999999999865
No 284
>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]
Probab=100.00 E-value=3.1e-35 Score=266.70 Aligned_cols=228 Identities=29% Similarity=0.466 Sum_probs=179.0
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-------
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE------- 95 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------- 95 (317)
.+...+.||+||||.||+|+++ |+.||||.++..... +.+++..+|++++++++|+|||+++++-++
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~----r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL----RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhccc----chHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence 3455677999999999999975 999999999876542 446678999999999999999999998643
Q ss_pred CceEEEEEccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC---CCceEEcccC
Q 021127 96 PVMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED---LKTIKLADFG 171 (317)
Q Consensus 96 ~~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~---~~~~kl~Dfg 171 (317)
....+|||||.||+|...+..-.. ..+++..++.++.+++.||.|||++|||||||||.||++-.. ....||+|||
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 247899999999999999985322 349999999999999999999999999999999999998632 1247999999
Q ss_pred cccccccccccccccCccceecccccccccccccccccccCC--------------------------------------
Q 021127 172 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------------- 213 (317)
Q Consensus 172 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------------- 213 (317)
.|+..+......+..||..|.+||++..........+.|+.+
T Consensus 170 ~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 170 AARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred ccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 999888887888889999999999988533333333333332
Q ss_pred --------------CCCCCCCCCh----HHHHHHHHHhhhcCCCCCC--CHHHHHHHHHHhhh
Q 021127 214 --------------NVRPSAENVP----EELSIILTSCWKEDPNARP--NFTQIIQMLLNYLS 256 (317)
Q Consensus 214 --------------~~~~~~~~~~----~~l~~li~~cl~~~p~~Rp--s~~~~~~~l~~~~~ 256 (317)
...|.+..++ ..+..++..+|..+|.+|- ...+....+.+.+.
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 1112222333 3356778889999999998 77776666666554
No 285
>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent
Probab=100.00 E-value=6.3e-34 Score=246.60 Aligned_cols=218 Identities=26% Similarity=0.408 Sum_probs=173.5
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC---CCCeeeEEeeeecC-ce
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ---HRNLVKFIGACKEP-VM 98 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~-~~ 98 (317)
.|++.+.||+|+||.||+|.+. ++.||+|.+....... ...++.+|+.++++++ |||++++++++.++ ..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~ 77 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDD----DVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL 77 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCch----hHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence 5788899999999999999974 7899999987654332 2345788999999986 99999999988655 78
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+++++|.+++... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 78 WIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNT-GNVKLCDFGVAALLNQ 153 (277)
T ss_pred EEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCC-CCEEEccCCceeecCC
Confidence 9999999999999998653 38999999999999999999999999999999999999987 7999999999875433
Q ss_pred cc-ccccccCccceecccccccccccccccccccCC---------------------------CCCC-C-CCCChHHHHH
Q 021127 179 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRP-S-AENVPEELSI 228 (317)
Q Consensus 179 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~-~-~~~~~~~l~~ 228 (317)
.. ......|+..|+|||.+.+........+.|+.+ ...+ . ...++.++.+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (277)
T cd06917 154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLRE 233 (277)
T ss_pred CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHH
Confidence 22 223346889999999875432222222333211 0001 1 1136789999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 021127 229 ILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 229 li~~cl~~~p~~Rps~~~~~~~ 250 (317)
++.+||+.||++||++.+++.+
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhC
Confidence 9999999999999999999886
No 286
>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as
Probab=100.00 E-value=3.5e-34 Score=253.06 Aligned_cols=163 Identities=25% Similarity=0.387 Sum_probs=130.0
Q ss_pred cceeccccceEEEEeEEC----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee---cCceEEE
Q 021127 29 GPRIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK---EPVMVIV 101 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~---~~~~~lv 101 (317)
+.+||+|+||.||+|+.. +..||+|.+...... ..+.+|+.++++++||||+++++++. +...++|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-------MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc-------HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence 467999999999999864 478999998754432 23678999999999999999999874 2478999
Q ss_pred EEccCCCCHHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC---CCCceEEcccC
Q 021127 102 TELLSGGTLRKYLLNM-------RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE---DLKTIKLADFG 171 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~-------~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~---~~~~~kl~Dfg 171 (317)
|||+. ++|.+++... ....+++..+..++.|++.||.|||++||+||||||+||++.. ..+.+||+|||
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 79 FDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 99995 6888877532 1224889999999999999999999999999999999999942 22689999999
Q ss_pred ccccccccc----ccccccCccceeccccccc
Q 021127 172 LAREESLTE----MMTAETGTYRWMAPELYST 199 (317)
Q Consensus 172 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~ 199 (317)
+++...... ......||+.|+|||++.+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 189 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLG 189 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcC
Confidence 998543321 1233468999999998765
No 287
>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.1e-34 Score=256.09 Aligned_cols=228 Identities=22% Similarity=0.331 Sum_probs=178.6
Q ss_pred CCceeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeee
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGAC 93 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 93 (317)
+..+.|....|+++++||+||.+.||++... .+.+|+|.+....... ....-|.+|+..|.+| .|.+||+|+++-
T Consensus 353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~---qtl~gy~nEI~lL~KLkg~~~IIqL~DYE 429 (677)
T KOG0596|consen 353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADN---QTLDGYRNEIALLNKLKGHDKIIQLYDYE 429 (677)
T ss_pred CeeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCH---HHHHHHHHHHHHHHHhcCCceEEEEeeee
Confidence 4567899999999999999999999999876 4667777665444333 3355699999999999 699999999997
Q ss_pred e-cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 94 K-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 94 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
. ++.+|+||||- ..+|.+.|.+.... .+.-.+..+..|++.|+.++|+.||||.||||.|+|+.. |.+||+|||+
T Consensus 430 v~d~~lYmvmE~G-d~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk--G~LKLIDFGI 505 (677)
T KOG0596|consen 430 VTDGYLYMVMECG-DIDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK--GRLKLIDFGI 505 (677)
T ss_pred ccCceEEEEeecc-cccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe--eeEEeeeech
Confidence 5 66999999976 67999999876654 332377889999999999999999999999999999998 5899999999
Q ss_pred cccccccc---ccccccCccceeccccccccccc----------ccccccccCC--------------------------
Q 021127 173 AREESLTE---MMTAETGTYRWMAPELYSTVTLR----------QGEKKHYNHK-------------------------- 213 (317)
Q Consensus 173 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~----------~~~~~~~~~~-------------------------- 213 (317)
|+...... .....+||+.||+||.+...... ....++|+.+
T Consensus 506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI 585 (677)
T KOG0596|consen 506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAI 585 (677)
T ss_pred hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhh
Confidence 98654332 23456899999999998765443 1234455544
Q ss_pred ---CC-CCCCCC-ChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 ---NV-RPSAEN-VPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 ---~~-~~~~~~-~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+. .+.+.. -..++.++|+.||..||.+||++.++|++
T Consensus 586 ~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 586 TDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred cCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 00 011111 12349999999999999999999999987
No 288
>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1. Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25
Probab=100.00 E-value=2.5e-34 Score=249.21 Aligned_cols=220 Identities=26% Similarity=0.422 Sum_probs=174.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
+.|+..+.||+|+||.||+|.+. ++.||+|.+....... ....+.+|+.++++++|+||+++++++..+ ..++
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED----EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI 79 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH----HHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence 45778889999999999999875 7889999987554322 245688999999999999999999988655 7999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 80 IMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCC-CCEEEccccccccccCcc
Confidence 9999999999998864 238999999999999999999999999999999999999988 789999999997544322
Q ss_pred -ccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHHH
Q 021127 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li~ 231 (317)
......++..|+|||++.+.... ...+.|+.+ ........++.++.+++.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVE 234 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCc-hhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHH
Confidence 12234578899999987654322 112222211 001112346788999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHH
Q 021127 232 SCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 232 ~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+||+.+|.+||++.+++++.+
T Consensus 235 ~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 235 ACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred HHccCCcccCcCHHHHHHhHH
Confidence 999999999999999999743
No 289
>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros. Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male
Probab=100.00 E-value=3.7e-34 Score=246.93 Aligned_cols=217 Identities=33% Similarity=0.593 Sum_probs=168.7
Q ss_pred ceeccccceEEEEeEECC--------eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 30 PRIGEGAHAKVYEGKYKN--------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~~--------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
+.||+|+||.||+|++.+ +.+|||.+...... .....+.+|+.+++.++||||+++++++... ..++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD----QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI 76 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccch----hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence 468999999999998742 67999988654322 2244688999999999999999999998654 7999
Q ss_pred EEEccCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCC-----ceEEccc
Q 021127 101 VTELLSGGTLRKYLLNMR-----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK-----TIKLADF 170 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~-----~~kl~Df 170 (317)
||||+++++|.+++.... ...+++..++.++.|++.||+|||+++++|+||+|+||+++.+ + .++|+||
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~~~~~~l~df 155 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEK-GYDADRVVKIGDF 155 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecC-CCCCCcceEECCc
Confidence 999999999999997532 2237889999999999999999999999999999999999986 4 7999999
Q ss_pred Ccccccccccc---cccccCccceecccccccccccccccccccCC-----------------------------CCCCC
Q 021127 171 GLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPS 218 (317)
Q Consensus 171 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~ 218 (317)
|+++....... .....++..|+|||++.+..... ..+.|+.+ .....
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTT-QSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQK 234 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCccc-chhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCC
Confidence 99875432211 12234567899999876533221 11211111 11123
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+..+|..+.+++.+||+.+|.+||+++++++.|.
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 4567889999999999999999999999998875
No 290
>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin. Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre
Probab=100.00 E-value=1.1e-33 Score=246.96 Aligned_cols=221 Identities=26% Similarity=0.395 Sum_probs=173.2
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeec----
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE---- 95 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---- 95 (317)
-++|.+.+.||+|+||.||++... ++.+|+|++...... ...+.+|+.+++++ +|||++++++++..
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~------~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV------DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH------HHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 478999999999999999999884 789999998654321 23467889999998 89999999998853
Q ss_pred --CceEEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 96 --PVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 96 --~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
...++||||+++++|.+++... ....+++..++.++.|++.||+|||+.|++|+||||+||+++.+ +.+||+|||
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~-~~~kl~dfg 173 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE-GGVKLVDFG 173 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-CCEEEeecc
Confidence 2589999999999999988642 23348999999999999999999999999999999999999988 689999999
Q ss_pred ccccccccc-ccccccCccceecccccccccc----cccccccccCC---------------------------C---CC
Q 021127 172 LAREESLTE-MMTAETGTYRWMAPELYSTVTL----RQGEKKHYNHK---------------------------N---VR 216 (317)
Q Consensus 172 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~~~---------------------------~---~~ 216 (317)
++....... ......|+..|+|||++..... .....++|+.+ . ..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T cd06639 174 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL 253 (291)
T ss_pred cchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC
Confidence 987543222 2233468899999998754221 12223333322 0 00
Q ss_pred CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
..+..++..+.++|.+||+.+|++||++.+++++
T Consensus 254 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 254 LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1133456789999999999999999999999886
No 291
>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=2.5e-34 Score=250.14 Aligned_cols=222 Identities=24% Similarity=0.387 Sum_probs=176.4
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
..++|++.+.||+|+||+||++.+. ++.||+|++...... ....++.+|+++++.++||||+++++.+... .+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS----SVRKQILRELQIMHECRSPYIVSFYGAFLNENNI 78 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcc----hHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEE
Confidence 4468999999999999999999886 889999998765432 2345688999999999999999999998765 89
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
++||||+++++|.+++...+. +++..+..++.+++.||.|||+ .+++||||+|+||+++.+ +.++|+|||++....
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~-~~~~l~d~gl~~~~~ 155 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKGGP--IPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSR-GQIKLCDFGVSGELI 155 (284)
T ss_pred EEEEecCCCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCC-CcEEEccCCcccchh
Confidence 999999999999999876543 8999999999999999999997 589999999999999988 789999999986442
Q ss_pred cccccccccCccceecccccccccccccccccccCC--------------------------------------C-CCCC
Q 021127 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------------------------------N-VRPS 218 (317)
Q Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------------------------------~-~~~~ 218 (317)
.. ......|+..|+|||++.+..... ..+.|+.+ . ....
T Consensus 156 ~~-~~~~~~~~~~~~aPE~~~~~~~~~-~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd06620 156 NS-IADTFVGTSTYMSPERIQGGKYTV-KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL 233 (284)
T ss_pred hh-ccCccccCcccCCHHHHccCCCCc-cchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCC
Confidence 22 223457899999999875432211 11222111 0 0001
Q ss_pred -CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 219 -AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 219 -~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
...++.++.+|+.+||+.||++||++.+++++.+
T Consensus 234 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 234 PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 1236778999999999999999999999998743
No 292
>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage
Probab=100.00 E-value=1.3e-33 Score=243.70 Aligned_cols=217 Identities=24% Similarity=0.386 Sum_probs=162.7
Q ss_pred ceeccccceEEEEeEEC----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEc
Q 021127 30 PRIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTEL 104 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 104 (317)
+.||+|+||.||+|... ...+++|.+...... .....+.+|+.+++.++||||+++++.+.+. ..++||||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS----KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEY 76 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh----HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEec
Confidence 36899999999999753 234677776654432 2345789999999999999999999998765 78999999
Q ss_pred cCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc---
Q 021127 105 LSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT--- 179 (317)
Q Consensus 105 ~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~--- 179 (317)
+++|+|.+++..... ...++..++.++.||+.||+|||+++++||||||+||+++.+ +.++|+|||++......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~-~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD-LTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCC-ccEEecccccccccCcchhh
Confidence 999999999976432 236777888999999999999999999999999999999988 78999999998642211
Q ss_pred cccccccCccceecccccccccc------cccccccccCC------------------------------C---C-CCCC
Q 021127 180 EMMTAETGTYRWMAPELYSTVTL------RQGEKKHYNHK------------------------------N---V-RPSA 219 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~------~~~~~~~~~~~------------------------------~---~-~~~~ 219 (317)
.......++..|+|||++..... .....++|+.+ . . ....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE 235 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence 11233467889999998743110 01112222211 0 0 1113
Q ss_pred CCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 220 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 220 ~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
..++..+.+++..|| .+|++||++.++++.|.
T Consensus 236 ~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 236 LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 346788999999999 68999999999988763
No 293
>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the
Probab=100.00 E-value=6.1e-34 Score=248.53 Aligned_cols=220 Identities=25% Similarity=0.354 Sum_probs=170.0
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|++|.||+|... ++.||||.+....... ....+.+|++++++++|+||+++++++.++ ..++
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG----APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC----CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 68999999999999999999875 7899999987543221 122467899999999999999999998765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+. ++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||+++......
T Consensus 81 v~e~~~-~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 81 VFEYLD-TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISER-GELKLADFGLARAKSVPS 157 (291)
T ss_pred EEecCC-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCC-CCEEECccccccccCCCC
Confidence 999996 599998876443 48999999999999999999999999999999999999988 789999999987543221
Q ss_pred -ccccccCccceecccccccccccccccccccCC--------CCCC----------------------------------
Q 021127 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVRP---------------------------------- 217 (317)
Q Consensus 181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~~---------------------------------- 217 (317)
......++..|+|||++.+........++|+.+ ...+
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 112234688999999875432222222222211 0000
Q ss_pred ----------------CCCCCh--HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 ----------------SAENVP--EELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 ----------------~~~~~~--~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
....++ ..+.+++.+||+.+|++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 001233 778899999999999999999999875
No 294
>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They
Probab=100.00 E-value=9.2e-34 Score=242.39 Aligned_cols=221 Identities=27% Similarity=0.454 Sum_probs=179.0
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|.+.+.||.|++|.||++.+. +..||+|++....... .....+.+|+++++.++|+|++++++.+.++ ..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv 77 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE---KEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV 77 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCCh---HHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEE
Confidence 5889999999999999999986 8899999987655432 3345688999999999999999999988654 88999
Q ss_pred EEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 102 TELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+||+++++|.+++.... ...+++..+..++.+++.||.|||++|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSST 156 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC-CcEEECCccceeecccC
Confidence 99999999999998753 3459999999999999999999999999999999999999987 68999999999755433
Q ss_pred c-ccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHH
Q 021127 180 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIIL 230 (317)
Q Consensus 180 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li 230 (317)
. ......|++.|+|||.+....... ..+.|..+ ...+.+..++..+.+++
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~-~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQNKPYNY-KSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLV 235 (258)
T ss_pred cceecceeeeecccChhHhccCCCCc-cccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 2 223346888999999866543222 12222211 11222446789999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 021127 231 TSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 231 ~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+||..+|++||++.+++++
T Consensus 236 ~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 236 SSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHHcCCChhhCcCHHHHhcC
Confidence 99999999999999999876
No 295
>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi
Probab=100.00 E-value=5.6e-34 Score=247.40 Aligned_cols=215 Identities=24% Similarity=0.303 Sum_probs=163.8
Q ss_pred eeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHH---HhcCCCCeeeEEeeeec-CceEEEEEc
Q 021127 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML---SRVQHRNLVKFIGACKE-PVMVIVTEL 104 (317)
Q Consensus 31 ~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~-~~~~lv~e~ 104 (317)
.||+|+||.||++.+. ++.+|+|.+........ .....+.+|..++ ...+|+||+.+++++.. +..++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK--QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc--hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence 4899999999999875 78999999876543221 1122234444433 33479999999998865 489999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccccccc
Q 021127 105 LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTA 184 (317)
Q Consensus 105 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~ 184 (317)
+++++|.+++...+. +++..+..++.|++.||+|||+++++||||||+||+++.+ +.++|+|||++....... ...
T Consensus 79 ~~~~~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~-~~~~l~dfg~~~~~~~~~-~~~ 154 (279)
T cd05633 79 MNGGDLHYHLSQHGV--FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKKK-PHA 154 (279)
T ss_pred CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCC-CCEEEccCCcceeccccC-ccC
Confidence 999999999876544 9999999999999999999999999999999999999988 799999999987543222 233
Q ss_pred ccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHHHHHhh
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSIILTSCW 234 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~cl 234 (317)
..|+..|+|||.+..........+.|+.+ .....+..++.++.+++.+||
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 234 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLL 234 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHh
Confidence 46899999999875422222222333221 011124467889999999999
Q ss_pred hcCCCCCC-----CHHHHHHHH
Q 021127 235 KEDPNARP-----NFTQIIQML 251 (317)
Q Consensus 235 ~~~p~~Rp-----s~~~~~~~l 251 (317)
+.||.+|| ++.++++|.
T Consensus 235 ~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 235 QRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred cCCHHHhcCCCCCCHHHHHhCc
Confidence 99999999 599998873
No 296
>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins. Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily
Probab=100.00 E-value=1e-33 Score=249.10 Aligned_cols=223 Identities=27% Similarity=0.373 Sum_probs=174.8
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
..+.|.+.+.||+|+||.||+|... ++.||+|.+....... ......+.+|+++++.++||||+++++++.++ ..
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS--NEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCc--HHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 3467999999999999999999874 8899999987543322 23345688999999999999999999998764 78
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+. |+|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 91 ~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~-~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 91 WLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEP-GTVKLADFGSASLVSP 167 (307)
T ss_pred EEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCC-CCEEEeecCcceecCC
Confidence 99999995 67877776433 348999999999999999999999999999999999999988 7899999999875432
Q ss_pred ccccccccCccceecccccccc--cccccccccccCC-----------------------------CCCCCCCCChHHHH
Q 021127 179 TEMMTAETGTYRWMAPELYSTV--TLRQGEKKHYNHK-----------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~ 227 (317)
. ....++..|+|||++.+. .......++|+.+ ........++..+.
T Consensus 168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (307)
T cd06607 168 A---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFR 244 (307)
T ss_pred C---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHH
Confidence 2 234678899999987431 1122223333322 00011234677899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+++.+||..+|.+||++.+++.+.+
T Consensus 245 ~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 245 NFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred HHHHHHhcCChhhCcCHHHHhcChh
Confidence 9999999999999999999998754
No 297
>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the
Probab=100.00 E-value=4.1e-34 Score=249.91 Aligned_cols=221 Identities=24% Similarity=0.280 Sum_probs=173.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---Cce
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PVM 98 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~ 98 (317)
++|++.+.||.|+||.||+|.+. ++.+|+|.++...... .....+.+|+.++++++||||+++++++.. ...
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE---GFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc---cchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 57999999999999999999986 7889999997654322 223356789999999999999999998753 579
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+. ++|.+++..... .+++..++.++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||++.....
T Consensus 82 ~lv~e~~~-~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 82 YMVMEYVE-HDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNR-GILKICDFGLAREYGS 158 (293)
T ss_pred EEEehhcC-cCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC-CcEEEeecCceeeccC
Confidence 99999996 599998876433 48999999999999999999999999999999999999988 7999999999885543
Q ss_pred c-cccccccCccceecccccccccccccccccccCC--------C-----------------------------------
Q 021127 179 T-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N----------------------------------- 214 (317)
Q Consensus 179 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~----------------------------------- 214 (317)
. .......+++.|+|||++.+........+.|+.+ .
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 3 2223345788999999876533222222222211 0
Q ss_pred --------------C-CCCCCC-ChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 215 --------------V-RPSAEN-VPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 215 --------------~-~~~~~~-~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
. ...+.. ++..+.++|.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 000111 47889999999999999999999999876
No 298
>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi
Probab=100.00 E-value=7.7e-34 Score=248.25 Aligned_cols=219 Identities=26% Similarity=0.407 Sum_probs=174.1
Q ss_pred CCceeecceeccccceEEEEeEE--CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
.++|.+.+.||+|+||.||++.. ++..||+|.+...... ....+.+|+.+++.++||||+++++.+..+ ..+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP-----KKELIINEILVMRENKHPNIVNYLDSYLVGDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch-----HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence 36899999999999999999976 3788999998644322 234688999999999999999999998654 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+|+||+++++|.+++.... +++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 93 lv~e~~~~~~L~~~~~~~~---l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~-~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 93 VVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPE 168 (293)
T ss_pred EEEecCCCCcHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCC-CCEEEccCcceeccccc
Confidence 9999999999999987532 7899999999999999999999999999999999999988 68999999988644322
Q ss_pred c-ccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHH
Q 021127 180 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSI 228 (317)
Q Consensus 180 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~ 228 (317)
. ......+++.|+|||.+....... ..+.|+.+ .....+..++..+.+
T Consensus 169 ~~~~~~~~~~~~y~~PE~~~~~~~~~-~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 247 (293)
T cd06647 169 QSKRSTMVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 247 (293)
T ss_pred ccccccccCChhhcCchhhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHH
Confidence 2 223346888999999876533211 22222211 001112345678999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHH
Q 021127 229 ILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 229 li~~cl~~~p~~Rps~~~~~~~l 251 (317)
++.+||+.+|.+||++.+++.+-
T Consensus 248 li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 248 FLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred HHHHHccCChhhCcCHHHHhcCH
Confidence 99999999999999999999883
No 299
>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4. Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates
Probab=100.00 E-value=2.8e-34 Score=250.25 Aligned_cols=223 Identities=23% Similarity=0.338 Sum_probs=171.6
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecC-ce
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP-VM 98 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~~ 98 (317)
.++|+..+.||+|+||.||++.+. ++.||+|.+...... .....+.+|+.++.++. |+||+++++++..+ ..
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~ 78 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE----KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDC 78 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh----HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcE
Confidence 356778889999999999999885 789999998765433 23456889999999995 99999999987654 78
Q ss_pred EEEEEccCCCCHHHHH---HhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 99 VIVTELLSGGTLRKYL---LNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l---~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+++|||+. ++|.++. .......+++..+..++.|++.||+|||+. +++||||||+||+++.+ +.+||+|||++.
T Consensus 79 ~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~ 156 (288)
T cd06616 79 WICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRN-GNIKLCDFGISG 156 (288)
T ss_pred EEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccC-CcEEEeecchhH
Confidence 99999984 5665543 222334599999999999999999999985 99999999999999987 689999999997
Q ss_pred ccccccccccccCccceeccccccccc--ccccccccccCC----------------------------CCCC-----CC
Q 021127 175 EESLTEMMTAETGTYRWMAPELYSTVT--LRQGEKKHYNHK----------------------------NVRP-----SA 219 (317)
Q Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~~~----------------------------~~~~-----~~ 219 (317)
............|+..|+|||++.+.. ......++|+.+ ...+ ..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd06616 157 QLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEE 236 (288)
T ss_pred HhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCC
Confidence 544333334446889999999886541 222223333221 0000 11
Q ss_pred CCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 220 ENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 220 ~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
..++.++.+|+.+||+.+|++|||+++++++-
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~ 268 (288)
T cd06616 237 REFSPSFVNFINLCLIKDESKRPKYKELLEHP 268 (288)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 24778899999999999999999999999873
No 300
>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity
Probab=100.00 E-value=3.3e-34 Score=246.64 Aligned_cols=219 Identities=23% Similarity=0.369 Sum_probs=176.0
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l 100 (317)
++|++.+.||+|++|.||++.+. ++.||+|.+...... ....++.+|++++++++||||+++++.+.. ...++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE----AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISI 76 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh----HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEE
Confidence 46888999999999999999886 789999998876543 335578899999999999999999998865 48999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
++||+++++|.+++.... ..+++..+..++.|++.||+|||+ .|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~-~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 77 CMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSR-GQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCC-CCEEEeecccchhhHHH
Confidence 999999999999998653 348999999999999999999999 999999999999999997 78999999998754332
Q ss_pred cccccccCccceecccccccccccccccccccCC---------------------------------CCCCCCCC-ChHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------------NVRPSAEN-VPEE 225 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~-~~~~ 225 (317)
.. ....++..|+|||.+.+..... ..+.|+.+ .....+.. ++.+
T Consensus 155 ~~-~~~~~~~~y~~PE~~~~~~~~~-~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (265)
T cd06605 155 LA-KTFVGTSSYMAPERIQGNDYSV-KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPD 232 (265)
T ss_pred Hh-hcccCChhccCHHHHcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence 22 2267889999999876542221 12222211 00011122 6788
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+.++|.+||..||.+|||+.+++.+
T Consensus 233 ~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 233 FQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHHHHcCCCchhCcCHHHHhhC
Confidence 9999999999999999999999877
No 301
>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi
Probab=100.00 E-value=1.3e-33 Score=242.59 Aligned_cols=214 Identities=26% Similarity=0.341 Sum_probs=172.1
Q ss_pred eccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCCC
Q 021127 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGG 108 (317)
Q Consensus 32 lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g 108 (317)
||.|++|.||++++. ++.||+|++....... ......+.+|+.+++.++|+||+++++.+.++ ..++||||++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE--TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchh--hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence 699999999999997 8899999998654332 23345789999999999999999999998755 899999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccccccccCc
Q 021127 109 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT 188 (317)
Q Consensus 109 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt 188 (317)
+|.+++..... +++..+..++.|++.||+|||++|++|+||+|+||+++.+ +.++|+|||++.............++
T Consensus 79 ~L~~~l~~~~~--l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~-~~~~l~df~~~~~~~~~~~~~~~~~~ 155 (262)
T cd05572 79 ELWTILRDRGL--FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQKTWTFCGT 155 (262)
T ss_pred cHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCC-CCEEEeeCCcccccCcccccccccCC
Confidence 99999986544 8999999999999999999999999999999999999988 78999999999865443333345688
Q ss_pred cceecccccccccccccccccccCC-------------------------------CCCCCCCCChHHHHHHHHHhhhcC
Q 021127 189 YRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVPEELSIILTSCWKED 237 (317)
Q Consensus 189 ~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l~~li~~cl~~~ 237 (317)
..|+|||.+.+..... ..+.|..+ .....+...+.++.++|.+||+.+
T Consensus 156 ~~~~~PE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 156 PEYVAPEIILNKGYDF-SVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred cCccChhHhcCCCCCC-hhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCC
Confidence 9999999875432211 12222211 111223445789999999999999
Q ss_pred CCCCCC-----HHHHHHHH
Q 021127 238 PNARPN-----FTQIIQML 251 (317)
Q Consensus 238 p~~Rps-----~~~~~~~l 251 (317)
|++||+ +.+++++-
T Consensus 235 p~~R~~~~~~~~~~l~~~~ 253 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHK 253 (262)
T ss_pred hhhCcCCcccCHHHHhcCh
Confidence 999999 88888763
No 302
>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase. Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm
Probab=100.00 E-value=5.9e-34 Score=249.04 Aligned_cols=223 Identities=25% Similarity=0.327 Sum_probs=170.4
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-c--
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-V-- 97 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~-- 97 (317)
++|++.+.||+|+||.||+|.+. ++.||||.+....... .....+.+|+.+++++ +|+||+++++++... .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 77 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE---GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG 77 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc---CCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence 47899999999999999999875 7899999887543221 1223578899999999 469999999988643 2
Q ss_pred ---eEEEEEccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 98 ---MVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 98 ---~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
.++||||+++ +|.+++.... ...+++..++.++.||+.||+|||++|++||||+|+||+++.+.+.+||+|||
T Consensus 78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 8998886543 23489999999999999999999999999999999999999833799999999
Q ss_pred cccccccc-cccccccCccceecccccccccccccccccccCC--------CCCC-------------------------
Q 021127 172 LAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVRP------------------------- 217 (317)
Q Consensus 172 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~~------------------------- 217 (317)
++...... .......+++.|+|||++.+........++|+.+ ...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 98754322 1122335688899999875432222223333221 0000
Q ss_pred ----------------------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 ----------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 ----------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
....++.++.++|.+||+.||.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 013467889999999999999999999999876
No 303
>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast
Probab=100.00 E-value=1.8e-33 Score=240.31 Aligned_cols=219 Identities=29% Similarity=0.508 Sum_probs=177.7
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.+.||+|++|.||++.+. ++.|++|.+....... .....+.+|++++.+++|+|++++++++.++ ..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE---EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII 77 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCH---HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Confidence 5889999999999999999875 7889999998765432 3345789999999999999999999988654 88999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
|||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||+|+||+++.+ +.++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 78 LEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSK 154 (254)
T ss_pred EecCCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC-CCEEEeccccceecCCCcc
Confidence 99999999999998754 38999999999999999999999999999999999999987 7999999999986543322
Q ss_pred -cccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHHHH
Q 021127 182 -MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 182 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
.....++..|+|||.+.+.. .....+.|..+ .....+..++..+.+++.+
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQ 233 (254)
T ss_pred cccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHH
Confidence 23346788999999875543 12222222211 1122345678999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 021127 233 CWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 233 cl~~~p~~Rps~~~~~~~ 250 (317)
||..+|++||++.+++.+
T Consensus 234 ~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 234 CFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HHhCChhhCcCHHHHhcC
Confidence 999999999999999864
No 304
>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.5e-35 Score=278.32 Aligned_cols=226 Identities=24% Similarity=0.317 Sum_probs=185.2
Q ss_pred eeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 96 (317)
..+.+++|.++++||+|+||.|.+++.+ ++.||+|++.+-..-. ......|.+|-++|..-+.+-|+.++..|+++
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK--r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK--RAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh--chhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 3467789999999999999999999885 7889999988632221 11234688999999999999999999888876
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
++|+||||++||+|..++.+.. .++++.+..|+..|+.||.-||+.|+|||||||+||||+.+ |.+||+|||.+-.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~-GHikLADFGsClk 224 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKS-GHIKLADFGSCLK 224 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEeccc-CcEeeccchhHHh
Confidence 8999999999999999999876 49999999999999999999999999999999999999999 8999999999875
Q ss_pred ccccc--ccccccCccceeccccccccccc----ccccccccCC-------------------------------CCCCC
Q 021127 176 ESLTE--MMTAETGTYRWMAPELYSTVTLR----QGEKKHYNHK-------------------------------NVRPS 218 (317)
Q Consensus 176 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~----~~~~~~~~~~-------------------------------~~~~~ 218 (317)
..... .....+|||.|++||++..+... ....+||+.+ ...|.
T Consensus 225 m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~ 304 (1317)
T KOG0612|consen 225 MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPD 304 (1317)
T ss_pred cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCc
Confidence 54332 23456899999999998765433 2334566655 11223
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 021127 219 AENVPEELSIILTSCWKEDPNARPN---FTQIIQM 250 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps---~~~~~~~ 250 (317)
...+|++.++||.+.+. +|+.|.+ ++++..|
T Consensus 305 ~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 305 ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 35689999999998775 8888877 9998877
No 305
>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express
Probab=100.00 E-value=2.5e-34 Score=251.27 Aligned_cols=217 Identities=27% Similarity=0.392 Sum_probs=171.0
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
+.|.....||+|+||.||++.+. +..||||.+..... .....+.+|+.+++.++|+||+++++.+..+ ..++
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l 96 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ-----QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV 96 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH-----HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence 34555678999999999999874 78999999865332 2345688999999999999999999988654 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
||||+++++|.+++... .+++..++.++.||+.||+|||++|++||||||+||+++.+ +.++|+|||++......
T Consensus 97 v~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 97 VMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred EEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-CCEEEccCcchhhccccc
Confidence 99999999999988542 38999999999999999999999999999999999999988 78999999998743222
Q ss_pred cccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSII 229 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~l 229 (317)
.......|+..|+|||.+.+..... ..+.|+.+ ...+....++..+.++
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 251 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGT-EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGF 251 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHH
Confidence 1123346889999999875533221 22222211 0011123467889999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 021127 230 LTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~ 250 (317)
+.+||..||.+|||+.+++++
T Consensus 252 i~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 252 LDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHccCChhHCcCHHHHhhC
Confidence 999999999999999999987
No 306
>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of
Probab=100.00 E-value=2.2e-33 Score=241.18 Aligned_cols=219 Identities=26% Similarity=0.397 Sum_probs=178.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
.+|++.+.||+|++|.||++.+. ++.||||.+...... .....+.+|+..+.+++|+||+++++++..+ ..++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE----EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISI 76 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch----HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEE
Confidence 36889999999999999999886 889999998876542 2345688999999999999999999998754 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
||||+++++|.+++..... +++..++.++.|++.||+|||+ ++++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 77 v~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~-~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 77 VLEYMDGGSLADLLKKVGK--IPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSK-GEVKIADFGISKVLENT 153 (264)
T ss_pred EEEecCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCC-CCEEEccCccceecccC
Confidence 9999999999999987543 8999999999999999999999 999999999999999998 78999999999865433
Q ss_pred ccc-ccccCccceecccccccccccccccccccCC-------------------------------CCCCCCCC-ChHHH
Q 021127 180 EMM-TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAEN-VPEEL 226 (317)
Q Consensus 180 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~-~~~~l 226 (317)
... ....++..|+|||.+.+..... ..+.|..+ .....+.. ++..+
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~-~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (264)
T cd06623 154 LDQCNTFVGTVTYMSPERIQGESYSY-AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232 (264)
T ss_pred CCcccceeecccccCHhhhCCCCCCc-hhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence 222 2446788999999876542211 12222211 11112333 78899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+++.+||..+|.+||++.+++++
T Consensus 233 ~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 233 RDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHHHccCChhhCCCHHHHHhC
Confidence 999999999999999999999987
No 307
>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.
Probab=100.00 E-value=1.2e-33 Score=243.93 Aligned_cols=226 Identities=25% Similarity=0.422 Sum_probs=175.5
Q ss_pred ceeecceeccccceEEEEeEEC---CeEEEEEEeecCCChH-----HHHHHHHHHHHHHHHHHh-cCCCCeeeEEeeeec
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPE-----EIAKKESRFAREVAMLSR-VQHRNLVKFIGACKE 95 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~---~~~vaiK~~~~~~~~~-----~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 95 (317)
+|++.+.||+|+||.||++.+. ++.+|+|.+....... .......++.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4788999999999999999885 4789999886432111 112334567788888875 799999999998865
Q ss_pred C-ceEEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
+ ..++||||+++++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||+|+||+++.+ +.++|+|||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~-~~~~l~dfg 159 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGED-DKVTITDFG 159 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCC-CcEEEeccc
Confidence 4 899999999999999988542 23458999999999999999999996 689999999999999988 689999999
Q ss_pred cccccccccccccccCccceecccccccccccccccccccCC----------------------------CCCCC-CCCC
Q 021127 172 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPS-AENV 222 (317)
Q Consensus 172 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~-~~~~ 222 (317)
.+.............|+..|+|||.+.+.... ...+.|+.+ ...+. ...+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd08528 160 LAKQKQPESKLTSVVGTILYSCPEIVKNEPYG-EKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238 (269)
T ss_pred ceeecccccccccccCcccCcChhhhcCCCCc-hHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccC
Confidence 99865544334455788999999987653321 122222211 11111 2256
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+..+.+++.+||+.||++||++.++..++.
T Consensus 239 ~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 239 SEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 789999999999999999999999998864
No 308
>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati
Probab=100.00 E-value=9.6e-34 Score=252.49 Aligned_cols=220 Identities=26% Similarity=0.326 Sum_probs=172.8
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-----
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP----- 96 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 96 (317)
.+|.+.+.||+|+||+||++.+. +..||||.+....... ....++.+|+.+++.++|+||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR---IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc---chhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 47999999999999999999875 7899999987543221 2234577899999999999999999987532
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
..++|+||+ +++|.+++..... +++..+..++.|++.||.|||+++++||||||+||+++.+ +.+||+|||+++.
T Consensus 82 ~~~~lv~e~~-~~~L~~~~~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~ 157 (337)
T cd07858 82 NDVYIVYELM-DTDLHQIIRSSQT--LSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFGLART 157 (337)
T ss_pred CcEEEEEeCC-CCCHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEECcCccccc
Confidence 479999999 5799998876543 9999999999999999999999999999999999999988 7899999999985
Q ss_pred cccc-cccccccCccceecccccccccccccccccccCC--------CC-------------------------------
Q 021127 176 ESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------------------------- 215 (317)
Q Consensus 176 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------------------------- 215 (317)
.... .......++..|+|||.+..........+.|+.+ ..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 5332 2223446788999999875422222223333211 00
Q ss_pred -------------------CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 -------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 -------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
......++.++.++|.+||+.+|++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00123567889999999999999999999999998
No 309
>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10. Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing
Probab=100.00 E-value=1.2e-33 Score=248.81 Aligned_cols=224 Identities=27% Similarity=0.322 Sum_probs=172.4
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---C
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---P 96 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~ 96 (317)
..++|++.+.||.|+||.||+|.+. ++.||+|.+....... .....+.+|+.++++++|+||+++++++.+ +
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD---GIPISSLREITLLLNLRHPNIVELKEVVVGKHLD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC---CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence 4478999999999999999999885 8899999987543322 112235679999999999999999999854 3
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++||||+. ++|.+++.... ..+++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++...
T Consensus 82 ~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~kL~dfg~~~~~ 158 (309)
T cd07845 82 SIFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDK-GCLKIADFGLARTY 158 (309)
T ss_pred eEEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECccceeeec
Confidence 5899999995 58988887643 348999999999999999999999999999999999999988 79999999999855
Q ss_pred ccc-cccccccCccceecccccccccccccccccccCC--------C---------------------------------
Q 021127 177 SLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N--------------------------------- 214 (317)
Q Consensus 177 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~--------------------------------- 214 (317)
... .......++..|+|||++.+........+.|+.+ .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 432 1222334578899999876432222222222211 0
Q ss_pred --------CCCC--------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 215 --------VRPS--------AENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 215 --------~~~~--------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
.... ....+.++.++|.+||+.||++|||+.+++.+-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0000 112478889999999999999999999999873
No 310
>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.1e-34 Score=248.53 Aligned_cols=221 Identities=28% Similarity=0.465 Sum_probs=173.2
Q ss_pred CceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc--CCCCeeeEEeeeec--C---
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV--QHRNLVKFIGACKE--P--- 96 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~--~--- 96 (317)
.++++.+.||+|.||.||+|+|.|+.||||++.... +..+.+|.++++.. +|+||+.+++.... +
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd--------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD--------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccc--------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 678899999999999999999999999999997654 34578888888774 99999999987632 2
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCcEEeeCCCCceEEc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--------GIIHRDLKPENLLLTEDLKTIKLA 168 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~--------~ivH~Dlkp~Nill~~~~~~~kl~ 168 (317)
.+|||++|.+.|||++||..+. ++.+..++++..++.||++||.. .|.|||||..|||+.++ +++.|+
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~t---v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn-~~C~IA 358 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRNT---VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIA 358 (513)
T ss_pred EEEEeeecccCCcHHHHHhhcc---CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC-CcEEEe
Confidence 6999999999999999998743 99999999999999999999963 49999999999999999 799999
Q ss_pred ccCcccccccc-----cccccccCccceeccccccccccc--------------------------------cccccccc
Q 021127 169 DFGLAREESLT-----EMMTAETGTYRWMAPELYSTVTLR--------------------------------QGEKKHYN 211 (317)
Q Consensus 169 Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~--------------------------------~~~~~~~~ 211 (317)
|+|+|...+.. -..+..+||.+|||||++...... +...+++.
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 99999754332 123556899999999987541110 00011111
Q ss_pred CC----------------CCCCCCC------CChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 212 HK----------------NVRPSAE------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 212 ~~----------------~~~~~~~------~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
.. ..+|..+ ..-..+..+|+.||..||..|-|+-.+.+.|.++..
T Consensus 439 ~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 439 VVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 11 1122111 112457889999999999999999999888887763
No 311
>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess
Probab=100.00 E-value=2.1e-33 Score=245.23 Aligned_cols=220 Identities=24% Similarity=0.354 Sum_probs=168.2
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|.+.+.||+|+||.||+|... ++.||+|++....... ....+.+|+.+++.++|+||+++++++.++ ..++
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG----VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC----CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 68999999999999999999875 7899999987554321 122467899999999999999999998765 7899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
||||+. ++|.+++.... ..+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||+++.....
T Consensus 81 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYL-GELKLADFGLARAKSIPS 157 (291)
T ss_pred EEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCC-CcEEEeccccccccCCCC
Confidence 999994 78887776533 337888899999999999999999999999999999999988 78999999998753322
Q ss_pred cccccccCccceecccccccccccccccccccCC--------CCC-----------------------------------
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR----------------------------------- 216 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~----------------------------------- 216 (317)
.......+++.|+|||++.+........+.|+.+ ...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 1223345788999999875422111112222211 000
Q ss_pred ----------C-------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 ----------P-------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 ----------~-------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+ .....+..+.+++.+|++.||.+|||+.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0 001125678999999999999999999999875
No 312
>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int
Probab=100.00 E-value=2.2e-33 Score=243.31 Aligned_cols=217 Identities=27% Similarity=0.431 Sum_probs=173.4
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
-|++.++||+|+||.||+|.+. +..||||.+...... .....+.+|+.++.+++|+||+++++++.++ ..++|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 80 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE----DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 80 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence 4678889999999999999874 789999998654432 2345688999999999999999999998765 79999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc-
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE- 180 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~- 180 (317)
|||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~-~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 81 MEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC-CCEEEeecccceecccchh
Confidence 9999999999998642 38999999999999999999999999999999999999988 789999999987543322
Q ss_pred ccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHHHH
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
......++..|+|||.+.+..... ..+.|+.+ ........++.++.+++.+
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~-~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDS-KADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA 235 (277)
T ss_pred hhccccCCccccChhhhccCCCCc-hhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHH
Confidence 122346788999999876532221 12222211 0111234567899999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 021127 233 CWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 233 cl~~~p~~Rps~~~~~~~ 250 (317)
||+.+|.+||++.+++++
T Consensus 236 ~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 236 CLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HccCChhhCcCHHHHHhC
Confidence 999999999999999997
No 313
>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase
Probab=100.00 E-value=7.9e-34 Score=252.93 Aligned_cols=218 Identities=28% Similarity=0.341 Sum_probs=169.3
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-----
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP----- 96 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 96 (317)
++|++.++||+|+||.||+|.+. ++.||||.+...... ....++.+|+.++++++|+||+++++++...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ----TFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc----hhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 68999999999999999999874 789999998643222 2344578899999999999999999886432
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
..++|+||+. ++|.+++... .+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++..
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~ 155 (336)
T cd07849 81 NDVYIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTN-CDLKICDFGLARI 155 (336)
T ss_pred ceEEEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC-CCEEECcccceee
Confidence 4799999995 5888877542 38999999999999999999999999999999999999988 7899999999875
Q ss_pred ccccc----ccccccCccceecccccccccccccccccccCC--------CCC---------------------------
Q 021127 176 ESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR--------------------------- 216 (317)
Q Consensus 176 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~--------------------------- 216 (317)
..... ......|+..|+|||++.+........++|+.+ ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 43221 112346789999999865422222222333221 000
Q ss_pred -----------------C------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 -----------------P------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 -----------------~------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+ .....+.++.++|.+||+.+|++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 012356779999999999999999999999988
No 314
>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3e-35 Score=254.23 Aligned_cols=234 Identities=23% Similarity=0.302 Sum_probs=196.2
Q ss_pred eecCCceeecCCceeecceeccccceEEEEeE--ECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEE
Q 021127 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGK--YKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (317)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 90 (317)
|+..+.+-+..+.|..-++||+||||.||-+. .+|+-+|+|.+.+..... .+.+...++|-.+|.+++.+.||.+-
T Consensus 174 WK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk--r~ge~maLnEk~iL~kV~s~FiVsla 251 (591)
T KOG0986|consen 174 WKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK--RKGETMALNEKQILEKVSSPFIVSLA 251 (591)
T ss_pred HHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH--hhhhHHhhHHHHHHHHhccCcEEEEe
Confidence 44555567888899999999999999999764 468999999887654332 34456778999999999999999998
Q ss_pred eeeecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcc
Q 021127 91 GACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (317)
Q Consensus 91 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~D 169 (317)
..++.. .+++||..|.||+|.-+|.+.+...+++..++.++.+|+-||++||+.+||+|||||+|||+|+. |.+.|+|
T Consensus 252 YAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~-GhvRISD 330 (591)
T KOG0986|consen 252 YAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDH-GHVRISD 330 (591)
T ss_pred eeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccC-CCeEeec
Confidence 777655 89999999999999999999887789999999999999999999999999999999999999998 8999999
Q ss_pred cCcccccccccccccccCccceecccccccccccccccccccCC-------------------------------CCCCC
Q 021127 170 FGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPS 218 (317)
Q Consensus 170 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~ 218 (317)
+|+|............+||.+|||||++.+.. .....+||+.+ .....
T Consensus 331 LGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey 409 (591)
T KOG0986|consen 331 LGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEY 409 (591)
T ss_pred cceEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhc
Confidence 99999887777777779999999999998877 34444555444 11223
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 021127 219 AENVPEELSIILTSCWKEDPNARPN-----FTQIIQM 250 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps-----~~~~~~~ 250 (317)
++.++++.++|.+..|..||.+|.. ++++.+|
T Consensus 410 ~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 410 SDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred ccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 5788999999999999999999954 5566655
No 315
>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5. Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the
Probab=100.00 E-value=8.6e-34 Score=252.49 Aligned_cols=222 Identities=26% Similarity=0.338 Sum_probs=174.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-----C
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-----P 96 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~ 96 (317)
.+|++.+.||.|++|.||+|... ++.||+|++....... .....+.+|+.++++++|+||+++++++.. .
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP---TLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccc---cchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 78999999999999999999875 8899999987643322 223457789999999999999999988742 3
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++||||+ +++|.+++..... +++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++...
T Consensus 82 ~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~dfg~~~~~ 157 (334)
T cd07855 82 DVYVVMDLM-ESDLHHIIHSDQP--LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNED-CELRIGDFGMARGL 157 (334)
T ss_pred eEEEEEehh-hhhHHHHhccCCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEecccccceee
Confidence 689999999 4689998875444 8999999999999999999999999999999999999998 79999999998754
Q ss_pred cccc-----ccccccCccceecccccccccccccccccccCCC--------C----------------------------
Q 021127 177 SLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKN--------V---------------------------- 215 (317)
Q Consensus 177 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~--------~---------------------------- 215 (317)
.... ......++..|+|||++..........+.|+.+. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 3221 1123468889999998755332233333333220 0
Q ss_pred -----------------CC-----CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 216 -----------------RP-----SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 216 -----------------~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.. .....+.++.++|.+||+.+|.+||++.+++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 296 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence 00 01346788999999999999999999999998844
No 316
>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK
Probab=100.00 E-value=4.6e-33 Score=238.06 Aligned_cols=219 Identities=30% Similarity=0.476 Sum_probs=179.1
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---CceE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PVMV 99 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~ 99 (317)
+|.+.+.||+|++|.||+|.+. +..|++|++...... ......+.+|+..+++++|+||+++++.+.+ ...+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS---EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc---hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence 4788899999999999999986 889999998766543 2345678899999999999999999998865 4789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+|+||+++++|.+++.... .+++..++.++.|++.||+|||++|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 78 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD-GVVKLADFGCAKRLGDI 154 (260)
T ss_pred EEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC-CCEEEcccccEEecccc
Confidence 9999999999999998765 49999999999999999999999999999999999999997 78999999999865544
Q ss_pred cc---cccccCccceecccccccccccccccccccC------------------------------CCCCCCCCCChHHH
Q 021127 180 EM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNH------------------------------KNVRPSAENVPEEL 226 (317)
Q Consensus 180 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~l 226 (317)
.. .....++..|+|||.+.+..... ..+.|.. ......+..++..+
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGR-AADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEA 233 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHH
Confidence 32 34456889999999876543111 1111111 11222355678999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+++.+||+.||.+||++.+++++
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 234 KDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHHHHHhCcCChhhCCCHHHHhhC
Confidence 999999999999999999999876
No 317
>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1. Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron
Probab=100.00 E-value=4.9e-33 Score=245.88 Aligned_cols=224 Identities=26% Similarity=0.381 Sum_probs=175.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
..|...+.||+|+||.||++++. +..||+|.+....... .+....+.+|+.++++++|+|++++++++.++ ..++
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS--NEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCc--hHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence 56788999999999999999874 7899999987653322 23345688999999999999999999998755 7899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+. |+|.+.+.... ..+++..+..++.|++.||.|||++|++||||+|+||+++.+ +.++|+|||++.....
T Consensus 103 v~e~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~-~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 103 VMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSASIASP-- 177 (317)
T ss_pred EEeCCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCC-CCEEEecCCCccccCC--
Confidence 999996 58877775433 348999999999999999999999999999999999999988 7899999999865432
Q ss_pred ccccccCccceecccccccc--cccccccccccCC-----------------------------CCCCCCCCChHHHHHH
Q 021127 181 MMTAETGTYRWMAPELYSTV--TLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSII 229 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~l 229 (317)
.....|+..|+|||++... .......++|+.+ ........++..+.++
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 256 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 256 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHH
Confidence 2344688899999987421 1111122222211 1111234567889999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 230 LTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
+.+||+.+|.+||++.+++++++...
T Consensus 257 i~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 257 VDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HHHHccCCcccCcCHHHHHhChhhhc
Confidence 99999999999999999999877644
No 318
>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=3.4e-35 Score=280.71 Aligned_cols=220 Identities=28% Similarity=0.397 Sum_probs=182.2
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv 101 (317)
+++-+..||.|.||.||-|.+. |...|+|-+...... .+....+.+|..++..++|||+|+++|+-.. ...+|-
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~---~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD---HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc---cccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 4566788999999999999774 888999988765543 3445568899999999999999999999754 478999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc--
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-- 179 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-- 179 (317)
||||++|+|.+.++..+. .++-....+..|++.|++|||+.|||||||||.||+++.+ |.+|++|||.|......
T Consensus 1313 MEyC~~GsLa~ll~~gri--~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~-g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRI--EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFN-GLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHhccCcHHHHHHhcch--hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecC-CcEEeecccceeEecCchh
Confidence 999999999999987544 7777778899999999999999999999999999999998 79999999999855433
Q ss_pred ---cccccccCccceeccccccccc--ccccccccccCC-----------------------------CCCCCCCCChHH
Q 021127 180 ---EMMTAETGTYRWMAPELYSTVT--LRQGEKKHYNHK-----------------------------NVRPSAENVPEE 225 (317)
Q Consensus 180 ---~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~ 225 (317)
.......||+.|||||++.+.. ..-+..++|+.+ ...+.|..++.+
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~ 1469 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSE 1469 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHh
Confidence 1234557999999999998744 233445555544 234457778999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
-++|+.+||+.||++|.++.|++++
T Consensus 1470 g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHHHHHHHHhcCchhhhHHHHHHHh
Confidence 9999999999999999999999887
No 319
>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7. Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it
Probab=100.00 E-value=1.8e-33 Score=246.26 Aligned_cols=230 Identities=23% Similarity=0.385 Sum_probs=178.0
Q ss_pred CCceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEee
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGA 92 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 92 (317)
+..|.++.++|++.+.||+|++|.||+|.+. ++.||||.+....... ....+..|+.++.+. .|+||++++++
T Consensus 7 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~e~~~~~~~~~~~~i~~~~~~ 82 (296)
T cd06618 7 GQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE----ENKRILMDLDVVLKSHDCPYIVKCYGY 82 (296)
T ss_pred ceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH----HHHHHHHHHHHHHhccCCCchHhhhee
Confidence 3467788899999999999999999999987 8999999997654332 234566777777666 59999999999
Q ss_pred eecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCCceEEccc
Q 021127 93 CKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADF 170 (317)
Q Consensus 93 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~~~kl~Df 170 (317)
+.+. ..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+ .|++||||+|+||+++.+ +.+||+||
T Consensus 83 ~~~~~~~~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~-~~~kL~df 159 (296)
T cd06618 83 FITDSDVFICMELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDAS-GNVKLCDF 159 (296)
T ss_pred eecCCeEEEEeecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCC-CCEEECcc
Confidence 8765 899999998 557877776533 358999999999999999999997 599999999999999987 79999999
Q ss_pred CcccccccccccccccCccceecccccccccc---cccccccccCC-------------------------------CCC
Q 021127 171 GLAREESLTEMMTAETGTYRWMAPELYSTVTL---RQGEKKHYNHK-------------------------------NVR 216 (317)
Q Consensus 171 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~~~-------------------------------~~~ 216 (317)
|++.............++..|+|||.+.+... .....++|+.+ ...
T Consensus 160 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T cd06618 160 GISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL 239 (296)
T ss_pred ccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC
Confidence 99875543333334457889999998865320 11112222211 011
Q ss_pred CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 217 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 217 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+....++.++.+|+.+||..||.+||++.+++++.+
T Consensus 240 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 112246889999999999999999999999998844
No 320
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=100.00 E-value=1.5e-34 Score=274.88 Aligned_cols=221 Identities=26% Similarity=0.384 Sum_probs=169.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee-------
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK------- 94 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~------- 94 (317)
.+|+.++.||+||||.||+++++ |+.||||.++... .+ +...++.+|+..+++|+|||||+++..+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~---~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SD---KLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HH---HHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 35567889999999999999986 9999999998876 22 44567899999999999999999974220
Q ss_pred -------------------------------------------------c------------------------------
Q 021127 95 -------------------------------------------------E------------------------------ 95 (317)
Q Consensus 95 -------------------------------------------------~------------------------------ 95 (317)
.
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0
Q ss_pred ----------------------------------CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 021127 96 ----------------------------------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141 (317)
Q Consensus 96 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~l 141 (317)
-.+||=||||+...|.++++.+.... .....|+++.+|++||+|+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHH
Confidence 01467789998888888887655321 4677899999999999999
Q ss_pred HhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-------------------cccccccccCccceeccccccccc-
Q 021127 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-------------------LTEMMTAETGTYRWMAPELYSTVT- 201 (317)
Q Consensus 142 H~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~- 201 (317)
|++|||||||||.|||++.+ +.|||+|||+|+... .....+..+||--|+|||++.+..
T Consensus 714 H~~giIHRDLKP~NIFLd~~-~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSR-NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred HhCceeeccCCcceeEEcCC-CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 99999999999999999988 789999999997511 011234567999999999998766
Q ss_pred -ccccccccccCC-------------------------CCCCCCC----CChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 202 -LRQGEKKHYNHK-------------------------NVRPSAE----NVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 202 -~~~~~~~~~~~~-------------------------~~~~~~~----~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
....+.+.|+.+ ...|.+. +--+.-..+|+.|++.||.+|||+.|+++.
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLYPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 344444444433 1111121 112345789999999999999999999864
No 321
>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=3.7e-34 Score=248.77 Aligned_cols=225 Identities=30% Similarity=0.422 Sum_probs=176.4
Q ss_pred eecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHh--cCCCCeeeEEeeeec--
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSR--VQHRNLVKFIGACKE-- 95 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~-- 95 (317)
..+-..+++.+++|+|.||.||+|..+++.||||+++... .+.|.+|-++... ++|+||+++++.-..
T Consensus 206 l~~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~--------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t 277 (534)
T KOG3653|consen 206 LLELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQE--------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGT 277 (534)
T ss_pred cccCCchhhHHHhhcCccceeehhhccCceeEEEecCHHH--------HHHHHhHHHHHhccCccchhHHHhhchhccCC
Confidence 3445678899999999999999999999999999998543 4457788777765 589999999987642
Q ss_pred ---CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccCCCCCcEEeeCCCC
Q 021127 96 ---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH---------GIIHRDLKPENLLLTEDLK 163 (317)
Q Consensus 96 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---------~ivH~Dlkp~Nill~~~~~ 163 (317)
..++||++|.+.|+|.++|..+. ++|....+|+..+++||+|||+. .|+|||||..||||.+| .
T Consensus 278 ~~~~eywLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D-l 353 (534)
T KOG3653|consen 278 ADRMEYWLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND-L 353 (534)
T ss_pred ccccceeEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC-C
Confidence 37999999999999999998755 99999999999999999999973 69999999999999999 6
Q ss_pred ceEEcccCccccccccc---ccccccCccceeccccccccccccc-----------------------------cccccc
Q 021127 164 TIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQG-----------------------------EKKHYN 211 (317)
Q Consensus 164 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-----------------------------~~~~~~ 211 (317)
++.|+|||+|-...... .....+||.+|||||++.+....+. ..+.|.
T Consensus 354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yq 433 (534)
T KOG3653|consen 354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQ 433 (534)
T ss_pred cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCccc
Confidence 99999999997654332 2233689999999999887433221 111111
Q ss_pred CC---------------------CCCCC------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 212 HK---------------------NVRPS------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 212 ~~---------------------~~~~~------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
.. ..+|. .......+++.+..||..||+.|.|+.=+.+.++++..
T Consensus 434 lpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 434 LPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 10 01111 01123568999999999999999999988888877654
No 322
>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3. Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac
Probab=100.00 E-value=4.2e-33 Score=240.90 Aligned_cols=224 Identities=27% Similarity=0.472 Sum_probs=171.6
Q ss_pred eeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC----
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP---- 96 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 96 (317)
|.+.+.||+|+||.||+|.+. ++.||||++....... ....++.+|+.++++++||||+++++++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS---SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG 77 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh---HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence 567889999999999999753 5889999987654333 2345688999999999999999999987431
Q ss_pred ---ceEEEEEccCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcc
Q 021127 97 ---VMVIVTELLSGGTLRKYLLNMR----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (317)
Q Consensus 97 ---~~~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~D 169 (317)
..+++++|+.+|+|..++.... ...+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|
T Consensus 78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~-~~~kl~d 156 (273)
T cd05074 78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN-MTVCVAD 156 (273)
T ss_pred cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCC-CCEEECc
Confidence 2478899999999998875322 1247899999999999999999999999999999999999988 6899999
Q ss_pred cCccccccccc---ccccccCccceecccccccccccccccccccCC-----------------------------CCCC
Q 021127 170 FGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRP 217 (317)
Q Consensus 170 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~ 217 (317)
||+++...... ......+++.|++||.+....... ..++|+.+ ....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~-~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTT-HSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK 235 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccch-hhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 99988543221 112234567899999765432221 11222211 1112
Q ss_pred CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 218 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 218 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
.+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 236 ~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 236 QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2345678999999999999999999999999998764
No 323
>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85. Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.
Probab=100.00 E-value=1.9e-33 Score=244.36 Aligned_cols=220 Identities=24% Similarity=0.385 Sum_probs=171.5
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.++||.|++|.||+|++. +..||||++....... ....+.+|+.++++++|+||+++++++.+. ..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG----TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLV 76 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc----chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence 5889999999999999999985 8899999987654321 123467899999999999999999998764 78999
Q ss_pred EEccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 102 TELLSGGTLRKYLLNMR-PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
|||++ ++|.+++.... ...+++..+..++.|++.||+|||+.|++||||+|+||+++.+ +.++|+|||++......
T Consensus 77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~-~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 77 FEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR-GELKLADFGLARAFGIPV 154 (284)
T ss_pred EecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC-CcEEEeecchhhhhcCCc
Confidence 99997 58999887644 2348999999999999999999999999999999999999988 78999999999754322
Q ss_pred cccccccCccceecccccccccccccccccccCC--------CCC-----------------------------------
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR----------------------------------- 216 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~----------------------------------- 216 (317)
.......++..|++||++.+........++|..+ ...
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 1223345788999999875432222222222211 000
Q ss_pred ----C---------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 ----P---------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 ----~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+ ....++..+.+++.+||+.||.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 012356788999999999999999999999865
No 324
>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK
Probab=100.00 E-value=2.7e-33 Score=251.21 Aligned_cols=220 Identities=26% Similarity=0.323 Sum_probs=171.5
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec----
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---- 95 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---- 95 (317)
..++|++.+.||+|+||.||+|.+. ++.||||.+....... ....++.+|+.++++++|+||+++++++..
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNV---THAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccCh---hHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence 3578999999999999999999874 8899999986543222 223457789999999999999999998742
Q ss_pred ---CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 96 ---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 96 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
...++||||+. ++|.+.+... +++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+
T Consensus 91 ~~~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~-~~~kL~Dfg~ 164 (353)
T cd07850 91 EEFQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGL 164 (353)
T ss_pred cccCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEccCcc
Confidence 24799999994 6888887642 8899999999999999999999999999999999999998 7899999999
Q ss_pred ccccccccccccccCccceecccccccccccccccccccCC--------C------------------------------
Q 021127 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N------------------------------ 214 (317)
Q Consensus 173 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~------------------------------ 214 (317)
++............++..|+|||++.+..... ..++|+.+ .
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 165 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred ceeCCCCCCCCCCcccccccCHHHHhCCCCCC-chhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 98655443334456889999999876533221 11222111 0
Q ss_pred ------------C---------------CC-----CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 215 ------------V---------------RP-----SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 215 ------------~---------------~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
. .+ .....+..++++|.+||+.||.+|||+.+++++-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 0 00 0113466789999999999999999999999873
No 325
>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc
Probab=100.00 E-value=1.2e-33 Score=245.62 Aligned_cols=220 Identities=27% Similarity=0.382 Sum_probs=172.3
Q ss_pred eeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEE
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVT 102 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 102 (317)
|++.+.||.|++|.||+|.++ +..||+|++....... .....+.+|+++++.++|+|++++++++.++ ..+++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~ 77 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE---GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVF 77 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc---cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEE
Confidence 577889999999999999874 8999999987654322 1223578899999999999999999998765 899999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc-c
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-M 181 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-~ 181 (317)
||+ +++|.+++.......+++..++.++.|++.||+|||+++++||||+|+||+++.+ +.++|+|||++....... .
T Consensus 78 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 78 EFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRT 155 (283)
T ss_pred ecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-CcEEEeecccccccCCCccc
Confidence 999 5799999987654458999999999999999999999999999999999999987 799999999997543221 1
Q ss_pred cccccCccceecccccccccccccccccccCC--------C---------------------------------------
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N--------------------------------------- 214 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~--------------------------------------- 214 (317)
.....++..|+|||++.+........+.|+.+ .
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 22335688999999875432222222222211 0
Q ss_pred ---------CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 215 ---------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 215 ---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.......++..+.+++.+||+.+|.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000124566889999999999999999999999875
No 326
>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=3.3e-33 Score=264.98 Aligned_cols=238 Identities=30% Similarity=0.545 Sum_probs=194.6
Q ss_pred eecCCceeecCCceeecceeccccceEEEEeEEC---------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-C
Q 021127 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-Q 82 (317)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 82 (317)
...+..|+++.++..+.+.||+|.||.|++|... ...||||.++..... .....+..|+++++.+ .
T Consensus 285 ~~~~~~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~----~~~~~~~~El~~m~~~g~ 360 (609)
T KOG0200|consen 285 LPEDPKWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS----SEKKDLMSELNVLKELGK 360 (609)
T ss_pred cCcCCceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc----HHHHHHHHHHHHHHHhcC
Confidence 4455699999999999999999999999998753 356999998876654 2355789999999998 7
Q ss_pred CCCeeeEEeeeec-CceEEEEEccCCCCHHHHHHhcC-------C-------CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 021127 83 HRNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMR-------P-------RCLDVCVAIGFALDIARAMECLHSHGII 147 (317)
Q Consensus 83 h~niv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~-------~-------~~l~~~~~~~i~~~i~~~L~~lH~~~iv 147 (317)
|+||+.++|+|.+ +..++|+||+..|+|.++++..+ . ..++..+.+.++.||+.|++||+++++|
T Consensus 361 H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~v 440 (609)
T KOG0200|consen 361 HPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCV 440 (609)
T ss_pred CcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCcc
Confidence 9999999999976 58999999999999999999866 0 1288999999999999999999999999
Q ss_pred ccCCCCCcEEeeCCCCceEEcccCcccccccccccc--ccc--CccceecccccccccccccccccccCC----------
Q 021127 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT--AET--GTYRWMAPELYSTVTLRQGEKKHYNHK---------- 213 (317)
Q Consensus 148 H~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~--gt~~y~aPE~~~~~~~~~~~~~~~~~~---------- 213 (317)
||||.++|||+..+ ..+||+|||+|+......... ... -...|||||.+....+... .+.|+.+
T Consensus 441 HRDLAaRNVLi~~~-~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~k-SDVWSfGI~L~EifsLG 518 (609)
T KOG0200|consen 441 HRDLAARNVLITKN-KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSK-SDVWSFGILLWEIFTLG 518 (609)
T ss_pred chhhhhhhEEecCC-CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccccc-chhhHHHHHHHHHhhCC
Confidence 99999999999998 699999999998543332222 122 2456999998876333322 2333322
Q ss_pred --------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 214 --------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 214 --------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
.....|..++.+++++|..||+.+|++||++.++.+.+...+.
T Consensus 519 ~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 519 GTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 3445677889999999999999999999999999999998654
No 327
>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases. Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core
Probab=100.00 E-value=4.1e-33 Score=237.37 Aligned_cols=218 Identities=30% Similarity=0.512 Sum_probs=176.8
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|.+.+.||+|++|.||++.+. +..+++|++..... .....+.+|++++++++|+||+++++++... ..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 4788899999999999999986 78899999976553 2345688999999999999999999988654 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
+||+++++|.+++.... ..+++..+..++.|++.||+|||++|++||||+|+||+++.+ +.++|+|||.+........
T Consensus 76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 76 MEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC-CeEEEeecccccccccccc
Confidence 99999999999987753 348999999999999999999999999999999999999987 7899999999986554332
Q ss_pred cccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHHHH
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~ 231 (317)
.....++..|+|||.+.+... ....+.|..+ ...+....++..+.+++.
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 232 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLK 232 (253)
T ss_pred ccceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHH
Confidence 344568899999998765432 2222333221 001112223788999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 021127 232 SCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 232 ~cl~~~p~~Rps~~~~~~~ 250 (317)
+||+.||.+|||+.+++++
T Consensus 233 ~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 233 KCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHccCChhhCCCHHHHhcC
Confidence 9999999999999999876
No 328
>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili
Probab=100.00 E-value=2.2e-33 Score=243.92 Aligned_cols=219 Identities=29% Similarity=0.390 Sum_probs=172.2
Q ss_pred eeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecC-ceEEE
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~~~lv 101 (317)
|++.+.||+|++|.||+|... ++.||||.+....... ......+|+..+++++ |+||+++++++.++ ..++|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 76 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW----EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV 76 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch----hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence 678899999999999999985 7889999987654321 1223557899999998 99999999988654 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
|||+ +++|.+++.......+++..++.++.|++.+|.|||++|++|+||+|+||+++.+ +.++|+|||++........
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~-~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP-EVVKIADFGLAREIRSRPP 154 (283)
T ss_pred EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-CCEEEeecccceeccCCCC
Confidence 9999 8899999987654458999999999999999999999999999999999999988 7999999999986554333
Q ss_pred cccccCccceecccccccccccccccccccCCCC----------------------------------------------
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKNV---------------------------------------------- 215 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~---------------------------------------------- 215 (317)
.....++..|+|||++..........+.|+.+..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 3445688899999987543322222332221100
Q ss_pred ------C-----CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 ------R-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 ------~-----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
. ......+..+.+++.+||+.+|.+||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0 0011235789999999999999999999999875
No 329
>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl
Probab=100.00 E-value=3e-33 Score=246.16 Aligned_cols=226 Identities=24% Similarity=0.294 Sum_probs=170.5
Q ss_pred eeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 96 (317)
+.-+-++|++.++||+|+||.||+|... ++.||||.+....... .....+.+|+.++++++||||+++++++...
T Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (310)
T cd07865 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTK 83 (310)
T ss_pred ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC---CchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence 3445578999999999999999999885 8899999987543322 1123456899999999999999999987532
Q ss_pred ---------ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEE
Q 021127 97 ---------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (317)
Q Consensus 97 ---------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl 167 (317)
..++||||+. ++|.+.+.... ..+++..++.++.|++.||+|||++|++|+||||+||+++.+ +.+||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl 160 (310)
T cd07865 84 ATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKD-GILKL 160 (310)
T ss_pred cccccCCCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCC-CcEEE
Confidence 4599999995 58888886543 248999999999999999999999999999999999999988 79999
Q ss_pred cccCcccccccccc-----cccccCccceecccccccccccccccccccCCC--------CC------------------
Q 021127 168 ADFGLAREESLTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKN--------VR------------------ 216 (317)
Q Consensus 168 ~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~--------~~------------------ 216 (317)
+|||++........ .....++..|+|||++.+........+.|+.+. ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~ 240 (310)
T cd07865 161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC 240 (310)
T ss_pred CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999975432211 123457788999998754322222223332210 00
Q ss_pred ----------------------CC-----------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 ----------------------PS-----------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 ----------------------~~-----------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+. ....+..+.+||.+||..||.+|||+++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00 00124567899999999999999999999876
No 330
>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i
Probab=100.00 E-value=9.4e-34 Score=248.20 Aligned_cols=218 Identities=26% Similarity=0.369 Sum_probs=172.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
..|.....||+|+||.||++.+. ++.||+|++...... ....+.+|+.++..++||||+++++.+..+ ..++
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~i 95 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ-----RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWV 95 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc-----hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEE
Confidence 44556668999999999999874 889999998754332 234578899999999999999999988654 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++++|..++... .+++..++.++.|++.||+|||++|++||||+|+||+++.+ +.+||+|||++.......
T Consensus 96 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~-~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 96 LMEFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDV 171 (297)
T ss_pred EEecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccC-CcEEEeechhHhhccccc
Confidence 99999999999987652 38999999999999999999999999999999999999988 799999999987443221
Q ss_pred -ccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHH
Q 021127 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSII 229 (317)
Q Consensus 181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~l 229 (317)
......|+..|+|||++.+.... ...+.|+.+ ........++..+.++
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 250 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPYG-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDF 250 (297)
T ss_pred ccccceecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHH
Confidence 22335688999999987653322 122222211 0011133567889999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHH
Q 021127 230 LTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~l 251 (317)
+.+||+.+|.+||++.+++++-
T Consensus 251 i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 251 LERMLTREPQERATAQELLDHP 272 (297)
T ss_pred HHHHhcCCcccCcCHHHHhhCh
Confidence 9999999999999999999973
No 331
>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase. Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.
Probab=100.00 E-value=3.2e-33 Score=242.69 Aligned_cols=217 Identities=25% Similarity=0.332 Sum_probs=167.7
Q ss_pred eeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeec---CceE
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKE---PVMV 99 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~---~~~~ 99 (317)
|++.++||+|+||.||+|.+. ++.||+|.+........ .....+|+.++.++. |+||+++++++.+ +..+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE----QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch----hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence 678899999999999999874 78999999876433221 123457888898885 9999999998864 4789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+||||++ ++|.+++.... ..+++..++.++.|++.||+|||++|++||||+|+||+++. +.+||+|||+++.....
T Consensus 77 lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 77 LVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD--DILKLADFGSCRGIYSK 152 (282)
T ss_pred EEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC--CCeEEEecccccccccC
Confidence 9999995 68888887643 34899999999999999999999999999999999999998 68999999999865433
Q ss_pred cccccccCccceecccccccccccccccccccCC--------CC------------------------------------
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------------------------------ 215 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------------------------------ 215 (317)
.......++..|+|||++..........++|+.+ ..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 3333446788999999764322222223333211 00
Q ss_pred ------------CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 ------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 ------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
......++..+.++|.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00012467899999999999999999999999876
No 332
>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co
Probab=100.00 E-value=5.4e-33 Score=241.12 Aligned_cols=214 Identities=23% Similarity=0.316 Sum_probs=164.0
Q ss_pred eeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHH---HHHHhcCCCCeeeEEeeeecC-ceEEEEEc
Q 021127 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREV---AMLSRVQHRNLVKFIGACKEP-VMVIVTEL 104 (317)
Q Consensus 31 ~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 104 (317)
.||+|+||.||++.+. ++.||+|.+........ .....+..|. ..++...||||+++++++.+. ..++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK--QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc--hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEec
Confidence 4899999999999874 78999999876543211 1111233343 344446899999999988764 88999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccccccc
Q 021127 105 LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTA 184 (317)
Q Consensus 105 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~ 184 (317)
+.|++|..++.... .+++..+..++.|++.||+|||+++++||||||+||+++.+ +.+||+|||++...... ....
T Consensus 79 ~~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~-~~~kl~dfg~~~~~~~~-~~~~ 154 (278)
T cd05606 79 MNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPHA 154 (278)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCC-CCEEEccCcCccccCcc-CCcC
Confidence 99999999887644 39999999999999999999999999999999999999988 78999999998754322 2234
Q ss_pred ccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHHHHHhh
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSIILTSCW 234 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~cl 234 (317)
..|+..|+|||++.+........+.|+.+ .....+..++.++.+++.+||
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l 234 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 234 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHh
Confidence 57899999999986432222333333322 011223456789999999999
Q ss_pred hcCCCCCC-----CHHHHHHH
Q 021127 235 KEDPNARP-----NFTQIIQM 250 (317)
Q Consensus 235 ~~~p~~Rp-----s~~~~~~~ 250 (317)
..+|.+|| ++.+++++
T Consensus 235 ~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 235 QRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred hcCHHhccCCCCCCHHHHHhC
Confidence 99999999 99999876
No 333
>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=3e-33 Score=244.04 Aligned_cols=222 Identities=24% Similarity=0.303 Sum_probs=172.3
Q ss_pred ceeecceeccccceEEEEeEE-----CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-c
Q 021127 25 HLFVGPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-V 97 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 97 (317)
+|++.+.||+|+||.||+++. ++..||+|++....... .......+.+|+.++.++ +|+||+++++++..+ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQ-KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhh-cchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence 488999999999999999886 47889999987543211 112345678899999999 699999999988765 7
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++||||+++++|.+++..... +++..+..++.|++.||.|||++|++||||+|+||+++.+ +.+||+|||++....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~ 156 (290)
T cd05613 80 LHLILDYINGGELFTHLSQRER--FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCC-CCEEEeeCccceecc
Confidence 8899999999999999986543 8899999999999999999999999999999999999988 799999999987543
Q ss_pred ccc--ccccccCccceeccccccccc-ccccccccccCC-------------------------------CCCCCCCCCh
Q 021127 178 LTE--MMTAETGTYRWMAPELYSTVT-LRQGEKKHYNHK-------------------------------NVRPSAENVP 223 (317)
Q Consensus 178 ~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~~-------------------------------~~~~~~~~~~ 223 (317)
... ......|+..|+|||.+.... ......+.|+.+ ...+.+..++
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 236 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCC
Confidence 321 222346889999999875421 111112222211 1122344577
Q ss_pred HHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 021127 224 EELSIILTSCWKEDPNARP-----NFTQIIQM 250 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rp-----s~~~~~~~ 250 (317)
..+.+++.+||+.||++|| ++.+++.+
T Consensus 237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 8899999999999999997 67777765
No 334
>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely
Probab=100.00 E-value=1.9e-33 Score=246.57 Aligned_cols=223 Identities=24% Similarity=0.293 Sum_probs=171.5
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC---
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP--- 96 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 96 (317)
.-++|++.+.||+|+||.||+|.+. ++.||+|.+....... .....+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE---GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc---CchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 3468999999999999999999985 7899999987643222 1223567899999999999999999987532
Q ss_pred --------ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEc
Q 021127 97 --------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (317)
Q Consensus 97 --------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~ 168 (317)
..++|+||+++ +|...+... ...+++..++.++.|++.||+|||+.||+|+||+|+||+++.+ +.+||+
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~-~~~kl~ 158 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK-GQIKLA 158 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CcEEeC
Confidence 58999999965 787877654 2348999999999999999999999999999999999999988 789999
Q ss_pred ccCccccccccc--ccccccCccceecccccccccccccccccccCC------------------------------C--
Q 021127 169 DFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------N-- 214 (317)
Q Consensus 169 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~-- 214 (317)
|||++....... ......++..|+|||.+.+........++|+.+ .
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999997543322 112234577899999875432222222222211 0
Q ss_pred -------------------------CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 215 -------------------------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 215 -------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.......++..+.+++.+||+.+|.+||++.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000122468899999999999999999999999875
No 335
>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=9.9e-33 Score=240.52 Aligned_cols=221 Identities=27% Similarity=0.403 Sum_probs=172.5
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---Cce
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PVM 98 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~ 98 (317)
++|...++||.|++|.||++.+. ++.+|+|.+...... ....++.+|++++++++|+||+++++++.+ +.+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP----DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch----HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence 46889999999999999999984 789999998865442 234568899999999999999999998853 368
Q ss_pred EEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 99 VIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
++||||+++++|.+++... ....+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~ 155 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK-GQVKLCDFGVSGEL 155 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecC-CeEEEeeccccccc
Confidence 9999999999999987642 23448999999999999999999999999999999999999988 68999999998754
Q ss_pred ccccccccccCccceecccccccccccccccccccCC-------------------------------C-CCCC------
Q 021127 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------N-VRPS------ 218 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~-~~~~------ 218 (317)
.... .....++..|+|||.+.+...... .+.|..+ . ..+.
T Consensus 156 ~~~~-~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 156 VNSL-AGTFTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred cccc-cccccCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 3221 123457889999998654322111 1111100 0 0000
Q ss_pred -CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 219 -AENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 219 -~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
....++.+.+++.+||+.+|.+|||+.+++++-
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 123467899999999999999999999999874
No 336
>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun
Probab=100.00 E-value=5.5e-33 Score=241.91 Aligned_cols=216 Identities=27% Similarity=0.401 Sum_probs=171.3
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv 101 (317)
.|.-.+.||+|++|.||++.+. ++.+|+|.+..... .....+.+|+.+++.++|+||+++++++.. +..++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-----hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEE
Confidence 4555679999999999999874 78899998864432 224458899999999999999999998865 489999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-c
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-E 180 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~ 180 (317)
+||+++++|.+++.. . .+++..+..++.|++.||+|||++|++||||+|+||+++.+ +.++|+|||.+...... .
T Consensus 95 ~e~~~~~~L~~~~~~-~--~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 95 MEFLEGGALTDIVTH-T--RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EeccCCCCHHHHHHh-C--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC-CcEEEcccccchhhccCCc
Confidence 999999999999876 2 38999999999999999999999999999999999999988 79999999988644322 1
Q ss_pred ccccccCccceecccccccccccccccccccCC---------------------------C---CCCCCCCChHHHHHHH
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------N---VRPSAENVPEELSIIL 230 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~---~~~~~~~~~~~l~~li 230 (317)
......|++.|+|||.+.+.... ...+.|+.+ . ....+..++..+.+++
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 249 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFL 249 (285)
T ss_pred ccccccCCccccCHHHhcCCCCC-CcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHH
Confidence 22334688999999987653322 122222211 0 0111233778999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 021127 231 TSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 231 ~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+||+.+|.+||++.+++++
T Consensus 250 ~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 250 DRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred HHHcccChhhCcCHHHHccC
Confidence 99999999999999999876
No 337
>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the
Probab=100.00 E-value=2.4e-33 Score=247.44 Aligned_cols=171 Identities=25% Similarity=0.349 Sum_probs=137.1
Q ss_pred ceeecceeccccceEEEEeEE----CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---Cc
Q 021127 25 HLFVGPRIGEGAHAKVYEGKY----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PV 97 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~ 97 (317)
+|.+.++||+|+||.||+|.+ .++.||||.+....... ......+.+|+.++.+++||||+++++++.+ ..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQY--TGISQSACREIALLRELKHENVVSLVEVFLEHADKS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccc--cCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence 488899999999999999988 46899999998743111 1123356789999999999999999999864 36
Q ss_pred eEEEEEccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC----CCCceEEccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE----DLKTIKLADF 170 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~----~~~~~kl~Df 170 (317)
.++||||++ ++|.+++.... ...+++..++.++.|++.||+|||+++++||||||+||+++. + +.+||+||
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~-~~~kl~Df 156 (316)
T cd07842 79 VYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPER-GVVKIGDL 156 (316)
T ss_pred EEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCcc-ceEEECCC
Confidence 899999995 57777765322 225899999999999999999999999999999999999998 6 78999999
Q ss_pred Ccccccccccc----cccccCccceeccccccc
Q 021127 171 GLAREESLTEM----MTAETGTYRWMAPELYST 199 (317)
Q Consensus 171 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~~ 199 (317)
|++........ .....++..|+|||++.+
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 189 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLG 189 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhC
Confidence 99885432211 223457889999997654
No 338
>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou
Probab=100.00 E-value=7.8e-33 Score=240.97 Aligned_cols=220 Identities=25% Similarity=0.416 Sum_probs=177.5
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-Cce
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 98 (317)
..+.|++.+.||+|++|.||++.+. +..|++|++..... ....+.+|+++++.++|+||+++++.+.. ...
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ------NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL 90 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence 3467889999999999999999986 88999999976543 24458899999999999999999998865 489
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++|+||+++++|.+++.... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKD-GSVKLADFGFAAQLTK 168 (286)
T ss_pred EEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCC-CCEEECccchhhhhcc
Confidence 99999999999999998755 249999999999999999999999999999999999999987 7899999998864432
Q ss_pred cc-ccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHH
Q 021127 179 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 179 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~ 227 (317)
.. ......++..|+|||++.+.... ...+.|..+ ........++..+.
T Consensus 169 ~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 247 (286)
T cd06614 169 EKSKRNSVVGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFK 247 (286)
T ss_pred chhhhccccCCcccCCHhHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHH
Confidence 21 12334578899999987654332 223333221 00111233788999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+++.+||+.+|.+||++.+++++
T Consensus 248 ~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 248 DFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHHHHHhccChhhCcCHHHHhhC
Confidence 99999999999999999999886
No 339
>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1. Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto
Probab=100.00 E-value=1.7e-33 Score=243.93 Aligned_cols=221 Identities=29% Similarity=0.406 Sum_probs=176.2
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecC-ceE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~~~ 99 (317)
++|.+.+.||+|++|.||++... ++.||+|++....... ......+.+|+.++++++ |+||+++++++.++ ..+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK--EKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccc--hHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence 47999999999999999999884 8899999987643222 133456888999999998 99999999988654 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+|||++++++|.+++..... +++..++.++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~-~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKD-MHIKITDFGTAKVLDPN 155 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEecCCccccccCCc
Confidence 99999999999999987543 9999999999999999999999999999999999999988 78999999998754322
Q ss_pred c---------------------ccccccCccceecccccccccccccccccccCC-------------------------
Q 021127 180 E---------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------- 213 (317)
Q Consensus 180 ~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------- 213 (317)
. ......++..|+|||++....... ..+.|..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGK-SSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCCh-hhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 1 112335788999999866533211 12222211
Q ss_pred --CCCCCCCCChHHHHHHHHHhhhcCCCCCCCH----HHHHHH
Q 021127 214 --NVRPSAENVPEELSIILTSCWKEDPNARPNF----TQIIQM 250 (317)
Q Consensus 214 --~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~----~~~~~~ 250 (317)
.....+..++..+.+++.+||+.+|.+||++ .+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 235 LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 1123355678899999999999999999999 888765
No 340
>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi
Probab=100.00 E-value=4e-33 Score=248.98 Aligned_cols=219 Identities=21% Similarity=0.259 Sum_probs=169.8
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC----
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP---- 96 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 96 (317)
.++|.+.+.||.|+||.||+|.+. +..||+|.+...... ....+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~-----~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ-----SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCc-----hHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 478999999999999999999885 789999998765542 234578899999999999999999876432
Q ss_pred -----------ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCce
Q 021127 97 -----------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165 (317)
Q Consensus 97 -----------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~ 165 (317)
..++||||+. ++|.+++... .+++..+..++.||+.||.|||+.|++||||||+||+++.+.+.+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceE
Confidence 4789999996 6898888642 389999999999999999999999999999999999998654678
Q ss_pred EEcccCccccccccc----ccccccCccceecccccccccccccccccccCC--------CC------------------
Q 021127 166 KLADFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------------ 215 (317)
Q Consensus 166 kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------------ 215 (317)
||+|||+++...... ......++..|+|||++..........+.|+.+ ..
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999997543211 112335788999999764422222223333221 00
Q ss_pred -------------------------C------CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 -------------------------R------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 -------------------------~------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
. .....++.++.+|+.+||+.||.+|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0 0012467789999999999999999999999987
No 341
>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=5e-33 Score=257.18 Aligned_cols=222 Identities=28% Similarity=0.427 Sum_probs=182.9
Q ss_pred cCCceeecceeccccceEEEEeEE--CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeee----
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK---- 94 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~---- 94 (317)
+..-++|.+.||.|.+|.||+++. +++.+|+|++......++ .+..|.++++.. .|||++.++|++.
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~de------EiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEE------EIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccH------HHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 335678899999999999998866 489999999887665443 356788899887 7999999999873
Q ss_pred --cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 95 --EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 95 --~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
++.+|+|||||.||+..+++.+.....+.|+.+..|++.++.||.+||.+.++|||||-.|||++.+ +.|||+|||+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e-~~VKLvDFGv 169 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTEN-AEVKLVDFGV 169 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEecc-CcEEEeeeee
Confidence 3489999999999999999998888889999999999999999999999999999999999999999 7899999999
Q ss_pred ccccccc-cccccccCccceecccccccccccc----cccccccCC---------------------------CCCC---
Q 021127 173 AREESLT-EMMTAETGTYRWMAPELYSTVTLRQ----GEKKHYNHK---------------------------NVRP--- 217 (317)
Q Consensus 173 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~----~~~~~~~~~---------------------------~~~~--- 217 (317)
+...+.+ ....+..||+.|||||++....... ...+.|+.+ +.+|
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLk 249 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK 249 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcccc
Confidence 9866544 3456678999999999987543322 223334433 1111
Q ss_pred CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+...+.++-++|..||..|-++||++.++++|
T Consensus 250 rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 250 RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred chhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 145667899999999999999999999998876
No 342
>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an
Probab=100.00 E-value=5e-33 Score=237.87 Aligned_cols=220 Identities=25% Similarity=0.402 Sum_probs=176.7
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.++||.|++|.||++.+. ++.+|+|.+....... ....++.+|+.+++.++|+||+++++++.+. ..++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ---KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV 77 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH---HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence 5889999999999999999875 7889999987654332 2345678899999999999999999887654 89999
Q ss_pred EEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 102 TELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
|||+++++|.+++.... ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.+ +.+||+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~-~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAN-DLVKIGDLGISKVLKKN 156 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecC-CcEEEeeccchhhhccC
Confidence 99999999999987632 2348999999999999999999999999999999999999987 68999999999765443
Q ss_pred cccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li~ 231 (317)
......++..|+|||.+.+..... ..+.|+.+ .....+..++.++.+++.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~~-~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYSY-KSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence 333456888999999876543322 22222211 111223456788999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 021127 232 SCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 232 ~cl~~~p~~Rps~~~~~~~ 250 (317)
+||+.+|++||++.+++++
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 235 SMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHcCCCcccCCCHHHHhcC
Confidence 9999999999999999876
No 343
>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta. Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig
Probab=100.00 E-value=7.8e-33 Score=245.74 Aligned_cols=167 Identities=19% Similarity=0.320 Sum_probs=134.9
Q ss_pred cceeccc--cceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEE
Q 021127 29 GPRIGEG--AHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTE 103 (317)
Q Consensus 29 ~~~lG~G--~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 103 (317)
...||+| +||+||++.+. ++.||+|++....... ...+.+.+|+.+++.++||||+++++++..+ ..++|||
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e 79 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE---EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISP 79 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEe
Confidence 3456766 99999999884 8999999987654433 2345788899999999999999999999765 7899999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc--
Q 021127 104 LLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM-- 181 (317)
Q Consensus 104 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~-- 181 (317)
|+.+++|.+++.......+++..+..++.|++.||+|||++|++||||||+||+++.+ +.++++||+.+........
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~-~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC-CcEEEechHHHhhhhccCccc
Confidence 9999999999987655568999999999999999999999999999999999999988 7899999986532211100
Q ss_pred ------cccccCccceeccccccc
Q 021127 182 ------MTAETGTYRWMAPELYST 199 (317)
Q Consensus 182 ------~~~~~gt~~y~aPE~~~~ 199 (317)
.....++..|+|||++.+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~ 182 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQ 182 (328)
T ss_pred cccccccccccCccCccChhhhcC
Confidence 011234567999998754
No 344
>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]
Probab=100.00 E-value=8.4e-34 Score=231.17 Aligned_cols=227 Identities=21% Similarity=0.375 Sum_probs=182.3
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeee
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGAC 93 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 93 (317)
+++..+.++++.+..||+|..|.||+++.. |...|||.+++....++ .++++..++++... ..|+||+.+|+|
T Consensus 85 ~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee----~kRILmDldvv~~s~dcpyIV~c~GyF 160 (391)
T KOG0983|consen 85 QRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEE----NKRILMDLDVVLKSHDCPYIVQCFGYF 160 (391)
T ss_pred cccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHH----HHHHHHhhhHHhhccCCCeeeeeeeEE
Confidence 345566777788899999999999999886 68999999998776543 45688888887766 489999999999
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEeeCCCCceEEcccC
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
..+ ..++.||.| +..+..++...+ .++++..+-.+...++.||.||..+ ||+|||+||+|||+|.. |.+|+||||
T Consensus 161 i~n~dV~IcMelM-s~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~-GniKlCDFG 237 (391)
T KOG0983|consen 161 ITNTDVFICMELM-STCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER-GNIKLCDFG 237 (391)
T ss_pred eeCchHHHHHHHH-HHHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccC-CCEEeeccc
Confidence 755 788999998 556666666543 4489998999999999999999976 89999999999999998 799999999
Q ss_pred cccccccccccccccCccceeccccccccc--ccccccccccCC-------------------------------CCCCC
Q 021127 172 LAREESLTEMMTAETGTYRWMAPELYSTVT--LRQGEKKHYNHK-------------------------------NVRPS 218 (317)
Q Consensus 172 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~~~-------------------------------~~~~~ 218 (317)
++-........+...|.+.|||||-+.... ...-..+.|+.+ ...+.
T Consensus 238 IsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~ 317 (391)
T KOG0983|consen 238 ISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPG 317 (391)
T ss_pred ccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCc
Confidence 998776666667778999999999876532 122233344433 11122
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
..++++.+.+|+..||..|+.+||...++++|
T Consensus 318 ~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 318 HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 34589999999999999999999999999987
No 345
>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein. Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc
Probab=100.00 E-value=3.3e-33 Score=246.52 Aligned_cols=223 Identities=18% Similarity=0.317 Sum_probs=170.4
Q ss_pred eeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEc
Q 021127 26 LFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTEL 104 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 104 (317)
+.+++.+|.|+++.|+++..+++.||||++....... .....+.+|+.+++.++|+||+++++++.+. ..+++|||
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 80 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSK---EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPL 80 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccch---hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEec
Confidence 4566677777888888887789999999998653222 2345689999999999999999999988754 88999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc----
Q 021127 105 LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---- 180 (317)
Q Consensus 105 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---- 180 (317)
+++++|.+++.......+++..+..++.|++.||+|||+++|+||||||+||+++.+ +.+||+|||.+.......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~-~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC-CceEEecCccceeecccccccc
Confidence 999999999987655558999999999999999999999999999999999999987 789999999886432111
Q ss_pred ----ccccccCccceeccccccccc-ccccccccccCC--------C---------------------------------
Q 021127 181 ----MMTAETGTYRWMAPELYSTVT-LRQGEKKHYNHK--------N--------------------------------- 214 (317)
Q Consensus 181 ----~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~~--------~--------------------------------- 214 (317)
......++..|+|||++.... ......+.|+.+ .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 112335678899999875421 111112222111 0
Q ss_pred --------------------CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 215 --------------------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 215 --------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.......++.++.+|+.+||+.||++|||+++++++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 00001123467889999999999999999999998744
No 346
>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul
Probab=100.00 E-value=8.8e-33 Score=246.32 Aligned_cols=219 Identities=25% Similarity=0.344 Sum_probs=171.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeec--C-c
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE--P-V 97 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--~-~ 97 (317)
++|++.+.||+|+||.||+|.+. ++.+|||.+....... .....+.+|+.+++++ +|+||+++++++.. . .
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA---TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc---hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 67899999999999999999874 7899999886533221 2234577899999999 99999999998753 2 6
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++||||+. ++|..++... .+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~-~~~kl~d~g~~~~~~ 158 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSD-CRVKLADFGLARSLS 158 (337)
T ss_pred EEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEEeeccchhccc
Confidence 899999996 6999988764 38899999999999999999999999999999999999998 799999999987543
Q ss_pred ccc------ccccccCccceecccccccccccccccccccCC--------CC----------------------------
Q 021127 178 LTE------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV---------------------------- 215 (317)
Q Consensus 178 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~---------------------------- 215 (317)
... ......|+..|+|||++.+........+.|+.+ ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 221 222345888999999875533222333333322 00
Q ss_pred ----------------------CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 ----------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 ----------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
......++.++.+++.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00012367889999999999999999999999987
No 347
>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co
Probab=100.00 E-value=1e-32 Score=245.39 Aligned_cols=219 Identities=24% Similarity=0.308 Sum_probs=166.9
Q ss_pred ceeecceeccccceEEEEeEEC----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeee---c-
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK---E- 95 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~---~- 95 (317)
+|.+.+.||+|+||.||++.+. +..||||.+....... .....+.+|+.+++++ .|+||+++++.+. .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 77 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKK---ILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN 77 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccc---hhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence 5889999999999999999885 5589999987543222 2244578899999999 5999999998642 2
Q ss_pred -CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
...+++++++ +++|.+++..... +++..++.++.||+.||+|||++|++||||||+||+++.+ +.+||+|||++.
T Consensus 78 ~~~~~~~~e~~-~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~-~~~kl~Dfg~a~ 153 (332)
T cd07857 78 FNELYLYEELM-EADLHQIIRSGQP--LTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD-CELKICDFGLAR 153 (332)
T ss_pred CCcEEEEEecc-cCCHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCC-CCEEeCcCCCce
Confidence 2578889988 5799998875443 8999999999999999999999999999999999999988 789999999997
Q ss_pred cccccc-----ccccccCccceecccccccccccccccccccCC--------CC--------------------------
Q 021127 175 EESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV-------------------------- 215 (317)
Q Consensus 175 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~-------------------------- 215 (317)
...... ......|+..|+|||++.+........++|+.+ ..
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 543221 122346889999999865422111222222211 00
Q ss_pred ---------------------C---CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 ---------------------R---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 ---------------------~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
. ......+..+.+++.+||+.||.+|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 0012346789999999999999999999999987
No 348
>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=4.1e-34 Score=219.77 Aligned_cols=220 Identities=26% Similarity=0.421 Sum_probs=176.0
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee-cCceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~lv 101 (317)
+|.-.++||+|.+|+||+|++. ++.||+|.++.....+.... ..++|+-+++.+.|+|||+++++.. ++.+-+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvps---salreicllkelkhknivrl~dvlhsdkkltlv 79 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPS---SALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcH---HHHHHHHHHHHhhhcceeehhhhhccCceeEEe
Confidence 4666789999999999999875 78999999987765543322 4688999999999999999999986 4589999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-c
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-E 180 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~ 180 (317)
+||| ..+|..+...... .++.+.+..++.|+++||.|+|++++.|||+||.|.+|+.+ |.+|++|||+++..... .
T Consensus 80 fe~c-dqdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~n-gelkladfglarafgipvr 156 (292)
T KOG0662|consen 80 FEFC-DQDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRN-GELKLADFGLARAFGIPVR 156 (292)
T ss_pred HHHh-hHHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccC-CcEEecccchhhhcCCceE
Confidence 9999 6689998876443 39999999999999999999999999999999999999999 89999999999865543 3
Q ss_pred ccccccCccceecccccccccccccccccccCC-----------------------------------------CCCC--
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------------------NVRP-- 217 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~-- 217 (317)
..+..+-|..|.+|.++-+........+.|+.+ ...+
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 445667899999999987755554444444332 0000
Q ss_pred -----C---------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 -----S---------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 -----~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
. .+.+...-++++...|.-+|.+|.+++..+++
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 0 11223446889999999999999999998876
No 349
>PHA03210 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=1.1e-33 Score=263.83 Aligned_cols=226 Identities=19% Similarity=0.251 Sum_probs=160.9
Q ss_pred CceeecceeccccceEEEEeEEC---CeEEEEEEeecCCC------------hHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGET------------PEEIAKKESRFAREVAMLSRVQHRNLVK 88 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~---~~~vaiK~~~~~~~------------~~~~~~~~~~~~~E~~~l~~l~h~niv~ 88 (317)
++|++.++||+|+||+||++... +..+++|.+..... ..........+.+|+.++++++|+||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 67999999999999999998653 22222221110000 0001123456889999999999999999
Q ss_pred EEeeeecC-ceEEEEEccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCc
Q 021127 89 FIGACKEP-VMVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 164 (317)
Q Consensus 89 l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~ 164 (317)
+++++.+. ..++|++++ +++|..++.... ........+..|+.||+.||+|||++|||||||||+|||++.+ +.
T Consensus 228 l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~-~~ 305 (501)
T PHA03210 228 IEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD-GK 305 (501)
T ss_pred EeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CC
Confidence 99999765 789999998 568888775432 1123466778899999999999999999999999999999988 78
Q ss_pred eEEcccCccccccccc--ccccccCccceecccccccccccccccccccCC---------CC------------------
Q 021127 165 IKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------NV------------------ 215 (317)
Q Consensus 165 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------~~------------------ 215 (317)
+||+|||+++...... ......||..|+|||++.+..+.. ..++|+.+ ..
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~ 384 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCE-ITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCc-HHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence 9999999998554322 223457999999999876533211 11222111 00
Q ss_pred ---------CC--------------------------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 216 ---------RP--------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 216 ---------~~--------------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.+ ....++..+.+++.+||+.||.+|||+.|++++-+
T Consensus 385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 00 01124556778899999999999999999998743
No 350
>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and
Probab=100.00 E-value=3.1e-33 Score=248.48 Aligned_cols=219 Identities=27% Similarity=0.328 Sum_probs=175.1
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC------
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP------ 96 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 96 (317)
+|++.+.||.|++|.||+|.+. ++.||||.+....... ...+.+.+|+.+++.++|+||+++++++...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDL---IDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN 77 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccc---hhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence 5889999999999999999875 7899999987643211 2345688999999999999999999988543
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++||||+. ++|.+++.... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++...
T Consensus 78 ~~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~-~~~~L~dfg~~~~~ 153 (330)
T cd07834 78 DVYIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN-CDLKICDFGLARGV 153 (330)
T ss_pred ceEEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEcccCceEee
Confidence 6899999996 58999887654 49999999999999999999999999999999999999998 79999999999865
Q ss_pred cccc----ccccccCccceecccccccccccccccccccCC--------CCC----------------------------
Q 021127 177 SLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR---------------------------- 216 (317)
Q Consensus 177 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~---------------------------- 216 (317)
.... ......++..|+|||++.+........+.|+.+ ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 4432 233446788999999987653333333333221 000
Q ss_pred ----------------------CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 ----------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 ----------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.....++.++.++|.+||+.+|.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0012367889999999999999999999999987
No 351
>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check
Probab=100.00 E-value=2.2e-33 Score=240.95 Aligned_cols=223 Identities=24% Similarity=0.382 Sum_probs=169.6
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|.+.++||+|+||.||++.+. +..+++|+++.............++.+|+.++++++||||+++++++.+. ..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5889999999999999999876 44566666554222111112233466789999999999999999988654 78999
Q ss_pred EEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 102 TELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
|||+++++|.+++... ....+++..++.++.|++.||.|||++|++|+||+|+||+++.+ .++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~--~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN--LLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC--CEeecccCceeecCCC
Confidence 9999999999988752 22358999999999999999999999999999999999999864 6999999998754322
Q ss_pred -cccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHH
Q 021127 180 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIIL 230 (317)
Q Consensus 180 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li 230 (317)
.......|+..|+|||.+.+..... ..+.|+.+ .....+..++.++.++|
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~~~~~~-~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKHQGYDS-KSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIM 237 (260)
T ss_pred cccccCCCCCcCccCHHHHccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHH
Confidence 2223446788999999875533221 12222211 11122456788999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 021127 231 TSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 231 ~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+||..+|++||++.+++++
T Consensus 238 ~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 238 QSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHhcCChhhCcCHHHHhhC
Confidence 99999999999999999876
No 352
>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U
Probab=100.00 E-value=1.6e-32 Score=243.67 Aligned_cols=219 Identities=28% Similarity=0.364 Sum_probs=170.4
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec--Cce
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE--PVM 98 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 98 (317)
.++|++.+.||.|+||.||++.+. ++.||||.+.+..... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP---VLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc---chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 467999999999999999999875 7889999886543222 223457789999999999999999998854 378
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++|+||+ +++|.+++... .+++..+..++.|++.||+|||++|++||||+|+||+++.+ +.++|+|||++.....
T Consensus 86 ~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~-~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN-CDLKICDFGLARIQDP 160 (328)
T ss_pred EEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCC-CCEEeCccccccccCC
Confidence 9999999 67898887642 38888899999999999999999999999999999999987 7899999999875432
Q ss_pred ccccccccCccceecccccccccccccccccccCC--------C------------------------------------
Q 021127 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N------------------------------------ 214 (317)
Q Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~------------------------------------ 214 (317)
. .....++..|+|||++.+........+.|+.+ .
T Consensus 161 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 161 Q--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred C--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 2 23346788999999875422222222222211 0
Q ss_pred ---------CCC-----CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 215 ---------VRP-----SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 215 ---------~~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
..+ ....++.++.++|.+||+.+|++||++.+++.+-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~ 289 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289 (328)
T ss_pred HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 000 0134678899999999999999999999998873
No 353
>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po
Probab=100.00 E-value=1e-32 Score=239.93 Aligned_cols=219 Identities=26% Similarity=0.330 Sum_probs=170.2
Q ss_pred eeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---CceEE
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PVMVI 100 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~l 100 (317)
|++.++||.|++|.||+|.+. ++.+|+|.+....... .....+.+|+.++++++|+|++++++++.+ +..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKE---GFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccc---cchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence 678899999999999999886 6899999998764221 223457889999999999999999999864 47999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||++ ++|.+++.... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.+ +.+||+|||++.......
T Consensus 78 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~-~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 78 VFEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND-GVLKLADFGLARPYTKRN 154 (287)
T ss_pred Eecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCC-CCEEEccccceeeccCCC
Confidence 999996 58998887643 348999999999999999999999999999999999999998 799999999998554332
Q ss_pred --ccccccCccceecccccccccccccccccccCC--------C--------------------------CCC-------
Q 021127 181 --MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N--------------------------VRP------- 217 (317)
Q Consensus 181 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~--------------------------~~~------- 217 (317)
......++..|+|||.+.+........+.|+.+ . ..+
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 123345688899999765422222222222211 0 000
Q ss_pred ----------------CCCC-ChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 ----------------SAEN-VPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 ----------------~~~~-~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.... ++..+.+++.+||..+|.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0011 37789999999999999999999999875
No 354
>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3. Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co
Probab=100.00 E-value=2.3e-32 Score=241.14 Aligned_cols=217 Identities=25% Similarity=0.390 Sum_probs=169.5
Q ss_pred eeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEE
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVT 102 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 102 (317)
|...++||+|+||+||+|++. ++.|++|.+....... ......+.+|+++++.++|+|++++++++.+. ..++||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQT--NEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCc--hHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 556778999999999999874 7899999987654322 13345688899999999999999999998765 789999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccccc
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM 182 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~ 182 (317)
||+. ++|.+++.... ..+++..++.++.|++.||+|||++|++|+||+|+||+++.+ +.+||+|||++.... ..
T Consensus 101 e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~-~~~kL~dfg~~~~~~---~~ 174 (313)
T cd06633 101 EYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSASKSS---PA 174 (313)
T ss_pred ecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCC-CCEEEeecCCCcccC---CC
Confidence 9995 68888776533 348999999999999999999999999999999999999988 689999999986432 22
Q ss_pred ccccCccceecccccccc--cccccccccccCC-----------------------------CCCCCCCCChHHHHHHHH
Q 021127 183 TAETGTYRWMAPELYSTV--TLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 183 ~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~ 231 (317)
....|+..|+|||++... .......+.|+.+ ........++..+.+|+.
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 254 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVD 254 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence 345688999999997431 1111122222211 001112346678999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 021127 232 SCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 232 ~cl~~~p~~Rps~~~~~~~ 250 (317)
+||+.+|.+||++.+++.+
T Consensus 255 ~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 255 YCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHccCChhhCcCHHHHhcC
Confidence 9999999999999999876
No 355
>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines
Probab=100.00 E-value=9.2e-33 Score=240.78 Aligned_cols=223 Identities=23% Similarity=0.297 Sum_probs=171.9
Q ss_pred ceeecceeccccceEEEEeEE-----CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-c
Q 021127 25 HLFVGPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-V 97 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 97 (317)
+|++.+.||+|++|.||++.. ++..||||++....... ......++.+|+.++.++ +|+||+++++.+..+ .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~-~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQ-KAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHh-hhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence 478999999999999999875 36789999987543211 123345688999999999 699999999988655 7
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++||||+.+++|.+++.... .+++..+..++.|++.||.|||+.+++||||+|+||+++.+ +.++|+|||+++...
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~ 156 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEEECccccccc
Confidence 889999999999999987644 38999999999999999999999999999999999999988 689999999987543
Q ss_pred ccc--ccccccCccceeccccccccc-ccccccccccCC-------------------------------CCCCCCCCCh
Q 021127 178 LTE--MMTAETGTYRWMAPELYSTVT-LRQGEKKHYNHK-------------------------------NVRPSAENVP 223 (317)
Q Consensus 178 ~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~~-------------------------------~~~~~~~~~~ 223 (317)
... ......|+..|+|||.+.+.. ......+.|..+ ...+.+..++
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMS 236 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccC
Confidence 221 112345789999999875432 111122222211 1122244577
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
..+.+++.+||+.||++|||+.++.+.|
T Consensus 237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l 264 (288)
T cd05583 237 AEARDFIQKLLEKDPKKRLGANGADEIK 264 (288)
T ss_pred HHHHHHHHHHhcCCHhhccCcchHHHHh
Confidence 8999999999999999999977665543
No 356
>PHA02882 putative serine/threonine kinase; Provisional
Probab=100.00 E-value=1.7e-32 Score=239.84 Aligned_cols=227 Identities=17% Similarity=0.229 Sum_probs=162.0
Q ss_pred eecCCceeecceeccccceEEEEeEECC-----eEEEEEEeecCCChHHHHH------HHHHHHHHHHHHHhcCCCCeee
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYKN-----QTVAIKIVHKGETPEEIAK------KESRFAREVAMLSRVQHRNLVK 88 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~vaiK~~~~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~ 88 (317)
.+..++|++.++||+|+||.||+|.+.+ ..+|+|+............ .......+...+..+.|+|+++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 3666899999999999999999998753 3567776443332211010 0112233444556679999999
Q ss_pred EEeeeecC-----ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCC
Q 021127 89 FIGACKEP-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 163 (317)
Q Consensus 89 l~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~ 163 (317)
+++++... ..+++++++ ..++.+.+..... .++..+..++.|++.||+|||+++|+||||||+|||++.+ +
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~-~ 163 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKC--KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN-N 163 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhcc--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-C
Confidence 99876432 346788887 4577777665332 6788899999999999999999999999999999999987 6
Q ss_pred ceEEcccCcccccccc--------cccccccCccceecccccccccccccccccccCC----------------------
Q 021127 164 TIKLADFGLAREESLT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------- 213 (317)
Q Consensus 164 ~~kl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------- 213 (317)
.++|+|||+++..... .......||+.|+|||++.+..... ..+.|+.+
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~-~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTR-RGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCc-HHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 8999999999754211 1122346999999999876543221 12222211
Q ss_pred -------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 214 -------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 214 -------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
.........+..+.+++..||..+|++||+++++++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 IHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 00112345678899999999999999999999998865
No 357
>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do
Probab=100.00 E-value=1.9e-32 Score=235.18 Aligned_cols=212 Identities=25% Similarity=0.342 Sum_probs=162.3
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHH-HhcCCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML-SRVQHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||.||+|.+. ++.||||+++...... ......+..|..++ ...+|+|++++++++.++ ..++|+||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA--KNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH--HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence 57899999999999884 7899999987543221 11222344554444 445899999999999765 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE 185 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 185 (317)
++++|.+++..... +++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||+++.... ....
T Consensus 80 ~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~---~~~~ 153 (260)
T cd05611 80 NGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT-GHLKLTDFGLSRNGLE---NKKF 153 (260)
T ss_pred CCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CcEEEeecccceeccc---cccC
Confidence 99999999986544 8999999999999999999999999999999999999988 7899999999875432 2334
Q ss_pred cCccceecccccccccccccccccccCC----------------------------C---CCCCCCCChHHHHHHHHHhh
Q 021127 186 TGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------N---VRPSAENVPEELSIILTSCW 234 (317)
Q Consensus 186 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~---~~~~~~~~~~~l~~li~~cl 234 (317)
.++..|+|||.+.+.. .....++|..+ . .......++..+.+++.+||
T Consensus 154 ~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 232 (260)
T cd05611 154 VGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232 (260)
T ss_pred CCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHc
Confidence 6888999999876643 22223333221 0 00112357899999999999
Q ss_pred hcCCCCCCCH---HHHHHH
Q 021127 235 KEDPNARPNF---TQIIQM 250 (317)
Q Consensus 235 ~~~p~~Rps~---~~~~~~ 250 (317)
+.+|++||++ .|++.+
T Consensus 233 ~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 233 CMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cCCHHHccCCCcHHHHHcC
Confidence 9999999966 455554
No 358
>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14
Probab=100.00 E-value=2.1e-32 Score=244.56 Aligned_cols=219 Identities=24% Similarity=0.268 Sum_probs=170.3
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-----
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE----- 95 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 95 (317)
.++|++.+.||+|+||.||++.+. ++.||+|++....... .....+.+|+.++++++|+||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI---IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhh---HHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 478999999999999999999864 8899999987643222 234457889999999999999999998742
Q ss_pred --CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 96 --PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 96 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
...+++++++ +++|.+++... .+++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kl~dfg~~ 167 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGLA 167 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCC-CCEEEeccccc
Confidence 2467888877 88998887643 38999999999999999999999999999999999999998 78999999998
Q ss_pred cccccccccccccCccceecccccccccccccccccccCC--------CCCC----------------------------
Q 021127 174 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVRP---------------------------- 217 (317)
Q Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~~---------------------------- 217 (317)
..... ......++..|+|||++.+........++|+.+ ...+
T Consensus 168 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 168 RHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred ccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 75432 223446788999999875422222223333221 0000
Q ss_pred ----------------------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 218 ----------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 218 ----------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
.....+.++.++|.+||+.||.+||++.+++++-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 0113467789999999999999999999999883
No 359
>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2. Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin
Probab=100.00 E-value=2.2e-32 Score=240.81 Aligned_cols=221 Identities=25% Similarity=0.360 Sum_probs=173.0
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
..|...+.||.|+||.||+|++. +..+|+|.+....... .....++.+|+++++.++|+|++++++++.+. ..++
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS--NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccC--hHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 46778899999999999999885 7889999987533221 12345688999999999999999999988755 7899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+. |+|.+.+.... ..+++..+..++.|++.||.|||+++++||||+|+||+++.+ +.++|+|||++......
T Consensus 93 v~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 93 VMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCC-CcEEECCcccceeecCc-
Confidence 999995 68888776433 348999999999999999999999999999999999999988 78999999998754322
Q ss_pred ccccccCccceecccccccc--cccccccccccCC---------------------------C--CCCCCCCChHHHHHH
Q 021127 181 MMTAETGTYRWMAPELYSTV--TLRQGEKKHYNHK---------------------------N--VRPSAENVPEELSII 229 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~~---------------------------~--~~~~~~~~~~~l~~l 229 (317)
....++..|+|||.+.+. .......++|+.+ . .......++..+.+|
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHH
Confidence 334678899999987431 1112223333322 0 011133577889999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHH
Q 021127 230 LTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
|.+||+.+|.+||++.+++++.+
T Consensus 247 i~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 247 VDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HHHHhhCCcccCCCHHHHhhCcc
Confidence 99999999999999999998844
No 360
>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12
Probab=100.00 E-value=2e-32 Score=244.60 Aligned_cols=218 Identities=24% Similarity=0.304 Sum_probs=170.3
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC----
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP---- 96 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 96 (317)
.++|++.+.||+|+||.||++.+. +..||||.+....... .....+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSE---LFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccch---HHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 567999999999999999999875 8899999986543222 2344678999999999999999999988532
Q ss_pred ---ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 97 ---VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 97 ---~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
.+++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+||+++.+ +.++|+|||++
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~-~~~kl~dfg~~ 165 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLA 165 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccc
Confidence 358999999 7899888764 238999999999999999999999999999999999999988 68999999999
Q ss_pred cccccccccccccCccceecccccccccccccccccccCC--------CC------------------------------
Q 021127 174 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------------------------ 215 (317)
Q Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------------------------ 215 (317)
...... .....+++.|+|||++.+........+.|+.+ ..
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 166 RQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred cccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 754322 23346788999999875422111112222111 00
Q ss_pred --------------------CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 --------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 --------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
......++..+.+++.+||+.||.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00013567789999999999999999999999976
No 361
>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re
Probab=100.00 E-value=6.8e-33 Score=238.06 Aligned_cols=213 Identities=30% Similarity=0.406 Sum_probs=166.9
Q ss_pred eccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCCC
Q 021127 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGG 108 (317)
Q Consensus 32 lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g 108 (317)
||.|+||.||++.+. ++.+|+|++....... ......+.+|++++++++|+||+++++.+..+ ..++||||++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR--KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhh--hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence 689999999999986 8999999987654322 24456788999999999999999999988655 799999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc--------
Q 021127 109 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-------- 180 (317)
Q Consensus 109 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-------- 180 (317)
+|.+++.... .+++..++.++.|++.||+|||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 79 ~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 79 DLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCC-CCEEEEecccchhcccCccccccccc
Confidence 9999998755 38999999999999999999999999999999999999998 799999999987543221
Q ss_pred -ccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCC--ChHHHHHHH
Q 021127 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAEN--VPEELSIIL 230 (317)
Q Consensus 181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~--~~~~l~~li 230 (317)
......++..|+|||....... ....+.|..+ .....+.. ++..+.+++
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 234 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLI 234 (265)
T ss_pred ccccCcccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHH
Confidence 1223457889999998655331 1122222211 01112222 388999999
Q ss_pred HHhhhcCCCCCCCH---HHHHHH
Q 021127 231 TSCWKEDPNARPNF---TQIIQM 250 (317)
Q Consensus 231 ~~cl~~~p~~Rps~---~~~~~~ 250 (317)
.+||+.+|.+|||+ .+++++
T Consensus 235 ~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 235 SKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred HHHhcCCHhhcCCCccHHHHhcC
Confidence 99999999999999 555543
No 362
>PTZ00024 cyclin-dependent protein kinase; Provisional
Probab=100.00 E-value=1.1e-32 Score=245.52 Aligned_cols=224 Identities=24% Similarity=0.335 Sum_probs=169.0
Q ss_pred Ccee-ecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHH---------HHHHHHHHHHHHHhcCCCCeeeEEe
Q 021127 24 KHLF-VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAK---------KESRFAREVAMLSRVQHRNLVKFIG 91 (317)
Q Consensus 24 ~~y~-~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~ 91 (317)
++|. +.+.||.|+||.||+|.+. ++.||||.+........... ....+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 5678999999999999875 88999999876543221000 0124778999999999999999999
Q ss_pred eeecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEccc
Q 021127 92 ACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (317)
Q Consensus 92 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Df 170 (317)
++... ..++||||+. ++|.+++..... +++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~-~~~kl~df 163 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIR--LTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK-GICKIADF 163 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCC-CCEEECCc
Confidence 98654 8899999995 699999876443 8999999999999999999999999999999999999988 78999999
Q ss_pred Cccccccc---------------ccccccccCccceecccccccccccccccccccCC--------CC------------
Q 021127 171 GLAREESL---------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------ 215 (317)
Q Consensus 171 g~a~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------ 215 (317)
|++..... ........++..|+|||.+.+........+.|+.+ ..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99875431 11112234678899999876532222222222211 00
Q ss_pred -----------------------------------CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 216 -----------------------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 216 -----------------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
.......+..+.+++.+||+.+|++||++++++.+.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 000124577899999999999999999999999873
No 363
>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo
Probab=100.00 E-value=2.5e-32 Score=238.61 Aligned_cols=219 Identities=26% Similarity=0.410 Sum_probs=171.2
Q ss_pred cceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 29 GPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
..+||+|+||.||++... ++.||||.+..... .....+.+|+.+++.++|+||+++++.+..+ ..++||||+
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch-----hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 457999999999999874 78999998764332 2345688999999999999999999988754 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc-cccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-MMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-~~~~ 184 (317)
++++|.+++... .+++..+..++.|++.||+|||++|++|+||+|+||+++.+ +.++|+|||++....... ....
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~-~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 100 EGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEcccccceecccccccccc
Confidence 999999987543 28999999999999999999999999999999999999988 789999999987543221 1233
Q ss_pred ccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHHHHHhh
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSIILTSCW 234 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~cl 234 (317)
..|+..|+|||.+.+..... ..+.|+.+ ........++..+.+++.+||
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~-~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 254 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGP-EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLL 254 (292)
T ss_pred cccCccccCHHHhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHH
Confidence 46788999999876533221 12222211 011123356788999999999
Q ss_pred hcCCCCCCCHHHHHHHHHHhhhccC
Q 021127 235 KEDPNARPNFTQIIQMLLNYLSAIA 259 (317)
Q Consensus 235 ~~~p~~Rps~~~~~~~l~~~~~~~~ 259 (317)
+.+|.+||++.+++++ .++....
T Consensus 255 ~~~P~~R~~~~~ll~~--~~~~~~~ 277 (292)
T cd06657 255 VRDPAQRATAAELLKH--PFLAKAG 277 (292)
T ss_pred hCCcccCcCHHHHhcC--hHHhccC
Confidence 9999999999999987 4444433
No 364
>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK
Probab=100.00 E-value=1.3e-32 Score=245.81 Aligned_cols=222 Identities=25% Similarity=0.326 Sum_probs=172.7
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
.|.+ .++|++.+.||+|++|.||+|++. ++.||||++....... .....+.+|+.++++++|+|++++++++..
T Consensus 10 ~~~~-~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07851 10 VWEV-PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA---IHAKRTYRELRLLKHMDHENVIGLLDVFTP 85 (343)
T ss_pred eecc-cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh---hHHHHHHHHHHHHHhccCCCHHHHHHHhhc
Confidence 3444 467999999999999999999885 7899999986543222 233457789999999999999999987643
Q ss_pred C-------ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEc
Q 021127 96 P-------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (317)
Q Consensus 96 ~-------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~ 168 (317)
. ..++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+.|++||||+|+||+++.+ +.++|+
T Consensus 86 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~-~~~kL~ 160 (343)
T cd07851 86 ASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED-CELKIL 160 (343)
T ss_pred cccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEc
Confidence 2 389999999 7799998875 238999999999999999999999999999999999999988 789999
Q ss_pred ccCcccccccccccccccCccceecccccccccccccccccccCC--------CCCC-----------------------
Q 021127 169 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVRP----------------------- 217 (317)
Q Consensus 169 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~~----------------------- 217 (317)
|||++...... .....++..|+|||++.+........++|+.+ ...+
T Consensus 161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 161 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred ccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 99999865332 23446788999999865422222222222211 0000
Q ss_pred ---------------------------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 ---------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 ---------------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
....++..+.+++.+||+.+|.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 012357889999999999999999999999887
No 365
>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins. Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic
Probab=100.00 E-value=1.9e-32 Score=241.12 Aligned_cols=222 Identities=23% Similarity=0.293 Sum_probs=167.7
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-----
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE----- 95 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 95 (317)
-++|++.++||+|++|.||+|.+. ++.||||.+......+. ....+.+|++++++++|+||+++++++.+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC---cchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 378999999999999999999885 78899999876543221 12246789999999999999999987632
Q ss_pred ----CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 96 ----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 96 ----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
..+++||||+. ++|...+.... ..+++..+..++.|+++||+|||++|++|+||||+||+++.+ +.++|+|||
T Consensus 84 ~~~~~~~~lv~~~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg 160 (311)
T cd07866 84 KRKRGSVYMVTPYMD-HDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQ-GILKIADFG 160 (311)
T ss_pred cccCceEEEEEecCC-cCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECcCc
Confidence 24799999995 57877776533 349999999999999999999999999999999999999998 799999999
Q ss_pred cccccccccc------------cccccCccceecccccccccccccccccccCC--------CCC---------------
Q 021127 172 LAREESLTEM------------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR--------------- 216 (317)
Q Consensus 172 ~a~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~--------------- 216 (317)
++........ .....+++.|+|||++.+........++|+.+ ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9974332111 12234678899999875432222223333221 000
Q ss_pred -----------------C-----------------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 -----------------P-----------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 -----------------~-----------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+ ....++..+.+++.+||+.||.+|||+.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 0 002334678899999999999999999999875
No 366
>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both
Probab=100.00 E-value=5e-32 Score=235.70 Aligned_cols=219 Identities=29% Similarity=0.387 Sum_probs=168.8
Q ss_pred eeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc---CCCCeeeEEeeeecC-c--
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV---QHRNLVKFIGACKEP-V-- 97 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-~-- 97 (317)
|++.+.||+|+||.||+|++. ++.||+|.+....... .....+.+|+.++.++ +|+||+++++++... .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 77 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE---GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR 77 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc---hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence 678899999999999999985 7899999997554322 1123456677777665 699999999998653 3
Q ss_pred ---eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 98 ---MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 98 ---~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
.+++|||+. ++|.+++.......+++..++.++.|++.||+|||+.+++|+||+|+||+++.+ +.+||+|||++.
T Consensus 78 ~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~-~~~~l~dfg~~~ 155 (287)
T cd07838 78 ELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSD-GQVKIADFGLAR 155 (287)
T ss_pred CceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccC-CCEEEeccCcce
Confidence 899999996 589998877554458999999999999999999999999999999999999998 799999999997
Q ss_pred ccccccccccccCccceecccccccccccccccccccCC--------CCC------------------------------
Q 021127 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR------------------------------ 216 (317)
Q Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~------------------------------ 216 (317)
............++..|+|||++.+..... ..++|+.+ ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~-~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYAT-PVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCC-cchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 654443333445788999999876533221 12222211 000
Q ss_pred --------C--------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 --------P--------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 --------~--------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
. ....++..+.+++.+||+.||.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 011345778899999999999999999999875
No 367
>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They
Probab=100.00 E-value=2.2e-32 Score=237.42 Aligned_cols=219 Identities=27% Similarity=0.351 Sum_probs=171.7
Q ss_pred eeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEE
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVT 102 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 102 (317)
|++.+.||+|++|.||++... ++.+++|.+....... .....+.+|+.++++++|+||+++++++..+ ..++|+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE---GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF 77 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc---hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEE
Confidence 567889999999999999875 8889999987654432 2345688899999999999999999988654 899999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc-c
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-M 181 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-~ 181 (317)
||++ ++|.+++.... ..+++..+..++.|++.||.|||+++++|+||+|+||+++.+ +.++|+|||.+....... .
T Consensus 78 e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 78 EFMD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred eccC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC-CcEEEeeeeeeEecCCCccc
Confidence 9996 58988887643 348999999999999999999999999999999999999988 689999999987554332 2
Q ss_pred cccccCccceecccccccccccccccccccCC--------CC--------------------------------------
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV-------------------------------------- 215 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~-------------------------------------- 215 (317)
.....++..|+|||.+.+........+.|..+ ..
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 23345788999999876542222222222211 00
Q ss_pred -----------CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 -----------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 -----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
......++.++.++|.+||+.||.+||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00012467889999999999999999999999876
No 368
>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the
Probab=100.00 E-value=5.6e-32 Score=230.67 Aligned_cols=213 Identities=31% Similarity=0.372 Sum_probs=170.3
Q ss_pred eccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCCC
Q 021127 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGG 108 (317)
Q Consensus 32 lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g 108 (317)
||.|+||.||++.+. ++.+|+|++....... ......+..|+.++++++|+||+++++.+..+ ..++||||++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIK--RKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcc--hHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence 699999999999885 7899999988765432 12355688999999999999999999988755 799999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-cccccccC
Q 021127 109 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAETG 187 (317)
Q Consensus 109 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~g 187 (317)
+|.+++..... +++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++...... .......+
T Consensus 79 ~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (250)
T cd05123 79 ELFSHLSKEGR--FSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFCG 155 (250)
T ss_pred cHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC-CcEEEeecCcceecccCCCcccCCcC
Confidence 99999986543 8999999999999999999999999999999999999988 78999999999765432 22344568
Q ss_pred ccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcCCCC
Q 021127 188 TYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKEDPNA 240 (317)
Q Consensus 188 t~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~ 240 (317)
+..|+|||.+.+..... ..+.|..+ .....+..++..+.+++.+||..||++
T Consensus 156 ~~~~~~Pe~~~~~~~~~-~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~ 234 (250)
T cd05123 156 TPEYLAPEVLLGKGYGK-AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTK 234 (250)
T ss_pred CccccChHHhCCCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhh
Confidence 88999999875533211 12222111 112335566899999999999999999
Q ss_pred CCCH---HHHHHH
Q 021127 241 RPNF---TQIIQM 250 (317)
Q Consensus 241 Rps~---~~~~~~ 250 (317)
||++ .+++++
T Consensus 235 R~~~~~~~~l~~~ 247 (250)
T cd05123 235 RLGSGGAEEIKAH 247 (250)
T ss_pred CCCcccHHHHHhC
Confidence 9999 666554
No 369
>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional
Probab=100.00 E-value=7.8e-32 Score=232.47 Aligned_cols=211 Identities=22% Similarity=0.262 Sum_probs=162.1
Q ss_pred Cceeeccee--ccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-c
Q 021127 24 KHLFVGPRI--GEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-V 97 (317)
Q Consensus 24 ~~y~~~~~l--G~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 97 (317)
++|.+.+.+ |+|+||.||++... +..+|+|.+....... .|+.....+ +|+||+++++++... .
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----------~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----------IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 355666665 99999999999875 7889999987543221 122222222 799999999998654 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++||||+|+||+++.+.+.++|+|||++....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 999999999999999998754 499999999999999999999999999999999999999883389999999987554
Q ss_pred cccccccccCccceecccccccccccccccccccCC-------------------------------CCCCCCCCChHHH
Q 021127 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVPEEL 226 (317)
Q Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l 226 (317)
.. ....++..|+|||++.+..... ..++|+.+ ...+.+..++..+
T Consensus 162 ~~---~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T PHA03390 162 TP---SCYDGTLDYFSPEKIKGHNYDV-SFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNA 237 (267)
T ss_pred CC---ccCCCCCcccChhhhcCCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHH
Confidence 22 2346889999999986543321 22222211 0112234578999
Q ss_pred HHHHHHhhhcCCCCCCC-HHHHHHH
Q 021127 227 SIILTSCWKEDPNARPN-FTQIIQM 250 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps-~~~~~~~ 250 (317)
.++|.+||+.+|.+||+ +++++++
T Consensus 238 ~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 238 NDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHHHHHhccChhhCCchHHHHhcC
Confidence 99999999999999996 6999876
No 370
>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13
Probab=100.00 E-value=4.3e-32 Score=242.33 Aligned_cols=222 Identities=25% Similarity=0.320 Sum_probs=170.2
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
..|.+. .+|.+.+.||+|+||.||+|.+. ++.||||.+....... .....+.+|+.+++.++|+||+++++++.
T Consensus 9 ~~~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 84 (342)
T cd07879 9 TVWELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE---IFAKRAYRELTLLKHMQHENVIGLLDVFT 84 (342)
T ss_pred hhhccc-cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc---cchhHHHHHHHHHHhcCCCCccchhheec
Confidence 356663 58999999999999999999874 8899999987643222 22345788999999999999999999875
Q ss_pred cC-------ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEE
Q 021127 95 EP-------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (317)
Q Consensus 95 ~~-------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl 167 (317)
.. .+++|+||+. .+|..++. ..+++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~-~~~kL 158 (342)
T cd07879 85 SAVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNED-CELKI 158 (342)
T ss_pred ccccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEE
Confidence 32 4689999995 57776552 238999999999999999999999999999999999999988 79999
Q ss_pred cccCcccccccccccccccCccceecccccccccccccccccccCC--------CC------------------------
Q 021127 168 ADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------------------ 215 (317)
Q Consensus 168 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------------------ 215 (317)
+|||+++..... .....++..|+|||++.+........++|+.+ ..
T Consensus 159 ~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (342)
T cd07879 159 LDFGLARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGP 236 (342)
T ss_pred eeCCCCcCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 999998754322 23346788999999875522222222222211 00
Q ss_pred ------------------C--CC------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 ------------------R--PS------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 ------------------~--~~------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
. +. ....+..+.+||.+||+.||.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00 12456788999999999999999999999987
No 371
>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=8.2e-33 Score=253.85 Aligned_cols=227 Identities=23% Similarity=0.429 Sum_probs=185.5
Q ss_pred ceeecceeccccceEEEEeEEC------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCce
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVM 98 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 98 (317)
.....++||+|+||+||+|.+- .-+||||++....... ....+++|+-++.+++|||+++|+|+|..+..
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~----~s~e~LdeAl~masldHpnl~RLLgvc~~s~~ 772 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPK----ASIELLDEALRMASLDHPNLLRLLGVCMLSTL 772 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCch----hhHHHHHHHHHHhcCCCchHHHHhhhcccchH
Confidence 4556789999999999999873 4679999998766543 34468999999999999999999999999889
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
.||++|++.|+|.++++..+.. +-....+.|..||++||.|||.+++|||||..+|||+..- +.+||+|||+++....
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~-igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP-~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDN-IGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSP-NHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhcc-ccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCC-CeEEEEecchhhccCc
Confidence 9999999999999999986544 8899999999999999999999999999999999999987 6899999999997654
Q ss_pred cccc---ccccCccceeccccccccccccccccc----------------------------ccCCCCCCCCCCChHHHH
Q 021127 179 TEMM---TAETGTYRWMAPELYSTVTLRQGEKKH----------------------------YNHKNVRPSAENVPEELS 227 (317)
Q Consensus 179 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~l~ 227 (317)
.... ....-.+.|||=|.+....+....+.| ...+...+.|+.++.+++
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy 930 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVY 930 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHH
Confidence 4322 222235688998876654333322221 112244566888999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 228 IILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
.+|.+||..|++.||+++++...+..+.+.
T Consensus 931 ~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 931 MVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred HHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 999999999999999999999988877653
No 372
>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-32 Score=237.00 Aligned_cols=225 Identities=22% Similarity=0.313 Sum_probs=178.0
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHH--HHHHHHHHHHHHHHHhcCCCCeeeEEeeee--cCc
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEI--AKKESRFAREVAMLSRVQHRNLVKFIGACK--EPV 97 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~ 97 (317)
++|-++.+||+|||+.||+|.+- .+.||||+-.......+. ....+...+|.++++.|.||.||++|+++. ...
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 78999999999999999999774 789999987665544321 122345678999999999999999999984 347
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCCCcEEeeCC--CCceEEcccCcc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--GIIHRDLKPENLLLTED--LKTIKLADFGLA 173 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~--~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~a 173 (317)
++-|+|||+|.+|+-+|..++- ++++.+..|+.||+.||.||.+. .|||-||||.|||+... .|.+||+|||++
T Consensus 543 FCTVLEYceGNDLDFYLKQhkl--mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKL--MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhh--hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 9999999999999999988765 99999999999999999999987 69999999999999643 357999999999
Q ss_pred ccccccc--------ccccccCccceecccccccc---cccccccccccCC-----------------------------
Q 021127 174 REESLTE--------MMTAETGTYRWMAPELYSTV---TLRQGEKKHYNHK----------------------------- 213 (317)
Q Consensus 174 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~---~~~~~~~~~~~~~----------------------------- 213 (317)
+..+... .++...||.+|++||.|.-. +......++|+.+
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl 700 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL 700 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence 9654332 23456799999999986532 1122333444433
Q ss_pred ----CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 ----NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 ----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
...|.-+.++.+.++||++||++--++|....++...
T Consensus 701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 1123345678899999999999999999988887543
No 373
>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the
Probab=99.98 E-value=3.6e-32 Score=235.97 Aligned_cols=219 Identities=26% Similarity=0.363 Sum_probs=171.0
Q ss_pred eeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEE
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVT 102 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 102 (317)
|++.+.||+|++|.||+|... ++.||+|++....... .....+..|+.++++++|+|++++++++.+. ..++||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 77 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEE---GIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF 77 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccc---cccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEe
Confidence 567889999999999999886 7899999998754222 2234577899999999999999999988764 899999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc-c
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-M 181 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-~ 181 (317)
||++ ++|.+++.... ..+++..++.++.|++.||+|||++|++||||+|+||+++.+ +.++|+|||++....... .
T Consensus 78 e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 78 EYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred cCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCC-CCEEEecCCcccccCCCccc
Confidence 9996 69999998753 239999999999999999999999999999999999999998 789999999997543322 2
Q ss_pred cccccCccceecccccccccccccccccccCC--------C---------------------------------------
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N--------------------------------------- 214 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~--------------------------------------- 214 (317)
.....++..|+|||.+.+........+.|..+ .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 22345677899999875542222222222211 0
Q ss_pred ---------CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 215 ---------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 215 ---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.......++..+.+++.+||+.||++||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000012346789999999999999999999999876
No 374
>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.98 E-value=1.3e-31 Score=240.00 Aligned_cols=224 Identities=22% Similarity=0.326 Sum_probs=174.2
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
.++..-|..++.||-|+||.|.+++.. ...+|+|.+++...-. ..+...+..|.+||..-..+-||+||..|++.
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~--rnQvaHVKAERDILAEADn~WVVrLyySFQDkd 702 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLM--RNQVAHVKAERDILAEADNEWVVRLYYSFQDKD 702 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHh--hhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC
Confidence 467788889999999999999998654 6789999998765433 23455677899999999999999999999876
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
.+|+||+|++||++..+|...+- |.+..+..++..+..|+++.|..|+|||||||+|||||.+ |.+||+|||++...
T Consensus 703 nLYFVMdYIPGGDmMSLLIrmgI--FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrd-GHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 703 NLYFVMDYIPGGDMMSLLIRMGI--FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGF 779 (1034)
T ss_pred ceEEEEeccCCccHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccC-Cceeeeeccccccc
Confidence 89999999999999999987665 8999999999999999999999999999999999999999 89999999998521
Q ss_pred ccc---------c----------------------------------ccccccCccceecccccccccccccccccccCC
Q 021127 177 SLT---------E----------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 213 (317)
Q Consensus 177 ~~~---------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~ 213 (317)
... . .....+||+.|+|||++....+.+.. +||..+
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~c-dwws~g 858 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLC-DWWSVG 858 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccc-hhhHhh
Confidence 000 0 00122599999999998764443322 222222
Q ss_pred -------------------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCC---CHHHHHHH
Q 021127 214 -------------------------------NVRPSAENVPEELSIILTSCWKEDPNARP---NFTQIIQM 250 (317)
Q Consensus 214 -------------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp---s~~~~~~~ 250 (317)
...+...+++.+..++|.+++. +++.|. .++++-.|
T Consensus 859 vil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaH 928 (1034)
T KOG0608|consen 859 VILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAH 928 (1034)
T ss_pred HHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcC
Confidence 2234456788999999876443 666664 45556555
No 375
>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]
Probab=99.97 E-value=1.8e-33 Score=246.25 Aligned_cols=226 Identities=23% Similarity=0.311 Sum_probs=191.7
Q ss_pred ecCCceeecceeccccceEEEEeEECCeE--EEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQT--VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
+.-++++.+.-||-||||+|=+.+.+++. +|+|++++...-+ .++.+.+..|-++|..++.|.||++|..|.++ .
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd--tkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD--TKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccc--hhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 44567788888999999999999887555 8999998877655 35667788999999999999999999999876 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
+|++||-|-||.|...|++++. ++..+...++..+++|++|||++|||+|||||+|.+++.+ |-+||.|||+|+...
T Consensus 495 vYmLmEaClGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~-Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNR-GYLKLVDFGFAKKIG 571 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccC-CceEEeehhhHHHhc
Confidence 9999999999999999998765 9999999999999999999999999999999999999998 899999999999998
Q ss_pred cccccccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHHH
Q 021127 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSI 228 (317)
Q Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~ 228 (317)
....+.++|||+.|+|||++.+..-+... ++|..+ .....|..++....+
T Consensus 572 ~g~KTwTFcGTpEYVAPEIILnKGHD~av-DyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~ 650 (732)
T KOG0614|consen 572 SGRKTWTFCGTPEYVAPEIILNKGHDRAV-DYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATD 650 (732)
T ss_pred cCCceeeecCCcccccchhhhccCcchhh-HHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHH
Confidence 88888999999999999998763322221 111111 223346678889999
Q ss_pred HHHHhhhcCCCCCCC-----HHHHHHHHH
Q 021127 229 ILTSCWKEDPNARPN-----FTQIIQMLL 252 (317)
Q Consensus 229 li~~cl~~~p~~Rps-----~~~~~~~l~ 252 (317)
||+++...+|.+|.. +.+|..|-|
T Consensus 651 Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 651 LIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred HHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 999999999999965 788888865
No 376
>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]
Probab=99.97 E-value=4.4e-33 Score=226.07 Aligned_cols=227 Identities=23% Similarity=0.323 Sum_probs=183.1
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeee-
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGAC- 93 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~- 93 (317)
.|.+...+++-+..||.|+||+|++..++ |+..|||.++..... +..++++.|.+...+- +.||||++||.+
T Consensus 58 ~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~----keq~rll~e~d~~mks~~cp~IVkfyGa~F 133 (361)
T KOG1006|consen 58 LHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE----KEQKRLLMEHDTVMKSSNCPNIVKFYGALF 133 (361)
T ss_pred ccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch----HHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence 57788888888999999999999998886 899999999877663 3455788888877665 899999999975
Q ss_pred ecCceEEEEEccCCCCHHHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEeeCCCCceEEcc
Q 021127 94 KEPVMVIVTELLSGGTLRKYLL---NMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLAD 169 (317)
Q Consensus 94 ~~~~~~lv~e~~~~g~L~~~l~---~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~Dlkp~Nill~~~~~~~kl~D 169 (317)
.++..||.||+| ..+|..+.. .-.+..+++.-+-.|....+.||.||-.. .|||||+||+|||++.. |.+||||
T Consensus 134 ~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~-G~vKLCD 211 (361)
T KOG1006|consen 134 SEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRH-GDVKLCD 211 (361)
T ss_pred cCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecC-CCEeeec
Confidence 677999999999 678776543 23344599998889999999999999975 89999999999999998 7999999
Q ss_pred cCcccccccccccccccCccceecccccccccc-cccccccccCC----------------------------CCCC---
Q 021127 170 FGLAREESLTEMMTAETGTYRWMAPELYSTVTL-RQGEKKHYNHK----------------------------NVRP--- 217 (317)
Q Consensus 170 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~~~----------------------------~~~~--- 217 (317)
||++-.....-..+...|...|||||-+....- ..-..+.|+.+ ...|
T Consensus 212 FGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~ 291 (361)
T KOG1006|consen 212 FGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILL 291 (361)
T ss_pred ccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeec
Confidence 999987766656677789999999998875433 33334444443 0011
Q ss_pred ---CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 ---SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 ---~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
..-.++..+..+|..||.+|-..||...++.++
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 123478899999999999999999999999876
No 377
>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.97 E-value=6.9e-34 Score=229.23 Aligned_cols=231 Identities=24% Similarity=0.309 Sum_probs=176.6
Q ss_pred CCceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
...+.++.+.|+-..++|+|.||.||+|+.. ++.||+|.+--..... ..-..-++|+++|..+.|+|++.++..|
T Consensus 9 ~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe---GfpitalreikiL~~lkHenv~nliEic 85 (376)
T KOG0669|consen 9 YEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEIC 85 (376)
T ss_pred cCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc---CCcHHHHHHHHHHHHhcchhHHHHHHHH
Confidence 3457788889999999999999999999775 7888888654321111 1112357899999999999999999887
Q ss_pred ec---------CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCc
Q 021127 94 KE---------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 164 (317)
Q Consensus 94 ~~---------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~ 164 (317)
.. ..+|+||++| ..+|.-.|.+.. ..++..++..++.++..||.|+|...|+|||+||.|+||+.+ +.
T Consensus 86 ~tk~Tp~~r~r~t~ylVf~~c-ehDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~d-gi 162 (376)
T KOG0669|consen 86 RTKATPTNRDRATFYLVFDFC-EHDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKD-GI 162 (376)
T ss_pred hhccCCcccccceeeeeHHHh-hhhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCC-ce
Confidence 31 2589999999 468888887653 349999999999999999999999999999999999999999 79
Q ss_pred eEEcccCccccccccc-----ccccccCccceecccccccccccccccccccCC--------------------------
Q 021127 165 IKLADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------- 213 (317)
Q Consensus 165 ~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------- 213 (317)
+||+|||+++..+... ..+..+-|+.|.+||.+.+........+.|..+
T Consensus 163 lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 163 LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 9999999997543221 234456699999999887754443333333322
Q ss_pred -----------------------CCCCCC-------------CCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 -----------------------NVRPSA-------------ENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 -----------------------~~~~~~-------------~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
...|.+ -.-.++..+|+..++..||.+|++++++++|-+
T Consensus 243 ~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 243 QLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred HHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 001111 111347889999999999999999999999844
No 378
>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]
Probab=99.97 E-value=1e-32 Score=228.53 Aligned_cols=177 Identities=24% Similarity=0.303 Sum_probs=140.8
Q ss_pred CceeecceeccccceEEEEeEEC------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee--c
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK--E 95 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~ 95 (317)
..|++...||+|.+|.||+|..+ ...+|||.++....... ......+|+.+++.++||||+.|..++. +
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG---iS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG---ISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC---cCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 57889999999999999999543 23689999886643221 1223678999999999999999999885 4
Q ss_pred CceEEEEEccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC---CCceEEcc
Q 021127 96 PVMVIVTELLSGGTLRKYLLNM---RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED---LKTIKLAD 169 (317)
Q Consensus 96 ~~~~lv~e~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~---~~~~kl~D 169 (317)
..+++++||.+ -+|.+.|+-. +.+.++...+..|++||+.|+.|||++=|+||||||.|||+..+ .|.|||+|
T Consensus 101 ~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 58999999995 5898888643 22459999999999999999999999999999999999999865 36899999
Q ss_pred cCccccccccc----ccccccCccceecccccccccccc
Q 021127 170 FGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQ 204 (317)
Q Consensus 170 fg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~ 204 (317)
||+++...+.- .....+-|..|.|||++.+..-..
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT 218 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYT 218 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhccccccc
Confidence 99998654331 123345799999999887744333
No 379
>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=99.97 E-value=2.9e-32 Score=226.59 Aligned_cols=217 Identities=26% Similarity=0.388 Sum_probs=170.4
Q ss_pred cceeccccceEEEEeEE--CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEEEEEc
Q 021127 29 GPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTEL 104 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~ 104 (317)
.+.||+|+++.|--+.. ++..+|||++.+... ..+.++.+|++++.+. .|+||+.|+++|++. .+|+|||-
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g-----HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK 157 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG-----HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK 157 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCc-----hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence 56799999999988765 589999999987743 3467899999999998 699999999999876 89999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC--CCceEEcccCcccccccc---
Q 021127 105 LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLAREESLT--- 179 (317)
Q Consensus 105 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~a~~~~~~--- 179 (317)
+.||+|..+|.+++- +++..+.++.++|+.||.|||.+||.||||||+|||-..- -.-+|||||.+.......
T Consensus 158 m~GGplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 158 MRGGPLLSHIQKRKH--FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred ccCchHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 999999999997655 9999999999999999999999999999999999998643 235899999998642211
Q ss_pred -----cccccccCccceeccccccc----ccccccccc--------------------------cccCCC----------
Q 021127 180 -----EMMTAETGTYRWMAPELYST----VTLRQGEKK--------------------------HYNHKN---------- 214 (317)
Q Consensus 180 -----~~~~~~~gt~~y~aPE~~~~----~~~~~~~~~--------------------------~~~~~~---------- 214 (317)
....+.+|+..|||||+..- ..+....-+ -|+.+.
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 12234578889999997432 111111111 122110
Q ss_pred ----------CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 215 ----------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 215 ----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.......++.+.++++..+|..++.+|.++.+++++.|
T Consensus 316 esIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw 363 (463)
T KOG0607|consen 316 ESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW 363 (463)
T ss_pred HHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence 11123457889999999999999999999999998754
No 380
>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins. Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha
Probab=99.97 E-value=5e-31 Score=223.46 Aligned_cols=194 Identities=22% Similarity=0.243 Sum_probs=151.7
Q ss_pred ccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCCCCHH
Q 021127 35 GAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLR 111 (317)
Q Consensus 35 G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~ 111 (317)
|.+|.||++.+. ++.||+|.+..... +.+|...+....||||+++++++.+. ..++||||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence 889999999885 88999999876432 23344555556799999999998765 899999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccccccccCccce
Q 021127 112 KYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRW 191 (317)
Q Consensus 112 ~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y 191 (317)
+++..... +++..+..++.|++.||+|||++|++||||||+||+++.+ +.++++|||.+...... .....++..|
T Consensus 74 ~~l~~~~~--l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~df~~~~~~~~~--~~~~~~~~~y 148 (237)
T cd05576 74 SHISKFLN--IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR-GHIQLTYFSRWSEVEDS--CDGEAVENMY 148 (237)
T ss_pred HHHHHhcC--CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-CCEEEecccchhccccc--cccCCcCccc
Confidence 99976543 8999999999999999999999999999999999999988 68999999987654322 2233557789
Q ss_pred ecccccccccccccccccccCC-----------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCH
Q 021127 192 MAPELYSTVTLRQGEKKHYNHK-----------------------NVRPSAENVPEELSIILTSCWKEDPNARPNF 244 (317)
Q Consensus 192 ~aPE~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 244 (317)
+|||.+....... ..+.|+.+ .....+..++..+++++.+||+.||.+||++
T Consensus 149 ~aPE~~~~~~~~~-~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 149 CAPEVGGISEETE-ACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred cCCcccCCCCCCc-hhhHHHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 9999875433221 22222211 0111245678899999999999999999996
No 381
>PLN03225 Serine/threonine-protein kinase SNT7; Provisional
Probab=99.97 E-value=4e-31 Score=248.52 Aligned_cols=171 Identities=23% Similarity=0.300 Sum_probs=121.0
Q ss_pred eeecCCceeecceeccccceEEEEeEEC------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEee
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 92 (317)
.....++|++.++||+|+||.||+|++. +..||||.+....... .+..+ .+....+.+++.++..
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-------~~~~e--~l~~~~~~~~~~~~~~ 197 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-------IWMNE--RVRRACPNSCADFVYG 197 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-------HHHHH--HHHhhchhhHHHHHHh
Confidence 3456689999999999999999999874 5789999876433211 01111 1122222222222211
Q ss_pred -------eecCceEEEEEccCCCCHHHHHHhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 021127 93 -------CKEPVMVIVTELLSGGTLRKYLLNMRPR------------------CLDVCVAIGFALDIARAMECLHSHGII 147 (317)
Q Consensus 93 -------~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------~l~~~~~~~i~~~i~~~L~~lH~~~iv 147 (317)
..+...++|+||+.+++|.+++...... ......+..++.|++.||+|||+++|+
T Consensus 198 ~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIi 277 (566)
T PLN03225 198 FLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIV 277 (566)
T ss_pred hhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 1234799999999999999998753210 012344667999999999999999999
Q ss_pred ccCCCCCcEEeeCCCCceEEcccCcccccccc--cccccccCccceecccccc
Q 021127 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLT--EMMTAETGTYRWMAPELYS 198 (317)
Q Consensus 148 H~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~ 198 (317)
||||||+|||++.+.+.+||+|||+++..... .......+++.|+|||.+.
T Consensus 278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~ 330 (566)
T PLN03225 278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYI 330 (566)
T ss_pred eCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhh
Confidence 99999999999975468999999999754322 2234567899999999764
No 382
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=99.97 E-value=1.8e-30 Score=260.96 Aligned_cols=213 Identities=24% Similarity=0.349 Sum_probs=162.0
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
.+...+.||+|+||.||+|.+. +..||||.+...... ...|++.+++++|||||+++|++.+. ..++|
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence 3556678999999999999874 889999998654321 12468889999999999999999765 78999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH---SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
|||+++|+|.++++. +++..+..|+.|++.||+||| +.+|+||||||+||+++.+ ...++. ||.+.....
T Consensus 762 ~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~-~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 762 HEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK-DEPHLR-LSLPGLLCT 834 (968)
T ss_pred EeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-CceEEE-ecccccccc
Confidence 999999999999963 899999999999999999999 6699999999999999987 466664 665543211
Q ss_pred ccccccccCccceecccccccccccccccccccCC--------CCC------------------------------CC--
Q 021127 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR------------------------------PS-- 218 (317)
Q Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~------------------------------~~-- 218 (317)
.....+++.|+|||++.+..+.. ..++|+.+ ... +.
T Consensus 835 ---~~~~~~t~~y~aPE~~~~~~~~~-~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (968)
T PLN00113 835 ---DTKCFISSAYVAPETRETKDITE-KSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIR 910 (968)
T ss_pred ---CCCccccccccCcccccCCCCCc-ccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcccc
Confidence 12336789999999876543322 22333221 000 00
Q ss_pred -----CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 219 -----AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 219 -----~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
......++.+++.+||+.||++||++.++++.|++..+.
T Consensus 911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 001123567899999999999999999999999887653
No 383
>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]
Probab=99.97 E-value=3.7e-31 Score=243.70 Aligned_cols=213 Identities=24% Similarity=0.378 Sum_probs=160.2
Q ss_pred ecceeccccceE-EEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEEEEEc
Q 021127 28 VGPRIGEGAHAK-VYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTEL 104 (317)
Q Consensus 28 ~~~~lG~G~~g~-V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~ 104 (317)
-.+.+|.|+.|+ ||+|...++.||||.+-... .....+|+..|+.- +|||||++++.-.+. ..||..|.
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~--------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF--------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred cHHHcccCCCCcEEEEEeeCCceehHHHHhhHh--------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 356689999985 89999999999999875432 23467899999887 799999999988765 89999999
Q ss_pred cCCCCHHHHHHhcC-C-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC---C-CCceEEcccCccccccc
Q 021127 105 LSGGTLRKYLLNMR-P-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE---D-LKTIKLADFGLAREESL 178 (317)
Q Consensus 105 ~~~g~L~~~l~~~~-~-~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~---~-~~~~kl~Dfg~a~~~~~ 178 (317)
| ..+|.+++.... . ........+..+.|+++||++||+.+||||||||.||||.. + ..+++|+|||+++....
T Consensus 585 C-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 585 C-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred h-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 9 569999998741 1 11122445778999999999999999999999999999986 2 24789999999996543
Q ss_pred c----cccccccCccceecccccccccccccccccccCC---------CCCCCC--------------------CCChHH
Q 021127 179 T----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------NVRPSA--------------------ENVPEE 225 (317)
Q Consensus 179 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------~~~~~~--------------------~~~~~~ 225 (317)
. .......||.+|+|||++....... ..++++.+ ...|.. .....+
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~-avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~e 742 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQ-AVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDCE 742 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCc-ccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchHH
Confidence 3 2234557999999999987644333 22222211 000000 000117
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
..+||.+|++++|..||++.+++.|
T Consensus 743 A~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 743 AKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred HHHHHHHhcCCCcccCCCHHHHhCC
Confidence 8999999999999999999999887
No 384
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=99.97 E-value=2.7e-31 Score=239.15 Aligned_cols=215 Identities=25% Similarity=0.337 Sum_probs=174.5
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ce
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~ 98 (317)
..+|.+...+|.|+|+.|-.+.+. ++..++|++.+.... -.+|+.++... +||||+++.+++.++ +.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~---------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD---------NQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc---------cccccchhhhhcCCCcceeecceecCCcee
Confidence 467888888999999999998775 888999999877332 24577666555 899999999999877 89
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee-CCCCceEEcccCcccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT-EDLKTIKLADFGLAREES 177 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~-~~~~~~kl~Dfg~a~~~~ 177 (317)
|+|||.+.|+-|.+.+..... +. ..+..|+.+|+.|+.|||++|+|||||||+|||++ .. ++++|+|||.++...
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~-g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSA-GHLRLTYFGFWSELE 467 (612)
T ss_pred eeeehhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCC-CcEEEEEechhhhCc
Confidence 999999999999998876543 33 77778999999999999999999999999999995 55 789999999998765
Q ss_pred cccccccccCccceecccccccccccccccccccCC--------------------------CCCCCCCCChHHHHHHHH
Q 021127 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~l~~li~ 231 (317)
.. ..+.+-|..|.|||++....+ ....++|+.+ ...+....+|.+.++|+.
T Consensus 468 ~~--~~tp~~t~~y~APEvl~~~~y-t~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~ 544 (612)
T KOG0603|consen 468 RS--CDTPALTLQYVAPEVLAIQEY-TEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQ 544 (612)
T ss_pred hh--hcccchhhcccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHH
Confidence 44 344577899999999884333 3344455544 111112678999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHH
Q 021127 232 SCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 232 ~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
+||+.||.+||++.++..+-|.
T Consensus 545 ~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 545 QLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HhccCChhhCcChhhhccCcch
Confidence 9999999999999999998554
No 385
>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]
Probab=99.97 E-value=2e-31 Score=212.20 Aligned_cols=216 Identities=20% Similarity=0.360 Sum_probs=174.9
Q ss_pred cCCceeecceeccccceEEEEeEE--CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecC--
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP-- 96 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-- 96 (317)
..++|++.+++|+|.++.||.|.. +++.++||+++.- ..+++.+|+.+|..|. ||||++|+++..++
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S 107 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPES 107 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence 457899999999999999999985 5889999999743 3446889999999996 99999999998764
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
...+|+||..+.+....... ++...+..++.+++.||.|+|+.||.|||+||.|++|+.....++|+|+|+|-+
T Consensus 108 ktpaLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 108 KTPSLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred cCchhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhh
Confidence 67899999999887776654 888889999999999999999999999999999999997767899999999987
Q ss_pred cccccccccccCccceecccccccccccccccccccCC------------------------------------------
Q 021127 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------------------ 213 (317)
Q Consensus 176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------------------ 213 (317)
.-.....+..+.+..|--||++.......-..+.|+.+
T Consensus 183 YHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 183 YHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred cCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 66655556667788899999866533333222222222
Q ss_pred ---------------C--------CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 ---------------N--------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 ---------------~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
. ......-++++..+|+.++|..|-.+|+|+.|++.|
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0 000112246889999999999999999999999887
No 386
>PLN03224 probable serine/threonine protein kinase; Provisional
Probab=99.97 E-value=6.5e-30 Score=235.11 Aligned_cols=230 Identities=20% Similarity=0.206 Sum_probs=162.3
Q ss_pred ecCCceeecceeccccceEEEEeEE------------------CCeEEEEEEeecCCChHHH---------HHHHHHHHH
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKY------------------KNQTVAIKIVHKGETPEEI---------AKKESRFAR 73 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~------------------~~~~vaiK~~~~~~~~~~~---------~~~~~~~~~ 73 (317)
+..++|.+.++||+|+||.||+|.. .++.||||.+......... ....+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 3578999999999999999999864 2467999998654321100 001122345
Q ss_pred HHHHHHhcCCCCe-----eeEEeeee---------cCceEEEEEccCCCCHHHHHHhcCC--------------------
Q 021127 74 EVAMLSRVQHRNL-----VKFIGACK---------EPVMVIVTELLSGGTLRKYLLNMRP-------------------- 119 (317)
Q Consensus 74 E~~~l~~l~h~ni-----v~l~~~~~---------~~~~~lv~e~~~~g~L~~~l~~~~~-------------------- 119 (317)
|+.++.+++|.++ ++++++|. ++..++||||+++++|.+++.....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777788876654 66677653 3468999999999999999874211
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccccc--cccCccceeccc
Q 021127 120 --RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT--AETGTYRWMAPE 195 (317)
Q Consensus 120 --~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~gt~~y~aPE 195 (317)
..+++..+..++.|++.||.|||+++|+||||||+||+++.+ +.+||+|||++.......... ...+++.|+|||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCC-CcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 124677888999999999999999999999999999999988 689999999997543322222 223578999999
Q ss_pred cccccccc---------------------ccccccccCC-----------------------------------------
Q 021127 196 LYSTVTLR---------------------QGEKKHYNHK----------------------------------------- 213 (317)
Q Consensus 196 ~~~~~~~~---------------------~~~~~~~~~~----------------------------------------- 213 (317)
++...... ....+.|+.+
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 87532110 0011222221
Q ss_pred CCCCCCCCChHHHHHHHHHhhhcCC---CCCCCHHHHHHHH
Q 021127 214 NVRPSAENVPEELSIILTSCWKEDP---NARPNFTQIIQML 251 (317)
Q Consensus 214 ~~~~~~~~~~~~l~~li~~cl~~~p---~~Rps~~~~~~~l 251 (317)
.........+...++|+.+||..+| .+|+|+.|+++|-
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 0001123456789999999999766 6899999999883
No 387
>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.97 E-value=1.2e-31 Score=229.85 Aligned_cols=218 Identities=24% Similarity=0.307 Sum_probs=176.6
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 96 (317)
.|...+|.++.+||+|+||.|-+|..+ ++.+|||++++...-.+ ...+--+.|-++|+.. +-|.++++..+++.-
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd--DDvectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD--DDVECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeec--CcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence 577788999999999999999999876 67899999987543221 1122234567777655 678899999888764
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
.+|+||||+.||+|.-++++.+. +.+..+..++..|+-||-+||++|||+||||.+|||++.+ |.+||+|||+++.
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~e-GHiKi~DFGmcKE 499 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKE 499 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccC-CceEeeecccccc
Confidence 89999999999999999998776 9999999999999999999999999999999999999999 8999999999985
Q ss_pred c-ccccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHH
Q 021127 176 E-SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 176 ~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~ 227 (317)
. .....+.+.+||+.|+|||++....+... .+||..+ .....|..++.+..
T Consensus 500 ni~~~~TTkTFCGTPdYiAPEIi~YqPYgks-vDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv 578 (683)
T KOG0696|consen 500 NIFDGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAV 578 (683)
T ss_pred cccCCcceeeecCCCcccccceEEecccccc-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHH
Confidence 3 23344567899999999999876555433 3444433 11234677889999
Q ss_pred HHHHHhhhcCCCCCCC
Q 021127 228 IILTSCWKEDPNARPN 243 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps 243 (317)
.+....|...|.+|..
T Consensus 579 ~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 579 AICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHHHHhhcCCccccC
Confidence 9999999999999943
No 388
>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.97 E-value=3.7e-32 Score=221.72 Aligned_cols=220 Identities=27% Similarity=0.360 Sum_probs=174.7
Q ss_pred eeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC------c
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP------V 97 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 97 (317)
++-.+.||.|+||.||-.++. |+.||+|.+..-... ....+++.+|+.+|..++|.||+..++..+-. +
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~---L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQN---LASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHH---HHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 344577999999999998885 899999988643322 23456799999999999999999999887532 4
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
+|+|+|++ ..+|.+.+-. ++.++.+.+.-+++||++||+|||+.+|.||||||.|.|+++| ..+||||||+++...
T Consensus 132 iYV~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSN-CvLKICDFGLARvee 207 (449)
T KOG0664|consen 132 LYVLTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSN-CILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccC-ceEEecccccccccc
Confidence 67888988 5688887764 3449999999999999999999999999999999999999999 689999999999654
Q ss_pred cc--cccccccCccceecccccccccccccccccccCC------------------------------------------
Q 021127 178 LT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------------------ 213 (317)
Q Consensus 178 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------------------ 213 (317)
.. ..++..+-|.+|.|||++.+..-.++..++|+.+
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 33 3345556789999999999887777777777765
Q ss_pred -------CCCCC------------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 -------NVRPS------------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 -------~~~~~------------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
...+. +..-..+...++..++..||++|.+..+.+.++.
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 00011 1222345677888899999999999999887743
No 389
>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]
Probab=99.97 E-value=3.3e-30 Score=219.01 Aligned_cols=172 Identities=24% Similarity=0.295 Sum_probs=141.4
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC-C-----CeeeEEeeee
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH-R-----NLVKFIGACK 94 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~-----niv~l~~~~~ 94 (317)
..+|++.+.+|+|.||.|-.+.+. +..||||+++.- .+.++.-+-|+++++++.+ . -+|.+.+||+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V------~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV------DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH------HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 579999999999999999998775 788999998643 2344456679999999932 1 3567777775
Q ss_pred -cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC------------
Q 021127 95 -EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED------------ 161 (317)
Q Consensus 95 -~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~------------ 161 (317)
.++.+||+|.+ |-++.+++.++.-.+++..++..|++|++++++|||+.+++|.||||+||++.+.
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence 56999999999 7799999999887889999999999999999999999999999999999998432
Q ss_pred -------CCceEEcccCcccccccccccccccCccceeccccccccccc
Q 021127 162 -------LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR 203 (317)
Q Consensus 162 -------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 203 (317)
...++|+|||.|...... .+..+.|..|.|||++.+..+.
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGwS 287 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGWS 287 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccCcC
Confidence 125899999999865432 3566789999999998774443
No 390
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=99.97 E-value=1.9e-31 Score=240.24 Aligned_cols=221 Identities=25% Similarity=0.380 Sum_probs=177.2
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee-cCce
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVM 98 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~ 98 (317)
+..+|++..++|+|.+|.||++++. ++..|+|+++.....+ ..-+.+|+-+++..+|+|||.++|.+. ....
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-----~~~iqqei~~~~dc~h~nivay~gsylr~dkl 87 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-----FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKL 87 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-----ccccccceeeeecCCCcChHHHHhhhhhhcCc
Confidence 4479999999999999999999986 8999999998766544 233678999999999999999999875 4589
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
|++||||.||+|.+..+..+. +++.++...++..+.||+|||++|-+|||||-.||+++.. |.+|+.|||.+-....
T Consensus 88 wicMEycgggslQdiy~~Tgp--lselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~-gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVTGP--LSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDE-GDVKLADFGVSAQITA 164 (829)
T ss_pred EEEEEecCCCcccceeeeccc--chhHHHHHHHhhhhccchhhhcCCcccccccccceeeccc-CceeecccCchhhhhh
Confidence 999999999999997776555 9999999999999999999999999999999999999988 7999999999875543
Q ss_pred c-cccccccCccceecccccccc--cccccccccccCC--------------------------------CCCCCCCCCh
Q 021127 179 T-EMMTAETGTYRWMAPELYSTV--TLRQGEKKHYNHK--------------------------------NVRPSAENVP 223 (317)
Q Consensus 179 ~-~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~~--------------------------------~~~~~~~~~~ 223 (317)
. .....+.||++|||||+-.-. .-.....++|..+ .........+
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws 244 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS 244 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence 3 233567899999999974210 0011111122211 1111234567
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+.+.+|++.||-.+|++||+++.+++|
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheec
Confidence 889999999999999999999988764
No 391
>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.96 E-value=1.1e-30 Score=218.66 Aligned_cols=220 Identities=24% Similarity=0.309 Sum_probs=177.7
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeee
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGAC 93 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 93 (317)
..|-+.-.+|.++++||+|+|.+|.+++.. .+.+|+|++++....++ +...-+..|-.+..+. +||.+|-+..+|
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndd--edidwvqtek~vfe~asn~pflvglhscf 320 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDD--EDIDWVQTEKHVFEQASNNPFLVGLHSCF 320 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCc--ccchhHHhhHHHHHhccCCCeEEehhhhh
Confidence 467788899999999999999999998875 78999999987654432 2233355566666555 899999999999
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
+.. .+++|.||++||+|.-+++.+++ ++++.+..+...|+.||.|||++|||+||||.+|+|++.. |.+||+|+|+
T Consensus 321 qtesrlffvieyv~ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldae-ghikltdygm 397 (593)
T KOG0695|consen 321 QTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGM 397 (593)
T ss_pred cccceEEEEEEEecCcceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccC-Cceeecccch
Confidence 754 89999999999999988887665 9999999999999999999999999999999999999998 7999999999
Q ss_pred ccc-cccccccccccCccceecccccccccccccccccccCC-----------------------------------CCC
Q 021127 173 ARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------------NVR 216 (317)
Q Consensus 173 a~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------------~~~ 216 (317)
++. ......+++.|||+.|+|||++.+..+.-.. +||..+ .-.
T Consensus 398 cke~l~~gd~tstfcgtpnyiapeilrgeeygfsv-dwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi 476 (593)
T KOG0695|consen 398 CKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSV-DWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI 476 (593)
T ss_pred hhcCCCCCcccccccCCCcccchhhhcccccCcee-hHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc
Confidence 984 3556677889999999999999885543222 222211 111
Q ss_pred CCCCCChHHHHHHHHHhhhcCCCCCC
Q 021127 217 PSAENVPEELSIILTSCWKEDPNARP 242 (317)
Q Consensus 217 ~~~~~~~~~l~~li~~cl~~~p~~Rp 242 (317)
..|..++.....+++..|++||.+|.
T Consensus 477 riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cccceeehhhHHHHHHhhcCCcHHhc
Confidence 22455666778899999999999994
No 392
>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain. Phosphotransferases. Serine or threonine-specific kinase subfamily.
Probab=99.96 E-value=6.8e-29 Score=209.94 Aligned_cols=207 Identities=32% Similarity=0.471 Sum_probs=166.9
Q ss_pred cceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEEEEEccCCCCHHH
Q 021127 36 AHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTELLSGGTLRK 112 (317)
Q Consensus 36 ~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~~g~L~~ 112 (317)
+||.||+|.+. ++.+|+|++........ ...+.+|+..+++++|+||+++++.+.. ...++++|++++++|.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~ 76 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK----RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD 76 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH----HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence 58999999986 68999999886654321 4568899999999999999999999875 48999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccccccccCcccee
Q 021127 113 YLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWM 192 (317)
Q Consensus 113 ~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~ 192 (317)
++..... +++..++.++.+++.+|.|||+.+++|+||+|+||+++.+ +.++|+|||.+.............++..|+
T Consensus 77 ~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 153 (244)
T smart00220 77 LLKKRGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED-GHVKLADFGLARQLDPGGLLTTFVGTPEYM 153 (244)
T ss_pred HHHhccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC-CcEEEccccceeeeccccccccccCCcCCC
Confidence 9987554 8999999999999999999999999999999999999998 799999999998665544445567889999
Q ss_pred cccccccccccccccccccCC-----------------------------CCCCCCC--CChHHHHHHHHHhhhcCCCCC
Q 021127 193 APELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAE--NVPEELSIILTSCWKEDPNAR 241 (317)
Q Consensus 193 aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~--~~~~~l~~li~~cl~~~p~~R 241 (317)
+||.+....... ..+.|..+ ....... .++.++.+++.+||..+|.+|
T Consensus 154 ~pE~~~~~~~~~-~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 232 (244)
T smart00220 154 APEVLLGKGYGK-AVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR 232 (244)
T ss_pred CHHHHccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence 999876433222 22222211 0000111 178899999999999999999
Q ss_pred CCHHHHHHH
Q 021127 242 PNFTQIIQM 250 (317)
Q Consensus 242 ps~~~~~~~ 250 (317)
|++.+++++
T Consensus 233 p~~~~~~~~ 241 (244)
T smart00220 233 LTAEEALQH 241 (244)
T ss_pred cCHHHHhhC
Confidence 999999874
No 393
>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481
Probab=99.96 E-value=1e-28 Score=237.44 Aligned_cols=169 Identities=30% Similarity=0.431 Sum_probs=144.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|.+.++||.|+||.||+|.+. ++.||||++....... ......+..|+.++..++|+||+++++++... ..++
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~--~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMIN--KNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccC--HHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 68999999999999999999987 8999999997654322 23345688999999999999999999988654 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+.+++|.+++...+. +++..++.|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||+++......
T Consensus 82 VmEy~~g~~L~~li~~~~~--l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~-g~vkL~DFGls~~~~~~~ 158 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNE-GHIKLTDFGLSKVTLNRE 158 (669)
T ss_pred EEeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCC-CCEEEEeCCCCccccCCc
Confidence 9999999999999976543 8999999999999999999999999999999999999988 799999999998643322
Q ss_pred -ccccccCccceeccccc
Q 021127 181 -MMTAETGTYRWMAPELY 197 (317)
Q Consensus 181 -~~~~~~gt~~y~aPE~~ 197 (317)
......+|+.|++||..
T Consensus 159 ~~~~~~~~t~~~~~pe~~ 176 (669)
T cd05610 159 LNMMDILTTPSMAKPKND 176 (669)
T ss_pred ccccccccCccccCcccc
Confidence 23345789999999864
No 394
>cd00180 PKc Catalytic domain of Protein Kinases. Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which
Probab=99.96 E-value=1.5e-28 Score=203.06 Aligned_cols=209 Identities=32% Similarity=0.519 Sum_probs=169.3
Q ss_pred eccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEEEEEccCCC
Q 021127 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTELLSGG 108 (317)
Q Consensus 32 lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~~g 108 (317)
||+|++|.||++... ++.+++|++....... ....+.+|+..++.+.|++|+++++++.. ...++++|++.++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~ 76 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG 76 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence 689999999999997 8999999998765432 24568899999999999999999999876 4899999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC-CCCceEEcccCccccccccc-cccccc
Q 021127 109 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE-DLKTIKLADFGLAREESLTE-MMTAET 186 (317)
Q Consensus 109 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~-~~~~~kl~Dfg~a~~~~~~~-~~~~~~ 186 (317)
+|.+++.... ..+++..++.++.+++.+|++||++|++|+||+|.||+++. + +.++|+|||.+....... ......
T Consensus 77 ~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (215)
T cd00180 77 SLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDN-GKVKLADFGLSKLLTSDKSLLKTIV 154 (215)
T ss_pred cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCC-CcEEEecCCceEEccCCcchhhccc
Confidence 9999998652 23899999999999999999999999999999999999998 6 689999999997554332 123345
Q ss_pred CccceecccccccccccccccccccCCCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 187 GTYRWMAPELYSTVTLRQGEKKHYNHKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 187 gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+...|++||.+..........+.|..+...... ..+.+++..|++.+|.+||++.+++++
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 788999999987642333334444332111111 789999999999999999999999865
No 395
>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]
Probab=99.96 E-value=5.5e-29 Score=195.36 Aligned_cols=181 Identities=25% Similarity=0.374 Sum_probs=149.2
Q ss_pred CCceeecCCceeecceeccccceEEEEeEE--CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEee
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGA 92 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 92 (317)
++.++++.+.+.-+..||+|++|.|-+.++ +|...|+|.+....... ..++.+.|+++..+. ..|.+|.+||.
T Consensus 38 ~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q----~q~r~L~dldi~~r~~~CPf~V~FyGa 113 (282)
T KOG0984|consen 38 DRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQ----EQKRLLMDLDIIMRTVDCPFTVHFYGA 113 (282)
T ss_pred cCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChH----HHHHHHHhhhhhccCCCCCeEEEeehh
Confidence 344778888888899999999998866655 59999999998766533 345678899987765 89999999996
Q ss_pred e-ecCceEEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEeeCCCCceEEc
Q 021127 93 C-KEPVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLA 168 (317)
Q Consensus 93 ~-~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~Dlkp~Nill~~~~~~~kl~ 168 (317)
. .+...||.||.| ..+|..+..+. ....+++..+-+|+..+++||.|||++ .+||||+||+||||+.+ |++|||
T Consensus 114 ~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~-GqVKiC 191 (282)
T KOG0984|consen 114 LFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYD-GQVKIC 191 (282)
T ss_pred hhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccC-CcEEEc
Confidence 5 566899999999 67998877642 334589999999999999999999987 89999999999999999 899999
Q ss_pred ccCcccccccccccccccCccceecccccccccc
Q 021127 169 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTL 202 (317)
Q Consensus 169 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 202 (317)
|||++-...+.-..+...|+..|||||.+.....
T Consensus 192 DFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n 225 (282)
T KOG0984|consen 192 DFGISGYLVDSIAKTMDAGCKPYMAPERINPELN 225 (282)
T ss_pred ccccceeehhhhHHHHhcCCCccCChhhcCcccC
Confidence 9999987655544455689999999999876443
No 396
>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]
Probab=99.96 E-value=2.9e-29 Score=208.75 Aligned_cols=222 Identities=27% Similarity=0.349 Sum_probs=175.3
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee-
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK- 94 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~- 94 (317)
.....+.+|.-++.+|.|.- .|.-+-+. +++||+|.+....... ..-++-.+|..++..++|+||++++.++.
T Consensus 11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~---~~akra~rel~l~~~v~~~nii~l~n~ftP 86 (369)
T KOG0665|consen 11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQ---THAKRAYRELKLMKCVNHKNIISLLNVFTP 86 (369)
T ss_pred cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccC---ccchhhhhhhhhhhhhcccceeeeeeccCc
Confidence 56677789999999999998 66666664 8999999876542221 12234678999999999999999999883
Q ss_pred ------cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEc
Q 021127 95 ------EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (317)
Q Consensus 95 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~ 168 (317)
....|+|||+| ..+|.+.+.. . ++-+++..|+.|++.|++|||+.||+||||||+||++..+ +.+||.
T Consensus 87 ~~~l~~~~e~y~v~e~m-~~nl~~vi~~--e--lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~-~~lKi~ 160 (369)
T KOG0665|consen 87 QKTLEEFQEVYLVMELM-DANLCQVILM--E--LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSD-CTLKIL 160 (369)
T ss_pred cccHHHHHhHHHHHHhh-hhHHHHHHHH--h--cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecch-hheeec
Confidence 12689999999 6799998872 1 7889999999999999999999999999999999999998 799999
Q ss_pred ccCcccccccccccccccCccceecccccccccccccccccccCC-----------------------------------
Q 021127 169 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------------- 213 (317)
Q Consensus 169 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------------- 213 (317)
|||+|+.....-..+..+.|..|.|||++.+..+.. ..++|+.+
T Consensus 161 dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke-~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 161 DFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred cchhhcccCcccccCchhheeeccCchheeccCCcc-cchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence 999999766655667778999999999988766332 22333322
Q ss_pred -------------------------CCCC---------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 -------------------------NVRP---------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 -------------------------~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
...+ ....-+..+++++.+||..||++|.+++++++|
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000 011223568999999999999999999999988
No 397
>PRK09188 serine/threonine protein kinase; Provisional
Probab=99.96 E-value=2.8e-28 Score=215.53 Aligned_cols=167 Identities=20% Similarity=0.181 Sum_probs=127.2
Q ss_pred eecCCceeecceeccccceEEEEeEEC---CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeee-EEeeeec
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK-FIGACKE 95 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~ 95 (317)
..-.++|.+.+.||+|+||+||+|.+. ++.||||++...............+.+|++++++++|+|++. ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 345578999999999999999999873 677899987643210001123456899999999999999985 4432
Q ss_pred CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCcEEeeCCCCceEEcccCccc
Q 021127 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDL-KPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dl-kp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+..++||||++|++|.. +. . .. ...++.+++.+|.|||++||+|||| ||+|||++.+ +.+||+|||+|+
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~---~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~-~~ikLiDFGlA~ 160 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-AR---P--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPD-GEAAVIDFQLAS 160 (365)
T ss_pred CCcEEEEEccCCCCHHH-hC---c--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCC-CCEEEEECccce
Confidence 45899999999999963 21 1 11 1467899999999999999999999 9999999877 689999999998
Q ss_pred cccccc---------ccccccCccceeccccccc
Q 021127 175 EESLTE---------MMTAETGTYRWMAPELYST 199 (317)
Q Consensus 175 ~~~~~~---------~~~~~~gt~~y~aPE~~~~ 199 (317)
...... ......+++.|+|||++..
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 543221 1124467888999998654
No 398
>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]
Probab=99.96 E-value=3e-29 Score=222.88 Aligned_cols=196 Identities=23% Similarity=0.285 Sum_probs=158.9
Q ss_pred cCCceeecCC---ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHH---HHHHHHHHHHHHHHHhcC---C
Q 021127 15 LDAKWLIDPK---HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEI---AKKESRFAREVAMLSRVQ---H 83 (317)
Q Consensus 15 ~~~~~~i~~~---~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~---h 83 (317)
-+..|+..++ +|...+.||.|+||.|++|.++ ...|+||.+.+...-.+. .+..-.+--||.+|..++ |
T Consensus 549 ~~~~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH 628 (772)
T KOG1152|consen 549 GNIGCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSH 628 (772)
T ss_pred ccccceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCc
Confidence 3445555554 4789999999999999999987 567999998765432110 011122345999999997 9
Q ss_pred CCeeeEEeeeecC-ceEEEEEcc-CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC
Q 021127 84 RNLVKFIGACKEP-VMVIVTELL-SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 161 (317)
Q Consensus 84 ~niv~l~~~~~~~-~~~lv~e~~-~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~ 161 (317)
+||++++++|+++ .+||+||-- +|-+|.++|.-.. .+++..+..|++||+.|+++||+.||||||||-+|+.++.+
T Consensus 629 ~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~ 706 (772)
T KOG1152|consen 629 ENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSN 706 (772)
T ss_pred cchhhhhheeecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCceecccccccEEEecC
Confidence 9999999999876 788888865 4568899997543 39999999999999999999999999999999999999999
Q ss_pred CCceEEcccCcccccccccccccccCccceecccccccccccccccccccCCC
Q 021127 162 LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKN 214 (317)
Q Consensus 162 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~ 214 (317)
|.+||+|||.+....+. ....++||..|.|||++.+..+.....++|..+.
T Consensus 707 -g~~klidfgsaa~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgi 757 (772)
T KOG1152|consen 707 -GFVKLIDFGSAAYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGI 757 (772)
T ss_pred -CeEEEeeccchhhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhh
Confidence 89999999999765544 3356789999999999999998888888887663
No 399
>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]
Probab=99.96 E-value=9.8e-29 Score=217.21 Aligned_cols=191 Identities=23% Similarity=0.283 Sum_probs=153.4
Q ss_pred cccccceecCCceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC--
Q 021127 7 FYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-- 82 (317)
Q Consensus 7 ~~~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-- 82 (317)
|...+.+.-....++-.++|.+....|+|-|++|.+|.+. ++.||||+++....-. +.=+.|+++|++|+
T Consensus 415 WdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~------KtGl~EleiLkKL~~A 488 (752)
T KOG0670|consen 415 WDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH------KTGLKELEILKKLNDA 488 (752)
T ss_pred cccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh------hhhhHHHHHHHHhhcc
Confidence 3334444445555667789999999999999999999986 8899999998764321 22467999999994
Q ss_pred ----CCCeeeEEeeee-cCceEEEEEccCCCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 021127 83 ----HRNLVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPR-CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 156 (317)
Q Consensus 83 ----h~niv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~-~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Ni 156 (317)
--|+++|+..|. .++++||+|.+ ..+|.+.|.+.+.. .|....+..|+.|+..||..|-..||+|.||||+||
T Consensus 489 D~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNi 567 (752)
T KOG0670|consen 489 DPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNI 567 (752)
T ss_pred CchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccce
Confidence 357888887775 56999999999 78999999987643 588899999999999999999999999999999999
Q ss_pred EeeCCCCceEEcccCcccccccccccccccCccceeccccccccccccc
Q 021127 157 LLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQG 205 (317)
Q Consensus 157 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 205 (317)
|+++..+.+||||||.|........+ ...-+..|.|||++.+..+.-+
T Consensus 568 LVNE~k~iLKLCDfGSA~~~~eneit-PYLVSRFYRaPEIiLG~~yd~~ 615 (752)
T KOG0670|consen 568 LVNESKNILKLCDFGSASFASENEIT-PYLVSRFYRAPEIILGLPYDYP 615 (752)
T ss_pred EeccCcceeeeccCcccccccccccc-HHHHHHhccCcceeecCcccCC
Confidence 99988789999999999876544432 2344668999999888655443
No 400
>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]
Probab=99.95 E-value=2.5e-28 Score=210.00 Aligned_cols=141 Identities=30% Similarity=0.493 Sum_probs=126.6
Q ss_pred cCCceeecceeccccceEEEEeEE-----CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeec
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE 95 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 95 (317)
-.+.|.++++||.|.|++||++.+ +++.||+|.+.....+. ++.+|+++|..+ -+.||+++.+++..
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~-------ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS-------RILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch-------HHHHHHHHHHHhccchhhhcchhhhcc
Confidence 346788999999999999999865 36789999998877655 588999999998 69999999999875
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+ ...+|+||++.....+++.. ++...+..+++.++.||+++|.+|||||||||+|++.+...+.-.|+|||+|.
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHH
Confidence 4 89999999999999998876 78899999999999999999999999999999999999887889999999985
No 401
>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.95 E-value=1.9e-27 Score=207.72 Aligned_cols=145 Identities=25% Similarity=0.335 Sum_probs=121.4
Q ss_pred cccccceecCCceeecC-CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-
Q 021127 7 FYLADELKLDAKWLIDP-KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ- 82 (317)
Q Consensus 7 ~~~~~~~~~~~~~~i~~-~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~- 82 (317)
.|...-++.+....... ++|.+.++||=|-|++||++.++ .+.||+|+.+.... ..+.-+.||.+|++++
T Consensus 60 dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh------YtEaAlDEIklL~~v~~ 133 (590)
T KOG1290|consen 60 DYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH------YTEAALDEIKLLQQVRE 133 (590)
T ss_pred hhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH------HHHHHHHHHHHHHHHHh
Confidence 34444556666666555 89999999999999999999987 78999999875432 2334678999999883
Q ss_pred -------CCCeeeEEeeee-----cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-Ccccc
Q 021127 83 -------HRNLVKFIGACK-----EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHR 149 (317)
Q Consensus 83 -------h~niv~l~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~ 149 (317)
-.+||+|++.|. ..++++|+|++ |.+|..+|....-+.++...+.+|++||+.||.|||.+ ||||.
T Consensus 134 ~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHT 212 (590)
T KOG1290|consen 134 GDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHT 212 (590)
T ss_pred cCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence 357999999985 23899999999 89999999887666799999999999999999999986 99999
Q ss_pred CCCCCcEEe
Q 021127 150 DLKPENLLL 158 (317)
Q Consensus 150 Dlkp~Nill 158 (317)
||||+|||+
T Consensus 213 DlKPENvLl 221 (590)
T KOG1290|consen 213 DLKPENVLL 221 (590)
T ss_pred CCCcceeee
Confidence 999999998
No 402
>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.94 E-value=8.3e-25 Score=183.26 Aligned_cols=237 Identities=23% Similarity=0.336 Sum_probs=183.7
Q ss_pred ceeecCCceeecceeccccceEEEEeEE--CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeee
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK 94 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 94 (317)
...|-+-+|.++++||.|+||.++.|++ ++++||||.-+...... ++..|.+..+.| ..++|..+|.+-.
T Consensus 22 ~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP-------QLrdEYr~YKlL~g~~GIP~vYYFGq 94 (449)
T KOG1165|consen 22 GVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP-------QLRDEYRTYKLLGGTEGIPQVYYFGQ 94 (449)
T ss_pred CceEecccceeccccccCcceeeecccccccCceEEEEeccccCCcc-------hHHHHHHHHHHHcCCCCCCceeeecc
Confidence 3457778999999999999999999987 49999999877665433 366788888887 5799999987777
Q ss_pred cC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC----CCCceEEcc
Q 021127 95 EP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE----DLKTIKLAD 169 (317)
Q Consensus 95 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~----~~~~~kl~D 169 (317)
++ +..||||++ |.+|.++..-.+ +.|+.++++.++.|++.-++|+|++.+|.|||||+|+||.. +.+.+.|+|
T Consensus 95 eG~~NiLVidLL-GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 95 EGKYNILVIDLL-GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred ccchhhhhhhhh-CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEe
Confidence 76 788999999 899999776544 44999999999999999999999999999999999999963 334689999
Q ss_pred cCccccccccccc--------ccccCccceeccccccccc----------------ccccccccccCC------------
Q 021127 170 FGLAREESLTEMM--------TAETGTYRWMAPELYSTVT----------------LRQGEKKHYNHK------------ 213 (317)
Q Consensus 170 fg~a~~~~~~~~~--------~~~~gt~~y~aPE~~~~~~----------------~~~~~~~~~~~~------------ 213 (317)
||+|+........ ....||..||+--...+.. +..+..+|....
T Consensus 173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG 252 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG 252 (449)
T ss_pred ccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc
Confidence 9999865433322 3346999999987544421 122222222211
Q ss_pred ------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCCCCC
Q 021127 214 ------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEP 263 (317)
Q Consensus 214 ------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~~~~ 263 (317)
.....+.++|.++...++..-..+-.+-|..+-+...+.+++........
T Consensus 253 e~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~D 308 (449)
T KOG1165|consen 253 ETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDD 308 (449)
T ss_pred cccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccc
Confidence 11112567899999999999999999999999999999998886654443
No 403
>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]
Probab=99.93 E-value=6.8e-26 Score=184.88 Aligned_cols=216 Identities=22% Similarity=0.308 Sum_probs=160.8
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeee-ec-Cce
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGAC-KE-PVM 98 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~-~~-~~~ 98 (317)
+.|.+.+.||+|.||.+-++++. ...+|+|.++.... ..++|.+|...--.| .|.||+.-|++- +. +.+
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t------t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT------TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh------hHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 57889999999999999999997 67899999987653 345688888765555 699999988764 33 378
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee-CCCCceEEcccCcccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT-EDLKTIKLADFGLAREES 177 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~-~~~~~~kl~Dfg~a~~~~ 177 (317)
++++||++.|+|..-+...+ +-+.....++.|+++||.|||++++||||||.+||||- .|..++||||||+....+
T Consensus 98 vF~qE~aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred EEeeccCccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 89999999999998886643 88888899999999999999999999999999999984 555689999999997654
Q ss_pred cccccccccCccceecccccccccc----cccccccccCC--------------------------------CCCC---C
Q 021127 178 LTEMMTAETGTYRWMAPELYSTVTL----RQGEKKHYNHK--------------------------------NVRP---S 218 (317)
Q Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~~~--------------------------------~~~~---~ 218 (317)
..-. ..-.+..|.+||+...... .....+.|..+ .... .
T Consensus 175 ~tV~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~ 252 (378)
T KOG1345|consen 175 TTVK--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKK 252 (378)
T ss_pred ceeh--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchh
Confidence 3211 1224667999997654211 11112222222 0111 1
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
-..+++.+..+.++-|..+|++|-.+.++.++
T Consensus 253 F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 253 FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred hcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 23456778888999999999999555555443
No 404
>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]
Probab=99.93 E-value=2.4e-26 Score=196.05 Aligned_cols=234 Identities=22% Similarity=0.383 Sum_probs=187.8
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 91 (317)
..+.+.++++..++.+|.||+||+|.+. .+.|-+|.++...++- +...++.|--++..+.|||+..+.+
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~i----Qv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQI----QVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHH----HHHHHHHHHHHHhcCcCCCccceeE
Confidence 4567788999999999999999999653 3557788887766643 4567889999999999999999999
Q ss_pred eeecC--ceEEEEEccCCCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCC
Q 021127 92 ACKEP--VMVIVTELLSGGTLRKYLLNM------RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 163 (317)
Q Consensus 92 ~~~~~--~~~lv~e~~~~g~L~~~l~~~------~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~ 163 (317)
++.+. ..++++.++.-|+|..||... ..+.++..+...++.|++.|++|||+.|+||.||..+|++|++. -
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~-L 433 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ-L 433 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh-e
Confidence 98543 788999999999999999832 23457888899999999999999999999999999999999998 5
Q ss_pred ceEEcccCccccccccccc---ccccCccceeccccccccccccccccccc----------------------------C
Q 021127 164 TIKLADFGLAREESLTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYN----------------------------H 212 (317)
Q Consensus 164 ~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~----------------------------~ 212 (317)
++||+|=.+++..-..+.. ........||+||.+....+.+..+.|.. .
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd 513 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD 513 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence 8999999999865433221 22234678999999877655554433211 1
Q ss_pred CCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 213 KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 213 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+.....|-++|+++..+|..||...|++||+++|+...|.++-.+
T Consensus 514 GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 514 GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 233445789999999999999999999999999999999887654
No 405
>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.93 E-value=9.9e-25 Score=175.35 Aligned_cols=237 Identities=22% Similarity=0.296 Sum_probs=179.1
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC-CCeeeEEeeeecC
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH-RNLVKFIGACKEP 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~ 96 (317)
+|..++|.++++||+|+||.+|.|..- |..||||+-....... .+..|..+.+.|++ ..|+.+..+..+.
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp-------qL~yEskvY~iL~~g~GiP~i~~y~~e~ 83 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP-------QLLYESKVYRILQGGVGIPHIRHYGTEK 83 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc-------chhHHHHHHHHhccCCCCchhhhhcccc
Confidence 567789999999999999999999874 8999999977655433 36778888888864 6677777666655
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC--CCceEEcccCcc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLA 173 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~a 173 (317)
...+||+++ |.+|.+++.- -.+.++..+++-++-|++.-++|+|.+++|||||||+|+|+.-+ .+.+.++|||+|
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred ccceeeeecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccch
Confidence 788999999 8899887653 23449999999999999999999999999999999999998633 247899999999
Q ss_pred cccccccc--------cccccCccceeccccccccc----------------ccccccccccCC----------------
Q 021127 174 REESLTEM--------MTAETGTYRWMAPELYSTVT----------------LRQGEKKHYNHK---------------- 213 (317)
Q Consensus 174 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~----------------~~~~~~~~~~~~---------------- 213 (317)
+....... .....||..|.+--...+.. +..+..+|....
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~ 241 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM 241 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence 85432211 12346899998876544321 222222222211
Q ss_pred --CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCCCCCCC
Q 021127 214 --NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 265 (317)
Q Consensus 214 --~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~~~~~~ 265 (317)
.....+.++|.++...+..|-..--++-|...-+.+.+.-++...+-.....
T Consensus 242 s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~i 295 (341)
T KOG1163|consen 242 STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYI 295 (341)
T ss_pred CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeE
Confidence 1112267889999999999999999999999998888888877666554443
No 406
>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c
Probab=99.93 E-value=2.2e-25 Score=181.62 Aligned_cols=143 Identities=20% Similarity=0.177 Sum_probs=108.1
Q ss_pred cceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHH---------------------HHHHHHHHHHHHHHhcCCCCe
Q 021127 29 GPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIA---------------------KKESRFAREVAMLSRVQHRNL 86 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~---------------------~~~~~~~~E~~~l~~l~h~ni 86 (317)
...||+|+||.||+|.+. |+.||||+++......... -.......|+..+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 467999999999999875 8999999998653211000 001223459999999987776
Q ss_pred eeEEeeeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCcEEeeCCCCce
Q 021127 87 VKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL-HSHGIIHRDLKPENLLLTEDLKTI 165 (317)
Q Consensus 87 v~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~l-H~~~ivH~Dlkp~Nill~~~~~~~ 165 (317)
........ ...++||||++|+++....... ..++...+..++.|++.+|.++ |+.||+||||||+||+++. +.+
T Consensus 82 ~~p~~~~~-~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~--~~v 156 (190)
T cd05147 82 PCPEPILL-KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD--GKL 156 (190)
T ss_pred CCCcEEEe-cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC--CcE
Confidence 43322222 2348999999888776554332 2489999999999999999999 6999999999999999985 579
Q ss_pred EEcccCccccc
Q 021127 166 KLADFGLAREE 176 (317)
Q Consensus 166 kl~Dfg~a~~~ 176 (317)
+|+|||+|...
T Consensus 157 ~LiDFG~a~~~ 167 (190)
T cd05147 157 YIIDVSQSVEH 167 (190)
T ss_pred EEEEccccccC
Confidence 99999999744
No 407
>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro
Probab=99.92 E-value=4.4e-24 Score=174.51 Aligned_cols=145 Identities=20% Similarity=0.157 Sum_probs=110.5
Q ss_pred ecceeccccceEEEEeEEC-CeEEEEEEeecCCChH---------------------HHHHHHHHHHHHHHHHHhcCCCC
Q 021127 28 VGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPE---------------------EIAKKESRFAREVAMLSRVQHRN 85 (317)
Q Consensus 28 ~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~---------------------~~~~~~~~~~~E~~~l~~l~h~n 85 (317)
+...||+|++|.||+|.+. |+.||||+++...... ........+..|.+.+.++.|++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 3568999999999999875 9999999998753210 00011223457899999999988
Q ss_pred eeeEEeeeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCCc
Q 021127 86 LVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKT 164 (317)
Q Consensus 86 iv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~~ 164 (317)
+.....+... ..++||||++|+++........ .++...+..++.|++.+|.++|+ +||+||||||+||+++ + +.
T Consensus 81 i~~p~~~~~~-~~~lVmE~~~g~~~~~~~l~~~--~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~-~~ 155 (190)
T cd05145 81 VPVPEPILLK-KNVLVMEFIGDDGSPAPRLKDV--PLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D-GK 155 (190)
T ss_pred CCCceEEEec-CCEEEEEEecCCCchhhhhhhc--cCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C-CC
Confidence 7443333222 3489999998886544322222 37888999999999999999999 9999999999999999 5 68
Q ss_pred eEEcccCcccccc
Q 021127 165 IKLADFGLAREES 177 (317)
Q Consensus 165 ~kl~Dfg~a~~~~ 177 (317)
++|+|||+++...
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999998654
No 408
>smart00221 STYKc Protein kinase; unclassified specificity. Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.
Probab=99.91 E-value=8.7e-24 Score=176.85 Aligned_cols=167 Identities=40% Similarity=0.598 Sum_probs=142.0
Q ss_pred eeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEEEE
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVT 102 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~ 102 (317)
|.+.+.||+|++|.||++... ++.+|+|.+...... .....+.+|++.+++++|+|++++++.+.. ...++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 76 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM 76 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence 567889999999999999886 589999999876543 235578899999999999999999998875 4899999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc--
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-- 180 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-- 180 (317)
|++++++|.+++...... +++..+..++.+++.+|.+||+.+++|+||+|.||+++.+ +.++|+|||.+.......
T Consensus 77 e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 77 EYCEGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD-GLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred eccCCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeeCceeeEecCcccc
Confidence 999999999999865432 7899999999999999999999999999999999999988 689999999998654332
Q ss_pred ccccccCccceecccccc
Q 021127 181 MMTAETGTYRWMAPELYS 198 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~ 198 (317)
......++..|++||.+.
T Consensus 155 ~~~~~~~~~~~~~pe~~~ 172 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLL 172 (225)
T ss_pred cccceeccCCcCCHhHhc
Confidence 233456788899999874
No 409
>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.91 E-value=6.9e-23 Score=181.12 Aligned_cols=228 Identities=25% Similarity=0.339 Sum_probs=170.5
Q ss_pred ceeecceeccccceEEEEeEECC---eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC----CCCeeeEEeeee-c-
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYKN---QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ----HRNLVKFIGACK-E- 95 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----h~niv~l~~~~~-~- 95 (317)
+|.+.++||+|+||.||.+.+.. ..+|+|+......... ..+..|+.++..+. ..++..+++... .
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~-----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP-----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC-----ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence 89999999999999999999863 4799998876533221 13566888888876 368899998883 4
Q ss_pred CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCC----CceEEcccC
Q 021127 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL----KTIKLADFG 171 (317)
Q Consensus 96 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~----~~~kl~Dfg 171 (317)
...++||+.+ |.+|.++......+.++..+++.++.|++.+|++||+.|++||||||+|+++.... ..+.|.|||
T Consensus 94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 4789999998 99999988766656799999999999999999999999999999999999998542 369999999
Q ss_pred ccc--cccccc--------c-cccccCccceecccccccccccccc----------------cccccCCC----------
Q 021127 172 LAR--EESLTE--------M-MTAETGTYRWMAPELYSTVTLRQGE----------------KKHYNHKN---------- 214 (317)
Q Consensus 172 ~a~--~~~~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~~~----------------~~~~~~~~---------- 214 (317)
+++ ...... . .....||..|+++.+..+....... .+|-....
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 321111 1 1234599999999976553322211 11111110
Q ss_pred ----CCC-CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 215 ----VRP-SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 215 ----~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
... .....+.++..+...+-..+...+|....+...+.......
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 000 12335678888888888899999999999999988877654
No 410
>PRK10345 hypothetical protein; Provisional
Probab=99.89 E-value=2.2e-22 Score=165.54 Aligned_cols=134 Identities=17% Similarity=0.250 Sum_probs=103.6
Q ss_pred cceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-----CCCCeeeEEeeeecC----c-e
Q 021127 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-----QHRNLVKFIGACKEP----V-M 98 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~----~-~ 98 (317)
.+.||+|+||.||....++.. +||++...... ....+.+|+.+++.+ .||||++++|++.++ . +
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~-----~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDG-----GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEECCCCcCe-EEEEEeccccc-----hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 467999999999973333444 79988764332 234689999999999 679999999999765 3 3
Q ss_pred EEEEEc--cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHHhCCccccCCCCCcEEeeCC---CCceEEcccCc
Q 021127 99 VIVTEL--LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM-ECLHSHGIIHRDLKPENLLLTED---LKTIKLADFGL 172 (317)
Q Consensus 99 ~lv~e~--~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L-~~lH~~~ivH~Dlkp~Nill~~~---~~~~kl~Dfg~ 172 (317)
.+|+|| +.+++|.+++.+. . +++. ..++.+++.++ +|||+++|+||||||+|||++.. ...++|+||+.
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-~--~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-R--YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-c--ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 378999 5579999999753 2 6665 35678888888 99999999999999999999742 13799999544
Q ss_pred c
Q 021127 173 A 173 (317)
Q Consensus 173 a 173 (317)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 4
No 411
>PLN00181 protein SPA1-RELATED; Provisional
Probab=99.89 E-value=8.4e-24 Score=208.04 Aligned_cols=170 Identities=18% Similarity=0.241 Sum_probs=119.0
Q ss_pred hcCC-CCeeeEEeeee--------cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 021127 80 RVQH-RNLVKFIGACK--------EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRD 150 (317)
Q Consensus 80 ~l~h-~niv~l~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~D 150 (317)
.++| +||.++++++. ...+++++|++ +++|.++|... ...+++..++.++.||+.||+|||++||+|||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 3445 57778888761 23567788887 77999999753 23499999999999999999999999999999
Q ss_pred CCCCcEEeeCC------------------CCceEEcccCcccccccc-----------------cccccccCccceeccc
Q 021127 151 LKPENLLLTED------------------LKTIKLADFGLAREESLT-----------------EMMTAETGTYRWMAPE 195 (317)
Q Consensus 151 lkp~Nill~~~------------------~~~~kl~Dfg~a~~~~~~-----------------~~~~~~~gt~~y~aPE 195 (317)
|||+||||+.. .+.+||+|||+++..... .......||+.|||||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 99999999532 145677777777532110 0011235788999999
Q ss_pred ccccccccccccccccCCC--------C------------------CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 021127 196 LYSTVTLRQGEKKHYNHKN--------V------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 249 (317)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~--------~------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~ 249 (317)
++.+..+. ...++|+.+- . .+..........+++.+||+.+|.+||++.++++
T Consensus 186 ~~~~~~~~-~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 186 EDNGSSSN-CASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred hhccCCCC-chhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 98765542 3344444330 0 0000111335678899999999999999999988
Q ss_pred HHH
Q 021127 250 MLL 252 (317)
Q Consensus 250 ~l~ 252 (317)
+.+
T Consensus 265 h~~ 267 (793)
T PLN00181 265 SEF 267 (793)
T ss_pred chh
Confidence 643
No 412
>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional
Probab=99.89 E-value=3.8e-22 Score=164.75 Aligned_cols=142 Identities=14% Similarity=0.164 Sum_probs=116.7
Q ss_pred ecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHH------HHHHHHHHHhcCCCCeeeEEeeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESR------FAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~------~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
+-.++|.+.+.||.|+||.||++..++..+|||++.......+ ....+ +.+|+..+.+++|++|..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~--~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTE--RFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchH--HHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 4468999999999999999999877788999999986654432 22233 578999999999999999988754
Q ss_pred c---------CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCce
Q 021127 95 E---------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165 (317)
Q Consensus 95 ~---------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~ 165 (317)
. +..++||||++|.+|.++.. +++. ...+++.+|..||+.|++|||++|+||+++.+ + +
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~-g-i 173 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKN-G-L 173 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh------ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCC-C-E
Confidence 2 25789999999999988732 3332 45699999999999999999999999999987 6 9
Q ss_pred EEcccCccccc
Q 021127 166 KLADFGLAREE 176 (317)
Q Consensus 166 kl~Dfg~a~~~ 176 (317)
+|+|||..+..
T Consensus 174 ~liDfg~~~~~ 184 (232)
T PRK10359 174 RIIDLSGKRCT 184 (232)
T ss_pred EEEECCCcccc
Confidence 99999988644
No 413
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.88 E-value=2.5e-23 Score=195.56 Aligned_cols=220 Identities=24% Similarity=0.284 Sum_probs=163.4
Q ss_pred eecceeccccceEEEEeEEC--CeEEEEEEeecCC-ChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEE
Q 021127 27 FVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGE-TPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVT 102 (317)
Q Consensus 27 ~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 102 (317)
....++|.|++|.|+..... ...++.|.+.... ..+........+..|+-+-..+.|+|++..+..+.+. ..+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678899999977766543 3334444333110 1111112222377788888889999998877766543 333449
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc---
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT--- 179 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~--- 179 (317)
|||++ +|..++..... ++...+-.++.|++.|++|||+.||.|||+|++|++++.+ +.+||+|||.+......
T Consensus 401 E~~~~-Dlf~~~~~~~~--~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~-g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGK--LTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTEN-GILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccH-HHHHHHhcccc--cchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecC-CceEEeecCcceeeccCcch
Confidence 99999 99999987533 8899999999999999999999999999999999999998 79999999998743222
Q ss_pred --cccccccCccceecccccccccccccccccccCCCC------------------------------------CCCCCC
Q 021127 180 --EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKNV------------------------------------RPSAEN 221 (317)
Q Consensus 180 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~ 221 (317)
......+|+..|+|||++.+..++....+.|+.+.. ......
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSL 556 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHh
Confidence 233556799999999999988777776666665400 000123
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+|..-+.+|.++|+.||.+|.|+++|++-
T Consensus 557 lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 557 LPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred chhhHHHHHHHHccCChhheecHHHHhhC
Confidence 56778999999999999999999999876
No 414
>smart00090 RIO RIO-like kinase.
Probab=99.88 E-value=3.6e-22 Score=168.09 Aligned_cols=146 Identities=23% Similarity=0.230 Sum_probs=112.6
Q ss_pred ceeecceeccccceEEEEeE-E--CCeEEEEEEeecCCChH-------------------HHHHHHHHHHHHHHHHHhcC
Q 021127 25 HLFVGPRIGEGAHAKVYEGK-Y--KNQTVAIKIVHKGETPE-------------------EIAKKESRFAREVAMLSRVQ 82 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~-~--~~~~vaiK~~~~~~~~~-------------------~~~~~~~~~~~E~~~l~~l~ 82 (317)
-|.+.+.||+|++|.||+|. + +|+.||||+++...... ........+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 57899999999999999998 3 48999999998643210 00112234678999999996
Q ss_pred C--CCeeeEEeeeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCcEEee
Q 021127 83 H--RNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG-IIHRDLKPENLLLT 159 (317)
Q Consensus 83 h--~niv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~-ivH~Dlkp~Nill~ 159 (317)
+ ..+++++++ ...++||||++|++|........ .+....+..++.|++.+|++||+.| ++||||||+||+++
T Consensus 109 ~~~i~~p~~~~~---~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 109 EAGVPVPKPIAW---RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred hcCCCCCeeeEe---cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 5 334555543 34589999999988876553322 2666677899999999999999999 99999999999999
Q ss_pred CCCCceEEcccCcccccc
Q 021127 160 EDLKTIKLADFGLAREES 177 (317)
Q Consensus 160 ~~~~~~kl~Dfg~a~~~~ 177 (317)
+ +.++|+|||.+....
T Consensus 184 -~-~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 -D-GKVVIIDVSQSVELD 199 (237)
T ss_pred -C-CCEEEEEChhhhccC
Confidence 4 689999999987543
No 415
>PRK12274 serine/threonine protein kinase; Provisional
Probab=99.88 E-value=1.1e-21 Score=158.84 Aligned_cols=136 Identities=16% Similarity=0.155 Sum_probs=108.3
Q ss_pred ecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecCceEEEEEccC
Q 021127 28 VGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEPVMVIVTELLS 106 (317)
Q Consensus 28 ~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~lv~e~~~ 106 (317)
+...|++|+||+||.+...+.+++.+.+........ ......+.+|+++|++|. |+++++++++ +..+++|||+.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~-~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLR-GVAWWLARREALALRQLDGLPRTPRLLHW---DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhh-hHHHHHHHHHHHHHHhcCCCCCCCEEEEE---cCEEEEEeeec
Confidence 567899999999998888889998887765443211 112336889999999994 5889999886 34799999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCcEEeeCCCCceEEcccCcccccc
Q 021127 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDL-KPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 107 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dl-kp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
|.+|.+.+.. . ...++.|++.+|+++|++||+|||| ||+|||++.+ +.++|+|||++....
T Consensus 82 G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~-g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 82 GAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQED-GSPAVIDFQLAVRGN 143 (218)
T ss_pred CccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCC-CCEEEEECCCceecC
Confidence 9998754321 1 1357889999999999999999999 7999999987 789999999998443
No 416
>PRK14879 serine/threonine protein kinase; Provisional
Probab=99.87 E-value=4e-21 Score=159.80 Aligned_cols=138 Identities=28% Similarity=0.384 Sum_probs=112.8
Q ss_pred ceeccccceEEEEeEECCeEEEEEEeecCCChH---HHHHHHHHHHHHHHHHHhcCCCCeeeEEeee-ecCceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPE---EIAKKESRFAREVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~lv~e~~ 105 (317)
+.||+|++|.||+|.+.+..|++|+........ .......++.+|+.++..+.|++++....++ .....++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 578999999999999999999999866433211 1112335688899999999998886655554 345788999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
+|++|.+++... .. .+..++.+++.+|.++|+.|++|+|++|+||+++ + +.++|+|||.+..
T Consensus 82 ~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~-~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G-GKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C-CCEEEEECCcccC
Confidence 999999988652 22 7888999999999999999999999999999999 4 6899999999875
No 417
>TIGR03724 arch_bud32 Kae1-associated kinase Bud32. Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.
Probab=99.85 E-value=9.7e-21 Score=156.06 Aligned_cols=134 Identities=25% Similarity=0.360 Sum_probs=106.4
Q ss_pred eeccccceEEEEeEECCeEEEEEEeecCCCh---HHHHHHHHHHHHHHHHHHhcCCCCee--eEEeeeecCceEEEEEcc
Q 021127 31 RIGEGAHAKVYEGKYKNQTVAIKIVHKGETP---EEIAKKESRFAREVAMLSRVQHRNLV--KFIGACKEPVMVIVTELL 105 (317)
Q Consensus 31 ~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv--~l~~~~~~~~~~lv~e~~ 105 (317)
.||+|+||.||+|.+.+..|++|........ .+......++.+|++++..+.|+++. .++.. .+...++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-DPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-ECCCCEEEEEEE
Confidence 4799999999999999999999986643321 11222345678999999999887643 44433 344678999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
+|++|.+++.... . .++.+++.+|.+||+.|++|+|++|+||+++ + +.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~-~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D-DKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C-CcEEEEECCCCcCC
Confidence 9999999876421 1 7899999999999999999999999999999 4 68999999998753
No 418
>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated
Probab=99.85 E-value=9.9e-21 Score=178.25 Aligned_cols=148 Identities=23% Similarity=0.341 Sum_probs=116.3
Q ss_pred CceeecCCce---eecceeccccceEEEEeEECCeEEEEEEeecCCCh-H--HHHHHHHHHHHHHHHHHhcCCCCeeeEE
Q 021127 17 AKWLIDPKHL---FVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETP-E--EIAKKESRFAREVAMLSRVQHRNLVKFI 90 (317)
Q Consensus 17 ~~~~i~~~~y---~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~-~--~~~~~~~~~~~E~~~l~~l~h~niv~l~ 90 (317)
..|..+.... ...++||+|+||+||+|.+.+..+++|+....... . .......++.+|++++..++|++++...
T Consensus 323 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 402 (535)
T PRK09605 323 VTWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV 402 (535)
T ss_pred eeeccccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence 3466666543 34889999999999999998777777654332211 1 1112345688999999999999998776
Q ss_pred eeeec-CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcc
Q 021127 91 GACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (317)
Q Consensus 91 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~D 169 (317)
.++.+ ...++||||++|++|.+++. ....++.+++.+|.+||+.|++||||||+||+++ + +.++|+|
T Consensus 403 ~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~-~~~~liD 470 (535)
T PRK09605 403 IYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-D-DRLYLID 470 (535)
T ss_pred EEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-C-CcEEEEe
Confidence 66544 46789999999999999885 2467899999999999999999999999999995 3 5899999
Q ss_pred cCccccc
Q 021127 170 FGLAREE 176 (317)
Q Consensus 170 fg~a~~~ 176 (317)
||+++..
T Consensus 471 FGla~~~ 477 (535)
T PRK09605 471 FGLGKYS 477 (535)
T ss_pred CcccccC
Confidence 9999764
No 419
>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]
Probab=99.84 E-value=7.8e-22 Score=161.49 Aligned_cols=227 Identities=25% Similarity=0.436 Sum_probs=175.3
Q ss_pred ecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
|+-+++.+.-+|.....|..|+|++.|..+++|++...... .+..++|.+|.-.|+-+.||||..++|.|..+ ...
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t---~risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVT---ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcc---hhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 56677778889999999999999999999999998766543 34556799999999999999999999999876 889
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-Ccccc-CCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHR-DLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~-Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
++..||+.|+|+..|.....-..+..++.+++.++++|++|||+. .++-| -|....++|+++. +.+|+- +-+++.-
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarism-ad~kfsf 341 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISM-ADTKFSF 341 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheec-ccceeee
Confidence 999999999999999987766688899999999999999999997 34444 6888899999984 666642 2122111
Q ss_pred cccccccccCccceeccccccccccccc--ccccccC-----------------------------CCCCCCCCCChHHH
Q 021127 178 LTEMMTAETGTYRWMAPELYSTVTLRQG--EKKHYNH-----------------------------KNVRPSAENVPEEL 226 (317)
Q Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~~~~~~~-----------------------------~~~~~~~~~~~~~l 226 (317)
........+.||+||.+....-+.. ..+.|+. +.....|++++..+
T Consensus 342 ---qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm 418 (448)
T KOG0195|consen 342 ---QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHM 418 (448)
T ss_pred ---eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHH
Confidence 1122345789999998765332211 1111111 12223477889999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
..||.-|++.||.+||.++.++-.|+++.
T Consensus 419 ~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 419 NKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 99999999999999999999998887653
No 420
>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom
Probab=99.84 E-value=2.8e-20 Score=153.16 Aligned_cols=141 Identities=23% Similarity=0.226 Sum_probs=109.0
Q ss_pred ceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChH-----------------HHHHHHHHHHHHHHHHHhcCCC--
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPE-----------------EIAKKESRFAREVAMLSRVQHR-- 84 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~-----------------~~~~~~~~~~~E~~~l~~l~h~-- 84 (317)
.|.+.+.||+|+||.||++... ++.||||+++...... ........+..|+.++..+.|.
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 3788899999999999999884 8999999987543110 0011223467789999988777
Q ss_pred CeeeEEeeeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCc
Q 021127 85 NLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 164 (317)
Q Consensus 85 niv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~ 164 (317)
.++..++ ....++||||++|++|...... .....++.+++.++.++|+.|++||||+|+||+++.+ +.
T Consensus 96 ~v~~~~~---~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~-~~ 163 (198)
T cd05144 96 PVPKPID---WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD-EK 163 (198)
T ss_pred CCCceee---cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC-Cc
Confidence 4455444 2456899999999998765421 2356788999999999999999999999999999987 69
Q ss_pred eEEcccCcccccc
Q 021127 165 IKLADFGLAREES 177 (317)
Q Consensus 165 ~kl~Dfg~a~~~~ 177 (317)
++|+|||++....
T Consensus 164 ~~liDfg~~~~~~ 176 (198)
T cd05144 164 IYIIDWPQMVSTD 176 (198)
T ss_pred EEEEECCccccCC
Confidence 9999999996443
No 421
>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]
Probab=99.83 E-value=2.7e-19 Score=157.39 Aligned_cols=222 Identities=29% Similarity=0.455 Sum_probs=169.3
Q ss_pred eeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCC-CeeeEEeeeecC-ceEEEEE
Q 021127 26 LFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR-NLVKFIGACKEP-VMVIVTE 103 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~-~~~lv~e 103 (317)
|.+.+.||.|+||.||++.+. ..+++|.+........ .....+.+|+.++..+.|+ +++++++.+... ..+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS--KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch--hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 778899999999999999888 7889999887655432 2355789999999999988 799999999655 4699999
Q ss_pred ccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc--
Q 021127 104 LLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-- 180 (317)
Q Consensus 104 ~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-- 180 (317)
++.+++|.+++..... ..++......++.|++.++.|+|+.+++|||+||+||+++.....++++|||.++......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999999977765431 1489999999999999999999999999999999999999873269999999997443222
Q ss_pred -----ccccccCccceecccccccc--cccccccccccCC----------------C---------------CCC-C---
Q 021127 181 -----MMTAETGTYRWMAPELYSTV--TLRQGEKKHYNHK----------------N---------------VRP-S--- 218 (317)
Q Consensus 181 -----~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~~----------------~---------------~~~-~--- 218 (317)
......|+..|+|||.+.+. .......+.|..+ . ..+ .
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 23566799999999987753 1222111211100 0 000 0
Q ss_pred -CCCC----hHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 219 -AENV----PEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 219 -~~~~----~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.... ...+.+++..|+..+|..|.+..+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0011 1468899999999999999998887765
No 422
>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed
Probab=99.82 E-value=1.2e-19 Score=153.01 Aligned_cols=155 Identities=20% Similarity=0.216 Sum_probs=114.5
Q ss_pred eecCCceeecCCceee-cceec-cccceEEEEeEECCeEEEEEEeecCCChHH--------HHHHHHHHHHHHHHHHhcC
Q 021127 13 LKLDAKWLIDPKHLFV-GPRIG-EGAHAKVYEGKYKNQTVAIKIVHKGETPEE--------IAKKESRFAREVAMLSRVQ 82 (317)
Q Consensus 13 ~~~~~~~~i~~~~y~~-~~~lG-~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~~~~~E~~~l~~l~ 82 (317)
+..+..+..+++.+.. ...|| .||.|+||.+...+..+|||.+.....-.. ......++.+|++++.++.
T Consensus 19 ~~~~~~~~~~~~~~~~~~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~ 98 (239)
T PRK01723 19 LRDPDPALFDPDFWQQQARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY 98 (239)
T ss_pred cCCCchhhcCHHHHhhcCceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH
Confidence 3444444555544433 34577 899999999988899999998865321100 0123456889999999998
Q ss_pred CCCe--eeEEeeeec--C---ceEEEEEccCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 021127 83 HRNL--VKFIGACKE--P---VMVIVTELLSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 154 (317)
Q Consensus 83 h~ni--v~l~~~~~~--~---~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~ 154 (317)
|++| ++.+++... . ..++|||+++| .+|.+++... .+++.. +.+++.+|.+||++||+||||||.
T Consensus 99 ~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~ 171 (239)
T PRK01723 99 EAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVYHADLNAH 171 (239)
T ss_pred hCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCCCCCCCch
Confidence 8775 677776432 2 23599999997 6999888652 255543 578999999999999999999999
Q ss_pred cEEeeCCCCceEEcccCcccc
Q 021127 155 NLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 155 Nill~~~~~~~kl~Dfg~a~~ 175 (317)
|||++.+ +.++|+|||.++.
T Consensus 172 NILv~~~-~~v~LIDfg~~~~ 191 (239)
T PRK01723 172 NILLDPD-GKFWLIDFDRGEL 191 (239)
T ss_pred hEEEcCC-CCEEEEECCCccc
Confidence 9999987 6899999998865
No 423
>smart00750 KIND kinase non-catalytic C-lobe domain. It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features
Probab=99.82 E-value=5.5e-20 Score=148.44 Aligned_cols=134 Identities=21% Similarity=0.209 Sum_probs=102.3
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccccccccC
Q 021127 108 GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 187 (317)
Q Consensus 108 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g 187 (317)
|+|.+++...+ ..+++..++.|+.|++.||+|||+++ ||+||+++.+ +.+|+ ||+++..... ...|
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~-~~~~~--fG~~~~~~~~----~~~g 66 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWD-GLLKL--DGSVAFKTPE----QSRV 66 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCc-cceee--ccceEeeccc----cCCC
Confidence 68999998643 34999999999999999999999998 9999999988 68888 9999765432 2368
Q ss_pred ccceecccccccccccccccccccCC--------CC--------------------C-------CCCCCChH--HHHHHH
Q 021127 188 TYRWMAPELYSTVTLRQGEKKHYNHK--------NV--------------------R-------PSAENVPE--ELSIIL 230 (317)
Q Consensus 188 t~~y~aPE~~~~~~~~~~~~~~~~~~--------~~--------------------~-------~~~~~~~~--~l~~li 230 (317)
|+.|+|||++.+..+.. ..++|+.+ .. . +.+..++. ++.+++
T Consensus 67 ~~~y~aPE~~~~~~~~~-~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 67 DPYFMAPEVIQGQSYTE-KADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred cccccChHHhcCCCCcc-hhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 89999999987654432 33333322 00 0 01112223 689999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 231 TSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 231 ~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
.+||..||.+||++.+++++++....
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHHH
Confidence 99999999999999999999887654
No 424
>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=99.80 E-value=4.7e-19 Score=170.65 Aligned_cols=234 Identities=23% Similarity=0.300 Sum_probs=162.9
Q ss_pred eecCCceeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC---CCCeee
Q 021127 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ---HRNLVK 88 (317)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~ 88 (317)
++....+.+..+.|.|.+.||.|+||+||+|... ++.||||+-+.....+ |.--..++.+|+ -+.|..
T Consensus 687 l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE--------fYI~~q~~~RLk~~~~~~~~~ 758 (974)
T KOG1166|consen 687 LNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE--------FYICLQVMERLKPQMLPSIMH 758 (974)
T ss_pred cCccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee--------eeehHHHHHhhchhhhcchHH
Confidence 4455577888999999999999999999999875 8999999987776654 222233444444 122333
Q ss_pred EEeee-ecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC------C
Q 021127 89 FIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE------D 161 (317)
Q Consensus 89 l~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~------~ 161 (317)
+.... ..+..++|+||.+.|+|.+++...+ .+++.-+..+..|++..++.||..+|||+||||+|+||.. +
T Consensus 759 ~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~--~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~ 836 (974)
T KOG1166|consen 759 ISSAHVFQNASVLVSEYSPYGTLLDLINTNK--VMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSD 836 (974)
T ss_pred HHHHHccCCcceeeeeccccccHHHhhccCC--CCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCc
Confidence 33222 2456889999999999999998444 4999999999999999999999999999999999999953 2
Q ss_pred CCceEEcccCcccccc---cccccccccCccceeccccccccccccccc-----------------ccccCCCCCCCCCC
Q 021127 162 LKTIKLADFGLAREES---LTEMMTAETGTYRWMAPELYSTVTLRQGEK-----------------KHYNHKNVRPSAEN 221 (317)
Q Consensus 162 ~~~~kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~ 221 (317)
.-.++|+|||.+.... ........++|..+-.+|+..+..+.-..+ ..+..... ....+
T Consensus 837 ~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~~~g~~~-~~~~~ 915 (974)
T KOG1166|consen 837 SKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEVKNGSSW-MVKTN 915 (974)
T ss_pred ccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHhcCCcce-ecccc
Confidence 2358999999987432 222335567888999999877643321110 11111111 11122
Q ss_pred Ch----HH-HHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 222 VP----EE-LSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 222 ~~----~~-l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
++ .+ ..+|...+|+.|-..=|...++...++.++..
T Consensus 916 ~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 916 FPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred chhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 33 23 34677888884444458888888887776643
No 425
>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]
Probab=99.80 E-value=1.4e-19 Score=155.43 Aligned_cols=167 Identities=25% Similarity=0.361 Sum_probs=121.4
Q ss_pred CCCCeeeEEeeeec----------------------------CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHH
Q 021127 82 QHRNLVKFIGACKE----------------------------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133 (317)
Q Consensus 82 ~h~niv~l~~~~~~----------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ 133 (317)
+|||||++.+.|.+ ..+|+||... ..+|..++..+. .+.....-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence 59999999876511 2589999888 469999998654 677778889999
Q ss_pred HHHHHHHHHhCCccccCCCCCcEEeeCC---CCceEEcccCccccccc-------ccccccccCccceeccccccccccc
Q 021127 134 IARAMECLHSHGIIHRDLKPENLLLTED---LKTIKLADFGLAREESL-------TEMMTAETGTYRWMAPELYSTVTLR 203 (317)
Q Consensus 134 i~~~L~~lH~~~ivH~Dlkp~Nill~~~---~~~~kl~Dfg~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~ 203 (317)
+++|+.|||.+||.|||+|.+|||+.-+ --.+.|+|||.+--... ........|.-.-||||+.....-.
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 9999999999999999999999999532 12578999998742221 1222334577889999987653211
Q ss_pred c-----cc-----------------cccc------------cCCCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 021127 204 Q-----GE-----------------KKHY------------NHKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 249 (317)
Q Consensus 204 ~-----~~-----------------~~~~------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~ 249 (317)
. ++ .++| ......+.++.+|..+++++...|+.||.+|++..-..+
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHh
Confidence 1 11 1111 122345567889999999999999999999998766555
Q ss_pred HHH
Q 021127 250 MLL 252 (317)
Q Consensus 250 ~l~ 252 (317)
.+.
T Consensus 510 vl~ 512 (598)
T KOG4158|consen 510 VLN 512 (598)
T ss_pred HHH
Confidence 443
No 426
>cd05119 RIO RIO kinase family, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct
Probab=99.79 E-value=1.5e-18 Score=141.60 Aligned_cols=141 Identities=28% Similarity=0.318 Sum_probs=99.0
Q ss_pred ecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHH-------------------HHHHHHHHHHHHhcCCC--C
Q 021127 28 VGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKK-------------------ESRFAREVAMLSRVQHR--N 85 (317)
Q Consensus 28 ~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~-------------------~~~~~~E~~~l~~l~h~--n 85 (317)
+.+.||+|+||+||+|.+. ++.||||++............ ......|...+.++.+. .
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 3578999999999999887 899999998764322110000 00113456666666433 3
Q ss_pred eeeEEeeeecCceEEEEEccCCCCHHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCC
Q 021127 86 LVKFIGACKEPVMVIVTELLSGGTLRK-YLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLK 163 (317)
Q Consensus 86 iv~l~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~ 163 (317)
+.+.+++ ...++||||++++.+.. .+.... .. ..+..++.+++.++.++|. .||+|+||||+||+++ + +
T Consensus 81 ~~~~~~~---~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~-~ 151 (187)
T cd05119 81 VPKPIDL---NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D-G 151 (187)
T ss_pred CCceEec---CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C-C
Confidence 4454443 24689999999854322 122111 11 5678899999999999999 9999999999999999 5 6
Q ss_pred ceEEcccCcccccc
Q 021127 164 TIKLADFGLAREES 177 (317)
Q Consensus 164 ~~kl~Dfg~a~~~~ 177 (317)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 89999999997543
No 427
>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]
Probab=99.78 E-value=7.6e-20 Score=173.96 Aligned_cols=220 Identities=18% Similarity=0.223 Sum_probs=158.5
Q ss_pred ceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEEEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTE 103 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e 103 (317)
++...+.||++.|=+|.+|++....|+||++-+....-......++ ++|++ ...+++||++++..+... ...|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qr-L~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQR-LEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHH-HHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 7889999999999999999998767999999877654433333333 44455 556799999998877654 46788888
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc----
Q 021127 104 LLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT---- 179 (317)
Q Consensus 104 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~---- 179 (317)
|. .-+|++.|..+.- +..-+..+|+.|++.||.-+|..||+|||||.+||||+.- +.+.|+||..-+.....
T Consensus 102 yv-khnLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSW-NW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YV-KHNLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSW-NWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HH-hhhhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeee-chhhhhcccccCCccCCCCCc
Confidence 88 5699999876433 7778888999999999999999999999999999999987 68999999876632111
Q ss_pred -c---ccccccCccceeccccccccc-cc---------ccccccccCC--------C-C-----------CCCCC-----
Q 021127 180 -E---MMTAETGTYRWMAPELYSTVT-LR---------QGEKKHYNHK--------N-V-----------RPSAE----- 220 (317)
Q Consensus 180 -~---~~~~~~gt~~y~aPE~~~~~~-~~---------~~~~~~~~~~--------~-~-----------~~~~~----- 220 (317)
+ ...+...-..|+|||-|.... .. ....++++.+ . . +....
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~ 257 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQ 257 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHH
Confidence 1 112222345799999875522 11 1111222221 0 0 00000
Q ss_pred ----CChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 221 ----NVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 221 ----~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
--...+++++..|++.||.+|.++++.++.
T Consensus 258 ~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 258 LLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 112368999999999999999999999875
No 428
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=99.76 E-value=2.2e-19 Score=162.63 Aligned_cols=202 Identities=25% Similarity=0.355 Sum_probs=159.0
Q ss_pred eeccccceEEEEeE-----ECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecC-ceEEEEE
Q 021127 31 RIGEGAHAKVYEGK-----YKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP-VMVIVTE 103 (317)
Q Consensus 31 ~lG~G~~g~V~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~~~lv~e 103 (317)
.+|+|+||.|++++ +.+..+|+|++.+....... ......|..++..++ ||.++++...++.+ ..+++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~---~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld 77 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRD---RTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD 77 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccc---ccccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence 37999999999743 34788999988765443211 114556778888886 99999999888754 8999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccccc
Q 021127 104 LLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT 183 (317)
Q Consensus 104 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~ 183 (317)
+..||+|...+.+... +++.....+...++-+++++|+.+++|||+|++||+++.+ |.+++.|||+++..-..+..
T Consensus 78 ~~rgg~lft~l~~~~~--f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~-Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKEVM--FDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLE-GHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred hcccchhhhccccCCc--hHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeeccc-CccccCCchhhhHhHhhhhc-
Confidence 9999999998876554 8888888899999999999999999999999999999999 89999999999865444332
Q ss_pred cccCccceecccccccccccccccccccCC-----------------------CCCCCCCCChHHHHHHHHHhhhcCCCC
Q 021127 184 AETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------NVRPSAENVPEELSIILTSCWKEDPNA 240 (317)
Q Consensus 184 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~l~~li~~cl~~~p~~ 240 (317)
|||..|||||++.+ .....++|..+ .....+..++..+++++..++..+|..
T Consensus 154 --cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~n 228 (612)
T KOG0603|consen 154 --CGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGGDTMKRILKAELEMPRELSAEARSLFRQLFKRNPEN 228 (612)
T ss_pred --ccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCchHHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHH
Confidence 99999999999883 23334444432 123345667778899999999999999
Q ss_pred CCCH
Q 021127 241 RPNF 244 (317)
Q Consensus 241 Rps~ 244 (317)
|-..
T Consensus 229 rLg~ 232 (612)
T KOG0603|consen 229 RLGA 232 (612)
T ss_pred Hhcc
Confidence 9644
No 429
>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family. The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves
Probab=99.76 E-value=9.1e-18 Score=131.54 Aligned_cols=132 Identities=23% Similarity=0.267 Sum_probs=110.7
Q ss_pred ecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC--CCeeeEEeeeec-CceEEEEEc
Q 021127 28 VGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH--RNLVKFIGACKE-PVMVIVTEL 104 (317)
Q Consensus 28 ~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~-~~~~lv~e~ 104 (317)
+.+.||.|.++.||++...+..+++|....... ...+.+|+..+..+.| .++++++++... +..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc-------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 457799999999999999888999999866543 2357889999999976 588999887764 478999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 105 LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH---GIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 105 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
+.++.+..+ +......++.+++.+|++||.. +++|+|++|+||+++.. +.++++|||.+...
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~-~~~~l~Df~~~~~~ 139 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG-KILGIIDWEYAGYG 139 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC-cEEEEEecccccCC
Confidence 988777653 4566777899999999999985 79999999999999986 68999999998754
No 430
>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A.
Probab=99.73 E-value=1.4e-17 Score=141.76 Aligned_cols=211 Identities=18% Similarity=0.257 Sum_probs=127.3
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC----------CCeeeEEee
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH----------RNLVKFIGA 92 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~ 92 (317)
.+..++.||.|+++.||.+++. ++.+|||++....... ....+.+.+|.-....+.+ -.++.-++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~--~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADAS--ANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTH--TTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccc--hHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 4567888999999999999996 6999999988766332 2345556666544443321 111111111
Q ss_pred e---------e---cC------ceEEEEEccCCCCHHHHHHh---cCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 021127 93 C---------K---EP------VMVIVTELLSGGTLRKYLLN---MRPR--CLDVCVAIGFALDIARAMECLHSHGIIHR 149 (317)
Q Consensus 93 ~---------~---~~------~~~lv~e~~~~g~L~~~l~~---~~~~--~l~~~~~~~i~~~i~~~L~~lH~~~ivH~ 149 (317)
. . +. ..+++|+-+ .++|.+++.. .... .+....++.+..|++..+++||+.|+||+
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg 169 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG 169 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence 1 1 11 246788888 6799888653 2211 13344556777999999999999999999
Q ss_pred CCCCCcEEeeCCCCceEEcccCcccccccccccccccCccceeccccccccc-------ccccccccccCC---------
Q 021127 150 DLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVT-------LRQGEKKHYNHK--------- 213 (317)
Q Consensus 150 Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~~~~~~~~--------- 213 (317)
||+|+|++++.+ |.++|+||+.....+..... ...+..|.+||...... ......+.|..+
T Consensus 170 di~~~nfll~~~-G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 170 DIKPENFLLDQD-GGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp T-SGGGEEE-TT-S-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ccceeeEEEcCC-CCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999 89999999887654433222 34457788998653320 001111111111
Q ss_pred --------------CCCCCCCCChHHHHHHHHHhhhcCCCCC
Q 021127 214 --------------NVRPSAENVPEELSIILTSCWKEDPNAR 241 (317)
Q Consensus 214 --------------~~~~~~~~~~~~l~~li~~cl~~~p~~R 241 (317)
.....+.++|+.++.||..+|+.||.+|
T Consensus 247 ~lPf~~~~~~~~~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEWDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 0122344889999999999999999988
No 431
>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase. This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.
Probab=99.64 E-value=1.8e-15 Score=138.47 Aligned_cols=143 Identities=23% Similarity=0.285 Sum_probs=99.4
Q ss_pred ceeccccceEEEEeEEC-CeEEEEEEeecCCChHHH-----------------------------------HHHHHHHHH
Q 021127 30 PRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEI-----------------------------------AKKESRFAR 73 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~-----------------------------------~~~~~~~~~ 73 (317)
+.||+|++|.||+|+.. |+.||||+.+......-. ...+-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 56999999999999985 899999998754321100 001123556
Q ss_pred HHHHHHhcC----CCCeeeEEeeee--cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHHHhCCc
Q 021127 74 EVAMLSRVQ----HRNLVKFIGACK--EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR-AMECLHSHGI 146 (317)
Q Consensus 74 E~~~l~~l~----h~niv~l~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~-~L~~lH~~~i 146 (317)
|...+.++. +.+-+.+-.++. ....++||||++|++|.+....... ..+ ...++..++. .+..+|..|+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 666666652 333333333332 2357999999999999887653221 122 3445666655 4788999999
Q ss_pred cccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 147 IHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 147 vH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
+|+|++|+||+++.+ +.++++|||++...+
T Consensus 279 ~H~D~hPgNilv~~~-g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKD-GKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCC-CcEEEEeCCCeeECC
Confidence 999999999999888 789999999997654
No 432
>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]
Probab=99.64 E-value=4.9e-16 Score=140.57 Aligned_cols=177 Identities=33% Similarity=0.500 Sum_probs=132.7
Q ss_pred HhcCCCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-cccCCCCCcE
Q 021127 79 SRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI-IHRDLKPENL 156 (317)
Q Consensus 79 ~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i-vH~Dlkp~Ni 156 (317)
+.+.|.|+.+++|.+.++ ..++|.+||..|+|.+.+.... ..+++.....++++|+.||+|+|+..| .|+.++..|+
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 567899999999998665 8889999999999999998733 348899999999999999999999866 9999999999
Q ss_pred EeeCCCCceEEcccCcccccccc---cccccccCccceeccccccccccc------ccccccccCC--------------
Q 021127 157 LLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLR------QGEKKHYNHK-------------- 213 (317)
Q Consensus 157 ll~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~------~~~~~~~~~~-------------- 213 (317)
+++.. ..+||+|||+....... .......-..-|.|||++...... ....+.|+.+
T Consensus 81 lvd~~-w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 81 LVDSR-WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred eeeee-EEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 99998 58999999998765321 111111234579999987763111 1111111111
Q ss_pred ---------------------CCCCC---CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 214 ---------------------NVRPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 214 ---------------------~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
..+|. ....++++..++.+||..+|.+||+++++...+......
T Consensus 160 ~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 160 LRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 11221 114456789999999999999999999998887776654
No 433
>cd05151 ChoK Choline Kinase (ChoK). The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph
Probab=99.62 E-value=3e-15 Score=120.00 Aligned_cols=129 Identities=22% Similarity=0.225 Sum_probs=96.9
Q ss_pred cceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCC-eeeEEeeeecCceEEEEEccCC
Q 021127 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN-LVKFIGACKEPVMVIVTELLSG 107 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~lv~e~~~~ 107 (317)
.+.|+.|.++.||+++..+..|++|+....... ...+..|+.++..+.+.+ +++++++.. ...++||||++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~------~~~~~~E~~~l~~l~~~~~~P~~~~~~~-~~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL------LINRENEAENSKLAAEAGIGPKLYYFDP-ETGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCccc------ccCHHHHHHHHHHHHHhCCCCceEEEeC-CCCeEEEEecCC
Confidence 356889999999999999999999987654321 113567888888885444 445555543 345799999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----cccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 108 GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI-----IHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 108 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i-----vH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
.++... . .. ...++.+++.+|+.||+.++ +|+|++|+||+++ + +.++++|||.+...
T Consensus 76 ~~l~~~--~-----~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~-~~~~liDf~~a~~~ 137 (170)
T cd05151 76 SELLTE--D-----FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D-GRLWLIDWEYAGMN 137 (170)
T ss_pred Cccccc--c-----cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C-CeEEEEecccccCC
Confidence 887643 0 11 12356899999999999985 9999999999999 4 57999999998743
No 434
>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.
Probab=99.58 E-value=3.6e-14 Score=114.85 Aligned_cols=141 Identities=17% Similarity=0.161 Sum_probs=101.0
Q ss_pred cceeccccceEEEEeEEC--------CeEEEEEEeecCCChH-----HH------------HHHHHHHH----HHHHHHH
Q 021127 29 GPRIGEGAHAKVYEGKYK--------NQTVAIKIVHKGETPE-----EI------------AKKESRFA----REVAMLS 79 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~--------~~~vaiK~~~~~~~~~-----~~------------~~~~~~~~----~E~~~l~ 79 (317)
...||.|-=+.||.|... +..+|||+++.....- .. ...+..+. +|++.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 356899999999999764 3689999876422110 00 00122233 7999999
Q ss_pred hcC--CCCeeeEEeeeecCceEEEEEccCCCCHHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCc
Q 021127 80 RVQ--HRNLVKFIGACKEPVMVIVTELLSGGTLRK-YLLNMRPRCLDVCVAIGFALDIARAMECL-HSHGIIHRDLKPEN 155 (317)
Q Consensus 80 ~l~--h~niv~l~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~l~~~~~~~i~~~i~~~L~~l-H~~~ivH~Dlkp~N 155 (317)
++. .-++++.+++ ...++||||+.++.+.. .+.+ ..++......+..+++.+|..| |+.|+||+||++.|
T Consensus 82 rl~~~Gv~vP~pi~~---~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 82 RMQKAGIPCPEVVVL---KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHHcCCCCCeEEEe---cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 884 3567777765 45789999997654432 2322 1256667778889999999999 89999999999999
Q ss_pred EEeeCCCCceEEcccCcccccc
Q 021127 156 LLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 156 ill~~~~~~~kl~Dfg~a~~~~ 177 (317)
|++.. +.++|+|||.+....
T Consensus 156 IL~~~--~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWHD--GKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEEC--CcEEEEECCCceeCC
Confidence 99985 479999999886543
No 435
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=99.57 E-value=2.4e-15 Score=143.39 Aligned_cols=175 Identities=31% Similarity=0.430 Sum_probs=119.5
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCceEE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVI 100 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 100 (317)
..+|..++.+-.|++|.||..+++ .+++|+|+ .+... +++- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l----------ilRn--ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL----------ILRN--ILTFAGNPFVV------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch----------hhhc--cccccCCccee-------------
Confidence 367889999999999999999886 78899954 22211 2221 23223344444
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
|+-...+...+. ++... +.+++|||+.||+|||+||+|.+|+.- |.+|++|||+.+.....
T Consensus 136 -------gDc~tllk~~g~--lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~m-GhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGP--LPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSM-GHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred -------chhhhhcccCCC--Ccchh--------hHHhHhhccCCeecCCCCCCcceeeec-ccccccchhhhhhhhhhc
Confidence 555555655444 33322 788999999999999999999999987 89999999998732111
Q ss_pred --------------c-ccccccCccceecccccccccccccccccccCC------------------------------C
Q 021127 180 --------------E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------N 214 (317)
Q Consensus 180 --------------~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~ 214 (317)
. .....+||+.|+|||++....+... .+||..+ .
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkp-vdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~ 276 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 276 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCC-ccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence 0 1123479999999999765433222 2222211 1
Q ss_pred CCCCCCCChHHHHHHHHHhhhcCCCCCC
Q 021127 215 VRPSAENVPEELSIILTSCWKEDPNARP 242 (317)
Q Consensus 215 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp 242 (317)
.......++.++++++.++|+.+|..|-
T Consensus 277 wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 277 WPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 1222456789999999999999999994
No 436
>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]
Probab=99.55 E-value=1.3e-13 Score=107.62 Aligned_cols=148 Identities=24% Similarity=0.310 Sum_probs=111.5
Q ss_pred ecceeccccceEEEEeEECCeEEEEEEeecCC---ChHHHHHHHHHHHHHHHHHHhcCCCCe--eeEEeeeecCceEEEE
Q 021127 28 VGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGE---TPEEIAKKESRFAREVAMLSRVQHRNL--VKFIGACKEPVMVIVT 102 (317)
Q Consensus 28 ~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~~~lv~ 102 (317)
....+-+|+=+.|+++.+.|+.++||.-.... ..-+..-...+..+|++.+.++.--.| ++++ +++...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~-~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLI-FIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEE-EEecCCCeEEE
Confidence 45667899999999999999999999654322 222333446678899999988853333 3333 33444567899
Q ss_pred EccCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCce--EEcccCccccc
Q 021127 103 ELLSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI--KLADFGLAREE 176 (317)
Q Consensus 103 e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~--kl~Dfg~a~~~ 176 (317)
||++| .++.+++..........+....++..|-+.+.-||.++|||+||..+||++..+.+.+ .++|||++...
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99976 4888888876554444555588999999999999999999999999999998775555 89999998754
No 437
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.55 E-value=1e-15 Score=144.47 Aligned_cols=225 Identities=20% Similarity=0.303 Sum_probs=168.0
Q ss_pred cCCceeecceeccccceEEEEeEEC---CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecC-
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP- 96 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~- 96 (317)
....|.+.+-||+|+|+.|-..... ...+|+|.+....... ........|..+-..+. |.|++++++...+.
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~---~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~ 94 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSE---DSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR 94 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCcc---chhhhcCccccccccccccccccccCCccCCCc
Confidence 3467888888999999999877653 4556777665543111 11223445777777776 99999999998776
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCcEEeeCCCC-ceEEcccCccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH-SHGIIHRDLKPENLLLTEDLK-TIKLADFGLAR 174 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH-~~~ivH~Dlkp~Nill~~~~~-~~kl~Dfg~a~ 174 (317)
..++++++..|+++...+........+....-.++.|+..++.|+| ..++.|+||||+|.+++.. + ..++.|||+|.
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s-~~~l~~~df~~At 173 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDES-GSALKIADFGLAT 173 (601)
T ss_pred ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccC-CCcccCCCchhhc
Confidence 7889999999999999883222213777888889999999999999 9999999999999999988 5 89999999998
Q ss_pred cccc----ccccccccC-ccceecccccccccccccccccccCCC--------------------------------CCC
Q 021127 175 EESL----TEMMTAETG-TYRWMAPELYSTVTLRQGEKKHYNHKN--------------------------------VRP 217 (317)
Q Consensus 175 ~~~~----~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~~~~~~~~--------------------------------~~~ 217 (317)
.... .......+| ++.|+|||.+.+........+.|..+. ...
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQL 253 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccC
Confidence 5433 223345578 999999999887544444444443330 112
Q ss_pred CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
....++....+++.+++..+|..|.+.+++...
T Consensus 254 ~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 254 PWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ccccCChhhhhcccccccCCchhcccccccccc
Confidence 234566788899999999999999999887544
No 438
>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed
Probab=99.54 E-value=3.4e-14 Score=131.69 Aligned_cols=144 Identities=18% Similarity=0.228 Sum_probs=93.4
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChH-----------------------------HH------HHH
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPE-----------------------------EI------AKK 67 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~-----------------------------~~------~~~ 67 (317)
+|.. +.||+|++|.||+|+.. |+.||||+.+...... .. ...
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3444 68999999999999884 8999999998653110 00 111
Q ss_pred HHHHHHHHHHHHhcC----CCCeeeEEeeee--cCceEEEEEccCCCCHHHHH--HhcCCC--CCCHHHHHHHHHHHHHH
Q 021127 68 ESRFAREVAMLSRVQ----HRNLVKFIGACK--EPVMVIVTELLSGGTLRKYL--LNMRPR--CLDVCVAIGFALDIARA 137 (317)
Q Consensus 68 ~~~~~~E~~~l~~l~----h~niv~l~~~~~--~~~~~lv~e~~~~g~L~~~l--~~~~~~--~l~~~~~~~i~~~i~~~ 137 (317)
+-+|.+|...+.++. +.+.+.+=.++. ....++||||+.|+++.+.- ...+.. .+.+..+..++.|
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q---- 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ---- 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH----
Confidence 223455555555552 333343333333 24688999999999998743 222110 1223333333333
Q ss_pred HHHHHhCCccccCCCCCcEEeeCCCC----ceEEcccCcccccc
Q 021127 138 MECLHSHGIIHRDLKPENLLLTEDLK----TIKLADFGLAREES 177 (317)
Q Consensus 138 L~~lH~~~ivH~Dlkp~Nill~~~~~----~~kl~Dfg~a~~~~ 177 (317)
++..|++|+|+||+||+++.+ + +++++|||++...+
T Consensus 276 ---if~~GffHaDpHPGNIlv~~~-g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 ---VFRDGFFHADMHPGNIFVSYD-PPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ---HHhCCeeeCCCChHHeEEecC-CCCCCeEEEEecceEEECC
Confidence 446899999999999999987 5 89999999987543
No 439
>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.53 E-value=2.7e-13 Score=106.37 Aligned_cols=136 Identities=23% Similarity=0.306 Sum_probs=103.7
Q ss_pred ceeccccceEEEEeEECCeEEEEEEeecCCCh---HHHHHHHHHHHHHHHHHHhcCC--CCeeeEEeeeecCceEEEEEc
Q 021127 30 PRIGEGAHAKVYEGKYKNQTVAIKIVHKGETP---EEIAKKESRFAREVAMLSRVQH--RNLVKFIGACKEPVMVIVTEL 104 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~lv~e~ 104 (317)
..+++|+=+.+|.+.+.|..+++|.-...... -+..-...+-.+|.+++.++.- -+++.++++.. ....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~-~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP-DNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC-CCCEEEEEE
Confidence 45789999999999888888888865433221 1222334567789999988843 34445554433 357799999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 105 LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 105 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.+|..|.+.+... ...++..+-.-+.-||..||||+||.++||++..+ .+.++|||++....
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~--~i~~IDfGLg~~s~ 142 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG--RIYFIDFGLGEFSD 142 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC--cEEEEECCcccccc
Confidence 9998988888764 25578888999999999999999999999999986 59999999998544
No 440
>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]
Probab=99.48 E-value=8.7e-15 Score=130.58 Aligned_cols=145 Identities=28% Similarity=0.455 Sum_probs=108.1
Q ss_pred ceEEEEEccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
++||.|++|...+|.++|..... ...++...+.++.|++.|+.| ++.+|+|+||.||+...+ ..+||.|||+...
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d-~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDD-DQLKIGDFGLVTS 405 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccc-hhhhhhhhhheee
Confidence 58899999999999999974332 336778889999999999999 999999999999999988 5899999999875
Q ss_pred ccccc-------ccccccCccceecccccccccccccccccccCC--------------------------CCCC-CCCC
Q 021127 176 ESLTE-------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------------------NVRP-SAEN 221 (317)
Q Consensus 176 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------------------~~~~-~~~~ 221 (317)
..... ..+...||..||+||.+.+..+..... +|..+ ...+ ...+
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvd-IyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip~~~~~d 484 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVD-IYALGLILAELLIQFSTQFERIATLTDIRDGIIPPEFLQD 484 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcc-hhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCChHHhhc
Confidence 54443 445668999999999988744433221 11111 1110 1222
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHH
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQI 247 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~ 247 (317)
+| .-..|+.+++.+.|.+||++.+.
T Consensus 485 ~p-~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 485 YP-EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred Cc-HHHHHHHHhcCCCcccCchHHHH
Confidence 33 34679999999999999955443
No 441
>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional
Probab=99.36 E-value=4.6e-11 Score=102.08 Aligned_cols=138 Identities=17% Similarity=0.117 Sum_probs=97.3
Q ss_pred eEEEEeEECCeEEEEEEeecCCChHHHHH------HHHHHHHHHHHHHhcCCCC--eeeEEeeeec------CceEEEEE
Q 021127 38 AKVYEGKYKNQTVAIKIVHKGETPEEIAK------KESRFAREVAMLSRVQHRN--LVKFIGACKE------PVMVIVTE 103 (317)
Q Consensus 38 g~V~~~~~~~~~vaiK~~~~~~~~~~~~~------~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~------~~~~lv~e 103 (317)
..|++....|+.|.||............. -...+.+|...+.++...+ ++..+++... ...++|||
T Consensus 36 rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 36 RRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred ceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 34667888899999997643331110000 0013678888888874322 3344444321 24789999
Q ss_pred ccCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC------CCCceEEcccCcccc
Q 021127 104 LLSGG-TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE------DLKTIKLADFGLARE 175 (317)
Q Consensus 104 ~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~------~~~~~kl~Dfg~a~~ 175 (317)
++++. +|.+++........+......++.+++..+.-||..||+|+|++++|||++. +...+.++||+.+..
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99876 8999886533333667778889999999999999999999999999999985 125789999998853
No 442
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.36 E-value=8.2e-13 Score=120.02 Aligned_cols=224 Identities=24% Similarity=0.309 Sum_probs=157.8
Q ss_pred cCCceeecceecc--ccceEEEEeEE----CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeee
Q 021127 22 DPKHLFVGPRIGE--GAHAKVYEGKY----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK 94 (317)
Q Consensus 22 ~~~~y~~~~~lG~--G~~g~V~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 94 (317)
....+.+.+.+|. |.+|.||.++. .+..+|+|.-....... ....+=.+|+...+++ .|+|.++.+..+.
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p---~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPP---LDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCc---cccccccchhhcccccCccccccccCcccc
Confidence 3345567888999 99999999876 36788998733322211 1111234677777777 6999999877776
Q ss_pred cC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHHhCCccccCCCCCcEEeeCCCCceEEcc
Q 021127 95 EP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR----AMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (317)
Q Consensus 95 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~----~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~D 169 (317)
+. ..++=+|+| +.+|..+...... .++...++.++.+... ||.++|+.+++|-|+||.||++..+...++++|
T Consensus 189 ~~~~lfiqtE~~-~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 189 GSGILFIQTELC-GESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred cCCcceeeeccc-cchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCC
Confidence 65 667777777 7899888876432 2778888889999999 999999999999999999999998855899999
Q ss_pred cCccccccccccccc------ccCccceeccccccccccccc----------------------ccccccCC-CC-C--C
Q 021127 170 FGLAREESLTEMMTA------ETGTYRWMAPELYSTVTLRQG----------------------EKKHYNHK-NV-R--P 217 (317)
Q Consensus 170 fg~a~~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~----------------------~~~~~~~~-~~-~--~ 217 (317)
||+............ ..|...|++||+..+...... ....|... .. . .
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e 346 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLE 346 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchh
Confidence 999886654432211 146778999998765322111 11111111 10 0 1
Q ss_pred CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
...+.+.++...+.++++.+|..|++.+.+.++
T Consensus 347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred hhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 133446677789999999999999999887664
No 443
>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins. This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain
Probab=99.36 E-value=5.1e-12 Score=105.59 Aligned_cols=140 Identities=22% Similarity=0.308 Sum_probs=106.1
Q ss_pred ceeccccceEEEEeEECC-eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC--CCeeeEEeeeec----CceEEEE
Q 021127 30 PRIGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH--RNLVKFIGACKE----PVMVIVT 102 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~----~~~~lv~ 102 (317)
+.|+.|..+.||++...+ ..+++|........ .....+..|+.++..+.+ .++++++.+..+ +..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~----~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL----PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC----cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 568999999999998875 89999987654321 012347889999999865 446778877754 2568999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS--------------------------------------- 143 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~--------------------------------------- 143 (317)
||++|.++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 80 e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 80 ERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred EEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99999888775532 226777777888888888888884
Q ss_pred -----------------CCccccCCCCCcEEeeCC-CCceEEcccCccccc
Q 021127 144 -----------------HGIIHRDLKPENLLLTED-LKTIKLADFGLAREE 176 (317)
Q Consensus 144 -----------------~~ivH~Dlkp~Nill~~~-~~~~kl~Dfg~a~~~ 176 (317)
..++|+|++|+||+++.+ .+.+.|+||+.+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 236999999999999983 256889999988743
No 444
>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.
Probab=99.31 E-value=3.1e-11 Score=97.43 Aligned_cols=130 Identities=26% Similarity=0.271 Sum_probs=85.0
Q ss_pred EEEEeEEC-CeEEEEEEeecCCCh---------------------HHHHHHHHHHHHHHHHHHhcCCC--CeeeEEeeee
Q 021127 39 KVYEGKYK-NQTVAIKIVHKGETP---------------------EEIAKKESRFAREVAMLSRVQHR--NLVKFIGACK 94 (317)
Q Consensus 39 ~V~~~~~~-~~~vaiK~~~~~~~~---------------------~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 94 (317)
.||.|... +..+|||+.+..... .+.........+|.+.|.++..- ++++.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999875 889999987642111 11223345667899999999655 567777553
Q ss_pred cCceEEEEEccC--CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 95 EPVMVIVTELLS--GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMEC-LHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 95 ~~~~~lv~e~~~--~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~-lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
...|||||++ |..+..+.... ++.+....++.+++..+.. +|..||+|+||.+.||+++.+ .+.|+|||
T Consensus 80 --~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~--~~~iIDf~ 151 (188)
T PF01163_consen 80 --RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG--KVYIIDFG 151 (188)
T ss_dssp --TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT--CEEE--GT
T ss_pred --CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc--eEEEEecC
Confidence 3579999998 65665543321 2244456677888885555 579999999999999999986 79999999
Q ss_pred cccccc
Q 021127 172 LAREES 177 (317)
Q Consensus 172 ~a~~~~ 177 (317)
.+....
T Consensus 152 qav~~~ 157 (188)
T PF01163_consen 152 QAVDSS 157 (188)
T ss_dssp TEEETT
T ss_pred cceecC
Confidence 986543
No 445
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.29 E-value=5.5e-12 Score=114.68 Aligned_cols=223 Identities=18% Similarity=0.165 Sum_probs=152.1
Q ss_pred CCceeecceeccccceEEEEeEEC---CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeee-cCc
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK-EPV 97 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-~~~ 97 (317)
..++.++..||.|.|+.|+..... +..|++|.+........ ....-+.|+-+...+ .|.++++++..+. ...
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~---~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFA---SDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchH---hhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 367888999999999999986543 67889998776554331 111234566666665 6888888776554 457
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.|+=.|||+++++...+.- ...+++..++.+..|++.++.++|+..++|+|++|+||++..++...++.|||.+....
T Consensus 341 ~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 7788899999998877632 23388888999999999999999999999999999999999864578999999987421
Q ss_pred cccccccccCcccee--cccccccccccccccc----------------------cccC-CCCCCCCCCChHHHHHHHHH
Q 021127 178 LTEMMTAETGTYRWM--APELYSTVTLRQGEKK----------------------HYNH-KNVRPSAENVPEELSIILTS 232 (317)
Q Consensus 178 ~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~~~----------------------~~~~-~~~~~~~~~~~~~l~~li~~ 232 (317)
. ......+...+. ++++............ ++.. ....+.......++..+...
T Consensus 419 ~--~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~~~~~p~~~~~~~~~q~~~kv 496 (524)
T KOG0601|consen 419 F--SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIRSGDTPNLPGLKLQLQVLLKV 496 (524)
T ss_pred e--ecccccccccccccchhhccccccccccccccccccccccccCcccCcccccceeeecccccCCCchHHhhhhhhhh
Confidence 1 112223333444 3333222211111110 0000 02233344555788889999
Q ss_pred hhhcCCCCCCCHHHHHHHHH
Q 021127 233 CWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 233 cl~~~p~~Rps~~~~~~~l~ 252 (317)
+...++..||.+.++..+..
T Consensus 497 ~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 497 MINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred hcCCccccchhhhhhcccch
Confidence 99999999999988766543
No 446
>KOG1266 consensus Protein kinase [Signal transduction mechanisms]
Probab=99.20 E-value=1e-11 Score=105.05 Aligned_cols=174 Identities=23% Similarity=0.343 Sum_probs=116.5
Q ss_pred HHHHHhcCCCCeeeEEeeeec------CceEEEEEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC--
Q 021127 75 VAMLSRVQHRNLVKFIGACKE------PVMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSH-- 144 (317)
Q Consensus 75 ~~~l~~l~h~niv~l~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~-- 144 (317)
.+.+-++.|.|||+++.++.+ ....++.||+..|+|..+|+..+ ...+....+.+|+-||+.||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 445566789999999988753 25788999999999999998643 34588889999999999999999987
Q ss_pred CccccCCCCCcEEeeCCCCceEEcccCcccccc-----cccccccccCccceecccccccccccccccccccCCC-----
Q 021127 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREES-----LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKN----- 214 (317)
Q Consensus 145 ~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~----- 214 (317)
-|+|+++..+.|++..+ +-+||.--.-..... .........+-++|.|||.=.. ....+..+++..+.
T Consensus 198 piihgnlTc~tifiq~n-gLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHN-GLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEM 275 (458)
T ss_pred ccccCCcchhheeecCC-ceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHH
Confidence 59999999999999987 667764211111000 0111223346788999985222 22222223322220
Q ss_pred ----CCCC---------------CCCC-hHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 215 ----VRPS---------------AENV-PEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 215 ----~~~~---------------~~~~-~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
..+. ...+ ...-+.++..|++..|..||++.+++-|
T Consensus 276 ailEiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHheeccCCCcceeehhhhhhhheeeccCccccCcCcccccCCCCCCcchhhhhcC
Confidence 0000 0000 1123568899999999999999998765
No 447
>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane
Probab=99.17 E-value=4.8e-10 Score=92.63 Aligned_cols=106 Identities=29% Similarity=0.328 Sum_probs=82.7
Q ss_pred HHHHHHHHHHHhcC--CCCeeeEEeeeec-----CceEEEEEccCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Q 021127 69 SRFAREVAMLSRVQ--HRNLVKFIGACKE-----PVMVIVTELLSGG-TLRKYLLNMRPRCLDVCVAIGFALDIARAMEC 140 (317)
Q Consensus 69 ~~~~~E~~~l~~l~--h~niv~l~~~~~~-----~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~ 140 (317)
.+..+|...+..+. .-.+++.+++... ...++|+|++++. +|.+++..... .+......++.+++..++-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 35778888887774 3334555555543 1468999999884 89999886444 6677788899999999999
Q ss_pred HHhCCccccCCCCCcEEeeCCC--CceEEcccCccccc
Q 021127 141 LHSHGIIHRDLKPENLLLTEDL--KTIKLADFGLAREE 176 (317)
Q Consensus 141 lH~~~ivH~Dlkp~Nill~~~~--~~~kl~Dfg~a~~~ 176 (317)
||.+||+|+|+++.|||++.+. ..+.++||+-++..
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999999999999999872 16899999987643
No 448
>PRK09902 hypothetical protein; Provisional
Probab=99.13 E-value=1.6e-09 Score=88.09 Aligned_cols=141 Identities=14% Similarity=0.091 Sum_probs=102.4
Q ss_pred ccccceEEEEeEECCeEEEEEEeecCCChHHH-HHHHHHHHHHHHHHHhcCC--CCeeeEEeee--ecC---ceEEEEEc
Q 021127 33 GEGAHAKVYEGKYKNQTVAIKIVHKGETPEEI-AKKESRFAREVAMLSRVQH--RNLVKFIGAC--KEP---VMVIVTEL 104 (317)
Q Consensus 33 G~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h--~niv~l~~~~--~~~---~~~lv~e~ 104 (317)
|.||.+.|++....|..+-+|.-......... +--+.-|.+|+..+.++.. -.+++..... ..+ ..+||+|-
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 67999999998888888888865411111100 1123458999999998843 2245554221 111 47899997
Q ss_pred cCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCc--eEEcccCccc
Q 021127 105 LSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT--IKLADFGLAR 174 (317)
Q Consensus 105 ~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~--~kl~Dfg~a~ 174 (317)
+.| .+|.+++.+......+......++.+++..++-||+.|+.|+|+.+.||+++.+ +. ++++||.-++
T Consensus 107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~r 178 (216)
T PRK09902 107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE-GKAEAGFLDLEKSR 178 (216)
T ss_pred CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC-CCeeEEEEEhhccc
Confidence 744 589888876544446788888999999999999999999999999999999855 45 9999997665
No 449
>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]
Probab=99.10 E-value=9.6e-10 Score=91.63 Aligned_cols=138 Identities=28% Similarity=0.302 Sum_probs=100.1
Q ss_pred eecceeccccceEEEEeEEC-CeEEEEEEeecCCC-----------------hHHHHHHHHHHHHHHHHHHhcCCC--Ce
Q 021127 27 FVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGET-----------------PEEIAKKESRFAREVAMLSRVQHR--NL 86 (317)
Q Consensus 27 ~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~-----------------~~~~~~~~~~~~~E~~~l~~l~h~--ni 86 (317)
.++..||-|-=+.||.|... |.++|||.=+.+.. ..+....+....+|.+.|.+|... .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 46789999999999999987 99999995432211 112233344556789999988544 66
Q ss_pred eeEEeeeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceE
Q 021127 87 VKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166 (317)
Q Consensus 87 v~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~k 166 (317)
++-+++ +...+|||+.+|-.|...- ++.+..-.++..|+.-+.-+-..|+||+|+++-||+++++ |.+.
T Consensus 174 P~P~~~---nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~d-g~~~ 242 (304)
T COG0478 174 PKPIAW---NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTED-GDIV 242 (304)
T ss_pred CCcccc---ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecC-CCEE
Confidence 665443 4567999999987765532 2234444566667777777778999999999999999998 7899
Q ss_pred EcccCcccc
Q 021127 167 LADFGLARE 175 (317)
Q Consensus 167 l~Dfg~a~~ 175 (317)
++||-.+..
T Consensus 243 vIDwPQ~v~ 251 (304)
T COG0478 243 VIDWPQAVP 251 (304)
T ss_pred EEeCccccc
Confidence 999976653
No 450
>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY). The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process
Probab=99.07 E-value=5.2e-09 Score=85.49 Aligned_cols=141 Identities=19% Similarity=0.230 Sum_probs=95.3
Q ss_pred ecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHH------HHHHHHHHhcCC---CCeeeEEe
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRF------AREVAMLSRVQH---RNLVKFIG 91 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~------~~E~~~l~~l~h---~niv~l~~ 91 (317)
|-.++|.+.+.+-......|.+...++..+++|..+......+ +....| .+++..+.+++. .....++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~e--r~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPE--RRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHH--HHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 3457888888888888888988888899999998765432211 111111 223333333322 22223222
Q ss_pred eee------cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCce
Q 021127 92 ACK------EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165 (317)
Q Consensus 92 ~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~ 165 (317)
+.. ....++||||++|..|.+... +++ .+...+.+++.-||+.|+.|+|..|+|++++.+ .+
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~--~i 173 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN--GI 173 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC--cE
Confidence 221 235678999999988876543 333 245667788999999999999999999999975 59
Q ss_pred EEcccCcccc
Q 021127 166 KLADFGLARE 175 (317)
Q Consensus 166 kl~Dfg~a~~ 175 (317)
+++||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999987653
No 451
>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]
Probab=99.05 E-value=4.5e-09 Score=94.46 Aligned_cols=207 Identities=13% Similarity=0.160 Sum_probs=132.9
Q ss_pred ceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee-----cCceEEEEEccCC-C
Q 021127 37 HAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-----EPVMVIVTELLSG-G 108 (317)
Q Consensus 37 ~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----~~~~~lv~e~~~~-g 108 (317)
..+.|++... |..|++|+++....... .....-+++++++.|.|||++.+++. +..+++|++|.++ +
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-----nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST-----NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc-----ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 4578888764 88999999943322211 01234578899999999999998774 4578999999976 5
Q ss_pred CHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 109 TLRKYLLNMRP-------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 109 ~L~~~l~~~~~-------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
+|+++-..... ...++..+|.++.|+..||.++|+.|+.-+-|.|.+|+++.+. +++|+..|+...
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~-RIriS~C~i~Dv 442 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM-RIRISGCGIMDV 442 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc-eEEEecccceee
Confidence 78876654321 2377899999999999999999999999999999999999884 889987777654
Q ss_pred cccccc-cccccCccceecc-ccccc---ccccccccccccCCCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 176 ESLTEM-MTAETGTYRWMAP-ELYST---VTLRQGEKKHYNHKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 176 ~~~~~~-~~~~~gt~~y~aP-E~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
...... .........|.+= +++.. ........+.............++.++++++......++++ -++.+++.+
T Consensus 443 l~~d~~~~le~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 443 LQEDPTEPLESQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ecCCCCcchhHHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 332220 0000000000000 00000 00000011111111112224467889999999999999987 567776654
No 452
>KOG1243 consensus Protein kinase [General function prediction only]
Probab=99.02 E-value=1.8e-09 Score=99.77 Aligned_cols=117 Identities=19% Similarity=0.287 Sum_probs=97.0
Q ss_pred CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEEEEEccCCCCHHHHHHhcCCCCCCH
Q 021127 46 KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDV 124 (317)
Q Consensus 46 ~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~ 124 (317)
.+.+|.|..+..... .. .....+-+..++.++||||+++++.+.. +..|+|+|-+ ..|..++.+ +..
T Consensus 36 ~~~~vsVF~~~~~~~-~~----~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-----l~~ 103 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG-EV----TELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-----LGK 103 (690)
T ss_pred cCCceEEEEEeCCCc-hh----hHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-----hHH
Confidence 378888888876654 21 2235667888999999999999998865 4899999998 678888876 446
Q ss_pred HHHHHHHHHHHHHHHHHH-hCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 125 CVAIGFALDIARAMECLH-SHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 125 ~~~~~i~~~i~~~L~~lH-~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
..+...+.||+.||.||| ..+++|++|..+.|+++.. |..||++|.+++.
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~-GeWkLggle~v~~ 154 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNES-GEWKLGGLELVSK 154 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCC-CcEEEeeeEEEec
Confidence 677778999999999998 4689999999999999998 7999999988754
No 453
>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172. This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.
Probab=98.86 E-value=4.8e-08 Score=81.79 Aligned_cols=136 Identities=15% Similarity=0.195 Sum_probs=81.6
Q ss_pred ceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCC--eeeEEeeeecC-ceEEEEEccC
Q 021127 30 PRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN--LVKFIGACKEP-VMVIVTELLS 106 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~-~~~lv~e~~~ 106 (317)
..||+|..+.||+. .+..+++|..+...... ...+|.++++.+..-. +++.+++..++ ...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~~~~-------~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGFDKE-------TIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCCCHH-------HHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 46899999999984 35578899887544222 3577888888875333 46777777543 5788999998
Q ss_pred CCC-HHHHH--------------Hh----cCC---CCCCHHHHHH-HHH----------HHHHH-HHHHHh----CCccc
Q 021127 107 GGT-LRKYL--------------LN----MRP---RCLDVCVAIG-FAL----------DIARA-MECLHS----HGIIH 148 (317)
Q Consensus 107 ~g~-L~~~l--------------~~----~~~---~~l~~~~~~~-i~~----------~i~~~-L~~lH~----~~ivH 148 (317)
|.+ +...+ .. -.. .......... +.. .+... ..+|.. ..++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 21111 10 000 0111111110 100 01111 122221 24789
Q ss_pred cCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 149 RDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 149 ~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
+|+.|.||+++.+ + +.|+||+.+...
T Consensus 158 gD~~~~Nii~~~~-~-~~iIDwe~a~~G 183 (226)
T TIGR02172 158 GDFQIGNLITSGK-G-TYWIDLGDFGYG 183 (226)
T ss_pred cCCCCCcEEEcCC-C-cEEEechhcCcC
Confidence 9999999999987 5 899999988643
No 454
>COG0661 AarF Predicted unusual protein kinase [General function prediction only]
Probab=98.85 E-value=3.7e-08 Score=91.28 Aligned_cols=143 Identities=21% Similarity=0.251 Sum_probs=93.1
Q ss_pred ceeccccceEEEEeEEC-CeEEEEEEeecCCChHH-----------------------------------HHHHHHHHHH
Q 021127 30 PRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEE-----------------------------------IAKKESRFAR 73 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~-----------------------------------~~~~~~~~~~ 73 (317)
..|+.++-|.||+|+.. |+.||||+.+.+-...- ....+-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 56899999999999998 99999999875432210 0111223444
Q ss_pred HHHHHHhcC-----CCCeeeEEeeee--cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 021127 74 EVAMLSRVQ-----HRNLVKFIGACK--EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146 (317)
Q Consensus 74 E~~~l~~l~-----h~niv~l~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i 146 (317)
|...+.+++ .++| ++=.++. .+...++|||++|..+.+...... ..++.+.+.....++ -+..+-..|+
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgf 286 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence 555554441 2222 2222332 356889999999999998853322 225644443332222 2334445799
Q ss_pred cccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 147 IHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 147 vH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.|.|.+|.||+++.+ +.+.+.|||+....+
T Consensus 287 fHaDpHpGNi~v~~~-g~i~~lDfGi~g~l~ 316 (517)
T COG0661 287 FHADPHPGNILVRSD-GRIVLLDFGIVGRLD 316 (517)
T ss_pred cccCCCccceEEecC-CcEEEEcCcceecCC
Confidence 999999999999999 799999999986543
No 455
>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily.; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....
Probab=98.72 E-value=4.3e-07 Score=76.27 Aligned_cols=141 Identities=18% Similarity=0.223 Sum_probs=82.1
Q ss_pred cceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCC--CeeeEEeeeec----CceEEEE
Q 021127 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR--NLVKFIGACKE----PVMVIVT 102 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~----~~~~lv~ 102 (317)
++.|+.|..+.||+....+..+++|..... .....+.+|..+++.+... .+++++..... ...+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~-------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP-------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH-------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC-------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 356899999999999998889999996543 1233567788888877422 45677764422 2578999
Q ss_pred EccCCCCHHH----------------HHHh---c--CCCCCCHHH---------HHHH------------HHHHHH-HHH
Q 021127 103 ELLSGGTLRK----------------YLLN---M--RPRCLDVCV---------AIGF------------ALDIAR-AME 139 (317)
Q Consensus 103 e~~~~g~L~~----------------~l~~---~--~~~~l~~~~---------~~~i------------~~~i~~-~L~ 139 (317)
++++|..+.. .+.. . ....+.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999988877 1111 1 001111100 0000 111222 233
Q ss_pred HHHh-------CCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 140 CLHS-------HGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 140 ~lH~-------~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
.+++ ..++|+|+.|.||+++...+.+.|+||+.+...
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 3332 369999999999999933255679999988643
No 456
>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]
Probab=98.72 E-value=2.9e-07 Score=76.23 Aligned_cols=141 Identities=21% Similarity=0.188 Sum_probs=91.3
Q ss_pred ceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHH-------------------HHHHHHHHHHHHHHhcC--CCCee
Q 021127 30 PRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIA-------------------KKESRFAREVAMLSRVQ--HRNLV 87 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~--h~niv 87 (317)
-.|.+|--+.||+|... +..+|+|+++......... ....-..+|+..|.++. +-.++
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 35677777899998764 8999999987543322100 00011234666666662 33333
Q ss_pred eEEeeeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCCceE
Q 021127 88 KFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIK 166 (317)
Q Consensus 88 ~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~~~k 166 (317)
+-+++. ...+||||+... ..---..+...+..+....+..++++.+.-|-. .++||+||+.-|||+.. +.+.
T Consensus 134 ~Pi~~~---~nVLvMEfIg~~--g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~--~~p~ 206 (268)
T COG1718 134 EPIAFR---NNVLVMEFIGDD--GLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHD--GEPY 206 (268)
T ss_pred Cceeec---CCeEEEEeccCC--CCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEEC--CeEE
Confidence 333322 357999999443 110000111224444678889999999998888 89999999999999994 5899
Q ss_pred EcccCcccccc
Q 021127 167 LADFGLAREES 177 (317)
Q Consensus 167 l~Dfg~a~~~~ 177 (317)
|+|||.|....
T Consensus 207 iID~~QaV~~~ 217 (268)
T COG1718 207 IIDVSQAVTID 217 (268)
T ss_pred EEECccccccC
Confidence 99999987544
No 457
>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]
Probab=98.70 E-value=8.4e-07 Score=78.42 Aligned_cols=227 Identities=18% Similarity=0.240 Sum_probs=141.5
Q ss_pred cCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEee--------
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGA-------- 92 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-------- 92 (317)
-.+-+..++.||+|+-+.+|..-.-+.. +.|++........ .+.+..|... .||-+..=+.|
T Consensus 9 ~ge~i~~gr~LgqGgea~ly~l~e~~d~-VAKIYh~Pppa~~--------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~ 79 (637)
T COG4248 9 YGEPIPPGRPLGQGGEADLYTLGEVRDQ-VAKIYHAPPPAAQ--------AQKVAELAATPDAPLLNYRVAWPQATLHGG 79 (637)
T ss_pred cCcccCCCccccCCccceeeecchhhch-hheeecCCCchHH--------HHHHHHhccCCCCcchhhhhcccHHHhhCC
Confidence 3344557888999999999964332223 4588776554331 1123344444 56655442222
Q ss_pred eecCceEEEEEccCCCCH-HHHHHh----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEE
Q 021127 93 CKEPVMVIVTELLSGGTL-RKYLLN----MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (317)
Q Consensus 93 ~~~~~~~lv~e~~~~g~L-~~~l~~----~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl 167 (317)
-......++|..+.|..= ..++.- +.-....|...++.+..++.+.+-||+.|.+-+|+.++|+|+.++ +.+.|
T Consensus 80 ~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~-~~V~L 158 (637)
T COG4248 80 RRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD-SKVVL 158 (637)
T ss_pred CccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecC-ceEEE
Confidence 122247788888877532 222221 111237899999999999999999999999999999999999988 78999
Q ss_pred cccCcccccccccccccccCccceeccccccc----------------------------ccccccc-----------cc
Q 021127 168 ADFGLAREESLTEMMTAETGTYRWMAPELYST----------------------------VTLRQGE-----------KK 208 (317)
Q Consensus 168 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~----------------------------~~~~~~~-----------~~ 208 (317)
.|-..-....+.......+|...|.+||.-.- ....++. .+
T Consensus 159 VdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 159 VDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred EcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 88554433344444455678999999995220 0000000 00
Q ss_pred c------cc---CCCCCCC-----CCCChHHHHHHHHHhhhcC--CCCCCCHHHHHHHHHHhhhcc
Q 021127 209 H------YN---HKNVRPS-----AENVPEELSIILTSCWKED--PNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 209 ~------~~---~~~~~~~-----~~~~~~~l~~li~~cl~~~--p~~Rps~~~~~~~l~~~~~~~ 258 (317)
+ +. .....+. ..-+++++..+..+|+... +.-|||++-.+..|..+..++
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 0 00 0011121 2345788999999999653 568999998887777665544
No 458
>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]
Probab=98.68 E-value=1.6e-07 Score=73.63 Aligned_cols=134 Identities=22% Similarity=0.312 Sum_probs=95.2
Q ss_pred CceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCee-eEEeeeecCceEEEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV-KFIGACKEPVMVIVT 102 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~lv~ 102 (317)
......+.||+|.+|.||++.+.+..+|+|+-+.... +..+..|+++|..+...++. +++.+..+ ++.|
T Consensus 22 ~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~-------r~~l~kEakiLeil~g~~~~p~vy~yg~~---~i~m 91 (201)
T COG2112 22 YELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP-------RRNLEKEAKILEILAGEGVTPEVYFYGED---FIRM 91 (201)
T ss_pred hhhhhhhhhhcccccEEEEeeccCceEEEEEecCCcc-------hhhHHHHHHHHHHhhhcCCCceEEEechh---hhhh
Confidence 3445678899999999999999999999998765543 33477899999988776664 44444433 2449
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC-CCcEEeeCCCCceEEcccCcccccc
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLK-PENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlk-p~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
||+.|-+|.+.-... +.++ +..+++.---|-..||-|+.|. |..++|.++ +.+.|+||.-|+...
T Consensus 92 e~i~G~~L~~~~~~~-----~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~k~ 157 (201)
T COG2112 92 EYIDGRPLGKLEIGG-----DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVND-RDVYIIDFDSATFKK 157 (201)
T ss_pred hhhcCcchhhhhhcc-----cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecC-CcEEEEEccchhhcc
Confidence 999998988866531 2222 3445555445666799999886 445555555 479999999998443
No 459
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=98.66 E-value=5.9e-09 Score=100.62 Aligned_cols=221 Identities=21% Similarity=0.246 Sum_probs=147.3
Q ss_pred eeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee-ec
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC-KE 95 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~ 95 (317)
+.+-++.+.+.+-+-+|+++.++.++-. +...++|+......-. ....+....+-.++-...+|-++...-.+ ..
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~--~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r 876 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIR--TNDYESIRSKSNILITPRSPAVVRSFPSFPCR 876 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhc--cccccccCCccCccccCCCCceecccCCCCCC
Confidence 5567788888899999999999987654 4445555443222110 00011122222333223456666554443 23
Q ss_pred CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 96 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
...+++++|+.+++|...+++... .+.+-...+...+..+++|||+..++|+|++|.|+++..+ +..+++|||....
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~~--~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~-gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSGC--LSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYD-GHRPLTDFGTLSK 953 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCCC--cccccccchhHHHHhhhhccccchhhcccccccchhhccc-CCcccCccccccc
Confidence 468999999999999999987653 6666677778889999999999999999999999999998 7899999984321
Q ss_pred cc-------c-------------------------ccccccccCccceecccccccccccccccccccCC----------
Q 021127 176 ES-------L-------------------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------- 213 (317)
Q Consensus 176 ~~-------~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------- 213 (317)
.. . ........||+.|.+||...+..-....+ ||..+
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad-~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAAD-WWSSGVCLFEVLTGI 1032 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcch-hhhhhhhhhhhhcCC
Confidence 00 0 00112335899999999887654443333 33322
Q ss_pred -----------------CCCC---CCCCChHHHHHHHHHhhhcCCCCCCCHH
Q 021127 214 -----------------NVRP---SAENVPEELSIILTSCWKEDPNARPNFT 245 (317)
Q Consensus 214 -----------------~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~ 245 (317)
...+ .+...+.+.++++...+..+|.+|..+.
T Consensus 1033 pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 0011 1334567899999999999999997766
No 460
>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]
Probab=98.64 E-value=3.5e-07 Score=84.61 Aligned_cols=141 Identities=21% Similarity=0.263 Sum_probs=90.0
Q ss_pred ceeccccceEEEEeEEC-CeEEEEEEeecCCChHHH--------------------------------HHHHHHHHHHHH
Q 021127 30 PRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEI--------------------------------AKKESRFAREVA 76 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~--------------------------------~~~~~~~~~E~~ 76 (317)
+.||.-+.|.||+|+.. |+.||||+-+.+-...-. .-.+-+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 56899999999999987 889999986654322200 001123444554
Q ss_pred HHHhc----CCCC------eeeEEeeeecCceEEEEEccCCCCHHHH--HHhcCCCCCCHHHHHHHHHHHHHHHH-HHHh
Q 021127 77 MLSRV----QHRN------LVKFIGACKEPVMVIVTELLSGGTLRKY--LLNMRPRCLDVCVAIGFALDIARAME-CLHS 143 (317)
Q Consensus 77 ~l~~l----~h~n------iv~l~~~~~~~~~~lv~e~~~~g~L~~~--l~~~~~~~l~~~~~~~i~~~i~~~L~-~lH~ 143 (317)
...++ .|-+ |++++..+ .....|+||||+|..+.+. +.+.+ ++...+.. .+.++.. -|=.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~-st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i~~---~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL-STKRVLTMEYVDGIKINDLDAIDKRG---ISPHDILN---KLVEAYLEQIFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc-CcceEEEEEecCCccCCCHHHHHHcC---CCHHHHHH---HHHHHHHHHHHh
Confidence 44333 3545 34433222 2368999999999877654 33333 66664443 3333322 2334
Q ss_pred CCccccCCCCCcEEeeC---CCCceEEcccCcccccc
Q 021127 144 HGIIHRDLKPENLLLTE---DLKTIKLADFGLAREES 177 (317)
Q Consensus 144 ~~ivH~Dlkp~Nill~~---~~~~~kl~Dfg~a~~~~ 177 (317)
.|++|+|-+|.||+++. ....+.+.|||+....+
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 68999999999999994 23689999999987543
No 461
>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH). The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio
Probab=98.61 E-value=6.4e-07 Score=76.08 Aligned_cols=74 Identities=23% Similarity=0.255 Sum_probs=51.8
Q ss_pred eccccc-eEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEEEEEccCCC
Q 021127 32 IGEGAH-AKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTELLSGG 108 (317)
Q Consensus 32 lG~G~~-g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~~~g 108 (317)
|-.|.+ ..||+....+..++||....... ..+.+|+++++.+ .+--+++++++...+ ..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~~--------~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGPT--------YELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCcc--------cchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 444555 78999877777889998765431 1255688888777 344566778776543 678999999998
Q ss_pred CHHHH
Q 021127 109 TLRKY 113 (317)
Q Consensus 109 ~L~~~ 113 (317)
+|...
T Consensus 78 ~l~~~ 82 (244)
T cd05150 78 PAAAL 82 (244)
T ss_pred cHhHh
Confidence 77643
No 462
>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2
Probab=98.55 E-value=1.7e-06 Score=70.09 Aligned_cols=129 Identities=26% Similarity=0.368 Sum_probs=93.7
Q ss_pred Cceeecceeccccc-eEEEEeEECCeEEEEEEeec---CCCh--------H-----HHHHHHHHHHHHHHHHHhc---CC
Q 021127 24 KHLFVGPRIGEGAH-AKVYEGKYKNQTVAIKIVHK---GETP--------E-----EIAKKESRFAREVAMLSRV---QH 83 (317)
Q Consensus 24 ~~y~~~~~lG~G~~-g~V~~~~~~~~~vaiK~~~~---~~~~--------~-----~~~~~~~~~~~E~~~l~~l---~h 83 (317)
.+++.++.||.|.- |.||+++..|+.+|||++.. .... . ........|..|.+...+| .+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 78999999999999 99999999999999999322 1110 0 0012234688898888887 35
Q ss_pred CCe--eeEEeeee-c------------------CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 021127 84 RNL--VKFIGACK-E------------------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142 (317)
Q Consensus 84 ~ni--v~l~~~~~-~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH 142 (317)
.++ |+.+||.. + ....||.||.+... .++..+ +.+|.+-|..+|
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~~----~~~~~~dl~~~~ 181 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIRD----IPQMLRDLKILH 181 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchhH----HHHHHHHHHHHH
Confidence 566 99999871 1 12468888886644 133333 456777789999
Q ss_pred hCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 143 ~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
..||+-+|+++.|.. .-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~------~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR------GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc------CCEEEecccC
Confidence 999999999999984 2489999864
No 463
>PLN02876 acyl-CoA dehydrogenase
Probab=98.53 E-value=1.5e-06 Score=86.30 Aligned_cols=77 Identities=17% Similarity=0.283 Sum_probs=55.9
Q ss_pred cceeccccceEEEEeEECC----eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCe--eeEEeeeec----Cc
Q 021127 29 GPRIGEGAHAKVYEGKYKN----QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNL--VKFIGACKE----PV 97 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~----~~ 97 (317)
.+.++.|.++.+|+....+ ..+++|+.+...... ....+.+|+++++.+. |.+| ++++.+|.+ +.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~----~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~ 118 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ----SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT 118 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc----cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence 5678999999999987653 468888765443211 1224778999999984 6655 888888765 36
Q ss_pred eEEEEEccCCCC
Q 021127 98 MVIVTELLSGGT 109 (317)
Q Consensus 98 ~~lv~e~~~~g~ 109 (317)
.|+||||++|..
T Consensus 119 ~flVME~v~G~~ 130 (822)
T PLN02876 119 AFYIMEYLEGRI 130 (822)
T ss_pred ceEEEEecCCcc
Confidence 789999998864
No 464
>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members. The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista
Probab=98.41 E-value=2.3e-06 Score=72.29 Aligned_cols=72 Identities=14% Similarity=0.218 Sum_probs=45.6
Q ss_pred ceeccccce-EEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCC---CeeeEEeeeec----CceEEE
Q 021127 30 PRIGEGAHA-KVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR---NLVKFIGACKE----PVMVIV 101 (317)
Q Consensus 30 ~~lG~G~~g-~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~----~~~~lv 101 (317)
+.++.||.. .||+. +..+++|..+.... ...+.+|.+++..+... -+.++++.... +..++|
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~~-------~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAGY-------AGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccch-------HHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 457777776 59975 34577887554221 22477888888877432 34555554432 235889
Q ss_pred EEccCCCCHH
Q 021127 102 TELLSGGTLR 111 (317)
Q Consensus 102 ~e~~~~g~L~ 111 (317)
|++++|.++.
T Consensus 73 ~~~i~G~~l~ 82 (235)
T cd05155 73 YRWLEGETAT 82 (235)
T ss_pred EEeecCCCCC
Confidence 9999987663
No 465
>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C). Proteins in this uncharacterised family are described as transmembrane proteins.
Probab=98.39 E-value=1.2e-06 Score=71.02 Aligned_cols=99 Identities=23% Similarity=0.289 Sum_probs=79.0
Q ss_pred HHHHHHHHhcCC-CCeeeEEeeeecCceEEEEEccCCCCHHHH---HHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---C
Q 021127 72 AREVAMLSRVQH-RNLVKFIGACKEPVMVIVTELLSGGTLRKY---LLNMRPRCLDVCVAIGFALDIARAMECLHS---H 144 (317)
Q Consensus 72 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~lv~e~~~~g~L~~~---l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~ 144 (317)
..|.-+++.+++ +++++++|+|.+ ++|.||...+++... +..... .+|..+.+|+.++++.+.++++ .
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~---~~v~E~~~~~~~~~~~~~l~~~~~--~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR---FYVVEYVGAGSLYGIYRPLSQFLQ--SPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC---EEEEEeecCccccccccccccccc--cCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 357888888865 699999999965 578999977665421 111111 6899999999999999999998 3
Q ss_pred CccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 145 ~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
.+.-.|++++|+-++.+ +.+|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~-~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDD-GRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCC-CcEEEEechhcchh
Confidence 57788999999999988 78999999877543
No 466
>PRK10593 hypothetical protein; Provisional
Probab=98.35 E-value=1.1e-05 Score=70.63 Aligned_cols=79 Identities=18% Similarity=0.082 Sum_probs=57.8
Q ss_pred ceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC---CCeeeEEeeeec----Cc
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH---RNLVKFIGACKE----PV 97 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~----~~ 97 (317)
...-.+.||.|..+.||+....+..+++|..+..... ..+..|.+.++.+.. -.++++++++.. +.
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~~-------~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~ 87 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQGNPMPLMARSFSTP-------GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP 87 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCCCEEEEEecccccc-------hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence 3344567999999999998776567788875432121 247889999988843 468899988753 46
Q ss_pred eEEEEEccCCCCH
Q 021127 98 MVIVTELLSGGTL 110 (317)
Q Consensus 98 ~~lv~e~~~~g~L 110 (317)
.+||||+++|+++
T Consensus 88 ~~LVmE~i~G~~~ 100 (297)
T PRK10593 88 DVLLLERLRGVSV 100 (297)
T ss_pred eEEEEeccCCEec
Confidence 8999999998765
No 467
>KOG2137 consensus Protein kinase [Signal transduction mechanisms]
Probab=98.30 E-value=9.9e-07 Score=82.30 Aligned_cols=118 Identities=20% Similarity=0.322 Sum_probs=80.2
Q ss_pred HHHHHHHHHHHHhC-CccccCCCCCcEEeeCCCCceEEcccCcccccccc-c---------ccccccCccceeccccccc
Q 021127 131 ALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-E---------MMTAETGTYRWMAPELYST 199 (317)
Q Consensus 131 ~~~i~~~L~~lH~~-~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~---------~~~~~~gt~~y~aPE~~~~ 199 (317)
+.+++.||.|+|.. ++||++|.|++|.++.+ +.+||+.|+.+...... . ..........|.|||++..
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNAN-GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccC-cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34555999999975 89999999999999998 79999999987643221 0 0011124568999998765
Q ss_pred cccccc----------------ccccccCC---------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHH
Q 021127 200 VTLRQG----------------EKKHYNHK---------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQII 248 (317)
Q Consensus 200 ~~~~~~----------------~~~~~~~~---------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~ 248 (317)
...... ........ .......++|.++++=+.+++..++..||++..+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 221111 00000000 11122467899999999999999999999877765
Q ss_pred H
Q 021127 249 Q 249 (317)
Q Consensus 249 ~ 249 (317)
.
T Consensus 264 ~ 264 (700)
T KOG2137|consen 264 S 264 (700)
T ss_pred c
Confidence 4
No 468
>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP. PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].
Probab=98.28 E-value=3e-05 Score=63.30 Aligned_cols=133 Identities=20% Similarity=0.324 Sum_probs=89.5
Q ss_pred cceeccccceEEEEeEECCeEEEEEEeecCCChHHH-----------HHHHHHHHHHHHHHHhcC------CCCeeeEEe
Q 021127 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEI-----------AKKESRFAREVAMLSRVQ------HRNLVKFIG 91 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~------h~niv~l~~ 91 (317)
...||+|+.-.||.--. +...+||+.......... .....+..+|+.-...+. +.+|.+++|
T Consensus 6 ~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred CcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 35689999999997533 345678988766500000 011234566666666655 889999999
Q ss_pred eeecC-ceEEEEEccCC------CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCC--
Q 021127 92 ACKEP-VMVIVTELLSG------GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL-- 162 (317)
Q Consensus 92 ~~~~~-~~~lv~e~~~~------g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~-- 162 (317)
+.+.+ ...+|+|...+ .+|.+++.+.. ++. . +...+-+-..||-+.+|+.+|++|.||++....
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 99876 67888887643 36888885432 555 2 333444555688889999999999999997432
Q ss_pred C-ceEEcc
Q 021127 163 K-TIKLAD 169 (317)
Q Consensus 163 ~-~~kl~D 169 (317)
. .+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 2 467777
No 469
>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481
Probab=98.26 E-value=6.6e-07 Score=87.00 Aligned_cols=104 Identities=15% Similarity=0.123 Sum_probs=69.1
Q ss_pred cccCCCCC-cEEeeCCCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccCC---------
Q 021127 147 IHRDLKPE-NLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------- 213 (317)
Q Consensus 147 vH~Dlkp~-Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------- 213 (317)
.|++..|. |++++.. +..++.|||.++...... ......||+.|+|||++.+..+. ...++|..+
T Consensus 499 ~~~~~~p~~~~~~~p~-~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~-~~~DiwSlG~il~ElltG 576 (669)
T cd05610 499 PTQKPRPHGNLYQTPK-QVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHG-PAVDWWALGVCLFEFLTG 576 (669)
T ss_pred CCCCCCCCCceeECCc-cccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCC-cHHHHHHHHHHHHHHHHC
Confidence 45666666 5566655 577889999987543221 12345799999999998764432 222222221
Q ss_pred ---------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 ---------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 ---------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
........++..+.+++..||..||.+||++.+++++.+
T Consensus 577 ~~pf~~~~~~~~~~~il~~~~~~p~~~~~~~~~~~~~l~~lL~~dP~~R~ta~e~l~h~~ 636 (669)
T cd05610 577 IPPFNDETPQQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPL 636 (669)
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhHCcCHHHHHhCHh
Confidence 001112356788999999999999999999999999844
No 470
>TIGR02721 ycfN_thiK thiamine kinase. Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.
Probab=98.25 E-value=9e-06 Score=69.56 Aligned_cols=136 Identities=18% Similarity=0.179 Sum_probs=78.8
Q ss_pred eccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCC-eeeEEeeeecCceEEEEEccCCCCH
Q 021127 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN-LVKFIGACKEPVMVIVTELLSGGTL 110 (317)
Q Consensus 32 lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~lv~e~~~~g~L 110 (317)
+..|-.+.+|+....+..+++|......... .....+|..+++.+.... .+++++... -++||||++|..+
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~-----~~~r~~E~~~l~~l~~~g~~P~~i~~~~---~~~v~e~i~G~~~ 75 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKAL-----GVDRQREYQILQALSALGLAPKPILVNE---HWLLVEWLEGEVI 75 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccc-----cCcHHHHHHHHHHHHhcCCCCceEEEeC---CEEEEEeccCccc
Confidence 4567778999988778889999765432211 002356888888774322 345555443 3689999988765
Q ss_pred HH--------------HHHhcCC-----CCCCHHH-HHHHHHHH---------HHHHHHHHh--------CCccccCCCC
Q 021127 111 RK--------------YLLNMRP-----RCLDVCV-AIGFALDI---------ARAMECLHS--------HGIIHRDLKP 153 (317)
Q Consensus 111 ~~--------------~l~~~~~-----~~l~~~~-~~~i~~~i---------~~~L~~lH~--------~~ivH~Dlkp 153 (317)
.. .+.+-.. .+++... +..+..++ ...+..+-. ..++|+|+.|
T Consensus 76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 32 1111111 1122211 11221111 111222211 2589999999
Q ss_pred CcEEeeCCCCceEEcccCcccccc
Q 021127 154 ENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 154 ~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.||+++.+ + +.|+||..+...+
T Consensus 156 ~Nil~~~~-~-~~lIDwE~a~~gd 177 (256)
T TIGR02721 156 YNLVVTPQ-G-LKLIDWEYASDGD 177 (256)
T ss_pred CcEEEeCC-C-CEEEeccccCcCC
Confidence 99999987 4 7899999887543
No 471
>TIGR00938 thrB_alt homoserine kinase, Neisseria type. Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.
Probab=98.20 E-value=2e-05 Score=69.29 Aligned_cols=143 Identities=19% Similarity=0.236 Sum_probs=84.1
Q ss_pred ceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC--CCeeeEEeeee-------c
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH--RNLVKFIGACK-------E 95 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~-------~ 95 (317)
.....+.++.|....+|+...++..+++|+........ .+..|.+++..|.. -.+++++.... +
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~~~-------~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~ 95 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRVKAE-------ELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA 95 (307)
T ss_pred CceeccccCCccccceEEEEeCCCcEEEEEecCCCCHH-------HHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence 34456677888778999987766678899876543222 23445666666632 22455554321 3
Q ss_pred CceEEEEEccCCCCHH-----------HHHH---hcCCC---C----C---CHHHHH------------HHHHHHHHHHH
Q 021127 96 PVMVIVTELLSGGTLR-----------KYLL---NMRPR---C----L---DVCVAI------------GFALDIARAME 139 (317)
Q Consensus 96 ~~~~lv~e~~~~g~L~-----------~~l~---~~~~~---~----l---~~~~~~------------~i~~~i~~~L~ 139 (317)
+..++|++|++|..+. ..+. ..... . . .|.... .....+...++
T Consensus 96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~ 175 (307)
T TIGR00938 96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD 175 (307)
T ss_pred CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence 4578999999885432 1111 10000 0 0 011000 01112333455
Q ss_pred HHHh-------CCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 140 CLHS-------HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 140 ~lH~-------~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
++.. .+++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~~~ 217 (307)
T TIGR00938 176 YLDKFWPRDLPRGVIHADLFPDNVLFDGD-SVKGVIDFYFACT 217 (307)
T ss_pred HHHhhhhhcCCCccCCCCCCcCcEEEECC-ceEEEeecccccC
Confidence 5542 589999999999999987 5568999998863
No 472
>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo
Probab=98.18 E-value=2.2e-05 Score=66.21 Aligned_cols=72 Identities=18% Similarity=0.233 Sum_probs=46.8
Q ss_pred ceeccccceEEEEeEEC---CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecCceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEPVMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~lv~e~~ 105 (317)
+.|..|-...+|+.... +..|++|+........ ....+|+.+++.+. +.-.+++++.+.+ .+||||+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~------~d~~~E~~~~~~l~~~gl~P~v~~~~~~---~~l~e~i 74 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI------IDRERELRIHKLLSKHGLAPKLYATFQN---GLIYEFI 74 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce------ecHHHHHHHHHHHHhCCCCCeEEEEeCC---cEEEEee
Confidence 45777888899998765 4788999765432111 11236788888773 3334566554432 4799999
Q ss_pred CCCCH
Q 021127 106 SGGTL 110 (317)
Q Consensus 106 ~~g~L 110 (317)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 88765
No 473
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=98.18 E-value=3.6e-07 Score=84.48 Aligned_cols=161 Identities=21% Similarity=0.210 Sum_probs=112.5
Q ss_pred eeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCC-eeeEEeeee-cCceEEEE
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN-LVKFIGACK-EPVMVIVT 102 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~-~~~~~lv~ 102 (317)
+...+-+++|+.+++++.+.+ .+....+.+.... ...-++++|.+++||| .+..++.++ +...++++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~l----------~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~ 313 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTL----------SRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM 313 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccch----------hhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence 345666799999999998876 3334456554331 1345789999999999 666666555 44889999
Q ss_pred EccCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 103 ELLSGG-TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 103 e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
+++.++ +...... .....+..-+...+...-+++|+++|+.--+|+| ||+..+. ..+..||+..........
T Consensus 314 ~i~s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~ 386 (829)
T KOG0576|consen 314 RICSTGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE--EVKLLDFAVPPQLTRTMK 386 (829)
T ss_pred hhhcCCccccccCC-hhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc--ccccccccCCcccCcccc
Confidence 999776 2211111 0111244445556677788899999998888998 8887764 689999999887665555
Q ss_pred cccccCccceeccccccccccc
Q 021127 182 MTAETGTYRWMAPELYSTVTLR 203 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~ 203 (317)
.....+++.++|||+.....+.
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~ 408 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTID 408 (829)
T ss_pred cccCCCCCCCCCchhhcccccc
Confidence 5667899999999976654433
No 474
>cd05153 HomoserineK_II Homoserine Kinase, type II. Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.
Probab=98.14 E-value=1.5e-05 Score=69.79 Aligned_cols=138 Identities=19% Similarity=0.190 Sum_probs=82.6
Q ss_pred cceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCC--CeeeEEeee-------ecCceE
Q 021127 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR--NLVKFIGAC-------KEPVMV 99 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~-------~~~~~~ 99 (317)
.+.|..|....+|+....+..+++|+... ... ..+..|++++..+.+. .+++++... .++..+
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~-~~~-------~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK-VSA-------EELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC-CCh-------HhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 45677788889999877777899998765 211 1355677777776322 355555432 133568
Q ss_pred EEEEccCCCCHHH-----------HHH---hcC----CC-----CCCHHHHH----------HHHHHHHHHHHHHHh---
Q 021127 100 IVTELLSGGTLRK-----------YLL---NMR----PR-----CLDVCVAI----------GFALDIARAMECLHS--- 143 (317)
Q Consensus 100 lv~e~~~~g~L~~-----------~l~---~~~----~~-----~l~~~~~~----------~i~~~i~~~L~~lH~--- 143 (317)
+|+++++|..+.. .+. ... .. ...+.... .....+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999998876421 111 000 00 01111100 011112334444443
Q ss_pred ----CCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 144 ----HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 144 ----~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
.+++|+|+.|.||+++.+ +.+.|+||+.+..
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~-~~~~iIDfe~a~~ 205 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGD-ELSGVIDFYFACT 205 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCC-ceEEEeehhhhcC
Confidence 379999999999999986 5568999998864
No 475
>PRK09550 mtnK methylthioribose kinase; Reviewed
Probab=98.08 E-value=5.4e-05 Score=68.38 Aligned_cols=80 Identities=20% Similarity=0.092 Sum_probs=52.5
Q ss_pred cceeccccceEEEEeEECC--eEEEEEEeecCCC--hHHHHHHHHHHHHHHHHHHhc---CCCCeeeEEeeeecCceEEE
Q 021127 29 GPRIGEGAHAKVYEGKYKN--QTVAIKIVHKGET--PEEIAKKESRFAREVAMLSRV---QHRNLVKFIGACKEPVMVIV 101 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~~--~~vaiK~~~~~~~--~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~lv 101 (317)
.+.||.|.++.||++...+ +.|+||.-..... .+.-.....+...|.+.|..+ ...++++++.+.. ...++|
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~-~~~~lV 109 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE-ELAVTV 109 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC-CCCEEE
Confidence 4678999999999998874 4899997431110 000001133566677777775 2356788887744 457899
Q ss_pred EEccCCCC
Q 021127 102 TELLSGGT 109 (317)
Q Consensus 102 ~e~~~~g~ 109 (317)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99997643
No 476
>PRK05231 homoserine kinase; Provisional
Probab=98.03 E-value=0.00016 Score=64.00 Aligned_cols=138 Identities=17% Similarity=0.157 Sum_probs=75.8
Q ss_pred cceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC--CCCeeeEEeee-------ecCceE
Q 021127 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ--HRNLVKFIGAC-------KEPVMV 99 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~-------~~~~~~ 99 (317)
.+.|+.|....+|+...++..+++|++. ..... .+..|+..+..|. .-.+++.+... ..+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~-~~~~~-------~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQGEYVLTLFE-RLTAE-------DLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEeCCCcEEEEEec-cCChH-------HhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 4557778778999988776689999876 22211 1223444444442 11234444321 234678
Q ss_pred EEEEccCCCCH-----------HHHHHhc---CC-------C--CCCH-HHHHH------------HHHH-HHHHHHHHH
Q 021127 100 IVTELLSGGTL-----------RKYLLNM---RP-------R--CLDV-CVAIG------------FALD-IARAMECLH 142 (317)
Q Consensus 100 lv~e~~~~g~L-----------~~~l~~~---~~-------~--~l~~-~~~~~------------i~~~-i~~~L~~lH 142 (317)
++++|++|..+ .+.+.+. .. . .+.+ ..... .+.+ +...++.+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 99999988743 1122110 00 0 0111 11111 1111 111222332
Q ss_pred -------hCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 143 -------SHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 143 -------~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
..++||+|+.|+||+++.+ ...-|+||+.+..
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~-~~~~iIDf~~~~~ 217 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGD-RLSGFIDFYFACN 217 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECC-ceEEEEecccccC
Confidence 2389999999999999966 4457999999864
No 477
>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes. The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer
Probab=97.90 E-value=9.4e-05 Score=64.91 Aligned_cols=73 Identities=18% Similarity=0.243 Sum_probs=45.9
Q ss_pred ceeccccceEEEEeEEC--------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC-CCeeeEEeeeecCceEE
Q 021127 30 PRIGEGAHAKVYEGKYK--------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH-RNLVKFIGACKEPVMVI 100 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~l 100 (317)
+.|..|-...+|+.... ++.+++|+....... .....+|.+++..+.. .-.+++++.+.+ .+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~------~~~r~~E~~~~~~l~~~g~~P~~~~~~~~---~~ 74 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL------LIDRERELVVFARLSERNLGPKLYGIFPN---GR 74 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc------eechHHHHHHHHHHHhCCCCCceEEEeCC---Cc
Confidence 34556666789988765 378999986653221 1124567777777732 224566666643 35
Q ss_pred EEEccCCCCHH
Q 021127 101 VTELLSGGTLR 111 (317)
Q Consensus 101 v~e~~~~g~L~ 111 (317)
|++|++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999887664
No 478
>PLN02236 choline kinase
Probab=97.83 E-value=0.00018 Score=64.22 Aligned_cols=151 Identities=20% Similarity=0.294 Sum_probs=86.5
Q ss_pred CCcee--ecCCceeecceeccccceEEEEeEEC------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCC-e
Q 021127 16 DAKWL--IDPKHLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN-L 86 (317)
Q Consensus 16 ~~~~~--i~~~~y~~~~~lG~G~~g~V~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-i 86 (317)
...|. .+++.+.+... -.|-...+|+.... ++.|++|+........ . ...+|..+++.+..-+ -
T Consensus 27 ~~~w~~~~~~~~~~i~~l-~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-----i-dR~~E~~~~~~l~~~gl~ 99 (344)
T PLN02236 27 ASKWGDVVDDEALQVIPL-KGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-----F-DRDDEIRTFECMSRHGQG 99 (344)
T ss_pred cchhcCCCCcCcEEEEEc-CCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-----e-chHHHHHHHHHHHHcCCC
Confidence 44564 25556666644 34777899998753 3678999876543211 1 1256888888874333 3
Q ss_pred eeEEeeeecCceEEEEEccCCCCHHHH--------------HH---hcC-C--C-CCCHHHHHHHHHHH-----------
Q 021127 87 VKFIGACKEPVMVIVTELLSGGTLRKY--------------LL---NMR-P--R-CLDVCVAIGFALDI----------- 134 (317)
Q Consensus 87 v~l~~~~~~~~~~lv~e~~~~g~L~~~--------------l~---~~~-~--~-~l~~~~~~~i~~~i----------- 134 (317)
+++++.+.++ .|.+|+++.+|... +. ... . . ...++.+..+..++
T Consensus 100 P~~~~~~~~g---~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~ 176 (344)
T PLN02236 100 PRLLGRFPNG---RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKE 176 (344)
T ss_pred CceEEEECCc---eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhh
Confidence 4666766544 57899987766421 11 101 0 0 11122222332111
Q ss_pred ------HHHHHHH----H----hCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 135 ------ARAMECL----H----SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 135 ------~~~L~~l----H----~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
...+..| . ...++|+|+++.||+++++.+.+.++||..+...
T Consensus 177 ~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 177 FRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred cCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 1111122 1 2258999999999999864357999999998743
No 479
>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]
Probab=97.80 E-value=2.2e-05 Score=67.67 Aligned_cols=137 Identities=23% Similarity=0.281 Sum_probs=91.6
Q ss_pred eeecceeccccceEEEEeEEC-CeEEEEEEeecCC-----------------ChHHHHHHHHHHHHHHHHHHhcC-C-CC
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGE-----------------TPEEIAKKESRFAREVAMLSRVQ-H-RN 85 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~-----------------~~~~~~~~~~~~~~E~~~l~~l~-h-~n 85 (317)
+.+++.||-|.=+.||.+.+. |++.++|.=+.+. ...|+.-.+-...+|...+..|. | --
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 457889999999999998886 8899998533221 11122222223445777777773 2 23
Q ss_pred eeeEEeeeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCce
Q 021127 86 LVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165 (317)
Q Consensus 86 iv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~ 165 (317)
|++.++ .+..++|||++.|-.|.+.-+- .+..++. ..+..-+--|-..|+||+|+.--||+++.+ +.+
T Consensus 174 VPkpiD---~~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly---~~lm~~Iv~la~~GlIHgDFNEFNimv~dd-~~i 241 (465)
T KOG2268|consen 174 VPKPID---HNRHCVVMELVDGYPLRQVRHV-----EDPPTLY---DDLMGLIVRLANHGLIHGDFNEFNIMVKDD-DKI 241 (465)
T ss_pred CCCccc---ccceeeHHHhhcccceeeeeec-----CChHHHH---HHHHHHHHHHHHcCceecccchheeEEecC-CCE
Confidence 344333 3456789999999888764322 2333333 334444556778999999999999999987 689
Q ss_pred EEcccCccc
Q 021127 166 KLADFGLAR 174 (317)
Q Consensus 166 kl~Dfg~a~ 174 (317)
+++||-.+.
T Consensus 242 ~vIDFPQmv 250 (465)
T KOG2268|consen 242 VVIDFPQMV 250 (465)
T ss_pred EEeechHhh
Confidence 999997654
No 480
>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]
Probab=97.69 E-value=0.0004 Score=60.73 Aligned_cols=139 Identities=19% Similarity=0.264 Sum_probs=81.2
Q ss_pred ecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC--CCCeeeEEeeeecC---ceEEEE
Q 021127 28 VGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ--HRNLVKFIGACKEP---VMVIVT 102 (317)
Q Consensus 28 ~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~lv~ 102 (317)
+.+.+-.|-...+|....+++.+++. .+...... ....+..+|..+++.+. ---+.+.++.|.++ ..+.||
T Consensus 29 ~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~---~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPV---ESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred eeeeccCCcccceEEEecCCceEEEe-cCCccccc---hhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 34444344444577776678889988 44322221 12233556777777763 33455667777543 579999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHH-HHHHHHHHHHH---------------------------------------
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFA-LDIARAMECLH--------------------------------------- 142 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~-~~i~~~L~~lH--------------------------------------- 142 (317)
+|++|..+.+.+.... .. ..++ ..+++.|+-||
T Consensus 105 ~~veGe~~~~~~~~~~---~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~ 177 (321)
T COG3173 105 EWVEGEVVWSALPPES---LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRI 177 (321)
T ss_pred EEecceeccCcCCccc---ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCC
Confidence 9998843322211100 00 0111 13333333333
Q ss_pred -----------hC--------CccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 143 -----------SH--------GIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 143 -----------~~--------~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
.+ .++|+|+.+.|++++.+ +-+-|.||+++...+.
T Consensus 178 p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~-~~~gVlDwe~~~lGDP 231 (321)
T COG3173 178 PLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPG-RPTGVLDWELATLGDP 231 (321)
T ss_pred chHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCC-CeeEEEeccccccCCc
Confidence 22 48999999999999988 4688999999975443
No 481
>PLN02421 phosphotransferase, alcohol group as acceptor/kinase
Probab=97.67 E-value=0.00047 Score=61.28 Aligned_cols=150 Identities=17% Similarity=0.210 Sum_probs=84.6
Q ss_pred Ccee-ecCCceeecceeccccceEEEEeEECC-----eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCe-eeE
Q 021127 17 AKWL-IDPKHLFVGPRIGEGAHAKVYEGKYKN-----QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL-VKF 89 (317)
Q Consensus 17 ~~~~-i~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l 89 (317)
..|. ++.+.+++....| |-...+|+....+ ..|++|+........ -.-.+|..+++.+..-++ +++
T Consensus 7 ~~w~~~~~~~i~i~~l~g-GlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~------IdR~~E~~il~~l~~~gl~P~~ 79 (330)
T PLN02421 7 KGWSDLDDSDFSVERISG-GITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV------IDRERELQAIKYLSAAGFGAKL 79 (330)
T ss_pred CccccCCcCceEEEEeCC-cccceEEEEEecCCCCCCceEEEEEecCCcCeE------echHHHHHHHHHHHhcCCCCce
Confidence 3453 4456666666554 7777899886543 378899875432211 112467888888754444 566
Q ss_pred EeeeecCceEEEEEccCCCCHHH--------------HHHhcCCCC------C-CHHHHHHHHHHH--------------
Q 021127 90 IGACKEPVMVIVTELLSGGTLRK--------------YLLNMRPRC------L-DVCVAIGFALDI-------------- 134 (317)
Q Consensus 90 ~~~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~~~~------l-~~~~~~~i~~~i-------------- 134 (317)
++++..+ +|.+|++|..|.. .+....... . -+..+..+..++
T Consensus 80 l~~~~~G---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~ 156 (330)
T PLN02421 80 LGVFGNG---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKY 156 (330)
T ss_pred eEEeCCc---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhh
Confidence 6666443 5889987765521 111111100 1 122222222221
Q ss_pred --------HHHHHH---HH-hC----CccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 135 --------ARAMEC---LH-SH----GIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 135 --------~~~L~~---lH-~~----~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..-+.. +. .. -++|.|+.+.||+++.+.+.++++||..|...
T Consensus 157 ~~~~~~~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 157 ETISFEELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred cccCHHHHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 111111 11 11 27999999999999854367999999998643
No 482
>PLN02756 S-methyl-5-thioribose kinase
Probab=97.63 E-value=0.0011 Score=60.00 Aligned_cols=85 Identities=18% Similarity=0.035 Sum_probs=53.8
Q ss_pred ecceeccccceEEEEeEECCeEEEEEEeecCCC---hHHHHHHHHHHHHHHHHHHhcC---CCCeeeEEeeeecCceEEE
Q 021127 28 VGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET---PEEIAKKESRFAREVAMLSRVQ---HRNLVKFIGACKEPVMVIV 101 (317)
Q Consensus 28 ~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~lv 101 (317)
-.+.||.|....||+....+..++||.-..... ..+ .....+-..|.+.|+.+. ..++++++.++.+. .+++
T Consensus 36 ~~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~w-pl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~-~vlv 113 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESW-PMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM-ALIG 113 (418)
T ss_pred eEEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccc-cCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC-CEEE
Confidence 466789999999999988777899997551111 000 001112233456665542 36888999888855 6678
Q ss_pred EEccCC--CCHHHHH
Q 021127 102 TELLSG--GTLRKYL 114 (317)
Q Consensus 102 ~e~~~~--g~L~~~l 114 (317)
||++++ ..+.+.+
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999976 3444433
No 483
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=97.63 E-value=0.00035 Score=69.48 Aligned_cols=180 Identities=18% Similarity=0.162 Sum_probs=120.2
Q ss_pred HHHHHHHHHHhcCCCCeeeEEeeeecC-----ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 021127 70 RFAREVAMLSRVQHRNLVKFIGACKEP-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144 (317)
Q Consensus 70 ~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~ 144 (317)
-..-|...+..+.|+|++.++.+-.+. ...+..++|.+.++...+..-.. ++....+.+..++..||+|+|+.
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~--i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS--IPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc--cCHHHHHHHHHHHhhhHHHHHHh
Confidence 344577788888999999999887543 23456688999999998887554 88999999999999999999999
Q ss_pred CccccCCCCC---cEEeeCCCCceEEc--ccCcccccccccccccccCccceecccccccccccccc-cccccCC-----
Q 021127 145 GIIHRDLKPE---NLLLTEDLKTIKLA--DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGE-KKHYNHK----- 213 (317)
Q Consensus 145 ~ivH~Dlkp~---Nill~~~~~~~kl~--Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~~~~----- 213 (317)
...|.-+..+ +--.+.. +.+.++ ||+..+................+.|+|........... .+.|..+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGE-GVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred ccceeEEecccccccccCcc-ceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 6666655555 3333433 355555 88887765554444444455667777765543322221 1111111
Q ss_pred -------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 -------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 -------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.....+......+.+...+|+..++++|+++.+++.+.-
T Consensus 385 ~~~~~~i~~~~~~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 385 LSQGEDISEKSAVPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred hhhcCcccccccchhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchh
Confidence 000011122236788899999999999999999998743
No 484
>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]
Probab=97.52 E-value=0.00037 Score=61.32 Aligned_cols=143 Identities=22% Similarity=0.217 Sum_probs=92.1
Q ss_pred ecceeccccceEEEEeEEC-CeEEEEEEeecCCCh-------------------HHHHHHHH--HHHHHHHHHHhcCCCC
Q 021127 28 VGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETP-------------------EEIAKKES--RFAREVAMLSRVQHRN 85 (317)
Q Consensus 28 ~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~-------------------~~~~~~~~--~~~~E~~~l~~l~h~n 85 (317)
+-..|..|-=+.||.+... |..+|||+++..... ..+++..- -...|++.|.+++.-.
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 4456778888899998776 888999987532110 00011111 1234777788876554
Q ss_pred eeeEEeeeecCceEEEEEccCCCCHH-HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEeeCCCC
Q 021127 86 LVKFIGACKEPVMVIVTELLSGGTLR-KYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLK 163 (317)
Q Consensus 86 iv~l~~~~~~~~~~lv~e~~~~g~L~-~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~Dlkp~Nill~~~~~ 163 (317)
|.-- ....=....|||+|+....-- -.|. .-.++...+..+-.+++.-+.-|.+. ++||.||.--|+|+.. |
T Consensus 228 IP~P-ePIlLk~hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd--G 301 (520)
T KOG2270|consen 228 IPCP-EPILLKNHVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD--G 301 (520)
T ss_pred CCCC-CceeeecceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC--C
Confidence 3211 111112467999999432111 1122 22377778888888999888888764 8999999999999987 5
Q ss_pred ceEEcccCccccc
Q 021127 164 TIKLADFGLAREE 176 (317)
Q Consensus 164 ~~kl~Dfg~a~~~ 176 (317)
.+.|+|-+.+...
T Consensus 302 ~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 302 KLYIIDVSQSVEH 314 (520)
T ss_pred EEEEEEccccccC
Confidence 8999999887643
No 485
>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported
Probab=97.42 E-value=0.00096 Score=57.70 Aligned_cols=33 Identities=30% Similarity=0.537 Sum_probs=26.4
Q ss_pred CccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 145 ~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++|+|++|.||+++.+....-|+||+.+...+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD 218 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD 218 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence 489999999999999752335699999987543
No 486
>TIGR01767 MTRK 5-methylthioribose kinase. This enzyme is involved in the methionine salvage pathway in certain bacteria.
Probab=97.38 E-value=0.001 Score=59.05 Aligned_cols=74 Identities=20% Similarity=0.164 Sum_probs=44.4
Q ss_pred eeccccceEEEEeEECC--eEEEEEEeec-----CCChHHHHHHHHHHHHHHHHHHhcC--CC-CeeeEEeeeecCceEE
Q 021127 31 RIGEGAHAKVYEGKYKN--QTVAIKIVHK-----GETPEEIAKKESRFAREVAMLSRVQ--HR-NLVKFIGACKEPVMVI 100 (317)
Q Consensus 31 ~lG~G~~g~V~~~~~~~--~~vaiK~~~~-----~~~~~~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~l 100 (317)
.||.|....||++...+ +.|+||.-.. ..... -...+..-|.+.|+... -| .+++++. +......+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wp---l~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~D~e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWP---LTLDRARIESSALIRQGEHVPHLVPRIFH-FDTEMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCC---CCccHHHHHHHHHHHhhccCccccCeEEE-Ecccccee
Confidence 57999999999998774 5799996321 11100 11223345666665542 24 4555554 44445678
Q ss_pred EEEccCCC
Q 021127 101 VTELLSGG 108 (317)
Q Consensus 101 v~e~~~~g 108 (317)
|||+++..
T Consensus 78 vMEdL~~~ 85 (370)
T TIGR01767 78 VMEDLSHH 85 (370)
T ss_pred hHhhCccc
Confidence 99998543
No 487
>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []. Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.
Probab=97.34 E-value=0.0032 Score=54.64 Aligned_cols=75 Identities=15% Similarity=0.135 Sum_probs=47.2
Q ss_pred eeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc---CCCCeeeEEeeeec-CceEEE
Q 021127 26 LFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV---QHRNLVKFIGACKE-PVMVIV 101 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-~~~~lv 101 (317)
++-.+.++-|....+|+....++.+.||+-..... ..|..|.+-|+.| ..-.+++++++... +..++|
T Consensus 19 i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~~--------~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDTDGGSYFVKVNSESGR--------DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp --EEEEE--SSSSEEEEEETTS-EEEEEEEEGGGC--------CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeeEecCCCChhheEEEECCCccEEEEecChhhH--------HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 44566788899999999987789999998773222 2477888888888 34557788887653 356999
Q ss_pred EEccCCC
Q 021127 102 TELLSGG 108 (317)
Q Consensus 102 ~e~~~~g 108 (317)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999776
No 488
>TIGR02906 spore_CotS spore coat protein, CotS family. Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.
Probab=97.30 E-value=0.0084 Score=52.73 Aligned_cols=30 Identities=27% Similarity=0.524 Sum_probs=25.7
Q ss_pred CCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 144 ~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
.+++|+|+.+.||+++.+ .+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~--~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKDN--EVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeCC--cEEEEECccccc
Confidence 478999999999999874 578999997753
No 489
>PRK12396 5-methylribose kinase; Reviewed
Probab=97.23 E-value=0.001 Score=59.85 Aligned_cols=75 Identities=20% Similarity=0.124 Sum_probs=46.3
Q ss_pred cceeccccceEEEEeEEC--CeEEEEEEe----ecCCChHHHHHHHHHHHHHHHHHHhcC--CC-CeeeEEeeeecCceE
Q 021127 29 GPRIGEGAHAKVYEGKYK--NQTVAIKIV----HKGETPEEIAKKESRFAREVAMLSRVQ--HR-NLVKFIGACKEPVMV 99 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~--~~~vaiK~~----~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~ 99 (317)
.+.||.|--..||++.+. ++.|+||.- +...... -...|..-|.+.|+... -| .+++++.+ ......
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swp---L~~~R~~~E~~aL~~~~~~~P~~VP~vy~~-D~e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFK---LSTNRIRIESDVLQLEEELAPGLVPKVYLF-DSVMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCC---CChHHHHHHHHHHHHHHhhCCCcCCeEEEE-CcHHhh
Confidence 667899999999999975 667999853 2211111 11223445666666552 33 45666644 444567
Q ss_pred EEEEccCC
Q 021127 100 IVTELLSG 107 (317)
Q Consensus 100 lv~e~~~~ 107 (317)
+|||+++.
T Consensus 110 ~vMEdL~~ 117 (409)
T PRK12396 110 CVMEDLSD 117 (409)
T ss_pred HHHHhCcc
Confidence 88998854
No 490
>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function. All known members of this group are proteins from drosophila and Caenorhabditis elegans.
Probab=96.93 E-value=0.0078 Score=52.51 Aligned_cols=73 Identities=19% Similarity=0.246 Sum_probs=46.1
Q ss_pred ccccceEEEEeEEC----------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-------------CCCeeeE
Q 021127 33 GEGAHAKVYEGKYK----------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-------------HRNLVKF 89 (317)
Q Consensus 33 G~G~~g~V~~~~~~----------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-------------h~niv~l 89 (317)
|.|-.|.+|+++.+ ...++||..+..............|.+|+.+...+- ...++++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 67778889886542 245899997733333333344566778887776541 1345666
Q ss_pred EeeeecC-ceEEEEEcc
Q 021127 90 IGACKEP-VMVIVTELL 105 (317)
Q Consensus 90 ~~~~~~~-~~~lv~e~~ 105 (317)
+....++ ..+||||-+
T Consensus 82 ~~~~~~~~~~~lvlEDL 98 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDL 98 (294)
T ss_pred EEeccCCCceeeehhhh
Confidence 6666554 578899886
No 491
>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]
Probab=96.89 E-value=0.0089 Score=52.85 Aligned_cols=136 Identities=23% Similarity=0.308 Sum_probs=79.5
Q ss_pred eccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC---CCC---eeeEEeee---ecC--ceEE
Q 021127 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ---HRN---LVKFIGAC---KEP--VMVI 100 (317)
Q Consensus 32 lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~n---iv~l~~~~---~~~--~~~l 100 (317)
|.+ .-..+|+....+..+++|+.+...... .+..|...+..|. .+- +..+=|-. ... ..+-
T Consensus 34 l~s-~eN~~f~~~~~~g~~iLki~~~~~~~~-------~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~ 105 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRYILKIYRPGWTRA-------EIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA 105 (331)
T ss_pred ccc-ccCceEEEEecCCCeEEEEecCCCCHH-------HHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence 444 456788888876666999998763222 2445666666662 221 22222211 123 6778
Q ss_pred EEEccCCCCHHH-----HHHh--------------cC---CC---CCCHHH-------------HHHHHHHHHHHHHHHH
Q 021127 101 VTELLSGGTLRK-----YLLN--------------MR---PR---CLDVCV-------------AIGFALDIARAMECLH 142 (317)
Q Consensus 101 v~e~~~~g~L~~-----~l~~--------------~~---~~---~l~~~~-------------~~~i~~~i~~~L~~lH 142 (317)
|++|++|..+.. .+.. .. +. ...|.. -.....++...+..+.
T Consensus 106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~ 185 (331)
T COG2334 106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL 185 (331)
T ss_pred EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence 999999987772 1110 00 00 122220 0113344555555555
Q ss_pred hC--------C--ccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 143 SH--------G--IIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 143 ~~--------~--ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
+. + +||+|+.|+||+++.+...+.++|||-+..
T Consensus 186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 42 3 999999999999998732388999998864
No 492
>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2.7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....
Probab=96.86 E-value=0.0024 Score=52.81 Aligned_cols=30 Identities=40% Similarity=0.633 Sum_probs=20.3
Q ss_pred CccccCCCCCcEEe-eCCCCceEEcccCcccc
Q 021127 145 GIIHRDLKPENLLL-TEDLKTIKLADFGLARE 175 (317)
Q Consensus 145 ~ivH~Dlkp~Nill-~~~~~~~kl~Dfg~a~~ 175 (317)
.++|+|+.+.||++ +.+ +.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~-~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKD-GEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSS-SCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCC-CeEEEecHHHHhh
Confidence 58999999999999 444 6899999999864
No 493
>PTZ00384 choline kinase; Provisional
Probab=96.82 E-value=0.011 Score=53.53 Aligned_cols=85 Identities=16% Similarity=0.278 Sum_probs=49.1
Q ss_pred Ccee-ecCCceeecceeccccceEEEEeEECC---eE-----EEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCC-Ce
Q 021127 17 AKWL-IDPKHLFVGPRIGEGAHAKVYEGKYKN---QT-----VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR-NL 86 (317)
Q Consensus 17 ~~~~-i~~~~y~~~~~lG~G~~g~V~~~~~~~---~~-----vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-ni 86 (317)
..|. ++.+.+.+. .|..|-...+|++...+ .. |.++....... . .-.-.+|+.+++.+... .-
T Consensus 43 p~w~~~~~~~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~-l-----~IdR~~E~~i~~~Ls~~glg 115 (383)
T PTZ00384 43 PFWNNVNPEFIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNS-L-----VIDNDLQYNIAKLLGDNNFG 115 (383)
T ss_pred CccccCCcccEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEeccCCCc-e-----EeccHHHHHHHHHHHhCCCC
Confidence 3453 444555555 44458888999986542 12 44433211110 0 01124688888888544 44
Q ss_pred eeEEeeeecCceEEEEEccCCCCHH
Q 021127 87 VKFIGACKEPVMVIVTELLSGGTLR 111 (317)
Q Consensus 87 v~l~~~~~~~~~~lv~e~~~~g~L~ 111 (317)
.++++.+.+ ++|.||++|.+|.
T Consensus 116 P~l~~~f~~---g~l~efIeGr~l~ 137 (383)
T PTZ00384 116 PKIIGRFGD---FTIQEWVEGNTMG 137 (383)
T ss_pred CeEEEecCC---EEEEEEeccccCC
Confidence 666777654 5899999887764
No 494
>TIGR02904 spore_ysxE spore coat protein YsxE. Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.
Probab=96.76 E-value=0.023 Score=50.06 Aligned_cols=30 Identities=20% Similarity=0.243 Sum_probs=26.9
Q ss_pred CccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 145 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 145 ~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
+++|+|+.++|++++.+ +.+.|+||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~-~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDET-RGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCC-CCEEEEEhhhccc
Confidence 79999999999999887 6789999988864
No 495
>PRK06148 hypothetical protein; Provisional
Probab=96.75 E-value=0.016 Score=59.20 Aligned_cols=32 Identities=38% Similarity=0.511 Sum_probs=25.9
Q ss_pred CCccccCCCCCcEEeeCCC-CceE-EcccCcccc
Q 021127 144 HGIIHRDLKPENLLLTEDL-KTIK-LADFGLARE 175 (317)
Q Consensus 144 ~~ivH~Dlkp~Nill~~~~-~~~k-l~Dfg~a~~ 175 (317)
.++||+|+.+.||+++.+. +.+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999762 1444 999998864
No 496
>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]
Probab=96.69 E-value=0.019 Score=47.54 Aligned_cols=79 Identities=16% Similarity=0.180 Sum_probs=57.9
Q ss_pred ceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc---CCCCeeeEEeeeec-CceEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV---QHRNLVKFIGACKE-PVMVI 100 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-~~~~l 100 (317)
+++-.+.+.-|.....|...+...++-||+=.. .....|..|+.-|..| +.-.|.+++.+-.. .+.|+
T Consensus 17 ~i~er~~v~gG~inea~~v~dg~~~~FvK~n~~--------~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~syl 88 (286)
T COG3001 17 EIKEREEVSGGDINEAWRLRDGTDPFFVKCNQR--------EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYL 88 (286)
T ss_pred hhhcccccCCccccceeEeecCCcceEEEecch--------hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEE
Confidence 445556677777788888888888999997432 3345688888877776 34567788877654 48999
Q ss_pred EEEccCCCCHH
Q 021127 101 VTELLSGGTLR 111 (317)
Q Consensus 101 v~e~~~~g~L~ 111 (317)
||||++-+.+.
T Consensus 89 Vle~L~~~~~d 99 (286)
T COG3001 89 VLEYLPTGPLD 99 (286)
T ss_pred EEeeccCCCCC
Confidence 99999887665
No 497
>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length. The function of this family is unknown.
Probab=96.65 E-value=0.011 Score=48.65 Aligned_cols=157 Identities=15% Similarity=0.185 Sum_probs=90.2
Q ss_pred ccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCCCCHHHH
Q 021127 35 GAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKY 113 (317)
Q Consensus 35 G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~ 113 (317)
++.++.-.++.+-.+..+|.++.....- ...-|..+.++++++. .|+++..- ++ .+.++.|.|-....
T Consensus 73 ~gNsTl~~~kt~iG~L~lKKi~slp~~~----~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i--- 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGPLFLKKIRSLPCCI----NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI--- 141 (308)
T ss_pred CCceEEEEeccccchhhhhhccCCCccc----chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---
Confidence 4445555554442344555555433221 1224677888888775 47777632 33 67799999833110
Q ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCCCCcEEeeCCCCceEEcccCcccccccccccccccCccce
Q 021127 114 LLNMRPRCLDVCVAIGFALDIARAMECLHS--HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRW 191 (317)
Q Consensus 114 l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~--~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y 191 (317)
.. ..++..=+..|.-.|+ .+.+|+|-.|+|||-++. |.+||.|-+.--. .+..|
T Consensus 142 --------~~----~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~-G~lKlVDP~~Ll~-----------~~V~~ 197 (308)
T PF07387_consen 142 --------NF----SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKF-GYLKLVDPVCLLE-----------NQVNM 197 (308)
T ss_pred --------ch----hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCC-CCEEecChhhhhh-----------heeeE
Confidence 10 1112222456777784 479999999999999998 8999998653310 11122
Q ss_pred ecccccccccccccccccccCCCCCCCCCCChHHHHHHHHHhhhcCCCCC-CCHHHH
Q 021127 192 MAPELYSTVTLRQGEKKHYNHKNVRPSAENVPEELSIILTSCWKEDPNAR-PNFTQI 247 (317)
Q Consensus 192 ~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-ps~~~~ 247 (317)
.- +.+.+ .....+...++.+|+..-..+| .+.+++
T Consensus 198 vN-~~Y~~--------------------lT~~aE~~~fv~s~l~~v~~~~~~~~~ei 233 (308)
T PF07387_consen 198 VN-IEYES--------------------LTQEAEVKVFVKSCLKLVEKQRSAETEEI 233 (308)
T ss_pred Ee-eeccc--------------------cChHHHHHHHHHHHHHHHHHHhcCcHhhh
Confidence 22 11111 1233567778888888777766 456665
No 498
>PRK11768 serine/threonine protein kinase; Provisional
Probab=96.24 E-value=0.15 Score=45.32 Aligned_cols=29 Identities=31% Similarity=0.358 Sum_probs=24.4
Q ss_pred CCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 144 ~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
.++||+|+.++||+++ + .+.|+||+.+..
T Consensus 196 ~~liHgD~h~~NvL~~-d--~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D--GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C--CcEEEeCCCCCC
Confidence 3689999999999995 4 367999998864
No 499
>PTZ00296 choline kinase; Provisional
Probab=96.21 E-value=0.044 Score=50.62 Aligned_cols=83 Identities=16% Similarity=0.219 Sum_probs=49.5
Q ss_pred cee-ecCCceeecceeccccceEEEEeEEC----------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCe
Q 021127 18 KWL-IDPKHLFVGPRIGEGAHAKVYEGKYK----------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86 (317)
Q Consensus 18 ~~~-i~~~~y~~~~~lG~G~~g~V~~~~~~----------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 86 (317)
.|. +.++++ -.+.|..|-...+|+.... ++.|++++.-.....- . .-.+|..+++.+...+|
T Consensus 99 ~W~~~~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~l-----I-dR~~E~~v~~~ls~~gi 171 (442)
T PTZ00296 99 EWRRFTEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDEL-----Y-NPISEFEVYKTMSKYRI 171 (442)
T ss_pred ccccCCcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccce-----e-CHHHHHHHHHHHHHCCC
Confidence 354 455566 4556666777788988654 3578888765432211 1 12457777777744344
Q ss_pred -eeEEeeeecCceEEEEEccCCCCH
Q 021127 87 -VKFIGACKEPVMVIVTELLSGGTL 110 (317)
Q Consensus 87 -v~l~~~~~~~~~~lv~e~~~~g~L 110 (317)
.++++.+.+ +.|.+|++|.+|
T Consensus 172 ~P~l~~~f~g---g~I~efi~g~~l 193 (442)
T PTZ00296 172 APQLLNTFSG---GRIEEWLYGDPL 193 (442)
T ss_pred CCceEEEeCC---CEEEEeeCCccC
Confidence 356666543 357899987644
No 500
>PRK06149 hypothetical protein; Provisional
Probab=96.04 E-value=0.05 Score=55.56 Aligned_cols=32 Identities=22% Similarity=0.288 Sum_probs=25.7
Q ss_pred CCccccCCCCCcEEeeCCC-Cc---eEEcccCcccc
Q 021127 144 HGIIHRDLKPENLLLTEDL-KT---IKLADFGLARE 175 (317)
Q Consensus 144 ~~ivH~Dlkp~Nill~~~~-~~---~kl~Dfg~a~~ 175 (317)
.++||+|+.+.||+++.+. +. .-|+|||.+..
T Consensus 208 ~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~~ 243 (972)
T PRK06149 208 LQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLVR 243 (972)
T ss_pred ccccCCCCCcccEEEcCCCCCCcceeEEEEcccchh
Confidence 5899999999999998652 22 37999998863
Done!